{
    "55046d5ff8aee20f27000007": [
        {
            "text": "epidermal growth factor",
            "probability": 0.6867745340444876,
            "start_logit": -1.5473898649215698,
            "end_logit": -0.7569747567176819,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "growth factor",
            "probability": 0.12144647942601675,
            "start_logit": -3.2799222469329834,
            "end_logit": -0.7569747567176819,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor receptor",
            "probability": 0.038669514604317376,
            "start_logit": -1.5473898649215698,
            "end_logit": -3.6339292526245117,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "factor",
            "probability": 0.02577897065622315,
            "start_logit": -4.829836845397949,
            "end_logit": -0.7569747567176819,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth",
            "probability": 0.023642044055221398,
            "start_logit": -1.5473898649215698,
            "end_logit": -4.1259541511535645,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "mal growth factor",
            "probability": 0.015817231680808615,
            "start_logit": -5.318295955657959,
            "end_logit": -0.7569747567176819,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor receptor (EGFR) phosphorylation is thought to couple receptor activation to distinct signaling pathways.",
            "probability": 0.013555679983371188,
            "start_logit": -1.5473898649215698,
            "end_logit": -4.682175159454346,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "pidermal growth factor",
            "probability": 0.012966282361268611,
            "start_logit": -5.517043590545654,
            "end_logit": -0.7569747567176819,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor receptor (EGFR)",
            "probability": 0.011837193482709103,
            "start_logit": -1.5473898649215698,
            "end_logit": -4.817734241485596,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "ligand-regulated receptor dimerization",
            "probability": 0.009126298103116387,
            "start_logit": -2.867828845977783,
            "end_logit": -3.7573816776275635,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epidermal growth factor receptor (EGFR) phosphorylation",
            "probability": 0.007701591382302356,
            "start_logit": -1.5473898649215698,
            "end_logit": -5.247553825378418,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "growth factor receptor",
            "probability": 0.006838163293782045,
            "start_logit": -3.2799222469329834,
            "end_logit": -3.6339292526245117,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "ligand-regulated receptor dimerization dynamics and adaptor protein",
            "probability": 0.0042277569229658835,
            "start_logit": -2.867828845977783,
            "end_logit": -4.526870250701904,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "growth",
            "probability": 0.0041807651195689705,
            "start_logit": -3.2799222469329834,
            "end_logit": -4.1259541511535645,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "dimerization",
            "probability": 0.0041452621861062305,
            "start_logit": -3.6570229530334473,
            "end_logit": -3.7573816776275635,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "ligand-regulated receptor dimerization dynamics",
            "probability": 0.0031858641058016826,
            "start_logit": -2.867828845977783,
            "end_logit": -4.809818267822266,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "ligand-regulated receptor dimerization dynamics and adaptor protein concentrations",
            "probability": 0.0026462783870543605,
            "start_logit": -2.867828845977783,
            "end_logit": -4.995387554168701,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "ligand",
            "probability": 0.0026286927166590097,
            "start_logit": -2.867828845977783,
            "end_logit": -5.0020551681518555,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "adaptor protein",
            "probability": 0.002434264908897839,
            "start_logit": -3.4198555946350098,
            "end_logit": -4.526870250701904,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "growth factor receptor (EGFR) phosphorylation is thought to couple receptor activation to distinct signaling pathways.",
            "probability": 0.002397132579321168,
            "start_logit": -3.2799222469329834,
            "end_logit": -4.682175159454346,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        }
    ],
    "553fa78b1d53b76422000007": [
        {
            "text": "MEG3",
            "probability": 0.6411494292318077,
            "start_logit": 4.2053632736206055,
            "end_logit": 4.230904579162598,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 is associated with the\u00a0 development and progression of cancer, suggesting that MEG3",
            "probability": 0.16847725680366923,
            "start_logit": 3.5925443172454834,
            "end_logit": 3.5072617530822754,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 mediates epithelial-mesenchymal transition (EMT). However, deregulation of MEG3",
            "probability": 0.1580271008471012,
            "start_logit": 3.542957067489624,
            "end_logit": 3.492814779281616,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "(MEG3",
            "probability": 0.014884273479251874,
            "start_logit": 0.44240590929985046,
            "end_logit": 4.230904579162598,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3)",
            "probability": 0.011644527006176162,
            "start_logit": 4.2053632736206055,
            "end_logit": 0.22247831523418427,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "A maternally expressed gene 3 (MEG3",
            "probability": 0.001631837022273569,
            "start_logit": -1.7681928873062134,
            "end_logit": 4.230904579162598,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "maternally expressed gene 3 (MEG3",
            "probability": 0.0011451558193276872,
            "start_logit": -2.122358560562134,
            "end_logit": 4.230904579162598,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "3 (MEG3",
            "probability": 0.0006657869880037333,
            "start_logit": -2.664684772491455,
            "end_logit": 4.230904579162598,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG",
            "probability": 0.0004263989757615653,
            "start_logit": 4.2053632736206055,
            "end_logit": -3.084737777709961,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "epithelial-mesenchymal transition (EMT). However, deregulation of MEG3",
            "probability": 0.00039698880098815615,
            "start_logit": -2.4436566829681396,
            "end_logit": 3.492814779281616,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3) gene",
            "probability": 0.00033323153443493486,
            "start_logit": 4.2053632736206055,
            "end_logit": -3.331275701522827,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "(MEG3)",
            "probability": 0.0002703275033779935,
            "start_logit": 0.44240590929985046,
            "end_logit": 0.22247831523418427,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "3",
            "probability": 0.0002485137202000681,
            "start_logit": -3.6501564979553223,
            "end_logit": 4.230904579162598,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "ME",
            "probability": 0.00016126841858520646,
            "start_logit": 4.2053632736206055,
            "end_logit": -4.057043075561523,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "mesenchymal transition (EMT). However, deregulation of MEG3",
            "probability": 0.0001570941522289989,
            "start_logit": -3.3707194328308105,
            "end_logit": 3.492814779281616,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 mediates epithelial-mesenchymal transition",
            "probability": 0.00014533303200167907,
            "start_logit": 3.542957067489624,
            "end_logit": -3.4986791610717773,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "gene 3 (MEG3",
            "probability": 7.594644559758737e-05,
            "start_logit": -4.835626125335693,
            "end_logit": 4.230904579162598,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MEG3 mediates epithelial-mesenchymal transition (EMT). However, deregulation of MEG",
            "probability": 6.687225747260496e-05,
            "start_logit": 3.542957067489624,
            "end_logit": -4.274922847747803,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "3 mediates epithelial-mesenchymal transition (EMT). However, deregulation of MEG3",
            "probability": 6.302061136710324e-05,
            "start_logit": -4.284102916717529,
            "end_logit": 3.492814779281616,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "A maternally expressed gene 3 (MEG3)",
            "probability": 2.963735037292297e-05,
            "start_logit": -1.7681928873062134,
            "end_logit": 0.22247831523418427,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        }
    ],
    "5149199dd24251bc05000040": [
        {
            "text": "acetylcholinesterase inhibitors",
            "probability": 0.20311927044699146,
            "start_logit": -3.6241729259490967,
            "end_logit": -2.8004934787750244,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitors",
            "probability": 0.12583683843350668,
            "start_logit": -4.102980136871338,
            "end_logit": -2.8004934787750244,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitor",
            "probability": 0.09074301781783176,
            "start_logit": -3.6241729259490967,
            "end_logit": -3.606255292892456,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitors",
            "probability": 0.08920079489782787,
            "start_logit": -4.447076320648193,
            "end_logit": -2.8004934787750244,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor",
            "probability": 0.06434036004573934,
            "start_logit": -3.6241729259490967,
            "end_logit": -3.9500997066497803,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase",
            "probability": 0.06235311413799249,
            "start_logit": -3.6241729259490967,
            "end_logit": -3.981473207473755,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitor",
            "probability": 0.056217287739280794,
            "start_logit": -4.102980136871338,
            "end_logit": -3.606255292892456,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response",
            "probability": 0.05195536676456122,
            "start_logit": -4.102980136871338,
            "end_logit": -3.6850945949554443,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor",
            "probability": 0.03986026276094904,
            "start_logit": -4.102980136871338,
            "end_logit": -3.9500997066497803,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitor",
            "probability": 0.03985022840504319,
            "start_logit": -4.447076320648193,
            "end_logit": -3.606255292892456,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase",
            "probability": 0.038629120380068695,
            "start_logit": -4.102980136871338,
            "end_logit": -3.981473207473755,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "inhibitors and immunomodulatory treatment was unexpectedly poor",
            "probability": 0.02825537551145434,
            "start_logit": -4.447076320648193,
            "end_logit": -3.9500997066497803,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitors and immunomodulatory treatment",
            "probability": 0.017725946830091127,
            "start_logit": -3.6241729259490967,
            "end_logit": -5.239257335662842,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "poor",
            "probability": 0.01706173386507019,
            "start_logit": -4.951521873474121,
            "end_logit": -3.9500997066497803,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "antibodies, consistent with the diagnosis of myasthenia gravis. Nevertheless, response to acetylcholinesterase inhibitors",
            "probability": 0.014691836859556082,
            "start_logit": -6.250674247741699,
            "end_logit": -2.8004934787750244,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "consistent with the diagnosis of myasthenia gravis. Nevertheless, response to acetylcholinesterase inhibitors",
            "probability": 0.013038254731273133,
            "start_logit": -6.3700785636901855,
            "end_logit": -2.8004934787750244,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor.",
            "probability": 0.01292008989378204,
            "start_logit": -3.6241729259490967,
            "end_logit": -5.5555033683776855,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase inhibitors and immunomodulatory treatment was unexpectedly poor. As the disease progressed,",
            "probability": 0.011965448009572005,
            "start_logit": -3.6241729259490967,
            "end_logit": -5.632263660430908,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "to acetylcholinesterase inhibitors",
            "probability": 0.011254040028450003,
            "start_logit": -6.517239093780518,
            "end_logit": -2.8004934787750244,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "response to acetylcholinesterase inhibitors and immunomodulatory treatment",
            "probability": 0.010981612440958558,
            "start_logit": -4.102980136871338,
            "end_logit": -5.239257335662842,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        }
    ],
    "5709e4b2cf1c32585100001c": [
        {
            "text": "Nlk2",
            "probability": 0.18498315336461352,
            "start_logit": 1.3294764757156372,
            "end_logit": 0.3742956221103668,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK",
            "probability": 0.15987321478977173,
            "start_logit": 1.313010811805725,
            "end_logit": 0.2448776215314865,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK, Xenopus nlk",
            "probability": 0.15816204138747705,
            "start_logit": 1.313010811805725,
            "end_logit": 0.23411661386489868,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "nlk",
            "probability": 0.06424755401371739,
            "start_logit": 0.4121343791484833,
            "end_logit": 0.23411661386489868,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK, Xenopus nlk and zebrafish nlk",
            "probability": 0.05586950220543273,
            "start_logit": 1.313010811805725,
            "end_logit": -0.8064848184585571,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk, human NLK",
            "probability": 0.052942453402209246,
            "start_logit": 0.20783525705337524,
            "end_logit": 0.2448776215314865,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk, human NLK, Xenopus nlk",
            "probability": 0.052375793638513295,
            "start_logit": 0.20783525705337524,
            "end_logit": 0.23411661386489868,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk2 gene encoded a 480-aa Nlk2",
            "probability": 0.03770519903895157,
            "start_logit": 1.3294764757156372,
            "end_logit": -1.216171145439148,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk",
            "probability": 0.03689145486250662,
            "start_logit": 0.20783525705337524,
            "end_logit": -0.11634796857833862,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse Nlk, human NLK",
            "probability": 0.032577947899518025,
            "start_logit": -0.2777346670627594,
            "end_logit": 0.2448776215314865,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse Nlk, human NLK, Xenopus nlk",
            "probability": 0.03222925585613664,
            "start_logit": -0.2777346670627594,
            "end_logit": 0.23411661386489868,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nemo",
            "probability": 0.023978411640555468,
            "start_logit": 0.4010055363178253,
            "end_logit": -0.7403442859649658,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse Nlk",
            "probability": 0.022701023794979805,
            "start_logit": -0.2777346670627594,
            "end_logit": -0.11634796857833862,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "nlk and zebrafish nlk",
            "probability": 0.022694945191490484,
            "start_logit": 0.4121343791484833,
            "end_logit": -0.8064848184585571,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nlk, human NLK, Xenopus nlk and zebrafish nlk",
            "probability": 0.018501338832807322,
            "start_logit": 0.20783525705337524,
            "end_logit": -0.8064848184585571,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "mouse Nlk, human NLK, Xenopus nlk and zebrafish nlk",
            "probability": 0.011384732173015895,
            "start_logit": -0.2777346670627594,
            "end_logit": -0.8064848184585571,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK, Xenopus nlk and zebrafish",
            "probability": 0.010533192508179707,
            "start_logit": 1.313010811805725,
            "end_logit": -2.4749720096588135,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Nemo (Nmo",
            "probability": 0.00810428365215734,
            "start_logit": 0.4010055363178253,
            "end_logit": -1.8251054286956787,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Diego (Dgo) and Nemo",
            "probability": 0.007738485470935247,
            "start_logit": -0.7299423813819885,
            "end_logit": -0.7403442859649658,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "NLK, Xenopus nlk and zebrafish nlk, respectively. Rat Nlk2",
            "probability": 0.006506016277030873,
            "start_logit": 1.313010811805725,
            "end_logit": -2.9567761421203613,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        }
    ],
    "53061af558348c0f52000002": [
        {
            "text": "cell-cycle arrest",
            "probability": 0.36666987177849586,
            "start_logit": 5.617630481719971,
            "end_logit": 5.326910495758057,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell expansion and cell-cycle arrest",
            "probability": 0.31000695341819995,
            "start_logit": 5.449763298034668,
            "end_logit": 5.326910495758057,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell expansion",
            "probability": 0.21110034651418527,
            "start_logit": 5.449763298034668,
            "end_logit": 4.9426493644714355,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "expansion and cell-cycle arrest",
            "probability": 0.057423860918528885,
            "start_logit": 3.7636284828186035,
            "end_logit": 5.326910495758057,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "expansion",
            "probability": 0.03910298399575239,
            "start_logit": 3.7636284828186035,
            "end_logit": 4.9426493644714355,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "irreversible cell-cycle arrest",
            "probability": 0.013603612747642593,
            "start_logit": 4.236752986907959,
            "end_logit": 3.413661479949951,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell",
            "probability": 0.0005523844903227612,
            "start_logit": 5.449763298034668,
            "end_logit": -1.0031951665878296,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle",
            "probability": 0.0003240886274047508,
            "start_logit": 5.617630481719971,
            "end_logit": -1.7042896747589111,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell expansion and cell-cycle",
            "probability": 0.0002740059539986596,
            "start_logit": 5.449763298034668,
            "end_logit": -1.7042896747589111,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "arrest",
            "probability": 0.00027229878330145964,
            "start_logit": -1.5876867771148682,
            "end_logit": 5.326910495758057,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cycle arrest",
            "probability": 0.0002470888961093144,
            "start_logit": -1.6848385334014893,
            "end_logit": 5.326910495758057,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell expansion and cell",
            "probability": 0.0001283874524707925,
            "start_logit": 5.449763298034668,
            "end_logit": -2.4623868465423584,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle arrest. We provide evidence for the compatibility of the proposed model with recent findings showing senescence in postmitotic tissues, wound healing",
            "probability": 6.47950105004101e-05,
            "start_logit": 5.617630481719971,
            "end_logit": -3.3140780925750732,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "expansion and cell-cycle",
            "probability": 5.075524797033184e-05,
            "start_logit": 3.7636284828186035,
            "end_logit": -1.7042896747589111,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "irreversible cell-cycle",
            "probability": 4.2850347273903486e-05,
            "start_logit": 4.236752986907959,
            "end_logit": -2.3467154502868652,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cellular senescence is a phenotype that results from the coordination of two processes: cell expansion and cell-cycle arrest",
            "probability": 3.7315349154859746e-05,
            "start_logit": -3.5751819610595703,
            "end_logit": 5.326910495758057,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "irreversible",
            "probability": 3.258421675420087e-05,
            "start_logit": 4.236752986907959,
            "end_logit": -2.620601177215576,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cellular senescence is a phenotype that results from the coordination of two processes: cell expansion",
            "probability": 2.5410020807701803e-05,
            "start_logit": -3.5751819610595703,
            "end_logit": 4.9426493644714355,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "expansion and cell",
            "probability": 2.3781735000058227e-05,
            "start_logit": 3.7636284828186035,
            "end_logit": -2.4623868465423584,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cell-cycle arrest.",
            "probability": 1.662449612582919e-05,
            "start_logit": 5.617630481719971,
            "end_logit": -4.674429416656494,
            "question_text": "Which are the major characteristics of cellular senescence?"
        }
    ],
    "53137541e3eabad021000010": [
        {
            "text": "induction of pluripotent stem cells (iPSC) reprogramming",
            "probability": 0.14425601426549417,
            "start_logit": -4.5095534324646,
            "end_logit": -4.6018147468566895,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "induction of pluripotent stem cells",
            "probability": 0.11360679229568867,
            "start_logit": -4.5095534324646,
            "end_logit": -4.84066104888916,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming",
            "probability": 0.1095259798006932,
            "start_logit": -4.215631008148193,
            "end_logit": -5.1711649894714355,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "pluripotent stem cells (iPSC) reprogramming",
            "probability": 0.07534670501834446,
            "start_logit": -5.159042835235596,
            "end_logit": -4.6018147468566895,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramome,",
            "probability": 0.06263889146529501,
            "start_logit": -4.498424530029297,
            "end_logit": -5.447146892547607,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "pluripotent stem cells",
            "probability": 0.059338236334671134,
            "start_logit": -5.159042835235596,
            "end_logit": -4.84066104888916,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming.",
            "probability": 0.05560928351146973,
            "start_logit": -5.26080846786499,
            "end_logit": -4.803799152374268,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming legitimacy of a gene response to reprogramming.",
            "probability": 0.050626745000864906,
            "start_logit": -5.354678630828857,
            "end_logit": -4.803799152374268,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming factors. This report also tallied 438 genes reprogrammed significantly but insufficiently up to 72 h,",
            "probability": 0.036746046502959456,
            "start_logit": -5.068991661071777,
            "end_logit": -5.409935474395752,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming. Using RNA-seq, this study scored 579 genes successfully reprogrammed within 48 h,",
            "probability": 0.033481771039938005,
            "start_logit": -5.26080846786499,
            "end_logit": -5.311148166656494,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming is still unclear. Previous studies about transcriptional responses to reprogramming",
            "probability": 0.032927243928675555,
            "start_logit": -5.141107082366943,
            "end_logit": -5.447550296783447,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming. Using RNA-seq,",
            "probability": 0.029264403888300504,
            "start_logit": -5.26080846786499,
            "end_logit": -5.445777416229248,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming legitimacy of a gene response to reprogramming",
            "probability": 0.028380890023857446,
            "start_logit": -5.354678630828857,
            "end_logit": -5.38256311416626,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming factors",
            "probability": 0.02830461210482484,
            "start_logit": -4.974615573883057,
            "end_logit": -5.765317440032959,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming legitimacy of a gene response to reprogramming. Using RNA-seq,",
            "probability": 0.026642341344853483,
            "start_logit": -5.354678630828857,
            "end_logit": -5.445777416229248,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "RNA-seq, this study scored 579 genes successfully reprogrammed within 48 h,",
            "probability": 0.02614125064938763,
            "start_logit": -5.508295059204102,
            "end_logit": -5.311148166656494,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "gene response to reprogramming.",
            "probability": 0.024890261386170648,
            "start_logit": -6.0646820068359375,
            "end_logit": -4.803799152374268,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "RNA-seq,",
            "probability": 0.02284849616337362,
            "start_logit": -5.508295059204102,
            "end_logit": -5.445777416229248,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "reprogramming is still unclear. Previous studies about transcriptional responses to reprogramming overlooked human reprogramming",
            "probability": 0.022050235086023526,
            "start_logit": -5.141107082366943,
            "end_logit": -5.848527431488037,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "upreprogramming or downreprogramming,",
            "probability": 0.01737380018911397,
            "start_logit": -5.918829917907715,
            "end_logit": -5.309164524078369,
            "question_text": "Which are the Yamanaka factors?"
        }
    ],
    "5718bbb37de986d80d00000b": [
        {
            "text": "Alpers syndrome",
            "probability": 0.2659206175269856,
            "start_logit": 5.0343146324157715,
            "end_logit": 4.8029680252075195,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia",
            "probability": 0.14386613911649812,
            "start_logit": 5.0343146324157715,
            "end_logit": 4.188653469085693,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy syndromes",
            "probability": 0.10513009422424513,
            "start_logit": 5.038384437561035,
            "end_logit": 3.870898962020874,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndromes",
            "probability": 0.10470310469729942,
            "start_logit": 5.0343146324157715,
            "end_logit": 3.870898962020874,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy syndrome",
            "probability": 0.07065256080384813,
            "start_logit": 5.038384437561035,
            "end_logit": 3.4734747409820557,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndrome",
            "probability": 0.07036560297566632,
            "start_logit": 5.0343146324157715,
            "end_logit": 3.4734747409820557,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia",
            "probability": 0.06861208314253622,
            "start_logit": 4.293900012969971,
            "end_logit": 4.188653469085693,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy syndromes",
            "probability": 0.04993460010041346,
            "start_logit": 4.293900012969971,
            "end_logit": 3.870898962020874,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy syndrome",
            "probability": 0.033558491465678464,
            "start_logit": 4.293900012969971,
            "end_logit": 3.4734747409820557,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia",
            "probability": 0.021815060837246363,
            "start_logit": 5.038384437561035,
            "end_logit": 2.2983009815216064,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia",
            "probability": 0.021726458210416036,
            "start_logit": 5.0343146324157715,
            "end_logit": 2.2983009815216064,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "ataxia-neuropathy",
            "probability": 0.0120644139799599,
            "start_logit": 5.038384437561035,
            "end_logit": 1.7059605121612549,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy",
            "probability": 0.012015413943802865,
            "start_logit": 5.0343146324157715,
            "end_logit": 1.7059605121612549,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia",
            "probability": 0.01036169849472909,
            "start_logit": 4.293900012969971,
            "end_logit": 2.2983009815216064,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia, and ataxia-neuropathy",
            "probability": 0.005730344788335614,
            "start_logit": 4.293900012969971,
            "end_logit": 1.7059605121612549,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome,",
            "probability": 0.0014808529079030374,
            "start_logit": 5.0343146324157715,
            "end_logit": -0.38761159777641296,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "neuropathy syndromes",
            "probability": 0.0006624633896274913,
            "start_logit": -0.02860412187874317,
            "end_logit": 3.870898962020874,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, progressive external ophthalmoplegia,",
            "probability": 0.0006464765335280554,
            "start_logit": 5.0343146324157715,
            "end_logit": -1.216448187828064,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "neuropathy syndrome",
            "probability": 0.00044520777101316004,
            "start_logit": -0.02860412187874317,
            "end_logit": 3.4734747409820557,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "progressive external ophthalmoplegia,",
            "probability": 0.00030831509026740074,
            "start_logit": 4.293900012969971,
            "end_logit": -1.216448187828064,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        }
    ],
    "52bf202003868f1b06000018": [
        {
            "text": "epilepsy",
            "probability": 0.7285727875656143,
            "start_logit": 3.333962917327881,
            "end_logit": 2.7825610637664795,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "depression and anxiety have a high prevalence in adult patients with epilepsy",
            "probability": 0.08646295331602516,
            "start_logit": 1.1805152893066406,
            "end_logit": 2.8046371936798096,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "Mood disorders such as depression and anxiety have a high prevalence in adult patients with epilepsy",
            "probability": 0.05311575436321747,
            "start_logit": 0.6932728290557861,
            "end_logit": 2.8046371936798096,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "anxiety have a high prevalence in adult patients with epilepsy",
            "probability": 0.04704149134838591,
            "start_logit": 0.5718292593955994,
            "end_logit": 2.8046371936798096,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy, and their evaluation is crucial in choosing the most appropriate antiepileptic",
            "probability": 0.025514544905507683,
            "start_logit": 2.9415977001190186,
            "end_logit": -0.1769125759601593,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "depression and anxiety",
            "probability": 0.009357028283535187,
            "start_logit": 1.1805152893066406,
            "end_logit": 0.5810489058494568,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "depression",
            "probability": 0.006775430339023764,
            "start_logit": 1.1805152893066406,
            "end_logit": 0.2582240402698517,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "antiepileptic",
            "probability": 0.006222896243767512,
            "start_logit": 1.530584454536438,
            "end_logit": -0.1769125759601593,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "pilepsy",
            "probability": 0.005959930448084974,
            "start_logit": -1.494141936302185,
            "end_logit": 2.8046371936798096,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "Mood disorders such as depression and anxiety",
            "probability": 0.005748191529629578,
            "start_logit": 0.6932728290557861,
            "end_logit": 0.5810489058494568,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "anxiety",
            "probability": 0.005090834260977543,
            "start_logit": 0.5718292593955994,
            "end_logit": 0.5810489058494568,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "depression and anxiety have a high prevalence in adult patients with epilepsy, and their evaluation is crucial in choosing the most appropriate antiepileptic",
            "probability": 0.004384897573601427,
            "start_logit": 1.1805152893066406,
            "end_logit": -0.1769125759601593,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "Mood disorders such as depression",
            "probability": 0.00416226927013811,
            "start_logit": 0.6932728290557861,
            "end_logit": 0.2582240402698517,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "psy",
            "probability": 0.0030378201624079093,
            "start_logit": -2.168060541152954,
            "end_logit": 2.8046371936798096,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "anxiety have a high prevalence in adult patients with epilepsy, and their evaluation is crucial in choosing the most appropriate antiepileptic",
            "probability": 0.0023856705486128603,
            "start_logit": 0.5718292593955994,
            "end_logit": -0.1769125759601593,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy, and their evaluation is crucial in choosing the most appropriate antiepileptic drug",
            "probability": 0.0020187829198650446,
            "start_logit": 2.9415977001190186,
            "end_logit": -2.7136664390563965,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy, and their evaluation is crucial in choosing the most appropriate anti",
            "probability": 0.001250028587401136,
            "start_logit": 2.9415977001190186,
            "end_logit": -3.1929948329925537,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epile",
            "probability": 0.0012068440636783435,
            "start_logit": 3.333962917327881,
            "end_logit": -3.6205177307128906,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "Mood disorders",
            "probability": 0.0008778244285132648,
            "start_logit": 0.6932728290557861,
            "end_logit": -1.298145055770874,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy,",
            "probability": 0.0008140198420129644,
            "start_logit": 2.9415977001190186,
            "end_logit": -3.621931791305542,
            "question_text": "What are the main indications of lacosamide?"
        }
    ],
    "56be0da3ef6e394741000007": [
        {
            "text": "thrombocytopenia",
            "probability": 0.4747630472923873,
            "start_logit": 4.674068927764893,
            "end_logit": 4.604916095733643,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute kidney injury",
            "probability": 0.2331632511397352,
            "start_logit": 4.674068927764893,
            "end_logit": 3.893839120864868,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute kidney injury",
            "probability": 0.15261055347466693,
            "start_logit": 4.250219345092773,
            "end_logit": 3.893839120864868,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.061079377885050405,
            "start_logit": 2.623427391052246,
            "end_logit": 4.604916095733643,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury",
            "probability": 0.029996998305767585,
            "start_logit": 2.623427391052246,
            "end_logit": 3.893839120864868,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "kidney injury",
            "probability": 0.0136789313193735,
            "start_logit": 1.8381868600845337,
            "end_logit": 3.893839120864868,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia",
            "probability": 0.008805574799358014,
            "start_logit": 2.623427391052246,
            "end_logit": 2.6681268215179443,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia,",
            "probability": 0.005530146184258321,
            "start_logit": 4.674068927764893,
            "end_logit": 0.15231451392173767,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.004127033237116162,
            "start_logit": -0.07118809968233109,
            "end_logit": 4.604916095733643,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute kidney injury (AKI)",
            "probability": 0.0038443663098213674,
            "start_logit": 4.674068927764893,
            "end_logit": -0.21129095554351807,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia, thrombocytopenia",
            "probability": 0.003153045459635196,
            "start_logit": -0.3403781056404114,
            "end_logit": 4.604916095733643,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute kidney injury (AKI)",
            "probability": 0.002516223579116234,
            "start_logit": 4.250219345092773,
            "end_logit": -0.21129095554351807,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia, thrombocytopenia, and acute kidney injury",
            "probability": 0.002026847903634601,
            "start_logit": -0.07118809968233109,
            "end_logit": 3.893839120864868,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia, thrombocytopenia, and acute kidney injury",
            "probability": 0.0015485079021054454,
            "start_logit": -0.3403781056404114,
            "end_logit": 3.893839120864868,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia,",
            "probability": 0.0007114662576926715,
            "start_logit": 2.623427391052246,
            "end_logit": 0.15231451392173767,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.0005949782255028123,
            "start_logit": -0.07118809968233109,
            "end_logit": 2.6681268215179443,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia,",
            "probability": 0.0004986884643058033,
            "start_logit": 2.623427391052246,
            "end_logit": -0.20303189754486084,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury (AKI)",
            "probability": 0.0004945867289067365,
            "start_logit": 2.623427391052246,
            "end_logit": -0.21129095554351807,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia",
            "probability": 0.00045456222053940416,
            "start_logit": -0.3403781056404114,
            "end_logit": 2.6681268215179443,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia, and acute",
            "probability": 0.0004018133110261542,
            "start_logit": 4.674068927764893,
            "end_logit": -2.469667434692383,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        }
    ],
    "56a92be0a17756b72f000009": [
        {
            "text": "ccna1",
            "probability": 0.4358348111684141,
            "start_logit": 4.754814624786377,
            "end_logit": 3.693977117538452,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna1",
            "probability": 0.32342687509482876,
            "start_logit": 4.45652437210083,
            "end_logit": 3.693977117538452,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog",
            "probability": 0.13841755895734376,
            "start_logit": 4.45652437210083,
            "end_logit": 2.8452789783477783,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "ccna1,",
            "probability": 0.02605405873501566,
            "start_logit": 4.754814624786377,
            "end_logit": 0.8768873810768127,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog and ccna1",
            "probability": 0.023100290538510045,
            "start_logit": 1.8173965215682983,
            "end_logit": 3.693977117538452,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna1,",
            "probability": 0.019334350043340307,
            "start_logit": 4.45652437210083,
            "end_logit": 0.8768873810768127,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "ccna",
            "probability": 0.010621864749665196,
            "start_logit": 4.754814624786377,
            "end_logit": -0.020371591672301292,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog",
            "probability": 0.009886271283450028,
            "start_logit": 1.8173965215682983,
            "end_logit": 2.8452789783477783,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna",
            "probability": 0.007882336232973904,
            "start_logit": 4.45652437210083,
            "end_logit": -0.020371591672301292,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog and ccna1,",
            "probability": 0.0013809276153797167,
            "start_logit": 1.8173965215682983,
            "end_logit": 0.8768873810768127,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "microRNA activity. Furthermore, dynamic 3'-UTR structures contain RNA-decay elements, such as the regulatory elements in nanog",
            "probability": 0.0006146884067582589,
            "start_logit": -0.9603903293609619,
            "end_logit": 2.8452789783477783,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "RNA-decay elements, such as the regulatory elements in nanog and ccna",
            "probability": 0.0005629843130708754,
            "start_logit": 1.8173965215682983,
            "end_logit": -0.020371591672301292,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "ccna1, two genes encoding key maternal",
            "probability": 0.00041635036432124733,
            "start_logit": 4.754814624786377,
            "end_logit": -3.259514331817627,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "ccna1, two genes encoding key maternal factors orchestrating the maternal-to-zygotic transition",
            "probability": 0.0004130859729838632,
            "start_logit": 4.754814624786377,
            "end_logit": -3.267385721206665,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "ccna1, two genes encoding key maternal factors",
            "probability": 0.000406684480442748,
            "start_logit": 4.754814624786377,
            "end_logit": -3.283003807067871,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "na",
            "probability": 0.0003690812420560054,
            "start_logit": 4.45652437210083,
            "end_logit": -3.0817344188690186,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "cc",
            "probability": 0.0003604729520519785,
            "start_logit": 4.754814624786377,
            "end_logit": -3.4036245346069336,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna1, two genes encoding key maternal",
            "probability": 0.00030896774150741254,
            "start_logit": 4.45652437210083,
            "end_logit": -3.259514331817627,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna1, two genes encoding key maternal factors orchestrating the maternal-to-zygotic transition",
            "probability": 0.00030654528267144585,
            "start_logit": 4.45652437210083,
            "end_logit": -3.267385721206665,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "nanog and ccna1, two genes encoding key maternal factors",
            "probability": 0.0003017948252149493,
            "start_logit": 4.45652437210083,
            "end_logit": -3.283003807067871,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        }
    ],
    "56c3327c50c68dd41600000c": [
        {
            "text": "negative DNA superhelicity",
            "probability": 0.18131673833520656,
            "start_logit": -3.4368743896484375,
            "end_logit": -1.6148478984832764,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA superhelicity",
            "probability": 0.1674426344591465,
            "start_logit": -3.516479015350342,
            "end_logit": -1.6148478984832764,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology, in particular negative DNA superhelicity",
            "probability": 0.16666168182640442,
            "start_logit": -3.5211539268493652,
            "end_logit": -1.6148478984832764,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "superhelicity",
            "probability": 0.13062513762763847,
            "start_logit": -3.7647881507873535,
            "end_logit": -1.6148478984832764,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology",
            "probability": 0.09657214872164895,
            "start_logit": -3.5211539268493652,
            "end_logit": -2.1605234146118164,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "topology, in particular negative DNA superhelicity",
            "probability": 0.07306953024198598,
            "start_logit": -4.34570837020874,
            "end_logit": -1.6148478984832764,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "topology",
            "probability": 0.042340155602774716,
            "start_logit": -4.34570837020874,
            "end_logit": -2.1605234146118164,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "in particular negative DNA superhelicity",
            "probability": 0.01482644104027916,
            "start_logit": -5.940707683563232,
            "end_logit": -1.6148478984832764,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "Escherichia coli revealed that DNA topology, in particular negative DNA superhelicity",
            "probability": 0.013315734745525406,
            "start_logit": -6.048173427581787,
            "end_logit": -1.6148478984832764,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "negative DNA",
            "probability": 0.013060704035449847,
            "start_logit": -3.4368743896484375,
            "end_logit": -4.245485305786133,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA",
            "probability": 0.012061317182663499,
            "start_logit": -3.516479015350342,
            "end_logit": -4.245485305786133,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology, in particular negative DNA",
            "probability": 0.012005063185952547,
            "start_logit": -3.5211539268493652,
            "end_logit": -4.245485305786133,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "negative DNA superhelicity,",
            "probability": 0.011769047520955485,
            "start_logit": -3.4368743896484375,
            "end_logit": -4.349620342254639,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA superhelicity,",
            "probability": 0.01086849642276535,
            "start_logit": -3.516479015350342,
            "end_logit": -4.349620342254639,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology, in particular negative DNA superhelicity,",
            "probability": 0.010817805743400907,
            "start_logit": -3.5211539268493652,
            "end_logit": -4.349620342254639,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology,",
            "probability": 0.01041148115801772,
            "start_logit": -3.5211539268493652,
            "end_logit": -4.387904644012451,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "negative DNA superhelicity, plays a key role in driving R-loops. A clear role for DNA",
            "probability": 0.008568454004870212,
            "start_logit": -3.4368743896484375,
            "end_logit": -4.667006015777588,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "superhelicity,",
            "probability": 0.008478717774687223,
            "start_logit": -3.7647881507873535,
            "end_logit": -4.349620342254639,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA superhelicity, plays a key role in driving R-loops. A clear role for DNA",
            "probability": 0.007912807857623536,
            "start_logit": -3.516479015350342,
            "end_logit": -4.667006015777588,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "DNA topology, in particular negative DNA superhelicity, plays a key role in driving R-loops. A clear role for DNA",
            "probability": 0.00787590251300355,
            "start_logit": -3.5211539268493652,
            "end_logit": -4.667006015777588,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        }
    ],
    "5314a7a4dae131f847000003": [
        {
            "text": "K280N",
            "probability": 0.7288216149741858,
            "start_logit": 4.994523525238037,
            "end_logit": 4.437028408050537,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(K280N",
            "probability": 0.15034971576128933,
            "start_logit": 3.4160585403442383,
            "end_logit": 4.437028408050537,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "K280N)",
            "probability": 0.06663152078783872,
            "start_logit": 4.994523525238037,
            "end_logit": 2.0447771549224854,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "homozygous mutation (K280N",
            "probability": 0.02133272553941455,
            "start_logit": 1.4633368253707886,
            "end_logit": 4.437028408050537,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(K280N)",
            "probability": 0.013745517428909983,
            "start_logit": 3.4160585403442383,
            "end_logit": 2.0447771549224854,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "K280",
            "probability": 0.007409830402262965,
            "start_logit": 4.994523525238037,
            "end_logit": -0.15159304440021515,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "homozygous mutation (K280N)",
            "probability": 0.0019503152980597377,
            "start_logit": 1.4633368253707886,
            "end_logit": 2.0447771549224854,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(K280",
            "probability": 0.001528585146118445,
            "start_logit": 3.4160585403442383,
            "end_logit": -0.15159304440021515,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "N",
            "probability": 0.0012009273299779907,
            "start_logit": -1.413811445236206,
            "end_logit": 4.437028408050537,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "a homozygous mutation (K280N",
            "probability": 0.0011890049868443085,
            "start_logit": -1.4237886667251587,
            "end_logit": 4.437028408050537,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "K280N) in the cardiac troponin T gene",
            "probability": 0.0010405373196666454,
            "start_logit": 4.994523525238037,
            "end_logit": -2.1146633625030518,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "K280N) in the cardiac troponin T",
            "probability": 0.0009662996993287875,
            "start_logit": 4.994523525238037,
            "end_logit": -2.1886818408966064,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "280N",
            "probability": 0.0009642173185022003,
            "start_logit": -1.633344054222107,
            "end_logit": 4.437028408050537,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutation (K280N",
            "probability": 0.0009156861632064755,
            "start_logit": -1.6849870681762695,
            "end_logit": 4.437028408050537,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "K",
            "probability": 0.0008471386321496305,
            "start_logit": 4.994523525238037,
            "end_logit": -2.320291519165039,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "K280N) in the cardiac troponin T gene (",
            "probability": 0.00027335598132145403,
            "start_logit": 4.994523525238037,
            "end_logit": -3.451380968093872,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "homozygous mutation (K280",
            "probability": 0.00021688692406671324,
            "start_logit": 1.4633368253707886,
            "end_logit": -0.15159304440021515,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(K280N) in the cardiac troponin T gene",
            "probability": 0.00021465402100682084,
            "start_logit": 3.4160585403442383,
            "end_logit": -2.1146633625030518,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "K28",
            "probability": 0.0002021268560775506,
            "start_logit": 4.994523525238037,
            "end_logit": -3.753260374069214,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(K280N) in the cardiac troponin T",
            "probability": 0.00019933942977178076,
            "start_logit": 3.4160585403442383,
            "end_logit": -2.1886818408966064,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "56c6dd275795f9a73e000008": [
        {
            "text": "tri-methylation of lysine 9 on histone H3 (H3K9me3",
            "probability": 0.42303752463097244,
            "start_logit": 5.260499477386475,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3",
            "probability": 0.18413970895287243,
            "start_logit": 4.4287333488464355,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9",
            "probability": 0.18158284293178317,
            "start_logit": 5.260499477386475,
            "end_logit": 3.45365047454834,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9 on histone H3",
            "probability": 0.06803399528815621,
            "start_logit": 5.260499477386475,
            "end_logit": 2.4719460010528564,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation of lysine 9 on histone H3 (H3K9me3)",
            "probability": 0.060709976471395435,
            "start_logit": 5.260499477386475,
            "end_logit": 2.358046531677246,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3)",
            "probability": 0.026425829263563197,
            "start_logit": 4.4287333488464355,
            "end_logit": 2.358046531677246,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3 to influence cell identity challenges the original concept of H3K9me3",
            "probability": 0.01641023227754848,
            "start_logit": 3.555356979370117,
            "end_logit": 2.754986047744751,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3K9me3 as an important player in silencing lineage-inappropriate genes. The ability of H3K9me3",
            "probability": 0.010686479101101378,
            "start_logit": 2.7694249153137207,
            "end_logit": 3.111992359161377,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9 on histone H3 (H3K9me3",
            "probability": 0.006694047804102955,
            "start_logit": 1.1142573356628418,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "tri-methylation",
            "probability": 0.006341693239323502,
            "start_logit": 5.260499477386475,
            "end_logit": 0.0990842953324318,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3 (H3K9me3",
            "probability": 0.0035711549176832935,
            "start_logit": 0.48592764139175415,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "(H3K9me3",
            "probability": 0.0034132035235616125,
            "start_logit": 0.44068989157676697,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9",
            "probability": 0.002873324847602139,
            "start_logit": 1.1142573356628418,
            "end_logit": 3.45365047454834,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9 on histone H3",
            "probability": 0.0010765541831314158,
            "start_logit": 1.1142573356628418,
            "end_logit": 2.4719460010528564,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3 (H3K9me3",
            "probability": 0.0010582043712715151,
            "start_logit": -0.7303879261016846,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "t",
            "probability": 0.0010005712669821955,
            "start_logit": 5.260499477386475,
            "end_logit": -1.747490406036377,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9 on histone H3 (H3K9me3)",
            "probability": 0.0009606606057937694,
            "start_logit": 1.1142573356628418,
            "end_logit": 2.358046531677246,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "methylation of lysine 9 on histone H3 (H3K9me3",
            "probability": 0.0007893933689621615,
            "start_logit": -1.0234519243240356,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "9 on histone H3 (H3K9me3",
            "probability": 0.000620280529592541,
            "start_logit": -1.2645448446273804,
            "end_logit": 4.299399375915527,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3",
            "probability": 0.0005743224246002333,
            "start_logit": 0.48592764139175415,
            "end_logit": 2.4719460010528564,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        }
    ],
    "5322d9339b2d7acc7e000011": [
        {
            "text": "growth arrest, and apoptosis",
            "probability": 0.2058728960348749,
            "start_logit": 5.2668561935424805,
            "end_logit": 5.387530326843262,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis",
            "probability": 0.1637165092803863,
            "start_logit": 5.037733554840088,
            "end_logit": 5.387530326843262,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced cell viability, growth arrest, and apoptosis",
            "probability": 0.13917083802616342,
            "start_logit": 4.875299453735352,
            "end_logit": 5.387530326843262,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth arrest",
            "probability": 0.12147868181495719,
            "start_logit": 5.2668561935424805,
            "end_logit": 4.860010147094727,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced cell viability",
            "probability": 0.0995651635894342,
            "start_logit": 4.875299453735352,
            "end_logit": 5.052640438079834,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced cell viability, growth arrest",
            "probability": 0.08212003753829412,
            "start_logit": 4.875299453735352,
            "end_logit": 4.860010147094727,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth arrest, and apoptosis. Treatment with IM of mice xenografted with H295 cells inhibited further tumor growth",
            "probability": 0.056698824982226274,
            "start_logit": 5.2668561935424805,
            "end_logit": 4.098024845123291,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis. Treatment with IM of mice xenografted with H295 cells inhibited further tumor growth",
            "probability": 0.04508866337032138,
            "start_logit": 5.037733554840088,
            "end_logit": 4.098024845123291,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "pigmented nodular adrenocortical disease",
            "probability": 0.012432824464297531,
            "start_logit": 3.974982261657715,
            "end_logit": 3.872485399246216,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced c-KIT levels. Treatment of the CAR47 cells with IM resulted in reduced cell viability, growth arrest, and apoptosis",
            "probability": 0.011461251387110639,
            "start_logit": 2.3785691261291504,
            "end_logit": 5.387530326843262,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "cell viability, growth arrest, and apoptosis",
            "probability": 0.009990538631870728,
            "start_logit": 2.2412357330322266,
            "end_logit": 5.387530326843262,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "c-KIT levels. Treatment of the CAR47 cells with IM resulted in reduced cell viability, growth arrest, and apoptosis",
            "probability": 0.008678988831831496,
            "start_logit": 2.1005022525787354,
            "end_logit": 5.387530326843262,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced c-KIT levels. Treatment of the CAR47 cells with IM resulted in reduced cell viability",
            "probability": 0.008199572449817191,
            "start_logit": 2.3785691261291504,
            "end_logit": 5.052640438079834,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "cell viability",
            "probability": 0.007147399752251047,
            "start_logit": 2.2412357330322266,
            "end_logit": 5.052640438079834,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "reduced c-KIT levels. Treatment of the CAR47 cells with IM resulted in reduced cell viability, growth arrest",
            "probability": 0.00676289952330682,
            "start_logit": 2.3785691261291504,
            "end_logit": 4.860010147094727,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "c-KIT levels. Treatment of the CAR47 cells with IM resulted in reduced cell viability",
            "probability": 0.006209094915917113,
            "start_logit": 2.1005022525787354,
            "end_logit": 5.052640438079834,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "cell viability, growth arrest",
            "probability": 0.005895081319570456,
            "start_logit": 2.2412357330322266,
            "end_logit": 4.860010147094727,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "c-KIT levels. Treatment of the CAR47 cells with IM resulted in reduced cell viability, growth arrest",
            "probability": 0.005121179830292107,
            "start_logit": 2.1005022525787354,
            "end_logit": 4.860010147094727,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "primary pigmented nodular adrenocortical disease",
            "probability": 0.0028513554723793985,
            "start_logit": 2.502436637878418,
            "end_logit": 3.872485399246216,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "inhibited further tumor growth",
            "probability": 0.0015381987846977997,
            "start_logit": 1.6597148180007935,
            "end_logit": 4.098024845123291,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        }
    ],
    "56c1f005ef6e39474100003a": [
        {
            "text": "interleukin-13",
            "probability": 0.37832192015910526,
            "start_logit": 5.483813762664795,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4",
            "probability": 0.33009265389337195,
            "start_logit": 5.1565327644348145,
            "end_logit": 5.078724384307861,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13",
            "probability": 0.27272514020747346,
            "start_logit": 5.1565327644348145,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4",
            "probability": 0.00286360770876308,
            "start_logit": 0.409241646528244,
            "end_logit": 5.078724384307861,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4 and interleukin-13",
            "probability": 0.00236593515384286,
            "start_logit": 0.409241646528244,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signaling",
            "probability": 0.0022449253306554137,
            "start_logit": 5.483813762664795,
            "end_logit": -0.23925773799419403,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signaling.",
            "probability": 0.0016569324707198512,
            "start_logit": 5.483813762664795,
            "end_logit": -0.5429620146751404,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signaling",
            "probability": 0.001618324350068911,
            "start_logit": 5.1565327644348145,
            "end_logit": -0.23925773799419403,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "-4",
            "probability": 0.0014504071608839116,
            "start_logit": -0.2709963023662567,
            "end_logit": 5.078724384307861,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "13",
            "probability": 0.0012364963781969023,
            "start_logit": -0.23964983224868774,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "-4 and interleukin-13",
            "probability": 0.0011983377746957215,
            "start_logit": -0.2709963023662567,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signaling.",
            "probability": 0.0011944513820434815,
            "start_logit": 5.1565327644348145,
            "end_logit": -0.5429620146751404,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-4",
            "probability": 0.0007305426179951809,
            "start_logit": -0.95680832862854,
            "end_logit": 5.078724384307861,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-4 and interleukin-13",
            "probability": 0.0006035800420588245,
            "start_logit": -0.95680832862854,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "-13",
            "probability": 0.00045207570706400145,
            "start_logit": -1.2458373308181763,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "n-4",
            "probability": 0.00034076943425578524,
            "start_logit": -1.719389796257019,
            "end_logit": 5.078724384307861,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "n-4 and interleukin-13",
            "probability": 0.0002815463799017205,
            "start_logit": -1.719389796257019,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "ukin-13",
            "probability": 0.0002318313141378683,
            "start_logit": -1.9136769771575928,
            "end_logit": 4.887815475463867,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "interleukin",
            "probability": 0.0002067490369105401,
            "start_logit": 5.1565327644348145,
            "end_logit": -2.296898603439331,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "inter",
            "probability": 0.00018377349785521314,
            "start_logit": 5.1565327644348145,
            "end_logit": -2.4147002696990967,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        }
    ],
    "513ce3c8bee46bd34c000008": [
        {
            "text": "CDC45",
            "probability": 0.5159720411626841,
            "start_logit": 5.147327423095703,
            "end_logit": 4.899776458740234,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45",
            "probability": 0.1820056522576563,
            "start_logit": 5.147327423095703,
            "end_logit": 3.8577616214752197,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45)",
            "probability": 0.0710439759567046,
            "start_logit": 5.147327423095703,
            "end_logit": 2.917022943496704,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene",
            "probability": 0.062218685545534995,
            "start_logit": 5.147327423095703,
            "end_logit": 2.784379243850708,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45",
            "probability": 0.04654077313589443,
            "start_logit": 3.783618450164795,
            "end_logit": 3.8577616214752197,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22A-LCR22B",
            "probability": 0.020836823520459426,
            "start_logit": 5.147327423095703,
            "end_logit": 1.6904456615447998,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene,",
            "probability": 0.018744263815338093,
            "start_logit": 5.147327423095703,
            "end_logit": 1.5846116542816162,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45)",
            "probability": 0.018166697169339347,
            "start_logit": 3.783618450164795,
            "end_logit": 2.917022943496704,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene",
            "probability": 0.01590997693131525,
            "start_logit": 3.783618450164795,
            "end_logit": 2.784379243850708,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22A",
            "probability": 0.015404328521408217,
            "start_logit": 5.147327423095703,
            "end_logit": 1.3883724212646484,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene, located within the LCR22A-LCR22B",
            "probability": 0.005328196483511003,
            "start_logit": 3.783618450164795,
            "end_logit": 1.6904456615447998,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "the CDC45",
            "probability": 0.004865963186209306,
            "start_logit": 0.48353952169418335,
            "end_logit": 4.899776458740234,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene,",
            "probability": 0.004793106801947176,
            "start_logit": 3.783618450164795,
            "end_logit": 1.5846116542816162,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "Cell Division Cycle protein 45) gene, located within the LCR22A",
            "probability": 0.003939049969781854,
            "start_logit": 3.783618450164795,
            "end_logit": 1.3883724212646484,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "LCR22A-LCR22B",
            "probability": 0.003625421725258418,
            "start_logit": 3.398576259613037,
            "end_logit": 1.6904456615447998,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "LCR22A",
            "probability": 0.002680215975803392,
            "start_logit": 3.398576259613037,
            "end_logit": 1.3883724212646484,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "pathogenic variants in the CDC45",
            "probability": 0.002434978385207676,
            "start_logit": -0.20878727734088898,
            "end_logit": 4.899776458740234,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22",
            "probability": 0.0019120853433731205,
            "start_logit": 5.147327423095703,
            "end_logit": -0.6980816721916199,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "CDC45 (Cell Division Cycle protein 45) gene, located within the LCR22A-LCR22",
            "probability": 0.0018613284670059046,
            "start_logit": 5.147327423095703,
            "end_logit": -0.724985659122467,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "the CDC45 (Cell Division Cycle protein 45",
            "probability": 0.0017164356455673367,
            "start_logit": 0.48353952169418335,
            "end_logit": 3.8577616214752197,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        }
    ],
    "56d06e043975bb303a000011": [
        {
            "text": "acute lymphoblastic leukemia",
            "probability": 0.7512010872931927,
            "start_logit": 2.2149147987365723,
            "end_logit": 1.8187520503997803,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "metastatic breast cancer",
            "probability": 0.0492688153594991,
            "start_logit": 0.5715950727462769,
            "end_logit": 0.737689733505249,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "lymphoblastic leukemia",
            "probability": 0.041671474256369884,
            "start_logit": -0.6769417524337769,
            "end_logit": 1.8187520503997803,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer",
            "probability": 0.03743174701478058,
            "start_logit": 0.2968229353427887,
            "end_logit": 0.737689733505249,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced breast cancer",
            "probability": 0.03708737978394657,
            "start_logit": 1.0114542245864868,
            "end_logit": 0.013815993443131447,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced",
            "probability": 0.02565578230226332,
            "start_logit": 1.0114542245864868,
            "end_logit": -0.3546917736530304,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "leukemia",
            "probability": 0.012755207179192672,
            "start_logit": -1.8608189821243286,
            "end_logit": 1.8187520503997803,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "metastatic",
            "probability": 0.0090371694361494,
            "start_logit": 0.5715950727462769,
            "end_logit": -0.9582555890083313,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment with letrozole",
            "probability": 0.00490250016557743,
            "start_logit": 2.2149147987365723,
            "end_logit": -3.2131760120391846,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "a case of acute lymphoblastic leukemia",
            "probability": 0.00476502115316594,
            "start_logit": -2.845456600189209,
            "end_logit": 1.8187520503997803,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced breast cancer.",
            "probability": 0.0045869801131769965,
            "start_logit": 1.0114542245864868,
            "end_logit": -2.0762388706207275,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "leukemia that was diagnosed in a patient undergoing treatment with letrozole and palbociclib for metastatic breast cancer",
            "probability": 0.004327012186161233,
            "start_logit": -1.8608189821243286,
            "end_logit": 0.737689733505249,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "acute lymphoblastic",
            "probability": 0.0035476780427110203,
            "start_logit": 2.2149147987365723,
            "end_logit": -3.536628007888794,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment",
            "probability": 0.003413446334217123,
            "start_logit": 2.2149147987365723,
            "end_logit": -3.5751988887786865,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "case of acute lymphoblastic leukemia",
            "probability": 0.002269019159399548,
            "start_logit": -3.5874109268188477,
            "end_logit": 1.8187520503997803,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia",
            "probability": 0.0018512539748937156,
            "start_logit": 1.0114542245864868,
            "end_logit": -2.98359751701355,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "first time, we present a case of acute lymphoblastic leukemia",
            "probability": 0.0018224267155410195,
            "start_logit": -3.8065896034240723,
            "end_logit": 1.8187520503997803,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "metastatic breast",
            "probability": 0.0016339078103217535,
            "start_logit": 0.5715950727462769,
            "end_logit": -2.6686270236968994,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer.",
            "probability": 0.0015307380689577473,
            "start_logit": -0.08601763844490051,
            "end_logit": -2.0762388706207275,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast",
            "probability": 0.0012413536504820024,
            "start_logit": 0.2968229353427887,
            "end_logit": -2.6686270236968994,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        }
    ],
    "571e1e11bb137a4b0c000004": [
        {
            "text": "weight loss",
            "probability": 0.34766606458860394,
            "start_logit": 1.3726240396499634,
            "end_logit": 0.9893599152565002,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight loss effect. This effect is likely to increase blood levels of other drugs. Reason for the report: SGLT2 inhibitor-induced weight reduction",
            "probability": 0.2916077122212223,
            "start_logit": 1.3726240396499634,
            "end_logit": 0.8135269284248352,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight reduction",
            "probability": 0.2198808850377956,
            "start_logit": 1.0903005599975586,
            "end_logit": 0.8135269284248352,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight loss effect",
            "probability": 0.04477329429678926,
            "start_logit": 1.3726240396499634,
            "end_logit": -1.0602706670761108,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "hypoglycemic agents characterized by a weight loss",
            "probability": 0.03258154046136495,
            "start_logit": -0.994872510433197,
            "end_logit": 0.9893599152565002,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "Sodium glucose cotransporter 2 (SGLT2) inhibitors are hypoglycemic agents characterized by a weight loss",
            "probability": 0.023367308963404467,
            "start_logit": -1.3272804021835327,
            "end_logit": 0.9893599152565002,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight loss effect. This effect is likely to increase blood levels of other drugs. Reason for the report: SGLT2 inhibitor-induced weight",
            "probability": 0.007409935649510945,
            "start_logit": 1.3726240396499634,
            "end_logit": -2.859060764312744,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight",
            "probability": 0.005587311790476726,
            "start_logit": 1.0903005599975586,
            "end_logit": -2.859060764312744,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight reduction could bring unexpected side effects of other drugs whose blood concentrations are affected by body weight",
            "probability": 0.004850798049259166,
            "start_logit": 1.0903005599975586,
            "end_logit": -3.000415802001953,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "hypoglycemic agents characterized by a weight loss effect",
            "probability": 0.0041959312348923946,
            "start_logit": -0.994872510433197,
            "end_logit": -1.0602706670761108,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "a weight loss",
            "probability": 0.004107039010677773,
            "start_logit": -3.065916061401367,
            "end_logit": 0.9893599152565002,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "Sodium glucose cotransporter 2 (SGLT2) inhibitors are hypoglycemic agents characterized by a weight loss effect",
            "probability": 0.0030092997496909096,
            "start_logit": -1.3272804021835327,
            "end_logit": -1.0602706670761108,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight reduction could bring unexpected side effects",
            "probability": 0.0027210601775154593,
            "start_logit": 1.0903005599975586,
            "end_logit": -3.5785374641418457,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "SGLT2 inhibitor-induced weight reduction",
            "probability": 0.0021031532760396516,
            "start_logit": -3.559347629547119,
            "end_logit": 0.8135269284248352,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "glycemic agents characterized by a weight loss",
            "probability": 0.0016427035419816522,
            "start_logit": -3.9822750091552734,
            "end_logit": 0.9893599152565002,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight reduction could bring unexpected",
            "probability": 0.0010646977171198117,
            "start_logit": 1.0903005599975586,
            "end_logit": -4.5168681144714355,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "induced weight reduction",
            "probability": 0.0010464330435850677,
            "start_logit": -4.2573981285095215,
            "end_logit": 0.8135269284248352,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "weight loss effect.",
            "probability": 0.0008403037482456795,
            "start_logit": 1.3726240396499634,
            "end_logit": -5.035874366760254,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "ypoglycemic agents characterized by a weight loss",
            "probability": 0.0007889508634711342,
            "start_logit": -4.715669631958008,
            "end_logit": 0.9893599152565002,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "loss",
            "probability": 0.0007555765783531691,
            "start_logit": -4.75889253616333,
            "end_logit": 0.9893599152565002,
            "question_text": "List side effects of SGLT2 inhibitors?"
        }
    ],
    "56a3a386496b62f23f000007": [
        {
            "text": "8th",
            "probability": 0.28381849516732366,
            "start_logit": -0.4455287456512451,
            "end_logit": -1.2972182035446167,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release",
            "probability": 0.16464663320166434,
            "start_logit": -0.4455287456512451,
            "end_logit": -1.8417515754699707,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release of JASPAR",
            "probability": 0.1294314790519389,
            "start_logit": -0.4455287456512451,
            "end_logit": -2.0824015140533447,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release of JASPAR,",
            "probability": 0.08843983815378387,
            "start_logit": -0.4455287456512451,
            "end_logit": -2.463230609893799,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR",
            "probability": 0.07879541882194128,
            "start_logit": -0.9418255090713501,
            "end_logit": -2.0824015140533447,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR,",
            "probability": 0.05384048871971621,
            "start_logit": -0.9418255090713501,
            "end_logit": -2.463230609893799,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "In this 8th",
            "probability": 0.05136061195897756,
            "start_logit": -2.15499210357666,
            "end_logit": -1.2972182035446167,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "In this 8th release",
            "probability": 0.0297949287386553,
            "start_logit": -2.15499210357666,
            "end_logit": -1.8417515754699707,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "In this 8th release of JASPAR",
            "probability": 0.023422293064248905,
            "start_logit": -2.15499210357666,
            "end_logit": -2.0824015140533447,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "In this 8th release of JASPAR,",
            "probability": 0.016004327718154406,
            "start_logit": -2.15499210357666,
            "end_logit": -2.463230609893799,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "this 8th",
            "probability": 0.013541678274367332,
            "start_logit": -3.488091468811035,
            "end_logit": -1.2972182035446167,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release of JASPAR, the CORE collection has been expanded with 245 new PFMs",
            "probability": 0.010811736246677164,
            "start_logit": -0.4455287456512451,
            "end_logit": -4.564920902252197,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR 2020",
            "probability": 0.009490644829305752,
            "start_logit": -1.618911862373352,
            "end_logit": -3.5218634605407715,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "8th release of JASPAR, the CORE collection has been expanded with 245",
            "probability": 0.008513250286300619,
            "start_logit": -0.4455287456512451,
            "end_logit": -4.803929328918457,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "this 8th release",
            "probability": 0.007855695713065708,
            "start_logit": -3.488091468811035,
            "end_logit": -1.8417515754699707,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR (http://jaspar.genereg.net)",
            "probability": 0.006875487113356038,
            "start_logit": -1.8434258699417114,
            "end_logit": -3.6196935176849365,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR, the CORE collection has been expanded with 245 new PFMs",
            "probability": 0.0065819790671435485,
            "start_logit": -0.9418255090713501,
            "end_logit": -4.564920902252197,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "this 8th release of JASPAR",
            "probability": 0.006175494119449704,
            "start_logit": -3.488091468811035,
            "end_logit": -2.0824015140533447,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "release",
            "probability": 0.005416815154101295,
            "start_logit": -3.8598222732543945,
            "end_logit": -1.8417515754699707,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR, the CORE collection has been expanded with 245",
            "probability": 0.005182704599828336,
            "start_logit": -0.9418255090713501,
            "end_logit": -4.803929328918457,
            "question_text": "List the releases of JASPAR database"
        }
    ],
    "571529efcb4ef8864c000001": [
        {
            "text": "penicillin",
            "probability": 0.9207008974256364,
            "start_logit": 2.6641712188720703,
            "end_logit": 2.812495231628418,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics",
            "probability": 0.07223959571497451,
            "start_logit": 2.6641712188720703,
            "end_logit": 0.2673483192920685,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics,",
            "probability": 0.0017920221804305471,
            "start_logit": 2.6641712188720703,
            "end_logit": -3.429295301437378,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "pen",
            "probability": 0.0008889753240442588,
            "start_logit": 2.6641712188720703,
            "end_logit": -4.130325794219971,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics, a phenotype that is exacerbated by the additional deletion of hbhA.",
            "probability": 0.0007958424950896452,
            "start_logit": 2.6641712188720703,
            "end_logit": -4.240993976593018,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin antibiotics, a phenotype that is exacerbated by the additional deletion of hbhA",
            "probability": 0.0007734467848740417,
            "start_logit": 2.6641712188720703,
            "end_logit": -4.269538402557373,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "llin",
            "probability": 0.0006824387713094528,
            "start_logit": -4.543046474456787,
            "end_logit": 2.812495231628418,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "penicillin anti",
            "probability": 0.0004756177928534323,
            "start_logit": 2.6641712188720703,
            "end_logit": -4.7557806968688965,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "MSMEG_1285 enhances Mycobacterium smegmatis resistance to penicillin",
            "probability": 0.0004572340486702181,
            "start_logit": -4.94352388381958,
            "end_logit": 2.812495231628418,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "Mycobacterium smegmatis resistance to penicillin",
            "probability": 0.0003936560637937381,
            "start_logit": -5.0932416915893555,
            "end_logit": 2.812495231628418,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "resistance to penicillin",
            "probability": 0.00021959397532785724,
            "start_logit": -5.676939010620117,
            "end_logit": 2.812495231628418,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "Deletion of MSMEG_1285 enhances Mycobacterium smegmatis resistance to penicillin",
            "probability": 0.00015654913102927922,
            "start_logit": -6.015349388122559,
            "end_logit": 2.812495231628418,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "icillin",
            "probability": 0.00014916910540405443,
            "start_logit": -6.063638687133789,
            "end_logit": 2.812495231628418,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "antibiotics",
            "probability": 0.00010454011462948552,
            "start_logit": -3.8740015029907227,
            "end_logit": 0.2673483192920685,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "llin antibiotics",
            "probability": 5.3545186148361085e-05,
            "start_logit": -4.543046474456787,
            "end_logit": 0.2673483192920685,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "MSMEG_1285 enhances Mycobacterium smegmatis resistance to penicillin antibiotics",
            "probability": 3.587528036022724e-05,
            "start_logit": -4.94352388381958,
            "end_logit": 0.2673483192920685,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "Mycobacterium smegmatis resistance to penicillin antibiotics",
            "probability": 3.088685476328072e-05,
            "start_logit": -5.0932416915893555,
            "end_logit": 0.2673483192920685,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "resistance to penicillin antibiotics",
            "probability": 1.722967800236097e-05,
            "start_logit": -5.676939010620117,
            "end_logit": 0.2673483192920685,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "PonA1",
            "probability": 1.6820812383748795e-05,
            "start_logit": -2.597579002380371,
            "end_logit": -2.8360280990600586,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "PonA",
            "probability": 1.6063260275000786e-05,
            "start_logit": -2.597579002380371,
            "end_logit": -2.882110357284546,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        }
    ],
    "52b2d405f828ad283c000009": [
        {
            "text": "Fibroblast-like synoviocytes",
            "probability": 0.5962060762759092,
            "start_logit": 4.73333740234375,
            "end_logit": 4.792006969451904,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes",
            "probability": 0.2845790939327267,
            "start_logit": 3.993762254714966,
            "end_logit": 4.792006969451904,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast",
            "probability": 0.09114676023729276,
            "start_logit": 4.73333740234375,
            "end_logit": 2.913891553878784,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like",
            "probability": 0.010741275323770751,
            "start_logit": 4.73333740234375,
            "end_logit": 0.7755144238471985,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocytes are the major cell types that make up the synovial intima structure,",
            "probability": 0.0029885203993746247,
            "start_logit": 4.73333740234375,
            "end_logit": -0.5038009881973267,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocytes are the major cell types",
            "probability": 0.0029325935433936077,
            "start_logit": 4.73333740234375,
            "end_logit": -0.5226922035217285,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocy",
            "probability": 0.00225434770352885,
            "start_logit": 4.73333740234375,
            "end_logit": -0.7857187390327454,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes are the major cell types that make up the synovial intima structure,",
            "probability": 0.0014264705800481055,
            "start_logit": 3.993762254714966,
            "end_logit": -0.5038009881973267,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes are the major cell types",
            "probability": 0.0013997757598594254,
            "start_logit": 3.993762254714966,
            "end_logit": -0.5226922035217285,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocy",
            "probability": 0.0010760377198548957,
            "start_logit": 3.993762254714966,
            "end_logit": -0.7857187390327454,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocytes are the major cell types that make up the synovial intima structure",
            "probability": 0.0010503265448846453,
            "start_logit": 4.73333740234375,
            "end_logit": -1.54947829246521,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocytes are the major cell types that make up the synovial intima",
            "probability": 0.0009137948665864491,
            "start_logit": 4.73333740234375,
            "end_logit": -1.6887285709381104,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like s",
            "probability": 0.0007426053762644256,
            "start_logit": 4.73333740234375,
            "end_logit": -1.896169900894165,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes are the major cell types that make up the synovial intima structure",
            "probability": 0.0005013383599573377,
            "start_logit": 3.993762254714966,
            "end_logit": -1.54947829246521,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "synoviocytes are the major cell types that make up the synovial intima",
            "probability": 0.0004361695150741895,
            "start_logit": 3.993762254714966,
            "end_logit": -1.6887285709381104,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "broblast-like synoviocytes",
            "probability": 0.0003657446740756674,
            "start_logit": -2.6630687713623047,
            "end_logit": 4.792006969451904,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "s",
            "probability": 0.00035445791905868405,
            "start_logit": 3.993762254714966,
            "end_logit": -1.896169900894165,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fi",
            "probability": 0.0003012585454437899,
            "start_logit": 4.73333740234375,
            "end_logit": -2.798365831375122,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Fibroblast-like synoviocytes are the major cell",
            "probability": 0.0002931323306044786,
            "start_logit": 4.73333740234375,
            "end_logit": -2.8257105350494385,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "like synoviocytes",
            "probability": 0.0002902203922913262,
            "start_logit": -2.8943636417388916,
            "end_logit": 4.792006969451904,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        }
    ],
    "552faa43bc4f83e828000004": [
        {
            "text": "BCL11B",
            "probability": 0.9860317700515498,
            "start_logit": 5.119910717010498,
            "end_logit": 4.705101013183594,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "SPRY1",
            "probability": 0.009042445919759326,
            "start_logit": 2.8198490142822266,
            "end_logit": 2.313403844833374,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "SPRY1, a repressed target of BCL11B",
            "probability": 0.0025327065719544847,
            "start_logit": 2.8198490142822266,
            "end_logit": 1.0407626628875732,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "SPRY",
            "probability": 0.0012084325019385226,
            "start_logit": 2.8198490142822266,
            "end_logit": 0.3007982075214386,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B,",
            "probability": 0.00021924235586696618,
            "start_logit": 2.963212013244629,
            "end_logit": -1.5494663715362549,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "CL11B",
            "probability": 0.000200413101890572,
            "start_logit": -3.381152391433716,
            "end_logit": 4.705101013183594,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B, a zinc finger transcription factor, acts as a transcriptional repressor in Ewing's sarcoma",
            "probability": 0.0001995573391083546,
            "start_logit": 2.963212013244629,
            "end_logit": -1.6435425281524658,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "11B",
            "probability": 9.902543823008698e-05,
            "start_logit": -4.086156368255615,
            "end_logit": 4.705101013183594,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "L11B",
            "probability": 9.546197671682013e-05,
            "start_logit": -4.122805118560791,
            "end_logit": 4.705101013183594,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing sarcoma cells lines. BCL11B",
            "probability": 9.176102182477828e-05,
            "start_logit": -1.819839596748352,
            "end_logit": 2.3625950813293457,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "SPRY1,",
            "probability": 6.558737776887455e-05,
            "start_logit": 2.8198490142822266,
            "end_logit": -2.6128978729248047,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "SPRY1, a repressed target of BCL11B,",
            "probability": 5.7289982493751625e-05,
            "start_logit": 2.8198490142822266,
            "end_logit": -2.748155355453491,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "SPRY1, a repressed target of BCL11B, limits the transformation capacity of Ewing sarcoma",
            "probability": 5.4974626326740145e-05,
            "start_logit": 2.8198490142822266,
            "end_logit": -2.7894093990325928,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B, a zinc finger transcription factor,",
            "probability": 4.35116055795986e-05,
            "start_logit": 2.963212013244629,
            "end_logit": -3.166616439819336,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing's sarcoma and contributes to the EWS/FLI repressed gene signature. BCL11B",
            "probability": 2.0916762415400535e-05,
            "start_logit": -2.3190813064575195,
            "end_logit": 1.3832000494003296,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "BCL11B, limits the transformation capacity of Ewing sarcoma",
            "probability": 2.040024351294572e-05,
            "start_logit": 1.828524112701416,
            "end_logit": -2.7894093990325928,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "transformation in patient derived Ewing sarcoma cells lines. BCL11B",
            "probability": 1.0028305215956839e-05,
            "start_logit": -4.033615589141846,
            "end_logit": 2.3625950813293457,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing sarcoma cells lines.",
            "probability": 3.5009643018206928e-06,
            "start_logit": -1.819839596748352,
            "end_logit": -0.9035540819168091,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing sarcoma cells lines. BCL11B,",
            "probability": 1.8351498783290173e-06,
            "start_logit": -1.819839596748352,
            "end_logit": -1.5494663715362549,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "Ewing's sarcoma and contributes to the EWS/FLI repressed gene signature.",
            "probability": 1.1387036666678253e-06,
            "start_logit": -2.3190813064575195,
            "end_logit": -1.5274603366851807,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        }
    ],
    "533c3af6c45e13371400000d": [
        {
            "text": "CYLD cutaneous syndrome",
            "probability": 0.7485172226008956,
            "start_logit": 4.848246097564697,
            "end_logit": 5.150852680206299,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous syndrome",
            "probability": 0.12385037219337271,
            "start_logit": 3.0492260456085205,
            "end_logit": 5.150852680206299,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity. In contrast with CYLD cutaneous syndrome",
            "probability": 0.051657721964470195,
            "start_logit": 2.1747915744781494,
            "end_logit": 5.150852680206299,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous",
            "probability": 0.020812171115772105,
            "start_logit": 4.848246097564697,
            "end_logit": 1.5682964324951172,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous syndrome, a skin tumour disorder",
            "probability": 0.009939186664748032,
            "start_logit": 4.477900981903076,
            "end_logit": 1.1995887756347656,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "amyotrophic lateral sclerosis",
            "probability": 0.009115064823085195,
            "start_logit": 2.994387149810791,
            "end_logit": 2.596545934677124,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "a skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity. In contrast with CYLD cutaneous syndrome",
            "probability": 0.006409148177993057,
            "start_logit": 0.0878782570362091,
            "end_logit": 5.150852680206299,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Frontotemporal dementia",
            "probability": 0.005178063379588981,
            "start_logit": 2.2928109169006348,
            "end_logit": 2.7326247692108154,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Frontotemporal dementia and amyotrophic lateral sclerosis",
            "probability": 0.004519278182202002,
            "start_logit": 2.2928109169006348,
            "end_logit": 2.596545934677124,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous",
            "probability": 0.0034436016447077704,
            "start_logit": 3.0492260456085205,
            "end_logit": 1.5682964324951172,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous syndrome, a skin tumour",
            "probability": 0.0033827311942478265,
            "start_logit": 4.477900981903076,
            "end_logit": 0.12178701162338257,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD cutaneous syndrome,",
            "probability": 0.0033464006642109244,
            "start_logit": 4.477900981903076,
            "end_logit": 0.11098892241716385,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "skin tumour disorder",
            "probability": 0.0018681644600167804,
            "start_logit": 2.1747915744781494,
            "end_logit": 1.8311693668365479,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cutaneous syndrome, a skin tumour disorder",
            "probability": 0.0017358218946984865,
            "start_logit": 2.7328968048095703,
            "end_logit": 1.1995887756347656,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity. In contrast with CYLD cutaneous",
            "probability": 0.0014363187866804424,
            "start_logit": 2.1747915744781494,
            "end_logit": 1.5682964324951172,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "frontotemporal dementia",
            "probability": 0.0011117074494659644,
            "start_logit": 1.655792474746704,
            "end_logit": 1.8311091661453247,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "amyotrophic lateral sclerosis and no mutation in known amyotrophic lateral sclerosis",
            "probability": 0.0010332089372151537,
            "start_logit": 2.1675009727478027,
            "end_logit": 1.2461730241775513,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "skin tumour disorder,",
            "probability": 0.000927318195464481,
            "start_logit": 2.1747915744781494,
            "end_logit": 1.1307544708251953,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "frontotemporal dementia and amyotrophic lateral sclerosis",
            "probability": 0.0008601335077930976,
            "start_logit": 1.655792474746704,
            "end_logit": 1.5745444297790527,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "CYLD",
            "probability": 0.000856364163370865,
            "start_logit": 4.848246097564697,
            "end_logit": -1.6223011016845703,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        }
    ],
    "571f3b320fd6f91b68000007": [
        {
            "text": "Adrenocorticotropic hormone",
            "probability": 0.6079269027865,
            "start_logit": -0.556556224822998,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing syndrome",
            "probability": 0.05977253861070079,
            "start_logit": -0.556556224822998,
            "end_logit": -3.611738920211792,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs",
            "probability": 0.0494675886821218,
            "start_logit": -1.9959791898727417,
            "end_logit": -2.361544609069824,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing syndrome, known as Cushing disease (CD),",
            "probability": 0.04566911751167482,
            "start_logit": -0.556556224822998,
            "end_logit": -3.8808629512786865,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing syndrome,",
            "probability": 0.03949997402062659,
            "start_logit": -0.556556224822998,
            "end_logit": -4.025985240936279,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic",
            "probability": 0.03237058255573607,
            "start_logit": -0.556556224822998,
            "end_logit": -4.225035190582275,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Ad",
            "probability": 0.029613442057637555,
            "start_logit": -0.556556224822998,
            "end_logit": -4.314056873321533,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs and symptoms",
            "probability": 0.023319094384547514,
            "start_logit": -1.9959791898727417,
            "end_logit": -3.1135897636413574,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent Cushing",
            "probability": 0.018109931664214356,
            "start_logit": -0.556556224822998,
            "end_logit": -4.8058247566223145,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs and symptoms of which differ from those seen in adult patients.",
            "probability": 0.01726584737731315,
            "start_logit": -1.9959791898727417,
            "end_logit": -3.4141318798065186,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocorticotropic hormone-dependent",
            "probability": 0.015925071802609162,
            "start_logit": -0.556556224822998,
            "end_logit": -4.934390544891357,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenoc",
            "probability": 0.013060425702470244,
            "start_logit": -0.556556224822998,
            "end_logit": -5.1326985359191895,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Adrenocortico",
            "probability": 0.011273230776873148,
            "start_logit": -0.556556224822998,
            "end_logit": -5.2798542976379395,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "tropic hormone",
            "probability": 0.009083334562919166,
            "start_logit": -4.760169506072998,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "renocorticotropic hormone",
            "probability": 0.006629042563719258,
            "start_logit": -5.075150489807129,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Cushing syndrome, known as Cushing disease (CD), is a rare disease in paediatric patients, the signs",
            "probability": 0.004797011545988279,
            "start_logit": -4.329303741455078,
            "end_logit": -2.361544609069824,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "signs and symptoms of which differ from those seen in adult patients",
            "probability": 0.004503877475717542,
            "start_logit": -1.9959791898727417,
            "end_logit": -4.757923603057861,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "Cushing disease (CD), is a rare disease in paediatric patients, the signs",
            "probability": 0.004423626786698247,
            "start_logit": -4.410336971282959,
            "end_logit": -2.361544609069824,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "ocorticotropic hormone",
            "probability": 0.003802785619373116,
            "start_logit": -5.6308770179748535,
            "end_logit": -1.2922306060791016,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "symptoms",
            "probability": 0.003486573512559446,
            "start_logit": -3.896332263946533,
            "end_logit": -3.1135897636413574,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        }
    ],
    "54d65b6b3706e8952800000c": [
        {
            "text": "PMP22",
            "probability": 0.8460421853544722,
            "start_logit": 4.442772388458252,
            "end_logit": 4.346029758453369,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene",
            "probability": 0.1328306053075371,
            "start_logit": 4.442772388458252,
            "end_logit": 2.494535207748413,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the PMP22",
            "probability": 0.008095817450182955,
            "start_logit": -0.20644927024841309,
            "end_logit": 4.346029758453369,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "duplication of the PMP22",
            "probability": 0.004225830468620294,
            "start_logit": -0.8565810322761536,
            "end_logit": 4.346029758453369,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22",
            "probability": 0.0017475782722078928,
            "start_logit": -1.7395658493041992,
            "end_logit": 4.346029758453369,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the PMP22 gene",
            "probability": 0.0012710623075096038,
            "start_logit": -0.20644927024841309,
            "end_logit": 2.494535207748413,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "deletion of the PMP22",
            "probability": 0.0010939571541819858,
            "start_logit": -1.289624810218811,
            "end_logit": 3.427659273147583,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PM",
            "probability": 0.0008442839948780119,
            "start_logit": 4.442772388458252,
            "end_logit": -2.5638058185577393,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP",
            "probability": 0.0007790840817017559,
            "start_logit": 4.442772388458252,
            "end_logit": -2.6441757678985596,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22 gene and hereditary neuropathy with liability to pressure palsy (HNPP) induced by deletion of the PMP22",
            "probability": 0.0006975790068582289,
            "start_logit": -1.7395658493041992,
            "end_logit": 3.427659273147583,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "duplication of the PMP22 gene",
            "probability": 0.0006634652843447597,
            "start_logit": -0.8565810322761536,
            "end_logit": 2.494535207748413,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "induced by duplication of the PMP22",
            "probability": 0.00030397998879082196,
            "start_logit": -3.4885902404785156,
            "end_logit": 4.346029758453369,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy with liability to pressure palsy (HNPP) induced by deletion of the PM",
            "probability": 0.0002767273103452769,
            "start_logit": 4.442772388458252,
            "end_logit": -3.679262161254883,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22 gene",
            "probability": 0.0002743738831680317,
            "start_logit": -1.7395658493041992,
            "end_logit": 2.494535207748413,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy with liability to pressure palsy",
            "probability": 0.00026658181970486914,
            "start_logit": 4.442772388458252,
            "end_logit": -3.716613531112671,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy",
            "probability": 0.00012332600164768372,
            "start_logit": 4.442772388458252,
            "end_logit": -4.487463474273682,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "by duplication of the PMP22",
            "probability": 0.00012256616206769092,
            "start_logit": -4.3969011306762695,
            "end_logit": 4.346029758453369,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22 gene and hereditary neuropathy with liability to pressure palsy (HNPP) induced",
            "probability": 0.0001160185783516307,
            "start_logit": 4.442772388458252,
            "end_logit": -4.548544406890869,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "hereditary neuropathy with liability to pressure palsy (HNPP) induced by deletion of the PMP22",
            "probability": 0.00011267432997586677,
            "start_logit": -3.5626800060272217,
            "end_logit": 3.427659273147583,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "deletion of the PMP22 gene",
            "probability": 0.00011230324345332133,
            "start_logit": -1.289624810218811,
            "end_logit": 1.1513051986694336,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        }
    ],
    "517a8c918ed59a060a000043": [
        {
            "text": "Polymerase chain reaction",
            "probability": 0.21451651628924828,
            "start_logit": -1.1890889406204224,
            "end_logit": -2.793790102005005,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymer",
            "probability": 0.12212773780702046,
            "start_logit": -1.1890889406204224,
            "end_logit": -3.357109308242798,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences in up to 67% of cases of myocarditis.",
            "probability": 0.09693340432894096,
            "start_logit": -1.1890889406204224,
            "end_logit": -3.5881526470184326,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences",
            "probability": 0.09261648664368659,
            "start_logit": -1.1890889406204224,
            "end_logit": -3.633709669113159,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses",
            "probability": 0.0870747809032508,
            "start_logit": -1.1890889406204224,
            "end_logit": -3.6954095363616943,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral",
            "probability": 0.06042336133437283,
            "start_logit": -1.1890889406204224,
            "end_logit": -4.060801029205322,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences in up to 67% of cases of myocarditis",
            "probability": 0.054191103072959795,
            "start_logit": -1.1890889406204224,
            "end_logit": -4.1696600914001465,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "giant cell myocarditis",
            "probability": 0.052870589333081426,
            "start_logit": -2.808009624481201,
            "end_logit": -2.575408935546875,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues",
            "probability": 0.03614196105380817,
            "start_logit": -1.1890889406204224,
            "end_logit": -4.5747222900390625,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "viral sequences in up to 67% of cases of myocarditis. However, viruses have not been implicated in giant cell myocarditis",
            "probability": 0.026210181971061598,
            "start_logit": -3.509708881378174,
            "end_logit": -2.575408935546875,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain",
            "probability": 0.025733494338456234,
            "start_logit": -1.1890889406204224,
            "end_logit": -4.914383411407471,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences in up to 67% of cases of myocarditis. However,",
            "probability": 0.025656574160733796,
            "start_logit": -1.1890889406204224,
            "end_logit": -4.91737699508667,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "giant cell myocarditis (GCM)",
            "probability": 0.02002141474942567,
            "start_logit": -2.808009624481201,
            "end_logit": -3.5464537143707275,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences in up to 67% of cases of myocarditis. However, viruses",
            "probability": 0.019799581089198503,
            "start_logit": -1.1890889406204224,
            "end_logit": -5.176516056060791,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have detected viral sequences in up to 67%",
            "probability": 0.01940104660699421,
            "start_logit": -1.1890889406204224,
            "end_logit": -5.196849822998047,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Polymerase chain reaction analyses of cardiac tissues have",
            "probability": 0.011961743582296128,
            "start_logit": -1.1890889406204224,
            "end_logit": -5.6804633140563965,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "viral sequences in up to 67% of cases of myocarditis.",
            "probability": 0.009520089486962317,
            "start_logit": -3.509708881378174,
            "end_logit": -3.5881526470184326,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "viral sequences",
            "probability": 0.00909611342880172,
            "start_logit": -3.509708881378174,
            "end_logit": -3.633709669113159,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "sequences in up to 67% of cases of myocarditis. However, viruses have not been implicated in giant cell myocarditis",
            "probability": 0.00786137494559295,
            "start_logit": -4.713895320892334,
            "end_logit": -2.575408935546875,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "viruses have not been implicated in giant cell myocarditis",
            "probability": 0.007842444874107778,
            "start_logit": -4.716306209564209,
            "end_logit": -2.575408935546875,
            "question_text": "Which viruses are best known to cause myocarditis?"
        }
    ],
    "571f2b5bbb137a4b0c000010": [
        {
            "text": "three",
            "probability": 0.3336147941985807,
            "start_logit": -2.164193868637085,
            "end_logit": -1.1544520854949951,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three",
            "probability": 0.3280694996949868,
            "start_logit": -2.180955410003662,
            "end_logit": -1.1544520854949951,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "three genes considered to be associated with CCMs,",
            "probability": 0.07328925376002225,
            "start_logit": -2.164193868637085,
            "end_logit": -2.670025110244751,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three genes considered to be associated with CCMs,",
            "probability": 0.0720710509011705,
            "start_logit": -2.180955410003662,
            "end_logit": -2.670025110244751,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "three genes considered",
            "probability": 0.02632679269639456,
            "start_logit": -2.164193868637085,
            "end_logit": -3.693851947784424,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three genes considered",
            "probability": 0.02588919274167051,
            "start_logit": -2.180955410003662,
            "end_logit": -3.693851947784424,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "considered to be associated with CCMs,",
            "probability": 0.0236493020493424,
            "start_logit": -3.295274257659912,
            "end_logit": -2.670025110244751,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There",
            "probability": 0.020776999159059492,
            "start_logit": -2.180955410003662,
            "end_logit": -3.9138309955596924,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "three genes",
            "probability": 0.014816209429189472,
            "start_logit": -2.164193868637085,
            "end_logit": -4.268717288970947,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three genes",
            "probability": 0.014569936643508166,
            "start_logit": -2.180955410003662,
            "end_logit": -4.268717288970947,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "are three",
            "probability": 0.012042707585580095,
            "start_logit": -5.485721588134766,
            "end_logit": -1.1544520854949951,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "considered",
            "probability": 0.008495246445080836,
            "start_logit": -3.295274257659912,
            "end_logit": -3.693851947784424,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "three genes considered to be associated",
            "probability": 0.008453502047855362,
            "start_logit": -2.164193868637085,
            "end_logit": -4.829858303070068,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three genes considered to be associated",
            "probability": 0.008312989219116152,
            "start_logit": -2.180955410003662,
            "end_logit": -4.829858303070068,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "three genes considered to be associated with CCMs",
            "probability": 0.006171775317024905,
            "start_logit": -2.164193868637085,
            "end_logit": -5.1444525718688965,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three genes considered to be associated with CCMs",
            "probability": 0.006069189003893531,
            "start_logit": -2.180955410003662,
            "end_logit": -5.1444525718688965,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "autosomal dominant mode of inheritance with incomplete penetrance and variable clinical expressivity. There are three",
            "probability": 0.0055145445461247085,
            "start_logit": -6.266791820526123,
            "end_logit": -1.1544520854949951,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "associated with CCMs,",
            "probability": 0.004384634231353957,
            "start_logit": -4.980501651763916,
            "end_logit": -2.670025110244751,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "three genes considered to",
            "probability": 0.0037725434878240535,
            "start_logit": -2.164193868637085,
            "end_logit": -5.63668966293335,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "There are three genes considered to",
            "probability": 0.003709836842221439,
            "start_logit": -2.180955410003662,
            "end_logit": -5.63668966293335,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        }
    ],
    "511a4d391159fa8212000003": [
        {
            "text": "Single-stranded DNA (ssDNA) plant viruses",
            "probability": 0.255875207182365,
            "start_logit": -2.150505304336548,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA (ssDNA",
            "probability": 0.1483941175452255,
            "start_logit": -2.150505304336548,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA (ssDNA)",
            "probability": 0.11669457694308052,
            "start_logit": -2.150505304336548,
            "end_logit": -4.277733325958252,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA",
            "probability": 0.07901750398610577,
            "start_logit": -2.150505304336548,
            "end_logit": -4.667623996734619,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "ssDNA) plant viruses",
            "probability": 0.05607833602647572,
            "start_logit": -3.668445587158203,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded",
            "probability": 0.05158707311556996,
            "start_logit": -2.150505304336548,
            "end_logit": -5.094022274017334,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA (ssDNA) plant viruses",
            "probability": 0.04425009799029237,
            "start_logit": -3.9053375720977783,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "ssDNA",
            "probability": 0.03252247562274578,
            "start_logit": -3.668445587158203,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "viruses",
            "probability": 0.0302503486921885,
            "start_logit": -4.285687446594238,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA (ssDNA",
            "probability": 0.025662721741849772,
            "start_logit": -3.9053375720977783,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "ssDNA)",
            "probability": 0.025575114409648488,
            "start_logit": -3.668445587158203,
            "end_logit": -4.277733325958252,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded DNA (ssDNA) plant viruses belong to the families",
            "probability": 0.02173613568008741,
            "start_logit": -2.150505304336548,
            "end_logit": -5.958317279815674,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single",
            "probability": 0.021667340935855737,
            "start_logit": -2.150505304336548,
            "end_logit": -5.961487293243408,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA (ssDNA)",
            "probability": 0.020180722163467637,
            "start_logit": -3.9053375720977783,
            "end_logit": -4.277733325958252,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "Single-stranded D",
            "probability": 0.016312506213354477,
            "start_logit": -2.150505304336548,
            "end_logit": -6.245361328125,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DNA",
            "probability": 0.013664990574258655,
            "start_logit": -3.9053375720977783,
            "end_logit": -4.667623996734619,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "stranded DNA (ssDNA) plant viruses",
            "probability": 0.013582591378601204,
            "start_logit": -5.086406230926514,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "plant viruses",
            "probability": 0.010028698935385955,
            "start_logit": -5.389744281768799,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": ") plant viruses",
            "probability": 0.009042254621757567,
            "start_logit": -5.493286609649658,
            "end_logit": -3.4926035404205322,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "stranded DNA (ssDNA",
            "probability": 0.007877186241683784,
            "start_logit": -5.086406230926514,
            "end_logit": -4.037421703338623,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        }
    ],
    "517137c18ed59a060a000001": [
        {
            "text": "CDYL2",
            "probability": 0.514965999296543,
            "start_logit": 5.0373053550720215,
            "end_logit": 4.126786708831787,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY",
            "probability": 0.36096272639225946,
            "start_logit": 4.404176712036133,
            "end_logit": 4.4045891761779785,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL",
            "probability": 0.10591991790512223,
            "start_logit": 5.0373053550720215,
            "end_logit": 2.5453691482543945,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL2 chromodomain",
            "probability": 0.006325716484955041,
            "start_logit": 5.0373053550720215,
            "end_logit": -0.27269086241722107,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY chromodomain",
            "probability": 0.005051755548177698,
            "start_logit": 4.404176712036133,
            "end_logit": 0.13555029034614563,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL, and CDYL2",
            "probability": 0.0012871474374180653,
            "start_logit": 2.155019998550415,
            "end_logit": 1.0173996686935425,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY) family of proteins adjacent to a putative catalytic motif. The human genome encodes three CDY family proteins, CDY",
            "probability": 0.0008602522028167861,
            "start_logit": 2.1601552963256836,
            "end_logit": 0.6093062162399292,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY chromodomain exhibits discriminatory binding to lysine-methylated ARK(S/T) motifs,",
            "probability": 0.0007018967894614091,
            "start_logit": 4.404176712036133,
            "end_logit": -1.8381544351577759,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL",
            "probability": 0.0006734222757020213,
            "start_logit": 1.4324980974197388,
            "end_logit": 1.0921103954315186,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL, and CDYL2",
            "probability": 0.0006249438832419638,
            "start_logit": 1.4324980974197388,
            "end_logit": 1.0173996686935425,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "the CDYL2",
            "probability": 0.00056758591623269,
            "start_logit": -1.7731586694717407,
            "end_logit": 4.126786708831787,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL, and CDYL",
            "probability": 0.0004943748990795342,
            "start_logit": 2.155019998550415,
            "end_logit": 0.06051004305481911,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL chromodomain",
            "probability": 0.00036473783500472234,
            "start_logit": 3.677885055541992,
            "end_logit": -1.7664703130722046,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "The CDY",
            "probability": 0.00031712973012192297,
            "start_logit": -2.633042335510254,
            "end_logit": 4.4045891761779785,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDYL, and CDY",
            "probability": 0.00024729038321201876,
            "start_logit": 2.155019998550415,
            "end_logit": -0.6322208046913147,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL, and CDYL",
            "probability": 0.00024003199651149906,
            "start_logit": 1.4324980974197388,
            "end_logit": 0.06051004305481911,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDYL, and CDY",
            "probability": 0.0001200659752568166,
            "start_logit": 1.4324980974197388,
            "end_logit": -0.6322208046913147,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "the CDYL",
            "probability": 0.0001167429572701766,
            "start_logit": -1.7731586694717407,
            "end_logit": 2.5453691482543945,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CDY, CDY",
            "probability": 8.176848445180406e-05,
            "start_logit": 1.4324980974197388,
            "end_logit": -1.0163702964782715,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "(CDY",
            "probability": 7.649360716119305e-05,
            "start_logit": -1.4236305952072144,
            "end_logit": 1.773073673248291,
            "question_text": "In which proteins is the chromodomain present?"
        }
    ],
    "531d7430267d7dd053000008": [
        {
            "text": "psychotropic drugs",
            "probability": 0.8167001662873824,
            "start_logit": 4.6063313484191895,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "psychotropic",
            "probability": 0.17737702771137814,
            "start_logit": 4.6063313484191895,
            "end_logit": 2.710858106613159,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ps",
            "probability": 0.0022880007411812324,
            "start_logit": 4.6063313484191895,
            "end_logit": -1.639741063117981,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "drugs",
            "probability": 0.0014108141506405747,
            "start_logit": -1.754773736000061,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "psychotropic drugs.",
            "probability": 0.000747490509481496,
            "start_logit": 4.6063313484191895,
            "end_logit": -2.758453130722046,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment with psychotropic drugs",
            "probability": 0.00044585463537266895,
            "start_logit": -2.906702995300293,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ropic drugs",
            "probability": 0.00030185783088382755,
            "start_logit": -3.2967398166656494,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "depression and, secondly, to analyse the changes in time after treatment with psychotropic drugs",
            "probability": 0.00012411566826393055,
            "start_logit": -4.185482025146484,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "psych",
            "probability": 0.00011727631102649927,
            "start_logit": 4.6063313484191895,
            "end_logit": -4.610641956329346,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment with psychotropic",
            "probability": 9.683403197191943e-05,
            "start_logit": -2.906702995300293,
            "end_logit": 2.710858106613159,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ychotropic drugs",
            "probability": 7.416262567020949e-05,
            "start_logit": -4.700435638427734,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ropic",
            "probability": 6.555973298863816e-05,
            "start_logit": -3.2967398166656494,
            "end_logit": 2.710858106613159,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "anxiety and depression and, secondly, to analyse the changes in time after treatment with psychotropic drugs",
            "probability": 4.670110659111883e-05,
            "start_logit": -5.162928104400635,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "otropic drugs",
            "probability": 4.24326396556497e-05,
            "start_logit": -5.258778095245361,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "with psychotropic drugs",
            "probability": 4.079140981033612e-05,
            "start_logit": -5.298224449157715,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "pain, anxiety and depression and, secondly, to analyse the changes in time after treatment with psychotropic drugs",
            "probability": 4.057652064869122e-05,
            "start_logit": -5.303506374359131,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "changes in time after treatment with psychotropic drugs",
            "probability": 2.7131635396117623e-05,
            "start_logit": -5.705995559692383,
            "end_logit": 4.237852573394775,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "depression and, secondly, to analyse the changes in time after treatment with psychotropic",
            "probability": 2.695636567474463e-05,
            "start_logit": -4.185482025146484,
            "end_logit": 2.710858106613159,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "ychotropic",
            "probability": 1.6107191661847156e-05,
            "start_logit": -4.700435638427734,
            "end_logit": 2.710858106613159,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "anxiety and depression and, secondly, to analyse the changes in time after treatment with psychotropic",
            "probability": 1.0142894320227209e-05,
            "start_logit": -5.162928104400635,
            "end_logit": 2.710858106613159,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        }
    ],
    "52df8ce798d023950500000d": [
        {
            "text": "cocoa flavanols",
            "probability": 0.8369075609104382,
            "start_logit": 6.163944721221924,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa",
            "probability": 0.08506211305139491,
            "start_logit": 6.163944721221924,
            "end_logit": 3.982024908065796,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "flavanols",
            "probability": 0.07449177220742702,
            "start_logit": 3.744919776916504,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavan",
            "probability": 0.002141291280009424,
            "start_logit": 6.163944721221924,
            "end_logit": 0.3000522255897522,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "avanols",
            "probability": 0.0002573988845243802,
            "start_logit": -1.922897219657898,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "coa flavanols",
            "probability": 0.0002132989766687422,
            "start_logit": -2.1108293533325195,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "ols",
            "probability": 0.00021096767516021962,
            "start_logit": -2.121819257736206,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "flavan",
            "probability": 0.00019059283212436129,
            "start_logit": 3.744919776916504,
            "end_logit": 0.3000522255897522,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "co",
            "probability": 0.0001809978628228573,
            "start_logit": 6.163944721221924,
            "end_logit": -2.1706268787384033,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Antioxidants such as cocoa flavanols",
            "probability": 0.00010760784858543495,
            "start_logit": -2.7950305938720703,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa fl",
            "probability": 8.040090592523247e-05,
            "start_logit": 6.163944721221924,
            "end_logit": -2.982086658477783,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavanols have been used as a supplement to prevent oxidative stress",
            "probability": 3.3050933916323416e-05,
            "start_logit": 6.163944721221924,
            "end_logit": -3.8710622787475586,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "such as cocoa flavanols",
            "probability": 3.1308517411866674e-05,
            "start_logit": -4.02963399887085,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "coa",
            "probability": 2.1679409428928603e-05,
            "start_logit": -2.1108293533325195,
            "end_logit": 3.982024908065796,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavanols have been used as a supplement to prevent oxidative stress;",
            "probability": 1.84674285231082e-05,
            "start_logit": 6.163944721221924,
            "end_logit": -4.453103542327881,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavanols have been used",
            "probability": 1.4296990337345291e-05,
            "start_logit": 6.163944721221924,
            "end_logit": -4.7090630531311035,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "Antioxidants such as cocoa",
            "probability": 1.0937111108942653e-05,
            "start_logit": -2.7950305938720703,
            "end_logit": 3.982024908065796,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "cocoa flavanols after a MS inducing protocol.",
            "probability": 1.0619659861551982e-05,
            "start_logit": 4.124051570892334,
            "end_logit": -2.9665119647979736,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "nts such as cocoa flavanols",
            "probability": 7.867117854411396e-06,
            "start_logit": -5.410832405090332,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "as cocoa flavanols",
            "probability": 7.770396476838016e-06,
            "start_logit": -5.423202991485596,
            "end_logit": 6.268356800079346,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        }
    ],
    "5505b9ff8e1671127b000001": [
        {
            "text": "Atg5",
            "probability": 0.24698413461057464,
            "start_logit": 4.43502950668335,
            "end_logit": 4.630110263824463,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5, Atg7",
            "probability": 0.18760126162753255,
            "start_logit": 4.43502950668335,
            "end_logit": 4.355104923248291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7",
            "probability": 0.17397601684504227,
            "start_logit": 4.359628200531006,
            "end_logit": 4.355104923248291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5, Atg7, Atg12",
            "probability": 0.09096297334104841,
            "start_logit": 4.43502950668335,
            "end_logit": 3.6312386989593506,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12",
            "probability": 0.08435644645971198,
            "start_logit": 4.359628200531006,
            "end_logit": 3.6312386989593506,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12",
            "probability": 0.06768560856617012,
            "start_logit": 4.139450550079346,
            "end_logit": 3.6312386989593506,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5, Atg7, Atg12, Beclin-1",
            "probability": 0.024069154386200036,
            "start_logit": 4.43502950668335,
            "end_logit": 2.3017172813415527,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12, Beclin-1",
            "probability": 0.022321041834213896,
            "start_logit": 4.359628200531006,
            "end_logit": 2.3017172813415527,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12, Beclin-1",
            "probability": 0.01790987368228299,
            "start_logit": 4.139450550079346,
            "end_logit": 2.3017172813415527,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Beclin-1",
            "probability": 0.013626906674722725,
            "start_logit": 3.8661446571350098,
            "end_logit": 2.3017172813415527,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Ki67) and autophagy-related factors (Atg5",
            "probability": 0.011515289403224594,
            "start_logit": 1.369381070137024,
            "end_logit": 4.630110263824463,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Ki67) and autophagy-related factors (Atg5, Atg7",
            "probability": 0.008746646109302755,
            "start_logit": 1.369381070137024,
            "end_logit": 4.355104923248291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg5, Atg7, Atg12, Beclin-1 and LC3-II/LC3-I",
            "probability": 0.008693190233474195,
            "start_logit": 4.43502950668335,
            "end_logit": 1.2833261489868164,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "PCNA and Ki67) and autophagy-related factors (Atg5",
            "probability": 0.008392601947060582,
            "start_logit": 1.053056001663208,
            "end_logit": 4.630110263824463,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg7, Atg12, Beclin-1 and LC3-II/LC3-I",
            "probability": 0.008061814709427842,
            "start_logit": 4.359628200531006,
            "end_logit": 1.2833261489868164,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Atg12, Beclin-1 and LC3-II/LC3-I",
            "probability": 0.006468608596687783,
            "start_logit": 4.139450550079346,
            "end_logit": 1.2833261489868164,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "PCNA and Ki67) and autophagy-related factors (Atg5, Atg7",
            "probability": 0.006374752435368942,
            "start_logit": 1.053056001663208,
            "end_logit": 4.355104923248291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Beclin-1 and LC3-II/LC3-I",
            "probability": 0.004921705603628653,
            "start_logit": 3.8661446571350098,
            "end_logit": 1.2833261489868164,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Ki67) and autophagy-related factors (Atg5, Atg7, Atg12",
            "probability": 0.0042410212488002,
            "start_logit": 1.369381070137024,
            "end_logit": 3.6312386989593506,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "PCNA and Ki67) and autophagy-related factors (Atg5, Atg7, Atg12",
            "probability": 0.0030909516855250545,
            "start_logit": 1.053056001663208,
            "end_logit": 3.6312386989593506,
            "question_text": "List markers for autophagy."
        }
    ],
    "57090784cf1c325851000011": [
        {
            "text": "Weaver syndrome",
            "probability": 0.8816166815126507,
            "start_logit": 5.689672470092773,
            "end_logit": 5.594993591308594,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590). EED-associated overgrowth (Cohen-Gibson syndrome",
            "probability": 0.06758569283190217,
            "start_logit": 5.689672470092773,
            "end_logit": 3.02663254737854,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver",
            "probability": 0.03983895547859707,
            "start_logit": 5.689672470092773,
            "end_logit": 2.4980814456939697,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Cohen-Gibson syndrome",
            "probability": 0.004893069518864476,
            "start_logit": 3.064095973968506,
            "end_logit": 3.02663254737854,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590)",
            "probability": 0.002159805873983392,
            "start_logit": 5.689672470092773,
            "end_logit": -0.4167454242706299,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590).",
            "probability": 0.0006258060201198661,
            "start_logit": 5.689672470092773,
            "end_logit": -1.655478596687317,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "OGID), along with other features similar to Weaver syndrome",
            "probability": 0.000548327477152556,
            "start_logit": 0.9388434290885925,
            "end_logit": 2.9631826877593994,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "OGID",
            "probability": 0.0005483165938666867,
            "start_logit": 1.7860480546951294,
            "end_logit": 2.1159582138061523,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590). EED-associated overgrowth",
            "probability": 0.000525894941304022,
            "start_logit": 5.689672470092773,
            "end_logit": -1.8294175863265991,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Weaver syndrome (OMIM #277590). EED-associated overgrowth (Cohen-Gibson",
            "probability": 0.0005165483666272045,
            "start_logit": 5.689672470092773,
            "end_logit": -1.8473501205444336,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "classical Weaver syndrome",
            "probability": 0.00035404811982182416,
            "start_logit": -2.1304073333740234,
            "end_logit": 5.594993591308594,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "syndrome",
            "probability": 0.00019967634174268719,
            "start_logit": -2.7031424045562744,
            "end_logit": 5.594993591308594,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "dysmorphic features to classical Weaver syndrome",
            "probability": 0.0001276092912436577,
            "start_logit": -3.150866985321045,
            "end_logit": 5.594993591308594,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "overgrowth (Cohen-Gibson syndrome",
            "probability": 0.00010614293252443323,
            "start_logit": -0.7666925191879272,
            "end_logit": 3.02663254737854,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "EZH2), has a phenotypic spectrum ranging from tall stature without obvious intellectual disability or dysmorphic features to classical Weaver syndrome",
            "probability": 8.484910859657672e-05,
            "start_logit": -3.5589656829833984,
            "end_logit": 5.594993591308594,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "tall stature without obvious intellectual disability or dysmorphic features to classical Weaver syndrome",
            "probability": 7.977029991935242e-05,
            "start_logit": -3.6206889152526855,
            "end_logit": 5.594993591308594,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "EED-associated overgrowth (Cohen-Gibson syndrome",
            "probability": 6.828909858445035e-05,
            "start_logit": -1.2077289819717407,
            "end_logit": 3.02663254737854,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "(Cohen-Gibson syndrome",
            "probability": 5.597740620760027e-05,
            "start_logit": -1.4065309762954712,
            "end_logit": 3.02663254737854,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Cohen-Gibson",
            "probability": 3.739707269183691e-05,
            "start_logit": 3.064095973968506,
            "end_logit": -1.8473501205444336,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "classical Weaver syndrome (OMIM #277590). EED-associated overgrowth (Cohen-Gibson syndrome",
            "probability": 2.7141713599309817e-05,
            "start_logit": -2.1304073333740234,
            "end_logit": 3.02663254737854,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        }
    ],
    "56ebfa13107309bc2f000004": [
        {
            "text": "topologically associating domains",
            "probability": 0.12191724791573816,
            "start_logit": 3.445733070373535,
            "end_logit": 2.3632400035858154,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "active) and B- (inactive) compartments, which are then further partitioned into topologically associating domains",
            "probability": 0.11091154811694605,
            "start_logit": 3.351123571395874,
            "end_logit": 2.3632400035858154,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "active",
            "probability": 0.09986681298397455,
            "start_logit": 3.351123571395874,
            "end_logit": 2.2583444118499756,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "active) and B- (inactive",
            "probability": 0.07519120005302402,
            "start_logit": 3.351123571395874,
            "end_logit": 1.974541187286377,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "topologically associating domains (TADs), each of which is made up from multiple loops stabilized mainly by the CTCF",
            "probability": 0.06922375498132963,
            "start_logit": 3.445733070373535,
            "end_logit": 1.7972415685653687,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "inactive) compartments, which are then further partitioned into topologically associating domains",
            "probability": 0.061833991913620726,
            "start_logit": 2.766843795776367,
            "end_logit": 2.3632400035858154,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "topologically associating domains (TADs",
            "probability": 0.04952021060607004,
            "start_logit": 3.445733070373535,
            "end_logit": 1.4622783660888672,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "folding",
            "probability": 0.04834036799123463,
            "start_logit": 2.341395378112793,
            "end_logit": 2.5425021648406982,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "active) and B- (inactive) compartments, which are then further partitioned into topologically associating domains (TADs",
            "probability": 0.045049927842797356,
            "start_logit": 3.351123571395874,
            "end_logit": 1.4622783660888672,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "inactive",
            "probability": 0.04191963898251414,
            "start_logit": 2.766843795776367,
            "end_logit": 1.974541187286377,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "associating domains",
            "probability": 0.0413911850600208,
            "start_logit": 2.3654584884643555,
            "end_logit": 2.3632400035858154,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "folding of chromosomes dividing chromosomal territories into A- (active",
            "probability": 0.03638327659318861,
            "start_logit": 2.341395378112793,
            "end_logit": 2.2583444118499756,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "CTCF",
            "probability": 0.029297732619502876,
            "start_logit": 2.5858991146087646,
            "end_logit": 1.7972415685653687,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "folding of chromosomes dividing chromosomal territories into A- (active) and B- (inactive",
            "probability": 0.027393506883432277,
            "start_logit": 2.341395378112793,
            "end_logit": 1.974541187286377,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "A- (active) and B- (inactive) compartments, which are then further partitioned into topologically associating domains",
            "probability": 0.025185215680995222,
            "start_logit": 1.8686476945877075,
            "end_logit": 2.3632400035858154,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "inactive) compartments, which are then further partitioned into topologically associating domains (TADs",
            "probability": 0.025115661274546012,
            "start_logit": 2.766843795776367,
            "end_logit": 1.4622783660888672,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "cohesin chromatin-binding complexes",
            "probability": 0.023678902350450042,
            "start_logit": 2.677745819091797,
            "end_logit": 1.4924691915512085,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "associating domains (TADs), each of which is made up from multiple loops stabilized mainly by the CTCF",
            "probability": 0.023501623453328284,
            "start_logit": 2.3654584884643555,
            "end_logit": 1.7972415685653687,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "A- (active",
            "probability": 0.022677234851351997,
            "start_logit": 1.8686476945877075,
            "end_logit": 2.2583444118499756,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "CTCF and cohesin chromatin-binding complexes",
            "probability": 0.021600959845934336,
            "start_logit": 2.5858991146087646,
            "end_logit": 1.4924691915512085,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        }
    ],
    "533c2230c45e133714000002": [
        {
            "text": "autophagy",
            "probability": 0.09467301273924647,
            "start_logit": 4.303925037384033,
            "end_logit": 4.377879619598389,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "apoptosis",
            "probability": 0.09116187545727285,
            "start_logit": 4.313366413116455,
            "end_logit": 4.33064603805542,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "autophagy, apoptosis",
            "probability": 0.09030523224720749,
            "start_logit": 4.303925037384033,
            "end_logit": 4.33064603805542,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "tumour suppression",
            "probability": 0.08590097771560169,
            "start_logit": 4.4179911613464355,
            "end_logit": 4.166579723358154,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "apoptosis, DNA repair, and tumour suppression",
            "probability": 0.07736778370272143,
            "start_logit": 4.313366413116455,
            "end_logit": 4.166579723358154,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "autophagy, apoptosis, DNA repair, and tumour suppression",
            "probability": 0.07664076282634856,
            "start_logit": 4.303925037384033,
            "end_logit": 4.166579723358154,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "apoptosis, DNA repair",
            "probability": 0.0609229794869794,
            "start_logit": 4.313366413116455,
            "end_logit": 3.927619695663452,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "autophagy, apoptosis, DNA repair",
            "probability": 0.0603504895458424,
            "start_logit": 4.303925037384033,
            "end_logit": 3.927619695663452,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "DNA repair, and tumour suppression",
            "probability": 0.05902041254711936,
            "start_logit": 4.042679309844971,
            "end_logit": 4.166579723358154,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "DNA repair",
            "probability": 0.046475408895482344,
            "start_logit": 4.042679309844971,
            "end_logit": 3.927619695663452,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy",
            "probability": 0.03377892267579139,
            "start_logit": 3.2733330726623535,
            "end_logit": 4.377879619598389,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy, apoptosis",
            "probability": 0.0322205174319256,
            "start_logit": 3.2733330726623535,
            "end_logit": 4.33064603805542,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy",
            "probability": 0.031171077840511457,
            "start_logit": 3.1929867267608643,
            "end_logit": 4.377879619598389,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy, apoptosis",
            "probability": 0.029732986648857904,
            "start_logit": 3.1929867267608643,
            "end_logit": 4.33064603805542,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy, apoptosis, DNA repair, and tumour suppression",
            "probability": 0.02734509366946233,
            "start_logit": 3.2733330726623535,
            "end_logit": 4.166579723358154,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy, apoptosis, DNA repair, and tumour suppression",
            "probability": 0.025233961766867315,
            "start_logit": 3.1929867267608643,
            "end_logit": 4.166579723358154,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation, autophagy, apoptosis, DNA repair",
            "probability": 0.021532794413439863,
            "start_logit": 3.2733330726623535,
            "end_logit": 3.927619695663452,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation, autophagy, apoptosis, DNA repair",
            "probability": 0.0198703912859275,
            "start_logit": 3.1929867267608643,
            "end_logit": 3.927619695663452,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "cellular differentiation",
            "probability": 0.018876316670374604,
            "start_logit": 3.2733330726623535,
            "end_logit": 3.7959506511688232,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation",
            "probability": 0.01741900243301959,
            "start_logit": 3.1929867267608643,
            "end_logit": 3.7959506511688232,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        }
    ],
    "514241fcd24251bc05000006": [
        {
            "text": "SFPQ",
            "probability": 0.8275227477105052,
            "start_logit": 6.035194396972656,
            "end_logit": 5.378966808319092,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA:DNA hybrid related telomere instability. NONO and SFPQ",
            "probability": 0.17054104069960235,
            "start_logit": 5.322572708129883,
            "end_logit": 4.512127876281738,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "TERRA binding proteins NONO and SFPQ",
            "probability": 0.0005136660391435298,
            "start_logit": -0.40855005383491516,
            "end_logit": 4.4380927085876465,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA binding proteins SFPQ",
            "probability": 0.00046343369086428214,
            "start_logit": 0.701932430267334,
            "end_logit": 3.2247002124786377,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "S",
            "probability": 0.0002588405429649019,
            "start_logit": 6.035194396972656,
            "end_logit": -2.6910128593444824,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA:DNA hybrid related telomere instability. NONO and SFPQ",
            "probability": 0.00023753429674110862,
            "start_logit": -1.253846526145935,
            "end_logit": 4.512127876281738,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "NONO and SFPQ",
            "probability": 0.00010331973166781728,
            "start_logit": -2.953169107437134,
            "end_logit": 5.378966808319092,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "Q",
            "probability": 0.00010326400144693944,
            "start_logit": -2.9537086486816406,
            "end_logit": 5.378966808319092,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA:DNA hybrid related telomere instability.",
            "probability": 4.941019391364132e-05,
            "start_logit": 5.322572708129883,
            "end_logit": -3.634446620941162,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA:DNA hybrid related telomere instability. NONO and S",
            "probability": 4.394307776637284e-05,
            "start_logit": 5.322572708129883,
            "end_logit": -3.7517082691192627,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SF",
            "probability": 4.140678355110245e-05,
            "start_logit": 6.035194396972656,
            "end_logit": -4.523780345916748,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "FPQ",
            "probability": 4.0570341024881104e-05,
            "start_logit": -3.887960195541382,
            "end_logit": 5.378966808319092,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ as novel regulators of RNA:DNA",
            "probability": 3.082118911517897e-05,
            "start_logit": 5.322572708129883,
            "end_logit": -4.106400966644287,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "Q as novel regulators of RNA:DNA hybrid related telomere instability. NONO and SFPQ",
            "probability": 2.1748614381469774e-05,
            "start_logit": -3.644608497619629,
            "end_logit": 4.512127876281738,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "DNA hybrid related telomere instability. NONO and SFPQ",
            "probability": 8.24132129792499e-06,
            "start_logit": -4.614997863769531,
            "end_logit": 4.512127876281738,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "SFPQ and NONO",
            "probability": 7.592105282417375e-06,
            "start_logit": 3.676070213317871,
            "end_logit": -3.860991954803467,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "proteins NONO and SFPQ",
            "probability": 5.7180661851931786e-06,
            "start_logit": -4.906492710113525,
            "end_logit": 4.4380927085876465,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA",
            "probability": 4.226710509693741e-06,
            "start_logit": 0.701932430267334,
            "end_logit": -1.4725390672683716,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "TERRA",
            "probability": 1.282454055737031e-06,
            "start_logit": -0.40855005383491516,
            "end_logit": -1.5547051429748535,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "NONO/SFPQ",
            "probability": 1.1924299801197966e-06,
            "start_logit": -3.6801702976226807,
            "end_logit": 1.6441328525543213,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        }
    ],
    "531376c8e3eabad021000012": [
        {
            "text": "R9C PLN mutation",
            "probability": 0.47614213928242777,
            "start_logit": -1.0328484773635864,
            "end_logit": -2.1954662799835205,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "R9C PLN",
            "probability": 0.34333167709366985,
            "start_logit": -1.0328484773635864,
            "end_logit": -2.5224857330322266,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "R9C",
            "probability": 0.04064543169992044,
            "start_logit": -1.0328484773635864,
            "end_logit": -4.656296253204346,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN mutation",
            "probability": 0.026452128696959194,
            "start_logit": -3.9232282638549805,
            "end_logit": -2.1954662799835205,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "R9C PLN mutation showed activation of a hypertrophic phenotype,",
            "probability": 0.025414639045208087,
            "start_logit": -1.0328484773635864,
            "end_logit": -5.125857353210449,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban",
            "probability": 0.02418757493514578,
            "start_logit": -2.8139381408691406,
            "end_logit": -3.394253969192505,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN",
            "probability": 0.019073828924092796,
            "start_logit": -3.9232282638549805,
            "end_logit": -2.5224857330322266,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutation",
            "probability": 0.008260848742911485,
            "start_logit": -5.087037563323975,
            "end_logit": -2.1954662799835205,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban (PLN)",
            "probability": 0.007627479773783289,
            "start_logit": -2.8139381408691406,
            "end_logit": -4.548335552215576,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban (PLN).",
            "probability": 0.0068457725951655635,
            "start_logit": -2.8139381408691406,
            "end_logit": -4.656461715698242,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban (PLN). We used CRISPR/Cas9 to insert the R9C PLN",
            "probability": 0.005483302109705062,
            "start_logit": -2.8139381408691406,
            "end_logit": -4.878385543823242,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban (PLN). We used CRISPR/Cas9 to insert the R9C PLN mutation",
            "probability": 0.004145511938745029,
            "start_logit": -2.8139381408691406,
            "end_logit": -5.158066749572754,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "mutations in the cardiac protein phospholamban",
            "probability": 0.002151348928786912,
            "start_logit": -5.233682155609131,
            "end_logit": -3.394253969192505,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "phospholamban (PLN",
            "probability": 0.00212284911992168,
            "start_logit": -2.8139381408691406,
            "end_logit": -5.827333927154541,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "by mutations in the cardiac protein phospholamban",
            "probability": 0.0015400663971344593,
            "start_logit": -5.567951679229736,
            "end_logit": -3.394253969192505,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(PLN)",
            "probability": 0.0014509600135941454,
            "start_logit": -4.473470211029053,
            "end_logit": -4.548335552215576,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN mutation showed activation of a hypertrophic phenotype,",
            "probability": 0.0014119130556765212,
            "start_logit": -3.9232282638549805,
            "end_logit": -5.125857353210449,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(PLN).",
            "probability": 0.0013022574418203982,
            "start_logit": -4.473470211029053,
            "end_logit": -4.656461715698242,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Dilated cardiomyopathy (DCM) can be caused by mutations in the cardiac protein phospholamban",
            "probability": 0.0012090978968339137,
            "start_logit": -5.809902667999268,
            "end_logit": -3.394253969192505,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "cardiac protein phospholamban",
            "probability": 0.0012011723084982145,
            "start_logit": -5.816479206085205,
            "end_logit": -3.394253969192505,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "5312280ce3eabad02100000a": [
        {
            "text": "17",
            "probability": 0.14931564571847322,
            "start_logit": 0.5223694443702698,
            "end_logit": 0.11345621943473816,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6q, and 17",
            "probability": 0.14064851601867337,
            "start_logit": 0.4625709354877472,
            "end_logit": 0.11345621943473816,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6",
            "probability": 0.13109690323609519,
            "start_logit": 0.4625709354877472,
            "end_logit": 0.043129004538059235,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3",
            "probability": 0.11562871050828283,
            "start_logit": 0.1964205801486969,
            "end_logit": 0.18372687697410583,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6q, and 17",
            "probability": 0.10778231903617899,
            "start_logit": 0.1964205801486969,
            "end_logit": 0.11345621943473816,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6",
            "probability": 0.10046268989693372,
            "start_logit": 0.1964205801486969,
            "end_logit": 0.043129004538059235,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "studies have indicated that susceptibility loci for the disease are located on chromosomes 3",
            "probability": 0.02490109117857813,
            "start_logit": -1.3390520811080933,
            "end_logit": 0.18372687697410583,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "studies have indicated that susceptibility loci for the disease are located on chromosomes 3p, 6q, and 17",
            "probability": 0.023211340349300485,
            "start_logit": -1.3390520811080933,
            "end_logit": 0.11345621943473816,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "12",
            "probability": 0.02252918644890993,
            "start_logit": -0.41276147961616516,
            "end_logit": -0.8426637053489685,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "studies have indicated that susceptibility loci for the disease are located on chromosomes 3p, 6",
            "probability": 0.02163502983101733,
            "start_logit": -1.3390520811080933,
            "end_logit": 0.043129004538059235,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "8q23 [maximum LOD score (MLS) of 3.6] and suggestive evidence for linkage to 12",
            "probability": 0.019545779506220332,
            "start_logit": -0.5548137426376343,
            "end_logit": -0.8426637053489685,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "susceptibility loci for the disease are located on chromosomes 3",
            "probability": 0.01849921594288651,
            "start_logit": -1.6362353563308716,
            "end_logit": 0.18372687697410583,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6q",
            "probability": 0.017468918088275904,
            "start_logit": 0.4625709354877472,
            "end_logit": -1.9723845720291138,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "susceptibility loci for the disease are located on chromosomes 3p, 6q, and 17",
            "probability": 0.01724388679862113,
            "start_logit": -1.6362353563308716,
            "end_logit": 0.11345621943473816,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "8",
            "probability": 0.01720635435752499,
            "start_logit": -0.5548137426376343,
            "end_logit": -0.9701443314552307,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q",
            "probability": 0.01627929604335239,
            "start_logit": 0.5223694443702698,
            "end_logit": -2.1027121543884277,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "susceptibility loci for the disease are located on chromosomes 3p, 6",
            "probability": 0.016072833351138092,
            "start_logit": -1.6362353563308716,
            "end_logit": 0.043129004538059235,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "6q, and 17q",
            "probability": 0.015334353070027274,
            "start_logit": 0.4625709354877472,
            "end_logit": -2.1027121543884277,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6q",
            "probability": 0.013386849402360231,
            "start_logit": 0.1964205801486969,
            "end_logit": -1.9723845720291138,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "3p, 6q, and 17q",
            "probability": 0.01175108121715026,
            "start_logit": 0.1964205801486969,
            "end_logit": -2.1027121543884277,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        }
    ],
    "532ad23ad6d3ac6a34000011": [
        {
            "text": "N2",
            "probability": 0.5306336294440291,
            "start_logit": -0.9311685562133789,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "N2 numbering",
            "probability": 0.3199614512829286,
            "start_logit": -0.9311685562133789,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "N2 numbering). From the location of these residues on the three-dimensional structure of the N8 NA,",
            "probability": 0.020393159972110924,
            "start_logit": -0.9311685562133789,
            "end_logit": -5.569146156311035,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "400 (N2",
            "probability": 0.018919304675027747,
            "start_logit": -4.265057563781738,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "(N2",
            "probability": 0.014186799622603536,
            "start_logit": -4.552928447723389,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "150, 199, 367, 399, and 400 (N2",
            "probability": 0.01159134684546931,
            "start_logit": -4.754981517791748,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "400 (N2 numbering",
            "probability": 0.011407961812424644,
            "start_logit": -4.265057563781738,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "199, 367, 399, and 400 (N2",
            "probability": 0.009298989437505406,
            "start_logit": -4.975334644317627,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "(N2 numbering",
            "probability": 0.008554356046118495,
            "start_logit": -4.552928447723389,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "367, 399, and 400 (N2",
            "probability": 0.00796185756335539,
            "start_logit": -5.13057804107666,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "150, 199, 367, 399, and 400 (N2 numbering",
            "probability": 0.006989350001970346,
            "start_logit": -4.754981517791748,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "399, and 400 (N2",
            "probability": 0.006455772069043805,
            "start_logit": -5.34026575088501,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "199, 367, 399, and 400 (N2 numbering",
            "probability": 0.0056071043951855075,
            "start_logit": -4.975334644317627,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "400",
            "probability": 0.004874307601999044,
            "start_logit": -4.265057563781738,
            "end_logit": -3.6664786338806152,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "367, 399, and 400 (N2 numbering",
            "probability": 0.00480084065449881,
            "start_logit": -5.13057804107666,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Group 2 antibodies recognized a novel epitope containing residues 150, 199, 367, 399, and 400 (N2",
            "probability": 0.004731885739844141,
            "start_logit": -5.650916576385498,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "399, and 400 (N2 numbering",
            "probability": 0.0038927012645754828,
            "start_logit": -5.34026575088501,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "epitope containing residues 150, 199, 367, 399, and 400 (N2",
            "probability": 0.003686533820781228,
            "start_logit": -5.9005537033081055,
            "end_logit": -2.3102738857269287,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numbering",
            "probability": 0.0030662911683622483,
            "start_logit": -5.578900337219238,
            "end_logit": -2.816145181655884,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "150, 199, 367, 399, and 400",
            "probability": 0.002986356582166297,
            "start_logit": -4.754981517791748,
            "end_logit": -3.6664786338806152,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        }
    ],
    "5156be75d24251bc05000088": [
        {
            "text": "ischemic cerebrovascular disease",
            "probability": 0.9349938132221679,
            "start_logit": 4.883828639984131,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovascular",
            "probability": 0.04213324921311101,
            "start_logit": 4.883828639984131,
            "end_logit": 1.5913411378860474,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "cerebrovascular disease",
            "probability": 0.016427188174472925,
            "start_logit": 0.842226505279541,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic",
            "probability": 0.0027735444428724767,
            "start_logit": 4.883828639984131,
            "end_logit": -1.1293699741363525,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "cerebrovascular",
            "probability": 0.0007402517572180745,
            "start_logit": 0.842226505279541,
            "end_logit": 1.5913411378860474,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "disease",
            "probability": 0.0005325433523873478,
            "start_logit": -2.5868022441864014,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovascular disease remains unknown.",
            "probability": 0.00037165633175011967,
            "start_logit": 4.883828639984131,
            "end_logit": -3.139281749725342,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic c",
            "probability": 0.00035258314715230966,
            "start_logit": 4.883828639984131,
            "end_logit": -3.191964864730835,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "chemic cerebrovascular disease",
            "probability": 0.0002370752199166742,
            "start_logit": -3.3960890769958496,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "is",
            "probability": 0.00022201789921247252,
            "start_logit": 4.883828639984131,
            "end_logit": -3.6544933319091797,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovas",
            "probability": 0.00019727890724995325,
            "start_logit": 4.883828639984131,
            "end_logit": -3.7726328372955322,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "cular disease",
            "probability": 0.0001921162909476626,
            "start_logit": -3.60636568069458,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "erebrovascular disease",
            "probability": 0.00015050524225343405,
            "start_logit": -3.850468635559082,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebrovascular disease remains unknown",
            "probability": 0.00013787186351750882,
            "start_logit": 4.883828639984131,
            "end_logit": -4.130926609039307,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "vascular disease",
            "probability": 0.00013620080900240725,
            "start_logit": -3.950336217880249,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "brovascular disease",
            "probability": 0.000122273282809553,
            "start_logit": -4.058207988739014,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cerebro",
            "probability": 0.00010835245686088076,
            "start_logit": 4.883828639984131,
            "end_logit": -4.371861934661865,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ischemic cere",
            "probability": 0.0001039973267915656,
            "start_logit": 4.883828639984131,
            "end_logit": -4.412886142730713,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "mic cerebrovascular disease",
            "probability": 5.679783525978976e-05,
            "start_logit": -4.824968338012695,
            "end_logit": 4.691043853759766,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "chemic cerebrovascular",
            "probability": 1.0683225045713606e-05,
            "start_logit": -3.3960890769958496,
            "end_logit": 1.5913411378860474,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        }
    ],
    "57169b63cb4ef8864c00000b": [
        {
            "text": "EAAT5",
            "probability": 0.8773427017686506,
            "start_logit": 2.614112377166748,
            "end_logit": 3.6195497512817383,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "hEAAT5",
            "probability": 0.03302099724912053,
            "start_logit": 1.5272578001022339,
            "end_logit": 1.4266502857208252,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "EAAT5)",
            "probability": 0.0263230458508939,
            "start_logit": 1.7827433347702026,
            "end_logit": 0.9444659352302551,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "EAAT5, hEAAT5",
            "probability": 0.014203266308840867,
            "start_logit": 0.6835861206054688,
            "end_logit": 1.4266502857208252,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "(EAAT5",
            "probability": 0.013892564224358304,
            "start_logit": -1.084438443183899,
            "end_logit": 3.1725566387176514,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "5 (EAAT5",
            "probability": 0.008680889533174113,
            "start_logit": -1.5546681880950928,
            "end_logit": 3.1725566387176514,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "hEAAT5v",
            "probability": 0.007142912394250266,
            "start_logit": 1.5272578001022339,
            "end_logit": -0.10437276214361191,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "5",
            "probability": 0.005880773118905277,
            "start_logit": -1.5546681880950928,
            "end_logit": 2.78312087059021,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "EAAT5, hEAAT5v",
            "probability": 0.003072368959388672,
            "start_logit": 0.6835861206054688,
            "end_logit": -0.10437276214361191,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Excitatory amino acid transporter 5 (EAAT5",
            "probability": 0.0025198974115309457,
            "start_logit": -2.791574001312256,
            "end_logit": 3.1725566387176514,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Excitatory amino acid transporter 5",
            "probability": 0.0017070767809565384,
            "start_logit": -2.791574001312256,
            "end_logit": 2.78312087059021,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "(EAAT5)",
            "probability": 0.0014967005404176428,
            "start_logit": -1.084438443183899,
            "end_logit": 0.9444659352302551,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "EAAT",
            "probability": 0.0010587503970006832,
            "start_logit": 2.614112377166748,
            "end_logit": -3.1002585887908936,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "5 (EAAT5)",
            "probability": 0.0009352263445237146,
            "start_logit": -1.5546681880950928,
            "end_logit": 0.9444659352302551,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "hEAAT5v. Accordingly, we infer that EAAT5",
            "probability": 0.0007141970626926735,
            "start_logit": -2.251067638397217,
            "end_logit": 1.371235728263855,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "E",
            "probability": 0.0006322072304937907,
            "start_logit": 2.614112377166748,
            "end_logit": -3.6158859729766846,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "transporter 5 (EAAT5",
            "probability": 0.00043747218206742413,
            "start_logit": -4.542534351348877,
            "end_logit": 3.1725566387176514,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "We recently identified a human-specific splicing form of EAAT5",
            "probability": 0.000371113474352085,
            "start_logit": -4.653010845184326,
            "end_logit": 3.118527889251709,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "transporter 5",
            "probability": 0.0002963607172674458,
            "start_logit": -4.542534351348877,
            "end_logit": 2.78312087059021,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Excitatory amino acid transporter 5 (EAAT5)",
            "probability": 0.00027147845111434723,
            "start_logit": -2.791574001312256,
            "end_logit": 0.9444659352302551,
            "question_text": "Which are the human glutamate transporters?"
        }
    ],
    "55391ce8bc4f83e828000018": [
        {
            "text": "RAS/MAPK/ERK",
            "probability": 0.09832938252880413,
            "start_logit": 3.390437126159668,
            "end_logit": 2.5419039726257324,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "RAS/MAPK",
            "probability": 0.08000864467608823,
            "start_logit": 3.390437126159668,
            "end_logit": 2.3357157707214355,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "RAS",
            "probability": 0.07736069270468106,
            "start_logit": 3.390437126159668,
            "end_logit": 2.3020598888397217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT",
            "probability": 0.07484931099548572,
            "start_logit": 3.062714099884033,
            "end_logit": 2.596781015396118,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR and RAS/MAPK/ERK",
            "probability": 0.07085247247993717,
            "start_logit": 3.062714099884033,
            "end_logit": 2.5419039726257324,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR and RAS/MAPK",
            "probability": 0.05765123454740519,
            "start_logit": 3.062714099884033,
            "end_logit": 2.3357157707214355,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR",
            "probability": 0.056700426156921106,
            "start_logit": 3.062714099884033,
            "end_logit": 2.3190858364105225,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K/AKT/mTOR and RAS",
            "probability": 0.05574321947238565,
            "start_logit": 3.062714099884033,
            "end_logit": 2.3020598888397217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "MAPK/ERK",
            "probability": 0.05402273238483603,
            "start_logit": 2.7915191650390625,
            "end_logit": 2.5419039726257324,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR and RAS/MAPK/ERK",
            "probability": 0.046130004110225,
            "start_logit": 2.633577823638916,
            "end_logit": 2.5419039726257324,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "MAPK",
            "probability": 0.04395721287625905,
            "start_logit": 2.7915191650390625,
            "end_logit": 2.3357157707214355,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "PI3K",
            "probability": 0.04067444607014661,
            "start_logit": 3.062714099884033,
            "end_logit": 1.9869041442871094,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR and RAS/MAPK",
            "probability": 0.03753505831972774,
            "start_logit": 2.633577823638916,
            "end_logit": 2.3357157707214355,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR",
            "probability": 0.03691601436224994,
            "start_logit": 2.633577823638916,
            "end_logit": 2.3190858364105225,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "mTOR and RAS",
            "probability": 0.03629280465980153,
            "start_logit": 2.633577823638916,
            "end_logit": 2.3020598888397217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT",
            "probability": 0.03151771011818864,
            "start_logit": 2.197786808013916,
            "end_logit": 2.596781015396118,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR and RAS/MAPK/ERK",
            "probability": 0.029834712692469276,
            "start_logit": 2.197786808013916,
            "end_logit": 2.5419039726257324,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR and RAS/MAPK",
            "probability": 0.024275906808686683,
            "start_logit": 2.197786808013916,
            "end_logit": 2.3357157707214355,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR",
            "probability": 0.023875538350638673,
            "start_logit": 2.197786808013916,
            "end_logit": 2.3190858364105225,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "AKT/mTOR and RAS",
            "probability": 0.02347247568506249,
            "start_logit": 2.197786808013916,
            "end_logit": 2.3020598888397217,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        }
    ],
    "51542dc3d24251bc0500007e": [
        {
            "text": "toxic epidermal necrolysis",
            "probability": 0.44130241815434806,
            "start_logit": 3.980304718017578,
            "end_logit": 3.209462881088257,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis",
            "probability": 0.23323132957790513,
            "start_logit": 3.3426051139831543,
            "end_logit": 3.209462881088257,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Stevens-Johnson syndrome",
            "probability": 0.1752037316687652,
            "start_logit": 3.3426051139831543,
            "end_logit": 2.9233815670013428,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome (DIHS) and Stevens-Johnson syndrome",
            "probability": 0.03145184020091088,
            "start_logit": 1.6251131296157837,
            "end_logit": 2.9233815670013428,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "eosinophilia",
            "probability": 0.0312726983921956,
            "start_logit": 1.9635196924209595,
            "end_logit": 2.5792629718780518,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug-induced hypersensitivity syndrome (DIHS) and Stevens-Johnson syndrome",
            "probability": 0.01808409633677149,
            "start_logit": 1.0716885328292847,
            "end_logit": 2.9233815670013428,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "eosinophilia and systemic symptoms",
            "probability": 0.017206822008040804,
            "start_logit": 1.9635196924209595,
            "end_logit": 1.981823444366455,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "systemic symptoms",
            "probability": 0.012266836122584125,
            "start_logit": 1.6251131296157837,
            "end_logit": 1.981823444366455,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "epidermal necrolysis",
            "probability": 0.009428637770356482,
            "start_logit": 0.13432595133781433,
            "end_logit": 3.209462881088257,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug reaction with eosinophilia",
            "probability": 0.005078003218671041,
            "start_logit": 0.1456923484802246,
            "end_logit": 2.5792629718780518,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Johnson syndrome (SJS)/toxic epidermal necrolysis",
            "probability": 0.00426780603686771,
            "start_logit": -0.6583257913589478,
            "end_logit": 3.209462881088257,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "Johnson syndrome",
            "probability": 0.003205982425478323,
            "start_logit": -0.6583257913589478,
            "end_logit": 2.9233815670013428,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "cutaneous adverse reactions include syndromes such as drug reaction with eosinophilia",
            "probability": 0.003172222258709722,
            "start_logit": -0.32479339838027954,
            "end_logit": 2.5792629718780518,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "eosinophilia and systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome",
            "probability": 0.003000452758166325,
            "start_logit": 1.9635196924209595,
            "end_logit": 0.23528070747852325,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "drug reaction with eosinophilia and systemic symptoms",
            "probability": 0.0027940120946434383,
            "start_logit": 0.1456923484802246,
            "end_logit": 1.981823444366455,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "systemic symptoms (DRESS) or drug-induced hypersensitivity syndrome",
            "probability": 0.0021390389382061514,
            "start_logit": 1.6251131296157837,
            "end_logit": 0.23528070747852325,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "necrolysis",
            "probability": 0.0019194932864366131,
            "start_logit": -1.4573644399642944,
            "end_logit": 3.209462881088257,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "eosinophilia and systemic",
            "probability": 0.0018851962943965978,
            "start_logit": 1.9635196924209595,
            "end_logit": -0.2294505387544632,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "cutaneous adverse reactions include syndromes such as drug reaction with eosinophilia and systemic symptoms",
            "probability": 0.0017454158605381266,
            "start_logit": -0.32479339838027954,
            "end_logit": 1.981823444366455,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "systemic",
            "probability": 0.0013439665960082198,
            "start_logit": 1.6251131296157837,
            "end_logit": -0.2294505387544632,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        }
    ],
    "51595fb0d24251bc0500009c": [
        {
            "text": "D-3-phosphoglycerate dehydrogenase",
            "probability": 0.2575282589635282,
            "start_logit": 3.7764594554901123,
            "end_logit": 3.561744451522827,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "D-3-phosphoglycerate dehydrogenase (Phgdh)",
            "probability": 0.20561300802313395,
            "start_logit": 3.7764594554901123,
            "end_logit": 3.336610794067383,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Phgdh)",
            "probability": 0.17703300188792945,
            "start_logit": 3.6267998218536377,
            "end_logit": 3.336610794067383,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "D-3-phosphoglycerate dehydrogenase (Phgdh",
            "probability": 0.07189266604975375,
            "start_logit": 3.7764594554901123,
            "end_logit": 2.2857892513275146,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "phosphoglycerate dehydrogenase",
            "probability": 0.06319062494696051,
            "start_logit": 2.371485948562622,
            "end_logit": 3.561744451522827,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Phgdh",
            "probability": 0.06189965609122529,
            "start_logit": 3.6267998218536377,
            "end_logit": 2.2857892513275146,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "phosphoglycerate dehydrogenase (Phgdh)",
            "probability": 0.05045199515772874,
            "start_logit": 2.371485948562622,
            "end_logit": 3.336610794067383,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "D-3-phosphoglycerate dehydrogenase (Phgdh),",
            "probability": 0.037065535849786134,
            "start_logit": 3.7764594554901123,
            "end_logit": 1.6233025789260864,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Phgdh),",
            "probability": 0.03191346277728704,
            "start_logit": 3.6267998218536377,
            "end_logit": 1.6233025789260864,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "phosphoglycerate dehydrogenase (Phgdh",
            "probability": 0.01764055919560444,
            "start_logit": 2.371485948562622,
            "end_logit": 2.2857892513275146,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "phosphoglycerate dehydrogenase (Phgdh),",
            "probability": 0.009094902376028809,
            "start_logit": 2.371485948562622,
            "end_logit": 1.6233025789260864,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "(Phgdh)",
            "probability": 0.00412683576125824,
            "start_logit": -0.13202539086341858,
            "end_logit": 3.336610794067383,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "D-3-phosphoglycerate dehydrogenase (Phgdh), a candidate oncogene",
            "probability": 0.0036461251069595906,
            "start_logit": 3.7764594554901123,
            "end_logit": -0.6957200169563293,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Phgdh), a candidate oncogene",
            "probability": 0.0031393172987935637,
            "start_logit": 3.6267998218536377,
            "end_logit": -0.6957200169563293,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "(Phgdh",
            "probability": 0.001442949685327977,
            "start_logit": -0.13202539086341858,
            "end_logit": 2.2857892513275146,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "3-phosphoglycerate dehydrogenase",
            "probability": 0.0010491796346161406,
            "start_logit": -1.7266614437103271,
            "end_logit": 3.561744451522827,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "phosphoglycerate dehydrogenase (Phgdh), a candidate oncogene",
            "probability": 0.0008946626870032531,
            "start_logit": 2.371485948562622,
            "end_logit": -0.6957200169563293,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "3-phosphoglycerate dehydrogenase (Phgdh)",
            "probability": 0.0008376749856433764,
            "start_logit": -1.7266614437103271,
            "end_logit": 3.336610794067383,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "D-3",
            "probability": 0.0007956452836433817,
            "start_logit": 3.7764594554901123,
            "end_logit": -2.217986822128296,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "(Phgdh),",
            "probability": 0.0007439382377883725,
            "start_logit": -0.13202539086341858,
            "end_logit": 1.6233025789260864,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        }
    ],
    "5547d700f35db75526000007": [
        {
            "text": "Speech Motor Delay",
            "probability": 0.21250818718022335,
            "start_logit": 5.413477897644043,
            "end_logit": 5.350466728210449,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Speech Motor Delay (26.7%), Childhood Dysarthria",
            "probability": 0.1488278562573732,
            "start_logit": 5.413477897644043,
            "end_logit": 4.994276523590088,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Speech Motor Delay (26.7%), Childhood Dysarthria and Childhood Apraxia of Speech",
            "probability": 0.09883476866860141,
            "start_logit": 5.413477897644043,
            "end_logit": 4.584935665130615,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria (37.8%), Speech Motor Delay",
            "probability": 0.09132287425543363,
            "start_logit": 4.568898677825928,
            "end_logit": 5.350466728210449,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Ataxia",
            "probability": 0.07028075526189269,
            "start_logit": 4.9175896644592285,
            "end_logit": 4.739872455596924,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria (37.8%), Speech Motor Delay (26.7%), Childhood Dysarthria",
            "probability": 0.06395700694190806,
            "start_logit": 4.568898677825928,
            "end_logit": 4.994276523590088,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech (11.1%). Ataxia",
            "probability": 0.05911018592748268,
            "start_logit": 4.744494915008545,
            "end_logit": 4.739872455596924,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria",
            "probability": 0.04824267139222713,
            "start_logit": 4.568898677825928,
            "end_logit": 4.71230936050415,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Speech Motor Delay (26.7%), Childhood Dysarthria and Childhood Apraxia",
            "probability": 0.03713341767684316,
            "start_logit": 5.413477897644043,
            "end_logit": 3.606003522872925,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech (22.2%), and Childhood Apraxia of Speech (11.1%). Ataxia",
            "probability": 0.03456650547538229,
            "start_logit": 4.207976818084717,
            "end_logit": 4.739872455596924,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech",
            "probability": 0.021874373736020008,
            "start_logit": 4.744494915008545,
            "end_logit": 3.7457849979400635,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria and Childhood Apraxia of Speech (22.2%), and Childhood Apraxia of Speech",
            "probability": 0.01902088651050743,
            "start_logit": 4.604716777801514,
            "end_logit": 3.7457849979400635,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Dysarthria and Childhood Apraxia of Speech",
            "probability": 0.018193814256946682,
            "start_logit": 4.604716777801514,
            "end_logit": 3.701328992843628,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Apraxia of Speech (22.2%), and Childhood Apraxia of Speech (11.1%). Ataxia",
            "probability": 0.015295201637987227,
            "start_logit": 3.3926308155059814,
            "end_logit": 4.739872455596924,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Dysarthria (37.8%), Speech Motor Delay",
            "probability": 0.014286819235953329,
            "start_logit": 2.713834762573242,
            "end_logit": 5.350466728210449,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Childhood Apraxia of Speech (22.2%), and Childhood Apraxia of Speech",
            "probability": 0.012791715127479298,
            "start_logit": 4.207976818084717,
            "end_logit": 3.7457849979400635,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Dysarthria (37.8%), Speech Motor Delay (26.7%), Childhood Dysarthria",
            "probability": 0.010005622408421795,
            "start_logit": 2.713834762573242,
            "end_logit": 4.994276523590088,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Speech Motor Delay (26.7%)",
            "probability": 0.00880310270550137,
            "start_logit": 5.413477897644043,
            "end_logit": 2.166590452194214,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Dysarthria",
            "probability": 0.007547225503573516,
            "start_logit": 2.713834762573242,
            "end_logit": 4.71230936050415,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "Ataxia was the most prevalent dysarthria",
            "probability": 0.007397009840241658,
            "start_logit": 4.9175896644592285,
            "end_logit": 2.488450288772583,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        }
    ],
    "531b1e3cb166e2b80600003b": [
        {
            "text": "H3K27me3",
            "probability": 0.8242215105466417,
            "start_logit": 3.2837705612182617,
            "end_logit": 2.695218086242676,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "met",
            "probability": 0.0590714453995695,
            "start_logit": 3.368955373764038,
            "end_logit": -0.025658393278717995,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "PRC2), a widely conserved PcG protein complex which functions as a H3K27me3",
            "probability": 0.0444685463957072,
            "start_logit": 0.36411336064338684,
            "end_logit": 2.695218086242676,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone met",
            "probability": 0.022191617368986626,
            "start_logit": 3.2837705612182617,
            "end_logit": -0.9195066094398499,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "methylation",
            "probability": 0.019959827902532232,
            "start_logit": 3.368955373764038,
            "end_logit": -1.1106843948364258,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H",
            "probability": 0.010266659393673242,
            "start_logit": 3.2837705612182617,
            "end_logit": -1.690319538116455,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "3",
            "probability": 0.00280429099703228,
            "start_logit": -2.3995180130004883,
            "end_logit": 2.695218086242676,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "K27me3",
            "probability": 0.002000927517431699,
            "start_logit": -2.73705792427063,
            "end_logit": 2.695218086242676,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone methyltransferase",
            "probability": 0.0017917242876452108,
            "start_logit": 3.2837705612182617,
            "end_logit": -3.4360427856445312,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 his",
            "probability": 0.0016652307060258421,
            "start_logit": 3.2837705612182617,
            "end_logit": -3.5092575550079346,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "(PRC2), a widely conserved PcG protein complex which functions as a H3K27me3",
            "probability": 0.0016316161386003684,
            "start_logit": -2.9410977363586426,
            "end_logit": 2.695218086242676,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me",
            "probability": 0.0015587527259461468,
            "start_logit": 3.2837705612182617,
            "end_logit": -3.5753352642059326,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "me3",
            "probability": 0.0015220631631365378,
            "start_logit": -3.0106019973754883,
            "end_logit": 2.695218086242676,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "PRC2), a widely conserved PcG protein complex which functions as a H3K27me3 histone met",
            "probability": 0.001197286110519097,
            "start_logit": 0.36411336064338684,
            "end_logit": -0.9195066094398499,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "methyl",
            "probability": 0.0011704325174325839,
            "start_logit": 3.368955373764038,
            "end_logit": -3.9470326900482178,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27",
            "probability": 0.0010377589411408054,
            "start_logit": 3.2837705612182617,
            "end_logit": -3.9821577072143555,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "PRC2",
            "probability": 0.00092980043366517,
            "start_logit": 0.36411336064338684,
            "end_logit": -1.1723493337631226,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone methyltransferase.",
            "probability": 0.0008881206747746033,
            "start_logit": 3.2837705612182617,
            "end_logit": -4.137868881225586,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3K27me3 histone",
            "probability": 0.0008848392073728684,
            "start_logit": 3.2837705612182617,
            "end_logit": -4.141570568084717,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "H3",
            "probability": 0.0007375495721659576,
            "start_logit": 3.2837705612182617,
            "end_logit": -4.323643207550049,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        }
    ],
    "56bb616dac7ad10019000008": [
        {
            "text": "warfarin",
            "probability": 0.32534357790087587,
            "start_logit": 5.423335552215576,
            "end_logit": 5.058692455291748,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban (15/10\u00a0mg/d) and warfarin",
            "probability": 0.260295706586035,
            "start_logit": 5.200272083282471,
            "end_logit": 5.058692455291748,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban",
            "probability": 0.21471110090123985,
            "start_logit": 5.200272083282471,
            "end_logit": 4.8661675453186035,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban (20/15\u00a0mg/d) versus warfarin",
            "probability": 0.1101229433677097,
            "start_logit": 4.72029447555542,
            "end_logit": 4.6784491539001465,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban",
            "probability": 0.044094127189907614,
            "start_logit": 4.278208255767822,
            "end_logit": 4.205264568328857,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin in Japanese patients with atrial fibrillation. Data about rivaroxaban",
            "probability": 0.032681579278562786,
            "start_logit": 5.423335552215576,
            "end_logit": 2.760622262954712,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban following J-ROCKET AF criteria compared with warfarin",
            "probability": 0.006882654370833782,
            "start_logit": 2.9051949977874756,
            "end_logit": 3.7209556102752686,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban (15/10\u00a0mg/d)",
            "probability": 0.0024969102540850887,
            "start_logit": 5.200272083282471,
            "end_logit": 0.4119282066822052,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban (20/15\u00a0mg/d)",
            "probability": 0.0024898388530969315,
            "start_logit": 4.72029447555542,
            "end_logit": 0.8890697360038757,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfari",
            "probability": 0.00022886826493184338,
            "start_logit": 5.423335552215576,
            "end_logit": -2.2007980346679688,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin in patients with atrial fibrillation",
            "probability": 0.00015088306033999611,
            "start_logit": 5.02394437789917,
            "end_logit": -2.218048334121704,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban (20/15\u00a0mg/d) versus warfarin in patients with atrial fibrillation.",
            "probability": 0.00011136968907790567,
            "start_logit": 4.72029447555542,
            "end_logit": -2.218048334121704,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "ban",
            "probability": 6.153681914433282e-05,
            "start_logit": -2.9571409225463867,
            "end_logit": 4.8661675453186035,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) evaluated rivaroxaban",
            "probability": 5.219238501662871e-05,
            "start_logit": -2.758061408996582,
            "end_logit": 4.502388954162598,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin in Japanese patients with atrial fibrillation",
            "probability": 4.978827697249153e-05,
            "start_logit": 5.423335552215576,
            "end_logit": -3.7261650562286377,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "compared rivaroxaban (15/10\u00a0mg/d) and warfarin",
            "probability": 4.936664160912013e-05,
            "start_logit": -3.3700265884399414,
            "end_logit": 5.058692455291748,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "war",
            "probability": 4.797792404947691e-05,
            "start_logit": 5.423335552215576,
            "end_logit": -3.7632036209106445,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "n",
            "probability": 4.5655036238738467e-05,
            "start_logit": -3.4481875896453857,
            "end_logit": 5.058692455291748,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism",
            "probability": 4.320195247815734e-05,
            "start_logit": 4.278208255767822,
            "end_logit": -2.7229316234588623,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "compared rivaroxaban",
            "probability": 4.0721247794333804e-05,
            "start_logit": -3.3700265884399414,
            "end_logit": 4.8661675453186035,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        }
    ],
    "56b3a3ce8525abca1e000005": [
        {
            "text": "perilipin 2",
            "probability": 0.6082820239797161,
            "start_logit": 4.063565731048584,
            "end_logit": 2.9018259048461914,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin",
            "probability": 0.3623163138822486,
            "start_logit": 4.063565731048584,
            "end_logit": 2.383704900741577,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 2,",
            "probability": 0.017087161757055252,
            "start_logit": 4.063565731048584,
            "end_logit": -0.6704853177070618,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 2, a broadly expressed, lipid droplet-associated protein,",
            "probability": 0.0038016963319324804,
            "start_logit": 4.063565731048584,
            "end_logit": -2.173365354537964,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 2, a broadly expressed, lipid droplet-associated protein",
            "probability": 0.002735356147897166,
            "start_logit": 4.063565731048584,
            "end_logit": -2.5025510787963867,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 2, a broadly expressed, lipid droplet-associated",
            "probability": 0.0025778291589233122,
            "start_logit": 4.063565731048584,
            "end_logit": -2.5618650913238525,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 2, a broadly expressed, lipid droplet-associated protein, widely used as a marker for lipid droplet accumulation,",
            "probability": 0.001111914664092655,
            "start_logit": 4.063565731048584,
            "end_logit": -3.4027292728424072,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 2, a broadly expressed, lipid droplet-associated protein, widely used as a marker for lipid droplet accumulation",
            "probability": 0.0008114977295162969,
            "start_logit": 4.063565731048584,
            "end_logit": -3.717686414718628,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "per",
            "probability": 0.0005062863817471949,
            "start_logit": 4.063565731048584,
            "end_logit": -4.189465522766113,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Immunofluorescent detection of perilipin 2",
            "probability": 0.00023602291572670346,
            "start_logit": -3.7908992767333984,
            "end_logit": 2.9018259048461914,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "2",
            "probability": 0.00020069409948882507,
            "start_logit": -3.9530463218688965,
            "end_logit": 2.9018259048461914,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Immunofluorescent detection of perilipin",
            "probability": 0.00014058438264927486,
            "start_logit": -3.7908992767333984,
            "end_logit": 2.383704900741577,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "pin 2",
            "probability": 9.151514604002168e-05,
            "start_logit": -4.73832368850708,
            "end_logit": 2.9018259048461914,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "pin",
            "probability": 5.450996260037759e-05,
            "start_logit": -4.73832368850708,
            "end_logit": 2.383704900741577,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "lipid droplet-associated protein,",
            "probability": 1.2760194670527135e-05,
            "start_logit": -1.6333063840866089,
            "end_logit": -2.173365354537964,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "lipid droplet-associated protein",
            "probability": 9.181079679409532e-06,
            "start_logit": -1.6333063840866089,
            "end_logit": -2.5025510787963867,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "lipid droplet-associated",
            "probability": 8.652348589478793e-06,
            "start_logit": -1.6333063840866089,
            "end_logit": -2.5618650913238525,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "Immunofluorescent detection of perilipin 2,",
            "probability": 6.630085355815949e-06,
            "start_logit": -3.7908992767333984,
            "end_logit": -0.6704853177070618,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "2,",
            "probability": 5.637668723490746e-06,
            "start_logit": -3.9530463218688965,
            "end_logit": -0.6704853177070618,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "lipid droplet-associated protein, widely used as a marker for lipid droplet accumulation,",
            "probability": 3.7320833470210095e-06,
            "start_logit": -1.6333063840866089,
            "end_logit": -3.4027292728424072,
            "question_text": "List proteins of lipids droplets"
        }
    ],
    "535d59349a4572de6f000009": [
        {
            "text": "rheumatoid arthritis",
            "probability": 0.5572290830817489,
            "start_logit": 2.3756747245788574,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "Anaemia affects quality of life and radiographic outcome in rheumatoid arthritis",
            "probability": 0.16870546142339127,
            "start_logit": 1.1808526515960693,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "radiographic outcome in rheumatoid arthritis",
            "probability": 0.1274765876607407,
            "start_logit": 0.9006310105323792,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "arthritis",
            "probability": 0.045461462659306125,
            "start_logit": -0.1304367184638977,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "Anaemia",
            "probability": 0.03956300869712421,
            "start_logit": 1.1808526515960693,
            "end_logit": 1.2560478448867798,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron deficiency",
            "probability": 0.017816967169824532,
            "start_logit": 1.5198044776916504,
            "end_logit": 0.11935267597436905,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "quality of life and radiographic outcome in rheumatoid arthritis",
            "probability": 0.009509807106007951,
            "start_logit": -1.69497811794281,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "Anaemia affects quality of life",
            "probability": 0.0065058815218495625,
            "start_logit": 1.1808526515960693,
            "end_logit": -0.5491400957107544,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "rheumatoid arthritis (RA)",
            "probability": 0.006266085743600814,
            "start_logit": 2.3756747245788574,
            "end_logit": -1.7815169095993042,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "itis",
            "probability": 0.004410761098505131,
            "start_logit": -2.463254451751709,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "Anaemia affects quality of life and radiographic outcome",
            "probability": 0.003682075754375757,
            "start_logit": 1.1808526515960693,
            "end_logit": -1.1183700561523438,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "radiographic outcome",
            "probability": 0.0027822362638171777,
            "start_logit": 0.9006310105323792,
            "end_logit": -1.1183700561523438,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "Anaemia affects quality of life and radiographic outcome in rheumatoid arthritis (RA)",
            "probability": 0.001897106448296459,
            "start_logit": 1.1808526515960693,
            "end_logit": -1.7815169095993042,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "radiographic outcome in rheumatoid arthritis (RA)",
            "probability": 0.001433484455201454,
            "start_logit": 0.9006310105323792,
            "end_logit": -1.7815169095993042,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "outcome in rheumatoid arthritis",
            "probability": 0.0013995069206127345,
            "start_logit": -3.6111817359924316,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "mia affects quality of life and radiographic outcome in rheumatoid arthritis",
            "probability": 0.0013814346853305952,
            "start_logit": -3.6241791248321533,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "life and radiographic outcome in rheumatoid arthritis",
            "probability": 0.0012479436836859811,
            "start_logit": -3.725804567337036,
            "end_logit": 2.7063076496124268,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "rheumatoid art",
            "probability": 0.0011831273610713568,
            "start_logit": 2.3756747245788574,
            "end_logit": -3.44850754737854,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "inflammation",
            "probability": 0.0010290008117059602,
            "start_logit": -0.990314781665802,
            "end_logit": -0.22209103405475616,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "iron",
            "probability": 0.0010189774538036493,
            "start_logit": 1.5198044776916504,
            "end_logit": -2.7419989109039307,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        }
    ],
    "5713bf261174fb1755000011": [
        {
            "text": "heart",
            "probability": 0.8387446234860964,
            "start_logit": 2.1656694412231445,
            "end_logit": 2.8201241493225098,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "valentine heart",
            "probability": 0.133139544813921,
            "start_logit": 0.325160950422287,
            "end_logit": 2.8201241493225098,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel networks valentine heart",
            "probability": 0.007535058821246276,
            "start_logit": -2.5466701984405518,
            "end_logit": 2.8201241493225098,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "a micro-fluid channel networks valentine heart",
            "probability": 0.005124385707356461,
            "start_logit": -2.9322261810302734,
            "end_logit": 2.8201241493225098,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "heart-like constructs",
            "probability": 0.0036414974302144145,
            "start_logit": 1.1023266315460205,
            "end_logit": -1.556044340133667,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "heart-like",
            "probability": 0.0024211018081718156,
            "start_logit": 1.1023266315460205,
            "end_logit": -1.9642165899276733,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "construct a micro-fluid channel networks valentine heart",
            "probability": 0.0019147499093624793,
            "start_logit": -3.91664981842041,
            "end_logit": 2.8201241493225098,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "heart with a self-defined height and hollow in suitable mechanical properties",
            "probability": 0.0013306125345995772,
            "start_logit": 2.1656694412231445,
            "end_logit": -3.626142740249634,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "heart with a self-defined height and hollow",
            "probability": 0.0010307271047099707,
            "start_logit": 2.1656694412231445,
            "end_logit": -3.8815176486968994,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "channel networks valentine heart",
            "probability": 0.0010079313902654305,
            "start_logit": -4.5583367347717285,
            "end_logit": 2.8201241493225098,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "valentine heart-like constructs",
            "probability": 0.0008632029545089793,
            "start_logit": -0.33717378973960876,
            "end_logit": -1.556044340133667,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "micro-fluid channel networks complex structure. The 3D-bioprinting technology can construct a micro-fluid channel networks valentine heart",
            "probability": 0.0006523172242232678,
            "start_logit": -4.9934611320495605,
            "end_logit": 2.8201241493225098,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "valentine heart-like",
            "probability": 0.0005739128679977918,
            "start_logit": -0.33717378973960876,
            "end_logit": -1.9642165899276733,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "heart with a self-defined height",
            "probability": 0.0004469206211646389,
            "start_logit": 2.1656694412231445,
            "end_logit": -4.717156410217285,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "heart with a self-defined height and hollow in suitable mechanical properties. The cells proliferate and maintain their biological properties within the printed constructs",
            "probability": 0.00040716769868336496,
            "start_logit": 2.1656694412231445,
            "end_logit": -4.810312271118164,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "heart-like construct",
            "probability": 0.00030731281782069204,
            "start_logit": 1.1023266315460205,
            "end_logit": -4.0283284187316895,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "cells proliferate and maintain their biological properties within the printed constructs. This study demonstrates that valentine heart",
            "probability": 0.0002605325836956214,
            "start_logit": -4.519813537597656,
            "end_logit": 1.428673505783081,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "valentine heart with a self-defined height and hollow in suitable mechanical properties",
            "probability": 0.00021121702866357881,
            "start_logit": 0.325160950422287,
            "end_logit": -3.626142740249634,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "This study demonstrates that valentine heart",
            "probability": 0.00020279735486496288,
            "start_logit": -4.770334243774414,
            "end_logit": 1.428673505783081,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "study demonstrates that valentine heart",
            "probability": 0.00018438584243320682,
            "start_logit": -4.865510940551758,
            "end_logit": 1.428673505783081,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        }
    ],
    "5309f8f5970c65fa6b000001": [
        {
            "text": "KRAS",
            "probability": 0.37400668212615495,
            "start_logit": 4.5934977531433105,
            "end_logit": 4.098671913146973,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS. In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic KRAS",
            "probability": 0.30919768470470177,
            "start_logit": 4.403204917907715,
            "end_logit": 4.098671913146973,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS",
            "probability": 0.2735560116460988,
            "start_logit": 4.403204917907715,
            "end_logit": 3.9761974811553955,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras",
            "probability": 0.02380269442945718,
            "start_logit": 3.3004350662231445,
            "end_logit": 2.6372597217559814,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "oncogenic KRAS",
            "probability": 0.010268891480164927,
            "start_logit": 0.9983431696891785,
            "end_logit": 4.098671913146973,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "oncogenic RAS",
            "probability": 0.005190129763987288,
            "start_logit": 0.4384572207927704,
            "end_logit": 3.9761974811553955,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced senescence after reduction of ERK",
            "probability": 0.001932662270120352,
            "start_logit": 3.3004350662231445,
            "end_logit": 0.12635940313339233,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS.",
            "probability": 0.0007037886518175222,
            "start_logit": 4.403204917907715,
            "end_logit": -1.986586093902588,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "ERK",
            "probability": 0.00029859602448058914,
            "start_logit": 1.4328728914260864,
            "end_logit": 0.12635940313339233,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "K",
            "probability": 0.00017529501705849376,
            "start_logit": 4.5934977531433105,
            "end_logit": -3.5668866634368896,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS. In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic",
            "probability": 0.00016842514121362281,
            "start_logit": 4.403204917907715,
            "end_logit": -3.4165728092193604,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS. In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic K",
            "probability": 0.00014491937177869772,
            "start_logit": 4.403204917907715,
            "end_logit": -3.5668866634368896,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "R",
            "probability": 0.00010906751428242093,
            "start_logit": 4.403204917907715,
            "end_logit": -3.8510971069335938,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "AS. In the context of pancreatic ductal adenocarcinoma (PDAC), oncogenic KRAS",
            "probability": 0.00010717061558903041,
            "start_logit": -3.5641090869903564,
            "end_logit": 4.098671913146973,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS. In the context of pancreatic ductal adenocarcinoma (PDAC),",
            "probability": 0.00010342334795359843,
            "start_logit": 4.403204917907715,
            "end_logit": -3.904233455657959,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "AS",
            "probability": 9.481690069636724e-05,
            "start_logit": -3.5641090869903564,
            "end_logit": 3.9761974811553955,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "KRAS induces benign pancreatic intraepithelial neoplasias (PanINs),",
            "probability": 5.856705791795598e-05,
            "start_logit": 4.5934977531433105,
            "end_logit": -4.663184642791748,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "pancreatic ductal adenocarcinoma (PDAC), oncogenic KRAS",
            "probability": 2.8557993923755322e-05,
            "start_logit": -4.886594295501709,
            "end_logit": 4.098671913146973,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS. In the context of pancreatic ductal adenocarcinoma",
            "probability": 2.6888611278538516e-05,
            "start_logit": 4.403204917907715,
            "end_logit": -5.25136137008667,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "RAS. In the context of pancreatic ductal adenocarcinoma (PDAC)",
            "probability": 2.5727331323875575e-05,
            "start_logit": 4.403204917907715,
            "end_logit": -5.295510292053223,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        }
    ],
    "56d1d94667f0cb3d66000005": [
        {
            "text": "glia scars",
            "probability": 0.1637744059099087,
            "start_logit": 1.8949686288833618,
            "end_logit": 1.8913850784301758,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "development",
            "probability": 0.13748603932149256,
            "start_logit": 1.310634732246399,
            "end_logit": 2.3007514476776123,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "glia scars after spinal cord injury",
            "probability": 0.11936274139424291,
            "start_logit": 1.8949686288833618,
            "end_logit": 1.5750622749328613,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "development. However, it is not clear whether YAP signaling participates in the process of the formation of glia scars",
            "probability": 0.09130047685166799,
            "start_logit": 1.310634732246399,
            "end_logit": 1.8913850784301758,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "development. However, it is not clear whether YAP signaling participates in the process of the formation of glia scars after spinal cord injury",
            "probability": 0.0665419919985029,
            "start_logit": 1.310634732246399,
            "end_logit": 1.5750622749328613,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "formation of glia scars",
            "probability": 0.06155130452045748,
            "start_logit": 0.9163497686386108,
            "end_logit": 1.8913850784301758,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "liver during development",
            "probability": 0.0615450973192229,
            "start_logit": 0.5068825483322144,
            "end_logit": 2.3007514476776123,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "spinal cord injury",
            "probability": 0.061241987460390654,
            "start_logit": 1.2276345491409302,
            "end_logit": 1.5750622749328613,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "formation of glia scars after spinal cord injury",
            "probability": 0.04486007690356187,
            "start_logit": 0.9163497686386108,
            "end_logit": 1.5750622749328613,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "liver during development. However, it is not clear whether YAP signaling participates in the process of the formation of glia scars",
            "probability": 0.040870307711664194,
            "start_logit": 0.5068825483322144,
            "end_logit": 1.8913850784301758,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "size of multiple organs, such as liver during development",
            "probability": 0.036021443443728665,
            "start_logit": -0.02877323515713215,
            "end_logit": 2.3007514476776123,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "liver during development. However, it is not clear whether YAP signaling participates in the process of the formation of glia scars after spinal cord injury",
            "probability": 0.029787267082343007,
            "start_logit": 0.5068825483322144,
            "end_logit": 1.5750622749328613,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "the size of multiple organs, such as liver during development",
            "probability": 0.020520413019689404,
            "start_logit": -0.5914674997329712,
            "end_logit": 2.3007514476776123,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "controlling the size of multiple organs, such as liver during development",
            "probability": 0.014592029286750704,
            "start_logit": -0.9324122071266174,
            "end_logit": 2.3007514476776123,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "multiple organs, such as liver during development",
            "probability": 0.011000250139434262,
            "start_logit": -1.2149696350097656,
            "end_logit": 2.3007514476776123,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "liver",
            "probability": 0.010828570401112538,
            "start_logit": 0.5068825483322144,
            "end_logit": 0.5631693005561829,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organs, such as liver during development",
            "probability": 0.008321747854715742,
            "start_logit": -1.4940153360366821,
            "end_logit": 2.3007514476776123,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "multiple organs, such as liver during development. However, it is not clear whether YAP signaling participates in the process of the formation of glia scars",
            "probability": 0.007304945928869838,
            "start_logit": -1.2149696350097656,
            "end_logit": 1.8913850784301758,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "size of multiple organs",
            "probability": 0.006751099902158389,
            "start_logit": -0.02877323515713215,
            "end_logit": 0.6263424754142761,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "size of multiple organs, such as liver",
            "probability": 0.00633780355008519,
            "start_logit": -0.02877323515713215,
            "end_logit": 0.5631693005561829,
            "question_text": "List processes which are under the control of the YAP protein."
        }
    ],
    "56d29d4df22319765a000003": [
        {
            "text": "metabolomics",
            "probability": 0.22026882153906932,
            "start_logit": 0.15501153469085693,
            "end_logit": -0.5703920722007751,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "metabolomics, and meta-omics",
            "probability": 0.10574475499258656,
            "start_logit": 0.15501153469085693,
            "end_logit": -1.3042125701904297,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics, metabolomics",
            "probability": 0.09813874885709764,
            "start_logit": -0.6534548997879028,
            "end_logit": -0.5703920722007751,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, proteomics, metabolomics",
            "probability": 0.08324083566470214,
            "start_logit": -0.8180991411209106,
            "end_logit": -0.5703920722007751,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics",
            "probability": 0.07226179907076004,
            "start_logit": -0.6534548997879028,
            "end_logit": -0.8764787316322327,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "meta-omics",
            "probability": 0.06212262159266185,
            "start_logit": -0.37690648436546326,
            "end_logit": -1.3042125701904297,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, proteomics",
            "probability": 0.06129212580490151,
            "start_logit": -0.8180991411209106,
            "end_logit": -0.8764787316322327,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics",
            "probability": 0.0586295775028709,
            "start_logit": -0.8180991411209106,
            "end_logit": -0.9208908081054688,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics, metabolomics, and meta-omics",
            "probability": 0.04711360364422742,
            "start_logit": -0.6534548997879028,
            "end_logit": -1.3042125701904297,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics, proteomics, metabolomics, and meta-omics",
            "probability": 0.03996154204321114,
            "start_logit": -0.8180991411209106,
            "end_logit": -1.3042125701904297,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, proteomics, metabolomics",
            "probability": 0.03950433171597597,
            "start_logit": -1.5634268522262573,
            "end_logit": -0.5703920722007751,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, proteomics",
            "probability": 0.02908794043259349,
            "start_logit": -1.5634268522262573,
            "end_logit": -0.8764787316322327,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics",
            "probability": 0.027824351588328352,
            "start_logit": -1.5634268522262573,
            "end_logit": -0.9208908081054688,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics, transcriptomics, proteomics, metabolomics, and meta-omics",
            "probability": 0.018964898660025747,
            "start_logit": -1.5634268522262573,
            "end_logit": -1.3042125701904297,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genomics",
            "probability": 0.010880788651866752,
            "start_logit": -1.5634268522262573,
            "end_logit": -1.8598036766052246,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "metabolomics, and meta",
            "probability": 0.007479909499252226,
            "start_logit": 0.15501153469085693,
            "end_logit": -3.9530200958251953,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genome",
            "probability": 0.005559844631932191,
            "start_logit": -0.9909381866455078,
            "end_logit": -3.1037209033966064,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "meta",
            "probability": 0.004848347426771926,
            "start_logit": 0.15501153469085693,
            "end_logit": -4.386602878570557,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "genome-scale models",
            "probability": 0.003742551754640164,
            "start_logit": -0.9909381866455078,
            "end_logit": -3.499523401260376,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics, metabolomics, and meta",
            "probability": 0.0033326049265248853,
            "start_logit": -0.6534548997879028,
            "end_logit": -3.9530200958251953,
            "question_text": "List omics technologies comprised in system biology."
        }
    ],
    "5318367cb166e2b806000012": [
        {
            "text": "SNCA, LRRK2",
            "probability": 0.06841694109958302,
            "start_logit": 4.327485084533691,
            "end_logit": 4.23455286026001,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2",
            "probability": 0.06702984250352448,
            "start_logit": 4.307002544403076,
            "end_logit": 4.23455286026001,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "DJ-1",
            "probability": 0.06477315530918741,
            "start_logit": 4.601067543029785,
            "end_logit": 3.9062411785125732,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "DJ-1, and Parkin",
            "probability": 0.05783280151704981,
            "start_logit": 4.601067543029785,
            "end_logit": 3.7929060459136963,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA, LRRK2, and VPS35",
            "probability": 0.0535537420267058,
            "start_logit": 4.327485084533691,
            "end_logit": 3.9896180629730225,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35",
            "probability": 0.05303499595349933,
            "start_logit": 4.317751407623291,
            "end_logit": 3.9896180629730225,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35",
            "probability": 0.052467982868447,
            "start_logit": 4.307002544403076,
            "end_logit": 3.9896180629730225,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA, LRRK2, and VPS35 and autosomal recessive mutations in PINK1",
            "probability": 0.0510926271634914,
            "start_logit": 4.327485084533691,
            "end_logit": 3.942572593688965,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35 and autosomal recessive mutations in PINK1",
            "probability": 0.05059772057605543,
            "start_logit": 4.317751407623291,
            "end_logit": 3.942572593688965,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35 and autosomal recessive mutations in PINK1",
            "probability": 0.050056765134753996,
            "start_logit": 4.307002544403076,
            "end_logit": 3.942572593688965,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1",
            "probability": 0.0498850608211756,
            "start_logit": 4.3035664558410645,
            "end_logit": 3.942572593688965,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA, LRRK2, and VPS35 and autosomal recessive mutations in PINK1, DJ-1",
            "probability": 0.04926967543754679,
            "start_logit": 4.327485084533691,
            "end_logit": 3.9062411785125732,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35 and autosomal recessive mutations in PINK1, DJ-1",
            "probability": 0.04879242679545117,
            "start_logit": 4.317751407623291,
            "end_logit": 3.9062411785125732,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35 and autosomal recessive mutations in PINK1, DJ-1",
            "probability": 0.048270772292663314,
            "start_logit": 4.307002544403076,
            "end_logit": 3.9062411785125732,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1, DJ-1",
            "probability": 0.04810519427738209,
            "start_logit": 4.3035664558410645,
            "end_logit": 3.9062411785125732,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "VPS35 and autosomal recessive mutations in PINK1, DJ-1, and Parkin",
            "probability": 0.043564385908436136,
            "start_logit": 4.317751407623291,
            "end_logit": 3.7929060459136963,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "LRRK2, and VPS35 and autosomal recessive mutations in PINK1, DJ-1, and Parkin",
            "probability": 0.0430986259624184,
            "start_logit": 4.307002544403076,
            "end_logit": 3.7929060459136963,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1, DJ-1, and Parkin",
            "probability": 0.042950789401922984,
            "start_logit": 4.3035664558410645,
            "end_logit": 3.7929060459136963,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "SNCA",
            "probability": 0.0293924402159652,
            "start_logit": 4.327485084533691,
            "end_logit": 3.389669895172119,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "Parkin",
            "probability": 0.027814054734740537,
            "start_logit": 3.8690528869628906,
            "end_logit": 3.7929060459136963,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        }
    ],
    "515d1ff7298dcd4e51000009": [
        {
            "text": "cancer",
            "probability": 0.27714503071624536,
            "start_logit": 0.483865350484848,
            "end_logit": -0.7569666504859924,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells",
            "probability": 0.24221727739766688,
            "start_logit": 0.483865350484848,
            "end_logit": -0.8916724324226379,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer",
            "probability": 0.1465735996821652,
            "start_logit": 0.483865350484848,
            "end_logit": -1.3939799070358276,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells",
            "probability": 0.12134143559346022,
            "start_logit": -0.20736145973205566,
            "end_logit": -0.8916724324226379,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing",
            "probability": 0.07659042654041202,
            "start_logit": 0.483865350484848,
            "end_logit": -2.0430355072021484,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell",
            "probability": 0.019185374686207783,
            "start_logit": 0.483865350484848,
            "end_logit": -3.4273593425750732,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug delivery",
            "probability": 0.01897662917748775,
            "start_logit": 0.483865350484848,
            "end_logit": -3.4382994174957275,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug delivery through multifunctional mesoporous silica nanogates",
            "probability": 0.016254946676205858,
            "start_logit": 0.483865350484848,
            "end_logit": -3.5931103229522705,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug",
            "probability": 0.014297418028440199,
            "start_logit": 0.483865350484848,
            "end_logit": -3.721428632736206,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system",
            "probability": 0.010431745415880572,
            "start_logit": 0.483865350484848,
            "end_logit": -4.036653995513916,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug delivery",
            "probability": 0.009506553173499126,
            "start_logit": -0.20736145973205566,
            "end_logit": -3.4382994174957275,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug delivery through multifunctional mesoporous silica nanogates",
            "probability": 0.008143096092801522,
            "start_logit": -0.20736145973205566,
            "end_logit": -3.5931103229522705,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug",
            "probability": 0.007162450373028034,
            "start_logit": -0.20736145973205566,
            "end_logit": -3.721428632736206,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug delivery through multifunctional mesoporous silica nanogates.",
            "probability": 0.006892697790129137,
            "start_logit": 0.483865350484848,
            "end_logit": -4.451045036315918,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cell killing system that kills the cancer cells",
            "probability": 0.006683069779144584,
            "start_logit": -3.1063923835754395,
            "end_logit": -0.8916724324226379,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cell killing system that kills the cancer cells via drug delivery through multifunctional mesoporous silica nanogates. Two",
            "probability": 0.004274075308607496,
            "start_logit": 0.483865350484848,
            "end_logit": -4.9289398193359375,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cell killing system that kills the cancer",
            "probability": 0.004044144187320264,
            "start_logit": -3.1063923835754395,
            "end_logit": -1.3939799070358276,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "a two-photon-actuated cancer",
            "probability": 0.0035070771355442737,
            "start_logit": -3.885892629623413,
            "end_logit": -0.7569666504859924,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "cancer cells via drug delivery through multifunctional mesoporous silica nanogates.",
            "probability": 0.003452973520105286,
            "start_logit": -0.20736145973205566,
            "end_logit": -4.451045036315918,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "two-photon-actuated cancer",
            "probability": 0.0033199787256484,
            "start_logit": -3.9407172203063965,
            "end_logit": -0.7569666504859924,
            "question_text": "Which cellular processes are regulated by Nanog?"
        }
    ],
    "56ed27202ac5ed145900000c": [
        {
            "text": "osteoblasts",
            "probability": 0.4551600022877524,
            "start_logit": 2.7381319999694824,
            "end_logit": 0.6643192172050476,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblast",
            "probability": 0.27697216505685923,
            "start_logit": 2.0865769386291504,
            "end_logit": 0.8191422820091248,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteosarcoma (OS). Here, we wanted to investigate the role of lamin A in normal osteoblasts",
            "probability": 0.10018708053436552,
            "start_logit": 1.2245222330093384,
            "end_logit": 0.6643192172050476,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteosarcoma",
            "probability": 0.045215001348047415,
            "start_logit": 1.2245222330093384,
            "end_logit": -0.13129110634326935,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteosarcoma (OS). Here, we wanted to investigate the role of lamin A in normal osteoblast",
            "probability": 0.04199146112915863,
            "start_logit": 1.2245222330093384,
            "end_logit": -0.2052537351846695,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs)",
            "probability": 0.04022069102909973,
            "start_logit": 2.7381319999694824,
            "end_logit": -1.7619482278823853,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteosarcoma (OS)",
            "probability": 0.017443255839369225,
            "start_logit": 1.2245222330093384,
            "end_logit": -1.0837669372558594,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "o",
            "probability": 0.005211498492473262,
            "start_logit": 2.7381319999694824,
            "end_logit": -3.80546236038208,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblasts (OBs) and OS cells. Thus, we studied the expression of lamin A/C in OS cells",
            "probability": 0.004820296381808258,
            "start_logit": 2.7381319999694824,
            "end_logit": -3.8834943771362305,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblast differentiation, all examined OS cell lines express lower lamin A levels relative to differentiated OBs",
            "probability": 0.0030443173560298696,
            "start_logit": 2.0865769386291504,
            "end_logit": -3.691498041152954,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteoblast differentiation",
            "probability": 0.0030143104999068135,
            "start_logit": 2.0865769386291504,
            "end_logit": -3.7014036178588867,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteob",
            "probability": 0.0022558403133826448,
            "start_logit": 2.0865769386291504,
            "end_logit": -3.9912521839141846,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osteosarcoma (OS). Here, we wanted to investigate the role of lamin A in normal o",
            "probability": 0.0011471236851784167,
            "start_logit": 1.2245222330093384,
            "end_logit": -3.80546236038208,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "oblasts",
            "probability": 0.000989031503587392,
            "start_logit": -3.3935461044311523,
            "end_logit": 0.6643192172050476,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "oblast",
            "probability": 0.0005141928290360156,
            "start_logit": -4.2024970054626465,
            "end_logit": 0.8191422820091248,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "steoblast",
            "probability": 0.00042389083689783116,
            "start_logit": -4.3956193923950195,
            "end_logit": 0.8191422820091248,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "osarcoma (OS). Here, we wanted to investigate the role of lamin A in normal osteoblasts",
            "probability": 0.0004004618934129439,
            "start_logit": -4.297653675079346,
            "end_logit": 0.6643192172050476,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "lamin A expression increases during osteoblast",
            "probability": 0.00036661908485471846,
            "start_logit": -4.540771961212158,
            "end_logit": 0.8191422820091248,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "steoblasts",
            "probability": 0.0003535789843855149,
            "start_logit": -4.422165393829346,
            "end_logit": 0.6643192172050476,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "oma (OS). Here, we wanted to investigate the role of lamin A in normal osteoblasts",
            "probability": 0.0002691809143941141,
            "start_logit": -4.694888591766357,
            "end_logit": 0.6643192172050476,
            "question_text": "In which cells are A-type lamins expressed?"
        }
    ],
    "530cf4e0c8a0b4a00c000004": [
        {
            "text": "troponin T",
            "probability": 0.23191252365396545,
            "start_logit": -4.165987968444824,
            "end_logit": -3.317948341369629,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "cardiac troponin T",
            "probability": 0.14347515208680614,
            "start_logit": -4.646186351776123,
            "end_logit": -3.317948341369629,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Mutations in the genes for beta-myosin heavy chain, myosin binding protein-C, and cardiac troponin T",
            "probability": 0.14061417407184576,
            "start_logit": -4.666328430175781,
            "end_logit": -3.317948341369629,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "myosin binding protein-C, and cardiac troponin T",
            "probability": 0.08666698239719292,
            "start_logit": -5.150275230407715,
            "end_logit": -3.317948341369629,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "beta-myosin heavy chain, myosin binding protein-C, and cardiac troponin T",
            "probability": 0.0601898825994285,
            "start_logit": -5.514843940734863,
            "end_logit": -3.317948341369629,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "T",
            "probability": 0.03825677329056465,
            "start_logit": -5.968027591705322,
            "end_logit": -3.317948341369629,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100",
            "probability": 0.03724235015200889,
            "start_logit": -4.477224826812744,
            "end_logit": -4.835625171661377,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations",
            "probability": 0.03349914931802011,
            "start_logit": -4.477224826812744,
            "end_logit": -4.941551685333252,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes, all encoding sarcomeric proteins, have been identified",
            "probability": 0.026063188909632527,
            "start_logit": -4.477224826812744,
            "end_logit": -5.192547798156738,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes, all encoding sarcomeric proteins, have been identified as responsible for this disease. Mutations",
            "probability": 0.02495277116960726,
            "start_logit": -4.477224826812744,
            "end_logit": -5.236086845397949,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes, all encoding sarcomeric proteins, have been identified as responsible for this disease.",
            "probability": 0.024006207380188972,
            "start_logit": -4.477224826812744,
            "end_logit": -5.274759292602539,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "troponin T are the most common. Other genes involved are alpha-tropomyosin",
            "probability": 0.021462683737557033,
            "start_logit": -4.165987968444824,
            "end_logit": -5.69799280166626,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More than 100 mutations in ten genes,",
            "probability": 0.02088241019604881,
            "start_logit": -4.477224826812744,
            "end_logit": -5.4141645431518555,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Mutations",
            "probability": 0.020653427403457787,
            "start_logit": -4.666328430175781,
            "end_logit": -5.236086845397949,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "titin, and alpha-myosin heavy chain. Some mutations are more frequently associated with a given phenotype,",
            "probability": 0.017806659697280066,
            "start_logit": -5.057961940765381,
            "end_logit": -4.992762088775635,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "More",
            "probability": 0.016897654066412283,
            "start_logit": -4.477224826812744,
            "end_logit": -5.62589693069458,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "titin, and alpha-myosin heavy chain.",
            "probability": 0.014313689615696573,
            "start_logit": -5.057961940765381,
            "end_logit": -5.211118221282959,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "100",
            "probability": 0.014189817180376997,
            "start_logit": -5.4421467781066895,
            "end_logit": -4.835625171661377,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Mutations in the genes for beta-myosin heavy chain, myosin binding protein-C",
            "probability": 0.01363638525207163,
            "start_logit": -4.666328430175781,
            "end_logit": -5.65122652053833,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "cardiac troponin T are the most common. Other genes involved are alpha-tropomyosin",
            "probability": 0.013278117821837443,
            "start_logit": -4.646186351776123,
            "end_logit": -5.69799280166626,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        }
    ],
    "530cf4e0c8a0b4a00c000005": [
        {
            "text": "aortic root dilatation",
            "probability": 0.18366448490039478,
            "start_logit": 5.244694709777832,
            "end_logit": 5.023197650909424,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dolichostenomelia",
            "probability": 0.17554350932261067,
            "start_logit": 4.901622295379639,
            "end_logit": 5.321046352386475,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "ectopia lentis",
            "probability": 0.13933508795347913,
            "start_logit": 4.9321417808532715,
            "end_logit": 5.059521675109863,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dolichostenomelia, ectopia lentis",
            "probability": 0.13514688868668662,
            "start_logit": 4.901622295379639,
            "end_logit": 5.059521675109863,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "ectopia lentis and aortic root dilatation",
            "probability": 0.13436469566850995,
            "start_logit": 4.9321417808532715,
            "end_logit": 5.023197650909424,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dolichostenomelia, ectopia lentis and aortic root dilatation",
            "probability": 0.13032589877860137,
            "start_logit": 4.901622295379639,
            "end_logit": 5.023197650909424,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "mitral valve prolapse",
            "probability": 0.04066936263026887,
            "start_logit": 4.539458751678467,
            "end_logit": 4.220798015594482,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic dissection was recorded in two other patients, and a mitral valve prolapse",
            "probability": 0.015497385811463399,
            "start_logit": 3.574655055999756,
            "end_logit": 4.220798015594482,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root",
            "probability": 0.010674277852300577,
            "start_logit": 5.244694709777832,
            "end_logit": 2.1779239177703857,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic dissection",
            "probability": 0.007850452314497587,
            "start_logit": 3.574655055999756,
            "end_logit": 3.5406978130340576,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "ectopia lentis and aortic root",
            "probability": 0.007809055168631572,
            "start_logit": 4.9321417808532715,
            "end_logit": 2.1779239177703857,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dolichostenomelia, ectopia lentis and aortic root",
            "probability": 0.007574326934616858,
            "start_logit": 4.901622295379639,
            "end_logit": 2.1779239177703857,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root dilation was present in eight patients, an acute type A aortic dissection",
            "probability": 0.0035998522576887815,
            "start_logit": 2.7949767112731934,
            "end_logit": 3.5406978130340576,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "a mitral valve prolapse",
            "probability": 0.0026233217933339654,
            "start_logit": 1.7984250783920288,
            "end_logit": 4.220798015594482,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "mitral valve",
            "probability": 0.0014058478329575157,
            "start_logit": 4.539458751678467,
            "end_logit": 0.8559635281562805,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "ortic root dilatation",
            "probability": 0.0011790484222250373,
            "start_logit": 0.1962917596101761,
            "end_logit": 5.023197650909424,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "aortic root dilation",
            "probability": 0.0008394360092998994,
            "start_logit": 2.7949767112731934,
            "end_logit": 2.084779977798462,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "root dilatation",
            "probability": 0.0007066052113736275,
            "start_logit": -0.31569910049438477,
            "end_logit": 5.023197650909424,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "melia",
            "probability": 0.0006205755492070128,
            "start_logit": -0.7433725595474243,
            "end_logit": 5.321046352386475,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "dilatation",
            "probability": 0.0005698869018526969,
            "start_logit": -0.5307332873344421,
            "end_logit": 5.023197650909424,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        }
    ],
    "5518e817622b194345000006": [
        {
            "text": "Three RAS genes encode 4 isoforms",
            "probability": 0.18192329055841902,
            "start_logit": -3.80916690826416,
            "end_logit": -3.5345585346221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three",
            "probability": 0.14545409144772556,
            "start_logit": -3.80916690826416,
            "end_logit": -3.7582831382751465,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes encode 4 isoforms",
            "probability": 0.08364262171361374,
            "start_logit": -4.586198806762695,
            "end_logit": -3.5345585346221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras",
            "probability": 0.08289700492399346,
            "start_logit": -3.813711166381836,
            "end_logit": -4.316000461578369,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes encode 4",
            "probability": 0.0796953491600155,
            "start_logit": -3.80916690826416,
            "end_logit": -4.3599324226379395,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "4 isoforms",
            "probability": 0.06013602535625655,
            "start_logit": -4.91614294052124,
            "end_logit": -3.5345585346221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes encode 4 isoforms.",
            "probability": 0.051243729743572955,
            "start_logit": -3.80916690826416,
            "end_logit": -4.801550388336182,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes",
            "probability": 0.050118719799979915,
            "start_logit": -3.80916690826416,
            "end_logit": -4.82374906539917,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes encode 4",
            "probability": 0.0366414213466801,
            "start_logit": -4.586198806762695,
            "end_logit": -4.3599324226379395,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS genes encode 4 isoforms. All Ras isoforms have long been considered membrane bound,",
            "probability": 0.02775719593460696,
            "start_logit": -3.80916690826416,
            "end_logit": -5.414648532867432,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "4",
            "probability": 0.026343859124092903,
            "start_logit": -4.91614294052124,
            "end_logit": -4.3599324226379395,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "genes encode 4 isoforms",
            "probability": 0.024864743554086587,
            "start_logit": -5.7993011474609375,
            "end_logit": -3.5345585346221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes encode 4 isoforms.",
            "probability": 0.023560259321276745,
            "start_logit": -4.586198806762695,
            "end_logit": -4.801550388336182,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "isoforms",
            "probability": 0.02339766008745316,
            "start_logit": -5.860116004943848,
            "end_logit": -3.5345585346221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "RAS genes",
            "probability": 0.023043015042948402,
            "start_logit": -4.586198806762695,
            "end_logit": -4.82374906539917,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras-driven tumor cell line",
            "probability": 0.01718603861529689,
            "start_logit": -3.813711166381836,
            "end_logit": -5.889502048492432,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "4 isoforms.",
            "probability": 0.01693897588236017,
            "start_logit": -4.91614294052124,
            "end_logit": -4.801550388336182,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "reduced GTP-loading of Ras proteins, and inhibited proliferation and MAPK signaling in an oncogenic N-Ras",
            "probability": 0.015950626057915918,
            "start_logit": -5.4618120193481445,
            "end_logit": -4.316000461578369,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Three RAS",
            "probability": 0.015186700717622648,
            "start_logit": -3.80916690826416,
            "end_logit": -6.017723560333252,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "proliferation and MAPK signaling in an oncogenic N-Ras",
            "probability": 0.014018671612082763,
            "start_logit": -5.5909199714660645,
            "end_logit": -4.316000461578369,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        }
    ],
    "5319abe4b166e2b80600002e": [
        {
            "text": "SNAI1 interacted with HDAC1",
            "probability": 0.2726495616961234,
            "start_logit": 5.6482720375061035,
            "end_logit": 5.077728748321533,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1",
            "probability": 0.26158847847847533,
            "start_logit": 5.6482720375061035,
            "end_logit": 5.036314010620117,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC1",
            "probability": 0.22438815794295613,
            "start_logit": 5.45346212387085,
            "end_logit": 5.077728748321533,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 interacted with HDAC",
            "probability": 0.06992088564189967,
            "start_logit": 5.6482720375061035,
            "end_logit": 3.7169058322906494,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC",
            "probability": 0.05754426536878983,
            "start_logit": 5.45346212387085,
            "end_logit": 3.7169058322906494,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI",
            "probability": 0.04006015177595714,
            "start_logit": 5.6482720375061035,
            "end_logit": 3.159923553466797,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 was found to be associated with HDAC1",
            "probability": 0.031122022225729025,
            "start_logit": 4.612443447113037,
            "end_logit": 3.9432857036590576,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail family transcriptional repressor 1 (SNAI1",
            "probability": 0.014597257860084855,
            "start_logit": 2.9764716625213623,
            "end_logit": 4.8221755027771,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 was found to be associated with HDAC",
            "probability": 0.008322289265708984,
            "start_logit": 4.612443447113037,
            "end_logit": 2.62430739402771,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1)",
            "probability": 0.0068943555451288375,
            "start_logit": 4.987185001373291,
            "end_logit": 2.0613315105438232,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 and HDAC1 in the induction of EMT in HLECs. In the present study, SNAI1",
            "probability": 0.002449216752900965,
            "start_logit": 2.827482223510742,
            "end_logit": 3.1860995292663574,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail family transcriptional repressor 1",
            "probability": 0.001941320361452473,
            "start_logit": 2.9764716625213623,
            "end_logit": 2.8047101497650146,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "HDAC1 in the induction of EMT in HLECs. In the present study, SNAI1",
            "probability": 0.0018440053422633521,
            "start_logit": 2.543653964996338,
            "end_logit": 3.1860995292663574,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 and HDAC",
            "probability": 0.001713596470607045,
            "start_logit": 3.3905255794525146,
            "end_logit": 2.2658822536468506,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail family transcriptional repressor 1 (SNAI",
            "probability": 0.001576815422669432,
            "start_logit": 2.9764716625213623,
            "end_logit": 2.5967490673065186,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail family transcriptional repressor 1 (SNAI1)",
            "probability": 0.0009231068392960057,
            "start_logit": 2.9764716625213623,
            "end_logit": 2.0613315105438232,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "(SNAI1",
            "probability": 0.0008255529471529241,
            "start_logit": 0.1039360910654068,
            "end_logit": 4.8221755027771,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail",
            "probability": 0.0007066865299167875,
            "start_logit": 2.9764716625213623,
            "end_logit": 1.7941737174987793,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "SNAI1 and HDAC1",
            "probability": 0.0005788891132078587,
            "start_logit": 2.827482223510742,
            "end_logit": 1.7436869144439697,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "transcriptional repressor 1 (SNAI1",
            "probability": 0.00035338441968009736,
            "start_logit": -0.7445608377456665,
            "end_logit": 4.8221755027771,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        }
    ],
    "54ff30dc6ad7dcbc1200000f": [
        {
            "text": "various diseases",
            "probability": 0.1517071664810368,
            "start_logit": -2.2319912910461426,
            "end_logit": -2.057809352874756,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting",
            "probability": 0.09207937080303012,
            "start_logit": -2.008444309234619,
            "end_logit": -2.7806575298309326,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "diseases",
            "probability": 0.08703206550628972,
            "start_logit": -2.7876667976379395,
            "end_logit": -2.057809352874756,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprinting",
            "probability": 0.07375463143820116,
            "start_logit": -2.230351448059082,
            "end_logit": -2.7806575298309326,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprint",
            "probability": 0.06517064124110161,
            "start_logit": -2.008444309234619,
            "end_logit": -3.1262993812561035,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "parent-of-origin monoallelic expression of specific genes, which precludes uniparental development and underlies various diseases",
            "probability": 0.055557689700536185,
            "start_logit": -3.2365214824676514,
            "end_logit": -2.057809352874756,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprint",
            "probability": 0.05220101509610345,
            "start_logit": -2.230351448059082,
            "end_logit": -3.1262993812561035,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes,",
            "probability": 0.04707825159016407,
            "start_logit": -2.008444309234619,
            "end_logit": -3.4514973163604736,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "various",
            "probability": 0.04679006586823883,
            "start_logit": -2.2319912910461426,
            "end_logit": -3.234090566635132,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes,",
            "probability": 0.03770919658231629,
            "start_logit": -2.230351448059082,
            "end_logit": -3.4514973163604736,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes",
            "probability": 0.0374884344797285,
            "start_logit": -2.008444309234619,
            "end_logit": -3.6792759895324707,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "monoallelic expression of specific genes, which precludes uniparental development and underlies various diseases",
            "probability": 0.032109431464822376,
            "start_logit": -3.7847936153411865,
            "end_logit": -2.057809352874756,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression",
            "probability": 0.03068954479136178,
            "start_logit": -2.008444309234619,
            "end_logit": -3.8793864250183105,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Genomic imprinting is an epigenetic mechanism",
            "probability": 0.03021222759618837,
            "start_logit": -2.008444309234619,
            "end_logit": -3.895061731338501,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes",
            "probability": 0.030027851451788375,
            "start_logit": -2.230351448059082,
            "end_logit": -3.6792759895324707,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "G",
            "probability": 0.028747546659775376,
            "start_logit": -2.008444309234619,
            "end_logit": -3.944756031036377,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "parent-of-origin monoallelic expression of specific genes, which precludes uniparental development",
            "probability": 0.0264890759285293,
            "start_logit": -3.2365214824676514,
            "end_logit": -2.7984988689422607,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "expression of specific genes, which precludes uniparental development and underlies various diseases",
            "probability": 0.025581231378558826,
            "start_logit": -4.012084484100342,
            "end_logit": -2.057809352874756,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "underlies various diseases",
            "probability": 0.024992551385977495,
            "start_logit": -4.035365581512451,
            "end_logit": -2.057809352874756,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression",
            "probability": 0.024582010556251192,
            "start_logit": -2.230351448059082,
            "end_logit": -3.8793864250183105,
            "question_text": "List human diseases involving genomic imprinting."
        }
    ],
    "55031628e9bde69634000024": [
        {
            "text": "cervical small-cell carcinoma",
            "probability": 0.8877088444223934,
            "start_logit": 2.6507697105407715,
            "end_logit": 2.5863029956817627,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Small-cell carcinoma",
            "probability": 0.06560747047244628,
            "start_logit": 0.8291304111480713,
            "end_logit": 1.802988052368164,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "small-cell carcinoma",
            "probability": 0.025857486375803467,
            "start_logit": -0.8852739334106445,
            "end_logit": 2.5863029956817627,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinoma",
            "probability": 0.009257834440864636,
            "start_logit": -1.1290889978408813,
            "end_logit": 1.802988052368164,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervical",
            "probability": 0.0017871423274163324,
            "start_logit": 2.6507697105407715,
            "end_logit": -3.621722936630249,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervical small-cell carcinoma presenting with an acute onset of severe hypokalemia in Cushing's syndrome",
            "probability": 0.001690423902394546,
            "start_logit": 2.6507697105407715,
            "end_logit": -3.677361488342285,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervical small-cell carcinoma associated with Cushing's syndrome",
            "probability": 0.0016695876397076002,
            "start_logit": 1.8956354856491089,
            "end_logit": -2.9346299171447754,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Small-cell carcinoma of the cervix",
            "probability": 0.0014815449879942673,
            "start_logit": 0.8291304111480713,
            "end_logit": -1.9876160621643066,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "uterine cervix carcinoma",
            "probability": 0.001060910635308299,
            "start_logit": -1.5445157289505005,
            "end_logit": 0.052072253078222275,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "c",
            "probability": 0.0008625112865468261,
            "start_logit": 2.6507697105407715,
            "end_logit": -4.350247859954834,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "oma",
            "probability": 0.000811461288239579,
            "start_logit": -4.346792697906494,
            "end_logit": 2.5863029956817627,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cell carcinoma",
            "probability": 0.0007181821413213793,
            "start_logit": -3.685591220855713,
            "end_logit": 1.802988052368164,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervical cancers and <1% of all neuroendocrine tumors. Small-cell carcinoma",
            "probability": 0.0006238921867495986,
            "start_logit": -3.8263368606567383,
            "end_logit": 1.802988052368164,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinoma of the cervix",
            "probability": 0.00020906000668481945,
            "start_logit": -1.1290889978408813,
            "end_logit": -1.9876160621643066,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "cervix carcinoma",
            "probability": 0.00019521575713629669,
            "start_logit": -3.237293243408203,
            "end_logit": 0.052072253078222275,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Neuroendocrine carcinoma",
            "probability": 0.00012875099045285345,
            "start_logit": -2.087312698364258,
            "end_logit": -1.5141334533691406,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "small-cell carcinoma associated with Cushing's syndrome",
            "probability": 0.00011100264988091207,
            "start_logit": -0.8151423931121826,
            "end_logit": -2.9346299171447754,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "primary uterine cervix carcinoma",
            "probability": 0.0001053097965698226,
            "start_logit": -3.8544921875,
            "end_logit": 0.052072253078222275,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinomas of the cervix",
            "probability": 5.811021403065298e-05,
            "start_logit": -1.597119688987732,
            "end_logit": -2.799865245819092,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "carcinomas of the cervix are very rare, accounting for only 1-2% of all cervical cancer",
            "probability": 5.525847805846011e-05,
            "start_logit": -1.597119688987732,
            "end_logit": -2.850184917449951,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        }
    ],
    "54d670163706e8952800000f": [
        {
            "text": "IRX",
            "probability": 0.8202681031389979,
            "start_logit": 2.9551784992218018,
            "end_logit": 2.0458452701568604,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes in the etiology of AIS. This study aimed to validate the relationship between the IRX",
            "probability": 0.0824336641061358,
            "start_logit": 1.7205387353897095,
            "end_logit": 0.9828476905822754,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family",
            "probability": 0.05227502310570331,
            "start_logit": 2.9551784992218018,
            "end_logit": -0.7072672843933105,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes",
            "probability": 0.011170712807286832,
            "start_logit": 1.7205387353897095,
            "end_logit": -1.0158507823944092,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes in the etiology of AIS. This study aimed to validate the relationship between the IRX family",
            "probability": 0.007895770619576688,
            "start_logit": 1.7205387353897095,
            "end_logit": -1.362818956375122,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family may have functional roles in the development of adolescent idiopathic scoliosis",
            "probability": 0.005193301699134556,
            "start_logit": 2.9551784992218018,
            "end_logit": -3.016416311264038,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family may have functional roles in the development of adolescent idiopathic scoliosis (AIS).",
            "probability": 0.004610218665058136,
            "start_logit": 2.9551784992218018,
            "end_logit": -3.1355106830596924,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "the IRX",
            "probability": 0.0022367665909490916,
            "start_logit": -2.9494214057922363,
            "end_logit": 2.0458452701568604,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "I",
            "probability": 0.002208588069791323,
            "start_logit": 2.9551784992218018,
            "end_logit": -3.8714325428009033,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family may have functional roles in the development of adolescent idiopathic scoliosis (AIS)",
            "probability": 0.0021697412787620653,
            "start_logit": 2.9551784992218018,
            "end_logit": -3.8891780376434326,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "Previous studies showed that several variants located around the IRX",
            "probability": 0.0020231239160883913,
            "start_logit": -3.0498099327087402,
            "end_logit": 2.0458452701568604,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "variants located around the IRX",
            "probability": 0.0016304971415039022,
            "start_logit": -3.2655677795410156,
            "end_logit": 2.0458452701568604,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "studies showed that several variants located around the IRX",
            "probability": 0.0009999661823961964,
            "start_logit": -3.754486560821533,
            "end_logit": 2.0458452701568604,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "X",
            "probability": 0.0009411540875737726,
            "start_logit": -3.815101146697998,
            "end_logit": 2.0458452701568604,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "several variants located around the IRX",
            "probability": 0.000917740010321529,
            "start_logit": -3.8402938842773438,
            "end_logit": 2.0458452701568604,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes in the etiology of AIS. This",
            "probability": 0.0007608800839853778,
            "start_logit": 1.7205387353897095,
            "end_logit": -3.702425718307495,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "This study aimed to validate the relationship between the IRX",
            "probability": 0.0006571428289631977,
            "start_logit": -3.111309051513672,
            "end_logit": 0.9828476905822754,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX family and AIS in a large-scale general population and to further investigate",
            "probability": 0.0006350175782932593,
            "start_logit": 1.8868376016616821,
            "end_logit": -4.0495476722717285,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "IRX genes in the etiology of AIS. This study",
            "probability": 0.0005634843983439653,
            "start_logit": 1.7205387353897095,
            "end_logit": -4.0027618408203125,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "study aimed to validate the relationship between the IRX",
            "probability": 0.00040910369113445974,
            "start_logit": -3.5852417945861816,
            "end_logit": 0.9828476905822754,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        }
    ],
    "5324cf139b2d7acc7e00001f": [
        {
            "text": "selective serotonin reuptake inhibitors",
            "probability": 0.7373661740704389,
            "start_logit": 1.872085690498352,
            "end_logit": 1.6029366254806519,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion prescriptions are common. We sought to compare the effects of selective serotonin reuptake inhibitors",
            "probability": 0.10576719790365606,
            "start_logit": -0.06975848972797394,
            "end_logit": 1.6029366254806519,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitors (SSRIs) and bupropion",
            "probability": 0.02571446187849953,
            "start_logit": 1.872085690498352,
            "end_logit": -1.7530944347381592,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "inhibitors",
            "probability": 0.014966034944772598,
            "start_logit": -2.0252156257629395,
            "end_logit": 1.6029366254806519,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitor",
            "probability": 0.014104099070781598,
            "start_logit": 1.872085690498352,
            "end_logit": -2.353682518005371,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "depression",
            "probability": 0.013498574440333283,
            "start_logit": -0.3318111002445221,
            "end_logit": -0.19366711378097534,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "prescriptions are common. We sought to compare the effects of selective serotonin reuptake inhibitors",
            "probability": 0.012249346510757868,
            "start_logit": -2.2255263328552246,
            "end_logit": 1.6029366254806519,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitors (SSRIs) and bupropion in overdose",
            "probability": 0.011403679295196449,
            "start_logit": 1.872085690498352,
            "end_logit": -2.5662119388580322,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "serotonin reuptake inhibitors",
            "probability": 0.010491464534299394,
            "start_logit": -2.380436897277832,
            "end_logit": 1.6029366254806519,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective",
            "probability": 0.010085295560057907,
            "start_logit": 1.872085690498352,
            "end_logit": -2.6890695095062256,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "bupropion",
            "probability": 0.007907701459219168,
            "start_logit": -0.06975848972797394,
            "end_logit": -0.9904666543006897,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "depression and attempted and completed suicide",
            "probability": 0.007892572286712125,
            "start_logit": -0.3318111002445221,
            "end_logit": -0.7303290963172913,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitors (SSRIs)",
            "probability": 0.006803910798760687,
            "start_logit": 1.872085690498352,
            "end_logit": -3.0826504230499268,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake",
            "probability": 0.0047781045402342836,
            "start_logit": 1.872085690498352,
            "end_logit": -3.4361040592193604,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "off-label bupropion prescriptions are common. We sought to compare the effects of selective serotonin reuptake inhibitors",
            "probability": 0.003914052059476906,
            "start_logit": -3.3664257526397705,
            "end_logit": 1.6029366254806519,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "depression, but off-label bupropion",
            "probability": 0.0030034706653811086,
            "start_logit": -1.0378271341323853,
            "end_logit": -0.9904666543006897,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin reuptake inhibitors (SSRIs) and bupropion in overdose.",
            "probability": 0.00268781397430496,
            "start_logit": 1.872085690498352,
            "end_logit": -4.011419773101807,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "attempted and completed suicide",
            "probability": 0.002619402933943108,
            "start_logit": -1.4347867965698242,
            "end_logit": -0.7303290963172913,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "selective serotonin",
            "probability": 0.0026048602635873157,
            "start_logit": 1.872085690498352,
            "end_logit": -4.042768955230713,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "common. We sought to compare the effects of selective serotonin reuptake inhibitors",
            "probability": 0.0021417828095865728,
            "start_logit": -3.9693603515625,
            "end_logit": 1.6029366254806519,
            "question_text": "List the off-label use of SSRIs"
        }
    ],
    "56be0a18ef6e394741000006": [
        {
            "text": "pleural effusion",
            "probability": 0.2917962902858562,
            "start_logit": 2.325453758239746,
            "end_logit": 1.1827671527862549,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites",
            "probability": 0.2875933652503772,
            "start_logit": 1.647060513496399,
            "end_logit": 1.8466520309448242,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myocarditis",
            "probability": 0.18866738553977083,
            "start_logit": 1.7409008741378784,
            "end_logit": 1.331249713897705,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and pleural effusion",
            "probability": 0.14806667484944358,
            "start_logit": 1.647060513496399,
            "end_logit": 1.1827671527862549,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myocarditis with the formation of secondary cardiomyopathy",
            "probability": 0.060382305183424766,
            "start_logit": 1.7409008741378784,
            "end_logit": 0.19196021556854248,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "cardiomyopathy",
            "probability": 0.016127876635770807,
            "start_logit": 0.42075401544570923,
            "end_logit": 0.19196021556854248,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "p",
            "probability": 0.001934802677125243,
            "start_logit": 2.325453758239746,
            "end_logit": -3.8332834243774414,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and p",
            "probability": 0.000981780126851813,
            "start_logit": 1.647060513496399,
            "end_logit": -3.8332834243774414,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myopathy",
            "probability": 0.000660154014656412,
            "start_logit": -2.7750773429870605,
            "end_logit": 0.19196021556854248,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion are given.",
            "probability": 0.0006169021558323336,
            "start_logit": 2.325453758239746,
            "end_logit": -4.9763336181640625,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "myocarditis with the formation of secondary cardiomyopathy and Demons-Meigs syndrome",
            "probability": 0.0005044303222411816,
            "start_logit": 1.7409008741378784,
            "end_logit": -4.593061447143555,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "as",
            "probability": 0.0004427283348983309,
            "start_logit": 1.647060513496399,
            "end_logit": -4.62969446182251,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "my",
            "probability": 0.00041611574666979245,
            "start_logit": 1.7409008741378784,
            "end_logit": -4.78552770614624,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites and pleural effusion are given.",
            "probability": 0.00031303568264032326,
            "start_logit": 1.647060513496399,
            "end_logit": -4.9763336181640625,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural",
            "probability": 0.00031025187773472013,
            "start_logit": 2.325453758239746,
            "end_logit": -5.663659572601318,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "secondary cardiomyopathy",
            "probability": 0.0002828126002616638,
            "start_logit": -3.6227660179138184,
            "end_logit": 0.19196021556854248,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "s",
            "probability": 0.0002391627777182232,
            "start_logit": -5.445097923278809,
            "end_logit": 1.8466520309448242,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion are given",
            "probability": 0.00022605685487036753,
            "start_logit": 2.325453758239746,
            "end_logit": -5.980257511138916,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "effusion",
            "probability": 0.00021898436497775383,
            "start_logit": -4.869357109069824,
            "end_logit": 1.1827671527862549,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "itis",
            "probability": 0.00021888471887834718,
            "start_logit": -5.018294811248779,
            "end_logit": 1.331249713897705,
            "question_text": "List symptoms of Meigs' Syndrome."
        }
    ],
    "5311b99ae3eabad021000004": [
        {
            "text": "blood urea nitrogen and creatinine",
            "probability": 0.17884785467545264,
            "start_logit": 5.052976608276367,
            "end_logit": 4.918858051300049,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "blood urea nitrogen",
            "probability": 0.17513039201573244,
            "start_logit": 5.052976608276367,
            "end_logit": 4.897853374481201,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine",
            "probability": 0.17364749554690953,
            "start_logit": 5.023468494415283,
            "end_logit": 4.918858051300049,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride as well as blood urea nitrogen and creatinine",
            "probability": 0.11718853449673129,
            "start_logit": 4.63022518157959,
            "end_logit": 4.918858051300049,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride as well as blood urea nitrogen",
            "probability": 0.1147526987304624,
            "start_logit": 4.63022518157959,
            "end_logit": 4.897853374481201,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "urea nitrogen and creatinine",
            "probability": 0.03837334429475489,
            "start_logit": 3.5138041973114014,
            "end_logit": 4.918858051300049,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "urea nitrogen",
            "probability": 0.03757573073208062,
            "start_logit": 3.5138041973114014,
            "end_logit": 4.897853374481201,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium and chloride as well as blood urea nitrogen and creatinine",
            "probability": 0.03335238568051652,
            "start_logit": 3.373570442199707,
            "end_logit": 4.918858051300049,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium and chloride as well as blood urea nitrogen",
            "probability": 0.03265913583077749,
            "start_logit": 3.373570442199707,
            "end_logit": 4.897853374481201,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "chloride as well as blood urea nitrogen and creatinine",
            "probability": 0.023650100952237147,
            "start_logit": 3.029808521270752,
            "end_logit": 4.918858051300049,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride",
            "probability": 0.02329556711040834,
            "start_logit": 4.63022518157959,
            "end_logit": 3.3033370971679688,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "chloride as well as blood urea nitrogen",
            "probability": 0.023158519057961163,
            "start_logit": 3.029808521270752,
            "end_logit": 4.897853374481201,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium",
            "probability": 0.008646820032636664,
            "start_logit": 4.63022518157959,
            "end_logit": 2.312265634536743,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium and chloride",
            "probability": 0.006630023510827047,
            "start_logit": 3.373570442199707,
            "end_logit": 3.3033370971679688,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "chloride",
            "probability": 0.004701334616622754,
            "start_logit": 3.029808521270752,
            "end_logit": 3.3033370971679688,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "electrolytes potassium",
            "probability": 0.0024609239963365066,
            "start_logit": 3.373570442199707,
            "end_logit": 2.312265634536743,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "blood urea nitrogen and creatinine,",
            "probability": 0.0020617302226723375,
            "start_logit": 5.052976608276367,
            "end_logit": 0.455868124961853,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "creatinine,",
            "probability": 0.002001781292317408,
            "start_logit": 5.023468494415283,
            "end_logit": 0.455868124961853,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "potassium and chloride as well as blood urea nitrogen and creatinine,",
            "probability": 0.001350931179806612,
            "start_logit": 4.63022518157959,
            "end_logit": 0.455868124961853,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "sodium and fluid balance). Here she addresses the electrolytes potassium and chloride as well as blood urea nitrogen and creatinine",
            "probability": 0.0005146960247562593,
            "start_logit": -0.7977376580238342,
            "end_logit": 4.918858051300049,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        }
    ],
    "5131fa145274a5fb07000009": [
        {
            "text": "Chorioangiomas",
            "probability": 0.5658986259802523,
            "start_logit": 2.728792428970337,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "chorioangioma",
            "probability": 0.3302845194116286,
            "start_logit": 3.03417706489563,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "Chorioangiomas are generally small and associated with favorable outcomes, but large tumors",
            "probability": 0.043460642594447194,
            "start_logit": 2.728792428970337,
            "end_logit": 1.4800978899002075,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "giant chorioangioma",
            "probability": 0.026402079972163303,
            "start_logit": 0.5076653957366943,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors",
            "probability": 0.017262224618336677,
            "start_logit": 1.8054572343826294,
            "end_logit": 1.4800978899002075,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "chorioangioma causing fetal cardiac failure",
            "probability": 0.0034827064156554804,
            "start_logit": 3.03417706489563,
            "end_logit": -1.3493328094482422,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "orioangiomas",
            "probability": 0.0019690746586194406,
            "start_logit": -2.932058811187744,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "a giant chorioangioma",
            "probability": 0.0019068575038939913,
            "start_logit": -2.1203207969665527,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "mas",
            "probability": 0.0018220535524139524,
            "start_logit": -3.0096583366394043,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "large tumors",
            "probability": 0.0015933349018452101,
            "start_logit": -0.5772340893745422,
            "end_logit": 1.4800978899002075,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "iomas",
            "probability": 0.001396857717423899,
            "start_logit": -3.275397300720215,
            "end_logit": 4.046657085418701,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cardiac failure on ultrasonography are indications for urgent in utero interventions. We report a case of a giant chorioangioma",
            "probability": 0.001377537888200588,
            "start_logit": -2.44547963142395,
            "end_logit": 3.2028119564056396,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors can cause serious fetal complications, such as polyhydramnios",
            "probability": 0.0010705388633266014,
            "start_logit": 1.8054572343826294,
            "end_logit": -1.3002605438232422,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "Chorioangio",
            "probability": 0.000526459428194058,
            "start_logit": 2.728792428970337,
            "end_logit": -2.9333388805389404,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cardiac failure",
            "probability": 0.00034668162918080457,
            "start_logit": 0.34287136793136597,
            "end_logit": -0.9651852250099182,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "Chorioangiomas are generally small and associated with favorable outcomes, but large tumors can cause serious fetal complications",
            "probability": 0.0003043634574070323,
            "start_logit": 2.728792428970337,
            "end_logit": -3.481290578842163,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "giant chorioangioma causing fetal cardiac failure",
            "probability": 0.00027839843499024376,
            "start_logit": 0.5076653957366943,
            "end_logit": -1.3493328094482422,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors can cause serious fetal complications, such as polyhydramnios, fetal anemia, intrauterine growth restriction",
            "probability": 0.0002277508554217468,
            "start_logit": 1.8054572343826294,
            "end_logit": -2.8479256629943848,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "tumors can cause serious fetal complications, such as polyhydramnios,",
            "probability": 0.00021419533019465228,
            "start_logit": 1.8054572343826294,
            "end_logit": -2.909289598464966,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cardiac failure, fetal hydrops, and intrauterine fetal death",
            "probability": 0.0001750967864041535,
            "start_logit": 0.34287136793136597,
            "end_logit": -1.6482532024383545,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        }
    ],
    "5505eed08e1671127b000006": [
        {
            "text": "trypsin",
            "probability": 0.9945709607330411,
            "start_logit": 4.604744911193848,
            "end_logit": 4.073629379272461,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "tryps",
            "probability": 0.001994797583598207,
            "start_logit": 4.604744911193848,
            "end_logit": -2.138139486312866,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion parameters and comparison to in-solution protease",
            "probability": 0.0016395426227994267,
            "start_logit": 4.604744911193848,
            "end_logit": -2.3342647552490234,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "try",
            "probability": 0.0008602246648195867,
            "start_logit": 4.604744911193848,
            "end_logit": -2.979243755340576,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin dig",
            "probability": 0.00022159856740706444,
            "start_logit": 4.604744911193848,
            "end_logit": -4.335569858551025,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion parameters and comparison to in-solution protease digestion",
            "probability": 0.0002136917179287368,
            "start_logit": 4.604744911193848,
            "end_logit": -4.371902942657471,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion parameters",
            "probability": 0.00018040834818695413,
            "start_logit": 4.604744911193848,
            "end_logit": -4.541214466094971,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "Optimization of trypsin",
            "probability": 0.00012765817735572912,
            "start_logit": -4.355965614318848,
            "end_logit": 4.073629379272461,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion",
            "probability": 0.00012097203875280293,
            "start_logit": 4.604744911193848,
            "end_logit": -4.940877914428711,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "in",
            "probability": 6.627393367189236e-05,
            "start_logit": -5.0115251541137695,
            "end_logit": 4.073629379272461,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "protease",
            "probability": 2.4446226274462185e-06,
            "start_logit": -1.9035369157791138,
            "end_logit": -2.3342647552490234,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "protease digestion",
            "probability": 3.1862276813181205e-07,
            "start_logit": -1.9035369157791138,
            "end_logit": -4.371902942657471,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "Optimization of tryps",
            "probability": 2.560422873477728e-07,
            "start_logit": -4.355965614318848,
            "end_logit": -2.138139486312866,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "Optimization of trypsin digestion parameters and comparison to in-solution protease",
            "probability": 2.1044352910660366e-07,
            "start_logit": -4.355965614318848,
            "end_logit": -2.3342647552490234,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "alkylation",
            "probability": 1.515466511237964e-07,
            "start_logit": -3.223789691925049,
            "end_logit": -3.794764518737793,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "comparison to in-solution protease",
            "probability": 1.313271683139684e-07,
            "start_logit": -4.827491283416748,
            "end_logit": -2.3342647552490234,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "Optimization of try",
            "probability": 1.1041415561376667e-07,
            "start_logit": -4.355965614318848,
            "end_logit": -2.979243755340576,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "in digestion parameters and comparison to in-solution protease",
            "probability": 1.0925207282903514e-07,
            "start_logit": -5.0115251541137695,
            "end_logit": -2.3342647552490234,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "in-solution protease",
            "probability": 1.0799387135618984e-07,
            "start_logit": -5.02310848236084,
            "end_logit": -2.3342647552490234,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "alkylation, and protease digestion",
            "probability": 3.134730733172653e-08,
            "start_logit": -3.223789691925049,
            "end_logit": -5.370529651641846,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        }
    ],
    "54e1252fae9738404b000003": [
        {
            "text": "Hypermobile",
            "probability": 0.9318294720386234,
            "start_logit": 1.3724956512451172,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "Hypermobile Ehlers-Danlos syndrome",
            "probability": 0.05243660472307895,
            "start_logit": 1.3724956512451172,
            "end_logit": -2.9773008823394775,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "H",
            "probability": 0.003505452453306888,
            "start_logit": 1.3724956512451172,
            "end_logit": -5.682586193084717,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification, an update much needed since Villefranche nosology, in 1998. Hypermobile",
            "probability": 0.003066428861298132,
            "start_logit": -4.344140529632568,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "Hypermobile Ehlers-Danlos syndrome is the only subtype",
            "probability": 0.0017541425811737148,
            "start_logit": 1.3724956512451172,
            "end_logit": -6.37492561340332,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "revised Ehlers-Danlos syndrome classification, an update much needed since Villefranche nosology, in 1998. Hypermobile",
            "probability": 0.001487381527783851,
            "start_logit": -5.067636966705322,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "1998. Hypermobile",
            "probability": 0.0014056067941195418,
            "start_logit": -5.124185085296631,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "in 1998. Hypermobile",
            "probability": 0.000723856328402297,
            "start_logit": -5.787816524505615,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hypermobile",
            "probability": 0.0005496541007091465,
            "start_logit": -1.4273191690444946,
            "end_logit": -4.7355570793151855,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "nosology, in 1998. Hypermobile",
            "probability": 0.0005173424437827389,
            "start_logit": -6.123704433441162,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "mobile",
            "probability": 0.0005129002707720066,
            "start_logit": -6.132328033447266,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hypermobile Ehlers-Danlos syndrome",
            "probability": 0.00044229805578376247,
            "start_logit": -1.4273191690444946,
            "end_logit": -4.95286226272583,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": ", in 1998. Hypermobile",
            "probability": 0.00040900262663428824,
            "start_logit": -6.358687877655029,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "update much needed since Villefranche nosology, in 1998. Hypermobile",
            "probability": 0.00040575395489796416,
            "start_logit": -6.366662502288818,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": ". Hypermobile",
            "probability": 0.00023794381310085076,
            "start_logit": -6.900374889373779,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "ogy, in 1998. Hypermobile",
            "probability": 0.00023499625227230505,
            "start_logit": -6.912839889526367,
            "end_logit": -0.09975596517324448,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification, an update much needed since Villefranche nosology, in 1998. Hypermobile Ehlers-Danlos syndrome",
            "probability": 0.00017255637746631236,
            "start_logit": -4.344140529632568,
            "end_logit": -2.9773008823394775,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "classification",
            "probability": 0.0001339423540695697,
            "start_logit": -4.344140529632568,
            "end_logit": -3.2306153774261475,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hypermobile Ehlers-Danlos syndrome have been an ongoing challenge, even decades after the description of this condition. A recent international consortium",
            "probability": 9.556708631842585e-05,
            "start_logit": -1.4273191690444946,
            "end_logit": -6.485017776489258,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "1998. Hypermobile Ehlers-Danlos syndrome",
            "probability": 7.909735640585706e-05,
            "start_logit": -5.124185085296631,
            "end_logit": -2.9773008823394775,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        }
    ],
    "517a8bef8ed59a060a000041": [
        {
            "text": "Dlk1",
            "probability": 0.358601565149166,
            "start_logit": 4.511293888092041,
            "end_logit": 3.5910837650299072,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk1-Dio3",
            "probability": 0.29791212640233194,
            "start_logit": 4.511293888092041,
            "end_logit": 3.405670404434204,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk1",
            "probability": 0.09355296339092803,
            "start_logit": 3.167609691619873,
            "end_logit": 3.5910837650299072,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk1-Dio3",
            "probability": 0.07772013555891111,
            "start_logit": 3.167609691619873,
            "end_logit": 3.405670404434204,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dio3",
            "probability": 0.07238560531428448,
            "start_logit": 3.0965027809143066,
            "end_logit": 3.405670404434204,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "type III iodothyronine deiodinase (Dlk1",
            "probability": 0.021801768244567196,
            "start_logit": 1.7110730409622192,
            "end_logit": 3.5910837650299072,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "type III iodothyronine deiodinase (Dlk1-Dio3",
            "probability": 0.018112054626331996,
            "start_logit": 1.7110730409622192,
            "end_logit": 3.405670404434204,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk",
            "probability": 0.016377691521883345,
            "start_logit": 4.511293888092041,
            "end_logit": 0.5047919750213623,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "(Dlk1",
            "probability": 0.009023673520523785,
            "start_logit": 0.8289334774017334,
            "end_logit": 3.5910837650299072,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "(Dlk1-Dio3",
            "probability": 0.007496514314825792,
            "start_logit": 0.8289334774017334,
            "end_logit": 3.405670404434204,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk1-Dio3)",
            "probability": 0.006118645517970019,
            "start_logit": 4.511293888092041,
            "end_logit": -0.4797874093055725,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dlk1-Dio",
            "probability": 0.005449451921497191,
            "start_logit": 4.511293888092041,
            "end_logit": -0.5956131219863892,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk",
            "probability": 0.004272657244921198,
            "start_logit": 3.167609691619873,
            "end_logit": 0.5047919750213623,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase",
            "probability": 0.002614202990153929,
            "start_logit": 3.167609691619873,
            "end_logit": 0.013515302911400795,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk1-Dio3)",
            "probability": 0.001596249084709401,
            "start_logit": 3.167609691619873,
            "end_logit": -0.4797874093055725,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dio3)",
            "probability": 0.0014866862415786732,
            "start_logit": 3.0965027809143066,
            "end_logit": -0.4797874093055725,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine",
            "probability": 0.0014814086012339793,
            "start_logit": 3.167609691619873,
            "end_logit": -0.5544505715370178,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinase (Dlk1-Dio",
            "probability": 0.0014216680172613985,
            "start_logit": 3.167609691619873,
            "end_logit": -0.5956131219863892,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "Dio",
            "probability": 0.0013240880145843476,
            "start_logit": 3.0965027809143066,
            "end_logit": -0.5956131219863892,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "i",
            "probability": 0.0012508443223360048,
            "start_logit": 3.167609691619873,
            "end_logit": -0.7236251831054688,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        }
    ],
    "5148885ad24251bc05000032": [
        {
            "text": "VKORC1 genes. Studies implicate that polymorphisms in VKORC1",
            "probability": 0.15503845871292832,
            "start_logit": 4.46388053894043,
            "end_logit": 3.7058892250061035,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes. Studies implicate that polymorphisms in VKORC1 and CYP2C9",
            "probability": 0.1488561850817561,
            "start_logit": 4.46388053894043,
            "end_logit": 3.665196657180786,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1",
            "probability": 0.14336091615850732,
            "start_logit": 4.46388053894043,
            "end_logit": 3.6275813579559326,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1 genes. Studies implicate that polymorphisms in VKORC1",
            "probability": 0.13738338345790635,
            "start_logit": 4.342982769012451,
            "end_logit": 3.7058892250061035,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 and CYP2C9",
            "probability": 0.13587242461025112,
            "start_logit": 4.372616291046143,
            "end_logit": 3.665196657180786,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9",
            "probability": 0.12965606104388616,
            "start_logit": 4.325785160064697,
            "end_logit": 3.665196657180786,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1",
            "probability": 0.1270356263922186,
            "start_logit": 4.342982769012451,
            "end_logit": 3.6275813579559326,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes. Studies implicate that polymorphisms in VKORC1 and CYP2C9 genes",
            "probability": 0.003908086320923553,
            "start_logit": 4.46388053894043,
            "end_logit": 0.025263840332627296,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 and CYP2C9 genes",
            "probability": 0.003567209274632411,
            "start_logit": 4.372616291046143,
            "end_logit": 0.025263840332627296,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 genes",
            "probability": 0.003404004195809146,
            "start_logit": 4.325785160064697,
            "end_logit": 0.025263840332627296,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes. Studies implicate that polymorphisms in VKORC",
            "probability": 0.0030170860254220416,
            "start_logit": 4.46388053894043,
            "end_logit": -0.23349250853061676,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC",
            "probability": 0.002753925161434497,
            "start_logit": 4.372616291046143,
            "end_logit": -0.23349250853061676,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1 genes. Studies implicate that polymorphisms in VKORC",
            "probability": 0.002673513977093497,
            "start_logit": 4.342982769012451,
            "end_logit": -0.23349250853061676,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC",
            "probability": 0.001603416883374139,
            "start_logit": 4.342982769012451,
            "end_logit": -0.7447493076324463,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "VKORC1 genes",
            "probability": 0.0007492018908258073,
            "start_logit": 4.46388053894043,
            "end_logit": -1.6265307664871216,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "CYP2C9 and VKORC1 genes",
            "probability": 0.0006638861835262005,
            "start_logit": 4.342982769012451,
            "end_logit": -1.6265307664871216,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "polymorphisms in VKORC1",
            "probability": 0.00016640717601886616,
            "start_logit": -2.373110294342041,
            "end_logit": 3.7058892250061035,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "polymorphisms in VKORC1 and CYP2C9",
            "probability": 0.00015977156634575814,
            "start_logit": -2.373110294342041,
            "end_logit": 3.665196657180786,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "2C9",
            "probability": 6.544891774185715e-05,
            "start_logit": -3.265585422515869,
            "end_logit": 3.665196657180786,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "2C9 and VKORC1 genes. Studies implicate that polymorphisms in VKORC1",
            "probability": 6.498696939840757e-05,
            "start_logit": -3.313361167907715,
            "end_logit": 3.7058892250061035,
            "question_text": "Which genes are involved in patient response to warfarin?"
        }
    ],
    "571e189dbb137a4b0c000003": [
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor drugs are effective for treatment of type-2 diabetes mellitus.",
            "probability": 0.12269368613997042,
            "start_logit": -4.2793192863464355,
            "end_logit": -4.4163737297058105,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "type-2 diabetes mellitus.",
            "probability": 0.09882167588605222,
            "start_logit": -4.495693206787109,
            "end_logit": -4.4163737297058105,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2)",
            "probability": 0.07490557573406782,
            "start_logit": -4.2793192863464355,
            "end_logit": -4.909836292266846,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor drugs",
            "probability": 0.07253744106988416,
            "start_logit": -4.2793192863464355,
            "end_logit": -4.941961765289307,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor drugs are effective for treatment of type-2 diabetes mellitus",
            "probability": 0.06283126514259635,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.085611820220947,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor",
            "probability": 0.059439243844635246,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.141109943389893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium",
            "probability": 0.05485369810940958,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.221395015716553,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "type-2 diabetes mellitus",
            "probability": 0.05060644206539579,
            "start_logit": -4.495693206787109,
            "end_logit": -5.085611820220947,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2",
            "probability": 0.05029238996084343,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.308210849761963,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "(SGLT2) inhibitor drugs are effective for treatment of type-2 diabetes mellitus.",
            "probability": 0.04194489259246228,
            "start_logit": -5.352653503417969,
            "end_logit": -4.4163737297058105,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "effective for treatment of type-2 diabetes mellitus.",
            "probability": 0.03996541470319495,
            "start_logit": -5.40099573135376,
            "end_logit": -4.4163737297058105,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "inhibitor drugs are effective for treatment of type-2 diabetes mellitus.",
            "probability": 0.03810145729330704,
            "start_logit": -5.448757648468018,
            "end_logit": -4.4163737297058105,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2",
            "probability": 0.036079944927134115,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.640327453613281,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "treatment of type-2 diabetes mellitus.",
            "probability": 0.03476211466876761,
            "start_logit": -5.540482044219971,
            "end_logit": -4.4163737297058105,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor drugs are effective",
            "probability": 0.03066695730698776,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.8028788566589355,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (",
            "probability": 0.029441387036415488,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.843663215637207,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "Sodium-glucose co-transporter-2 (SGLT2) inhibitor drugs are effective for treatment",
            "probability": 0.0291246759701965,
            "start_logit": -4.2793192863464355,
            "end_logit": -5.85447883605957,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "(SGLT2)",
            "probability": 0.025607726261950427,
            "start_logit": -5.352653503417969,
            "end_logit": -4.909836292266846,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "(SGLT2) inhibitor drugs",
            "probability": 0.02479813974402356,
            "start_logit": -5.352653503417969,
            "end_logit": -4.941961765289307,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "inhibitor drugs",
            "probability": 0.02252587154270523,
            "start_logit": -5.448757648468018,
            "end_logit": -4.941961765289307,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        }
    ],
    "52bf1f4503868f1b06000016": [
        {
            "text": "psychosis",
            "probability": 0.8206386141961435,
            "start_logit": 2.621952533721924,
            "end_logit": 2.436652421951294,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "acute psychosis",
            "probability": 0.1748144010402348,
            "start_logit": 1.0755945444107056,
            "end_logit": 2.436652421951294,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "osis",
            "probability": 0.0023428312835042475,
            "start_logit": -3.2367701530456543,
            "end_logit": 2.436652421951294,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "ps",
            "probability": 0.0013425102549767332,
            "start_logit": 2.621952533721924,
            "end_logit": -3.978889226913452,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "acute ps",
            "probability": 0.0002859847465793713,
            "start_logit": 1.0755945444107056,
            "end_logit": -3.978889226913452,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "schizophrenia",
            "probability": 0.00018209007446668373,
            "start_logit": -1.3752292394638062,
            "end_logit": -1.9795024394989014,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis",
            "probability": 0.00012209905805471102,
            "start_logit": -1.6361021995544434,
            "end_logit": -2.118298292160034,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism",
            "probability": 4.6893117466250926e-05,
            "start_logit": -1.4423412084579468,
            "end_logit": -3.2690210342407227,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "acute",
            "probability": 4.6547809217133636e-05,
            "start_logit": 1.0755945444107056,
            "end_logit": -5.794347763061523,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "thromboembolism",
            "probability": 4.385417522739197e-05,
            "start_logit": -2.1109914779663086,
            "end_logit": -2.6673717498779297,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis and pulmonary embolism",
            "probability": 3.8633119413006746e-05,
            "start_logit": -1.6361021995544434,
            "end_logit": -3.2690210342407227,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism. Before atypical neuroleptic treatment is administered to hospitalized patients",
            "probability": 2.5795778406029103e-05,
            "start_logit": -1.4423412084579468,
            "end_logit": -3.8666810989379883,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis and pulmonary embolism. Before atypical neuroleptic treatment is administered to hospitalized patients",
            "probability": 2.125197558530455e-05,
            "start_logit": -1.6361021995544434,
            "end_logit": -3.8666810989379883,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism. Before atypical neuroleptic treatment",
            "probability": 1.129429689144947e-05,
            "start_logit": -1.4423412084579468,
            "end_logit": -4.692594051361084,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis and pulmonary embolism. Before atypical neuroleptic treatment",
            "probability": 9.304860586574323e-06,
            "start_logit": -1.6361021995544434,
            "end_logit": -4.692594051361084,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism. Before atypical neuroleptic treatment is administered to hospitalized patients,",
            "probability": 6.687343220469081e-06,
            "start_logit": -1.4423412084579468,
            "end_logit": -5.216675281524658,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism. Before atypical neuroleptic treatment is administered",
            "probability": 5.739309234464494e-06,
            "start_logit": -1.4423412084579468,
            "end_logit": -5.369553089141846,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis and pulmonary embolism. Before atypical neuroleptic treatment is administered to hospitalized patients,",
            "probability": 5.50939974033674e-06,
            "start_logit": -1.6361021995544434,
            "end_logit": -5.216675281524658,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "pulmonary embolism. Before atypical neuroleptic",
            "probability": 5.229803651429387e-06,
            "start_logit": -1.4423412084579468,
            "end_logit": -5.462518215179443,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "deep venous thrombosis and pulmonary embolism. Before atypical neuroleptic treatment is administered",
            "probability": 4.7283574004824225e-06,
            "start_logit": -1.6361021995544434,
            "end_logit": -5.369553089141846,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        }
    ],
    "52eeddfcc8da898910000010": [
        {
            "text": "periodic paralysis",
            "probability": 0.1875528684933077,
            "start_logit": 5.8976263999938965,
            "end_logit": 6.046358108520508,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia",
            "probability": 0.1761256917617311,
            "start_logit": 5.8976263999938965,
            "end_logit": 5.983495235443115,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia",
            "probability": 0.1455861795211323,
            "start_logit": 5.7071967124938965,
            "end_logit": 5.983495235443115,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia characterized by QT prolongation, and dysmorphic features",
            "probability": 0.08748405379045274,
            "start_logit": 5.8976263999938965,
            "end_logit": 5.283753871917725,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia characterized by QT prolongation, and dysmorphic features",
            "probability": 0.07231465797507601,
            "start_logit": 5.7071967124938965,
            "end_logit": 5.283753871917725,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia characterized by QT prolongation",
            "probability": 0.06971119560084427,
            "start_logit": 5.8976263999938965,
            "end_logit": 5.0566582679748535,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "dysmorphic features",
            "probability": 0.0622558962131772,
            "start_logit": 5.557423114776611,
            "end_logit": 5.283753871917725,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia characterized by QT prolongation",
            "probability": 0.05762354450313348,
            "start_logit": 5.7071967124938965,
            "end_logit": 5.0566582679748535,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "episodic paralytic attacks and/or arrhythmia",
            "probability": 0.022261665858127114,
            "start_logit": 4.634532451629639,
            "end_logit": 5.178257465362549,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, arrhythmia characterized by QT prolongation, and dysmorphic",
            "probability": 0.0151081961163249,
            "start_logit": 5.8976263999938965,
            "end_logit": 3.5275347232818604,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "paralytic attacks and/or arrhythmia",
            "probability": 0.014939391261824326,
            "start_logit": 4.235667705535889,
            "end_logit": 5.178257465362549,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "episodic paralytic attacks",
            "probability": 0.013517901987786692,
            "start_logit": 4.634532451629639,
            "end_logit": 4.67940616607666,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmia characterized by QT prolongation, and dysmorphic",
            "probability": 0.012488493473214405,
            "start_logit": 5.7071967124938965,
            "end_logit": 3.5275347232818604,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "QT prolongation, and dysmorphic features",
            "probability": 0.011522406207589077,
            "start_logit": 3.8704633712768555,
            "end_logit": 5.283753871917725,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "dysmorphic",
            "probability": 0.01075137980733234,
            "start_logit": 5.557423114776611,
            "end_logit": 3.5275347232818604,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "skeletal muscle channelopathy with autosomal dominant inheritance resulting in periodic paralysis",
            "probability": 0.009738480944537192,
            "start_logit": 2.939650774002075,
            "end_logit": 6.046358108520508,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "QT prolongation",
            "probability": 0.00918156713283539,
            "start_logit": 3.8704633712768555,
            "end_logit": 5.0566582679748535,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "skeletal muscle channelopathy with autosomal dominant inheritance resulting in periodic paralysis, arrhythmia",
            "probability": 0.009145137085046775,
            "start_logit": 2.939650774002075,
            "end_logit": 5.983495235443115,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "paralytic attacks",
            "probability": 0.009071613423791113,
            "start_logit": 4.235667705535889,
            "end_logit": 4.67940616607666,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "skeletal muscle channelopathy with autosomal dominant inheritance resulting in periodic paralysis, arrhythmia characterized by QT prolongation",
            "probability": 0.0036196788427362856,
            "start_logit": 2.939650774002075,
            "end_logit": 5.0566582679748535,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        }
    ],
    "56f56a8609dd18d46b00000b": [
        {
            "text": "ABCA12",
            "probability": 0.7389701991140661,
            "start_logit": 3.9604082107543945,
            "end_logit": 3.2345495223999023,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ABCA12 gene",
            "probability": 0.24625698232214407,
            "start_logit": 3.9604082107543945,
            "end_logit": 2.135667562484741,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "BCA12",
            "probability": 0.004366163844363612,
            "start_logit": -1.1709645986557007,
            "end_logit": 3.2345495223999023,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "the ABCA12",
            "probability": 0.002412865373620935,
            "start_logit": -1.764034390449524,
            "end_logit": 3.2345495223999023,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "12",
            "probability": 0.0021058440690702135,
            "start_logit": -1.9001330137252808,
            "end_logit": 3.2345495223999023,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "BCA12 gene",
            "probability": 0.0014549955247533184,
            "start_logit": -1.1709645986557007,
            "end_logit": 2.135667562484741,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ABCA",
            "probability": 0.0008786570710202665,
            "start_logit": 3.9604082107543945,
            "end_logit": -3.5000686645507812,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "A",
            "probability": 0.0008114530573735409,
            "start_logit": 3.9604082107543945,
            "end_logit": -3.579636812210083,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "the ABCA12 gene",
            "probability": 0.000804071593644559,
            "start_logit": -1.764034390449524,
            "end_logit": 2.135667562484741,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "12 gene",
            "probability": 0.0007017587533461125,
            "start_logit": -1.9001330137252808,
            "end_logit": 2.135667562484741,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "CA12",
            "probability": 0.0006652313880061702,
            "start_logit": -3.0524697303771973,
            "end_logit": 3.2345495223999023,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "CA12 gene",
            "probability": 0.00022168400613822888,
            "start_logit": -3.0524697303771973,
            "end_logit": 2.135667562484741,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "gene",
            "probability": 0.0002045645836355444,
            "start_logit": -3.1328389644622803,
            "end_logit": 2.135667562484741,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "ABCA12 gene have a premature termination codon mutation on one allele and a silent variant on the second.",
            "probability": 0.00013280997412606305,
            "start_logit": 3.9604082107543945,
            "end_logit": -5.3895440101623535,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "BCA",
            "probability": 5.191495867739242e-06,
            "start_logit": -1.1709645986557007,
            "end_logit": -3.5000686645507812,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "the ABCA",
            "probability": 2.868967144404074e-06,
            "start_logit": -1.764034390449524,
            "end_logit": -3.5000686645507812,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "the A",
            "probability": 2.6495344288616393e-06,
            "start_logit": -1.764034390449524,
            "end_logit": -3.579636812210083,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "CA",
            "probability": 7.909794787895419e-07,
            "start_logit": -3.0524697303771973,
            "end_logit": -3.5000686645507812,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "BCA12 gene have a premature termination codon mutation on one allele and a silent variant on the second.",
            "probability": 7.8470025976051e-07,
            "start_logit": -1.1709645986557007,
            "end_logit": -5.3895440101623535,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "the ABCA12 gene have a premature termination codon mutation on one allele and a silent variant on the second.",
            "probability": 4.3364751139417106e-07,
            "start_logit": -1.764034390449524,
            "end_logit": -5.3895440101623535,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        }
    ],
    "532c0c21d6d3ac6a3400001b": [
        {
            "text": "three-dimensional molecular alignment",
            "probability": 0.5840921530727105,
            "start_logit": 4.237447261810303,
            "end_logit": 4.190657138824463,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular alignment",
            "probability": 0.21493482775438316,
            "start_logit": 3.2377233505249023,
            "end_logit": 4.190657138824463,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three-dimensional molecular alignment",
            "probability": 0.11195536903984497,
            "start_logit": 2.585488796234131,
            "end_logit": 4.190657138824463,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "alignment",
            "probability": 0.02604455928492566,
            "start_logit": 1.1271973848342896,
            "end_logit": 4.190657138824463,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.016706283781186316,
            "start_logit": 4.237447261810303,
            "end_logit": 0.6363832950592041,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular",
            "probability": 0.012262583063004805,
            "start_logit": 4.237447261810303,
            "end_logit": 0.32715097069740295,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.006147595388904552,
            "start_logit": 3.2377233505249023,
            "end_logit": 0.6363832950592041,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three",
            "probability": 0.004787122898392829,
            "start_logit": 4.237447261810303,
            "end_logit": -0.613472044467926,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular",
            "probability": 0.004512397854697179,
            "start_logit": 3.2377233505249023,
            "end_logit": 0.32715097069740295,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "dimensional molecular alignment",
            "probability": 0.003771756719499708,
            "start_logit": -0.8050706386566162,
            "end_logit": 4.190657138824463,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods",
            "probability": 0.0035189551022417713,
            "start_logit": 2.585488796234131,
            "end_logit": 0.7307209372520447,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.0032021628028518646,
            "start_logit": 2.585488796234131,
            "end_logit": 0.6363832950592041,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three-dimensional molecular",
            "probability": 0.002350420229031147,
            "start_logit": 2.585488796234131,
            "end_logit": 0.32715097069740295,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional",
            "probability": 0.001650906688903592,
            "start_logit": 4.237447261810303,
            "end_logit": -1.678076982498169,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "Methods of three",
            "probability": 0.0009175677295256262,
            "start_logit": 2.585488796234131,
            "end_logit": -0.613472044467926,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular alignment generally treat all pharmacophore features equally when super",
            "probability": 0.0008663576881058885,
            "start_logit": 4.237447261810303,
            "end_logit": -2.322859048843384,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "alignment generally treat all pharmacophore features equally when superimposing",
            "probability": 0.0007449300526996377,
            "start_logit": 1.1271973848342896,
            "end_logit": 0.6363832950592041,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "superimposing",
            "probability": 0.0006508797473209543,
            "start_logit": 0.9922319650650024,
            "end_logit": 0.6363832950592041,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing.",
            "probability": 0.0005643679138017889,
            "start_logit": 4.237447261810303,
            "end_logit": -2.751450538635254,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "molecular alignment generally treat all pharmacophore features equally when super",
            "probability": 0.00031880318796808846,
            "start_logit": 3.2377233505249023,
            "end_logit": -2.322859048843384,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        }
    ],
    "5166f41a298dcd4e5100005b": [
        {
            "text": "SAHA",
            "probability": 0.343211741932684,
            "start_logit": 5.560526371002197,
            "end_logit": 5.462747097015381,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5-Aza",
            "probability": 0.27496585100279325,
            "start_logit": 5.617938041687012,
            "end_logit": 5.1836347579956055,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5-Aza",
            "probability": 0.25962421045641065,
            "start_logit": 5.560526371002197,
            "end_logit": 5.1836347579956055,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5-Aza)",
            "probability": 0.03215026663461336,
            "start_logit": 5.617938041687012,
            "end_logit": 3.0374085903167725,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5-Aza)",
            "probability": 0.030356451757675835,
            "start_logit": 5.560526371002197,
            "end_logit": 3.0374085903167725,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA)",
            "probability": 0.016004107585268535,
            "start_logit": 5.560526371002197,
            "end_logit": 2.397244930267334,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(SAHA",
            "probability": 0.013525789419645665,
            "start_logit": 2.3267769813537598,
            "end_logit": 5.462747097015381,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(SAHA) and DNA methyltransferase inhibitor (5-Aza",
            "probability": 0.010231649940356448,
            "start_logit": 2.3267769813537598,
            "end_logit": 5.1836347579956055,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(5-Aza",
            "probability": 0.006004472300225567,
            "start_logit": 1.7937957048416138,
            "end_logit": 5.1836347579956055,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor",
            "probability": 0.005877562593415414,
            "start_logit": 5.560526371002197,
            "end_logit": 1.3955416679382324,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(SAHA) and DNA methyltransferase inhibitor (5-Aza)",
            "probability": 0.0011963313716769287,
            "start_logit": 2.3267769813537598,
            "end_logit": 3.0374085903167725,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5",
            "probability": 0.0010268785283414693,
            "start_logit": 5.617938041687012,
            "end_logit": -0.4064885079860687,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5",
            "probability": 0.0009695841362954797,
            "start_logit": 5.560526371002197,
            "end_logit": -0.4064885079860687,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "5-Aza),",
            "probability": 0.0008600148467427011,
            "start_logit": 5.617938041687012,
            "end_logit": -0.5838177800178528,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "SAHA) and DNA methyltransferase inhibitor (5-Aza),",
            "probability": 0.0008120305658032296,
            "start_logit": 5.560526371002197,
            "end_logit": -0.5838177800178528,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "Aza",
            "probability": 0.0007136396082086668,
            "start_logit": -0.33608606457710266,
            "end_logit": 5.1836347579956055,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(5-Aza)",
            "probability": 0.0007020704016457706,
            "start_logit": 1.7937957048416138,
            "end_logit": 3.0374085903167725,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "DNA methyltransferase inhibitor (5-Aza",
            "probability": 0.0006598404320888772,
            "start_logit": -0.41446611285209656,
            "end_logit": 5.1836347579956055,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "(SAHA)",
            "probability": 0.0006307132379234075,
            "start_logit": 2.3267769813537598,
            "end_logit": 2.397244930267334,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "histone deacetylase inhibitor (SAHA",
            "probability": 0.0004767932481847849,
            "start_logit": -1.0184935331344604,
            "end_logit": 5.462747097015381,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        }
    ],
    "517539af8ed59a060a000026": [
        {
            "text": "PGC-1\u03b1",
            "probability": 0.7942088421871092,
            "start_logit": 5.540432453155518,
            "end_logit": 3.991281032562256,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC-1",
            "probability": 0.06838717172729214,
            "start_logit": 5.540432453155518,
            "end_logit": 1.539119839668274,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC-1\u03b1 transcription",
            "probability": 0.0500312329719083,
            "start_logit": 5.540432453155518,
            "end_logit": 1.2265820503234863,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "SENP1",
            "probability": 0.019383200026132565,
            "start_logit": 3.414377450942993,
            "end_logit": 2.4043962955474854,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial",
            "probability": 0.01836731983919613,
            "start_logit": 3.5924363136291504,
            "end_logit": 2.172503709793091,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MEF-2C-mediated PGC-1\u03b1",
            "probability": 0.017589502630629042,
            "start_logit": 1.7303882837295532,
            "end_logit": 3.991281032562256,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression by de-SUMOylation of MEF-2C, which enhanced MEF-2C-mediated PGC-1",
            "probability": 0.00974923791768527,
            "start_logit": 3.5924363136291504,
            "end_logit": 1.539119839668274,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene",
            "probability": 0.0052172897371600396,
            "start_logit": 3.5924363136291504,
            "end_logit": 0.9139087796211243,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression",
            "probability": 0.002926430210934817,
            "start_logit": 3.5924363136291504,
            "end_logit": 0.33571404218673706,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC-1\u03b1 transcription.",
            "probability": 0.002840742155431341,
            "start_logit": 5.540432453155518,
            "end_logit": -1.6420000791549683,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression by de-SUMOylation of MEF-2C, which enhanced MEF-2C",
            "probability": 0.002198121343237586,
            "start_logit": 3.5924363136291504,
            "end_logit": 0.04953378066420555,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MEF-2C, which enhanced MEF-2C-mediated PGC-1\u03b1",
            "probability": 0.0021631219963319922,
            "start_logit": -0.36536145210266113,
            "end_logit": 3.991281032562256,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MEF-2C-mediated PGC-1",
            "probability": 0.0015145844179799402,
            "start_logit": 1.7303882837295532,
            "end_logit": 1.539119839668274,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MEF-2C-mediated PGC-1\u03b1 transcription",
            "probability": 0.0011080517582120657,
            "start_logit": 1.7303882837295532,
            "end_logit": 1.2265820503234863,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC-1\u03b1 transcription. Genetic induction of SENP1",
            "probability": 0.0007797799223270087,
            "start_logit": 5.540432453155518,
            "end_logit": -2.9348089694976807,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C-1\u03b1",
            "probability": 0.0007707136779593456,
            "start_logit": -1.3973523378372192,
            "end_logit": 3.991281032562256,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression by de-SUMOylation of MEF-2C,",
            "probability": 0.000767967898277421,
            "start_logit": 3.5924363136291504,
            "end_logit": -1.0020766258239746,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PGC",
            "probability": 0.000681222482824393,
            "start_logit": 5.540432453155518,
            "end_logit": -3.069931745529175,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "P",
            "probability": 0.0006695579193148503,
            "start_logit": 5.540432453155518,
            "end_logit": -3.087203025817871,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "mitochondrial gene expression by de-SUMOylation of MEF-2C",
            "probability": 0.0006459091800565059,
            "start_logit": 3.5924363136291504,
            "end_logit": -1.1751656532287598,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        }
    ],
    "52d2818403868f1b06000033": [
        {
            "text": "Kymriah",
            "probability": 0.9883655187689195,
            "start_logit": 4.288388729095459,
            "end_logit": 3.9484875202178955,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah,",
            "probability": 0.005325612767663572,
            "start_logit": 4.288388729095459,
            "end_logit": -1.2750372886657715,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "K",
            "probability": 0.0014463751139571848,
            "start_logit": 4.288388729095459,
            "end_logit": -2.5785045623779297,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122,",
            "probability": 0.0012052847305442465,
            "start_logit": 4.288388729095459,
            "end_logit": -2.7608492374420166,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LVs (e.g. Kymriah",
            "probability": 0.001034581798799015,
            "start_logit": -2.573666572570801,
            "end_logit": 3.9484875202178955,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "h",
            "probability": 0.000680986860912611,
            "start_logit": -2.9918761253356934,
            "end_logit": 3.9484875202178955,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia treatment",
            "probability": 0.0006739721109727585,
            "start_logit": 4.288388729095459,
            "end_logit": -3.3421316146850586,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122, for \u03b2-thalassemia treatment)",
            "probability": 0.000398729708616907,
            "start_logit": 4.288388729095459,
            "end_logit": -3.8670365810394287,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia treatment;",
            "probability": 0.0002228904681707991,
            "start_logit": 4.288388729095459,
            "end_logit": -4.448639869689941,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia",
            "probability": 0.00018789183271509009,
            "start_logit": 4.288388729095459,
            "end_logit": -4.6194539070129395,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kymriah, for B-cell Acute lymphoblastic leukemia treatment; LentiGlobin\u2122, for \u03b2-thalassemia",
            "probability": 0.00014648403329527813,
            "start_logit": 4.288388729095459,
            "end_logit": -4.868403911590576,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "(e.g. Kymriah",
            "probability": 9.703418700346575e-05,
            "start_logit": -4.9403557777404785,
            "end_logit": 3.9484875202178955,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "Kym",
            "probability": 9.586925277841367e-05,
            "start_logit": 4.288388729095459,
            "end_logit": -5.292335033416748,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "gene therapy products based on LVs (e.g. Kymriah",
            "probability": 5.9810852917945884e-05,
            "start_logit": -3.160554885864258,
            "end_logit": 1.6848104000091553,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "based on LVs (e.g. Kymriah",
            "probability": 3.2084558163438415e-05,
            "start_logit": -6.047044277191162,
            "end_logit": 3.9484875202178955,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "The approval of gene therapy products based on LVs (e.g. Kymriah",
            "probability": 9.489397572593764e-06,
            "start_logit": -5.0015668869018555,
            "end_logit": 1.6848104000091553,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "approval of gene therapy products based on LVs (e.g. Kymriah",
            "probability": 6.625545387360262e-06,
            "start_logit": -5.360809326171875,
            "end_logit": 1.6848104000091553,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LVs (e.g. Kymriah,",
            "probability": 5.5746400822837385e-06,
            "start_logit": -2.573666572570801,
            "end_logit": -1.2750372886657715,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "h,",
            "probability": 3.669363461409115e-06,
            "start_logit": -2.9918761253356934,
            "end_logit": -1.2750372886657715,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "LVs (e.g. K",
            "probability": 1.5140080655583984e-06,
            "start_logit": -2.573666572570801,
            "end_logit": -2.5785045623779297,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        }
    ],
    "571cd9537de986d80d00000e": [
        {
            "text": "caspase-11",
            "probability": 0.531202287227691,
            "start_logit": 2.5126023292541504,
            "end_logit": 2.427760362625122,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-1 and the noncanonical pathway regulated by mouse caspase-11",
            "probability": 0.10894534340306887,
            "start_logit": 0.9283057451248169,
            "end_logit": 2.427760362625122,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-11 and human caspases-4/5",
            "probability": 0.052954463878941586,
            "start_logit": 2.5126023292541504,
            "end_logit": 0.12204983085393906,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspases-4/5. All inflammatory caspases activate the pyroptosis effector protein gasdermin D",
            "probability": 0.05128619057239758,
            "start_logit": 2.219580888748169,
            "end_logit": 0.38306042551994324,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D",
            "probability": 0.047415905596278216,
            "start_logit": 2.1411170959472656,
            "end_logit": 0.38306042551994324,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspases-4/5",
            "probability": 0.039504355499991255,
            "start_logit": 2.219580888748169,
            "end_logit": 0.12204983085393906,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspases-4/5. All inflammatory caspases activate the pyroptosis effector protein gasdermin",
            "probability": 0.031024865096814652,
            "start_logit": 2.219580888748169,
            "end_logit": -0.11957211792469025,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin",
            "probability": 0.02868359022476446,
            "start_logit": 2.1411170959472656,
            "end_logit": -0.11957211792469025,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-11 and human caspases-4",
            "probability": 0.026205094401134305,
            "start_logit": 2.5126023292541504,
            "end_logit": -0.5814287066459656,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspases-4",
            "probability": 0.019549161473900113,
            "start_logit": 2.219580888748169,
            "end_logit": -0.5814287066459656,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D, but caspase-1",
            "probability": 0.01430853543516816,
            "start_logit": 2.1411170959472656,
            "end_logit": -0.8150410652160645,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "11",
            "probability": 0.011334375965594178,
            "start_logit": -1.334700345993042,
            "end_logit": 2.427760362625122,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-1 and the noncanonical pathway regulated by mouse caspase-11 and human caspases-4/5",
            "probability": 0.010860537295736173,
            "start_logit": 0.9283057451248169,
            "end_logit": 0.12204983085393906,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-1",
            "probability": 0.009630491706796524,
            "start_logit": 0.9283057451248169,
            "end_logit": 0.0018483272287994623,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "mouse caspase-11",
            "probability": 0.006647458052911208,
            "start_logit": -1.868306040763855,
            "end_logit": 2.427760362625122,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-1 and the noncanonical pathway regulated by mouse caspase-11 and human caspases-4",
            "probability": 0.005374455413851972,
            "start_logit": 0.9283057451248169,
            "end_logit": -0.5814287066459656,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "gasdermin D, but caspase-1 mostly activates the inflammatory cytokine precursors pro-interleukin-18",
            "probability": 0.001588733427728832,
            "start_logit": 2.1411170959472656,
            "end_logit": -3.012960195541382,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "11 and human caspases-4/5. All inflammatory caspases activate the pyroptosis effector protein gasdermin D",
            "probability": 0.001466883807074193,
            "start_logit": -1.334700345993042,
            "end_logit": 0.38306042551994324,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "11 and human caspases-4/5",
            "probability": 0.0011299006368982976,
            "start_logit": -1.334700345993042,
            "end_logit": 0.12204983085393906,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "11 and human caspases-4/5. All inflammatory caspases activate the pyroptosis effector protein gasdermin",
            "probability": 0.0008873708832582373,
            "start_logit": -1.334700345993042,
            "end_logit": -0.11957211792469025,
            "question_text": "List inflammatory caspase proteins?"
        }
    ],
    "553d061cf321868558000013": [
        {
            "text": "OncoBase",
            "probability": 0.7709244846603514,
            "start_logit": 3.2840962409973145,
            "end_logit": 2.768033742904663,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase",
            "probability": 0.12107898127288119,
            "start_logit": 3.2840962409973145,
            "end_logit": 0.9168863892555237,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/)",
            "probability": 0.02619494917905428,
            "start_logit": 3.2840962409973145,
            "end_logit": -0.613990068435669,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/),",
            "probability": 0.02528105793500045,
            "start_logit": 3.2840962409973145,
            "end_logit": -0.6495012640953064,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase",
            "probability": 0.01734976583997199,
            "start_logit": 1.341232180595398,
            "end_logit": 0.9168863892555237,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (",
            "probability": 0.008062871901123553,
            "start_logit": 3.2840962409973145,
            "end_logit": -1.7922868728637695,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/), an integrated database",
            "probability": 0.00692626371862156,
            "start_logit": 3.2840962409973145,
            "end_logit": -1.944236159324646,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols",
            "probability": 0.004131536866338068,
            "start_logit": 3.2840962409973145,
            "end_logit": -2.460907220840454,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/)",
            "probability": 0.0037535518524250268,
            "start_logit": 1.341232180595398,
            "end_logit": -0.613990068435669,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/),",
            "probability": 0.003622597669288982,
            "start_logit": 1.341232180595398,
            "end_logit": -0.6495012640953064,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase (http://www.oncobase.biols.ac.cn/), an integrated",
            "probability": 0.0036225952941296405,
            "start_logit": 3.2840962409973145,
            "end_logit": -2.5923659801483154,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "we present OncoBase",
            "probability": 0.0028798427928527965,
            "start_logit": -2.305758476257324,
            "end_logit": 2.768033742904663,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Herein, we present OncoBase",
            "probability": 0.001469822487076969,
            "start_logit": -2.9783525466918945,
            "end_logit": 2.768033742904663,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/), an integrated database",
            "probability": 0.0009924848425437876,
            "start_logit": 1.341232180595398,
            "end_logit": -1.944236159324646,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "present OncoBase",
            "probability": 0.00082570452991472,
            "start_logit": -3.5550124645233154,
            "end_logit": 2.768033742904663,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase is a useful resource for the functional annotation of regulatory noncoding regions",
            "probability": 0.0007249015816967055,
            "start_logit": 2.0235443115234375,
            "end_logit": -2.9407241344451904,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "OncoBase integrates local chromatin signatures",
            "probability": 0.0005951759378002854,
            "start_logit": 1.7220337390899658,
            "end_logit": -2.836392402648926,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols",
            "probability": 0.0005920201544199152,
            "start_logit": 1.341232180595398,
            "end_logit": -2.460907220840454,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "oncobase.biols.ac.cn/), an integrated",
            "probability": 0.0005190924091480682,
            "start_logit": 1.341232180595398,
            "end_logit": -2.5923659801483154,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "we present OncoBase (http://www.oncobase",
            "probability": 0.0004522990753605243,
            "start_logit": -2.305758476257324,
            "end_logit": 0.9168863892555237,
            "question_text": "List available databases containing information about conserved noncoding elements."
        }
    ],
    "56c1f043ef6e394741000057": [
        {
            "text": "melatonin receptor",
            "probability": 0.5093688012502807,
            "start_logit": -2.876643180847168,
            "end_logit": -3.0849244594573975,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin",
            "probability": 0.21658560039672622,
            "start_logit": -2.876643180847168,
            "end_logit": -3.940110921859741,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "receptor",
            "probability": 0.04536377381030329,
            "start_logit": -5.295101642608643,
            "end_logit": -3.0849244594573975,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor agonist",
            "probability": 0.04064609572492654,
            "start_logit": -2.876643180847168,
            "end_logit": -5.613193988800049,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor agonists",
            "probability": 0.038965456272663554,
            "start_logit": -2.876643180847168,
            "end_logit": -5.655421257019043,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor ago",
            "probability": 0.03300054225973791,
            "start_logit": -2.876643180847168,
            "end_logit": -5.821572780609131,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "me",
            "probability": 0.024926287483507125,
            "start_logit": -2.876643180847168,
            "end_logit": -6.102173805236816,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor agonists Tasimelteon",
            "probability": 0.023216766441068983,
            "start_logit": -2.876643180847168,
            "end_logit": -6.173222064971924,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "Selective melatonin receptor",
            "probability": 0.017290812284625003,
            "start_logit": -6.259640216827393,
            "end_logit": -3.0849244594573975,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "Selective melatonin",
            "probability": 0.007352120802884633,
            "start_logit": -6.259640216827393,
            "end_logit": -3.940110921859741,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatonin receptor agonists Tasimelteon, Ramelteon,",
            "probability": 0.007172837249771523,
            "start_logit": -2.876643180847168,
            "end_logit": -7.347795486450195,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "melatoni",
            "probability": 0.0069617891253207454,
            "start_logit": -2.876643180847168,
            "end_logit": -7.377660274505615,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "agonist",
            "probability": 0.004969995642685582,
            "start_logit": -4.9781270027160645,
            "end_logit": -5.613193988800049,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "agonists",
            "probability": 0.00476449568984386,
            "start_logit": -4.9781270027160645,
            "end_logit": -5.655421257019043,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "ago",
            "probability": 0.004035136667175067,
            "start_logit": -4.9781270027160645,
            "end_logit": -5.821572780609131,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "receptor agonist",
            "probability": 0.003619892479106733,
            "start_logit": -5.295101642608643,
            "end_logit": -5.613193988800049,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "receptor agonists",
            "probability": 0.0034702167475307247,
            "start_logit": -5.295101642608643,
            "end_logit": -5.655421257019043,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "receptor ago",
            "probability": 0.0029389886679622797,
            "start_logit": -5.295101642608643,
            "end_logit": -5.821572780609131,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "agonists Tasimelteon",
            "probability": 0.002838826853881554,
            "start_logit": -4.9781270027160645,
            "end_logit": -6.173222064971924,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "MT1",
            "probability": 0.002511564149997943,
            "start_logit": -5.346237659454346,
            "end_logit": -5.927596569061279,
            "question_text": "Which receptors are bound by Tasimelteon?"
        }
    ],
    "5318380bb166e2b806000013": [
        {
            "text": "RBR family",
            "probability": 0.43938036308084705,
            "start_logit": 2.853518009185791,
            "end_logit": 1.482847809791565,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "RBR",
            "probability": 0.4299534246853148,
            "start_logit": 2.853518009185791,
            "end_logit": 1.4611592292785645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "E3 ubiquitin ligase of the RBR family",
            "probability": 0.03392946027870235,
            "start_logit": 0.2924362123012543,
            "end_logit": 1.482847809791565,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "E3 ubiquitin ligase of the RBR",
            "probability": 0.03320150118285596,
            "start_logit": 0.2924362123012543,
            "end_logit": 1.4611592292785645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "RBR family.",
            "probability": 0.018921012945247354,
            "start_logit": 2.853518009185791,
            "end_logit": -1.6622445583343506,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "the RBR family",
            "probability": 0.006665572074365704,
            "start_logit": -1.334891676902771,
            "end_logit": 1.482847809791565,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "the RBR",
            "probability": 0.006522561729352939,
            "start_logit": -1.334891676902771,
            "end_logit": 1.4611592292785645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "an E3 ubiquitin ligase of the RBR family",
            "probability": 0.005295325206627888,
            "start_logit": -1.5650230646133423,
            "end_logit": 1.482847809791565,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "an E3 ubiquitin ligase of the RBR",
            "probability": 0.005181713610157871,
            "start_logit": -1.5650230646133423,
            "end_logit": 1.4611592292785645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "ubiquitin ligase of the RBR family",
            "probability": 0.0042093214180970884,
            "start_logit": -1.7945460081100464,
            "end_logit": 1.482847809791565,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "ubiquitin ligase of the RBR",
            "probability": 0.004119010113747571,
            "start_logit": -1.7945460081100464,
            "end_logit": 1.4611592292785645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "parkin, an E3 ubiquitin ligase of the RBR family",
            "probability": 0.0031281896965959263,
            "start_logit": -2.091392993927002,
            "end_logit": 1.482847809791565,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "parkin, an E3 ubiquitin ligase of the RBR",
            "probability": 0.0030610741538061306,
            "start_logit": -2.091392993927002,
            "end_logit": 1.4611592292785645,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "E3 ubiquitin ligase",
            "probability": 0.002440411708269926,
            "start_logit": 0.2924362123012543,
            "end_logit": -1.1492691040039062,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "E3 ubiquitin ligase of the RBR family.",
            "probability": 0.0014611025232378378,
            "start_logit": 0.2924362123012543,
            "end_logit": -1.6622445583343506,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "family",
            "probability": 0.0009748185391431044,
            "start_logit": -3.2573513984680176,
            "end_logit": 1.482847809791565,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "E3",
            "probability": 0.0005042810996144586,
            "start_logit": 0.2924362123012543,
            "end_logit": -2.726057291030884,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "an E3 ubiquitin ligase",
            "probability": 0.0003808717712336626,
            "start_logit": -1.5650230646133423,
            "end_logit": -1.1492691040039062,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "ubiquitin-binding site used by the E2~Ub",
            "probability": 0.00036722436319702056,
            "start_logit": -0.26741471886634827,
            "end_logit": -2.4833672046661377,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "ubiquitin ligase",
            "probability": 0.0003027598195849752,
            "start_logit": -1.7945460081100464,
            "end_logit": -1.1492691040039062,
            "question_text": "List Parkin binding partners"
        }
    ],
    "5173b5ea8ed59a060a00001f": [
        {
            "text": "RNA",
            "probability": 0.1295893864737503,
            "start_logit": -4.811938285827637,
            "end_logit": -5.4093756675720215,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and histone modifications is beginning to be recognized, a lack of knowledge exists regarding the role of HDACs",
            "probability": 0.12789501136848472,
            "start_logit": -4.811938285827637,
            "end_logit": -5.422536849975586,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and histone modifications is beginning to be recognized,",
            "probability": 0.08824999604208834,
            "start_logit": -4.811938285827637,
            "end_logit": -5.793572902679443,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and histone modifications is beginning to be recognized",
            "probability": 0.07245807811824664,
            "start_logit": -4.811938285827637,
            "end_logit": -5.990738391876221,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs",
            "probability": 0.07110209680012686,
            "start_logit": -5.590560436248779,
            "end_logit": -5.2310075759887695,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing",
            "probability": 0.061025013793527406,
            "start_logit": -4.811938285827637,
            "end_logit": -6.1624627113342285,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "histone deacetylases (HDACs",
            "probability": 0.060085096903524114,
            "start_logit": -5.539974689483643,
            "end_logit": -5.449948310852051,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and histone modifications is beginning to be recognized, a lack of knowledge",
            "probability": 0.05369730091056919,
            "start_logit": -4.811938285827637,
            "end_logit": -6.290383815765381,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "histone deacetylases (HDACs)",
            "probability": 0.045157953523053275,
            "start_logit": -5.539974689483643,
            "end_logit": -5.735543727874756,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs in splicing. Recent studies however, reveal that HDACs",
            "probability": 0.04358857691018701,
            "start_logit": -6.0798821449279785,
            "end_logit": -5.2310075759887695,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "histone deacetylases",
            "probability": 0.042611325773635834,
            "start_logit": -5.539974689483643,
            "end_logit": -5.793590068817139,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDAC",
            "probability": 0.04205464592393982,
            "start_logit": -5.864988327026367,
            "end_logit": -5.48172664642334,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing,",
            "probability": 0.029546179412763652,
            "start_logit": -5.300163269042969,
            "end_logit": -6.399567127227783,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "lack of knowledge exists regarding the role of HDACs in splicing. Recent studies however, reveal that HDACs",
            "probability": 0.023187523533993417,
            "start_logit": -6.711062908172607,
            "end_logit": -5.2310075759887695,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNA splicing and, thus, further support the potential link between HDACs",
            "probability": 0.019586988616956062,
            "start_logit": -6.016744136810303,
            "end_logit": -6.0940752029418945,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDAC-RNA",
            "probability": 0.019309709816303467,
            "start_logit": -5.864988327026367,
            "end_logit": -6.2600884437561035,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "lack of knowledge exists regarding the role of HDACs",
            "probability": 0.019145832756577337,
            "start_logit": -6.711062908172607,
            "end_logit": -5.422536849975586,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "a lack of knowledge exists regarding the role of HDACs in splicing. Recent studies however, reveal that HDACs",
            "probability": 0.018131543677002423,
            "start_logit": -6.957024097442627,
            "end_logit": -5.2310075759887695,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "HDACs) play critical roles in governing cellular behaviors and are indispensable in numerous biological processes. While the association between RNA",
            "probability": 0.017252337829962515,
            "start_logit": -6.828361511230469,
            "end_logit": -5.4093756675720215,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "recognized, a lack of knowledge exists regarding the role of HDACs in splicing. Recent studies however, reveal that HDACs",
            "probability": 0.01632540181530746,
            "start_logit": -7.061954975128174,
            "end_logit": -5.2310075759887695,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        }
    ],
    "5324cca79b2d7acc7e00001d": [
        {
            "text": "Otolaryngology",
            "probability": 0.9534151965729357,
            "start_logit": 6.706040859222412,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology (ORL)",
            "probability": 0.039367797673267986,
            "start_logit": 6.706040859222412,
            "end_logit": 3.0870862007141113,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "smartphone applications (apps) disseminated in the field of Otolaryngology",
            "probability": 0.001474889704731988,
            "start_logit": 0.2345735877752304,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngo",
            "probability": 0.0011148678101282825,
            "start_logit": 6.706040859222412,
            "end_logit": -0.4771261215209961,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "field of Otolaryngology",
            "probability": 0.0007402921100759158,
            "start_logit": -0.45472005009651184,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "laryngology",
            "probability": 0.0007252182228019541,
            "start_logit": -0.47529229521751404,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology (ORL",
            "probability": 0.0007168423410680508,
            "start_logit": 6.706040859222412,
            "end_logit": -0.9187613129615784,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "O",
            "probability": 0.0005494075190285811,
            "start_logit": 6.706040859222412,
            "end_logit": -1.184776782989502,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "tolaryngology",
            "probability": 0.0004657887457166284,
            "start_logit": -0.918032705783844,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "the field of Otolaryngology",
            "probability": 0.00043204761867443624,
            "start_logit": -0.99322909116745,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "logy",
            "probability": 0.0003015696168948102,
            "start_logit": -1.3527640104293823,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology (ORL),",
            "probability": 0.00014534360814428098,
            "start_logit": 6.706040859222412,
            "end_logit": -2.514516592025757,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "ngology",
            "probability": 0.0001094618555227559,
            "start_logit": -2.3661887645721436,
            "end_logit": 6.27418851852417,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Oto",
            "probability": 0.00010336422133092278,
            "start_logit": 6.706040859222412,
            "end_logit": -2.855358362197876,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "(ORL)",
            "probability": 8.195192731558839e-05,
            "start_logit": 0.5314702391624451,
            "end_logit": 3.0870862007141113,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology (",
            "probability": 6.642237023341712e-05,
            "start_logit": 6.706040859222412,
            "end_logit": -3.2975833415985107,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "Otolaryngology (ORL), these apps vary widely in quality.",
            "probability": 6.465137629090801e-05,
            "start_logit": 6.706040859222412,
            "end_logit": -3.3246078491210938,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "smartphone applications (apps) disseminated in the field of Otolaryngology (ORL)",
            "probability": 6.0900182517526154e-05,
            "start_logit": 0.2345735877752304,
            "end_logit": 3.0870862007141113,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "ORL)",
            "probability": 3.3418864955716e-05,
            "start_logit": -0.3655420243740082,
            "end_logit": 3.0870862007141113,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "field of Otolaryngology (ORL)",
            "probability": 3.0567658364731974e-05,
            "start_logit": -0.45472005009651184,
            "end_logit": 3.0870862007141113,
            "question_text": "What are the mobile applications fields of use for patients ?"
        }
    ],
    "54f431d664850a5854000006": [
        {
            "text": "NPM1",
            "probability": 0.5766681976494397,
            "start_logit": 2.7048516273498535,
            "end_logit": 2.1447248458862305,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Npm1",
            "probability": 0.20871455805487077,
            "start_logit": 2.59641695022583,
            "end_logit": 1.2368600368499756,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "nucleophosmin (NPM1",
            "probability": 0.13573342373377276,
            "start_logit": 2.0833027362823486,
            "end_logit": 1.3196995258331299,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Npm1 inactivation in adult hematopoietic stem cells results in bone marrow failure. We identify NPM1",
            "probability": 0.03030236742246531,
            "start_logit": -0.24118958413600922,
            "end_logit": 2.1447248458862305,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "nucleophosmin",
            "probability": 0.030030887040139655,
            "start_logit": 2.0833027362823486,
            "end_logit": -0.18876689672470093,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "nucleophosmin (NPM1)",
            "probability": 0.0045789785201272425,
            "start_logit": 2.0833027362823486,
            "end_logit": -2.0695173740386963,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Npm1 mutation",
            "probability": 0.0033507671758645687,
            "start_logit": 2.59641695022583,
            "end_logit": -2.894918203353882,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1)",
            "probability": 0.003014498620634193,
            "start_logit": 1.6652603149414062,
            "end_logit": -2.0695173740386963,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "RNA binding. Mice harboring a dyskeratosis congenita germline Npm1",
            "probability": 0.0022759618340524187,
            "start_logit": -1.9221478700637817,
            "end_logit": 1.2368600368499756,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "nucleophosmin (NPM1) as an essential regulator of 2'-O-Me on rRNA",
            "probability": 0.0014766899806565273,
            "start_logit": 2.0833027362823486,
            "end_logit": -3.201190233230591,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM",
            "probability": 0.0011164641700406699,
            "start_logit": 2.7048516273498535,
            "end_logit": -4.102375507354736,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1) as an essential regulator of 2'-O-Me on rRNA",
            "probability": 0.0009721556653359745,
            "start_logit": 1.6652603149414062,
            "end_logit": -3.201190233230591,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "NPM1 germline mutations",
            "probability": 0.0006610082776443384,
            "start_logit": 2.7048516273498535,
            "end_logit": -4.62653112411499,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "germline Npm1",
            "probability": 0.0006026188985842205,
            "start_logit": -3.251020908355713,
            "end_logit": 1.2368600368499756,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Mice harboring a dyskeratosis congenita germline Npm1",
            "probability": 0.0002436356690372411,
            "start_logit": -4.156631946563721,
            "end_logit": 1.2368600368499756,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "a dyskeratosis congenita germline Npm1",
            "probability": 0.00010440196414494794,
            "start_logit": -5.00405740737915,
            "end_logit": 1.2368600368499756,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Npm1 inactivation in adult hematopoietic stem cells results in bone marrow failure. We identify NPM",
            "probability": 5.866719828228946e-05,
            "start_logit": -0.24118958413600922,
            "end_logit": -4.102375507354736,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "RNA",
            "probability": 4.850451181797998e-05,
            "start_logit": -1.9221478700637817,
            "end_logit": -2.6116411685943604,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "RNA binding. Mice harboring a dyskeratosis congenita germline Npm1 mutation",
            "probability": 3.6538985483985474e-05,
            "start_logit": -1.9221478700637817,
            "end_logit": -2.894918203353882,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "germline Npm1 mutation",
            "probability": 9.674627605041382e-06,
            "start_logit": -3.251020908355713,
            "end_logit": -2.894918203353882,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        }
    ],
    "570a5343cf1c325851000022": [
        {
            "text": "Val60Leu",
            "probability": 0.7337991388573656,
            "start_logit": 2.1929714679718018,
            "end_logit": 1.7576061487197876,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60Leu variant",
            "probability": 0.13473124092307073,
            "start_logit": 2.411135196685791,
            "end_logit": -0.15551093220710754,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r' Val60Leu",
            "probability": 0.04139398909780655,
            "start_logit": -0.6821281909942627,
            "end_logit": 1.7576061487197876,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60",
            "probability": 0.03640533053793346,
            "start_logit": 2.1929714679718018,
            "end_logit": -1.2459139823913574,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "The Val60Leu",
            "probability": 0.02755132799580753,
            "start_logit": -0.8054825067520142,
            "end_logit": 1.4738755226135254,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "the 'r' Val60Leu",
            "probability": 0.005642466976021367,
            "start_logit": -2.6749424934387207,
            "end_logit": 1.7576061487197876,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "The Val60Leu variant",
            "probability": 0.00540143296756471,
            "start_logit": -0.8054825067520142,
            "end_logit": -0.15551093220710754,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "r' Val60Leu",
            "probability": 0.002941757283882086,
            "start_logit": -3.32625675201416,
            "end_logit": 1.7576061487197876,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r' Val60Leu variant",
            "probability": 0.0029247836749511547,
            "start_logit": -0.6821281909942627,
            "end_logit": -0.8923090100288391,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60Leu variant of the MC1R gene",
            "probability": 0.0021789929131790175,
            "start_logit": 2.411135196685791,
            "end_logit": -4.279930114746094,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "'r' Val60",
            "probability": 0.0020536435321194643,
            "start_logit": -0.6821281909942627,
            "end_logit": -1.2459139823913574,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60Leu variant of the MC1R gene could be a promising candidate as an independent predictor of high nevus count,",
            "probability": 0.0010770643055698051,
            "start_logit": 2.411135196685791,
            "end_logit": -4.984553813934326,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "The Val60",
            "probability": 0.0009066338081489886,
            "start_logit": -0.8054825067520142,
            "end_logit": -1.9401918649673462,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60Leu variant of the MC1R gene could be a promising candidate as an independent predictor of high nevus count",
            "probability": 0.0007088031782957185,
            "start_logit": 2.411135196685791,
            "end_logit": -5.402970314025879,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V",
            "probability": 0.0006779349275954789,
            "start_logit": 2.411135196685791,
            "end_logit": -5.4474968910217285,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "the 'r' Val60Leu variant",
            "probability": 0.0003986809596660204,
            "start_logit": -2.6749424934387207,
            "end_logit": -0.8923090100288391,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "Val60Leu variant of the MC1R",
            "probability": 0.00039501756325339613,
            "start_logit": 2.411135196685791,
            "end_logit": -5.9876179695129395,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "nine frequently occurring MC1R gene variants in participants without skin cancer (n\u2009=\u2009203) showed that the 'r' Val60Leu",
            "probability": 0.00032396939741468153,
            "start_logit": -5.532370090484619,
            "end_logit": 1.7576061487197876,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "the 'r' Val60",
            "probability": 0.0002799347456734479,
            "start_logit": -2.6749424934387207,
            "end_logit": -1.2459139823913574,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "r' Val60Leu variant",
            "probability": 0.00020785635468080312,
            "start_logit": -3.32625675201416,
            "end_logit": -0.8923090100288391,
            "question_text": "List variants of the MC1R gene."
        }
    ],
    "5141bcd423fec9037500000d": [
        {
            "text": "Navarixin",
            "probability": 0.9987267058982707,
            "start_logit": 6.292490482330322,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarix",
            "probability": 0.0004828866580924363,
            "start_logit": 6.292490482330322,
            "end_logit": -1.769303560256958,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Na",
            "probability": 0.00019320108344730714,
            "start_logit": 6.292490482330322,
            "end_logit": -2.685353994369507,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "antagonist Navarixin",
            "probability": 0.00011370187871534982,
            "start_logit": -2.788166046142578,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "varixin",
            "probability": 0.00010547706847386089,
            "start_logit": -2.8632524013519287,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "phase-II antagonist Navarixin",
            "probability": 0.00010409890390919016,
            "start_logit": -2.8764045238494873,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "in",
            "probability": 8.01155230859535e-05,
            "start_logit": -3.1382763385772705,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navar",
            "probability": 4.5190468678680466e-05,
            "start_logit": 6.292490482330322,
            "end_logit": -4.138199329376221,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CS-2) and clinically relevant (CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 2.4995336145518955e-05,
            "start_logit": -4.303056716918945,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "ixin",
            "probability": 2.419367498244686e-05,
            "start_logit": -4.3356547355651855,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarixin) CCR7 modulators with implications for multi-target strategies against cancer.",
            "probability": 2.0965184492182108e-05,
            "start_logit": 6.292490482330322,
            "end_logit": -4.906222343444824,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarixin)",
            "probability": 2.0602597075708604e-05,
            "start_logit": 6.292490482330322,
            "end_logit": -4.923668384552002,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CXCR2 phase-II antagonist Navarixin",
            "probability": 1.80557274802313e-05,
            "start_logit": -4.6282830238342285,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 1.5905838627829664e-05,
            "start_logit": -4.755059719085693,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "Navarixin) CCR7 modulators with implications for multi-target strategies against cancer",
            "probability": 1.5669967608734204e-05,
            "start_logit": 6.292490482330322,
            "end_logit": -5.1973395347595215,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "(CXCR1-CXCR2 phase-II antagonist Navarixin",
            "probability": 8.0464547653925e-06,
            "start_logit": -5.436514377593994,
            "end_logit": 5.8651509284973145,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "antagonist Navarix",
            "probability": 5.4975119727377515e-08,
            "start_logit": -2.788166046142578,
            "end_logit": -1.769303560256958,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "varix",
            "probability": 5.0998405069101846e-08,
            "start_logit": -2.8632524013519287,
            "end_logit": -1.769303560256958,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "phase-II antagonist Navarix",
            "probability": 5.0332059334072454e-08,
            "start_logit": -2.8764045238494873,
            "end_logit": -1.769303560256958,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "antagonist",
            "probability": 3.1430564199867256e-08,
            "start_logit": -2.788166046142578,
            "end_logit": -2.3284034729003906,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        }
    ],
    "52bf1af803868f1b06000008": [
        {
            "text": "polymorphic ventricular tachycardia",
            "probability": 0.3284920393316389,
            "start_logit": 1.6400200128555298,
            "end_logit": 2.330728769302368,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic ventricular tachycardia (CPVT)",
            "probability": 0.17770376804704377,
            "start_logit": 1.6400200128555298,
            "end_logit": 1.7163341045379639,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "Catecholaminergic polymorphic ventricular tachycardia",
            "probability": 0.15304833186719383,
            "start_logit": 0.8762611746788025,
            "end_logit": 2.330728769302368,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT",
            "probability": 0.08407489031205122,
            "start_logit": 1.4913984537124634,
            "end_logit": 1.1165456771850586,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "Catecholaminergic polymorphic ventricular tachycardia (CPVT)",
            "probability": 0.08279429030137615,
            "start_logit": 0.8762611746788025,
            "end_logit": 1.7163341045379639,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT)",
            "probability": 0.06740657516550015,
            "start_logit": 0.6706446409225464,
            "end_logit": 1.7163341045379639,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ventricular tachycardia",
            "probability": 0.05850577083227305,
            "start_logit": -0.08536719530820847,
            "end_logit": 2.330728769302368,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ventricular tachycardia (CPVT)",
            "probability": 0.03164976524406867,
            "start_logit": -0.08536719530820847,
            "end_logit": 1.7163341045379639,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "polymorphic ventricular tachycardia (CPVT",
            "probability": 0.006012684122597417,
            "start_logit": 1.6400200128555298,
            "end_logit": -1.669912576675415,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "Catecholaminergic polymorphic ventricular tachycardia (CPVT",
            "probability": 0.002801380748465718,
            "start_logit": 0.8762611746788025,
            "end_logit": -1.669912576675415,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "tachycardia",
            "probability": 0.0019070437704191783,
            "start_logit": -3.5089383125305176,
            "end_logit": 2.330728769302368,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ventricular tachycardia (CPVT",
            "probability": 0.0010708835443296225,
            "start_logit": -0.08536719530820847,
            "end_logit": -1.669912576675415,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "tachycardia (CPVT)",
            "probability": 0.0010316501566480704,
            "start_logit": -3.5089383125305176,
            "end_logit": 1.7163341045379639,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT cases are caused by dominant mutations in the cardiac ryanodine receptor (RYR2) gene,",
            "probability": 0.0009028509576978005,
            "start_logit": 1.4913984537124634,
            "end_logit": -3.4173600673675537,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ia",
            "probability": 0.0007241877631361559,
            "start_logit": -4.477197170257568,
            "end_logit": 2.330728769302368,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "(CPVT)",
            "probability": 0.0006563558106804781,
            "start_logit": -3.9611501693725586,
            "end_logit": 1.7163341045379639,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ia (CPVT)",
            "probability": 0.0003917625965752284,
            "start_logit": -4.477197170257568,
            "end_logit": 1.7163341045379639,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT cases",
            "probability": 0.00035912287711715047,
            "start_logit": 1.4913984537124634,
            "end_logit": -4.339252948760986,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "p",
            "probability": 0.0002540835070644552,
            "start_logit": 1.6400200128555298,
            "end_logit": -4.833876132965088,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "CPVT cases are caused by dominant mutations in the cardiac ryanodine receptor (RYR2) gene, <5%",
            "probability": 0.00021256304412268,
            "start_logit": 1.4913984537124634,
            "end_logit": -4.863678932189941,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        }
    ],
    "550303a5e9bde6963400000c": [
        {
            "text": "allergic rhinoconjunctivitis",
            "probability": 0.5444666122179969,
            "start_logit": 2.9365689754486084,
            "end_logit": 3.1031618118286133,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal allergic rhinoconjunctivitis",
            "probability": 0.30772186443692406,
            "start_logit": 2.3659586906433105,
            "end_logit": 3.1031618118286133,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "rhinoconjunctivitis",
            "probability": 0.13624524230969004,
            "start_logit": 1.551218867301941,
            "end_logit": 3.1031618118286133,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic rhinoconjunctivitis require evidence that exposure to the sensitizing pollen triggers allergic symptoms. Electronic clinical diaries,",
            "probability": 0.0018922599817595592,
            "start_logit": 2.9365689754486084,
            "end_logit": -2.558872938156128,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "itis",
            "probability": 0.0012446248872818614,
            "start_logit": -3.1444034576416016,
            "end_logit": 3.1031618118286133,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic",
            "probability": 0.0009737131942678727,
            "start_logit": 2.9365689754486084,
            "end_logit": -3.223283290863037,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "all",
            "probability": 0.0008813766077680433,
            "start_logit": 2.9365689754486084,
            "end_logit": -3.3229150772094727,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "conjunctivitis",
            "probability": 0.0007772016960948663,
            "start_logit": -3.615293025970459,
            "end_logit": 3.1031618118286133,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic r",
            "probability": 0.0006241121073889444,
            "start_logit": 2.9365689754486084,
            "end_logit": -3.668070077896118,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal",
            "probability": 0.0005746338148698071,
            "start_logit": 2.3659586906433105,
            "end_logit": -3.1800568103790283,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal allergic",
            "probability": 0.0005503236247055199,
            "start_logit": 2.3659586906433105,
            "end_logit": -3.223283290863037,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "junctivitis",
            "probability": 0.0005461451312644679,
            "start_logit": -3.9681081771850586,
            "end_logit": 3.1031618118286133,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic rhinoconjunctivitis require evidence that exposure to the sensitizing pollen triggers allergic symptoms. Electronic",
            "probability": 0.0005230349325832144,
            "start_logit": 2.9365689754486084,
            "end_logit": -3.8447518348693848,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "hinoconjunctivitis",
            "probability": 0.0005222739362255317,
            "start_logit": -4.012800693511963,
            "end_logit": 3.1031618118286133,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal all",
            "probability": 0.0004981367946670008,
            "start_logit": 2.3659586906433105,
            "end_logit": -3.3229150772094727,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic rhinoconjunctivitis require evidence that exposure to the sensitizing pollen triggers allergic symptoms. Electronic clinical diaries",
            "probability": 0.0004957170331915461,
            "start_logit": 2.9365689754486084,
            "end_logit": -3.898394823074341,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "rhinoconjunctivitis require evidence that exposure to the sensitizing pollen triggers allergic symptoms. Electronic clinical diaries,",
            "probability": 0.00047351189943036707,
            "start_logit": 1.551218867301941,
            "end_logit": -2.558872938156128,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "seasonal allergic r",
            "probability": 0.0003527359382442508,
            "start_logit": 2.3659586906433105,
            "end_logit": -3.668070077896118,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic rhinoconjunctivitis require evidence that exposure to the sensitizing pollen triggers allergic symptoms.",
            "probability": 0.0003264113344810327,
            "start_logit": 2.9365689754486084,
            "end_logit": -4.31624174118042,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "allergic rhino",
            "probability": 0.0003100681211650553,
            "start_logit": 2.9365689754486084,
            "end_logit": -4.367608070373535,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        }
    ],
    "51bdf045047fa84d1d000003": [
        {
            "text": "Atg4",
            "probability": 0.5161796691525682,
            "start_logit": -3.2421159744262695,
            "end_logit": -0.47221308946609497,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4",
            "probability": 0.4084896657109333,
            "start_logit": -3.476104259490967,
            "end_logit": -0.47221308946609497,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs are cysteine proteases, which play key roles in the macroautophagy",
            "probability": 0.010859474289641874,
            "start_logit": -3.2421159744262695,
            "end_logit": -4.333630084991455,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases, which play key roles in the macroautophagy/autophagy",
            "probability": 0.009295011782132465,
            "start_logit": -3.476104259490967,
            "end_logit": -4.255201816558838,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases, which play key roles in the macroautophagy",
            "probability": 0.008593873969610245,
            "start_logit": -3.476104259490967,
            "end_logit": -4.333630084991455,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "autophagy",
            "probability": 0.008094977035583631,
            "start_logit": -3.6143383979797363,
            "end_logit": -4.255201816558838,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs are cysteine proteases,",
            "probability": 0.007562367524891436,
            "start_logit": -3.2421159744262695,
            "end_logit": -4.695483684539795,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Human Atg4",
            "probability": 0.007369879991326269,
            "start_logit": -7.491169452667236,
            "end_logit": -0.47221308946609497,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases,",
            "probability": 0.005984639006215984,
            "start_logit": -3.476104259490967,
            "end_logit": -4.695483684539795,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "macroautophagy/autophagy",
            "probability": 0.0025741452733721187,
            "start_logit": -4.760064601898193,
            "end_logit": -4.255201816558838,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "macroautophagy",
            "probability": 0.0023799733208893993,
            "start_logit": -4.760064601898193,
            "end_logit": -4.333630084991455,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "autophagy process by cleaving Atg8 homologs for conjugation to lipid membranes",
            "probability": 0.0017326534391441288,
            "start_logit": -3.6143383979797363,
            "end_logit": -5.7967915534973145,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases, which play key roles in the macroautophagy/autophagy process",
            "probability": 0.0017207313626158626,
            "start_logit": -3.476104259490967,
            "end_logit": -5.941930294036865,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs",
            "probability": 0.0016431825926019417,
            "start_logit": -3.2421159744262695,
            "end_logit": -6.2220330238342285,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs are cysteine proteases, which",
            "probability": 0.0016211421605829303,
            "start_logit": -3.2421159744262695,
            "end_logit": -6.235537052154541,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "autophagy process",
            "probability": 0.001498575923438827,
            "start_logit": -3.6143383979797363,
            "end_logit": -5.941930294036865,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs",
            "probability": 0.0013003671939578023,
            "start_logit": -3.476104259490967,
            "end_logit": -6.2220330238342285,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases, which",
            "probability": 0.0012829250333195278,
            "start_logit": -3.476104259490967,
            "end_logit": -6.235537052154541,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "Atg4 homologs are cysteine proteases",
            "probability": 0.0010141646533540138,
            "start_logit": -3.2421159744262695,
            "end_logit": -6.7046027183532715,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "4 homologs are cysteine proteases",
            "probability": 0.0008025805838198897,
            "start_logit": -3.476104259490967,
            "end_logit": -6.7046027183532715,
            "question_text": "Which are the Atg8 homologs in human?"
        }
    ],
    "515db020298dcd4e51000011": [
        {
            "text": "randomized controlled trial",
            "probability": 0.28108601955929025,
            "start_logit": -1.7358819246292114,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in a large randomized controlled trial",
            "probability": 0.20654645517643505,
            "start_logit": -2.0440173149108887,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "large randomized controlled trial",
            "probability": 0.12757081575649418,
            "start_logit": -2.5258710384368896,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "in a large randomized controlled trial",
            "probability": 0.09170243371108773,
            "start_logit": -2.8559937477111816,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "a large randomized controlled trial",
            "probability": 0.06600783934656076,
            "start_logit": -3.1847691535949707,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "trial",
            "probability": 0.038206796961201286,
            "start_logit": -3.7315292358398438,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "evaluated in a large randomized controlled trial",
            "probability": 0.03561718500443256,
            "start_logit": -3.8017144203186035,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "the impact of a polypill in preventing clinical CV events has not been evaluated in a large randomized controlled trial",
            "probability": 0.020861118130412342,
            "start_logit": -4.336655616760254,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "controlled trial",
            "probability": 0.018001853947504757,
            "start_logit": -4.484067916870117,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated",
            "probability": 0.015920065325249203,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.298905611038208,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "randomized controlled",
            "probability": 0.014185480632801244,
            "start_logit": -1.7358819246292114,
            "end_logit": -3.722402334213257,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "has not been evaluated in a large randomized controlled trial",
            "probability": 0.013063352891076987,
            "start_logit": -4.804731845855713,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not",
            "probability": 0.01193196720981686,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.5872647762298584,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in",
            "probability": 0.011430178985209608,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.6302287578582764,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in a large randomized controlled",
            "probability": 0.01042371564502889,
            "start_logit": -2.0440173149108887,
            "end_logit": -3.722402334213257,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "impact of a polypill in preventing clinical CV events has not been evaluated in a large randomized controlled trial",
            "probability": 0.010134752651392784,
            "start_logit": -5.058572292327881,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "However, the impact of a polypill in preventing clinical CV events has not been evaluated in a large randomized controlled trial",
            "probability": 0.008032517209420897,
            "start_logit": -5.29104471206665,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "large randomized controlled",
            "probability": 0.006438076639534501,
            "start_logit": -2.5258710384368896,
            "end_logit": -3.722402334213257,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "been evaluated in a large randomized controlled trial",
            "probability": 0.0064237097619901,
            "start_logit": -5.514546871185303,
            "end_logit": -0.7359605431556702,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "not been evaluated in a large",
            "probability": 0.006415665455060119,
            "start_logit": -2.0440173149108887,
            "end_logit": -4.207743167877197,
            "question_text": "List all clinical trials of the polypill."
        }
    ],
    "56c1f007ef6e39474100003b": [
        {
            "text": "cancer",
            "probability": 0.8721569838665328,
            "start_logit": -1.2006384134292603,
            "end_logit": -0.32972559332847595,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "U373 cancer",
            "probability": 0.0459726422231388,
            "start_logit": -4.143561363220215,
            "end_logit": -0.32972559332847595,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields",
            "probability": 0.01696489981893698,
            "start_logit": -2.592423439025879,
            "end_logit": -2.877763509750366,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme,",
            "probability": 0.013661482915822424,
            "start_logit": -2.592423439025879,
            "end_logit": -3.094329595565796,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme",
            "probability": 0.013617150259121646,
            "start_logit": -2.592423439025879,
            "end_logit": -3.0975799560546875,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields,",
            "probability": 0.004782647911844589,
            "start_logit": -2.592423439025879,
            "end_logit": -4.14391565322876,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer cells",
            "probability": 0.004155384624749251,
            "start_logit": -1.2006384134292603,
            "end_logit": -5.676290035247803,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy,",
            "probability": 0.0035456291284068054,
            "start_logit": -2.592423439025879,
            "end_logit": -4.443194389343262,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer cells and IEC6 normal cells",
            "probability": 0.0030789022648424094,
            "start_logit": -1.2006384134292603,
            "end_logit": -5.97612190246582,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "tumor treating fields",
            "probability": 0.002702469947451353,
            "start_logit": -4.429403781890869,
            "end_logit": -2.877763509750366,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "The fractionated scheme, using tumor treating fields",
            "probability": 0.0025665432943725365,
            "start_logit": -4.4810099601745605,
            "end_logit": -2.877763509750366,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fraction",
            "probability": 0.0021904536164258285,
            "start_logit": -2.592423439025879,
            "end_logit": -4.924801349639893,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically applicable",
            "probability": 0.0021350663626389047,
            "start_logit": -2.592423439025879,
            "end_logit": -4.950412273406982,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "The fractionated scheme,",
            "probability": 0.0020667842276115515,
            "start_logit": -4.4810099601745605,
            "end_logit": -3.094329595565796,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "The fractionated scheme",
            "probability": 0.002060077339625682,
            "start_logit": -4.4810099601745605,
            "end_logit": -3.0975799560546875,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy",
            "probability": 0.0019070142924491526,
            "start_logit": -2.592423439025879,
            "end_logit": -5.063371181488037,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fractionated scheme, using tumor treating fields, reduced the treatment time while maintaining efficacy, suggesting that this method may be clinically applicable for cancer",
            "probability": 0.0017892280373055622,
            "start_logit": -2.592423439025879,
            "end_logit": -5.1271257400512695,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "fields",
            "probability": 0.0017389990575729212,
            "start_logit": -4.870260238647461,
            "end_logit": -2.877763509750366,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "using tumor treating fields",
            "probability": 0.0015927019968703091,
            "start_logit": -4.9581379890441895,
            "end_logit": -2.877763509750366,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "scheme, using tumor treating fields",
            "probability": 0.0013149388142804262,
            "start_logit": -5.149779796600342,
            "end_logit": -2.877763509750366,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        }
    ],
    "56e46ad951531f7e3300001a": [
        {
            "text": "Hedgehog",
            "probability": 0.19599398198765958,
            "start_logit": 4.060291767120361,
            "end_logit": 3.9982292652130127,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT",
            "probability": 0.1268840646833428,
            "start_logit": 4.060291767120361,
            "end_logit": 3.5634191036224365,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.10729259917655772,
            "start_logit": 4.060291767120361,
            "end_logit": 3.395704984664917,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT",
            "probability": 0.059578043140000425,
            "start_logit": 3.304305076599121,
            "end_logit": 3.5634191036224365,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor",
            "probability": 0.05838520573433221,
            "start_logit": 3.4517946243286133,
            "end_logit": 3.395704984664917,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein",
            "probability": 0.05282351917078594,
            "start_logit": 4.060291767120361,
            "end_logit": 2.6871018409729004,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT, bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.05037892755324778,
            "start_logit": 3.304305076599121,
            "end_logit": 3.395704984664917,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein (BMP), fibroblast growth factor (FGF)",
            "probability": 0.04568677955206663,
            "start_logit": 4.060291767120361,
            "end_logit": 2.541954278945923,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.032740311397549245,
            "start_logit": 2.8733391761779785,
            "end_logit": 3.395704984664917,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch, WNT, bone morphogenetic protein (BMP)",
            "probability": 0.031807228815644635,
            "start_logit": 4.060291767120361,
            "end_logit": 2.1798388957977295,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Notch, WNT",
            "probability": 0.029238596274112467,
            "start_logit": 2.5925076007843018,
            "end_logit": 3.5634191036224365,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor (FGF), insulin-like growth factor (IGF), and platelet-derived growth factor",
            "probability": 0.026889446739222295,
            "start_logit": 3.4517946243286133,
            "end_logit": 2.6203763484954834,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "platelet-derived growth factor",
            "probability": 0.026865089780436283,
            "start_logit": 3.4508883953094482,
            "end_logit": 2.6203763484954834,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Hedgehog, Notch",
            "probability": 0.026595311232502437,
            "start_logit": 4.060291767120361,
            "end_logit": 2.000880241394043,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor (FGF)",
            "probability": 0.024861286276577573,
            "start_logit": 3.4517946243286133,
            "end_logit": 2.541954278945923,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT, bone morphogenetic protein",
            "probability": 0.02480312962717434,
            "start_logit": 3.304305076599121,
            "end_logit": 2.6871018409729004,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Notch, WNT, bone morphogenetic protein (BMP), fibroblast growth factor",
            "probability": 0.024724026601390687,
            "start_logit": 2.5925076007843018,
            "end_logit": 3.395704984664917,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "WNT, bone morphogenetic protein (BMP), fibroblast growth factor (FGF)",
            "probability": 0.021452094318334426,
            "start_logit": 3.304305076599121,
            "end_logit": 2.541954278945923,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "fibroblast growth factor (FGF), insulin-like growth factor (IGF)",
            "probability": 0.016881273491122104,
            "start_logit": 3.4517946243286133,
            "end_logit": 2.1548473834991455,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "bone morphogenetic protein",
            "probability": 0.016119084447940298,
            "start_logit": 2.8733391761779785,
            "end_logit": 2.6871018409729004,
            "question_text": "List angiocrine factors"
        }
    ],
    "56cf2be73975bb303a000005": [
        {
            "text": "anti-IL-5 monoclonal antibodies",
            "probability": 0.5218167996081504,
            "start_logit": 5.120461940765381,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal antibodies",
            "probability": 0.42113862398251356,
            "start_logit": 4.906107425689697,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5",
            "probability": 0.03835906035908364,
            "start_logit": 5.120461940765381,
            "end_logit": 2.699857234954834,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 monoclonal antibodies",
            "probability": 0.006199568035013825,
            "start_logit": 0.687624990940094,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal antibodies (mAbs",
            "probability": 0.002550244043639015,
            "start_logit": 5.120461940765381,
            "end_logit": -0.010944461449980736,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "antibodies",
            "probability": 0.002277905774104815,
            "start_logit": -0.3135981261730194,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal antibodies (mAbs",
            "probability": 0.002058205615772131,
            "start_logit": 4.906107425689697,
            "end_logit": -0.010944461449980736,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two anti-IL-5 monoclonal antibodies",
            "probability": 0.0012987984140610017,
            "start_logit": -0.8754150867462158,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "lonal antibodies",
            "probability": 0.0011139225379304242,
            "start_logit": -1.028967022895813,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "al antibodies",
            "probability": 0.0004935583477307226,
            "start_logit": -1.8429688215255737,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal",
            "probability": 0.0004677441435428637,
            "start_logit": 5.120461940765381,
            "end_logit": -1.7069673538208008,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5",
            "probability": 0.00045573389862863753,
            "start_logit": 0.687624990940094,
            "end_logit": 2.699857234954834,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal",
            "probability": 0.00037749862621411115,
            "start_logit": 4.906107425689697,
            "end_logit": -1.7069673538208008,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 mon",
            "probability": 0.00032949629322471163,
            "start_logit": 5.120461940765381,
            "end_logit": -2.057323694229126,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "5 monoclonal antibodies",
            "probability": 0.00027028196513918524,
            "start_logit": -2.4451441764831543,
            "end_logit": 5.310183048248291,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "mon",
            "probability": 0.0002659240094228397,
            "start_logit": 4.906107425689697,
            "end_logit": -2.057323694229126,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti",
            "probability": 0.00025044283064169743,
            "start_logit": 5.120461940765381,
            "end_logit": -2.331658124923706,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 monoclonal antibodies (mAbs,",
            "probability": 0.00010000545456884492,
            "start_logit": 5.120461940765381,
            "end_logit": -3.249664068222046,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two anti-IL-5",
            "probability": 9.547543658360575e-05,
            "start_logit": -0.8754150867462158,
            "end_logit": 2.699857234954834,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal antibodies (mAbs,",
            "probability": 8.071062403413524e-05,
            "start_logit": 4.906107425689697,
            "end_logit": -3.249664068222046,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        }
    ],
    "5713bc991174fb1755000010": [
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP2",
            "probability": 0.40219816012455734,
            "start_logit": 3.651399612426758,
            "end_logit": 3.0082526206970215,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2",
            "probability": 0.27536330732535397,
            "start_logit": 3.651399612426758,
            "end_logit": 2.629399061203003,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "IGHMBP2",
            "probability": 0.17281755801848697,
            "start_logit": 2.8066911697387695,
            "end_logit": 3.0082526206970215,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP2)",
            "probability": 0.0904382916048866,
            "start_logit": 3.651399612426758,
            "end_logit": 1.5159754753112793,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "IGHMBP2)",
            "probability": 0.03885976181909948,
            "start_logit": 2.8066911697387695,
            "end_logit": 1.5159754753112793,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mu-binding protein 2 (IGHMBP2",
            "probability": 0.003869500587153798,
            "start_logit": -0.9924198389053345,
            "end_logit": 3.0082526206970215,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "(IGHMBP2",
            "probability": 0.0033521929787712224,
            "start_logit": -1.1359305381774902,
            "end_logit": 3.0082526206970215,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mu-binding protein 2",
            "probability": 0.0026492375774321967,
            "start_logit": -0.9924198389053345,
            "end_logit": 2.629399061203003,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "2 (IGHMBP2",
            "probability": 0.0012380383544408733,
            "start_logit": -2.132017135620117,
            "end_logit": 3.0082526206970215,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein",
            "probability": 0.0011700046143799585,
            "start_logit": 3.651399612426758,
            "end_logit": -2.8316845893859863,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "Rare variants (RV) in immunoglobulin mu-binding protein 2 (IGHMBP2",
            "probability": 0.0011633915967017494,
            "start_logit": -2.1942057609558105,
            "end_logit": 3.0082526206970215,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "IGHMBP2) [OMIM 600502] can cause an autosomal recessive",
            "probability": 0.0009830185610240005,
            "start_logit": 2.8066911697387695,
            "end_logit": -2.1611111164093018,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mu-binding protein 2 (IGHMBP2)",
            "probability": 0.0008700960301705962,
            "start_logit": -0.9924198389053345,
            "end_logit": 1.5159754753112793,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "2",
            "probability": 0.0008476178403424339,
            "start_logit": -2.132017135620117,
            "end_logit": 2.629399061203003,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "Rare variants (RV) in immunoglobulin mu-binding protein 2",
            "probability": 0.0007965112463048236,
            "start_logit": -2.1942057609558105,
            "end_logit": 2.629399061203003,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP",
            "probability": 0.0007855397095615545,
            "start_logit": 3.651399612426758,
            "end_logit": -3.230076551437378,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "(IGHMBP2)",
            "probability": 0.0007537742242184228,
            "start_logit": -1.1359305381774902,
            "end_logit": 1.5159754753112793,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "im",
            "probability": 0.0006538748807131953,
            "start_logit": 3.651399612426758,
            "end_logit": -3.413531541824341,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP2) [OMIM 600502]",
            "probability": 0.0006308178142311255,
            "start_logit": 3.651399612426758,
            "end_logit": -3.449430465698242,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "immunoglobulin mu-binding protein 2 (IGHMBP2) [OMIM 600502",
            "probability": 0.0005593050921696239,
            "start_logit": 3.651399612426758,
            "end_logit": -3.5697524547576904,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        }
    ],
    "515de993298dcd4e51000024": [
        {
            "text": "Guanfacin",
            "probability": 0.9140562571057248,
            "start_logit": 4.462283611297607,
            "end_logit": 4.181861877441406,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "guanfacin",
            "probability": 0.05838355688242987,
            "start_logit": 2.9743242263793945,
            "end_logit": 2.9189634323120117,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "guanfacin are similar in comorbid disorders and pure ADHD.<br/> CONCLUSION: Guanfacin",
            "probability": 0.011373000663773622,
            "start_logit": 0.07563367486000061,
            "end_logit": 4.181861877441406,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Stimulants are the first pharmacological choice. Recently, long-acting guanfacin",
            "probability": 0.0070924386885171,
            "start_logit": 0.8663191795349121,
            "end_logit": 2.9189634323120117,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "long-acting guanfacin",
            "probability": 0.0039303325237850986,
            "start_logit": 0.27601397037506104,
            "end_logit": 2.9189634323120117,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Stimulants",
            "probability": 0.0020071817280029863,
            "start_logit": 0.8663191795349121,
            "end_logit": 1.6566658020019531,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "guanfacin on comorbid symptoms is evaluated.<br/> RESULTS: Guanfacin",
            "probability": 0.0016280732156508796,
            "start_logit": -0.7471976280212402,
            "end_logit": 3.0608482360839844,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Guanfacin had an effect on autism symptoms, oppositional defiant symptoms and possibly on tics",
            "probability": 0.00044370289746496376,
            "start_logit": 3.290393590927124,
            "end_logit": -2.276740312576294,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Guanfacin is a treatment option",
            "probability": 0.00041640818366138233,
            "start_logit": 4.462283611297607,
            "end_logit": -3.5121195316314697,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "cin",
            "probability": 0.00023204068321904683,
            "start_logit": -3.816451072692871,
            "end_logit": 4.181861877441406,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Guanfacin had an effect on autism symptoms, oppositional defiant symptoms",
            "probability": 0.00013217358839990283,
            "start_logit": 3.290393590927124,
            "end_logit": -3.487779378890991,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics, autism spectrum disorder, anxiety and depression. Stimulants",
            "probability": 0.00011167374229606904,
            "start_logit": -2.0225861072540283,
            "end_logit": 1.6566658020019531,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "lants are the first pharmacological choice. Recently, long-acting guanfacin",
            "probability": 8.453671628376687e-05,
            "start_logit": -3.563279390335083,
            "end_logit": 2.9189634323120117,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "no effect was reported. The effect on depression needs to be further investigated. The side effects of guanfacin",
            "probability": 3.604445098586176e-05,
            "start_logit": -2.40063738822937,
            "end_logit": 0.9038884043693542,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "lants",
            "probability": 2.3924147916127636e-05,
            "start_logit": -3.563279390335083,
            "end_logit": 1.6566658020019531,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "depression needs to be further investigated. The side effects of guanfacin",
            "probability": 2.37398123973976e-05,
            "start_logit": -2.818236827850342,
            "end_logit": 0.9038884043693542,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "Stimulants are the first pharmacological choice",
            "probability": 1.2044309837316934e-05,
            "start_logit": 0.8663191795349121,
            "end_logit": -3.459228754043579,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "tics in children and adolescents with adhd. On anxiety symptoms, no effect was reported",
            "probability": 5.580650493934231e-06,
            "start_logit": -1.9214954376220703,
            "end_logit": -1.4407011270523071,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "anxiety symptoms, no effect was reported. The effect on depression needs to be further investigated. The side effects of guanfacin",
            "probability": 3.833831018644523e-06,
            "start_logit": -4.641525745391846,
            "end_logit": 0.9038884043693542,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "no effect was reported",
            "probability": 3.4561781407363473e-06,
            "start_logit": -2.40063738822937,
            "end_logit": -1.4407011270523071,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        }
    ],
    "54fc9b236ad7dcbc12000005": [
        {
            "text": "A2A",
            "probability": 0.15233552748836798,
            "start_logit": -4.638864994049072,
            "end_logit": -4.416191101074219,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2A receptor (A2AAR)",
            "probability": 0.0745360397734189,
            "start_logit": -4.638864994049072,
            "end_logit": -5.130993843078613,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2AAR)",
            "probability": 0.06633552942942844,
            "start_logit": -4.755422115325928,
            "end_logit": -5.130993843078613,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2A receptor",
            "probability": 0.06620325309479884,
            "start_logit": -4.638864994049072,
            "end_logit": -5.249547004699707,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2A receptor (A2AAR",
            "probability": 0.05563870353292882,
            "start_logit": -4.638864994049072,
            "end_logit": -5.423397541046143,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "(A2AAR)",
            "probability": 0.05484758822724388,
            "start_logit": -4.945589542388916,
            "end_logit": -5.130993843078613,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "discuss the A2A",
            "probability": 0.05371886807628624,
            "start_logit": -5.681186199188232,
            "end_logit": -4.416191101074219,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2AAR",
            "probability": 0.04951729212933135,
            "start_logit": -4.755422115325928,
            "end_logit": -5.423397541046143,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A",
            "probability": 0.04745248725856841,
            "start_logit": -4.638864994049072,
            "end_logit": -5.582547664642334,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "the A2A",
            "probability": 0.0462488003665891,
            "start_logit": -5.8309149742126465,
            "end_logit": -4.416191101074219,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2A, A2B",
            "probability": 0.04448384503463004,
            "start_logit": -4.875234127044678,
            "end_logit": -5.410781383514404,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "(A2AAR",
            "probability": 0.0409419216549262,
            "start_logit": -4.945589542388916,
            "end_logit": -5.423397541046143,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2B",
            "probability": 0.03884640921676021,
            "start_logit": -5.010744571685791,
            "end_logit": -5.410781383514404,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2A receptor (A2AAR) subtype",
            "probability": 0.03575086464021902,
            "start_logit": -4.638864994049072,
            "end_logit": -5.865702152252197,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "A2AAR) subtype",
            "probability": 0.031817528012998975,
            "start_logit": -4.755422115325928,
            "end_logit": -5.865702152252197,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "review shall discuss the A2A",
            "probability": 0.030655529922297493,
            "start_logit": -6.242137432098389,
            "end_logit": -4.416191101074219,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "agonists and antagonists identified that can interact with these receptors. This review shall discuss the A2A",
            "probability": 0.030062125249956804,
            "start_logit": -6.261684417724609,
            "end_logit": -4.416191101074219,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "adenosine. ARs are classified into 4 subtype receptors, namely, the A1, A2A",
            "probability": 0.02801626567782926,
            "start_logit": -5.736570835113525,
            "end_logit": -5.011785507202148,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "(A2AAR) subtype",
            "probability": 0.026307390471984077,
            "start_logit": -4.945589542388916,
            "end_logit": -5.865702152252197,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "discuss the A2A receptor (A2AAR)",
            "probability": 0.026284030741435874,
            "start_logit": -5.681186199188232,
            "end_logit": -5.130993843078613,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        }
    ],
    "54fe09036ad7dcbc12000009": [
        {
            "text": "fish fillet",
            "probability": 0.2528003675036745,
            "start_logit": -0.7578930258750916,
            "end_logit": -2.799685478210449,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish",
            "probability": 0.14169530834423372,
            "start_logit": -0.7578930258750916,
            "end_logit": -3.3786065578460693,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fillet",
            "probability": 0.1031509332156941,
            "start_logit": -1.6542998552322388,
            "end_logit": -2.799685478210449,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste of fish fillet",
            "probability": 0.09154598577301179,
            "start_logit": -1.7736517190933228,
            "end_logit": -2.799685478210449,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing",
            "probability": 0.07514546533755569,
            "start_logit": -0.7578930258750916,
            "end_logit": -4.01285982131958,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste of fish",
            "probability": 0.05131177936913084,
            "start_logit": -1.7736517190933228,
            "end_logit": -3.3786065578460693,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching",
            "probability": 0.03738960550411333,
            "start_logit": -1.7736517190933228,
            "end_logit": -3.695134162902832,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "waste of fish fillet",
            "probability": 0.030905939672777046,
            "start_logit": -2.8595447540283203,
            "end_logit": -2.799685478210449,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fillet processing",
            "probability": 0.030661841804418236,
            "start_logit": -1.6542998552322388,
            "end_logit": -4.01285982131958,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution, but these materials can still be used as raw material for fish feed",
            "probability": 0.028270679242869932,
            "start_logit": -0.7578930258750916,
            "end_logit": -4.990460395812988,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste of fish fillet processing",
            "probability": 0.02721224564912166,
            "start_logit": -1.7736517190933228,
            "end_logit": -4.01285982131958,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution",
            "probability": 0.022640723576065763,
            "start_logit": -0.7578930258750916,
            "end_logit": -5.212535381317139,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution, but these materials can still be used as raw material for fish feed.",
            "probability": 0.02111789996767574,
            "start_logit": -0.7578930258750916,
            "end_logit": -5.282164573669434,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "waste of fish",
            "probability": 0.01732286505295043,
            "start_logit": -2.8595447540283203,
            "end_logit": -3.3786065578460693,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish fillet processing will cause environmental pollution,",
            "probability": 0.014520163258894827,
            "start_logit": -0.7578930258750916,
            "end_logit": -5.656747341156006,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste",
            "probability": 0.014110204807915224,
            "start_logit": -1.7736517190933228,
            "end_logit": -4.669628620147705,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fillet processing will cause environmental pollution, but these materials can still be used as raw material for fish feed",
            "probability": 0.011535374633113216,
            "start_logit": -1.6542998552322388,
            "end_logit": -4.990460395812988,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fish catching and waste of fish fillet processing will cause environmental pollution, but these materials can still be used as raw material for fish feed",
            "probability": 0.010237592711266657,
            "start_logit": -1.7736517190933228,
            "end_logit": -4.990460395812988,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "fillet processing will cause environmental pollution",
            "probability": 0.009238166022507084,
            "start_logit": -1.6542998552322388,
            "end_logit": -5.212535381317139,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "waste of fish fillet processing",
            "probability": 0.009186858553010201,
            "start_logit": -2.8595447540283203,
            "end_logit": -4.01285982131958,
            "question_text": "List fish anti-freeze proteins."
        }
    ],
    "517295c18ed59a060a000016": [
        {
            "text": "MicroRNAs",
            "probability": 0.42574489584250513,
            "start_logit": 5.107692241668701,
            "end_logit": 5.181300640106201,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs",
            "probability": 0.32325981528396913,
            "start_logit": 5.107692241668701,
            "end_logit": 4.905916690826416,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs",
            "probability": 0.17103843752773917,
            "start_logit": 4.471124172210693,
            "end_logit": 4.905916690826416,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs)",
            "probability": 0.048399170646883614,
            "start_logit": 5.107692241668701,
            "end_logit": 3.0069429874420166,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs)",
            "probability": 0.025608251114693732,
            "start_logit": 4.471124172210693,
            "end_logit": 3.0069429874420166,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "(miRNAs",
            "probability": 0.003993178688776167,
            "start_logit": 0.7138234376907349,
            "end_logit": 4.905916690826416,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "(miRNAs)",
            "probability": 0.0005978674974240172,
            "start_logit": 0.7138234376907349,
            "end_logit": 3.0069429874420166,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "Micro",
            "probability": 0.00041583078040399144,
            "start_logit": 5.107692241668701,
            "end_logit": -1.7500165700912476,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (mi",
            "probability": 0.00018492216649230957,
            "start_logit": 5.107692241668701,
            "end_logit": -2.5603599548339844,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "mi",
            "probability": 9.784327319900436e-05,
            "start_logit": 4.471124172210693,
            "end_logit": -2.5603599548339844,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNA",
            "probability": 9.620592662903098e-05,
            "start_logit": 5.107692241668701,
            "end_logit": -3.213804006576538,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs) are",
            "probability": 9.60155523112786e-05,
            "start_logit": 5.107692241668701,
            "end_logit": -3.215784788131714,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (",
            "probability": 8.823318733713083e-05,
            "start_logit": 5.107692241668701,
            "end_logit": -3.300311803817749,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNA",
            "probability": 7.548962185418026e-05,
            "start_logit": 5.107692241668701,
            "end_logit": -3.4562997817993164,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs) are a class",
            "probability": 7.160717280661409e-05,
            "start_logit": 5.107692241668701,
            "end_logit": -3.5090997219085693,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "s",
            "probability": 5.199918149178237e-05,
            "start_logit": -3.9026753902435303,
            "end_logit": 5.181300640106201,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNA",
            "probability": 5.090305257114276e-05,
            "start_logit": 4.471124172210693,
            "end_logit": -3.213804006576538,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs) are",
            "probability": 5.080232453655803e-05,
            "start_logit": 4.471124172210693,
            "end_logit": -3.215784788131714,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "s (miRNAs",
            "probability": 3.94819667084614e-05,
            "start_logit": -3.9026753902435303,
            "end_logit": 4.905916690826416,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "MicroRNAs (miRNAs) are a",
            "probability": 3.904919166774823e-05,
            "start_logit": 5.107692241668701,
            "end_logit": -4.115472793579102,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        }
    ],
    "5505c9008e1671127b000002": [
        {
            "text": "RICTOR and SIN1",
            "probability": 0.37673986935172676,
            "start_logit": 4.342296600341797,
            "end_logit": 3.6136670112609863,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR",
            "probability": 0.30932767158390184,
            "start_logit": 4.342296600341797,
            "end_logit": 3.416513204574585,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN1",
            "probability": 0.2229001450145597,
            "start_logit": 3.8174655437469482,
            "end_logit": 3.6136670112609863,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR and SIN1",
            "probability": 0.039141949070304854,
            "start_logit": 2.0779364109039307,
            "end_logit": 3.6136670112609863,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR",
            "probability": 0.03213805851769104,
            "start_logit": 2.0779364109039307,
            "end_logit": 3.416513204574585,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR and SIN1, thus abrogating mTORC2",
            "probability": 0.005750164435739528,
            "start_logit": 4.342296600341797,
            "end_logit": -0.5686594843864441,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN1, thus abrogating mTORC2",
            "probability": 0.0034021153343536613,
            "start_logit": 3.8174655437469482,
            "end_logit": -0.5686594843864441,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR and SIN",
            "probability": 0.0027245344096807045,
            "start_logit": 4.342296600341797,
            "end_logit": -1.3155903816223145,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "RICTOR and SIN1,",
            "probability": 0.0019473946007110697,
            "start_logit": 4.342296600341797,
            "end_logit": -1.651395559310913,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN",
            "probability": 0.001611985256723675,
            "start_logit": 3.8174655437469482,
            "end_logit": -1.3155903816223145,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "SIN1,",
            "probability": 0.0011521863604348531,
            "start_logit": 3.8174655437469482,
            "end_logit": -1.651395559310913,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR and SIN1, thus abrogating mTORC2",
            "probability": 0.0005974218865576597,
            "start_logit": 2.0779364109039307,
            "end_logit": -0.5686594843864441,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2",
            "probability": 0.0005711867477268241,
            "start_logit": 2.0779364109039307,
            "end_logit": -0.6135668158531189,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "cofactors RICTOR and SIN1",
            "probability": 0.0004515206581450129,
            "start_logit": -2.384392499923706,
            "end_logit": 3.6136670112609863,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "cofactors RICTOR",
            "probability": 0.00037072751046062755,
            "start_logit": -2.384392499923706,
            "end_logit": 3.416513204574585,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "R",
            "probability": 0.00029821771894207203,
            "start_logit": 4.342296600341797,
            "end_logit": -3.5278193950653076,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR and SIN",
            "probability": 0.00028306955482976,
            "start_logit": 2.0779364109039307,
            "end_logit": -1.3155903816223145,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR association with mTORC2 cofactors RICTOR and SIN1",
            "probability": 0.00021386093879094523,
            "start_logit": -3.131687641143799,
            "end_logit": 3.6136670112609863,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2 cofactors RICTOR and SIN1,",
            "probability": 0.00020232745849804222,
            "start_logit": 2.0779364109039307,
            "end_logit": -1.651395559310913,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR association with mTORC2 cofactors RICTOR",
            "probability": 0.00017559359022123954,
            "start_logit": -3.131687641143799,
            "end_logit": 3.416513204574585,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        }
    ],
    "5326c6fed6d3ac6a3400000c": [
        {
            "text": "abdominal obesity",
            "probability": 0.12070823561467904,
            "start_logit": 5.381448745727539,
            "end_logit": 5.353183269500732,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia, abdominal obesity",
            "probability": 0.1145094373268769,
            "start_logit": 5.328729629516602,
            "end_logit": 5.353183269500732,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abdominal obesity, lipid abnormalities and high blood pressure",
            "probability": 0.08913144736281539,
            "start_logit": 5.381448745727539,
            "end_logit": 5.049919128417969,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia",
            "probability": 0.08770734183977012,
            "start_logit": 5.328729629516602,
            "end_logit": 5.086531639099121,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia, abdominal obesity, lipid abnormalities and high blood pressure",
            "probability": 0.08455422973977232,
            "start_logit": 5.328729629516602,
            "end_logit": 5.049919128417969,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "lipid abnormalities and high blood pressure",
            "probability": 0.08109124147227272,
            "start_logit": 5.286911487579346,
            "end_logit": 5.049919128417969,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "high blood pressure",
            "probability": 0.0702195917833897,
            "start_logit": 5.142963886260986,
            "end_logit": 5.049919128417969,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "cardiovascular diseases (CVD), two of the main causes of morbidity and mortality worldwide, which include hyperglycemia",
            "probability": 0.06469376130387881,
            "start_logit": 5.024388790130615,
            "end_logit": 5.086531639099121,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abdominal obesity, lipid abnormalities",
            "probability": 0.05059862278388391,
            "start_logit": 5.381448745727539,
            "end_logit": 4.483731269836426,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "hyperglycemia, abdominal obesity, lipid abnormalities",
            "probability": 0.04800020309295983,
            "start_logit": 5.328729629516602,
            "end_logit": 4.483731269836426,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "type 2 diabetes mellitus",
            "probability": 0.04682482563071224,
            "start_logit": 4.997125148773193,
            "end_logit": 4.790544033050537,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "lipid abnormalities",
            "probability": 0.046034315157369894,
            "start_logit": 5.286911487579346,
            "end_logit": 4.483731269836426,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "type 2 diabetes",
            "probability": 0.02717235862279746,
            "start_logit": 4.997125148773193,
            "end_logit": 4.246330738067627,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "cardiovascular diseases",
            "probability": 0.020814054784534533,
            "start_logit": 5.024388790130615,
            "end_logit": 3.9524953365325928,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "type 2 diabetes mellitus and cardiovascular diseases",
            "probability": 0.020254253643340308,
            "start_logit": 4.997125148773193,
            "end_logit": 3.9524953365325928,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "blood pressure",
            "probability": 0.011510175782235616,
            "start_logit": 3.3345680236816406,
            "end_logit": 5.049919128417969,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.005719446744860072,
            "start_logit": 2.8945837020874023,
            "end_logit": 4.790544033050537,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "obesity",
            "probability": 0.004105761931535384,
            "start_logit": 2.0004637241363525,
            "end_logit": 5.353183269500732,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetes",
            "probability": 0.003318984235007936,
            "start_logit": 2.8945837020874023,
            "end_logit": 4.246330738067627,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "obesity, lipid abnormalities and high blood pressure",
            "probability": 0.0030317111473079535,
            "start_logit": 2.0004637241363525,
            "end_logit": 5.049919128417969,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        }
    ],
    "5319a6c9b166e2b806000022": [
        {
            "text": "duvelisib",
            "probability": 0.25778638379687807,
            "start_logit": 5.445796966552734,
            "end_logit": 5.229430675506592,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "pictilisib",
            "probability": 0.20448580557499174,
            "start_logit": 5.153985500335693,
            "end_logit": 5.289609432220459,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "duvelisib) inhibitor. We uncover the mechanism of synergy between the PI3 kinase inhibitor GDC0941",
            "probability": 0.13767513466189624,
            "start_logit": 5.445796966552734,
            "end_logit": 4.602196216583252,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "GDC0941 (pictilisib",
            "probability": 0.11444673747264197,
            "start_logit": 4.573596477508545,
            "end_logit": 5.289609432220459,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "pictilisib) and the tubulin inhibitor vincristine",
            "probability": 0.08153532473741895,
            "start_logit": 5.153985500335693,
            "end_logit": 4.370147228240967,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "GDC0941",
            "probability": 0.057552428031065916,
            "start_logit": 4.573596477508545,
            "end_logit": 4.602196216583252,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "vincristine",
            "probability": 0.045682071590179084,
            "start_logit": 4.574655055999756,
            "end_logit": 4.370147228240967,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "GDC0941 (pictilisib) and the tubulin inhibitor vincristine",
            "probability": 0.04563373911813083,
            "start_logit": 4.573596477508545,
            "end_logit": 4.370147228240967,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "pictilisib)",
            "probability": 0.01878770377452924,
            "start_logit": 5.153985500335693,
            "end_logit": 2.902313470840454,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "IPI145 (duvelisib",
            "probability": 0.011563368543755734,
            "start_logit": 2.341507911682129,
            "end_logit": 5.229430675506592,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "GDC0941 (pictilisib)",
            "probability": 0.010515113240017854,
            "start_logit": 4.573596477508545,
            "end_logit": 2.902313470840454,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "duvelisib)",
            "probability": 0.005236245931579119,
            "start_logit": 5.445796966552734,
            "end_logit": 1.3329042196273804,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "(pictilisib",
            "probability": 0.0027669574771878066,
            "start_logit": 0.8512352705001831,
            "end_logit": 5.289609432220459,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "duvelisib) inhibitor. We uncover the mechanism of synergy between the PI3 kinase inhibitor",
            "probability": 0.0016770305798997007,
            "start_logit": 5.445796966552734,
            "end_logit": 0.19432412087917328,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "PI3 kinase inhibitor GDC0941 (pictilisib",
            "probability": 0.001414231148659002,
            "start_logit": 0.18007296323776245,
            "end_logit": 5.289609432220459,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "(pictilisib) and the tubulin inhibitor vincristine",
            "probability": 0.0011032784197551576,
            "start_logit": 0.8512352705001831,
            "end_logit": 4.370147228240967,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "PI3 kinase inhibitor GDC0941",
            "probability": 0.0007111817968768697,
            "start_logit": 0.18007296323776245,
            "end_logit": 4.602196216583252,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "PI3 kinase inhibitor GDC0941 (pictilisib) and the tubulin inhibitor vincristine",
            "probability": 0.0005639012235369892,
            "start_logit": 0.18007296323776245,
            "end_logit": 4.370147228240967,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "pictilisib) and the tubulin inhibitor",
            "probability": 0.0005535510817984509,
            "start_logit": 5.153985500335693,
            "end_logit": -0.6222903728485107,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "GDC0941 (pictilisib) and the tubulin inhibitor",
            "probability": 0.00030981179920114765,
            "start_logit": 4.573596477508545,
            "end_logit": -0.6222903728485107,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        }
    ],
    "56a37e33496b62f23f000003": [
        {
            "text": "word frequency",
            "probability": 0.30674203857273546,
            "start_logit": 0.3663090169429779,
            "end_logit": -1.1319608688354492,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word frequency with problems balancing word length",
            "probability": 0.117254886440811,
            "start_logit": 0.3663090169429779,
            "end_logit": -2.0936179161071777,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word frequency with problems balancing word length and window size",
            "probability": 0.09281175240549908,
            "start_logit": 0.3663090169429779,
            "end_logit": -2.327394723892212,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triplets",
            "probability": 0.06998806429646798,
            "start_logit": -0.36395785212516785,
            "end_logit": -1.8793764114379883,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word",
            "probability": 0.06045585069997175,
            "start_logit": 0.3663090169429779,
            "end_logit": -2.756054639816284,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word length",
            "probability": 0.04752707883715972,
            "start_logit": -0.5367414355278015,
            "end_logit": -2.0936179161071777,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triplets Markov model.",
            "probability": 0.04452233746451809,
            "start_logit": -0.36395785212516785,
            "end_logit": -2.33171010017395,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word length and window size",
            "probability": 0.037619510857807736,
            "start_logit": -0.5367414355278015,
            "end_logit": -2.327394723892212,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triplets Markov model",
            "probability": 0.03096808807107981,
            "start_logit": -0.36395785212516785,
            "end_logit": -2.6947438716888428,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word frequency with problems balancing word",
            "probability": 0.029939177904895805,
            "start_logit": 0.3663090169429779,
            "end_logit": -3.4588000774383545,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word frequency with problems balancing word length and window size,",
            "probability": 0.02680129338778887,
            "start_logit": 0.3663090169429779,
            "end_logit": -3.5695178508758545,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "frequency",
            "probability": 0.02370073782492546,
            "start_logit": -2.1941919326782227,
            "end_logit": -1.1319608688354492,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word frequency with problems balancing word length and window size, the method has been shown to work successfully with both bacterial whole genome data",
            "probability": 0.021433587342767662,
            "start_logit": 0.3663090169429779,
            "end_logit": -3.793008804321289,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word frequency with problems balancing word length and window",
            "probability": 0.021312020187708867,
            "start_logit": 0.3663090169429779,
            "end_logit": -3.798696756362915,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "window size",
            "probability": 0.01787703348478127,
            "start_logit": -1.280747413635254,
            "end_logit": -2.327394723892212,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "triplets Markov model. Without the alignment",
            "probability": 0.012452584064946554,
            "start_logit": -0.36395785212516785,
            "end_logit": -3.6057729721069336,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word length and window size,",
            "probability": 0.010863403841359594,
            "start_logit": -0.5367414355278015,
            "end_logit": -3.5695178508758545,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "genome signatures based on word frequency",
            "probability": 0.009838894833804719,
            "start_logit": -3.073354721069336,
            "end_logit": -1.1319608688354492,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "frequency with problems balancing word length",
            "probability": 0.009059818912190279,
            "start_logit": -2.1941919326782227,
            "end_logit": -2.0936179161071777,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "word length and window size, the method has been shown to work successfully with both bacterial whole genome data and individual eukaryotic genes",
            "probability": 0.008831840568780534,
            "start_logit": -0.5367414355278015,
            "end_logit": -3.7765541076660156,
            "question_text": "List types of avoided words in bacterial genomes"
        }
    ],
    "571ce13f7de986d80d000011": [
        {
            "text": "chorioamniotic membranes",
            "probability": 0.5798580667744233,
            "start_logit": -2.830540895462036,
            "end_logit": -3.9544575214385986,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "chorioamniotic membrane",
            "probability": 0.22877433648443823,
            "start_logit": -2.830540895462036,
            "end_logit": -4.884504795074463,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "chorioamniotic membranes from these patients.",
            "probability": 0.06790306442668553,
            "start_logit": -2.830540895462036,
            "end_logit": -6.0991597175598145,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "ch",
            "probability": 0.03622899094574996,
            "start_logit": -2.830540895462036,
            "end_logit": -6.727381229400635,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "membranes",
            "probability": 0.02988371736599228,
            "start_logit": -5.796010494232178,
            "end_logit": -3.9544575214385986,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "membrane",
            "probability": 0.011790174188872597,
            "start_logit": -5.796010494232178,
            "end_logit": -4.884504795074463,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "labor at term; and (3) whether gasdermin D is expressed in the chorioamniotic membranes",
            "probability": 0.007886491681336458,
            "start_logit": -7.128172874450684,
            "end_logit": -3.9544575214385986,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "spontaneous labor at term; and (3) whether gasdermin D is expressed in the chorioamniotic membranes",
            "probability": 0.006493589403636051,
            "start_logit": -7.322508811950684,
            "end_logit": -3.9544575214385986,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "Pyroptosis",
            "probability": 0.0038423843828109274,
            "start_logit": -6.203791618347168,
            "end_logit": -5.597897052764893,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "amniotic fluid",
            "probability": 0.0035545516489035056,
            "start_logit": -6.1017584800720215,
            "end_logit": -5.777794361114502,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "membranes from these patients.",
            "probability": 0.003499470132233642,
            "start_logit": -5.796010494232178,
            "end_logit": -6.0991597175598145,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "amniotic fluid of women who delivered at term;",
            "probability": 0.003241883676890388,
            "start_logit": -6.1017584800720215,
            "end_logit": -5.869868755340576,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "labor at term; and (3) whether gasdermin D is expressed in the chorioamniotic membrane",
            "probability": 0.003111497459411341,
            "start_logit": -7.128172874450684,
            "end_logit": -4.884504795074463,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "spontaneous labor at term; and (3) whether gasdermin D is expressed in the chorioamniotic membrane",
            "probability": 0.002561948677342679,
            "start_logit": -7.322508811950684,
            "end_logit": -4.884504795074463,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "amniotic fluid gasdermin D concentrations are associated with the process of spontaneous labor",
            "probability": 0.0022376080337413785,
            "start_logit": -6.417309761047363,
            "end_logit": -5.925064563751221,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "women who delivered at term;",
            "probability": 0.00209045126073894,
            "start_logit": -6.540533065795898,
            "end_logit": -5.869868755340576,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "women who delivered at term; (2) whether amniotic fluid gasdermin D concentrations are associated with the process of spontaneous labor",
            "probability": 0.0019781936859230836,
            "start_logit": -6.540533065795898,
            "end_logit": -5.925064563751221,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "amniotic fluid of women who delivered at term",
            "probability": 0.0017471780162511075,
            "start_logit": -6.1017584800720215,
            "end_logit": -6.488021373748779,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "Pyroptosis is an inflammatory form of programmed cell death that is mediated by the activation of the inflammasome",
            "probability": 0.0017440757377046967,
            "start_logit": -6.203791618347168,
            "end_logit": -6.387765407562256,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "amniotic fluid of women who delivered at term; (2) whether amniotic fluid",
            "probability": 0.00157232601691387,
            "start_logit": -6.1017584800720215,
            "end_logit": -6.5934672355651855,
            "question_text": "In which cells are gasdermins expressed?"
        }
    ],
    "533c3533c45e133714000004": [
        {
            "text": "miR-96",
            "probability": 0.07725686646417634,
            "start_logit": 2.3096656799316406,
            "end_logit": 2.6022040843963623,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a, miR-96",
            "probability": 0.07123683725908306,
            "start_logit": 2.2285399436950684,
            "end_logit": 2.6022040843963623,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22, miR-27a, miR-96",
            "probability": 0.07069237747195195,
            "start_logit": 2.22086763381958,
            "end_logit": 2.6022040843963623,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-223",
            "probability": 0.06482686130496504,
            "start_logit": 2.4498701095581055,
            "end_logit": 2.28658390045166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-142, miR-223",
            "probability": 0.05649337849856364,
            "start_logit": 2.3122735023498535,
            "end_logit": 2.28658390045166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96, miR-142, miR-223",
            "probability": 0.05634624573108352,
            "start_logit": 2.3096656799316406,
            "end_logit": 2.28658390045166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-142",
            "probability": 0.056249416208831976,
            "start_logit": 2.3122735023498535,
            "end_logit": 2.2822561264038086,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96, miR-142",
            "probability": 0.05610291882283908,
            "start_logit": 2.3096656799316406,
            "end_logit": 2.2822561264038086,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a",
            "probability": 0.055892442330203726,
            "start_logit": 2.2285399436950684,
            "end_logit": 2.3596231937408447,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22, miR-27a",
            "probability": 0.05546525902976234,
            "start_logit": 2.22086763381958,
            "end_logit": 2.3596231937408447,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22",
            "probability": 0.05356410089296969,
            "start_logit": 2.22086763381958,
            "end_logit": 2.3247454166412354,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a, miR-96, miR-142, miR-223",
            "probability": 0.051955619235045485,
            "start_logit": 2.2285399436950684,
            "end_logit": 2.28658390045166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-27a, miR-96, miR-142",
            "probability": 0.05173125290805495,
            "start_logit": 2.2285399436950684,
            "end_logit": 2.2822561264038086,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22, miR-27a, miR-96, miR-142, miR-223",
            "probability": 0.05155852488783158,
            "start_logit": 2.22086763381958,
            "end_logit": 2.28658390045166,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-22, miR-27a, miR-96, miR-142",
            "probability": 0.05133587338209552,
            "start_logit": 2.22086763381958,
            "end_logit": 2.2822561264038086,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-223, miR-296",
            "probability": 0.02739081179521993,
            "start_logit": 2.4498701095581055,
            "end_logit": 1.4250714778900146,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-142, miR-223, miR-296",
            "probability": 0.023869727254738567,
            "start_logit": 2.3122735023498535,
            "end_logit": 1.4250714778900146,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-96, miR-142, miR-223, miR-296",
            "probability": 0.0238075603402554,
            "start_logit": 2.3096656799316406,
            "end_logit": 1.4250714778900146,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-223, miR-296, miR-298",
            "probability": 0.022188017897294993,
            "start_logit": 2.4498701095581055,
            "end_logit": 1.214416265487671,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miR-296",
            "probability": 0.0220359082850333,
            "start_logit": 2.2323358058929443,
            "end_logit": 1.4250714778900146,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        }
    ],
    "52f112bb2059c6d71c000002": [
        {
            "text": "METTL1",
            "probability": 0.7606280081909785,
            "start_logit": 6.1226325035095215,
            "end_logit": 5.1044769287109375,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1 methyltransferase",
            "probability": 0.17288240206507896,
            "start_logit": 6.1226325035095215,
            "end_logit": 3.6229441165924072,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase",
            "probability": 0.016702705383679406,
            "start_logit": 3.7855916023254395,
            "end_logit": 3.6229441165924072,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL",
            "probability": 0.014710281201759894,
            "start_logit": 6.1226325035095215,
            "end_logit": 1.1588791608810425,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1 met",
            "probability": 0.01405544373339581,
            "start_logit": 6.1226325035095215,
            "end_logit": 1.11334228515625,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "the METTL1",
            "probability": 0.007156088762900591,
            "start_logit": 1.456451654434204,
            "end_logit": 5.1044769287109375,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "MET",
            "probability": 0.004466119508643284,
            "start_logit": 6.1226325035095215,
            "end_logit": -0.033147577196359634,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1 methyltransferase mediates m7G methylation",
            "probability": 0.0027655627857435905,
            "start_logit": 6.1226325035095215,
            "end_logit": -0.5124233365058899,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "the METTL1 methyltransferase",
            "probability": 0.0016265004725023835,
            "start_logit": 1.456451654434204,
            "end_logit": 3.6229441165924072,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "met",
            "probability": 0.0013579400384974975,
            "start_logit": 3.7855916023254395,
            "end_logit": 1.11334228515625,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1 methyltransferase mediates m7G met",
            "probability": 0.0011347040337803503,
            "start_logit": 6.1226325035095215,
            "end_logit": -1.403295636177063,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1 methyltransfer",
            "probability": 0.0008291639248856093,
            "start_logit": 6.1226325035095215,
            "end_logit": -1.7170048952102661,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1 methyl",
            "probability": 0.0005565370412899728,
            "start_logit": 6.1226325035095215,
            "end_logit": -2.1156890392303467,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase mediates m7G methylation",
            "probability": 0.0002671896033290564,
            "start_logit": 3.7855916023254395,
            "end_logit": -0.5124233365058899,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1-dependent N7-methylation",
            "probability": 0.0002111476047003431,
            "start_logit": 4.37981653213501,
            "end_logit": -1.3420493602752686,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "METTL1 methyltransferase mediates m7G methylation within miRNAs and that this enzyme regulates cell migration",
            "probability": 0.00018983853121996432,
            "start_logit": 6.1226325035095215,
            "end_logit": -3.191248893737793,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "the METTL",
            "probability": 0.00013839626844320866,
            "start_logit": 1.456451654434204,
            "end_logit": 1.1588791608810425,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "the METTL1 met",
            "probability": 0.0001322354710515487,
            "start_logit": 1.456451654434204,
            "end_logit": 1.11334228515625,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase mediates m7G met",
            "probability": 0.00010962727812383916,
            "start_logit": 3.7855916023254395,
            "end_logit": -1.403295636177063,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransfer",
            "probability": 8.010809999577784e-05,
            "start_logit": 3.7855916023254395,
            "end_logit": -1.7170048952102661,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        }
    ],
    "5358e067f1005d6b5800000b": [
        {
            "text": "Homer1b",
            "probability": 0.17862086535769509,
            "start_logit": 4.697621822357178,
            "end_logit": 3.7265126705169678,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a antagonizes Homer1b",
            "probability": 0.17267504597185135,
            "start_logit": 4.6637678146362305,
            "end_logit": 3.7265126705169678,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a",
            "probability": 0.10639966416296481,
            "start_logit": 4.6637678146362305,
            "end_logit": 3.2423036098480225,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer tetramer promotes actin bundling activity of Drebrin",
            "probability": 0.10088275710990688,
            "start_logit": 4.318729877471924,
            "end_logit": 3.5340981483459473,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer",
            "probability": 0.09642935321729071,
            "start_logit": 4.318729877471924,
            "end_logit": 3.488949775695801,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer tetramer promotes actin bundling activity of Drebrin in\u00a0vitro and stimulates Drebrin-induced",
            "probability": 0.04824792081167532,
            "start_logit": 4.318729877471924,
            "end_logit": 2.796491861343384,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin",
            "probability": 0.041244721431881334,
            "start_logit": 3.4242939949035645,
            "end_logit": 3.5340981483459473,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1b in promoting Drebrin-stimulated actin bundling. Our study suggests a potential regulatory role of Homer1",
            "probability": 0.04087103044669288,
            "start_logit": 4.697621822357178,
            "end_logit": 2.251668691635132,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1b in promoting Drebrin",
            "probability": 0.03980909208481779,
            "start_logit": 4.697621822357178,
            "end_logit": 2.2253425121307373,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a antagonizes Homer1b in promoting Drebrin",
            "probability": 0.03848395198443393,
            "start_logit": 4.6637678146362305,
            "end_logit": 2.2253425121307373,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin-induced filopodia formation and elongation in cells. We further show that monomeric Homer1a",
            "probability": 0.02746357757966985,
            "start_logit": 3.3094260692596436,
            "end_logit": 3.2423036098480225,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a antagonizes Homer",
            "probability": 0.021695350172554802,
            "start_logit": 4.6637678146362305,
            "end_logit": 1.652199149131775,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin in\u00a0vitro and stimulates Drebrin-induced",
            "probability": 0.019725591474240144,
            "start_logit": 3.4242939949035645,
            "end_logit": 2.796491861343384,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1",
            "probability": 0.019018716075285488,
            "start_logit": 4.697621822357178,
            "end_logit": 1.486670732498169,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer1a antagonizes Homer1",
            "probability": 0.018385632977698654,
            "start_logit": 4.6637678146362305,
            "end_logit": 1.486670732498169,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin is an actin bundling protein that plays critical roles in synaptic spine development and plasticity. Homer",
            "probability": 0.007490852067117679,
            "start_logit": 3.546781063079834,
            "end_logit": 1.705770492553711,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Drebrin-stimulated actin bundling. Our study suggests a potential regulatory role of Homer1",
            "probability": 0.006960168017773809,
            "start_logit": 2.9274039268493652,
            "end_logit": 2.251668691635132,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer binding motif 1 in complex with Homer EVH1 reveals a consensus Homer EVH1 binding motif. Homer",
            "probability": 0.005534183305711567,
            "start_logit": 1.4608632326126099,
            "end_logit": 3.488949775695801,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer EVH1 reveals a consensus Homer EVH1 binding motif. Homer",
            "probability": 0.005049243568638258,
            "start_logit": 1.3691576719284058,
            "end_logit": 3.488949775695801,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Homer EVH1 binding motif. Homer tetramer promotes actin bundling activity of Drebrin",
            "probability": 0.005012282182099795,
            "start_logit": 1.3166621923446655,
            "end_logit": 3.5340981483459473,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        }
    ],
    "52f893f92059c6d71c00003c": [
        {
            "text": "clinical trials for drugs to prevent or treat sarcopenia",
            "probability": 0.21150296392991158,
            "start_logit": -2.597487211227417,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs to prevent or treat sarcopenia",
            "probability": 0.21015028757110046,
            "start_logit": -2.603903293609619,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "sarcopenia",
            "probability": 0.12311856184625897,
            "start_logit": -3.138578414916992,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials for drugs",
            "probability": 0.08139838534878095,
            "start_logit": -2.597487211227417,
            "end_logit": -2.625347375869751,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs",
            "probability": 0.08087779845268818,
            "start_logit": -2.603903293609619,
            "end_logit": -2.625347375869751,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "conduct of clinical trials for drugs to prevent or treat sarcopenia",
            "probability": 0.0656565769030791,
            "start_logit": -3.7672884464263916,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "conduct of clinical trials for drugs",
            "probability": 0.025268389852019874,
            "start_logit": -3.7672884464263916,
            "end_logit": -2.625347375869751,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "formulated consensus recommendations for the conduct of clinical trials for drugs to prevent or treat sarcopenia",
            "probability": 0.023914922498789227,
            "start_logit": -4.777223587036133,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials for drugs to prevent or treat sarcopenia.",
            "probability": 0.02231625802226392,
            "start_logit": -2.597487211227417,
            "end_logit": -3.9193873405456543,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "drugs to prevent or treat sarcopenia.",
            "probability": 0.022173533428324666,
            "start_logit": -2.603903293609619,
            "end_logit": -3.9193873405456543,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "nia",
            "probability": 0.020851557438589612,
            "start_logit": -4.914297580718994,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "consensus recommendations for the conduct of clinical trials for drugs to prevent or treat sarcopenia",
            "probability": 0.020004956135099103,
            "start_logit": -4.955746173858643,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "prevent or treat sarcopenia",
            "probability": 0.019213587124956466,
            "start_logit": -4.996108531951904,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "trials for drugs to prevent or treat sarcopenia",
            "probability": 0.015865706294876766,
            "start_logit": -5.18756628036499,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "sarcopenia.",
            "probability": 0.012990577259246645,
            "start_logit": -3.138578414916992,
            "end_logit": -3.9193873405456543,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "clinical trials",
            "probability": 0.01288956061251931,
            "start_logit": -2.597487211227417,
            "end_logit": -4.468285083770752,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "formulated consensus recommendations for the conduct of clinical trials for drugs",
            "probability": 0.009203824102378813,
            "start_logit": -4.777223587036133,
            "end_logit": -2.625347375869751,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "treat sarcopenia",
            "probability": 0.007954906487808616,
            "start_logit": -5.877937316894531,
            "end_logit": -1.6704638004302979,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "consensus recommendations for the conduct of clinical trials for drugs",
            "probability": 0.00769904637794991,
            "start_logit": -4.955746173858643,
            "end_logit": -2.625347375869751,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Osteoarthritis (ESCEO) and formulated consensus recommendations for the conduct of clinical trials for drugs",
            "probability": 0.0069486003133577235,
            "start_logit": -5.058302402496338,
            "end_logit": -2.625347375869751,
            "question_text": "List clinical trials for prevention of sarcopenia"
        }
    ],
    "56f96333cf1c325851000004": [
        {
            "text": "disulfide bonds",
            "probability": 0.45494821137971087,
            "start_logit": 4.69482946395874,
            "end_logit": 3.9799704551696777,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide",
            "probability": 0.23060705420076755,
            "start_logit": 4.69482946395874,
            "end_logit": 3.300502061843872,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide crosslinks, which are insusceptible to water. Thus, the controlled cleavage of disulfide",
            "probability": 0.1510407815216853,
            "start_logit": 4.271664142608643,
            "end_logit": 3.300502061843872,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen bonds",
            "probability": 0.10419545301048554,
            "start_logit": 3.4064900875091553,
            "end_logit": 3.7943947315216064,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide crosslink",
            "probability": 0.020681183574205342,
            "start_logit": 4.271664142608643,
            "end_logit": 1.3121764659881592,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen",
            "probability": 0.01249751402458211,
            "start_logit": 3.4064900875091553,
            "end_logit": 1.6736559867858887,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide crosslinks",
            "probability": 0.006339780654523426,
            "start_logit": 4.271664142608643,
            "end_logit": 0.1297963559627533,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "crosslinks, which are insusceptible to water. Thus, the controlled cleavage of disulfide bonds",
            "probability": 0.005838420510298914,
            "start_logit": 0.33910617232322693,
            "end_logit": 3.9799704551696777,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "hydrogen bonds and ionic",
            "probability": 0.0036702858539012953,
            "start_logit": 3.4064900875091553,
            "end_logit": 0.4483957886695862,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "crosslinks, which are insusceptible to water. Thus, the controlled cleavage of disulfide",
            "probability": 0.0029594158662196654,
            "start_logit": 0.33910617232322693,
            "end_logit": 3.300502061843872,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "ionic",
            "probability": 0.002205400216577162,
            "start_logit": 2.897129535675049,
            "end_logit": 0.4483957886695862,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "di",
            "probability": 0.0008526018823399446,
            "start_logit": 4.69482946395874,
            "end_logit": -2.299675703048706,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "sulfide crosslinks, which are insusceptible to water. Thus, the controlled cleavage of disulfide bonds",
            "probability": 0.0008220368508721622,
            "start_logit": -1.6213241815567017,
            "end_logit": 3.9799704551696777,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "sulfide bonds",
            "probability": 0.0007278874611570162,
            "start_logit": -1.7429629564285278,
            "end_logit": 3.9799704551696777,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide crosslinks, which are insusceptible to water. Thus, the controlled cleavage of di",
            "probability": 0.0005584289478125452,
            "start_logit": 4.271664142608643,
            "end_logit": -2.299675703048706,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide cross",
            "probability": 0.0005200599982097203,
            "start_logit": 4.271664142608643,
            "end_logit": -2.370858907699585,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "sulfide crosslinks, which are insusceptible to water. Thus, the controlled cleavage of disulfide",
            "probability": 0.0004166792876253059,
            "start_logit": -1.6213241815567017,
            "end_logit": 3.300502061843872,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "crosslink",
            "probability": 0.000405216539434534,
            "start_logit": 0.33910617232322693,
            "end_logit": 1.3121764659881592,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "sulfide",
            "probability": 0.00036895624382837376,
            "start_logit": -1.7429629564285278,
            "end_logit": 3.300502061843872,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulfide crosslinks,",
            "probability": 0.00034463197576316236,
            "start_logit": 4.271664142608643,
            "end_logit": -2.7823259830474854,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        }
    ],
    "54c90dabf693c3b16b000004": [
        {
            "text": "sarcoplasmic reticulum calcium-ATPase",
            "probability": 0.6613869546155361,
            "start_logit": 4.056008815765381,
            "end_logit": 3.45953106880188,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium-ATPase",
            "probability": 0.27981826539049837,
            "start_logit": 3.045445680618286,
            "end_logit": 3.6098954677581787,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "ATPase",
            "probability": 0.01758159068259505,
            "start_logit": 0.27815771102905273,
            "end_logit": 3.6098954677581787,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium",
            "probability": 0.014279303263867726,
            "start_logit": 3.846673011779785,
            "end_logit": -0.16666103899478912,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium",
            "probability": 0.006408234689274002,
            "start_logit": 3.045445680618286,
            "end_logit": -0.16666103899478912,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Intracoronary sarcoplasmic reticulum calcium-ATPase",
            "probability": 0.005566116542981648,
            "start_logit": -0.871997058391571,
            "end_logit": 3.6098954677581787,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "intracoronary sarcoplasmic reticulum calcium-ATPase",
            "probability": 0.00406991598538673,
            "start_logit": -1.0347079038619995,
            "end_logit": 3.45953106880188,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium-ATPase gene",
            "probability": 0.0026634199890687963,
            "start_logit": 4.056008815765381,
            "end_logit": -2.05519700050354,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium-ATPase gene therapy",
            "probability": 0.0024139203753405568,
            "start_logit": 3.846673011779785,
            "end_logit": -1.9442200660705566,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sa",
            "probability": 0.0014769300182384366,
            "start_logit": 4.056008815765381,
            "end_logit": -2.6448423862457275,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium-ATPase gene therapy",
            "probability": 0.001083313940501934,
            "start_logit": 3.045445680618286,
            "end_logit": -1.9442200660705566,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium-ATPase gene",
            "probability": 0.0010667071511338215,
            "start_logit": 3.045445680618286,
            "end_logit": -1.9596683979034424,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium-ATPase gene therapy may improve the function of cardiac muscle cells. This study aimed to test the hypothesis that intracoronary sa",
            "probability": 0.000537623104413525,
            "start_logit": 3.045445680618286,
            "end_logit": -2.6448423862457275,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum",
            "probability": 0.0004295297323638927,
            "start_logit": 4.056008815765381,
            "end_logit": -3.8798723220825195,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "e",
            "probability": 0.00035922255202866055,
            "start_logit": -3.6125078201293945,
            "end_logit": 3.6098954677581787,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium-ATPas",
            "probability": 0.00029969883654239405,
            "start_logit": 4.056008815765381,
            "end_logit": -4.239785194396973,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic reticulum calcium-AT",
            "probability": 0.0001951647346396775,
            "start_logit": 4.056008815765381,
            "end_logit": -4.668719291687012,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Intracoronary sarcoplasmic reticulum calcium",
            "probability": 0.00012747195421821121,
            "start_logit": -0.871997058391571,
            "end_logit": -0.16666103899478912,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "This study aimed to test the hypothesis that intracoronary sarcoplasmic reticulum calcium-ATPase",
            "probability": 0.00011847252564330063,
            "start_logit": -4.571404457092285,
            "end_logit": 3.45953106880188,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "calcium-ATPas",
            "probability": 0.00011814391572736068,
            "start_logit": 3.045445680618286,
            "end_logit": -4.160096645355225,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        }
    ],
    "52f8995b2059c6d71c00004a": [
        {
            "text": "BTBD9",
            "probability": 0.9828314886194895,
            "start_logit": 4.397864818572998,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 to a higher risk of RLS. Knockout of BTBD9",
            "probability": 0.007137144712674179,
            "start_logit": 4.397864818572998,
            "end_logit": -1.1340727806091309,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "polymorphisms in BTBD9",
            "probability": 0.005269651624312361,
            "start_logit": -0.830608606338501,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 to a higher risk of RLS.",
            "probability": 0.0018303558182428117,
            "start_logit": 4.397864818572998,
            "end_logit": -2.494875192642212,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 to a higher risk of RLS",
            "probability": 0.0008132711465632163,
            "start_logit": 4.397864818572998,
            "end_logit": -3.3060762882232666,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 to a higher risk",
            "probability": 0.0003757226908523184,
            "start_logit": 4.397864818572998,
            "end_logit": -4.07828950881958,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "studies have linked polymorphisms in BTBD9",
            "probability": 0.0003649294183155113,
            "start_logit": -3.500624179840088,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "Genetic studies have linked polymorphisms in BTBD9",
            "probability": 0.00034218946026862526,
            "start_logit": -3.5649635791778564,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "9",
            "probability": 0.0002882276529194194,
            "start_logit": -3.7365775108337402,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "B",
            "probability": 0.00028793608906568444,
            "start_logit": 4.397864818572998,
            "end_logit": -4.344402313232422,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "linked polymorphisms in BTBD9",
            "probability": 0.0002576898168408433,
            "start_logit": -3.848571538925171,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "in BTBD9",
            "probability": 7.736622381899467e-05,
            "start_logit": -5.0517778396606445,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "s in BTBD9",
            "probability": 4.734887085418257e-05,
            "start_logit": -5.542785167694092,
            "end_logit": 3.7910521030426025,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "polymorphisms in BTBD9 to a higher risk of RLS. Knockout of BTBD9",
            "probability": 3.8267258084012154e-05,
            "start_logit": -0.830608606338501,
            "end_logit": -1.1340727806091309,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "BTBD9 homolog in mice (Btbd9",
            "probability": 1.2558710021276458e-05,
            "start_logit": 0.08745468407869339,
            "end_logit": -3.166316270828247,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "polymorphisms in BTBD9 to a higher risk of RLS.",
            "probability": 9.813826299176579e-06,
            "start_logit": -0.830608606338501,
            "end_logit": -2.494875192642212,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "polymorphisms",
            "probability": 6.542572586969083e-06,
            "start_logit": -0.830608606338501,
            "end_logit": -2.900336980819702,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "polymorphisms in BTBD9 to a higher risk of RLS",
            "probability": 4.360519242737096e-06,
            "start_logit": -0.830608606338501,
            "end_logit": -3.3060762882232666,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "studies have linked polymorphisms in BTBD9 to a higher risk of RLS. Knockout of BTBD9",
            "probability": 2.650051507902172e-06,
            "start_logit": -3.500624179840088,
            "end_logit": -1.1340727806091309,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "Genetic studies have linked polymorphisms in BTBD9 to a higher risk of RLS. Knockout of BTBD9",
            "probability": 2.4849180407513245e-06,
            "start_logit": -3.5649635791778564,
            "end_logit": -1.1340727806091309,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        }
    ],
    "52bf1dea03868f1b06000012": [
        {
            "text": "anhedonia",
            "probability": 0.3850306272058938,
            "start_logit": 6.490755081176758,
            "end_logit": 6.791991710662842,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhedonia",
            "probability": 0.3256116980950972,
            "start_logit": 6.3231377601623535,
            "end_logit": 6.791991710662842,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation",
            "probability": 0.28633369397621067,
            "start_logit": 6.3231377601623535,
            "end_logit": 6.6634440422058105,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhedonia)",
            "probability": 0.0009803728655848826,
            "start_logit": 6.490755081176758,
            "end_logit": 0.8188465237617493,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhedonia)",
            "probability": 0.0008290791718206558,
            "start_logit": 6.3231377601623535,
            "end_logit": 0.8188465237617493,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "dation or anhedonia",
            "probability": 0.0002807904845721055,
            "start_logit": -0.7327142953872681,
            "end_logit": 6.791991710662842,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "dation",
            "probability": 0.00024691918979342025,
            "start_logit": -0.7327142953872681,
            "end_logit": 6.6634440422058105,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhedonia) than classic KOP-r full agonists. We have recently found that NFF reduces excessive alcohol drinking",
            "probability": 0.00021398610536272456,
            "start_logit": 6.490755081176758,
            "end_logit": -0.7031753659248352,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhedonia) than classic KOP-r full agonists. We have recently found that NFF reduces excessive alcohol drinking",
            "probability": 0.00018096321230740413,
            "start_logit": 6.3231377601623535,
            "end_logit": -0.7031753659248352,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "onia",
            "probability": 8.752490395163484e-05,
            "start_logit": -1.8983997106552124,
            "end_logit": 6.791991710662842,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "hedonia",
            "probability": 4.14246213052273e-05,
            "start_logit": -2.6464476585388184,
            "end_logit": 6.791991710662842,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "se",
            "probability": 4.123689268617206e-05,
            "start_logit": 6.3231377601623535,
            "end_logit": -2.182135820388794,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "an",
            "probability": 3.131515564458087e-05,
            "start_logit": 6.490755081176758,
            "end_logit": -2.6249842643737793,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or an",
            "probability": 2.648251927265947e-05,
            "start_logit": 6.3231377601623535,
            "end_logit": -2.6249842643737793,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhed",
            "probability": 1.86826943605287e-05,
            "start_logit": 6.490755081176758,
            "end_logit": -3.141488790512085,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhed",
            "probability": 1.5799532312192977e-05,
            "start_logit": 6.3231377601623535,
            "end_logit": -3.141488790512085,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fewer side effects (e.g., sedation or anhedonia",
            "probability": 1.2777228220796771e-05,
            "start_logit": -3.8226585388183594,
            "end_logit": 6.791991710662842,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "fewer side effects (e.g., sedation",
            "probability": 1.1235932175168104e-05,
            "start_logit": -3.8226585388183594,
            "end_logit": 6.6634440422058105,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "anhedonia) than classic KOP-r full agonists. We have recently found that NFF reduces excessive alcohol",
            "probability": 2.9204526427326053e-06,
            "start_logit": 6.490755081176758,
            "end_logit": -4.997347831726074,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "sedation or anhedonia) than classic KOP-r full agonists. We have recently found that NFF reduces excessive alcohol",
            "probability": 2.4697607852841524e-06,
            "start_logit": 6.3231377601623535,
            "end_logit": -4.997347831726074,
            "question_text": "What are the side effects of Nalmefene?"
        }
    ],
    "530cf4d5e2bfff940c000004": [
        {
            "text": "protein-protein interaction (PPI) networks",
            "probability": 0.40039529983942956,
            "start_logit": 2.5410428047180176,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction",
            "probability": 0.38665739134414306,
            "start_logit": 2.5410428047180176,
            "end_logit": 0.9177326560020447,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI) networks.",
            "probability": 0.04122236763817944,
            "start_logit": 2.5410428047180176,
            "end_logit": -1.3208253383636475,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI)",
            "probability": 0.029090901090911444,
            "start_logit": 2.5410428047180176,
            "end_logit": -1.6693809032440186,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "networks",
            "probability": 0.0276423060342169,
            "start_logit": -0.13206207752227783,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein",
            "probability": 0.02410816391468265,
            "start_logit": 2.5410428047180176,
            "end_logit": -1.8572558164596558,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "interaction (PPI) networks",
            "probability": 0.014379081112660997,
            "start_logit": -0.7856350541114807,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "interaction",
            "probability": 0.01388572242275815,
            "start_logit": -0.7856350541114807,
            "end_logit": 0.9177326560020447,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "PPI) networks",
            "probability": 0.013146917202573969,
            "start_logit": -0.8752222061157227,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "(PPI) networks",
            "probability": 0.010679628344589104,
            "start_logit": -1.0830714702606201,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI) networks. Integrating functional information/similarity into disease-related PPI networks",
            "probability": 0.008576076715678178,
            "start_logit": 2.5410428047180176,
            "end_logit": -2.8908298015594482,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "protein-protein interaction (PPI) networks. Integrating functional information/similarity into disease-related PPI networks could improve the performance of prioritization",
            "probability": 0.006009860067473253,
            "start_logit": 2.5410428047180176,
            "end_logit": -3.2464048862457275,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Many methods have been developed to prioritize candidate genes in protein-protein interaction (PPI) networks",
            "probability": 0.004251198483213234,
            "start_logit": -2.004208564758301,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "Many methods have been developed to prioritize candidate genes in protein-protein interaction",
            "probability": 0.004105336192169594,
            "start_logit": -2.004208564758301,
            "end_logit": 0.9177326560020447,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "methods have been developed to prioritize candidate genes in protein-protein interaction (PPI) networks",
            "probability": 0.0037863823907587405,
            "start_logit": -2.1199984550476074,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "methods have been developed to prioritize candidate genes in protein-protein interaction",
            "probability": 0.0036564683412350124,
            "start_logit": -2.1199984550476074,
            "end_logit": 0.9177326560020447,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "networks.",
            "probability": 0.002845890803829418,
            "start_logit": -0.13206207752227783,
            "end_logit": -1.3208253383636475,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "in protein-protein interaction (PPI) networks",
            "probability": 0.002075924192331364,
            "start_logit": -2.7210030555725098,
            "end_logit": 0.9526459574699402,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "in protein-protein interaction",
            "probability": 0.002004697440646625,
            "start_logit": -2.7210030555725098,
            "end_logit": 0.9177326560020447,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "interaction (PPI) networks.",
            "probability": 0.0014803864285195664,
            "start_logit": -0.7856350541114807,
            "end_logit": -1.3208253383636475,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        }
    ],
    "55439140ed966d112c00000a": [
        {
            "text": "PBPs",
            "probability": 0.39373674217333043,
            "start_logit": -2.311816692352295,
            "end_logit": -1.3221441507339478,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(PBPs",
            "probability": 0.22611326061431622,
            "start_logit": -2.8664631843566895,
            "end_logit": -1.3221441507339478,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycobiliproteins (PBPs",
            "probability": 0.10498106550767358,
            "start_logit": -3.6337192058563232,
            "end_logit": -1.3221441507339478,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs)",
            "probability": 0.10076592596152363,
            "start_logit": -2.311816692352295,
            "end_logit": -2.6850264072418213,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(PBPs)",
            "probability": 0.05786737593300528,
            "start_logit": -2.8664631843566895,
            "end_logit": -2.6850264072418213,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycobiliproteins (PBPs)",
            "probability": 0.026866972627236387,
            "start_logit": -3.6337192058563232,
            "end_logit": -2.6850264072418213,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "phycobiliproteins",
            "probability": 0.012552657568421825,
            "start_logit": -3.6337192058563232,
            "end_logit": -3.4459917545318604,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are a class of water-soluble macromolecules of cyanobacteria",
            "probability": 0.008828002991229685,
            "start_logit": -2.311816692352295,
            "end_logit": -5.119897842407227,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": ")",
            "probability": 0.00801364652844792,
            "start_logit": -4.843471050262451,
            "end_logit": -2.6850264072418213,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "among which phycobiliproteins (PBPs",
            "probability": 0.007187694078616333,
            "start_logit": -6.315128803253174,
            "end_logit": -1.3221441507339478,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(",
            "probability": 0.0071528684918073055,
            "start_logit": -2.8664631843566895,
            "end_logit": -4.7756667137146,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are a class of water-soluble macromolecules of cyanobacteria with a wide range of applications",
            "probability": 0.0065583160446730975,
            "start_logit": -2.311816692352295,
            "end_logit": -5.417092800140381,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are a class of water-soluble macromolecules",
            "probability": 0.006405433679805133,
            "start_logit": -2.311816692352295,
            "end_logit": -5.440680027008057,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "bioactive metabolites, among which phycobiliproteins (PBPs",
            "probability": 0.0055935926535036215,
            "start_logit": -6.565877437591553,
            "end_logit": -1.3221441507339478,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "ins (PBPs",
            "probability": 0.005231216209657851,
            "start_logit": -6.632855415344238,
            "end_logit": -1.3221441507339478,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(PBPs) are a class of water-soluble macromolecules of cyanobacteria",
            "probability": 0.005069703503010005,
            "start_logit": -2.8664631843566895,
            "end_logit": -5.119897842407227,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "source of bioactive metabolites, among which phycobiliproteins (PBPs",
            "probability": 0.0046624720780842725,
            "start_logit": -6.747953414916992,
            "end_logit": -1.3221441507339478,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are a class of water-soluble macromolecules of cyanobacteria with a wide range of applications.",
            "probability": 0.004303354498344969,
            "start_logit": -2.311816692352295,
            "end_logit": -5.8384318351745605,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are a class",
            "probability": 0.004284597131264907,
            "start_logit": -2.311816692352295,
            "end_logit": -5.842800140380859,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "PBPs) are",
            "probability": 0.0038251017260476647,
            "start_logit": -2.311816692352295,
            "end_logit": -5.956241607666016,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        }
    ],
    "554143ad182542114d000004": [
        {
            "text": "consensus methods",
            "probability": 0.7804434344936156,
            "start_logit": 1.8512340784072876,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus",
            "probability": 0.15212287546761388,
            "start_logit": 1.8512340784072876,
            "end_logit": 0.79167640209198,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology prediction methods",
            "probability": 0.025417044000912135,
            "start_logit": 1.8512340784072876,
            "end_logit": -0.9975922107696533,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "methods",
            "probability": 0.010693493226010006,
            "start_logit": -2.438992738723755,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology prediction",
            "probability": 0.005248468494035598,
            "start_logit": 1.8512340784072876,
            "end_logit": -2.57507586479187,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "methods, consensus methods",
            "probability": 0.004947302535166162,
            "start_logit": -3.2097856998443604,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "transmembrane helix prediction methods, consensus methods",
            "probability": 0.004094435969066741,
            "start_logit": -3.3989992141723633,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "different transmembrane helix prediction methods, consensus methods",
            "probability": 0.0031614194094300276,
            "start_logit": -3.657607078552246,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "prediction methods, consensus methods",
            "probability": 0.0027466023416985556,
            "start_logit": -3.7982635498046875,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology",
            "probability": 0.0019154226992805544,
            "start_logit": 1.8512340784072876,
            "end_logit": -3.583073854446411,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods, topology prediction methods which can enable topology prediction",
            "probability": 0.0015146526682230691,
            "start_logit": 1.8512340784072876,
            "end_logit": -3.81782603263855,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "consensus methods,",
            "probability": 0.0013774320485475894,
            "start_logit": 1.8512340784072876,
            "end_logit": -3.9127912521362305,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "helix prediction methods, consensus methods",
            "probability": 0.0012660954281808973,
            "start_logit": -4.572690486907959,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "methods, consensus",
            "probability": 0.0009643208645172467,
            "start_logit": -3.2097856998443604,
            "end_logit": 0.79167640209198,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "transmembrane helix prediction methods, consensus",
            "probability": 0.0007980813797691754,
            "start_logit": -3.3989992141723633,
            "end_logit": 0.79167640209198,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "review, we discuss different transmembrane helix prediction methods, consensus methods",
            "probability": 0.000760485039546052,
            "start_logit": -5.082427024841309,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": ", consensus methods",
            "probability": 0.0007368171432692511,
            "start_logit": -5.114043712615967,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "discuss different transmembrane helix prediction methods, consensus methods",
            "probability": 0.0006291734623822488,
            "start_logit": -5.271976470947266,
            "end_logit": 2.4268500804901123,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "different transmembrane helix prediction methods, consensus",
            "probability": 0.0006162191772856226,
            "start_logit": -3.657607078552246,
            "end_logit": 0.79167640209198,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "topology prediction methods",
            "probability": 0.0005462241514494428,
            "start_logit": -1.988911747932434,
            "end_logit": -0.9975922107696533,
            "question_text": "List available methods for transmembrane protein topology prediction."
        }
    ],
    "5319abffb166e2b80600002f": [
        {
            "text": "transforming growth factor \u03b21",
            "probability": 0.7342706736118755,
            "start_logit": 5.391692638397217,
            "end_logit": 3.427650213241577,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21)",
            "probability": 0.15862719276535003,
            "start_logit": 5.391692638397217,
            "end_logit": 1.895329236984253,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b2",
            "probability": 0.059271305621081266,
            "start_logit": 5.391692638397217,
            "end_logit": 0.9108977913856506,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21",
            "probability": 0.02339707488019548,
            "start_logit": 5.391692638397217,
            "end_logit": -0.018616503104567528,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21). The majority of studies on TGF\u03b21",
            "probability": 0.010622106294781903,
            "start_logit": 5.391692638397217,
            "end_logit": -0.8082901835441589,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming",
            "probability": 0.005479284472986433,
            "start_logit": 5.391692638397217,
            "end_logit": -1.4702529907226562,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "TGF\u03b21)",
            "probability": 0.002176871410161562,
            "start_logit": 1.1030246019363403,
            "end_logit": 1.895329236984253,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (",
            "probability": 0.0019860343854621,
            "start_logit": 5.391692638397217,
            "end_logit": -2.4850876331329346,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor",
            "probability": 0.0019077551718952352,
            "start_logit": 5.391692638397217,
            "end_logit": -2.5253002643585205,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "TGF\u03b21",
            "probability": 0.0006543688475959077,
            "start_logit": 1.3041961193084717,
            "end_logit": 0.49218490719795227,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth",
            "probability": 0.0005887623561578089,
            "start_logit": 5.391692638397217,
            "end_logit": -3.700960159301758,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "transforming growth factor \u03b21 (TGF\u03b21).",
            "probability": 0.0003219928751902955,
            "start_logit": 5.391692638397217,
            "end_logit": -4.304453372955322,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "growth factor \u03b21",
            "probability": 0.00019448600230178786,
            "start_logit": -2.8445801734924316,
            "end_logit": 3.427650213241577,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "TGF\u03b21). The majority of studies on TGF\u03b21",
            "probability": 0.00014576920328542045,
            "start_logit": 1.1030246019363403,
            "end_logit": -0.8082901835441589,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "(TGF\u03b21)",
            "probability": 0.00010911360300606821,
            "start_logit": -1.8902298212051392,
            "end_logit": 1.895329236984253,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "\u03b21",
            "probability": 6.971119245118738e-05,
            "start_logit": -3.870579481124878,
            "end_logit": 3.427650213241577,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "triggered by many factors including transforming growth factor \u03b21",
            "probability": 5.9476910490304195e-05,
            "start_logit": -4.029352188110352,
            "end_logit": 3.427650213241577,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "1",
            "probability": 5.11733318520881e-05,
            "start_logit": -4.179721832275391,
            "end_logit": 3.427650213241577,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "growth factor \u03b21 (TGF\u03b21)",
            "probability": 4.201552599878893e-05,
            "start_logit": -2.8445801734924316,
            "end_logit": 1.895329236984253,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "by many factors including transforming growth factor \u03b21",
            "probability": 2.4831537880614323e-05,
            "start_logit": -4.902825832366943,
            "end_logit": 3.427650213241577,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        }
    ],
    "5171651e8ed59a060a000009": [
        {
            "text": "prostate cancer has recently been challenged due to poor sensitivity. In addition to prostate cancer",
            "probability": 0.3906193350131532,
            "start_logit": 0.49738356471061707,
            "end_logit": -2.982989549636841,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer",
            "probability": 0.16250408104820324,
            "start_logit": -0.37964683771133423,
            "end_logit": -2.982989549636841,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer, a number of conditions elevate prostate specific antigen,",
            "probability": 0.12321512465308088,
            "start_logit": -0.37964683771133423,
            "end_logit": -3.259760856628418,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer, a number of conditions elevate prostate specific antigen, of which benign prostatic hyperplasia",
            "probability": 0.06875883452449048,
            "start_logit": -0.37964683771133423,
            "end_logit": -3.8430874347686768,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostatic hyperplasia",
            "probability": 0.05176796635978475,
            "start_logit": -0.6634805202484131,
            "end_logit": -3.8430874347686768,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer, a number of conditions elevate prostate specific antigen",
            "probability": 0.0360136636014156,
            "start_logit": -0.37964683771133423,
            "end_logit": -4.4897942543029785,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "pro",
            "probability": 0.028185239512569526,
            "start_logit": 0.49738356471061707,
            "end_logit": -5.611924648284912,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer has recently been challenged due to poor sensitivity. In addition to prostate cancer,",
            "probability": 0.021355681509001807,
            "start_logit": 0.49738356471061707,
            "end_logit": -5.889405250549316,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate specific antigen,",
            "probability": 0.01718185895229374,
            "start_logit": -2.349724531173706,
            "end_logit": -3.259760856628418,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate specific antigen density for prostate cancer risk following holmium laser enucleation of the prostate.",
            "probability": 0.014728753728457503,
            "start_logit": -0.8913631439208984,
            "end_logit": -4.8721747398376465,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer has recently been challenged due to poor sensitivity. In addition to prostate",
            "probability": 0.012235505055194258,
            "start_logit": 0.49738356471061707,
            "end_logit": -6.446381092071533,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer has recently been challenged due to poor sensitivity. In addition to pro",
            "probability": 0.01209389705861101,
            "start_logit": 0.49738356471061707,
            "end_logit": -6.458022117614746,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate specific antigen, of which benign prostatic hyperplasia",
            "probability": 0.009588145934601876,
            "start_logit": -2.349724531173706,
            "end_logit": -3.8430874347686768,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "benign prostatic hyperplasia",
            "probability": 0.009208537888445872,
            "start_logit": -2.3901209831237793,
            "end_logit": -3.8430874347686768,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer, a number of conditions elevate prostate specific antigen, of which benign pro",
            "probability": 0.008916208907938592,
            "start_logit": -0.37964683771133423,
            "end_logit": -5.88582181930542,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate cancer,",
            "probability": 0.008884315464470256,
            "start_logit": -0.37964683771133423,
            "end_logit": -5.889405250549316,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostatic hyperplasia is most common. The objective of this study was to assess the positive predictive value of prostate specific antigen",
            "probability": 0.007236996337817502,
            "start_logit": -0.6634805202484131,
            "end_logit": -5.810652732849121,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostatic hyperplasia is most common.",
            "probability": 0.006444398601216317,
            "start_logit": -0.6634805202484131,
            "end_logit": -5.926647663116455,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "prostate specific antigen",
            "probability": 0.005667690232380109,
            "start_logit": -0.8913631439208984,
            "end_logit": -5.827194690704346,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Prostate specific antigen screening for prostate cancer has recently been challenged due to poor sensitivity. In addition to prostate cancer",
            "probability": 0.005393765616873688,
            "start_logit": -3.7851061820983887,
            "end_logit": -2.982989549636841,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        }
    ],
    "55414c65472cfd8617000001": [
        {
            "text": "MLBioMedLAT",
            "probability": 0.33727428745324045,
            "start_logit": 1.8611255884170532,
            "end_logit": 0.42218759655952454,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA",
            "probability": 0.2719265661586906,
            "start_logit": 1.8611255884170532,
            "end_logit": 0.20682314038276672,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA",
            "probability": 0.17558455894141478,
            "start_logit": 1.423714280128479,
            "end_logit": 0.20682314038276672,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT)",
            "probability": 0.05176177322121663,
            "start_logit": 1.8611255884170532,
            "end_logit": -1.4520570039749146,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMed",
            "probability": 0.023646751366151533,
            "start_logit": 1.8611255884170532,
            "end_logit": -2.235483169555664,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA)",
            "probability": 0.023553488817357738,
            "start_logit": 1.8611255884170532,
            "end_logit": -2.2394349575042725,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering",
            "probability": 0.018085749157057296,
            "start_logit": 1.8611255884170532,
            "end_logit": -2.503584623336792,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA) system",
            "probability": 0.01745748059182537,
            "start_logit": 1.8611255884170532,
            "end_logit": -2.538940668106079,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA)",
            "probability": 0.015208624166253173,
            "start_logit": 1.423714280128479,
            "end_logit": -2.2394349575042725,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA) system",
            "probability": 0.011272396343044848,
            "start_logit": 1.423714280128479,
            "end_logit": -2.538940668106079,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA system",
            "probability": 0.00816230120364012,
            "start_logit": 0.9465150833129883,
            "end_logit": -2.3845722675323486,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "(OAQA",
            "probability": 0.00742300319643468,
            "start_logit": -1.7398227453231812,
            "end_logit": 0.20682314038276672,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA) system for the task of biomedical question classification. We use 780 biomedical questions from BioASQ challenge",
            "probability": 0.0066050461524810415,
            "start_logit": 1.423714280128479,
            "end_logit": -3.0734636783599854,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "multi-labeled corpus (MLBioMedLAT",
            "probability": 0.00625637684435867,
            "start_logit": -2.1261696815490723,
            "end_logit": 0.42218759655952454,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "(MLBioMedLAT",
            "probability": 0.006217681639066839,
            "start_logit": -2.132373809814453,
            "end_logit": 0.42218759655952454,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "OAQA) system for the task of biomedical question classification. We use 780 biomedical questions from BioASQ",
            "probability": 0.005223905500969587,
            "start_logit": 1.423714280128479,
            "end_logit": -3.3080523014068604,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "multi-labeled corpus (MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA",
            "probability": 0.005044188469650423,
            "start_logit": -2.1261696815490723,
            "end_logit": 0.20682314038276672,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "(MLBioMedLAT) by exploring the process of Open Advancement of Question Answering (OAQA",
            "probability": 0.005012990555391181,
            "start_logit": -2.132373809814453,
            "end_logit": 0.20682314038276672,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Question Answering (OAQA",
            "probability": 0.0025798770667647634,
            "start_logit": -2.7966647148132324,
            "end_logit": 0.20682314038276672,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "a multi-labeled corpus (MLBioMedLAT",
            "probability": 0.0017029531549904234,
            "start_logit": -3.4274070262908936,
            "end_logit": 0.42218759655952454,
            "question_text": "List available biomedical question answering systems."
        }
    ],
    "530e1c985937551c09000004": [
        {
            "text": "coronary syndrome",
            "probability": 0.3031211024563404,
            "start_logit": -2.6889662742614746,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary syndromes",
            "probability": 0.16256984123662446,
            "start_logit": -2.6889662742614746,
            "end_logit": -3.735548496246338,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary syndrome",
            "probability": 0.10754280614567366,
            "start_logit": -3.7252097129821777,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary",
            "probability": 0.07219912029704227,
            "start_logit": -2.6889662742614746,
            "end_logit": -4.5472283363342285,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary syndromes",
            "probability": 0.05767733351313414,
            "start_logit": -3.7252097129821777,
            "end_logit": -3.735548496246338,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "coronary syndromes in the emergency department.",
            "probability": 0.03701364011707914,
            "start_logit": -2.6889662742614746,
            "end_logit": -5.215369701385498,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "symptoms of acute coronary syndrome",
            "probability": 0.03311117609948092,
            "start_logit": -4.903227806091309,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "describe barriers and lessons learned in launching a multisite clinical research study of symptoms of acute coronary syndrome",
            "probability": 0.027777278543651494,
            "start_logit": -5.078880310058594,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "multisite clinical research study of symptoms of acute coronary syndrome",
            "probability": 0.026856013661916582,
            "start_logit": -5.112608909606934,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary",
            "probability": 0.025615161514897622,
            "start_logit": -3.7252097129821777,
            "end_logit": -4.5472283363342285,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "clinical research study of symptoms of acute coronary syndrome",
            "probability": 0.023059884818669305,
            "start_logit": -5.2650041580200195,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "symptoms of acute coronary syndromes",
            "probability": 0.01775817849047921,
            "start_logit": -4.903227806091309,
            "end_logit": -3.735548496246338,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "describe barriers and lessons learned in launching a multisite clinical research study of symptoms of acute coronary syndromes",
            "probability": 0.014897503757519944,
            "start_logit": -5.078880310058594,
            "end_logit": -3.735548496246338,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "syndrome",
            "probability": 0.014843659478161892,
            "start_logit": -5.705525875091553,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "multisite clinical research study of symptoms of acute coronary syndromes",
            "probability": 0.01440341118413306,
            "start_logit": -5.112608909606934,
            "end_logit": -3.735548496246338,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "acute coronary syndromes in the emergency department.",
            "probability": 0.013131882576304973,
            "start_logit": -3.7252097129821777,
            "end_logit": -5.215369701385498,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "launching a multisite clinical research study of symptoms of acute coronary syndrome",
            "probability": 0.012631135728035203,
            "start_logit": -5.866933822631836,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "clinical research study of symptoms of acute coronary syndromes",
            "probability": 0.01236747221993848,
            "start_logit": -5.2650041580200195,
            "end_logit": -3.735548496246338,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "research study of symptoms of acute coronary syndrome",
            "probability": 0.012080959872238973,
            "start_logit": -5.911468029022217,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "lessons learned in launching a multisite clinical research study of symptoms of acute coronary syndrome",
            "probability": 0.011342438288678246,
            "start_logit": -5.974547386169434,
            "end_logit": -3.1125237941741943,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        }
    ],
    "5713b0a51174fb175500000e": [
        {
            "text": "Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.14354346925999306,
            "start_logit": 4.012527942657471,
            "end_logit": 4.092156887054443,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness",
            "probability": 0.1195519010210453,
            "start_logit": 3.807178258895874,
            "end_logit": 4.114619255065918,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts Syndrome",
            "probability": 0.11804281704199815,
            "start_logit": 3.8169374465942383,
            "end_logit": 4.092156887054443,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.11689641809403535,
            "start_logit": 3.807178258895874,
            "end_logit": 4.092156887054443,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.09632692671435017,
            "start_logit": 3.5911755561828613,
            "end_logit": 4.114619255065918,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.09418731615929704,
            "start_logit": 3.5911755561828613,
            "end_logit": 4.092156887054443,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease-5",
            "probability": 0.0883953997516135,
            "start_logit": 4.012527942657471,
            "end_logit": 3.6073389053344727,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease-5",
            "probability": 0.0719858984893152,
            "start_logit": 3.807178258895874,
            "end_logit": 3.6073389053344727,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease-5",
            "probability": 0.058001422888509804,
            "start_logit": 3.5911755561828613,
            "end_logit": 3.6073389053344727,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease",
            "probability": 0.026546472326909643,
            "start_logit": 4.012527942657471,
            "end_logit": 2.4044158458709717,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease",
            "probability": 0.021618451497974603,
            "start_logit": 3.807178258895874,
            "end_logit": 2.4044158458709717,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease",
            "probability": 0.01741870246594031,
            "start_logit": 3.5911755561828613,
            "end_logit": 2.4044158458709717,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness",
            "probability": 0.0078108351646592284,
            "start_logit": 1.0789395570755005,
            "end_logit": 4.114619255065918,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness, Charcot-Marie-Tooth disease-5, and Arts Syndrome",
            "probability": 0.007637341148685445,
            "start_logit": 1.0789395570755005,
            "end_logit": 4.092156887054443,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness, Charcot-Marie-Tooth disease-5",
            "probability": 0.0047031455165313825,
            "start_logit": 1.0789395570755005,
            "end_logit": 3.6073389053344727,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease-5,",
            "probability": 0.00185325105497688,
            "start_logit": 4.012527942657471,
            "end_logit": -0.2575396001338959,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness, Charcot-Marie-Tooth disease-5,",
            "probability": 0.0015092181572078573,
            "start_logit": 3.807178258895874,
            "end_logit": -0.2575396001338959,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness, Charcot-Marie-Tooth disease",
            "probability": 0.0014124255634892426,
            "start_logit": 1.0789395570755005,
            "end_logit": 2.4044158458709717,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "nonsyndromic sensorineural deafness,",
            "probability": 0.001342560622553667,
            "start_logit": 3.807178258895874,
            "end_logit": -0.3745526373386383,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness, Charcot-Marie-Tooth disease-5,",
            "probability": 0.001216027060914207,
            "start_logit": 3.5911755561828613,
            "end_logit": -0.2575396001338959,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        }
    ],
    "56c8605b5795f9a73e000014": [
        {
            "text": "Janus kinase (JAK)1/JAK2",
            "probability": 0.4109886672125004,
            "start_logit": 4.081207752227783,
            "end_logit": 3.208209753036499,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK2",
            "probability": 0.3704671833293033,
            "start_logit": 3.9774069786071777,
            "end_logit": 3.208209753036499,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)1",
            "probability": 0.06958477746208393,
            "start_logit": 4.081207752227783,
            "end_logit": 1.43218994140625,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase",
            "probability": 0.055491188965337376,
            "start_logit": 4.081207752227783,
            "end_logit": 1.2058683633804321,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "AAK1",
            "probability": 0.020931405599887286,
            "start_logit": 2.8179616928100586,
            "end_logit": 1.494140863418579,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)1/JAK",
            "probability": 0.01928990663127153,
            "start_logit": 4.081207752227783,
            "end_logit": 0.1492260992527008,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK",
            "probability": 0.017388015647344976,
            "start_logit": 3.9774069786071777,
            "end_logit": 0.1492260992527008,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "AAK",
            "probability": 0.0063776426404822196,
            "start_logit": 2.8179616928100586,
            "end_logit": 0.3056887090206146,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "AAK1, BIKE, and GAK",
            "probability": 0.005770672980866454,
            "start_logit": 2.8179616928100586,
            "end_logit": 0.20567888021469116,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK)1/JAK2",
            "probability": 0.005616999078307674,
            "start_logit": -0.21156033873558044,
            "end_logit": 3.208209753036499,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "1/JAK2",
            "probability": 0.0038991976735499034,
            "start_logit": -0.5765870809555054,
            "end_logit": 3.208209753036499,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)",
            "probability": 0.0031675128697136196,
            "start_logit": 4.081207752227783,
            "end_logit": -1.6574091911315918,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "(JAK)1/JAK2",
            "probability": 0.0029282076615815456,
            "start_logit": -0.8629673719406128,
            "end_logit": 3.208209753036499,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus",
            "probability": 0.0029091115183191504,
            "start_logit": 4.081207752227783,
            "end_logit": -1.7425081729888916,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "GAK",
            "probability": 0.0012211473659193544,
            "start_logit": 1.2649638652801514,
            "end_logit": 0.20567888021469116,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "J",
            "probability": 0.0009690982773881555,
            "start_logit": 4.081207752227783,
            "end_logit": -2.841745138168335,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK)1",
            "probability": 0.0009510180256787429,
            "start_logit": -0.21156033873558044,
            "end_logit": 1.43218994140625,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "kinase (JAK)1/JAK2",
            "probability": 0.000808206368744804,
            "start_logit": -2.1502957344055176,
            "end_logit": 3.208209753036499,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "1",
            "probability": 0.0006601758735463081,
            "start_logit": -0.5765870809555054,
            "end_logit": 1.43218994140625,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase (JAK)1/JAK2 inhibitor",
            "probability": 0.0005798648181734071,
            "start_logit": 4.081207752227783,
            "end_logit": -3.355316162109375,
            "question_text": "Which kinases does baricitinib inhibit?"
        }
    ],
    "550b0408c2af5d5b7000000c": [
        {
            "text": "shell",
            "probability": 0.47062752367392163,
            "start_logit": 2.7663283348083496,
            "end_logit": 3.2025508880615234,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic, shell",
            "probability": 0.12286040433546831,
            "start_logit": 1.4233101606369019,
            "end_logit": 3.2025508880615234,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid",
            "probability": 0.10043662316282098,
            "start_logit": 2.7663283348083496,
            "end_logit": 1.6580108404159546,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid (magnetic material dispersed in matrix",
            "probability": 0.048232090854675544,
            "start_logit": 2.7663283348083496,
            "end_logit": 0.9245085120201111,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "solid",
            "probability": 0.03112429053024395,
            "start_logit": 1.594789981842041,
            "end_logit": 1.6580108404159546,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "paramagnetic, shell",
            "probability": 0.028117095317760896,
            "start_logit": -0.05136086046695709,
            "end_logit": 3.2025508880615234,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material",
            "probability": 0.027166226957481793,
            "start_logit": 2.7663283348083496,
            "end_logit": 0.3504584729671478,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic, shell (coated with magnetic material), and solid",
            "probability": 0.026219639760004573,
            "start_logit": 1.4233101606369019,
            "end_logit": 1.6580108404159546,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "superparamagnetic/paramagnetic, shell",
            "probability": 0.024849242301850913,
            "start_logit": -0.17491136491298676,
            "end_logit": 3.2025508880615234,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid (magnetic material dispersed in matrix)",
            "probability": 0.017467500699724952,
            "start_logit": 2.7663283348083496,
            "end_logit": -0.09117402136325836,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material), and solid (magnetic material",
            "probability": 0.015415258749049355,
            "start_logit": 2.7663283348083496,
            "end_logit": -0.21615822613239288,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "solid (magnetic material dispersed in matrix",
            "probability": 0.014946635613270448,
            "start_logit": 1.594789981842041,
            "end_logit": 0.9245085120201111,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "shell (coated with magnetic material)",
            "probability": 0.014600907583627126,
            "start_logit": 2.7663283348083496,
            "end_logit": -0.27043238282203674,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic",
            "probability": 0.013780871666913379,
            "start_logit": 1.4233101606369019,
            "end_logit": 1.0147836208343506,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic, shell (coated with magnetic material), and solid (magnetic material dispersed in matrix",
            "probability": 0.012591303921392055,
            "start_logit": 1.4233101606369019,
            "end_logit": 0.9245085120201111,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic/paramagnetic, shell (coated with magnetic material",
            "probability": 0.007091921871058767,
            "start_logit": 1.4233101606369019,
            "end_logit": 0.3504584729671478,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "coated with magnetic material), and solid",
            "probability": 0.006509726331765917,
            "start_logit": 0.030098838731646538,
            "end_logit": 1.6580108404159546,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic",
            "probability": 0.006099342714066457,
            "start_logit": 1.4233101606369019,
            "end_logit": 0.19968311488628387,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "paramagnetic, shell (coated with magnetic material), and solid",
            "probability": 0.006000469511043074,
            "start_logit": -0.05136086046695709,
            "end_logit": 1.6580108404159546,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "ferromagnetic and superparamagnetic",
            "probability": 0.0058629244438599066,
            "start_logit": 1.4233101606369019,
            "end_logit": 0.16015063226222992,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        }
    ],
    "53188992b166e2b806000019": [
        {
            "text": "receptor tyrosine kinase inhibitor",
            "probability": 0.2968483959544995,
            "start_logit": 3.163353443145752,
            "end_logit": 0.783065140247345,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "receptor",
            "probability": 0.2795345807391095,
            "start_logit": 3.163353443145752,
            "end_logit": 0.7229695916175842,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "receptor tyrosine kinase",
            "probability": 0.23812062064585654,
            "start_logit": 3.163353443145752,
            "end_logit": 0.5626209378242493,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "kinase inhibitors (e.g. imatinib mesylate) and cyclo-oxygenase-2",
            "probability": 0.04323107344150646,
            "start_logit": 0.8884274959564209,
            "end_logit": 1.13132905960083,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "kinase inhibitor",
            "probability": 0.03051735719049671,
            "start_logit": 0.8884274959564209,
            "end_logit": 0.783065140247345,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "receptor tyrosine kinase inhibitors",
            "probability": 0.030112418837289705,
            "start_logit": 3.163353443145752,
            "end_logit": -1.505218744277954,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "kinase",
            "probability": 0.024479876373616025,
            "start_logit": 0.8884274959564209,
            "end_logit": 0.5626209378242493,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "KIT receptor tyrosine kinase inhibitor",
            "probability": 0.008112253535350873,
            "start_logit": -0.4364924132823944,
            "end_logit": 0.783065140247345,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "KIT receptor",
            "probability": 0.0076391027263669215,
            "start_logit": -0.4364924132823944,
            "end_logit": 0.7229695916175842,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "KIT receptor tyrosine kinase",
            "probability": 0.006507344735561181,
            "start_logit": -0.4364924132823944,
            "end_logit": 0.5626209378242493,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "receptor tyrosine",
            "probability": 0.005943117824541887,
            "start_logit": 3.163353443145752,
            "end_logit": -3.127922534942627,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "tyrosine kinase inhibitors (e.g. imatinib mesylate) and cyclo-oxygenase-2",
            "probability": 0.005150977126520362,
            "start_logit": -1.2389456033706665,
            "end_logit": 1.13132905960083,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "receptor t",
            "probability": 0.004352989254016071,
            "start_logit": 3.163353443145752,
            "end_logit": -3.439293622970581,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "inhibitors (e.g. imatinib mesylate) and cyclo-oxygenase-2",
            "probability": 0.004199579385867752,
            "start_logit": -1.4431476593017578,
            "end_logit": 1.13132905960083,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "tyrosine kinase inhibitor",
            "probability": 0.0036361393862401063,
            "start_logit": -1.2389456033706665,
            "end_logit": 0.783065140247345,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "kinase inhibitors",
            "probability": 0.0030956927982466404,
            "start_logit": 0.8884274959564209,
            "end_logit": -1.505218744277954,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "inhibitor",
            "probability": 0.0029645357833128798,
            "start_logit": -1.4431476593017578,
            "end_logit": 0.783065140247345,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "tyrosine kinase",
            "probability": 0.0029167742834596702,
            "start_logit": -1.2389456033706665,
            "end_logit": 0.5626209378242493,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "cyclo-oxygenase-2",
            "probability": 0.001814259767070953,
            "start_logit": -2.282454490661621,
            "end_logit": 1.13132905960083,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "KIT receptor tyrosine kinase inhibitors",
            "probability": 0.000822910211070207,
            "start_logit": -0.4364924132823944,
            "end_logit": -1.505218744277954,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        }
    ],
    "52ebb2c698d0239505000029": [
        {
            "text": "Pulmonary lymphangioleiomyomatosis",
            "probability": 0.6691556460284194,
            "start_logit": 5.287627696990967,
            "end_logit": 5.284307479858398,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphangioleiomyomatosis",
            "probability": 0.3129946860643345,
            "start_logit": 4.527797222137451,
            "end_logit": 5.284307479858398,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangioleiomyomatosis (PLAM)",
            "probability": 0.008754029737547265,
            "start_logit": 5.287627696990967,
            "end_logit": 0.9478049278259277,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphangioleiomyomatosis (PLAM)",
            "probability": 0.004094659898281852,
            "start_logit": 4.527797222137451,
            "end_logit": 0.9478049278259277,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangioleiomyomatosis (PLAM",
            "probability": 0.0012022531032802616,
            "start_logit": 5.287627696990967,
            "end_logit": -1.0375118255615234,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "neoplastic senescence",
            "probability": 0.0005741643184825696,
            "start_logit": 2.0664620399475098,
            "end_logit": 1.4446167945861816,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphangioleiomyomatosis (PLAM",
            "probability": 0.0005623487373445786,
            "start_logit": 4.527797222137451,
            "end_logit": -1.0375118255615234,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary",
            "probability": 0.0003796280347042993,
            "start_logit": 5.287627696990967,
            "end_logit": -2.190272569656372,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymph",
            "probability": 0.00036470088137193624,
            "start_logit": 5.287627696990967,
            "end_logit": -2.230386972427368,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "senescent cell, a state that I propose to characterize as a state of neoplastic senescence",
            "probability": 0.00034377356683933753,
            "start_logit": 1.5535296201705933,
            "end_logit": 1.4446167945861816,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphang",
            "probability": 0.0002664044477816664,
            "start_logit": 5.287627696990967,
            "end_logit": -2.5444488525390625,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "tosis",
            "probability": 0.0001989291206162153,
            "start_logit": -2.833195686340332,
            "end_logit": 5.284307479858398,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "angioleiomyomatosis",
            "probability": 0.0001911736680682174,
            "start_logit": -2.87296199798584,
            "end_logit": 5.284307479858398,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymph",
            "probability": 0.00017058727450018003,
            "start_logit": 4.527797222137451,
            "end_logit": -2.230386972427368,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary l",
            "probability": 0.00016390400699383453,
            "start_logit": 5.287627696990967,
            "end_logit": -3.0301835536956787,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangiol",
            "probability": 0.00012564256853969872,
            "start_logit": 5.287627696990967,
            "end_logit": -3.296023368835449,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphang",
            "probability": 0.00012460953889347254,
            "start_logit": 4.527797222137451,
            "end_logit": -2.5444488525390625,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "omyomatosis",
            "probability": 0.00012412172000567532,
            "start_logit": -3.3048815727233887,
            "end_logit": 5.284307479858398,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangiolei",
            "probability": 0.00011543819615114954,
            "start_logit": 5.287627696990967,
            "end_logit": -3.3807291984558105,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "ymphangioleiomyomatosis",
            "probability": 9.329908784381152e-05,
            "start_logit": -3.590333938598633,
            "end_logit": 5.284307479858398,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        }
    ],
    "57220e400fd6f91b68000015": [
        {
            "text": "fatigue",
            "probability": 0.3933156993503587,
            "start_logit": 4.265145301818848,
            "end_logit": 4.4439311027526855,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis, fatigue",
            "probability": 0.24218672550716083,
            "start_logit": 3.7802417278289795,
            "end_logit": 4.4439311027526855,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis",
            "probability": 0.11111078644509466,
            "start_logit": 3.7802417278289795,
            "end_logit": 3.66474986076355,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigue, and gait disorder",
            "probability": 0.10945842982565013,
            "start_logit": 4.265145301818848,
            "end_logit": 3.164863348007202,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis, fatigue, and gait disorder",
            "probability": 0.06739974718124705,
            "start_logit": 3.7802417278289795,
            "end_logit": 3.164863348007202,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "gait disorder",
            "probability": 0.049901686753936775,
            "start_logit": 3.4796552658081055,
            "end_logit": 3.164863348007202,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigue, and gait",
            "probability": 0.011556433808313109,
            "start_logit": 4.265145301818848,
            "end_logit": 0.9165608286857605,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis, fatigue, and gait",
            "probability": 0.007115950029959179,
            "start_logit": 3.7802417278289795,
            "end_logit": 0.9165608286857605,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "gait",
            "probability": 0.005268534737923921,
            "start_logit": 3.4796552658081055,
            "end_logit": 0.9165608286857605,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "tosis, fatigue",
            "probability": 0.0004270528085783385,
            "start_logit": -2.560314893722534,
            "end_logit": 4.4439311027526855,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis,",
            "probability": 0.00034001160720466663,
            "start_logit": 3.7802417278289795,
            "end_logit": -2.1245534420013428,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigue,",
            "probability": 0.0003003256506930492,
            "start_logit": 4.265145301818848,
            "end_logit": -2.733569383621216,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigue, and gait disorder. Based on radiologic findings thymoma",
            "probability": 0.000281510739955477,
            "start_logit": 4.265145301818848,
            "end_logit": -2.7982661724090576,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigue, and gait disorder.",
            "probability": 0.0002442777317438608,
            "start_logit": 4.265145301818848,
            "end_logit": -2.9401309490203857,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ait disorder",
            "probability": 0.00023580101266025658,
            "start_logit": -1.8751665353775024,
            "end_logit": 3.164863348007202,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "tosis",
            "probability": 0.0001959239232264308,
            "start_logit": -2.560314893722534,
            "end_logit": 3.66474986076355,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis, fatigue,",
            "probability": 0.0001849274922086596,
            "start_logit": 3.7802417278289795,
            "end_logit": -2.733569383621216,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis, fatigue, and gait disorder. Based on radiologic findings thymoma",
            "probability": 0.0001733420873296566,
            "start_logit": 3.7802417278289795,
            "end_logit": -2.7982661724090576,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "fatigue, and g",
            "probability": 0.00015241768880997985,
            "start_logit": 4.265145301818848,
            "end_logit": -3.4118120670318604,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "ptosis, fatigue, and gait disorder.",
            "probability": 0.0001504156179452752,
            "start_logit": 3.7802417278289795,
            "end_logit": -2.9401309490203857,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        }
    ],
    "5162c8a8298dcd4e51000047": [
        {
            "text": "CCR4 deadenylase family members, PDE12",
            "probability": 0.17221874812738946,
            "start_logit": 3.5946478843688965,
            "end_logit": 2.9940345287323,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4 deadenylase family members, PDE12 and CNOT6L",
            "probability": 0.1638521648435133,
            "start_logit": 3.5946478843688965,
            "end_logit": 2.9442336559295654,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT6L",
            "probability": 0.16232058176549338,
            "start_logit": 3.585256576538086,
            "end_logit": 2.9442336559295654,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12",
            "probability": 0.14898016302163944,
            "start_logit": 3.449695587158203,
            "end_logit": 2.9940345287323,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12 and CNOT6L",
            "probability": 0.14174253671719092,
            "start_logit": 3.449695587158203,
            "end_logit": 2.9442336559295654,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4",
            "probability": 0.06467161492570137,
            "start_logit": 3.5946478843688965,
            "end_logit": 2.0145914554595947,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4 deadenylase family members, PDE12 and CNOT6L, and to a DNA repair enzyme TDP2",
            "probability": 0.03918524553334938,
            "start_logit": 3.5946478843688965,
            "end_logit": 1.5135693550109863,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT6L, and to a DNA repair enzyme TDP2",
            "probability": 0.03881896743733367,
            "start_logit": 3.585256576538086,
            "end_logit": 1.5135693550109863,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12 and CNOT6L, and to a DNA repair enzyme TDP2",
            "probability": 0.03389772792497101,
            "start_logit": 3.449695587158203,
            "end_logit": 1.5135693550109863,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "TDP2",
            "probability": 0.007490960624777112,
            "start_logit": 1.940044641494751,
            "end_logit": 1.5135693550109863,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4 deadenylase family members, PDE12 and CNOT6L,",
            "probability": 0.0033968419639388765,
            "start_logit": 3.5946478843688965,
            "end_logit": -0.931884765625,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT6L,",
            "probability": 0.003365090502640544,
            "start_logit": 3.585256576538086,
            "end_logit": -0.931884765625,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4 deadenylase family members, PDE12 and CNOT",
            "probability": 0.0033293863601925574,
            "start_logit": 3.5946478843688965,
            "end_logit": -0.9519429206848145,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT",
            "probability": 0.003298265429844574,
            "start_logit": 3.585256576538086,
            "end_logit": -0.9519429206848145,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12 and CNOT6L,",
            "probability": 0.0029384841955303713,
            "start_logit": 3.449695587158203,
            "end_logit": -0.931884765625,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12 and CNOT",
            "probability": 0.0028801308109417433,
            "start_logit": 3.449695587158203,
            "end_logit": -0.9519429206848145,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4 deadenylase family members, PDE12 and CNOT6",
            "probability": 0.0023874103251626407,
            "start_logit": 3.5946478843688965,
            "end_logit": -1.2845216989517212,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT6",
            "probability": 0.0023650943718897537,
            "start_logit": 3.585256576538086,
            "end_logit": -1.2845216989517212,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "PDE12 and CNOT6",
            "probability": 0.002065261670461005,
            "start_logit": 3.449695587158203,
            "end_logit": -1.2845216989517212,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CCR4 deadenylase",
            "probability": 0.0007953234480391455,
            "start_logit": 3.5946478843688965,
            "end_logit": -2.383737325668335,
            "question_text": "What are the known families of deadenylases?"
        }
    ],
    "56a3bf0f496b62f23f00000a": [
        {
            "text": "CNVRanger",
            "probability": 0.9820284573170289,
            "start_logit": 5.256229400634766,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R",
            "probability": 0.005723170367829853,
            "start_logit": 5.256229400634766,
            "end_logit": -0.5793734788894653,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNV",
            "probability": 0.0038891403172797157,
            "start_logit": 5.256229400634766,
            "end_logit": -0.9657082557678223,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "C",
            "probability": 0.002157265587070328,
            "start_logit": 5.256229400634766,
            "end_logit": -1.5550549030303955,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "the CNVRanger",
            "probability": 0.0016415596846770261,
            "start_logit": -1.1377440690994263,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRang",
            "probability": 0.0009590521610223982,
            "start_logit": 5.256229400634766,
            "end_logit": -2.365706205368042,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R/Bioconductor package",
            "probability": 0.0006539122865333511,
            "start_logit": 5.256229400634766,
            "end_logit": -2.74867844581604,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CN",
            "probability": 0.0005676435857126825,
            "start_logit": 5.256229400634766,
            "end_logit": -2.89015793800354,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "Ranger",
            "probability": 0.0005011136899868796,
            "start_logit": -2.324313163757324,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox for structured downstream analysis of CNVs.",
            "probability": 0.0003189810187930453,
            "start_logit": 5.256229400634766,
            "end_logit": -3.466520071029663,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox for structured downstream analysis of CNVs",
            "probability": 0.0002891263544356494,
            "start_logit": 5.256229400634766,
            "end_logit": -3.5647878646850586,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "NVRanger",
            "probability": 0.0002750731176569732,
            "start_logit": -2.9241092205047607,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "VRanger",
            "probability": 0.0002399211498100565,
            "start_logit": -3.060835838317871,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R/Bioconductor",
            "probability": 0.00023602419203098398,
            "start_logit": 5.256229400634766,
            "end_logit": -3.7677173614501953,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "er",
            "probability": 0.0001667658718131933,
            "start_logit": -3.4245553016662598,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "CNVRanger R/Bioconductor package which implements a comprehensive toolbox for structured downstream analysis",
            "probability": 0.00015114719554408404,
            "start_logit": 5.256229400634766,
            "end_logit": -4.21339750289917,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "present the CNVRanger",
            "probability": 9.485688129583713e-05,
            "start_logit": -3.988776922225952,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "We present the CNVRanger",
            "probability": 9.072127397731999e-05,
            "start_logit": -4.03335428237915,
            "end_logit": 4.565723896026611,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "the CNVRanger R",
            "probability": 9.566856921881137e-06,
            "start_logit": -1.1377440690994263,
            "end_logit": -0.5793734788894653,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "the CNV",
            "probability": 6.501090579738023e-06,
            "start_logit": -1.1377440690994263,
            "end_logit": -0.9657082557678223,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        }
    ],
    "56c3326750c68dd41600000b": [
        {
            "text": "H2B",
            "probability": 0.5354194276785829,
            "start_logit": 3.744175434112549,
            "end_logit": 2.6854703426361084,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitination",
            "probability": 0.25084006836098277,
            "start_logit": 3.744175434112549,
            "end_logit": 1.92723548412323,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H2B",
            "probability": 0.10628100248567146,
            "start_logit": 2.127211570739746,
            "end_logit": 2.6854703426361084,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H2B monoubiquitination",
            "probability": 0.04979186886170214,
            "start_logit": 2.127211570739746,
            "end_logit": 1.92723548412323,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub1",
            "probability": 0.040111784870572396,
            "start_logit": 2.3980560302734375,
            "end_logit": 1.4402095079421997,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "monoubiquitination",
            "probability": 0.010732368322034454,
            "start_logit": 0.5926241278648376,
            "end_logit": 1.92723548412323,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B mon",
            "probability": 0.0017346272931571742,
            "start_logit": 3.744175434112549,
            "end_logit": -3.0467875003814697,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H",
            "probability": 0.001087152374104916,
            "start_logit": 3.744175434112549,
            "end_logit": -3.5140182971954346,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub1)",
            "probability": 0.0008231507190899661,
            "start_logit": 2.3980560302734375,
            "end_logit": -2.4460766315460205,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitination has mainly been described as a regulator of transcription elongation,",
            "probability": 0.0007242726478514875,
            "start_logit": 3.744175434112549,
            "end_logit": -3.9201674461364746,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2Bub",
            "probability": 0.0005019714839464449,
            "start_logit": 2.3980560302734375,
            "end_logit": -2.9406726360321045,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H2B monoubiquitination has mainly been described as a regulator of transcription elongation",
            "probability": 0.00038897360547957086,
            "start_logit": 3.744175434112549,
            "end_logit": -4.541823863983154,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H2B mon",
            "probability": 0.0003443243149675602,
            "start_logit": 2.127211570739746,
            "end_logit": -3.0467875003814697,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone",
            "probability": 0.00022042750597800644,
            "start_logit": 2.127211570739746,
            "end_logit": -3.492802619934082,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H",
            "probability": 0.00021580024594085163,
            "start_logit": 2.127211570739746,
            "end_logit": -3.5140182971954346,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "tone H2B",
            "probability": 0.0001924889282273872,
            "start_logit": -4.186591625213623,
            "end_logit": 2.6854703426361084,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "2B",
            "probability": 0.0001534498944501078,
            "start_logit": -4.4132561683654785,
            "end_logit": 2.6854703426361084,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "His",
            "probability": 0.00015283299249690212,
            "start_logit": 2.127211570739746,
            "end_logit": -3.859025716781616,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "Histone H2B monoubiquitination has mainly been described as a regulator of transcription elongation,",
            "probability": 0.00014376845349141395,
            "start_logit": 2.127211570739746,
            "end_logit": -3.9201674461364746,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "(H2Bub1",
            "probability": 0.00014023896127207281,
            "start_logit": -3.258021593093872,
            "end_logit": 1.4402095079421997,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        }
    ],
    "534df8c9aeec6fbd07000016": [
        {
            "text": "autoimmune diseases",
            "probability": 0.22583343992709534,
            "start_logit": 4.415804386138916,
            "end_logit": 3.1068785190582275,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases and cancer",
            "probability": 0.20283199120893156,
            "start_logit": 4.415804386138916,
            "end_logit": 2.9994587898254395,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases and cancers",
            "probability": 0.1776567005858957,
            "start_logit": 4.415804386138916,
            "end_logit": 2.866933822631836,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune",
            "probability": 0.1679617408242999,
            "start_logit": 4.415804386138916,
            "end_logit": 2.810817003250122,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "cancer",
            "probability": 0.1031694602878486,
            "start_logit": 3.7397992610931396,
            "end_logit": 2.9994587898254395,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "cancers",
            "probability": 0.09036417680821783,
            "start_logit": 3.7397992610931396,
            "end_logit": 2.866933822631836,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune diseases",
            "probability": 0.006037484662801238,
            "start_logit": 0.793994128704071,
            "end_logit": 3.1068785190582275,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune diseases and cancer",
            "probability": 0.005422558485779119,
            "start_logit": 0.793994128704071,
            "end_logit": 2.9994587898254395,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune diseases and cancers",
            "probability": 0.00474951630448298,
            "start_logit": 0.793994128704071,
            "end_logit": 2.866933822631836,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "many autoimmune",
            "probability": 0.004490328954345615,
            "start_logit": 0.793994128704071,
            "end_logit": 2.810817003250122,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "autoimmune diseases and cancers.",
            "probability": 0.0035801058646164267,
            "start_logit": 4.415804386138916,
            "end_logit": -1.0375268459320068,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "cancers.",
            "probability": 0.0018210026319042216,
            "start_logit": 3.7397992610931396,
            "end_logit": -1.0375268459320068,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "diseases",
            "probability": 0.00135177188036418,
            "start_logit": -0.7025771141052246,
            "end_logit": 3.1068785190582275,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "diseases and cancer",
            "probability": 0.0012140920416525613,
            "start_logit": -0.7025771141052246,
            "end_logit": 2.9994587898254395,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "diseases and cancers",
            "probability": 0.0010634002311075772,
            "start_logit": -0.7025771141052246,
            "end_logit": 2.866933822631836,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "auto",
            "probability": 0.0006074312711876705,
            "start_logit": 4.415804386138916,
            "end_logit": -2.8114354610443115,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "protein arginine deiminases (PADs). Abnormal citrullination is observed in many autoimmune diseases",
            "probability": 0.0004794918848715501,
            "start_logit": -1.7390216588974,
            "end_logit": 3.1068785190582275,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "ne diseases",
            "probability": 0.00047114263622749465,
            "start_logit": -1.7565877437591553,
            "end_logit": 3.1068785190582275,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "arginine deiminases (PADs). Abnormal citrullination is observed in many autoimmune diseases",
            "probability": 0.0004635085362438606,
            "start_logit": -1.7729238271713257,
            "end_logit": 3.1068785190582275,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "protein arginine deiminases (PADs). Abnormal citrullination is observed in many autoimmune diseases and cancer",
            "probability": 0.0004306549721264354,
            "start_logit": -1.7390216588974,
            "end_logit": 2.9994587898254395,
            "question_text": "List diseases where protein citrullination plays an important role."
        }
    ],
    "56e30dd551531f7e33000016": [
        {
            "text": "clock",
            "probability": 0.4954100560209922,
            "start_logit": 0.5100643634796143,
            "end_logit": 0.9531669616699219,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock",
            "probability": 0.24156122951051065,
            "start_logit": -0.20819847285747528,
            "end_logit": 0.9531669616699219,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes. Our results suggest a potential role of the core circadian clock",
            "probability": 0.1434876481471748,
            "start_logit": -0.09929843246936798,
            "end_logit": 0.3233928978443146,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock genes. Our results suggest a potential role of the core circadian clock",
            "probability": 0.06823019437612662,
            "start_logit": -0.8426601886749268,
            "end_logit": 0.3233928978443146,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Core circadian clock",
            "probability": 0.01413919470732635,
            "start_logit": -3.0463707447052,
            "end_logit": 0.9531669616699219,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes",
            "probability": 0.011718501254875608,
            "start_logit": 0.5100643634796143,
            "end_logit": -2.7910499572753906,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "core circadian clock",
            "probability": 0.008178404359931888,
            "start_logit": -3.2195053100585938,
            "end_logit": 0.5788478851318359,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock genes",
            "probability": 0.005713924327422747,
            "start_logit": -0.20819847285747528,
            "end_logit": -2.7910499572753906,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "core circadian clock genes. Our results suggest a potential role of the core circadian clock",
            "probability": 0.002455221848839337,
            "start_logit": -4.167330265045166,
            "end_logit": 0.3233928978443146,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock in the response of dental pulp to hypoxia. Future studies need to consider that regulation of the core circadian clock",
            "probability": 0.0022569981214914793,
            "start_logit": -0.6561263799667358,
            "end_logit": -3.2719924449920654,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock in the response of dental pulp to hypoxia. Future studies need to consider that regulation of the core circadian clock",
            "probability": 0.0015337095222785857,
            "start_logit": -1.0424727201461792,
            "end_logit": -3.2719924449920654,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circa",
            "probability": 0.0014329400362926958,
            "start_logit": -0.20819847285747528,
            "end_logit": -4.174227714538574,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "core clock",
            "probability": 0.0011029767569088217,
            "start_logit": -4.389368534088135,
            "end_logit": -0.2547732889652252,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian",
            "probability": 0.0008899444311070945,
            "start_logit": -0.20819847285747528,
            "end_logit": -4.650552272796631,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes. Our results suggest a potential role of the core circa",
            "probability": 0.0008409118995970111,
            "start_logit": -0.09929843246936798,
            "end_logit": -4.816124439239502,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock genes. Our results suggest a potential role of the core circa",
            "probability": 0.00039986426081673593,
            "start_logit": -0.8426601886749268,
            "end_logit": -4.816124439239502,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Core circadian clock genes",
            "probability": 0.0003344505605144872,
            "start_logit": -3.0463707447052,
            "end_logit": -2.7910499572753906,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "core circadian clock in the response of dental pulp to hypoxia. Future studies need to consider that regulation of the core circadian clock",
            "probability": 0.00017786550691691868,
            "start_logit": -3.196889638900757,
            "end_logit": -3.2719924449920654,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Core circa",
            "probability": 8.38736341014697e-05,
            "start_logit": -3.0463707447052,
            "end_logit": -4.174227714538574,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "Core circadian",
            "probability": 5.209071677446683e-05,
            "start_logit": -3.0463707447052,
            "end_logit": -4.650552272796631,
            "question_text": "List core circadian clock genes."
        }
    ],
    "52e6c92598d0239505000019": [
        {
            "text": "Duchenne muscular dystrophy",
            "probability": 0.16682386620122872,
            "start_logit": -0.7491526007652283,
            "end_logit": -2.0791351795196533,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Duchenne muscular dystrophy (DMD). The deltaE50-MD dog model of DMD",
            "probability": 0.10458708712423526,
            "start_logit": -0.7491526007652283,
            "end_logit": -2.546053647994995,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model of DMD",
            "probability": 0.1028462840443878,
            "start_logit": -0.7659372091293335,
            "end_logit": -2.546053647994995,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Duchenne muscular dystrophy (DMD). The deltaE50-MD dog model",
            "probability": 0.08438522703809251,
            "start_logit": -0.7491526007652283,
            "end_logit": -2.760681390762329,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model",
            "probability": 0.08298067445745659,
            "start_logit": -0.7659372091293335,
            "end_logit": -2.760681390762329,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Duchenne muscular dystrophy (DMD). The deltaE50-MD dog",
            "probability": 0.06189696120853344,
            "start_logit": -0.7491526007652283,
            "end_logit": -3.0706026554107666,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog",
            "probability": 0.060866715279826955,
            "start_logit": -0.7659372091293335,
            "end_logit": -3.0706026554107666,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Duchenne muscular dystrophy (DMD)",
            "probability": 0.03403868731097146,
            "start_logit": -0.7491526007652283,
            "end_logit": -3.6685760021209717,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Duchenne muscular dystrophy (DMD). The deltaE50",
            "probability": 0.03318471810313117,
            "start_logit": -0.7491526007652283,
            "end_logit": -3.693984270095825,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "dog model of DMD",
            "probability": 0.032818025237631374,
            "start_logit": -1.9081947803497314,
            "end_logit": -2.546053647994995,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50",
            "probability": 0.032632374012993355,
            "start_logit": -0.7659372091293335,
            "end_logit": -3.693984270095825,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Mutations in the gene encoding dystrophin, a protein that maintains muscle integrity and function, cause Duchenne muscular dystrophy",
            "probability": 0.028694858924724273,
            "start_logit": -2.509373188018799,
            "end_logit": -2.0791351795196533,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "dog model",
            "probability": 0.026478952486072717,
            "start_logit": -1.9081947803497314,
            "end_logit": -2.760681390762329,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "dystrophin, a protein that maintains muscle integrity and function, cause Duchenne muscular dystrophy",
            "probability": 0.026036309179388695,
            "start_logit": -2.6065990924835205,
            "end_logit": -2.0791351795196533,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model of DMD harbors a mutation corresponding to a mutational \"hotspot",
            "probability": 0.025811846220580307,
            "start_logit": -0.7659372091293335,
            "end_logit": -3.9284555912017822,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Duchenne muscular dystrophy (DMD).",
            "probability": 0.021577625337219877,
            "start_logit": -0.7491526007652283,
            "end_logit": -4.124416828155518,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD dog model of DMD harbors a mutation",
            "probability": 0.02058247696750323,
            "start_logit": -0.7659372091293335,
            "end_logit": -4.154849052429199,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "dog",
            "probability": 0.019422436277065344,
            "start_logit": -1.9081947803497314,
            "end_logit": -3.0706026554107666,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Duchenne muscular dystrophy (DMD). The deltaE50-MD",
            "probability": 0.017311508267952844,
            "start_logit": -0.7491526007652283,
            "end_logit": -4.344702243804932,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "deltaE50-MD",
            "probability": 0.01702336632100427,
            "start_logit": -0.7659372091293335,
            "end_logit": -4.344702243804932,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        }
    ],
    "531778ddb166e2b80600000f": [
        {
            "text": "Premenopausal breast cancer",
            "probability": 0.7872404120726665,
            "start_logit": -0.7361137866973877,
            "end_logit": -1.2735505104064941,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "breast cancer",
            "probability": 0.17600280262492934,
            "start_logit": -2.234147548675537,
            "end_logit": -1.2735505104064941,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "Premenopausal",
            "probability": 0.016765687478556276,
            "start_logit": -0.7361137866973877,
            "end_logit": -5.1227498054504395,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "Premenopausal breast cancer (BC)",
            "probability": 0.005009841599885534,
            "start_logit": -0.7361137866973877,
            "end_logit": -6.330679893493652,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "Premenopausal breast",
            "probability": 0.004459490730536775,
            "start_logit": -0.7361137866973877,
            "end_logit": -6.447049617767334,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "Pre",
            "probability": 0.0038138225709930724,
            "start_logit": -0.7361137866973877,
            "end_logit": -6.603452205657959,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "cancer",
            "probability": 0.003223589942106472,
            "start_logit": -6.234151840209961,
            "end_logit": -1.2735505104064941,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "breast cancer (BC)",
            "probability": 0.0011200468735660181,
            "start_logit": -2.234147548675537,
            "end_logit": -6.330679893493652,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "ausal breast cancer",
            "probability": 0.0011129910300112214,
            "start_logit": -7.297596454620361,
            "end_logit": -1.2735505104064941,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "breast",
            "probability": 0.000997005304628489,
            "start_logit": -2.234147548675537,
            "end_logit": -6.447049617767334,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239",
            "probability": 6.198518773848994e-05,
            "start_logit": -5.468435287475586,
            "end_logit": -5.990622520446777,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239 patients diagnosed before 46 years",
            "probability": 3.580767352288692e-05,
            "start_logit": -5.468435287475586,
            "end_logit": -6.539355754852295,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239 patients diagnosed before 46 years and without Chompret criteria for LFS or LFL",
            "probability": 2.8188939213240772e-05,
            "start_logit": -5.468435287475586,
            "end_logit": -6.77858829498291,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "239 patients diagnosed before 46 years and without Chompret criteria for LFS or LFL.",
            "probability": 2.483879279474728e-05,
            "start_logit": -5.468435287475586,
            "end_logit": -6.905111312866211,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "ausal",
            "probability": 2.370312739214684e-05,
            "start_logit": -7.297596454620361,
            "end_logit": -5.1227498054504395,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "315 patients unselected for age of diagnosis and family history (FH) and 2) 239",
            "probability": 2.197363431698103e-05,
            "start_logit": -6.505487442016602,
            "end_logit": -5.990622520446777,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "cancer (BC)",
            "probability": 2.051428603673728e-05,
            "start_logit": -6.234151840209961,
            "end_logit": -6.330679893493652,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "LFL) Syndromes,",
            "probability": 1.3129048467322331e-05,
            "start_logit": -6.838386535644531,
            "end_logit": -6.172739505767822,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "315 patients unselected for age of diagnosis and family history (FH) and 2) 239 patients diagnosed before 46 years",
            "probability": 1.2693753982859671e-05,
            "start_logit": -6.505487442016602,
            "end_logit": -6.539355754852295,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "c.1010G>A (p.Arg337His), was identified at a population frequency of 0.3%,",
            "probability": 1.1475328655138988e-05,
            "start_logit": -7.12797212600708,
            "end_logit": -6.017781734466553,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        }
    ],
    "52fb42752059c6d71c00005e": [
        {
            "text": "4,4'-methylenediphenol",
            "probability": 0.13634713301359097,
            "start_logit": 3.561561107635498,
            "end_logit": 2.9623796939849854,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-ethylidenebisphenol, 4,4'-methylenediphenol",
            "probability": 0.1355765459991922,
            "start_logit": 3.5558934211730957,
            "end_logit": 2.9623796939849854,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-cyclohexylidenebisphenol",
            "probability": 0.09952366701218518,
            "start_logit": 3.7337799072265625,
            "end_logit": 2.4753522872924805,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-dihydroxydiphenyl sulfone",
            "probability": 0.08491104437000234,
            "start_logit": 3.598818778991699,
            "end_logit": 2.4515221118927,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-ethylidenebisphenol",
            "probability": 0.08244487706544529,
            "start_logit": 3.5558934211730957,
            "end_logit": 2.464973211288452,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-(hexafluoroisopropylidene)diphenol",
            "probability": 0.07713419958909368,
            "start_logit": 3.2418441772460938,
            "end_logit": 2.7124392986297607,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "bisphenol A",
            "probability": 0.07531997937102816,
            "start_logit": 3.405696392059326,
            "end_logit": 2.5247857570648193,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-(1-phenylethylidene)bisphenol",
            "probability": 0.059238722711771316,
            "start_logit": 3.355980396270752,
            "end_logit": 2.334331750869751,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "2,2-bis(4-hydroxyphenyl)butane",
            "probability": 0.04960811032267175,
            "start_logit": 3.2120728492736816,
            "end_logit": 2.3008182048797607,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "bisphenol (BPP), 4,4'-dihydroxydiphenyl sulfone",
            "probability": 0.04520250440235646,
            "start_logit": 2.968367099761963,
            "end_logit": 2.4515221118927,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "bisphenol",
            "probability": 0.04122656650287284,
            "start_logit": 2.968367099761963,
            "end_logit": 2.359452486038208,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-(1,4-phenylenediisopropylidene)bisphenol",
            "probability": 0.036988734020405464,
            "start_logit": 2.8598976135253906,
            "end_logit": 2.359452486038208,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "2,2-bis(4-hydroxy-3,5-dimethylphenyl)propane",
            "probability": 0.022850800612398345,
            "start_logit": 2.8836891651153564,
            "end_logit": 1.8540337085723877,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "methylenediphenol",
            "probability": 0.014244403853303755,
            "start_logit": 1.3027211427688599,
            "end_logit": 2.9623796939849854,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-cyclohexylidenebisphenol (BPZ)",
            "probability": 0.009952486804790162,
            "start_logit": 3.7337799072265625,
            "end_logit": 0.17277926206588745,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "cyclohexylidenebisphenol",
            "probability": 0.008469740884002493,
            "start_logit": 1.2698843479156494,
            "end_logit": 2.4753522872924805,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "diphenol",
            "probability": 0.005609270308754802,
            "start_logit": 0.6207180619239807,
            "end_logit": 2.7124392986297607,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-methylenediphenol (BPF)",
            "probability": 0.005254552035568462,
            "start_logit": 3.561561107635498,
            "end_logit": -0.29372963309288025,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "4,4'-ethylidenebisphenol, 4,4'-methylenediphenol (BPF)",
            "probability": 0.0052248551180345375,
            "start_logit": 3.5558934211730957,
            "end_logit": -0.29372963309288025,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "2,2-bis(4-hydroxyphenyl)butane (BPB)",
            "probability": 0.0048718060025315845,
            "start_logit": 3.2120728492736816,
            "end_logit": -0.019871419295668602,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        }
    ],
    "5509b6d22e93f0133a000005": [
        {
            "text": "minimally invasive surgery",
            "probability": 0.9750807373828512,
            "start_logit": 5.414309024810791,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery",
            "probability": 0.022316799209983047,
            "start_logit": 1.637128472328186,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice",
            "probability": 0.000799288724654546,
            "start_logit": 5.414309024810791,
            "end_logit": -1.3463571071624756,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Rectal locations are very rare, and minimally invasive surgery",
            "probability": 0.0005427744099240505,
            "start_logit": -2.079272747039795,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of rectal GISTs.",
            "probability": 0.000358155026827293,
            "start_logit": 5.414309024810791,
            "end_logit": -2.149113416671753,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimal",
            "probability": 0.00032626383227482466,
            "start_logit": 5.414309024810791,
            "end_logit": -2.242372989654541,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment",
            "probability": 0.00023099573422094092,
            "start_logit": 5.414309024810791,
            "end_logit": -2.5876801013946533,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "invasive surgery",
            "probability": 0.00016179967637067755,
            "start_logit": -3.289607524871826,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive",
            "probability": 4.350190444514106e-05,
            "start_logit": 5.414309024810791,
            "end_logit": -4.257274627685547,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "mesenchymal tumors of the gastrointestinal tract. Rectal locations are very rare, and minimally invasive surgery",
            "probability": 2.8311319277291112e-05,
            "start_logit": -5.032704830169678,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of rectal GISTs",
            "probability": 2.477055729685856e-05,
            "start_logit": 5.414309024810791,
            "end_logit": -4.820423603057861,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of rectal",
            "probability": 2.1833063655578014e-05,
            "start_logit": 5.414309024810791,
            "end_logit": -4.946653842926025,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice",
            "probability": 1.8293424631477742e-05,
            "start_logit": 1.637128472328186,
            "end_logit": -1.3463571071624756,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "minimally invasive surgery is a good choice for the treatment of re",
            "probability": 1.0297788745055985e-05,
            "start_logit": 5.414309024810791,
            "end_logit": -5.698150157928467,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice for the treatment of rectal GISTs.",
            "probability": 8.197140517003674e-06,
            "start_logit": 1.637128472328186,
            "end_logit": -2.149113416671753,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "gastrointestinal tract. Rectal locations are very rare, and minimally invasive surgery",
            "probability": 7.762714830237332e-06,
            "start_logit": -6.326634407043457,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "ly invasive surgery",
            "probability": 7.23884835786779e-06,
            "start_logit": -6.3965044021606445,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "surgery is a good choice for the treatment",
            "probability": 5.286829306881568e-06,
            "start_logit": 1.637128472328186,
            "end_logit": -2.5876801013946533,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "rare, and minimally invasive surgery",
            "probability": 3.881063145586848e-06,
            "start_logit": -7.019857406616211,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "tract. Rectal locations are very rare, and minimally invasive surgery",
            "probability": 3.811348683998372e-06,
            "start_logit": -7.037983417510986,
            "end_logit": 5.760196208953857,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        }
    ],
    "56be0e4aef6e394741000008": [
        {
            "text": "bronchiectasis, and situs inversus",
            "probability": 0.1872689687515036,
            "start_logit": 4.405928134918213,
            "end_logit": 4.9140944480896,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis",
            "probability": 0.1725607369727658,
            "start_logit": 4.405928134918213,
            "end_logit": 4.8322978019714355,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus",
            "probability": 0.14163304281739317,
            "start_logit": 4.126621723175049,
            "end_logit": 4.9140944480896,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.09850013475352822,
            "start_logit": 3.7634401321411133,
            "end_logit": 4.9140944480896,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis",
            "probability": 0.09076386738445742,
            "start_logit": 3.7634401321411133,
            "end_logit": 4.8322978019714355,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis, and situs inversus",
            "probability": 0.08117357980484116,
            "start_logit": 3.569972038269043,
            "end_logit": 4.9140944480896,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis",
            "probability": 0.07479815180927323,
            "start_logit": 3.569972038269043,
            "end_logit": 4.8322978019714355,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis",
            "probability": 0.06595388925409539,
            "start_logit": 3.7634401321411133,
            "end_logit": 4.5129923820495605,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis",
            "probability": 0.05435234485925614,
            "start_logit": 3.569972038269043,
            "end_logit": 4.5129923820495605,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis,",
            "probability": 0.00565199872245876,
            "start_logit": 4.405928134918213,
            "end_logit": 1.413557767868042,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis, and situs inversus,",
            "probability": 0.005534886614433052,
            "start_logit": 4.405928134918213,
            "end_logit": 1.3926196098327637,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus,",
            "probability": 0.0041860797230727454,
            "start_logit": 4.126621723175049,
            "end_logit": 1.3926196098327637,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis,",
            "probability": 0.0031438499732458114,
            "start_logit": 3.7634401321411133,
            "end_logit": 1.4694846868515015,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis,",
            "probability": 0.0029728504380653687,
            "start_logit": 3.7634401321411133,
            "end_logit": 1.413557767868042,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, bronchiectasis, and situs inversus,",
            "probability": 0.0029112515597316648,
            "start_logit": 3.7634401321411133,
            "end_logit": 1.3926196098327637,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis,",
            "probability": 0.002590834594655979,
            "start_logit": 3.569972038269043,
            "end_logit": 1.4694846868515015,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis,",
            "probability": 0.0024499145395688133,
            "start_logit": 3.569972038269043,
            "end_logit": 1.413557767868042,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic sinusitis, bronchiectasis, and situs inversus,",
            "probability": 0.002399151142352949,
            "start_logit": 3.569972038269043,
            "end_logit": 1.3926196098327637,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis, and situs",
            "probability": 0.0006573255957765992,
            "start_logit": 4.405928134918213,
            "end_logit": -0.7380272746086121,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs",
            "probability": 0.0004971406895241317,
            "start_logit": 4.126621723175049,
            "end_logit": -0.7380272746086121,
            "question_text": "List Kartagener Syndrome Triad."
        }
    ],
    "54dfc6501388e8454a000009": [
        {
            "text": "cell cycle",
            "probability": 0.161485874588385,
            "start_logit": 4.108850479125977,
            "end_logit": 3.8853299617767334,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair",
            "probability": 0.10377797182699353,
            "start_logit": 4.108850479125977,
            "end_logit": 3.4431660175323486,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "antiviral",
            "probability": 0.09193782519134884,
            "start_logit": 4.346798419952393,
            "end_logit": 3.0840768814086914,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "antiviral and proliferative",
            "probability": 0.08531015070401107,
            "start_logit": 4.346798419952393,
            "end_logit": 3.0092577934265137,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair genes, whereas the other APOBEC3 members display specificity for immune processes",
            "probability": 0.07903173944170849,
            "start_logit": 4.108850479125977,
            "end_logit": 3.170761823654175,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "proliferative",
            "probability": 0.06500634127389841,
            "start_logit": 4.0749897956848145,
            "end_logit": 3.0092577934265137,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune processes",
            "probability": 0.04470331810772276,
            "start_logit": 3.539048671722412,
            "end_logit": 3.170761823654175,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair genes, whereas the other APOBEC3 members display specificity for immune processes and immune cell populations",
            "probability": 0.042579641733537524,
            "start_logit": 4.108850479125977,
            "end_logit": 2.55228853225708,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune processes and immune cell populations. We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral",
            "probability": 0.040991420438811085,
            "start_logit": 3.539048671722412,
            "end_logit": 3.0840768814086914,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "DNA repair",
            "probability": 0.04021946374855597,
            "start_logit": 3.160947799682617,
            "end_logit": 3.4431660175323486,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune processes and immune cell populations. We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral and proliferative",
            "probability": 0.038036403927635146,
            "start_logit": 3.539048671722412,
            "end_logit": 3.0092577934265137,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune cell populations. We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral",
            "probability": 0.03572962869067328,
            "start_logit": 3.4016661643981934,
            "end_logit": 3.0840768814086914,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune cell populations. We offer molecular insights into the functions of individual APOBEC3 proteins in antiviral and proliferative",
            "probability": 0.033153927688149364,
            "start_logit": 3.4016661643981934,
            "end_logit": 3.0092577934265137,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "DNA repair genes, whereas the other APOBEC3 members display specificity for immune processes",
            "probability": 0.03062898728412354,
            "start_logit": 3.160947799682617,
            "end_logit": 3.170761823654175,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune processes and immune cell populations",
            "probability": 0.024084643496061812,
            "start_logit": 3.539048671722412,
            "end_logit": 2.55228853225708,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "immune cell populations",
            "probability": 0.02099306050021053,
            "start_logit": 3.4016661643981934,
            "end_logit": 2.55228853225708,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "antiviral and proliferative contexts",
            "probability": 0.018524321108037138,
            "start_logit": 4.346798419952393,
            "end_logit": 1.4820488691329956,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "DNA repair genes, whereas the other APOBEC3 members display specificity for immune processes and immune cell populations",
            "probability": 0.01650186766015666,
            "start_logit": 3.160947799682617,
            "end_logit": 2.55228853225708,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "proliferative contexts",
            "probability": 0.014115534082156106,
            "start_logit": 4.0749897956848145,
            "end_logit": 1.4820488691329956,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cell cycle and DNA repair genes",
            "probability": 0.013187878507823846,
            "start_logit": 4.108850479125977,
            "end_logit": 1.3802103996276855,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        }
    ],
    "52e0c9a298d0239505000010": [
        {
            "text": "H3K9me2",
            "probability": 0.7591353114340734,
            "start_logit": 4.184747695922852,
            "end_logit": 3.6900360584259033,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3",
            "probability": 0.13514232760646144,
            "start_logit": 4.184747695922852,
            "end_logit": 1.9641845226287842,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3-modified chromatin. H3K9me2",
            "probability": 0.07699937221816495,
            "start_logit": 3.37209153175354,
            "end_logit": 2.2143094539642334,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3",
            "probability": 0.006325800712212426,
            "start_logit": 1.1230558156967163,
            "end_logit": 1.9641845226287842,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3-modified chromatin. H3K9me2",
            "probability": 0.004722700344861473,
            "start_logit": 0.5806750059127808,
            "end_logit": 2.2143094539642334,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3-modified chromatin. H3K9me2 and 3",
            "probability": 0.004514121053645648,
            "start_logit": 3.37209153175354,
            "end_logit": -0.6222773194313049,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me",
            "probability": 0.0038654865475566576,
            "start_logit": 4.184747695922852,
            "end_logit": -1.5900564193725586,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3. Here, we show that heterochromatin protein 1",
            "probability": 0.0017052272431933484,
            "start_logit": 4.184747695922852,
            "end_logit": -2.4084455966949463,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3 \"reader,\" interacts with SUV39H1, an H3K9me2",
            "probability": 0.0014656024763284154,
            "start_logit": 1.0239698886871338,
            "end_logit": 0.6009002327919006,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H",
            "probability": 0.0008879558625857464,
            "start_logit": 4.184747695922852,
            "end_logit": -3.0609772205352783,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3-modified chromatin.",
            "probability": 0.0008211334943952247,
            "start_logit": 3.37209153175354,
            "end_logit": -2.3265573978424072,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3-modified chromatin. H3K9me",
            "probability": 0.00073440174096691,
            "start_logit": 3.37209153175354,
            "end_logit": -2.4381868839263916,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3. Here, we show that heterochromatin protein 1 (HP1), an H3K9me2",
            "probability": 0.0006113008023555595,
            "start_logit": 1.1230558156967163,
            "end_logit": -0.3726182281970978,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9me2 and 3 \"reader,\" interacts with SUV39H1",
            "probability": 0.0005975589606348558,
            "start_logit": 1.0239698886871338,
            "end_logit": -0.296268492937088,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "SUV39H1, an H3K9me2",
            "probability": 0.0005954816041297116,
            "start_logit": 0.12331870198249817,
            "end_logit": 0.6009002327919006,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "TRIM28, an abundant HP1 scaffolding protein, to form complexes with increased multivalent engagement of H3K9me2",
            "probability": 0.0005635114834427656,
            "start_logit": -2.2349889278411865,
            "end_logit": 2.904025077819824,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "K9me2",
            "probability": 0.0005096026673545157,
            "start_logit": -3.121556282043457,
            "end_logit": 3.6900360584259033,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3K9me2",
            "probability": 0.00027781825966639146,
            "start_logit": -3.7282204627990723,
            "end_logit": 3.6900360584259033,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "3-modified chromatin. H3K9me2 and 3",
            "probability": 0.0002768703229994569,
            "start_logit": 0.5806750059127808,
            "end_logit": -0.6222773194313049,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "2",
            "probability": 0.0002484151649713036,
            "start_logit": -3.8400862216949463,
            "end_logit": 3.6900360584259033,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        }
    ],
    "51487ef9d24251bc05000031": [
        {
            "text": "Opicapone",
            "probability": 0.857275076138803,
            "start_logit": 6.257108211517334,
            "end_logit": 6.031494617462158,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone",
            "probability": 0.08797335876934177,
            "start_logit": 5.1011576652526855,
            "end_logit": 4.910720348358154,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "opicapone",
            "probability": 0.05416086250464676,
            "start_logit": 5.089208602905273,
            "end_logit": 4.437593936920166,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Op",
            "probability": 0.0001507829766096904,
            "start_logit": 6.257108211517334,
            "end_logit": -2.614177942276001,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapo",
            "probability": 0.0001242556383720625,
            "start_logit": 6.257108211517334,
            "end_logit": -2.807678461074829,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapone is",
            "probability": 0.00011333339612798226,
            "start_logit": 6.257108211517334,
            "end_logit": -2.8996856212615967,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "ne",
            "probability": 5.096814453706961e-05,
            "start_logit": -3.473205089569092,
            "end_logit": 6.031494617462158,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapone is a recent and selective third-generation COMT inhibitor",
            "probability": 2.5400084341205126e-05,
            "start_logit": 6.257108211517334,
            "end_logit": -4.395267009735107,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opica",
            "probability": 2.3556195361075556e-05,
            "start_logit": 6.257108211517334,
            "end_logit": -4.470630645751953,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "Opicapone is a recent and selective third-generation",
            "probability": 2.0093283415132894e-05,
            "start_logit": 6.257108211517334,
            "end_logit": -4.629633903503418,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "one",
            "probability": 1.6125179523846142e-05,
            "start_logit": -3.5032496452331543,
            "end_logit": 4.910720348358154,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "op",
            "probability": 1.4653393644753599e-05,
            "start_logit": 5.089208602905273,
            "end_logit": -3.7774479389190674,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "opicapo",
            "probability": 1.4553711293685006e-05,
            "start_logit": 5.089208602905273,
            "end_logit": -3.784273862838745,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "en",
            "probability": 1.3914438177469048e-05,
            "start_logit": 5.1011576652526855,
            "end_logit": -3.841141939163208,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "pone",
            "probability": 6.344751629524621e-06,
            "start_logit": -5.5567779541015625,
            "end_logit": 6.031494617462158,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacap",
            "probability": 4.56659854496428e-06,
            "start_logit": 5.1011576652526855,
            "end_logit": -4.955300331115723,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "icapone",
            "probability": 3.8141443217800743e-06,
            "start_logit": -6.065689563751221,
            "end_logit": 6.031494617462158,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "addition of catechol-O-methyl transferase (COMT) inhibitors. Opicapone",
            "probability": 3.7896848383522905e-06,
            "start_logit": -6.072123050689697,
            "end_logit": 6.031494617462158,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": ". Opicapone",
            "probability": 3.4439377011881244e-06,
            "start_logit": -6.167790412902832,
            "end_logit": 6.031494617462158,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "capone",
            "probability": 1.1070287687842686e-06,
            "start_logit": -6.181951999664307,
            "end_logit": 4.910720348358154,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        }
    ],
    "5505db6a8e1671127b000003": [
        {
            "text": "desmosoma",
            "probability": 0.9254337681663786,
            "start_logit": 1.7011469602584839,
            "end_logit": -0.8605875372886658,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal",
            "probability": 0.04112351084936242,
            "start_logit": 1.7011469602584839,
            "end_logit": -3.9742701053619385,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "des",
            "probability": 0.019261233374030278,
            "start_logit": 1.7011469602584839,
            "end_logit": -4.732755661010742,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmos",
            "probability": 0.004869103853228155,
            "start_logit": 1.7011469602584839,
            "end_logit": -6.107940196990967,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal proteins involved in maintaining skin structure.",
            "probability": 0.0021743440766910237,
            "start_logit": 1.7011469602584839,
            "end_logit": -6.914123058319092,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal proteins involved in maintaining skin structure",
            "probability": 0.0021558826952597266,
            "start_logit": 1.7011469602584839,
            "end_logit": -6.92264986038208,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "desmosomal proteins",
            "probability": 0.0020085686420145744,
            "start_logit": 1.7011469602584839,
            "end_logit": -6.993427753448486,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "mosoma",
            "probability": 0.0010045115135274554,
            "start_logit": -5.124614238739014,
            "end_logit": -0.8605875372886658,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3, keratins, and desmosoma",
            "probability": 0.0009242545556935936,
            "start_logit": -5.207883358001709,
            "end_logit": -0.8605875372886658,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "oma",
            "probability": 0.0005817929013787721,
            "start_logit": -5.6707563400268555,
            "end_logit": -0.8605875372886658,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "glycerol transporter aquaporin-3, keratins, and desmosoma",
            "probability": 0.0002928011859837412,
            "start_logit": -6.357377052307129,
            "end_logit": -0.8605875372886658,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "mosomal",
            "probability": 4.4637489516623146e-05,
            "start_logit": -5.124614238739014,
            "end_logit": -3.9742701053619385,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3, keratins, and desmosomal",
            "probability": 4.107111017133836e-05,
            "start_logit": -5.207883358001709,
            "end_logit": -3.9742701053619385,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "omal",
            "probability": 2.5853137755429918e-05,
            "start_logit": -5.6707563400268555,
            "end_logit": -3.9742701053619385,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3, keratins, and des",
            "probability": 1.923669019501825e-05,
            "start_logit": -5.207883358001709,
            "end_logit": -4.732755661010742,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "glycerol transporter aquaporin-3, keratins, and desmosomal",
            "probability": 1.301120962158772e-05,
            "start_logit": -6.357377052307129,
            "end_logit": -3.9742701053619385,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "l",
            "probability": 8.90100762293641e-06,
            "start_logit": -6.737023830413818,
            "end_logit": -3.9742701053619385,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "aquaporin-3",
            "probability": 6.13824764370765e-06,
            "start_logit": -5.207883358001709,
            "end_logit": -5.875035762786865,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "glycerol transporter aquaporin-3, keratins, and des",
            "probability": 6.094128147711754e-06,
            "start_logit": -6.357377052307129,
            "end_logit": -4.732755661010742,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "mos",
            "probability": 5.285165777794744e-06,
            "start_logit": -5.124614238739014,
            "end_logit": -6.107940196990967,
            "question_text": "What are the structures formed when keratin molecules come together?"
        }
    ],
    "54c225bcf693c3b16b000002": [
        {
            "text": "ryanodine receptor",
            "probability": 0.2633043482361003,
            "start_logit": 2.959977149963379,
            "end_logit": 1.8082234859466553,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2",
            "probability": 0.19366145928195072,
            "start_logit": 2.959977149963379,
            "end_logit": 1.5010244846343994,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2)",
            "probability": 0.12250848578464008,
            "start_logit": 2.959977149963379,
            "end_logit": 1.043093204498291,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2) gene",
            "probability": 0.06009295629266745,
            "start_logit": 2.959977149963379,
            "end_logit": 0.33080554008483887,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin",
            "probability": 0.05559905867168066,
            "start_logit": 2.29024338722229,
            "end_logit": 0.9228129386901855,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2",
            "probability": 0.05005913440449256,
            "start_logit": 1.6070705652236938,
            "end_logit": 1.5010244846343994,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2) or Triadin",
            "probability": 0.03175118713635024,
            "start_logit": 2.29024338722229,
            "end_logit": 0.36257678270339966,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2)",
            "probability": 0.031666955202767744,
            "start_logit": 1.6070705652236938,
            "end_logit": 1.043093204498291,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2) gene, <5% of cases are accounted for by recessive mutations in cardiac calsequestrin",
            "probability": 0.028078199275872046,
            "start_logit": 1.6070705652236938,
            "end_logit": 0.9228129386901855,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2) or Triadin (TRDN)",
            "probability": 0.023796397491231747,
            "start_logit": 2.29024338722229,
            "end_logit": 0.07418087124824524,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2",
            "probability": 0.021983056907225216,
            "start_logit": 2.29024338722229,
            "end_logit": -0.005081315990537405,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "Triadin",
            "probability": 0.017839628589894085,
            "start_logit": 1.713735580444336,
            "end_logit": 0.36257678270339966,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "cardiac ryanodine receptor",
            "probability": 0.01646153987699697,
            "start_logit": 0.18769331276416779,
            "end_logit": 1.8082234859466553,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2) gene",
            "probability": 0.015533299124005421,
            "start_logit": 1.6070705652236938,
            "end_logit": 0.33080554008483887,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2) or Triadin (TRDN",
            "probability": 0.014412268888452718,
            "start_logit": 2.29024338722229,
            "end_logit": -0.4272734820842743,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "Triadin (TRDN)",
            "probability": 0.013370173883516086,
            "start_logit": 1.713735580444336,
            "end_logit": 0.07418087124824524,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "cardiac ryanodine receptor (RYR2",
            "probability": 0.012107532047851576,
            "start_logit": 0.18769331276416779,
            "end_logit": 1.5010244846343994,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2)",
            "probability": 0.011953256933852133,
            "start_logit": 2.29024338722229,
            "end_logit": -0.6143495440483093,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "Triadin (TRDN",
            "probability": 0.008097634995616627,
            "start_logit": 1.713735580444336,
            "end_logit": -0.4272734820842743,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "(RYR2",
            "probability": 0.007723426974835748,
            "start_logit": -0.26187625527381897,
            "end_logit": 1.5010244846343994,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        }
    ],
    "532c0d7fd6d3ac6a3400001c": [
        {
            "text": "Flexi-pharma",
            "probability": 0.9876025047266285,
            "start_logit": 3.81990122795105,
            "end_logit": 3.6952786445617676,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma,",
            "probability": 0.006132070169580842,
            "start_logit": 3.6146271228790283,
            "end_logit": -1.1811951398849487,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma approach",
            "probability": 0.002201588747242418,
            "start_logit": 3.386478900909424,
            "end_logit": -1.9774000644683838,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Fl",
            "probability": 0.001631390930646437,
            "start_logit": 3.81990122795105,
            "end_logit": -2.71056866645813,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "virtual screening protocol, Flexi-pharma",
            "probability": 0.0009102628593872773,
            "start_logit": -2.778106689453125,
            "end_logit": 3.3039844036102295,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharmacophore-based virtual screening protocol, Flexi-pharma",
            "probability": 0.0003243358660966118,
            "start_logit": -3.810060501098633,
            "end_logit": 3.3039844036102295,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma, that overcomes these limitations. The protocol uses molecular dynamics",
            "probability": 0.0002557519133965872,
            "start_logit": 3.6146271228790283,
            "end_logit": -4.358274936676025,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "ma",
            "probability": 0.00024929258372905736,
            "start_logit": -4.464507102966309,
            "end_logit": 3.6952786445617676,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-pharma is computationally efficient allowing for the screening of thousands of compounds in minutes on a single CPU core",
            "probability": 0.0002180513645916615,
            "start_logit": 3.81990122795105,
            "end_logit": -4.723026275634766,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Flexi-phar",
            "probability": 0.00020756484774139385,
            "start_logit": 3.6146271228790283,
            "end_logit": -4.5670390129089355,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharma",
            "probability": 0.0001706000416176692,
            "start_logit": -4.843812465667725,
            "end_logit": 3.6952786445617676,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the Flexi-pharma",
            "probability": 7.537498893962413e-05,
            "start_logit": -5.044521808624268,
            "end_logit": 3.079141616821289,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "virtual screening protocol, Flexi-pharma,",
            "probability": 1.0263089043310162e-05,
            "start_logit": -2.778106689453125,
            "end_logit": -1.1811951398849487,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharmacophore-based virtual screening protocol, Flexi-pharma,",
            "probability": 3.6568424596926627e-06,
            "start_logit": -3.810060501098633,
            "end_logit": -1.1811951398849487,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "ma,",
            "probability": 1.473871246783076e-06,
            "start_logit": -4.718768119812012,
            "end_logit": -1.1811951398849487,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "virtual screening protocol, Fl",
            "probability": 1.4672477336462653e-06,
            "start_logit": -2.778106689453125,
            "end_logit": -3.1263606548309326,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "vote is a general strategy that can be applied with any pharmacophore-filtering",
            "probability": 1.357960708273014e-06,
            "start_logit": -3.0790066719055176,
            "end_logit": -2.902864933013916,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "vote",
            "probability": 1.312940559999225e-06,
            "start_logit": -3.0790066719055176,
            "end_logit": -2.936579704284668,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "filtering",
            "probability": 9.482783642081046e-07,
            "start_logit": -3.4380979537963867,
            "end_logit": -2.902864933013916,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "virtual screening",
            "probability": 7.307302860831169e-07,
            "start_logit": -2.778106689453125,
            "end_logit": -3.8234598636627197,
            "question_text": "List programs suitable for pharmacophore modelling"
        }
    ],
    "530c844e970c65fa6b000014": [
        {
            "text": "Ophthalmoplegia and juvenile SpinoCerebellar Ataxia-Epilepsy syndrome",
            "probability": 0.12413709959767069,
            "start_logit": 3.0826284885406494,
            "end_logit": 3.483607530593872,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "SpinoCerebellar Ataxia-Epilepsy syndrome",
            "probability": 0.10001708072904292,
            "start_logit": 2.8665828704833984,
            "end_logit": 3.483607530593872,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Epilepsy syndrome",
            "probability": 0.09378461881978323,
            "start_logit": 2.8022427558898926,
            "end_logit": 3.483607530593872,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ataxia-Epilepsy syndrome",
            "probability": 0.07603216795366961,
            "start_logit": 2.5923984050750732,
            "end_logit": 3.483607530593872,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Alpers-Huttenlocher hepatopathic poliodystrophy",
            "probability": 0.0722321382291007,
            "start_logit": 3.113576650619507,
            "end_logit": 2.9111578464508057,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ophthalmoplegia and juvenile SpinoCerebellar Ataxia",
            "probability": 0.06865289443516946,
            "start_logit": 3.0826284885406494,
            "end_logit": 2.891284227371216,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "juvenile SpinoCerebellar Ataxia-Epilepsy syndrome",
            "probability": 0.05701848497947949,
            "start_logit": 2.304617404937744,
            "end_logit": 3.483607530593872,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "SpinoCerebellar Ataxia",
            "probability": 0.055313537268544724,
            "start_logit": 2.8665828704833984,
            "end_logit": 2.891284227371216,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ophthalmoplegia",
            "probability": 0.047004478021077316,
            "start_logit": 3.0826284885406494,
            "end_logit": 2.5124638080596924,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Sensory-Ataxic Neuropathy Dysarthria and Ophthalmoplegia and juvenile SpinoCerebellar Ataxia",
            "probability": 0.04594592118218947,
            "start_logit": 2.6810302734375,
            "end_logit": 2.891284227371216,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Sensory-Ataxic Neuropathy Dysarthria",
            "probability": 0.04290629029996593,
            "start_logit": 2.6810302734375,
            "end_logit": 2.8228375911712646,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ataxia",
            "probability": 0.042048899298580834,
            "start_logit": 2.5923984050750732,
            "end_logit": 2.891284227371216,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "juvenile SpinoCerebellar Ataxia",
            "probability": 0.031533554778034725,
            "start_logit": 2.304617404937744,
            "end_logit": 2.891284227371216,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Sensory-Ataxic Neuropathy Dysarthria and Ophthalmoplegia",
            "probability": 0.03145772745832001,
            "start_logit": 2.6810302734375,
            "end_logit": 2.5124638080596924,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Epilepsy syndrome. Mitochondrial neuro-gastro-intestinal encephalomyopathy",
            "probability": 0.025155587385739142,
            "start_logit": 2.8022427558898926,
            "end_logit": 2.167686700820923,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ataxia-Epilepsy syndrome. Mitochondrial neuro-gastro-intestinal encephalomyopathy",
            "probability": 0.020393896879413176,
            "start_logit": 2.5923984050750732,
            "end_logit": 2.167686700820923,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Ophthalmoplegia and juvenile SpinoCerebellar Ataxia-Epilepsy",
            "probability": 0.02014720096307125,
            "start_logit": 3.0826284885406494,
            "end_logit": 1.6652863025665283,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "SpinoCerebellar Ataxia-Epilepsy",
            "probability": 0.01623257053466359,
            "start_logit": 2.8665828704833984,
            "end_logit": 1.6652863025665283,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Epilepsy",
            "probability": 0.01522105453350435,
            "start_logit": 2.8022427558898926,
            "end_logit": 1.6652863025665283,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "poliodystrophy",
            "probability": 0.01476479665297951,
            "start_logit": 1.5259373188018799,
            "end_logit": 2.9111578464508057,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        }
    ],
    "571653aecb4ef8864c000005": [
        {
            "text": "Detection of EGFR mutations",
            "probability": 0.5802255934332248,
            "start_logit": 0.04982473701238632,
            "end_logit": -0.41894885897636414,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "Detection of EGFR mutations in tumour tissue",
            "probability": 0.09783909446704009,
            "start_logit": 0.04982473701238632,
            "end_logit": -2.1990416049957275,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "EGFR mutations",
            "probability": 0.08153963662880882,
            "start_logit": -1.9125030040740967,
            "end_logit": -0.41894885897636414,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "mutations",
            "probability": 0.042690885988392664,
            "start_logit": -2.5596067905426025,
            "end_logit": -0.41894885897636414,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "Detection",
            "probability": 0.03273155851459667,
            "start_logit": 0.04982473701238632,
            "end_logit": -3.2940261363983154,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA",
            "probability": 0.028760820281565735,
            "start_logit": -0.964296817779541,
            "end_logit": -2.4092302322387695,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "tissue is the gold-standard approach to ascertain if a patient will benefit from treatment with an EGFR tyrosine kinase inhibitor",
            "probability": 0.02227570352338513,
            "start_logit": -3.453357219696045,
            "end_logit": -0.17568732798099518,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "inhibitor",
            "probability": 0.018876107554922646,
            "start_logit": -3.6189568042755127,
            "end_logit": -0.17568732798099518,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "Detection of EGFR mutations in tumour tissue is the gold-standard approach",
            "probability": 0.01794794764600598,
            "start_logit": 0.04982473701238632,
            "end_logit": -3.894890069961548,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "EGFR mutations in tumour tissue",
            "probability": 0.01374941798711309,
            "start_logit": -1.9125030040740967,
            "end_logit": -2.1990416049957275,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "gold-standard approach to ascertain if a patient will benefit from treatment with an EGFR tyrosine kinase inhibitor",
            "probability": 0.009055790899371826,
            "start_logit": -4.35344934463501,
            "end_logit": -0.17568732798099518,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating",
            "probability": 0.007599966979942946,
            "start_logit": -0.964296817779541,
            "end_logit": -3.740100383758545,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA (ctDNA),",
            "probability": 0.0074693662529417525,
            "start_logit": -0.964296817779541,
            "end_logit": -3.757434129714966,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "mutations in tumour tissue",
            "probability": 0.007198644241777451,
            "start_logit": -2.5596067905426025,
            "end_logit": -2.1990416049957275,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "scant",
            "probability": 0.006860220242448969,
            "start_logit": -2.518063545227051,
            "end_logit": -2.2887380123138428,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA (ctDNA)",
            "probability": 0.006233268046812476,
            "start_logit": -0.964296817779541,
            "end_logit": -3.9383435249328613,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "scant, another strategy is to use circulating tumour DNA",
            "probability": 0.006081475373224872,
            "start_logit": -2.518063545227051,
            "end_logit": -2.4092302322387695,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "Detection of EGFR",
            "probability": 0.005211387038978786,
            "start_logit": 0.04982473701238632,
            "end_logit": -5.131519794464111,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "circulating tumour DNA (ctDNA",
            "probability": 0.0046632713916019,
            "start_logit": -0.964296817779541,
            "end_logit": -4.228527069091797,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "EGFR tyrosine kinase inhibitor",
            "probability": 0.0029898435078432625,
            "start_logit": -5.46163272857666,
            "end_logit": -0.17568732798099518,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        }
    ],
    "517a8bab8ed59a060a000040": [
        {
            "text": "deiodinase gene single-nucleotide polymorphisms",
            "probability": 0.15751625452605494,
            "start_logit": -2.411449670791626,
            "end_logit": -3.7833142280578613,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase",
            "probability": 0.13772368636086615,
            "start_logit": -2.411449670791626,
            "end_logit": -3.917593479156494,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase gene single-nucleotide polymorphisms (SNPs)",
            "probability": 0.11840394481769721,
            "start_logit": -2.411449670791626,
            "end_logit": -4.0687408447265625,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinas",
            "probability": 0.09360468619586323,
            "start_logit": -2.411449670791626,
            "end_logit": -4.303762435913086,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase gene",
            "probability": 0.08763772832837621,
            "start_logit": -2.411449670791626,
            "end_logit": -4.369631290435791,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "deiodinase gene single-nucleotide polymorphism",
            "probability": 0.0775239344107855,
            "start_logit": -2.411449670791626,
            "end_logit": -4.492256164550781,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "dei",
            "probability": 0.05881390573645925,
            "start_logit": -2.411449670791626,
            "end_logit": -4.7684645652771,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "single-nucleotide polymorphisms",
            "probability": 0.03866344799286978,
            "start_logit": -3.8160836696624756,
            "end_logit": -3.7833142280578613,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "single-nucleotide polymorphisms (SNPs)",
            "probability": 0.029063062579693467,
            "start_logit": -3.8160836696624756,
            "end_logit": -4.0687408447265625,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "We studied the association of common variations in three deiodinase gene single-nucleotide polymorphisms",
            "probability": 0.024180590838395615,
            "start_logit": -4.285428047180176,
            "end_logit": -3.7833142280578613,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "We studied the association of common variations in three deiodinase",
            "probability": 0.021142199696582886,
            "start_logit": -4.285428047180176,
            "end_logit": -3.917593479156494,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "common variations in three deiodinase gene single-nucleotide polymorphisms",
            "probability": 0.02026879242883703,
            "start_logit": -4.461895942687988,
            "end_logit": -3.7833142280578613,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "single-nucleotide polymorphism",
            "probability": 0.01902878287267972,
            "start_logit": -3.8160836696624756,
            "end_logit": -4.492256164550781,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "We studied the association of common variations in three deiodinase gene single-nucleotide polymorphisms (SNPs)",
            "probability": 0.01817639298181207,
            "start_logit": -4.285428047180176,
            "end_logit": -4.0687408447265625,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "single-nucleotide polymorphisms (SNPs) with circulating TH concentrations and prognosis of brain tumor patients.",
            "probability": 0.01776022731379408,
            "start_logit": -3.8160836696624756,
            "end_logit": -4.5612473487854,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "common variations in three deiodinase",
            "probability": 0.01772193491891915,
            "start_logit": -4.461895942687988,
            "end_logit": -3.917593479156494,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "Thyroid hormone (TH) metabolism can have prognostic significance in brain tumors. We studied the association of common variations in three deiodinase",
            "probability": 0.016601168837008663,
            "start_logit": -4.527225971221924,
            "end_logit": -3.917593479156494,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "three deiodinase gene single-nucleotide polymorphisms",
            "probability": 0.01640312830843694,
            "start_logit": -4.673506259918213,
            "end_logit": -3.7833142280578613,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "common variations in three deiodinase gene single-nucleotide polymorphisms (SNPs)",
            "probability": 0.015235919540407858,
            "start_logit": -4.461895942687988,
            "end_logit": -4.0687408447265625,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "studied the association of common variations in three deiodinase gene single-nucleotide polymorphisms",
            "probability": 0.014530211314459859,
            "start_logit": -4.794748306274414,
            "end_logit": -3.7833142280578613,
            "question_text": "Which deiodinases are best known to be present in brain?"
        }
    ],
    "56c33e5695c1e7cc5b000001": [
        {
            "text": "nuclear envelope",
            "probability": 0.26940148915171275,
            "start_logit": -2.153918981552124,
            "end_logit": -1.554720401763916,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin",
            "probability": 0.18787773134376654,
            "start_logit": -2.6193654537200928,
            "end_logit": -1.4496853351593018,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin and heterochromatin, are spatially segregated in such a way that the transcriptionally active genome occupies the nuclear interior",
            "probability": 0.1322998872509572,
            "start_logit": -2.6193654537200928,
            "end_logit": -1.800405502319336,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear interior",
            "probability": 0.08671196057089454,
            "start_logit": -3.0418448448181152,
            "end_logit": -1.800405502319336,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "interior",
            "probability": 0.07380409313535388,
            "start_logit": -3.2030224800109863,
            "end_logit": -1.800405502319336,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.06374256628769119,
            "start_logit": -3.0418448448181152,
            "end_logit": -2.108144760131836,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.054253903014185964,
            "start_logit": -3.2030224800109863,
            "end_logit": -2.108144760131836,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "envelope",
            "probability": 0.024224933215237675,
            "start_logit": -4.009315013885498,
            "end_logit": -2.108144760131836,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin and heterochromatin",
            "probability": 0.0173637317437045,
            "start_logit": -2.6193654537200928,
            "end_logit": -3.8310930728912354,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin and heterochromatin, are spatially segregated in such a way that the transcriptionally active genome occupies the nuclear interior,",
            "probability": 0.013762181258140906,
            "start_logit": -2.6193654537200928,
            "end_logit": -4.063552379608154,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin and heterochromatin,",
            "probability": 0.011140533380310486,
            "start_logit": -2.6193654537200928,
            "end_logit": -4.274886608123779,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the nuclear interior",
            "probability": 0.010547914091008645,
            "start_logit": -5.148508548736572,
            "end_logit": -1.800405502319336,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear interior,",
            "probability": 0.009020005560260098,
            "start_logit": -3.0418448448181152,
            "end_logit": -4.063552379608154,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the nuclear envelope",
            "probability": 0.007808822328229614,
            "start_logit": -5.141443252563477,
            "end_logit": -2.108144760131836,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the nuclear interior, whereas silent genomic loci are preferentially associated with the nuclear envelope",
            "probability": 0.007753845129511118,
            "start_logit": -5.148508548736572,
            "end_logit": -2.108144760131836,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "interior,",
            "probability": 0.0076772953358212655,
            "start_logit": -3.2030224800109863,
            "end_logit": -4.063552379608154,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "heterochromatin, are spatially segregated in such a way that the transcriptionally active genome occupies the nuclear interior",
            "probability": 0.0074550721274249596,
            "start_logit": -5.495542049407959,
            "end_logit": -1.800405502319336,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "euchromatin and heterochromatin, are spatially segregated in such a way that the transcriptionally active genome occupies the nuclear",
            "probability": 0.005283510672426819,
            "start_logit": -2.6193654537200928,
            "end_logit": -5.020885944366455,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "tin",
            "probability": 0.0051626467948782135,
            "start_logit": -6.213707447052002,
            "end_logit": -1.4496853351593018,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "nuclear envelope, autonomous behavior of small genomic segments, and euchromatin",
            "probability": 0.0047078776084837235,
            "start_logit": -2.153918981552124,
            "end_logit": -5.601686000823975,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        }
    ],
    "570921e4cf1c325851000017": [
        {
            "text": "promoter region",
            "probability": 0.3662794240492386,
            "start_logit": 0.9652690291404724,
            "end_logit": 0.4488864243030548,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "promoter",
            "probability": 0.31069477358859254,
            "start_logit": 0.9652690291404724,
            "end_logit": 0.28430092334747314,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter region",
            "probability": 0.050581846890858984,
            "start_logit": -1.0145347118377686,
            "end_logit": 0.4488864243030548,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "normal and cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter region",
            "probability": 0.04465504054986987,
            "start_logit": -1.1391602754592896,
            "end_logit": 0.4488864243030548,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.042905810251944884,
            "start_logit": -1.0145347118377686,
            "end_logit": 0.28430092334747314,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "normal and cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.03787842505552853,
            "start_logit": -1.1391602754592896,
            "end_logit": 0.28430092334747314,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "the promoter region",
            "probability": 0.01899644476289737,
            "start_logit": -1.9938756227493286,
            "end_logit": 0.4488864243030548,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter region",
            "probability": 0.017935878624123477,
            "start_logit": -2.0513243675231934,
            "end_logit": 0.4488864243030548,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "the promoter",
            "probability": 0.016113643620350327,
            "start_logit": -1.9938756227493286,
            "end_logit": 0.28430092334747314,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.015214023454086801,
            "start_logit": -2.0513243675231934,
            "end_logit": 0.28430092334747314,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "upstream of the promoter region",
            "probability": 0.012073621271727123,
            "start_logit": -2.4471044540405273,
            "end_logit": 0.4488864243030548,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "in normal and cancer tissues, we pinpointed an Alu repeat (AluSq2) with differential methylation located upstream of the promoter",
            "probability": 0.01074380817947759,
            "start_logit": -2.39921236038208,
            "end_logit": 0.28430092334747314,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "upstream of the promoter",
            "probability": 0.01024139162922076,
            "start_logit": -2.4471044540405273,
            "end_logit": 0.28430092334747314,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "promoter region of the",
            "probability": 0.006956710003390171,
            "start_logit": 0.9652690291404724,
            "end_logit": -3.514803409576416,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer",
            "probability": 0.006890085074087929,
            "start_logit": -1.0145347118377686,
            "end_logit": -1.5446228981018066,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genome-wide study in normal and cancer",
            "probability": 0.00687108938154883,
            "start_logit": -1.017295479774475,
            "end_logit": -1.5446228981018066,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "cancer tissues",
            "probability": 0.0065085194390916284,
            "start_logit": -1.0145347118377686,
            "end_logit": -1.60159432888031,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genome-wide study in normal and cancer tissues",
            "probability": 0.006490575707944578,
            "start_logit": -1.017295479774475,
            "end_logit": -1.60159432888031,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "normal and cancer",
            "probability": 0.006082755915167111,
            "start_logit": -1.1391602754592896,
            "end_logit": -1.5446228981018066,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "located upstream of the promoter region",
            "probability": 0.005886132550852863,
            "start_logit": -3.1655282974243164,
            "end_logit": 0.4488864243030548,
            "question_text": "In which genomic regions are Alu enriched?"
        }
    ],
    "56bcc455d36b5da378000003": [
        {
            "text": "calreticulin",
            "probability": 0.9867439186722554,
            "start_logit": 4.031383991241455,
            "end_logit": 3.328895330429077,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "calreticulin-mutated primary myelofibrosis",
            "probability": 0.009030315746351908,
            "start_logit": 4.031383991241455,
            "end_logit": -1.364927887916565,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "ca",
            "probability": 0.0012291485054311971,
            "start_logit": 4.031383991241455,
            "end_logit": -3.3591935634613037,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "calreticulin-mutated",
            "probability": 0.0011373122152934562,
            "start_logit": 4.031383991241455,
            "end_logit": -3.436847448348999,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "ulin",
            "probability": 0.0008260419532016543,
            "start_logit": -3.054136276245117,
            "end_logit": 3.328895330429077,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "calreticulin-mutated primary myelofibrosis.",
            "probability": 0.00030845017224760023,
            "start_logit": 4.031383991241455,
            "end_logit": -4.741710186004639,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "lreticulin",
            "probability": 0.00014911469350543187,
            "start_logit": -4.766066074371338,
            "end_logit": 3.328895330429077,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "calreticulin-mutated primary myelofibrosis. Based on the detection of abnormal platelets, including large gray platelets",
            "probability": 0.00013252253272477146,
            "start_logit": 4.031383991241455,
            "end_logit": -5.586517810821533,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "cal",
            "probability": 0.0001020755711125461,
            "start_logit": 4.031383991241455,
            "end_logit": -5.847557067871094,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "calreticulin-mutated primary my",
            "probability": 8.916032565126997e-05,
            "start_logit": 4.031383991241455,
            "end_logit": -5.982834339141846,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "reticulin",
            "probability": 7.635243285119951e-05,
            "start_logit": -5.435421943664551,
            "end_logit": 3.328895330429077,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "myelofibrosis",
            "probability": 6.779796199292709e-05,
            "start_logit": -0.8604264855384827,
            "end_logit": -1.364927887916565,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "platelet dysfunction accompanied by calreticulin",
            "probability": 4.9576555238058304e-05,
            "start_logit": -5.8672637939453125,
            "end_logit": 3.328895330429077,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "acquired platelet dysfunction accompanied by calreticulin",
            "probability": 3.1024614946293465e-05,
            "start_logit": -6.336000919342041,
            "end_logit": 3.328895330429077,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "primary myelofibrosis",
            "probability": 1.0838977172911882e-05,
            "start_logit": -2.693809986114502,
            "end_logit": -1.364927887916565,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "ulin-mutated primary myelofibrosis",
            "probability": 7.559630737001596e-06,
            "start_logit": -3.054136276245117,
            "end_logit": -1.364927887916565,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "mutated primary myelofibrosis",
            "probability": 2.777759192767223e-06,
            "start_logit": -4.055314064025879,
            "end_logit": -1.364927887916565,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "myelofibrosis. Based on the detection of abnormal platelets, including large gray platelets,",
            "probability": 2.3312499353661323e-06,
            "start_logit": -0.8604264855384827,
            "end_logit": -4.735055446624756,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "myelofibrosis.",
            "probability": 2.3157875806505244e-06,
            "start_logit": -0.8604264855384827,
            "end_logit": -4.741710186004639,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "lreticulin-mutated primary myelofibrosis",
            "probability": 1.3646425777687455e-06,
            "start_logit": -4.766066074371338,
            "end_logit": -1.364927887916565,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        }
    ],
    "52f89fd32059c6d71c000051": [
        {
            "text": "MYEF2",
            "probability": 0.4004454478647372,
            "start_logit": 4.51260232925415,
            "end_logit": 4.130676746368408,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF2",
            "probability": 0.2371892806262692,
            "start_logit": 3.9888832569122314,
            "end_logit": 4.130676746368408,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1",
            "probability": 0.09438150721342141,
            "start_logit": 3.9888832569122314,
            "end_logit": 3.2091634273529053,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LDB1",
            "probability": 0.0639916848706024,
            "start_logit": 3.417633533477783,
            "end_logit": 3.3918211460113525,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1 has been shown to be part of a large transcription factor complex, together with LDB1",
            "probability": 0.044808665050471305,
            "start_logit": 3.06128191947937,
            "end_logit": 3.3918211460113525,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF2,",
            "probability": 0.022622055271809428,
            "start_logit": 4.51260232925415,
            "end_logit": 1.2570245265960693,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LDB1, GATA1, TAL1",
            "probability": 0.021635548271470597,
            "start_logit": 3.417633533477783,
            "end_logit": 2.307405710220337,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "TAL1",
            "probability": 0.018573609300399443,
            "start_logit": 3.2650375366210938,
            "end_logit": 2.307405710220337,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1",
            "probability": 0.01848279958886686,
            "start_logit": 3.06128191947937,
            "end_logit": 2.5062601566314697,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF",
            "probability": 0.01581851910443044,
            "start_logit": 4.51260232925415,
            "end_logit": 0.8992805480957031,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "RUNX1 has been shown to be part of a large transcription factor complex, together with LDB1, GATA1, TAL1",
            "probability": 0.015149781376126836,
            "start_logit": 3.06128191947937,
            "end_logit": 2.307405710220337,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF2,",
            "probability": 0.013399350760058113,
            "start_logit": 3.9888832569122314,
            "end_logit": 1.2570245265960693,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF",
            "probability": 0.009369523831421103,
            "start_logit": 3.9888832569122314,
            "end_logit": 0.8992805480957031,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF2, in erythroid cells.",
            "probability": 0.007893655694815474,
            "start_logit": 4.51260232925415,
            "end_logit": 0.20415855944156647,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF2, in erythroid cells.",
            "probability": 0.0046755195389239605,
            "start_logit": 3.9888832569122314,
            "end_logit": 0.20415855944156647,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LDB1, GATA1, TAL1, and ETO2",
            "probability": 0.0034733183941351715,
            "start_logit": 3.417633533477783,
            "end_logit": 0.4781784415245056,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "TAL1, and ETO2",
            "probability": 0.00298176214529425,
            "start_logit": 3.2650375366210938,
            "end_logit": 0.4781784415245056,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MYEF2, in erythroid cells. MYEF2",
            "probability": 0.0023000139341481283,
            "start_logit": 4.51260232925415,
            "end_logit": -1.028985619544983,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LDB1, GATA1",
            "probability": 0.0014456276533488883,
            "start_logit": 3.417633533477783,
            "end_logit": -0.39838841557502747,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "LSD1 and MYEF2, in erythroid cells. MYEF2",
            "probability": 0.0013623295092500647,
            "start_logit": 3.9888832569122314,
            "end_logit": -1.028985619544983,
            "question_text": "List interaction partners for the protein GATA1."
        }
    ],
    "551829a76487737b43000009": [
        {
            "text": "Tuberculosis",
            "probability": 0.527167595989442,
            "start_logit": 2.7812464237213135,
            "end_logit": 2.7886688709259033,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis",
            "probability": 0.45751325244159396,
            "start_logit": 2.7469727993011475,
            "end_logit": 2.681229829788208,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Tuberculosis (TB)",
            "probability": 0.0088369978292809,
            "start_logit": 2.7812464237213135,
            "end_logit": -1.2999024391174316,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis (TB)",
            "probability": 0.006008036378503067,
            "start_logit": 2.7469727993011475,
            "end_logit": -1.6514780521392822,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis (TB) is the time-consuming and difficult methodology for diagnosis.",
            "probability": 0.00029234616607661554,
            "start_logit": 2.7469727993011475,
            "end_logit": -4.6743927001953125,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "tuberculosis (TB) is the time-consuming and difficult methodology for diagnosis. Stable-isotope breath tests",
            "probability": 0.0001528310062854757,
            "start_logit": 2.7469727993011475,
            "end_logit": -5.322998523712158,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial metabolism that could, with development, allow rapid point-of-care diagnosis",
            "probability": 5.206272233349261e-06,
            "start_logit": -2.485440254211426,
            "end_logit": -3.4700541496276855,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial conversion of labeled CO to labeled CO2",
            "probability": 5.178090605142989e-06,
            "start_logit": -1.8449019193649292,
            "end_logit": -4.116020202636719,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial conversion of labeled CO",
            "probability": 4.413400084158964e-06,
            "start_logit": -1.8449019193649292,
            "end_logit": -4.275811195373535,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial conversion of labeled CO to labeled CO",
            "probability": 2.4503776648388732e-06,
            "start_logit": -1.8449019193649292,
            "end_logit": -4.8642144203186035,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial",
            "probability": 1.8828754858950677e-06,
            "start_logit": -1.8449019193649292,
            "end_logit": -5.12765645980835,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial conversion",
            "probability": 1.804085072469462e-06,
            "start_logit": -1.8449019193649292,
            "end_logit": -5.170403003692627,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "diagnosis",
            "probability": 1.6259689454328661e-06,
            "start_logit": -3.649200439453125,
            "end_logit": -3.4700541496276855,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial metabolism",
            "probability": 1.2408555975122036e-06,
            "start_logit": -2.485440254211426,
            "end_logit": -4.904117107391357,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "CO2",
            "probability": 9.968075757510855e-07,
            "start_logit": -3.4925358295440674,
            "end_logit": -4.116020202636719,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial metabolism that could, with development, allow rapid point-of-care diagnosis through measuring the mycobacterial",
            "probability": 9.92291650144631e-07,
            "start_logit": -2.485440254211426,
            "end_logit": -5.12765645980835,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial metabolism that could, with development, allow rapid point-of-care diagnosis through measuring the mycobacterial conversion",
            "probability": 9.507684214769076e-07,
            "start_logit": -2.485440254211426,
            "end_logit": -5.170403003692627,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "diagnosis through measuring the mycobacterial conversion of labeled CO to labeled CO2",
            "probability": 8.522612729119074e-07,
            "start_logit": -3.649200439453125,
            "end_logit": -4.116020202636719,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "diagnosis through measuring the mycobacterial conversion of labeled CO",
            "probability": 7.264009574994625e-07,
            "start_logit": -3.649200439453125,
            "end_logit": -4.275811195373535,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "mycobacterial metabolism that could, with development, allow rapid point-of-care diagnosis through",
            "probability": 6.197332513518675e-07,
            "start_logit": -2.485440254211426,
            "end_logit": -5.598384380340576,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        }
    ],
    "52bf209303868f1b0600001a": [
        {
            "text": "myocardial infarction",
            "probability": 0.5769322367274403,
            "start_logit": 5.417647838592529,
            "end_logit": 5.513254642486572,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute myocardial infarction",
            "probability": 0.39708867637957934,
            "start_logit": 5.0440826416015625,
            "end_logit": 5.513254642486572,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "intravenous alteplase in the early treatment of patients with acute myocardial infarction",
            "probability": 0.010515834617156994,
            "start_logit": 1.449304223060608,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "management of acute myocardial infarction",
            "probability": 0.00645118404534214,
            "start_logit": 0.9241867065429688,
            "end_logit": 5.513254642486572,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "infarction",
            "probability": 0.00285255741074409,
            "start_logit": 0.14463797211647034,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "patients with acute myocardial infarction",
            "probability": 0.0014661623228427465,
            "start_logit": -0.5209296345710754,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ardial infarction",
            "probability": 0.0008682383870094397,
            "start_logit": -1.081365942955017,
            "end_logit": 5.513254642486572,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "first-line option in the management of acute myocardial infarction",
            "probability": 0.0006628092996275742,
            "start_logit": -1.3513449430465698,
            "end_logit": 5.513254642486572,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ction",
            "probability": 0.0005548508268088033,
            "start_logit": -1.5291329622268677,
            "end_logit": 5.513254642486572,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "farction",
            "probability": 0.0004732138992537697,
            "start_logit": -1.6517857313156128,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "treatment of patients with acute myocardial infarction",
            "probability": 0.00031485612324517743,
            "start_logit": -2.0592174530029297,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ial infarction",
            "probability": 0.00031357717464611246,
            "start_logit": -2.0632877349853516,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "early treatment of patients with acute myocardial infarction",
            "probability": 0.0002631987398334481,
            "start_logit": -2.2384238243103027,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "myocardial infarction has been unequivocally proven,",
            "probability": 0.00025555430081929603,
            "start_logit": 5.2521138191223145,
            "end_logit": -2.0432565212249756,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "myocardial infar",
            "probability": 0.0001989247487692598,
            "start_logit": 5.2521138191223145,
            "end_logit": -2.29376482963562,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "my",
            "probability": 0.00019583533688190448,
            "start_logit": 5.2521138191223145,
            "end_logit": -2.309417247772217,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute myocardial infarction has been unequivocally proven,",
            "probability": 0.00016214767114060776,
            "start_logit": 4.797186374664307,
            "end_logit": -2.0432565212249756,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ocardial infarction",
            "probability": 0.00015398229591730695,
            "start_logit": -2.8109946250915527,
            "end_logit": 5.513254642486572,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "with acute myocardial infarction",
            "probability": 0.0001499431329318066,
            "start_logit": -2.801077127456665,
            "end_logit": 5.476755619049072,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute myocardial infar",
            "probability": 0.00012621656000997528,
            "start_logit": 4.797186374664307,
            "end_logit": -2.29376482963562,
            "question_text": "What are the indications for alteplase?"
        }
    ],
    "55152bd246478f2f2c000002": [
        {
            "text": "\u03b1-DG and transmembrane \u03b2-DG",
            "probability": 0.27755232870803476,
            "start_logit": 3.9642174243927,
            "end_logit": 4.456331729888916,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b1-DG",
            "probability": 0.19744367279300157,
            "start_logit": 3.9642174243927,
            "end_logit": 4.1157755851745605,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG",
            "probability": 0.16542716731293283,
            "start_logit": 3.4467389583587646,
            "end_logit": 4.456331729888916,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b2-DG",
            "probability": 0.12558224305714596,
            "start_logit": 3.171168804168701,
            "end_logit": 4.456331729888916,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG and transmembrane \u03b2-DG",
            "probability": 0.09504771317110111,
            "start_logit": 2.8925869464874268,
            "end_logit": 4.456331729888916,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "transmembrane \u03b2-DG",
            "probability": 0.041178136655714716,
            "start_logit": 2.0561153888702393,
            "end_logit": 4.456331729888916,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG may act as the scaffold in scratch mechanical force activating ERK pathway which can regulate the expression of AQP4",
            "probability": 0.0306230414551483,
            "start_logit": 3.8600332736968994,
            "end_logit": 2.3562591075897217,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "extracellular \u03b1-DG and transmembrane \u03b2-DG",
            "probability": 0.023456358630614467,
            "start_logit": 1.493349552154541,
            "end_logit": 4.456331729888916,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "extracellular \u03b1-DG",
            "probability": 0.01668625739851078,
            "start_logit": 1.493349552154541,
            "end_logit": 4.1157755851745605,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "dystroglycan",
            "probability": 0.0089144715760253,
            "start_logit": 2.7812328338623047,
            "end_logit": 2.2009828090667725,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "adhesion-mediated signaling in ERK/MAPK pathway. We hypothesize that after scratch, extracellular \u03b1-DG",
            "probability": 0.004770990500629748,
            "start_logit": 0.241318017244339,
            "end_logit": 4.1157755851745605,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG by siRNA led to no obvious effect of scratched-injury on the ERK signaling pathway. It demonstrated that DG",
            "probability": 0.004751191405508137,
            "start_logit": 0.7530355453491211,
            "end_logit": 3.5998995304107666,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "AQP4",
            "probability": 0.0026586139678699433,
            "start_logit": 1.4160854816436768,
            "end_logit": 2.3562591075897217,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b1-DG and transmembrane \u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 0.0014522461835003745,
            "start_logit": 3.9642174243927,
            "end_logit": -0.7965663075447083,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG may act as the scaffold in scratch mechanical force activating ERK pathway which may regulate the expression of AQP4",
            "probability": 0.0010623768311663877,
            "start_logit": 3.4467389583587646,
            "end_logit": -0.5916905999183655,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG may act as the scaffold in scratch mechanical force",
            "probability": 0.0008655700115930247,
            "start_logit": 3.4467389583587646,
            "end_logit": -0.7965663075447083,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b1-DG and transmembrane \u03b2",
            "probability": 0.0007705838059338611,
            "start_logit": 3.9642174243927,
            "end_logit": -1.4302846193313599,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "\u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 0.0006570881031483022,
            "start_logit": 3.171168804168701,
            "end_logit": -0.7965663075447083,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "scratch, extracellular \u03b1-DG and transmembrane \u03b2-DG",
            "probability": 0.000602627154859282,
            "start_logit": -2.1682486534118652,
            "end_logit": 4.456331729888916,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "DG and transmembrane \u03b2-DG may act as the scaffold in scratch mechanical force",
            "probability": 0.000497321277561214,
            "start_logit": 2.8925869464874268,
            "end_logit": -0.7965663075447083,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        }
    ],
    "516c3960298dcd4e51000073": [
        {
            "text": "DNMT1 and DNMT3s (DNMT3",
            "probability": 0.1877355540150461,
            "start_logit": 4.1921892166137695,
            "end_logit": 3.414698600769043,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1",
            "probability": 0.17903463390330612,
            "start_logit": 4.1921892166137695,
            "end_logit": 3.367243528366089,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3",
            "probability": 0.17874320349884792,
            "start_logit": 4.1431050300598145,
            "end_logit": 3.414698600769043,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s",
            "probability": 0.07644392809136834,
            "start_logit": 4.1921892166137695,
            "end_logit": 2.516221761703491,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3",
            "probability": 0.07479687166205383,
            "start_logit": 4.1921892166137695,
            "end_logit": 2.4944403171539307,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s",
            "probability": 0.07278233825645863,
            "start_logit": 4.1431050300598145,
            "end_logit": 2.516221761703491,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3",
            "probability": 0.07121417422879954,
            "start_logit": 4.1431050300598145,
            "end_logit": 2.4944403171539307,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3A",
            "probability": 0.03293634667837092,
            "start_logit": 4.1921892166137695,
            "end_logit": 1.674241065979004,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3A",
            "probability": 0.031358727694003184,
            "start_logit": 4.1431050300598145,
            "end_logit": 1.674241065979004,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3A and 3B",
            "probability": 0.01757946192368184,
            "start_logit": 4.1921892166137695,
            "end_logit": 1.0463955402374268,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3A and 3B",
            "probability": 0.01673742278872269,
            "start_logit": 4.1431050300598145,
            "end_logit": 1.0463955402374268,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3A",
            "probability": 0.011471907619829526,
            "start_logit": 3.1375136375427246,
            "end_logit": 1.674241065979004,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1 and DNMT3s (DNMT3A and 3B). DNMT1",
            "probability": 0.010467458446768958,
            "start_logit": 4.1921892166137695,
            "end_logit": 0.5279355049133301,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3s (DNMT3A and 3B). DNMT1",
            "probability": 0.009966077363889247,
            "start_logit": 4.1431050300598145,
            "end_logit": 0.5279355049133301,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3A and 3B",
            "probability": 0.006123021632123639,
            "start_logit": 3.1375136375427246,
            "end_logit": 1.0463955402374268,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methylation is performed by DNMT1 and DNMT3s (DNMT3",
            "probability": 0.005112641763640501,
            "start_logit": 0.5888711214065552,
            "end_logit": 3.414698600769043,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methylation is performed by DNMT1",
            "probability": 0.00487568777919802,
            "start_logit": 0.5888711214065552,
            "end_logit": 3.367243528366089,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methylation is performed by DNMT1 and DNMT3s (DNMT3",
            "probability": 0.004593788572225726,
            "start_logit": 0.48185995221138,
            "end_logit": 3.414698600769043,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methylation is performed by DNMT1",
            "probability": 0.00438088171189837,
            "start_logit": 0.48185995221138,
            "end_logit": 3.367243528366089,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT3A and 3B). DNMT1",
            "probability": 0.0036458723697669415,
            "start_logit": 3.1375136375427246,
            "end_logit": 0.5279355049133301,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        }
    ],
    "54e0ac041388e8454a00000f": [
        {
            "text": "L1",
            "probability": 0.33150142128406257,
            "start_logit": 2.213853597640991,
            "end_logit": 1.2195978164672852,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I",
            "probability": 0.1617808099799764,
            "start_logit": 2.213853597640991,
            "end_logit": 0.5022081136703491,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I",
            "probability": 0.12520331859308836,
            "start_logit": 1.9575501680374146,
            "end_logit": 0.5022081136703491,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retroviruses",
            "probability": 0.07134508750064357,
            "start_logit": 2.213853597640991,
            "end_logit": -0.3165057897567749,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retroviruses",
            "probability": 0.0552144702545403,
            "start_logit": 1.9575501680374146,
            "end_logit": -0.3165057897567749,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retroviruses (ERVs)",
            "probability": 0.035784871308922495,
            "start_logit": 2.213853597640991,
            "end_logit": -1.0065090656280518,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L",
            "probability": 0.03490782328108405,
            "start_logit": 2.213853597640991,
            "end_logit": -1.0313233137130737,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retroviruses (ERVs)",
            "probability": 0.027694166223164708,
            "start_logit": 1.9575501680374146,
            "end_logit": -1.0065090656280518,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class",
            "probability": 0.024859980364093235,
            "start_logit": 2.213853597640991,
            "end_logit": -1.3707749843597412,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class",
            "probability": 0.019239315479559826,
            "start_logit": 1.9575501680374146,
            "end_logit": -1.3707749843597412,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "endogenous retroviruses",
            "probability": 0.019113396207430106,
            "start_logit": 0.8967145681381226,
            "end_logit": -0.3165057897567749,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retrovirus",
            "probability": 0.017491595682702813,
            "start_logit": 2.213853597640991,
            "end_logit": -1.7223137617111206,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retrovirus",
            "probability": 0.013536870208734808,
            "start_logit": 1.9575501680374146,
            "end_logit": -1.7223137617111206,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III",
            "probability": 0.012515371239422752,
            "start_logit": 2.213853597640991,
            "end_logit": -2.0570766925811768,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II, and III endogenous retroviruses (ERVs",
            "probability": 0.012226444040632625,
            "start_logit": 2.213853597640991,
            "end_logit": -2.0804331302642822,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III",
            "probability": 0.009685734746872421,
            "start_logit": 1.9575501680374146,
            "end_logit": -2.0570766925811768,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "endogenous retroviruses (ERVs)",
            "probability": 0.009586790731081015,
            "start_logit": 0.8967145681381226,
            "end_logit": -1.0065090656280518,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "class I, II, and III endogenous retroviruses (ERVs",
            "probability": 0.009462131934370703,
            "start_logit": 1.9575501680374146,
            "end_logit": -2.0804331302642822,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "endogenous retrovirus",
            "probability": 0.0046860100715505745,
            "start_logit": 0.8967145681381226,
            "end_logit": -1.7223137617111206,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "L1 and class I, II",
            "probability": 0.004164390868066684,
            "start_logit": 2.213853597640991,
            "end_logit": -3.1574642658233643,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        }
    ],
    "55192f20622b194345000014": [
        {
            "text": "p50",
            "probability": 0.5589331646330977,
            "start_logit": -0.7373673915863037,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "p50 subunit of NF-kappaB",
            "probability": 0.18679224055248073,
            "start_logit": -0.7373673915863037,
            "end_logit": -2.0420923233032227,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "p50 subunit",
            "probability": 0.09656512738696109,
            "start_logit": -0.7373673915863037,
            "end_logit": -2.701871633529663,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "p50 subunit of NF-kappaB.",
            "probability": 0.026006645662022758,
            "start_logit": -0.7373673915863037,
            "end_logit": -4.013737201690674,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Nuclear Factor kappa-light-chain-enhancer of activated B cells",
            "probability": 0.02129444488973115,
            "start_logit": -2.3252055644989014,
            "end_logit": -2.625804901123047,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "NF-kappaB",
            "probability": 0.01708106129786178,
            "start_logit": -3.129394054412842,
            "end_logit": -2.0420923233032227,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "24\u00a0kDa homodimer of the p50",
            "probability": 0.013478483652037949,
            "start_logit": -4.4623026847839355,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "the p50",
            "probability": 0.012439409515575919,
            "start_logit": -4.542527675628662,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "dimers amongst themselves in various combinations. Here we report the backbone resonance assignments of the 24\u00a0kDa homodimer of the p50",
            "probability": 0.012169052026381773,
            "start_logit": -4.5645012855529785,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "backbone resonance assignments of the 24\u00a0kDa homodimer of the p50",
            "probability": 0.008842963526268684,
            "start_logit": -4.883775234222412,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "p50 subunit of NF-kappaB. This is the first step towards understanding the mechanism of dimer formation in solution.",
            "probability": 0.0062635860001996595,
            "start_logit": -0.7373673915863037,
            "end_logit": -5.437336444854736,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "p",
            "probability": 0.0058444180260781575,
            "start_logit": -0.7373673915863037,
            "end_logit": -5.5066022872924805,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "50",
            "probability": 0.005514466640214809,
            "start_logit": -5.356022357940674,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Here we report the backbone resonance assignments of the 24\u00a0kDa homodimer of the p50",
            "probability": 0.0051880969868970325,
            "start_logit": -5.417030334472656,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "24\u00a0kDa homodimer of the p50 subunit of NF-kappaB.",
            "probability": 0.004504431513322059,
            "start_logit": -4.4623026847839355,
            "end_logit": -2.0420923233032227,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "the p50 subunit of NF-kappaB",
            "probability": 0.004157178928699916,
            "start_logit": -4.542527675628662,
            "end_logit": -2.0420923233032227,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "report the backbone resonance assignments of the 24\u00a0kDa homodimer of the p50",
            "probability": 0.00403940943336188,
            "start_logit": -5.667298793792725,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "combinations. Here we report the backbone resonance assignments of the 24\u00a0kDa homodimer of the p50",
            "probability": 0.003993853094547753,
            "start_logit": -5.678640842437744,
            "end_logit": -0.9460594058036804,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kappaB",
            "probability": 0.0034620129737249275,
            "start_logit": -2.3252055644989014,
            "end_logit": -4.442400932312012,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kappaB)",
            "probability": 0.003429953260534272,
            "start_logit": -2.3252055644989014,
            "end_logit": -4.451704502105713,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        }
    ],
    "52fa73e82059c6d71c000059": [
        {
            "text": "In utero electroporation",
            "probability": 0.5493225909857414,
            "start_logit": 4.04083776473999,
            "end_logit": 4.791567325592041,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation",
            "probability": 0.2865651032712598,
            "start_logit": 3.390117645263672,
            "end_logit": 4.791567325592041,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "Bilateral in utero electroporation",
            "probability": 0.06957760126736999,
            "start_logit": 2.6273884773254395,
            "end_logit": 4.138773441314697,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "in utero electroporation",
            "probability": 0.03240784218997759,
            "start_logit": 1.8633462190628052,
            "end_logit": 4.138773441314697,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DNA plasmid to achieve a particular genetic manipulation. Bilateral in utero electroporation",
            "probability": 0.030881830468549965,
            "start_logit": 1.8151137828826904,
            "end_logit": 4.138773441314697,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero",
            "probability": 0.018235806242359123,
            "start_logit": 4.04083776473999,
            "end_logit": 1.3862684965133667,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DNA plasmid to achieve a particular genetic manipulation.",
            "probability": 0.002069317728403874,
            "start_logit": 1.8151137828826904,
            "end_logit": 1.4358243942260742,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "a DNA plasmid to achieve a particular genetic manipulation. Bilateral in utero electroporation",
            "probability": 0.0015312630992354475,
            "start_logit": -1.1889612674713135,
            "end_logit": 4.138773441314697,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "Bilateral in utero",
            "probability": 0.0013096231011967307,
            "start_logit": 2.6273884773254395,
            "end_logit": 0.1660701334476471,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DNA plasmid",
            "probability": 0.0012435931730560752,
            "start_logit": 1.8151137828826904,
            "end_logit": 0.9266103506088257,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electroporation offers a relatively quick and easy method to manipulate gene expression in a cell-type specific manner in vivo",
            "probability": 0.0011394877771310184,
            "start_logit": 4.04083776473999,
            "end_logit": -1.3865396976470947,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electro",
            "probability": 0.0008538512876089075,
            "start_logit": 4.04083776473999,
            "end_logit": -1.675116777420044,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "In utero electroporation offers a relatively quick and easy method",
            "probability": 0.0007650953399141087,
            "start_logit": 4.04083776473999,
            "end_logit": -1.784873366355896,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "developing a DNA plasmid to achieve a particular genetic manipulation. Bilateral in utero electroporation",
            "probability": 0.0006989312008635806,
            "start_logit": -1.9732571840286255,
            "end_logit": 4.138773441314697,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "in utero",
            "probability": 0.0006099960047320124,
            "start_logit": 1.8633462190628052,
            "end_logit": 0.1660701334476471,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "electroporation offers a relatively quick and easy method to manipulate gene expression in a cell-type specific manner in vivo",
            "probability": 0.0005944365622100628,
            "start_logit": 3.390117645263672,
            "end_logit": -1.3865396976470947,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DNA plasmid to achieve a particular genetic manipulation. Bilateral in utero",
            "probability": 0.0005812726775882834,
            "start_logit": 1.8151137828826904,
            "end_logit": 0.1660701334476471,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "poration",
            "probability": 0.0005751678621669105,
            "start_logit": -2.82094144821167,
            "end_logit": 4.791567325592041,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": ". Bilateral in utero electroporation",
            "probability": 0.0005343956614387157,
            "start_logit": -2.241672992706299,
            "end_logit": 4.138773441314697,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "ation",
            "probability": 0.0005027940991964272,
            "start_logit": -2.9554226398468018,
            "end_logit": 4.791567325592041,
            "question_text": "List the existing methods for genetic manipulation of cells."
        }
    ],
    "551910d3622b194345000008": [
        {
            "text": "TRK",
            "probability": 0.21881413336165514,
            "start_logit": -0.2767813801765442,
            "end_logit": -1.821173906326294,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN",
            "probability": 0.1745788378351893,
            "start_logit": -1.2092206478118896,
            "end_logit": -1.1145808696746826,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GFR\u03b13 by ARTN",
            "probability": 0.11434043787494644,
            "start_logit": -0.7363863587379456,
            "end_logit": -2.0106112957000732,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GFR\u03b13 by ARTN resulted in RET phosphorylation. Interestingly, activation of TrkA",
            "probability": 0.08880519561600438,
            "start_logit": -0.7363863587379456,
            "end_logit": -2.2633464336395264,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN in NBLS cells led to phosphorylation of TrkA. This suggests a physical association between RET and TRK",
            "probability": 0.08612359327857212,
            "start_logit": -1.2092206478118896,
            "end_logit": -1.821173906326294,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NRTN",
            "probability": 0.05398637880876934,
            "start_logit": -1.4885333776474,
            "end_logit": -2.0089128017425537,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NGF",
            "probability": 0.05087407108982771,
            "start_logit": -1.6253989934921265,
            "end_logit": -1.9314255714416504,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK inhibitor (CEP\u2011701). Conversely, RET activation by ARTN",
            "probability": 0.041177930712094836,
            "start_logit": -2.6536946296691895,
            "end_logit": -1.1145808696746826,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK proteins, and cross\u2011talk between these two receptor pathways. Finally, RET, GFR and TRK",
            "probability": 0.03410627482871947,
            "start_logit": -0.2767813801765442,
            "end_logit": -3.679915189743042,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TrkA by its cognate ligand NGF",
            "probability": 0.030926287787809773,
            "start_logit": -2.15297269821167,
            "end_logit": -1.9015986919403076,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TrkA",
            "probability": 0.021538861560823297,
            "start_logit": -2.15297269821167,
            "end_logit": -2.2633464336395264,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TrkA. This suggests a physical association between RET and TRK",
            "probability": 0.015779706536135356,
            "start_logit": -2.9062793254852295,
            "end_logit": -1.821173906326294,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN in NBLS cells led to phosphorylation of TrkA",
            "probability": 0.01566152989511485,
            "start_logit": -1.2092206478118896,
            "end_logit": -3.525749921798706,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "NRTN, and ARTN",
            "probability": 0.014064287156963439,
            "start_logit": -1.4885333776474,
            "end_logit": -3.354005813598633,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GFR",
            "probability": 0.009214364750400947,
            "start_logit": -0.7363863587379456,
            "end_logit": -4.529027938842773,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GFR\u03b13",
            "probability": 0.00830900658207009,
            "start_logit": -0.7363863587379456,
            "end_logit": -4.63245153427124,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK expression in primary tumors was investigated and a significant association between RET, its co\u2011receptors and TRK",
            "probability": 0.00684016772130543,
            "start_logit": -2.25307035446167,
            "end_logit": -3.310295343399048,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "TRK proteins, and cross\u2011talk between these two receptor pathways. Finally, RET, GFR",
            "probability": 0.006215745704301595,
            "start_logit": -0.2767813801765442,
            "end_logit": -5.38231086730957,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF, NRTN",
            "probability": 0.004396410875212449,
            "start_logit": -3.996476650238037,
            "end_logit": -2.0089128017425537,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "ARTN in NBLS cells led to phosphorylation of TrkA.",
            "probability": 0.004246778024084232,
            "start_logit": -1.2092206478118896,
            "end_logit": -4.830796718597412,
            "question_text": "Which proteins have been identified as RET ligands?"
        }
    ],
    "52fb78d82059c6d71c000068": [
        {
            "text": "C5607T",
            "probability": 0.9481139585014305,
            "start_logit": 2.7502269744873047,
            "end_logit": 2.038853406906128,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism",
            "probability": 0.026286212420565058,
            "start_logit": 2.7502269744873047,
            "end_logit": -1.546576738357544,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "a C5607T",
            "probability": 0.006226247954324678,
            "start_logit": -2.2754738330841064,
            "end_logit": 2.038853406906128,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C",
            "probability": 0.005772015926226831,
            "start_logit": 2.7502269744873047,
            "end_logit": -3.0625998973846436,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism in Korean subjects. A single nucleotide substitution of G",
            "probability": 0.0032459216077107456,
            "start_logit": 2.7502269744873047,
            "end_logit": -3.6382219791412354,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism in Korean subjects. A single nucleotide substitution of G to A",
            "probability": 0.0023235239380201916,
            "start_logit": 2.7502269744873047,
            "end_logit": -3.972536325454712,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism in Korean subjects. A single nucleotide substitution",
            "probability": 0.0023180560377317715,
            "start_logit": 2.7502269744873047,
            "end_logit": -3.9748923778533936,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.001307672341141726,
            "start_logit": -3.835999011993408,
            "end_logit": 2.038853406906128,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "C5607T polymorphism in Korean subjects.",
            "probability": 0.0012229765323237734,
            "start_logit": 2.7502269744873047,
            "end_logit": -4.614333629608154,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "novel single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.001078554549717293,
            "start_logit": -4.028625965118408,
            "end_logit": 2.038853406906128,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "T",
            "probability": 0.0009044968596305105,
            "start_logit": -4.204624176025391,
            "end_logit": 2.038853406906128,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "a novel single missense mutation associated with Brugada syndrome in the family and detected a C5607T",
            "probability": 0.0007135993168060355,
            "start_logit": -4.441681385040283,
            "end_logit": 2.038853406906128,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "a C5607T polymorphism",
            "probability": 0.00017262110197087686,
            "start_logit": -2.2754738330841064,
            "end_logit": -1.546576738357544,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "polymorphism",
            "probability": 7.929415982457471e-05,
            "start_logit": -3.05340838432312,
            "end_logit": -1.546576738357544,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "A single nucleotide substitution of G to A at nucleotide position 3934",
            "probability": 5.9670388923856136e-05,
            "start_logit": -1.7088757753372192,
            "end_logit": -3.1754379272460938,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "a C",
            "probability": 3.7904728678187724e-05,
            "start_logit": -2.2754738330841064,
            "end_logit": -3.0625998973846436,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "A single nucleotide substitution of G",
            "probability": 3.756421421262752e-05,
            "start_logit": -1.7088757753372192,
            "end_logit": -3.6382219791412354,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "single missense mutation associated with Brugada syndrome in the family and detected a C5607T polymorphism",
            "probability": 3.625487487820501e-05,
            "start_logit": -3.835999011993408,
            "end_logit": -1.546576738357544,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "single nucleotide substitution of G to A at nucleotide position 3934",
            "probability": 3.3018121535698655e-05,
            "start_logit": -2.3006551265716553,
            "end_logit": -3.1754379272460938,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "A single nucleotide substitution of G to A at nucleotide position 3934 changed the coding sense of exon 21",
            "probability": 3.0436424347241138e-05,
            "start_logit": -1.7088757753372192,
            "end_logit": -3.8486337661743164,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        }
    ],
    "55031270e9bde6963400001a": [
        {
            "text": "Hypocellular bone marrow failure (BMF)",
            "probability": 0.528523316911241,
            "start_logit": 0.22501879930496216,
            "end_logit": -1.5327935218811035,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone marrow failure",
            "probability": 0.14411770002457056,
            "start_logit": 0.22501879930496216,
            "end_logit": -2.8322501182556152,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular",
            "probability": 0.13811434222801933,
            "start_logit": 0.22501879930496216,
            "end_logit": -2.874798536300659,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone marrow failure (BMF",
            "probability": 0.0851264240202853,
            "start_logit": 0.22501879930496216,
            "end_logit": -3.3587429523468018,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "H",
            "probability": 0.035870755637853455,
            "start_logit": 0.22501879930496216,
            "end_logit": -4.222958087921143,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "BMF)",
            "probability": 0.01205618862733706,
            "start_logit": -3.555490016937256,
            "end_logit": -1.5327935218811035,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "(BMF)",
            "probability": 0.011932440476569675,
            "start_logit": -3.565807342529297,
            "end_logit": -1.5327935218811035,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone marrow failure (BMF) has myriad differential diagnoses,",
            "probability": 0.009081552004485774,
            "start_logit": 0.22501879930496216,
            "end_logit": -5.596635341644287,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone marrow failure (",
            "probability": 0.008174967661706311,
            "start_logit": 0.22501879930496216,
            "end_logit": -5.701803684234619,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular BMF",
            "probability": 0.00662409047023746,
            "start_logit": -2.144343614578247,
            "end_logit": -3.5428049564361572,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Hypocellular bone",
            "probability": 0.004172379536363883,
            "start_logit": 0.22501879930496216,
            "end_logit": -6.374393939971924,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "bone marrow failure (BMF)",
            "probability": 0.0035548056538228694,
            "start_logit": -4.776767730712891,
            "end_logit": -1.5327935218811035,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "failure (BMF)",
            "probability": 0.001971702220333943,
            "start_logit": -5.366170883178711,
            "end_logit": -1.5327935218811035,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "BMF",
            "probability": 0.001941825823611847,
            "start_logit": -3.555490016937256,
            "end_logit": -3.3587429523468018,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular BMF,",
            "probability": 0.0019338200738387623,
            "start_logit": -2.144343614578247,
            "end_logit": -4.774020671844482,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "(BMF",
            "probability": 0.0019218943707943748,
            "start_logit": -3.565807342529297,
            "end_logit": -3.3587429523468018,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": ")",
            "probability": 0.0018779077993242154,
            "start_logit": -5.414909839630127,
            "end_logit": -1.5327935218811035,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "cellular bone marrow failure (BMF)",
            "probability": 0.0012624460645556026,
            "start_logit": -5.81201696395874,
            "end_logit": -1.5327935218811035,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "bone marrow failure",
            "probability": 0.0009693241498923839,
            "start_logit": -4.776767730712891,
            "end_logit": -2.8322501182556152,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "hypocellular BMF, with a focus on genomic assessment,",
            "probability": 0.0007721162451563257,
            "start_logit": -2.144343614578247,
            "end_logit": -5.692138195037842,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        }
    ],
    "56d2ac03f22319765a000004": [
        {
            "text": "HAIs",
            "probability": 0.22995062478827868,
            "start_logit": -4.903078556060791,
            "end_logit": -5.310096740722656,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "HAIs) and admission swab positivity with ESKAPE or ESBL isolates.",
            "probability": 0.107183493440474,
            "start_logit": -4.903078556060791,
            "end_logit": -6.073419094085693,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "HAIs) and admission swab positivity with ESKAPE or ESBL",
            "probability": 0.07417324217518223,
            "start_logit": -4.903078556060791,
            "end_logit": -6.441557884216309,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Bokamoso hospital,",
            "probability": 0.06669530661132958,
            "start_logit": -6.252918720245361,
            "end_logit": -5.197986602783203,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "HAIs) and admission swab positivity with ESKAPE or ESBL isolates",
            "probability": 0.05153799093529746,
            "start_logit": -4.903078556060791,
            "end_logit": -6.805642127990723,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESBL isolates.",
            "probability": 0.04245435954586831,
            "start_logit": -5.829191207885742,
            "end_logit": -6.073419094085693,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE organisms were associated with 50-90% of clinical infections; however, there was no correlation between healthcare associated infections (HAIs",
            "probability": 0.04053641557847722,
            "start_logit": -6.638742446899414,
            "end_logit": -5.310096740722656,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "healthcare associated infections (HAIs",
            "probability": 0.03920074521819353,
            "start_logit": -6.672247409820557,
            "end_logit": -5.310096740722656,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Bokamoso hospital, ESKAPE organisms were associated with 50-90% of clinical infections;",
            "probability": 0.036724388422236444,
            "start_logit": -6.252918720245361,
            "end_logit": -5.794680118560791,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "infections (HAIs",
            "probability": 0.03337181621881462,
            "start_logit": -6.833231449127197,
            "end_logit": -5.310096740722656,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE organisms were associated with 50-90% of clinical infections; however, there was no correlation between healthcare associated infections",
            "probability": 0.033137592278068916,
            "start_logit": -6.638742446899414,
            "end_logit": -5.511629104614258,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "healthcare associated infections",
            "probability": 0.03204571231815251,
            "start_logit": -6.672247409820557,
            "end_logit": -5.511629104614258,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESBL",
            "probability": 0.029379313837505982,
            "start_logit": -5.829191207885742,
            "end_logit": -6.441557884216309,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Bokamoso hospital, ESKAPE organisms were associated with 50-90% of clinical infections",
            "probability": 0.02888139551792475,
            "start_logit": -6.252918720245361,
            "end_logit": -6.034923553466797,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "infections; however, there was no correlation between healthcare associated infections (HAIs",
            "probability": 0.02735551918112351,
            "start_logit": -7.03202486038208,
            "end_logit": -5.310096740722656,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "infections",
            "probability": 0.0272806962247763,
            "start_logit": -6.833231449127197,
            "end_logit": -5.511629104614258,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "associated with 50-90% of clinical infections; however, there was no correlation between healthcare associated infections (HAIs",
            "probability": 0.026699692907316795,
            "start_logit": -7.056291103363037,
            "end_logit": -5.310096740722656,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "ESKAPE organisms were associated with 50-90% of clinical infections;",
            "probability": 0.024968557726393503,
            "start_logit": -6.638742446899414,
            "end_logit": -5.794680118560791,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Lenmed Bokamoso hospital,",
            "probability": 0.02425845839681283,
            "start_logit": -7.264287948608398,
            "end_logit": -5.197986602783203,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "50-90% of clinical infections; however, there was no correlation between healthcare associated infections (HAIs",
            "probability": 0.02416467867777279,
            "start_logit": -7.156051158905029,
            "end_logit": -5.310096740722656,
            "question_text": "Which ones are the ESKAPE organisms?"
        }
    ],
    "51716a438ed59a060a00000a": [
        {
            "text": "Java",
            "probability": 0.9593748430523761,
            "start_logit": 2.125650644302368,
            "end_logit": 1.8655500411987305,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Java,",
            "probability": 0.014033989857992736,
            "start_logit": 2.125650644302368,
            "end_logit": -2.3592495918273926,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Using Java",
            "probability": 0.0049248295289235095,
            "start_logit": -3.146341562271118,
            "end_logit": 1.8655500411987305,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "alignment",
            "probability": 0.004417491936429227,
            "start_logit": -0.5208715796470642,
            "end_logit": -0.8686375021934509,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Java, we have developed a new visualization tool that allows effective comparative genome sequence analysis.",
            "probability": 0.0022273979371903565,
            "start_logit": 2.125650644302368,
            "end_logit": -4.199897766113281,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Java, we have developed a new visualization tool that allows effective comparative genome sequence analysis",
            "probability": 0.0022033004717904466,
            "start_logit": 2.125650644302368,
            "end_logit": -4.210775375366211,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "J",
            "probability": 0.0020655115453297986,
            "start_logit": 2.125650644302368,
            "end_logit": -4.275353908538818,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Java, we have developed a new visualization tool",
            "probability": 0.0014714347998659033,
            "start_logit": 2.125650644302368,
            "end_logit": -4.6144938468933105,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "alignment programs",
            "probability": 0.001350577181773669,
            "start_logit": -0.5208715796470642,
            "end_logit": -2.053677558898926,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "repeat masking, and alignment",
            "probability": 0.0013174854366644932,
            "start_logit": -1.730718731880188,
            "end_logit": -0.8686375021934509,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "ava",
            "probability": 0.0012872127163803526,
            "start_logit": -4.488152027130127,
            "end_logit": 1.8655500411987305,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "gene prediction, repeat masking, and alignment",
            "probability": 0.001039706501147029,
            "start_logit": -1.9675052165985107,
            "end_logit": -0.8686375021934509,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "database searching, gene prediction, repeat masking, and alignment",
            "probability": 0.0007433847673408074,
            "start_logit": -2.302985191345215,
            "end_logit": -0.8686375021934509,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "repeat masking",
            "probability": 0.000652797594044659,
            "start_logit": -1.730718731880188,
            "end_logit": -1.5708506107330322,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "analysis; not many exist for overall view/control of the results, which is necessary for large-scale genomic sequence analysis. Using Java",
            "probability": 0.0006330033511377591,
            "start_logit": -5.197910785675049,
            "end_logit": 1.8655500411987305,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "gene prediction",
            "probability": 0.00056602727325674,
            "start_logit": -1.9675052165985107,
            "end_logit": -1.4766889810562134,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "gene prediction, repeat masking",
            "probability": 0.000515161597671771,
            "start_logit": -1.9675052165985107,
            "end_logit": -1.5708506107330322,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "database searching, gene prediction",
            "probability": 0.00040470657091621823,
            "start_logit": -2.302985191345215,
            "end_logit": -1.4766889810562134,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "repeat masking, and alignment programs",
            "probability": 0.0004028000036410911,
            "start_logit": -1.730718731880188,
            "end_logit": -2.053677558898926,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "database searching, gene prediction, repeat masking",
            "probability": 0.0003683378761272088,
            "start_logit": -2.302985191345215,
            "end_logit": -1.5708506107330322,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        }
    ],
    "53215fca9b2d7acc7e000005": [
        {
            "text": "MICOS",
            "probability": 0.6239182324465194,
            "start_logit": 4.432192325592041,
            "end_logit": 3.435159206390381,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MICOS",
            "probability": 0.18463071644762116,
            "start_logit": 3.2145307064056396,
            "end_logit": 3.435159206390381,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MICOS)",
            "probability": 0.06486153080038184,
            "start_logit": 4.432192325592041,
            "end_logit": 1.1713945865631104,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MICOS) complex",
            "probability": 0.034371101805745784,
            "start_logit": 4.432192325592041,
            "end_logit": 0.5363560318946838,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system",
            "probability": 0.02997025513744164,
            "start_logit": 3.2145307064056396,
            "end_logit": 1.6170068979263306,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MICOS)",
            "probability": 0.019193910802391,
            "start_logit": 3.2145307064056396,
            "end_logit": 1.1713945865631104,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MICOS complex",
            "probability": 0.014353122449263135,
            "start_logit": 3.083796501159668,
            "end_logit": 1.0115032196044922,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MICOS) complex",
            "probability": 0.010171142341208833,
            "start_logit": 3.2145307064056396,
            "end_logit": 0.5363560318946838,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MICOS",
            "probability": 0.00525615796374368,
            "start_logit": -0.3444266617298126,
            "end_logit": 3.435159206390381,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MI",
            "probability": 0.0040978034047195085,
            "start_logit": 4.432192325592041,
            "end_logit": -1.5904090404510498,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system (MICOS",
            "probability": 0.003823029818675093,
            "start_logit": -0.6627837419509888,
            "end_logit": 3.435159206390381,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "cristae organizing system (MI",
            "probability": 0.0012126274552166035,
            "start_logit": 3.2145307064056396,
            "end_logit": -1.5904090404510498,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "CHCHD3), two core components of the mitochondrial contact site and cristae organizing system (MICOS",
            "probability": 0.0009142838008658672,
            "start_logit": -2.0934412479400635,
            "end_logit": 3.435159206390381,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "c",
            "probability": 0.0006401982982618849,
            "start_logit": 3.2145307064056396,
            "end_logit": -2.2291758060455322,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system",
            "probability": 0.0006205748494522294,
            "start_logit": -0.6627837419509888,
            "end_logit": 1.6170068979263306,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MICOS)",
            "probability": 0.0005464216846496084,
            "start_logit": -0.3444266617298126,
            "end_logit": 1.1713945865631104,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MICOS) complex.",
            "probability": 0.0005212900955953608,
            "start_logit": 4.432192325592041,
            "end_logit": -3.652308702468872,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system (MICOS)",
            "probability": 0.00039743599952583186,
            "start_logit": -0.6627837419509888,
            "end_logit": 1.1713945865631104,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MICOS) complex",
            "probability": 0.000289557078289744,
            "start_logit": -0.3444266617298126,
            "end_logit": 0.5363560318946838,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial contact site and cristae organizing system (MICOS) complex",
            "probability": 0.00021060732043176323,
            "start_logit": -0.6627837419509888,
            "end_logit": 0.5363560318946838,
            "question_text": "Which protein complexes contain mitofilin?"
        }
    ],
    "56ae40110a360a5e45000009": [
        {
            "text": "CS-Rosetta",
            "probability": 0.5562812212152622,
            "start_logit": 4.6427812576293945,
            "end_logit": 3.5399179458618164,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo structure prediction framework",
            "probability": 0.21641268636213246,
            "start_logit": 4.6427812576293945,
            "end_logit": 2.5958311557769775,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo structure prediction",
            "probability": 0.13158316254456306,
            "start_logit": 4.6427812576293945,
            "end_logit": 2.098283052444458,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "de novo structure prediction framework",
            "probability": 0.02104013777486886,
            "start_logit": 2.312026023864746,
            "end_logit": 2.5958311557769775,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "chemical shift-based CS-Rosetta",
            "probability": 0.016936802390150163,
            "start_logit": 1.150996208190918,
            "end_logit": 3.5399179458618164,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "de novo structure prediction",
            "probability": 0.01279281688762865,
            "start_logit": 2.312026023864746,
            "end_logit": 2.098283052444458,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "chemical shift-based CS-Rosetta de novo structure prediction framework",
            "probability": 0.00658900348214095,
            "start_logit": 1.150996208190918,
            "end_logit": 2.5958311557769775,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo",
            "probability": 0.006325064978471712,
            "start_logit": 4.6427812576293945,
            "end_logit": -0.9368357062339783,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "sPRE data in the chemical shift-based CS-Rosetta",
            "probability": 0.004451869777672179,
            "start_logit": -0.18516851961612701,
            "end_logit": 3.5399179458618164,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "chemical shift-based CS-Rosetta de novo structure prediction",
            "probability": 0.004006243491411838,
            "start_logit": 1.150996208190918,
            "end_logit": 2.098283052444458,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "Rosetta",
            "probability": 0.0036431609354893655,
            "start_logit": -0.3856410086154938,
            "end_logit": 3.5399179458618164,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "C",
            "probability": 0.003557310349745272,
            "start_logit": 4.6427812576293945,
            "end_logit": -1.5123512744903564,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de novo structure",
            "probability": 0.0030926264940197216,
            "start_logit": 4.6427812576293945,
            "end_logit": -1.652335286140442,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "the chemical shift-based CS-Rosetta",
            "probability": 0.0025790764324431343,
            "start_logit": -0.7310613393783569,
            "end_logit": 3.5399179458618164,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "structure prediction framework",
            "probability": 0.002567428941261996,
            "start_logit": 0.20849907398223877,
            "end_logit": 2.5958311557769775,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS-Rosetta de",
            "probability": 0.0019503878933258135,
            "start_logit": 4.6427812576293945,
            "end_logit": -2.113327741622925,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "sPRE data in the chemical shift-based CS-Rosetta de novo structure prediction framework",
            "probability": 0.001731931730169993,
            "start_logit": -0.18516851961612701,
            "end_logit": 2.5958311557769775,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "structure prediction",
            "probability": 0.0015610472074376763,
            "start_logit": 0.20849907398223877,
            "end_logit": 2.098283052444458,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "CS",
            "probability": 0.001480705166505864,
            "start_logit": 4.6427812576293945,
            "end_logit": -2.3888375759124756,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "Rosetta de novo structure prediction framework",
            "probability": 0.001417315945299075,
            "start_logit": -0.3856410086154938,
            "end_logit": 2.5958311557769775,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        }
    ],
    "52f509232059c6d71c00001f": [
        {
            "text": "KCNQ1",
            "probability": 0.6763291269081986,
            "start_logit": 4.624329566955566,
            "end_logit": 3.545273542404175,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene",
            "probability": 0.27400644230721444,
            "start_logit": 4.624329566955566,
            "end_logit": 2.6417453289031982,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "The KCNQ1",
            "probability": 0.03241731581216258,
            "start_logit": 1.586342453956604,
            "end_logit": 3.545273542404175,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "The KCNQ1 gene",
            "probability": 0.013133477505909263,
            "start_logit": 1.586342453956604,
            "end_logit": 2.6417453289031982,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene has a significant role in long QT syndrome, Jervell and Lange-Nielsen syndrome",
            "probability": 0.0008385363686901568,
            "start_logit": 4.624329566955566,
            "end_logit": -3.147503614425659,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "K",
            "probability": 0.000664274577223966,
            "start_logit": 4.624329566955566,
            "end_logit": -3.3804659843444824,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ",
            "probability": 0.0005963456658469383,
            "start_logit": 4.624329566955566,
            "end_logit": -3.4883410930633545,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene has a significant role in long QT syndrome, Jervell and Lange-Nielsen",
            "probability": 0.0004665906089978664,
            "start_logit": 4.624329566955566,
            "end_logit": -3.7337093353271484,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "1",
            "probability": 0.0003841964328097027,
            "start_logit": -2.848951578140259,
            "end_logit": 3.545273542404175,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene has a significant role",
            "probability": 0.00021934424189823338,
            "start_logit": 4.624329566955566,
            "end_logit": -4.488519191741943,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1 gene has a significant role in long QT syndrome, Jervell",
            "probability": 0.0001900892985805071,
            "start_logit": 4.624329566955566,
            "end_logit": -4.631667613983154,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "Q1",
            "probability": 0.00016551308346435294,
            "start_logit": -3.6910552978515625,
            "end_logit": 3.545273542404175,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "1 gene",
            "probability": 0.00015565246787840696,
            "start_logit": -2.848951578140259,
            "end_logit": 2.6417453289031982,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "gene",
            "probability": 0.00012740665106603384,
            "start_logit": -3.0491933822631836,
            "end_logit": 2.6417453289031982,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "CNQ1",
            "probability": 8.68547501657206e-05,
            "start_logit": -4.3358683586120605,
            "end_logit": 3.545273542404175,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "Q1 gene",
            "probability": 6.705559372060016e-05,
            "start_logit": -3.6910552978515625,
            "end_logit": 2.6417453289031982,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "NQ1",
            "probability": 4.455794922517107e-05,
            "start_logit": -5.003314971923828,
            "end_logit": 3.545273542404175,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "The KCNQ1 gene has a significant role in long QT syndrome, Jervell and Lange-Nielsen syndrome",
            "probability": 4.01921153508187e-05,
            "start_logit": 1.586342453956604,
            "end_logit": -3.147503614425659,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "CNQ1 gene",
            "probability": 3.518813569243391e-05,
            "start_logit": -4.3358683586120605,
            "end_logit": 2.6417453289031982,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "The K",
            "probability": 3.183952590405439e-05,
            "start_logit": 1.586342453956604,
            "end_logit": -3.3804659843444824,
            "question_text": "Which genes are implicated in short QT syndrome?"
        }
    ],
    "56be1723ef6e39474100000c": [
        {
            "text": "headache",
            "probability": 0.0972508656195682,
            "start_logit": 3.9534690380096436,
            "end_logit": 4.060060977935791,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "headache, photophobia",
            "probability": 0.08942457902326532,
            "start_logit": 3.9534690380096436,
            "end_logit": 3.9761626720428467,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "photophobia",
            "probability": 0.08243213875912445,
            "start_logit": 3.872048854827881,
            "end_logit": 3.9761626720428467,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "headache, photophobia and irritability along with abducens nerve palsy",
            "probability": 0.08236300761292405,
            "start_logit": 3.9534690380096436,
            "end_logit": 3.8939034938812256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "photophobia and irritability along with abducens nerve palsy",
            "probability": 0.07592273786831034,
            "start_logit": 3.872048854827881,
            "end_logit": 3.8939034938812256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "headache, photophobia and irritability",
            "probability": 0.07390608623941317,
            "start_logit": 3.9534690380096436,
            "end_logit": 3.78556227684021,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "photophobia and irritability",
            "probability": 0.0681270946150736,
            "start_logit": 3.872048854827881,
            "end_logit": 3.78556227684021,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache",
            "probability": 0.06739785963997275,
            "start_logit": 3.5867884159088135,
            "end_logit": 4.060060977935791,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache, photophobia",
            "probability": 0.06197400081712968,
            "start_logit": 3.5867884159088135,
            "end_logit": 3.9761626720428467,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache, photophobia and irritability along with abducens nerve palsy",
            "probability": 0.05708011328492387,
            "start_logit": 3.5867884159088135,
            "end_logit": 3.8939034938812256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever, headache, photophobia and irritability",
            "probability": 0.05121920504429342,
            "start_logit": 3.5867884159088135,
            "end_logit": 3.78556227684021,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "irritability along with abducens nerve palsy",
            "probability": 0.04429733688143707,
            "start_logit": 3.3332571983337402,
            "end_logit": 3.8939034938812256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy",
            "probability": 0.04215638626379466,
            "start_logit": 3.2837188243865967,
            "end_logit": 3.8939034938812256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "fever",
            "probability": 0.04019292663707741,
            "start_logit": 3.5867884159088135,
            "end_logit": 3.5431387424468994,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "irritability",
            "probability": 0.03974894670094719,
            "start_logit": 3.3332571983337402,
            "end_logit": 3.78556227684021,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever, headache",
            "probability": 0.006429386961930876,
            "start_logit": 1.2370543479919434,
            "end_logit": 4.060060977935791,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever, headache, photophobia",
            "probability": 0.005911980513340055,
            "start_logit": 1.2370543479919434,
            "end_logit": 3.9761626720428467,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever, headache, photophobia and irritability along with abducens nerve palsy",
            "probability": 0.005445130425506424,
            "start_logit": 1.2370543479919434,
            "end_logit": 3.8939034938812256,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever, headache, photophobia and irritability",
            "probability": 0.004886031854295507,
            "start_logit": 1.2370543479919434,
            "end_logit": 3.78556227684021,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "meningitis which include fever",
            "probability": 0.003834185237671951,
            "start_logit": 1.2370543479919434,
            "end_logit": 3.5431387424468994,
            "question_text": "List symptoms of Gradenigo's syndrome."
        }
    ],
    "516ec97f298dcd4e51000087": [
        {
            "text": "different genes and gene partitions",
            "probability": 0.28418515736683847,
            "start_logit": -0.9781200289726257,
            "end_logit": -1.254219651222229,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "different genes",
            "probability": 0.18015098323367593,
            "start_logit": -0.9781200289726257,
            "end_logit": -1.710050344467163,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "concatenated dataset of four genes",
            "probability": 0.10979094212247131,
            "start_logit": -0.8941582441329956,
            "end_logit": -2.289229393005371,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "gene partitions",
            "probability": 0.08325016547377433,
            "start_logit": -2.2058959007263184,
            "end_logit": -1.254219651222229,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "genes and gene partitions",
            "probability": 0.07821981232494725,
            "start_logit": -2.2682230472564697,
            "end_logit": -1.254219651222229,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "genes",
            "probability": 0.04958519378442799,
            "start_logit": -2.2682230472564697,
            "end_logit": -1.710050344467163,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "different genes and gene",
            "probability": 0.028653442014349665,
            "start_logit": -0.9781200289726257,
            "end_logit": -3.548572063446045,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "concatenated",
            "probability": 0.02419251226009677,
            "start_logit": -0.8941582441329956,
            "end_logit": -3.8017642498016357,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "different genes and gene partition",
            "probability": 0.023720168078167472,
            "start_logit": -0.9781200289726257,
            "end_logit": -3.7375199794769287,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "different",
            "probability": 0.02228439583483638,
            "start_logit": -0.9781200289726257,
            "end_logit": -3.7999589443206787,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "different genes and gene partitions.",
            "probability": 0.019037745646921827,
            "start_logit": -0.9781200289726257,
            "end_logit": -3.9574220180511475,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "concatenated dataset of four",
            "probability": 0.015318580791642559,
            "start_logit": -0.8941582441329956,
            "end_logit": -4.2587409019470215,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny reconstruction methods",
            "probability": 0.013262597503753217,
            "start_logit": -2.552198886871338,
            "end_logit": -2.744818925857544,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "evaluate the phylogenetic utility of different genes and gene partitions",
            "probability": 0.012887097826931065,
            "start_logit": -4.071519374847412,
            "end_logit": -1.254219651222229,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "concatenated dataset",
            "probability": 0.011295148535131028,
            "start_logit": -0.8941582441329956,
            "end_logit": -4.56343412399292,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "We also evaluate the phylogenetic utility of different genes and gene partitions",
            "probability": 0.009980044669124544,
            "start_logit": -4.327158451080322,
            "end_logit": -1.254219651222229,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "phylogeny reconstruction",
            "probability": 0.009641885206885593,
            "start_logit": -2.552198886871338,
            "end_logit": -3.063650131225586,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "gene",
            "probability": 0.008393836649282232,
            "start_logit": -2.2058959007263184,
            "end_logit": -3.548572063446045,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "evaluate the phylogenetic utility of different genes",
            "probability": 0.00816940394094315,
            "start_logit": -4.071519374847412,
            "end_logit": -1.710050344467163,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "The concatenated dataset of four genes",
            "probability": 0.007980886735799384,
            "start_logit": -3.5156867504119873,
            "end_logit": -2.289229393005371,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        }
    ],
    "54fc9ca16ad7dcbc12000006": [
        {
            "text": "orexin",
            "probability": 0.736952923807736,
            "start_logit": 5.893191814422607,
            "end_logit": 4.857234477996826,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor",
            "probability": 0.09757129158542065,
            "start_logit": 5.893191814422607,
            "end_logit": 2.835293769836426,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist",
            "probability": 0.08283763503587849,
            "start_logit": 5.893191814422607,
            "end_logit": 2.671592950820923,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist,",
            "probability": 0.0628430576431555,
            "start_logit": 5.893191814422607,
            "end_logit": 2.395350933074951,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin",
            "probability": 0.012762598411385757,
            "start_logit": 1.8371866941452026,
            "end_logit": 4.857234477996826,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin receptor",
            "probability": 0.001689745940013155,
            "start_logit": 1.8371866941452026,
            "end_logit": 2.835293769836426,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin receptor antagonist",
            "probability": 0.001434587522699992,
            "start_logit": 1.8371866941452026,
            "end_logit": 2.671592950820923,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual orexin receptor antagonist,",
            "probability": 0.001088320137871391,
            "start_logit": 1.8371866941452026,
            "end_logit": 2.395350933074951,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin",
            "probability": 0.0010674985205245458,
            "start_logit": -0.6440141201019287,
            "end_logit": 4.857234477996826,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "ore",
            "probability": 0.0006070549295768458,
            "start_logit": 5.893191814422607,
            "end_logit": -2.2444255352020264,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist, has been FDA approved for the treatment of insomnia",
            "probability": 0.0002746945053151314,
            "start_logit": 5.893191814422607,
            "end_logit": -3.0373852252960205,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "suvorexant, a dual orexin",
            "probability": 0.0001464435590230272,
            "start_logit": -2.6304473876953125,
            "end_logit": 4.857234477996826,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin receptor",
            "probability": 0.0001413349564785487,
            "start_logit": -0.6440141201019287,
            "end_logit": 2.835293769836426,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin receptor antagonist",
            "probability": 0.00011999281092156011,
            "start_logit": -0.6440141201019287,
            "end_logit": 2.671592950820923,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "xin",
            "probability": 0.00011080930549699267,
            "start_logit": -2.9092767238616943,
            "end_logit": 4.857234477996826,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": ", a dual orexin",
            "probability": 0.00011023578536031284,
            "start_logit": -2.91446590423584,
            "end_logit": 4.857234477996826,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "a dual orexin receptor antagonist,",
            "probability": 9.103006296886481e-05,
            "start_logit": -0.6440141201019287,
            "end_logit": 2.395350933074951,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "antagonist",
            "probability": 5.637908012728865e-05,
            "start_logit": -1.3993477821350098,
            "end_logit": 2.671592950820923,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "dual",
            "probability": 5.159557757175105e-05,
            "start_logit": 1.8371866941452026,
            "end_logit": -0.653603732585907,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "antagonist,",
            "probability": 4.2770822474262225e-05,
            "start_logit": -1.3993477821350098,
            "end_logit": 2.395350933074951,
            "question_text": "Which receptors are targeted by suvorexant?"
        }
    ],
    "56c1f030ef6e39474100004d": [
        {
            "text": "neonatal diabetes mellitus",
            "probability": 0.3089522478024726,
            "start_logit": 5.18112325668335,
            "end_logit": 4.781931400299072,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy",
            "probability": 0.25397449149643453,
            "start_logit": 4.948163986206055,
            "end_logit": 4.8189377784729,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy and neonatal diabetes mellitus",
            "probability": 0.24474759539483928,
            "start_logit": 4.948163986206055,
            "end_logit": 4.781931400299072,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.04673729755001243,
            "start_logit": 3.2924790382385254,
            "end_logit": 4.781931400299072,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy",
            "probability": 0.04125317164997571,
            "start_logit": 3.1306581497192383,
            "end_logit": 4.8189377784729,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy and neonatal diabetes mellitus",
            "probability": 0.03975444346498024,
            "start_logit": 3.1306581497192383,
            "end_logit": 4.781931400299072,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes",
            "probability": 0.021489946801934997,
            "start_logit": 5.18112325668335,
            "end_logit": 2.1163299083709717,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy and neonatal diabetes",
            "probability": 0.01702403152055822,
            "start_logit": 4.948163986206055,
            "end_logit": 2.1163299083709717,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal",
            "probability": 0.008178116706738995,
            "start_logit": 5.18112325668335,
            "end_logit": 1.1502065658569336,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epilepsy and neonatal",
            "probability": 0.006478588238375368,
            "start_logit": 4.948163986206055,
            "end_logit": 1.1502065658569336,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes",
            "probability": 0.0032509296992010287,
            "start_logit": 3.2924790382385254,
            "end_logit": 2.1163299083709717,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay",
            "probability": 0.0029207656043377895,
            "start_logit": 3.1306581497192383,
            "end_logit": 2.171055555343628,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy and neonatal diabetes",
            "probability": 0.00276521980752561,
            "start_logit": 3.1306581497192383,
            "end_logit": 2.1163299083709717,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "developmental delay, epilepsy and neonatal",
            "probability": 0.0010523195108000242,
            "start_logit": 3.1306581497192383,
            "end_logit": 1.1502065658569336,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "pilepsy",
            "probability": 0.00040243048855681583,
            "start_logit": -1.4993027448654175,
            "end_logit": 4.8189377784729,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "pilepsy and neonatal diabetes mellitus",
            "probability": 0.00038781018443040686,
            "start_logit": -1.4993027448654175,
            "end_logit": 4.781931400299072,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "e",
            "probability": 0.0002036632530952797,
            "start_logit": 4.948163986206055,
            "end_logit": -2.3095834255218506,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "epile",
            "probability": 0.00015522098045558404,
            "start_logit": 4.948163986206055,
            "end_logit": -2.5812015533447266,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neon",
            "probability": 0.0001416275165163081,
            "start_logit": 5.18112325668335,
            "end_logit": -2.9058101177215576,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus (DEND) syndrome.",
            "probability": 0.00013008232875860888,
            "start_logit": 5.18112325668335,
            "end_logit": -2.9908430576324463,
            "question_text": "List features of the DEND syndrome."
        }
    ],
    "550312b4e9bde6963400001c": [
        {
            "text": "RPL35A",
            "probability": 0.955031561080641,
            "start_logit": 4.291127681732178,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35",
            "probability": 0.03443785768724797,
            "start_logit": 4.291127681732178,
            "end_logit": 0.08002310246229172,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL",
            "probability": 0.001758973901590776,
            "start_logit": 4.291127681732178,
            "end_logit": -2.8944027423858643,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "R",
            "probability": 0.001255000686315874,
            "start_logit": 4.291127681732178,
            "end_logit": -3.23199725151062,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "heterozygous whole gene deletion in RPL35A",
            "probability": 0.0011921752330340024,
            "start_logit": -2.3948371410369873,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "whole gene deletion in RPL35A",
            "probability": 0.0010811603495599245,
            "start_logit": -2.492581844329834,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "A",
            "probability": 0.0009706403811120383,
            "start_logit": -2.6004159450531006,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "deletion in RPL35A",
            "probability": 0.0009500662764690646,
            "start_logit": -2.621840238571167,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "L35A",
            "probability": 0.0006841411631273178,
            "start_logit": -2.9502077102661133,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "sporadic heterozygous whole gene deletion in RPL35A",
            "probability": 0.0006208285503308998,
            "start_logit": -3.0473170280456543,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "35A",
            "probability": 0.0005711125392702002,
            "start_logit": -3.1307857036590576,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "gene deletion in RPL35A",
            "probability": 0.00032820232081615943,
            "start_logit": -3.684741735458374,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "in RPL35A",
            "probability": 0.00021030989978454353,
            "start_logit": -4.12978982925415,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35A in South Africa.",
            "probability": 0.00019455740957823457,
            "start_logit": 4.291127681732178,
            "end_logit": -5.096161365509033,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RP",
            "probability": 0.00018184205457374823,
            "start_logit": 4.291127681732178,
            "end_logit": -5.163750171661377,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "a sporadic heterozygous whole gene deletion in RPL35A",
            "probability": 0.00015430288089368443,
            "start_logit": -4.439454555511475,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "PL35A",
            "probability": 0.0001371876766208621,
            "start_logit": -4.5570220947265625,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35A in South Africa",
            "probability": 9.854242145813616e-05,
            "start_logit": 4.291127681732178,
            "end_logit": -5.776401519775391,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "girl\u00a0secondary to a sporadic heterozygous whole gene deletion in RPL35A",
            "probability": 9.579951814330866e-05,
            "start_logit": -4.916114330291748,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "on in RPL35A",
            "probability": 4.573796943211911e-05,
            "start_logit": -5.65544319152832,
            "end_logit": 3.402611017227173,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        }
    ],
    "54edaee3445c3b5a5f000003": [
        {
            "text": "Borrelia miyamotoi",
            "probability": 0.7166289895962763,
            "start_logit": 4.380728721618652,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "miyamotoi",
            "probability": 0.20611636851004708,
            "start_logit": 3.1346113681793213,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Lyme borreliosis and relapsing fever group Borrelia. Borrelia miyamotoi",
            "probability": 0.03430096664022654,
            "start_logit": 1.3413439989089966,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "relapsing fever group Borrelia. Borrelia miyamotoi",
            "probability": 0.032203045807624564,
            "start_logit": 1.2782315015792847,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "fever group Borrelia. Borrelia miyamotoi",
            "probability": 0.0022877630174400303,
            "start_logit": -1.3662550449371338,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia",
            "probability": 0.0015251144107835315,
            "start_logit": 4.380728721618652,
            "end_logit": -0.9240328073501587,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B",
            "probability": 0.001145490746270411,
            "start_logit": 4.380728721618652,
            "end_logit": -1.2102690935134888,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Lyme borreliosis",
            "probability": 0.0008123491331465444,
            "start_logit": 1.3413439989089966,
            "end_logit": 1.485457420349121,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia miyamotoi belongs to the relapsing fever",
            "probability": 0.0007987637337935993,
            "start_logit": 4.380728721618652,
            "end_logit": -1.570792317390442,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "ia miyamotoi",
            "probability": 0.0005959033259036065,
            "start_logit": -2.7115063667297363,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "i",
            "probability": 0.000580369245707561,
            "start_logit": -2.7379202842712402,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Lyme borreliosis and relapsing fever",
            "probability": 0.0005660270034694134,
            "start_logit": 1.3413439989089966,
            "end_logit": 1.1241689920425415,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "relapsing fever",
            "probability": 0.0005314075755434048,
            "start_logit": 1.2782315015792847,
            "end_logit": 1.1241689920425415,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia mi",
            "probability": 0.00046108657992140775,
            "start_logit": 4.380728721618652,
            "end_logit": -2.120271682739258,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "borreliosis and relapsing fever group Borrelia. Borrelia miyamotoi",
            "probability": 0.00044433635872232944,
            "start_logit": -3.005002975463867,
            "end_logit": 5.228456020355225,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "B. miyamotoi",
            "probability": 0.000314607174802912,
            "start_logit": -0.48244810104370117,
            "end_logit": 2.3606441020965576,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia miyamoto",
            "probability": 0.00025205522451863307,
            "start_logit": 4.380728721618652,
            "end_logit": -2.7242093086242676,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "miyamotoi belongs to the relapsing fever",
            "probability": 0.00022973991074490873,
            "start_logit": 3.1346113681793213,
            "end_logit": -1.570792317390442,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "mi",
            "probability": 0.00013261742519746366,
            "start_logit": 3.1346113681793213,
            "end_logit": -2.120271682739258,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Lyme borreliosis and relapsing fever group Borrelia. Borrelia",
            "probability": 7.299857985969269e-05,
            "start_logit": 1.3413439989089966,
            "end_logit": -0.9240328073501587,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        }
    ],
    "5335d4e8d6d3ac6a34000053": [
        {
            "text": "ETA",
            "probability": 0.6893364378993567,
            "start_logit": 2.768805503845215,
            "end_logit": 1.470719814300537,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETA receptor",
            "probability": 0.16227472225067885,
            "start_logit": 2.768805503845215,
            "end_logit": 0.024281078949570656,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETB",
            "probability": 0.09228438660787092,
            "start_logit": 1.5531188249588013,
            "end_logit": 0.6755520105361938,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETA receptor (ambrisentan",
            "probability": 0.02256851364165578,
            "start_logit": 2.768805503845215,
            "end_logit": -1.9484539031982422,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETA receptor (ambrisentan) or that block both receptor subtypes (bosentan",
            "probability": 0.01295036701652546,
            "start_logit": 2.768805503845215,
            "end_logit": -2.503885507583618,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETB receptor",
            "probability": 0.012604017076183515,
            "start_logit": 1.5531188249588013,
            "end_logit": -1.315307378768921,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ET",
            "probability": 0.0039009222956242202,
            "start_logit": 2.768805503845215,
            "end_logit": -3.703796625137329,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonists that are selective for the ETA",
            "probability": 0.0007633584291143929,
            "start_logit": -4.036951541900635,
            "end_logit": 1.470719814300537,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETA receptor (ambrisentan) or that block both receptor subtypes",
            "probability": 0.000718800417909079,
            "start_logit": 2.768805503845215,
            "end_logit": -5.395181179046631,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "the ETA",
            "probability": 0.000626823618931114,
            "start_logit": -4.23401403427124,
            "end_logit": 1.470719814300537,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETA receptor (ambrisentan) or that block both receptor subtypes (bosentan)",
            "probability": 0.0006005066341431518,
            "start_logit": 2.768805503845215,
            "end_logit": -5.574991226196289,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ETA receptor (ambrisentan) or that block both receptor subtypes (bosentan).",
            "probability": 0.0005770482229725732,
            "start_logit": 2.768805503845215,
            "end_logit": -5.61483907699585,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "antagonists that are selective for the ETA receptor",
            "probability": 0.0001797000278118741,
            "start_logit": -4.036951541900635,
            "end_logit": 0.024281078949570656,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "the ETA receptor",
            "probability": 0.000147558758060404,
            "start_logit": -4.23401403427124,
            "end_logit": 0.024281078949570656,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "the ETB",
            "probability": 0.0001265074980284572,
            "start_logit": -5.039209842681885,
            "end_logit": 0.6755520105361938,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "A",
            "probability": 0.00011082918210196218,
            "start_logit": -5.966689109802246,
            "end_logit": 1.470719814300537,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "pulmonary arterial hypertension, has been to use antagonists that are selective for the ETA",
            "probability": 0.00010979615508892636,
            "start_logit": -5.976053714752197,
            "end_logit": 1.470719814300537,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ambrisentan",
            "probability": 4.894285134108681e-05,
            "start_logit": -3.3648521900177,
            "end_logit": -1.9484539031982422,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "bosentan). Macitentan represents the next generation of antagonists, being more potent than bosentan",
            "probability": 4.267680731918219e-05,
            "start_logit": -3.4656636714935303,
            "end_logit": -1.984640121459961,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "ambrisentan) or that block both receptor subtypes (bosentan",
            "probability": 2.8084609282041212e-05,
            "start_logit": -3.3648521900177,
            "end_logit": -2.503885507583618,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        }
    ],
    "518ba4b5310faafe08000005": [
        {
            "text": "corticosteroids",
            "probability": 0.6334391208722702,
            "start_logit": 5.5358357429504395,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical corticosteroids",
            "probability": 0.3073393793013275,
            "start_logit": 4.812624454498291,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "budesonide",
            "probability": 0.05385174412422361,
            "start_logit": 4.415325164794922,
            "end_logit": 4.272937297821045,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "rticosteroids",
            "probability": 0.0009404308525986375,
            "start_logit": -0.9767453074455261,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "drugs (particularly swallowed topical corticosteroids",
            "probability": 0.0008262474457538946,
            "start_logit": -1.1061891317367554,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "swallowed topical corticosteroids",
            "probability": 0.0008037711863682983,
            "start_logit": -1.1337687969207764,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "budesonide effervescent tablet in Europe; (2) biologics",
            "probability": 0.0007284895244944366,
            "start_logit": 4.415325164794922,
            "end_logit": -0.03007952682673931,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "steroid formulations optimizing mucosal deposition have been developed, which has culminated in recent approval of a budesonide",
            "probability": 0.0004522453544455052,
            "start_logit": -0.36444005370140076,
            "end_logit": 4.272937297821045,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "icosteroids",
            "probability": 0.00043572902887320904,
            "start_logit": -1.7460628747940063,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "co",
            "probability": 0.00022957991772884668,
            "start_logit": 5.5358357429504395,
            "end_logit": -2.305312156677246,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "steroids",
            "probability": 0.00019857863572113687,
            "start_logit": -2.531898260116577,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "oids",
            "probability": 0.00015902050826542932,
            "start_logit": -2.7540502548217773,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "corticosteroids), dietary restriction, and endoscopic dilation",
            "probability": 0.00012006093701572704,
            "start_logit": 5.5358357429504395,
            "end_logit": -2.953563928604126,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical co",
            "probability": 0.00011139026165240817,
            "start_logit": 4.812624454498291,
            "end_logit": -2.305312156677246,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical",
            "probability": 8.56353825557024e-05,
            "start_logit": 4.812624454498291,
            "end_logit": -2.568253517150879,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "corticosteroids), dietary restriction",
            "probability": 6.434740827885837e-05,
            "start_logit": 5.5358357429504395,
            "end_logit": -3.5772666931152344,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "corticoster",
            "probability": 6.209762094388244e-05,
            "start_logit": 5.5358357429504395,
            "end_logit": -3.6128556728363037,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical corticosteroids), dietary restriction, and endoscopic dilation",
            "probability": 5.825256547138635e-05,
            "start_logit": 4.812624454498291,
            "end_logit": -2.953563928604126,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "corticosteroids)",
            "probability": 5.6557420640834794e-05,
            "start_logit": 5.5358357429504395,
            "end_logit": -3.7063069343566895,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "(particularly swallowed topical corticosteroids",
            "probability": 3.73216513704045e-05,
            "start_logit": -4.20350980758667,
            "end_logit": 5.617355823516846,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        }
    ],
    "56f8077a8b98c98849000002": [
        {
            "text": "small-cell lung cancer",
            "probability": 0.6178758563897625,
            "start_logit": 0.7881115674972534,
            "end_logit": 0.6770145893096924,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity is often associated with small-cell lung cancer",
            "probability": 0.13919853875714636,
            "start_logit": -0.702274739742279,
            "end_logit": 0.6770145893096924,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological autoimmunity is often associated with small-cell lung cancer",
            "probability": 0.10447040990859856,
            "start_logit": -0.9892721176147461,
            "end_logit": 0.6770145893096924,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "small-cell lung cancer (SCLC)",
            "probability": 0.035985950460904935,
            "start_logit": 0.7881115674972534,
            "end_logit": -2.166144371032715,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "lung cancer",
            "probability": 0.02163575012693518,
            "start_logit": -2.563828945159912,
            "end_logit": 0.6770145893096924,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity",
            "probability": 0.016920325896836817,
            "start_logit": -0.702274739742279,
            "end_logit": -1.4303710460662842,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological autoimmunity",
            "probability": 0.01269893633950857,
            "start_logit": -0.9892721176147461,
            "end_logit": -1.4303710460662842,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cancer",
            "probability": 0.011293808798547867,
            "start_logit": -3.213921308517456,
            "end_logit": 0.6770145893096924,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "small-cell lung cancer (SCLC),",
            "probability": 0.009449101059723485,
            "start_logit": 0.7881115674972534,
            "end_logit": -3.5033533573150635,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity is often associated with small-cell lung cancer (SCLC)",
            "probability": 0.008107116774579348,
            "start_logit": -0.702274739742279,
            "end_logit": -2.166144371032715,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "autoimmunity is often associated with small-cell lung cancer",
            "probability": 0.006521026064865307,
            "start_logit": -3.7631442546844482,
            "end_logit": 0.6770145893096924,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological autoimmunity is often associated with small-cell lung cancer (SCLC)",
            "probability": 0.0060845021806933165,
            "start_logit": -0.9892721176147461,
            "end_logit": -2.166144371032715,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological autoimmunity is often associated with small-cell lung cancer (SCLC),",
            "probability": 0.00212874648925011,
            "start_logit": -0.702274739742279,
            "end_logit": -3.5033533573150635,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "neurological",
            "probability": 0.00161040211272997,
            "start_logit": -0.702274739742279,
            "end_logit": -3.782402753829956,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological autoimmunity is often associated with small-cell lung cancer (SCLC),",
            "probability": 0.0015976533971484074,
            "start_logit": -0.9892721176147461,
            "end_logit": -3.5033533573150635,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "lung cancer (SCLC)",
            "probability": 0.001260096221920134,
            "start_logit": -2.563828945159912,
            "end_logit": -2.166144371032715,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Paraneoplastic neurological",
            "probability": 0.001208628842922648,
            "start_logit": -0.9892721176147461,
            "end_logit": -3.782402753829956,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "autoimmunity",
            "probability": 0.0007926655493976848,
            "start_logit": -3.7631442546844482,
            "end_logit": -1.4303710460662842,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cancer (SCLC)",
            "probability": 0.0006577671545772503,
            "start_logit": -3.213921308517456,
            "end_logit": -2.166144371032715,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "myelopathy",
            "probability": 0.0005027174739516161,
            "start_logit": -2.0137996673583984,
            "end_logit": -3.6350886821746826,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        }
    ],
    "5503145ee9bde69634000022": [
        {
            "text": "medullary thyroid cancer",
            "probability": 0.18595622123364,
            "start_logit": 4.835480213165283,
            "end_logit": 4.628930568695068,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic thyroid cancer",
            "probability": 0.1378153147329637,
            "start_logit": 4.877594470977783,
            "end_logit": 4.287219524383545,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC), and anaplastic thyroid cancer",
            "probability": 0.1321318426397098,
            "start_logit": 4.835480213165283,
            "end_logit": 4.287219524383545,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary thyroid cancer",
            "probability": 0.12806181008931897,
            "start_logit": 4.46248197555542,
            "end_logit": 4.628930568695068,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary thyroid cancer (MTC), and anaplastic thyroid cancer",
            "probability": 0.09099476654571441,
            "start_logit": 4.46248197555542,
            "end_logit": 4.287219524383545,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer",
            "probability": 0.08656369330613234,
            "start_logit": 4.46248197555542,
            "end_logit": 4.237298011779785,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic thyroid cancer (ATC)",
            "probability": 0.05216403906350669,
            "start_logit": 4.877594470977783,
            "end_logit": 3.3156983852386475,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC), and anaplastic thyroid cancer (ATC)",
            "probability": 0.050012806010320224,
            "start_logit": 4.835480213165283,
            "end_logit": 3.3156983852386475,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC)",
            "probability": 0.03931845510164632,
            "start_logit": 4.835480213165283,
            "end_logit": 3.075113296508789,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary thyroid cancer (MTC)",
            "probability": 0.02707730075836562,
            "start_logit": 4.46248197555542,
            "end_logit": 3.075113296508789,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary",
            "probability": 0.025715860624006458,
            "start_logit": 4.835480213165283,
            "end_logit": 2.650527238845825,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC), medullary",
            "probability": 0.017709650355699727,
            "start_logit": 4.46248197555542,
            "end_logit": 2.650527238845825,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated thyroid cancer (DTC)",
            "probability": 0.00857903878524393,
            "start_logit": 4.46248197555542,
            "end_logit": 1.9257394075393677,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "(DTC), medullary thyroid cancer",
            "probability": 0.0030005890218579717,
            "start_logit": 0.7087775468826294,
            "end_logit": 4.628930568695068,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic",
            "probability": 0.0027671744061414107,
            "start_logit": 4.877594470977783,
            "end_logit": 0.3791317641735077,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "differentiated",
            "probability": 0.0027612712860645974,
            "start_logit": 4.46248197555542,
            "end_logit": 0.7921087145805359,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC), and anaplastic",
            "probability": 0.0026530567658418205,
            "start_logit": 4.835480213165283,
            "end_logit": 0.3791317641735077,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "medullary thyroid cancer (MTC",
            "probability": 0.002578289983685046,
            "start_logit": 4.835480213165283,
            "end_logit": 0.3505456745624542,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "(DTC), medullary thyroid cancer (MTC), and anaplastic thyroid cancer",
            "probability": 0.002132079012104894,
            "start_logit": 0.7087775468826294,
            "end_logit": 4.287219524383545,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "anaplastic thyroid cancer (ATC",
            "probability": 0.0020067402780362628,
            "start_logit": 4.877594470977783,
            "end_logit": 0.05781668797135353,
            "question_text": "List the different subtypes of thyroid cancer."
        }
    ],
    "5333f728d6d3ac6a34000041": [
        {
            "text": "PPIN",
            "probability": 0.23202854750052032,
            "start_logit": -2.313687324523926,
            "end_logit": -2.9140145778656006,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction network (PPIN",
            "probability": 0.12164634180303828,
            "start_logit": -2.9594297409057617,
            "end_logit": -2.9140145778656006,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction",
            "probability": 0.0776424490016812,
            "start_logit": -2.6034393310546875,
            "end_logit": -3.719008684158325,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data. These computational approaches usually use the PPI data in the format of a huge protein-protein interaction network",
            "probability": 0.0744044369494958,
            "start_logit": -2.6034393310546875,
            "end_logit": -3.7616074085235596,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction network",
            "probability": 0.052118770731518396,
            "start_logit": -2.9594297409057617,
            "end_logit": -3.7616074085235596,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "PPIN) as input and output various sub-networks of the given PPIN",
            "probability": 0.04502646200785238,
            "start_logit": -2.313687324523926,
            "end_logit": -4.553624629974365,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein",
            "probability": 0.03909415816665018,
            "start_logit": -2.6034393310546875,
            "end_logit": -4.405149936676025,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "PPIN) as input and output various sub-networks",
            "probability": 0.0388670949934314,
            "start_logit": -2.313687324523926,
            "end_logit": -4.7007269859313965,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data. These computational approaches usually use the PPI data in the format of a huge protein-protein interaction",
            "probability": 0.037939991492906444,
            "start_logit": -2.6034393310546875,
            "end_logit": -4.435117244720459,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "PPIN) as input and output various sub-networks of the given PPIN as the predicted protein complexes",
            "probability": 0.03617305103573231,
            "start_logit": -2.313687324523926,
            "end_logit": -4.7725605964660645,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "interaction network (PPIN",
            "probability": 0.03275111480484594,
            "start_logit": -4.271610736846924,
            "end_logit": -2.9140145778656006,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "network (PPIN",
            "probability": 0.031331248092998525,
            "start_logit": -4.315931797027588,
            "end_logit": -2.9140145778656006,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "PPIN)",
            "probability": 0.030485232585637227,
            "start_logit": -2.313687324523926,
            "end_logit": -4.94363260269165,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "computational approaches usually use the PPI data in the format of a huge protein-protein interaction network (PPIN",
            "probability": 0.02454017967605552,
            "start_logit": -4.560235977172852,
            "end_logit": -2.9140145778656006,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "interaction (PPI) data. These computational approaches usually use the PPI data in the format of a huge protein-protein interaction network (PPIN",
            "probability": 0.024091994831948505,
            "start_logit": -4.578668117523193,
            "end_logit": -2.9140145778656006,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction network (PPIN) as input and output various sub-networks of the given PPIN",
            "probability": 0.023606165907565518,
            "start_logit": -2.9594297409057617,
            "end_logit": -4.553624629974365,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction (PPI) data. These computational approaches usually use the PPI data in the format of a huge protein",
            "probability": 0.02062987798928318,
            "start_logit": -2.6034393310546875,
            "end_logit": -5.044382572174072,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction network (PPIN) as input and output various sub-networks",
            "probability": 0.020376975046363686,
            "start_logit": -2.9594297409057617,
            "end_logit": -4.7007269859313965,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein-protein interaction network (PPIN) as input and output various sub-networks of the given PPIN as the predicted protein complexes",
            "probability": 0.018964560084321402,
            "start_logit": -2.9594297409057617,
            "end_logit": -4.7725605964660645,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "PPIN) as input and output various sub-networks of the given PPIN as the predicted protein complexes.",
            "probability": 0.018281347298153856,
            "start_logit": -2.313687324523926,
            "end_logit": -5.454993724822998,
            "question_text": "List algorithms suitable for predicting protein complexes"
        }
    ],
    "51601071298dcd4e51000038": [
        {
            "text": "recombinant protein",
            "probability": 0.22437196230956105,
            "start_logit": -2.056180000305176,
            "end_logit": -3.123847246170044,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology",
            "probability": 0.121386619103221,
            "start_logit": -2.056180000305176,
            "end_logit": -3.7381718158721924,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology and reverse vaccinology",
            "probability": 0.11910709377575997,
            "start_logit": -2.056180000305176,
            "end_logit": -3.757129430770874,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology and reverse vaccinology.",
            "probability": 0.09058958491969522,
            "start_logit": -2.056180000305176,
            "end_logit": -4.030813217163086,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation, as well as recombinant protein",
            "probability": 0.05852765811212852,
            "start_logit": -3.3999857902526855,
            "end_logit": -3.123847246170044,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA technology and reverse",
            "probability": 0.03468167394990904,
            "start_logit": -2.056180000305176,
            "end_logit": -4.990941047668457,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "reverse vaccinology",
            "probability": 0.03353243229849985,
            "start_logit": -3.3236899375915527,
            "end_logit": -3.757129430770874,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation, as well as recombinant protein DNA technology",
            "probability": 0.0316638249678389,
            "start_logit": -3.3999857902526855,
            "end_logit": -3.7381718158721924,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation, as well as recombinant protein DNA technology and reverse vaccinology",
            "probability": 0.03106920843175179,
            "start_logit": -3.3999857902526855,
            "end_logit": -3.757129430770874,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "cell cultures and sub-unit vaccines. The modern approach contributed to leaps and bounds to vaccine development using chemical conjugation",
            "probability": 0.030668573136979013,
            "start_logit": -3.2619848251342773,
            "end_logit": -3.908109188079834,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "recombinant protein DNA",
            "probability": 0.028647276275696052,
            "start_logit": -2.056180000305176,
            "end_logit": -5.182094097137451,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "vaccine development using chemical conjugation, as well as recombinant protein",
            "probability": 0.02825596871316854,
            "start_logit": -4.128180503845215,
            "end_logit": -3.123847246170044,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation",
            "probability": 0.026715328153865327,
            "start_logit": -3.3999857902526855,
            "end_logit": -3.908109188079834,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "reverse vaccinology.",
            "probability": 0.025503847226663653,
            "start_logit": -3.3236899375915527,
            "end_logit": -4.030813217163086,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "re",
            "probability": 0.024824966637106628,
            "start_logit": -2.056180000305176,
            "end_logit": -5.325302600860596,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "chemical conjugation, as well as recombinant protein DNA technology and reverse vaccinology.",
            "probability": 0.0236303867921987,
            "start_logit": -3.3999857902526855,
            "end_logit": -4.030813217163086,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "micro-organisms",
            "probability": 0.021178445385413795,
            "start_logit": -3.483025074005127,
            "end_logit": -4.057323455810547,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "cell cultures and sub-unit vaccines. The modern approach contributed to leaps and bounds to vaccine development",
            "probability": 0.015358911027076793,
            "start_logit": -3.2619848251342773,
            "end_logit": -4.59965181350708,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "vaccine development using chemical conjugation, as well as recombinant protein DNA technology",
            "probability": 0.015286653805905423,
            "start_logit": -4.128180503845215,
            "end_logit": -3.7381718158721924,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "vaccine development using chemical conjugation, as well as recombinant protein DNA technology and reverse vaccinology",
            "probability": 0.01499958497756069,
            "start_logit": -4.128180503845215,
            "end_logit": -3.757129430770874,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        }
    ],
    "515993f3d24251bc050000a0": [
        {
            "text": "thyrotropin",
            "probability": 0.8440997609225177,
            "start_logit": -2.934844970703125,
            "end_logit": -4.371496200561523,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thy",
            "probability": 0.04149037245036693,
            "start_logit": -2.934844970703125,
            "end_logit": -7.384305477142334,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thyroid-stimulating hormone (TSH; thyrotropin",
            "probability": 0.02369878540894672,
            "start_logit": -6.507691860198975,
            "end_logit": -4.371496200561523,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies",
            "probability": 0.02328182604645972,
            "start_logit": -5.488940238952637,
            "end_logit": -5.407998561859131,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "(TSH; thyrotropin",
            "probability": 0.008864465399914182,
            "start_logit": -7.49106502532959,
            "end_logit": -4.371496200561523,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "A number of different TSHR ligands have been reported, including TSH analogs, antibodies",
            "probability": 0.0067007835604780495,
            "start_logit": -6.734388828277588,
            "end_logit": -5.407998561859131,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds. In this review,",
            "probability": 0.006194901296750472,
            "start_logit": -5.488940238952637,
            "end_logit": -6.731945037841797,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds. In this review",
            "probability": 0.005781316630518977,
            "start_logit": -5.488940238952637,
            "end_logit": -6.801040172576904,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds",
            "probability": 0.00521913042918366,
            "start_logit": -5.488940238952637,
            "end_logit": -6.903340816497803,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "TSH analogs, antibodies",
            "probability": 0.005155134039320305,
            "start_logit": -6.996620178222656,
            "end_logit": -5.407998561859131,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "antibodies and small-molecule, drug-like compounds. In this review, we will provide an update",
            "probability": 0.005122929918088973,
            "start_logit": -5.488940238952637,
            "end_logit": -6.921945095062256,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "reported, including TSH analogs, antibodies",
            "probability": 0.003462178405834285,
            "start_logit": -7.394715309143066,
            "end_logit": -5.407998561859131,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "number of different TSHR ligands have been reported, including TSH analogs, antibodies",
            "probability": 0.003077505018993719,
            "start_logit": -7.512494087219238,
            "end_logit": -5.407998561859131,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "small-molecule, drug-like compounds. In this review,",
            "probability": 0.002943473212136365,
            "start_logit": -6.233076572418213,
            "end_logit": -6.731945037841797,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "small-molecule, drug-like compounds. In this review",
            "probability": 0.002746960737169034,
            "start_logit": -6.233076572418213,
            "end_logit": -6.801040172576904,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "A number of different TSHR ligands have been reported,",
            "probability": 0.002712280483758823,
            "start_logit": -6.734388828277588,
            "end_logit": -6.312433242797852,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "small-molecule, drug-like compounds",
            "probability": 0.0024798410617141208,
            "start_logit": -6.233076572418213,
            "end_logit": -6.903340816497803,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "small-molecule ligands.",
            "probability": 0.002473294048179327,
            "start_logit": -6.407393932342529,
            "end_logit": -6.7316670417785645,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "small-molecule, drug-like compounds. In this review, we will provide an update",
            "probability": 0.002434131919011626,
            "start_logit": -6.233076572418213,
            "end_logit": -6.921945095062256,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thyroid-stimulating hormone",
            "probability": 0.002060929010657381,
            "start_logit": -6.507691860198975,
            "end_logit": -6.81376314163208,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        }
    ],
    "53357c98d6d3ac6a3400004a": [
        {
            "text": "multi-gene panel",
            "probability": 0.16783993864911687,
            "start_logit": -2.899519443511963,
            "end_logit": -3.894366979598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi",
            "probability": 0.11147281898868576,
            "start_logit": -2.899519443511963,
            "end_logit": -4.3035969734191895,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene",
            "probability": 0.08680154167210002,
            "start_logit": -2.899519443511963,
            "end_logit": -4.55375337600708,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "a custom-designed multi-gene panel",
            "probability": 0.07319813046914951,
            "start_logit": -3.729360342025757,
            "end_logit": -3.894366979598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels (MGPs) are commercially available,",
            "probability": 0.05151556248283245,
            "start_logit": -3.444357395172119,
            "end_logit": -4.530655860900879,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene sequencing is the most cost- and time-efficient manner to investigate breast cancer predisposition. Numerous multi-gene",
            "probability": 0.05046193321089723,
            "start_logit": -3.7316956520080566,
            "end_logit": -4.26398229598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels (MGPs)",
            "probability": 0.04867323827992034,
            "start_logit": -3.444357395172119,
            "end_logit": -4.5874104499816895,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "a custom-designed multi",
            "probability": 0.048615377327776696,
            "start_logit": -3.729360342025757,
            "end_logit": -4.3035969734191895,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "custom-designed multi-gene panel",
            "probability": 0.03955933721829263,
            "start_logit": -4.344728469848633,
            "end_logit": -3.894366979598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "This study investigates the utility of a custom-designed multi-gene panel",
            "probability": 0.03857124196735983,
            "start_logit": -4.370023250579834,
            "end_logit": -3.894366979598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "a custom-designed multi-gene",
            "probability": 0.03785577272832927,
            "start_logit": -3.729360342025757,
            "end_logit": -4.55375337600708,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "panel",
            "probability": 0.0374968434441332,
            "start_logit": -4.398273468017578,
            "end_logit": -3.894366979598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene sequencing",
            "probability": 0.03133330375966932,
            "start_logit": -3.7316956520080566,
            "end_logit": -4.740520000457764,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "investigates the utility of a custom-designed multi-gene panel",
            "probability": 0.02931331612311729,
            "start_logit": -4.644488334655762,
            "end_logit": -3.894366979598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "of a custom-designed multi-gene panel",
            "probability": 0.02788878963001363,
            "start_logit": -4.694305419921875,
            "end_logit": -3.894366979598999,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "custom-designed multi",
            "probability": 0.02627378723169187,
            "start_logit": -4.344728469848633,
            "end_logit": -4.3035969734191895,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "a",
            "probability": 0.025656939037470683,
            "start_logit": -3.729360342025757,
            "end_logit": -4.942722797393799,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "This study investigates the utility of a custom-designed multi",
            "probability": 0.025617532445510856,
            "start_logit": -4.370023250579834,
            "end_logit": -4.3035969734191895,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "multi-gene panels",
            "probability": 0.021395749330342502,
            "start_logit": -3.444357395172119,
            "end_logit": -5.4093475341796875,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "custom-designed multi-gene",
            "probability": 0.020458846003590058,
            "start_logit": -4.344728469848633,
            "end_logit": -4.55375337600708,
            "question_text": "What genes are related to breast cancer?"
        }
    ],
    "5523e47f7b523f2123000004": [
        {
            "text": "green fluorescent protein",
            "probability": 0.20813989349366324,
            "start_logit": 3.2502646446228027,
            "end_logit": 3.2485427856445312,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein, DsRed",
            "probability": 0.18526430362973711,
            "start_logit": 3.507582426071167,
            "end_logit": 2.874798059463501,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent protein, DsRed",
            "probability": 0.14323199986734825,
            "start_logit": 3.2502646446228027,
            "end_logit": 2.874798059463501,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "DsRed",
            "probability": 0.11231823212404082,
            "start_logit": 3.0071351528167725,
            "end_logit": 2.874798059463501,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein",
            "probability": 0.10413393208497741,
            "start_logit": 3.507582426071167,
            "end_logit": 2.298692464828491,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent protein",
            "probability": 0.08050828494403953,
            "start_logit": 3.2502646446228027,
            "end_logit": 2.298692464828491,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP",
            "probability": 0.0289849065080326,
            "start_logit": 3.2502646446228027,
            "end_logit": 1.2771075963974,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent",
            "probability": 0.025858768206982952,
            "start_logit": 3.2502646446228027,
            "end_logit": 1.1629821062088013,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green",
            "probability": 0.019895803087646626,
            "start_logit": 3.2502646446228027,
            "end_logit": 0.9008411765098572,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP)",
            "probability": 0.018544528613442145,
            "start_logit": 3.2502646446228027,
            "end_logit": 0.8305071592330933,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP) and red fluorescent protein, DsRed",
            "probability": 0.01223202899684644,
            "start_logit": 0.7898567914962769,
            "end_logit": 2.874798059463501,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red",
            "probability": 0.01183965124082256,
            "start_logit": 3.507582426071167,
            "end_logit": 0.12446875870227814,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent protein, DsRed,",
            "probability": 0.009539232654184094,
            "start_logit": 3.507582426071167,
            "end_logit": -0.0915723666548729,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red",
            "probability": 0.00915350065679219,
            "start_logit": 3.2502646446228027,
            "end_logit": 0.12446875870227814,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent protein, DsRed,",
            "probability": 0.007374995309346733,
            "start_logit": 3.2502646446228027,
            "end_logit": -0.0915723666548729,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP) and red fluorescent protein",
            "probability": 0.006875416644561993,
            "start_logit": 0.7898567914962769,
            "end_logit": 2.298692464828491,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "DsRed,",
            "probability": 0.0057832498033685,
            "start_logit": 3.0071351528167725,
            "end_logit": -0.0915723666548729,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "red fluorescent",
            "probability": 0.004424938423271324,
            "start_logit": 3.507582426071167,
            "end_logit": -0.8597290515899658,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP) and red fluorescent",
            "probability": 0.003421019415168606,
            "start_logit": 3.2502646446228027,
            "end_logit": -0.8597290515899658,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP",
            "probability": 0.0024753142957264626,
            "start_logit": 0.7898567914962769,
            "end_logit": 1.2771075963974,
            "question_text": "List fluorescent reporter proteins."
        }
    ],
    "54fb5720d176fff445000002": [
        {
            "text": "Klf4",
            "probability": 0.09059427627539535,
            "start_logit": 5.390340328216553,
            "end_logit": 5.18490743637085,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4",
            "probability": 0.08801977108818802,
            "start_logit": 5.361510753631592,
            "end_logit": 5.18490743637085,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4",
            "probability": 0.07564776822775675,
            "start_logit": 5.2100372314453125,
            "end_logit": 5.18490743637085,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Myc",
            "probability": 0.07562035872781872,
            "start_logit": 5.469496726989746,
            "end_logit": 4.925085544586182,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4 and Myc",
            "probability": 0.06986530286319007,
            "start_logit": 5.390340328216553,
            "end_logit": 4.925085544586182,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4 and Myc",
            "probability": 0.06787987296604828,
            "start_logit": 5.361510753631592,
            "end_logit": 4.925085544586182,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Myc, termed OSKM",
            "probability": 0.0646264899541463,
            "start_logit": 5.469496726989746,
            "end_logit": 4.767984390258789,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "OSKM",
            "probability": 0.06345194493064467,
            "start_logit": 5.451155185699463,
            "end_logit": 4.767984390258789,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2",
            "probability": 0.06268278087070912,
            "start_logit": 5.361510753631592,
            "end_logit": 4.845432758331299,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4 and Myc, termed OSKM",
            "probability": 0.05970811788770763,
            "start_logit": 5.390340328216553,
            "end_logit": 4.767984390258789,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4 and Myc",
            "probability": 0.058338721334782996,
            "start_logit": 5.2100372314453125,
            "end_logit": 4.925085544586182,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4 and Myc, termed OSKM",
            "probability": 0.05801133454178185,
            "start_logit": 5.361510753631592,
            "end_logit": 4.767984390258789,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4",
            "probability": 0.057582726933579347,
            "start_logit": 5.361510753631592,
            "end_logit": 4.760568618774414,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2",
            "probability": 0.05387212918820014,
            "start_logit": 5.2100372314453125,
            "end_logit": 4.845432758331299,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4 and Myc, termed OSKM",
            "probability": 0.049857298374506746,
            "start_logit": 5.2100372314453125,
            "end_logit": 4.767984390258789,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Myc,",
            "probability": 0.0010201037746050356,
            "start_logit": 5.469496726989746,
            "end_logit": 0.6192643642425537,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4 and Myc,",
            "probability": 0.0009424692022579085,
            "start_logit": 5.390340328216553,
            "end_logit": 0.6192643642425537,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct4, Sox2, Klf4 and Myc,",
            "probability": 0.0009156861432198276,
            "start_logit": 5.361510753631592,
            "end_logit": 0.6192643642425537,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4 and Myc,",
            "probability": 0.0007869778832105796,
            "start_logit": 5.2100372314453125,
            "end_logit": 0.6192643642425537,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "(Oct4, Sox2, Klf4",
            "probability": 0.0005758688322506263,
            "start_logit": 0.3320739269256592,
            "end_logit": 5.18490743637085,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        }
    ],
    "5363bad27d100faa0900000e": [
        {
            "text": "RNA",
            "probability": 0.5511551559939806,
            "start_logit": 2.4911048412323,
            "end_logit": 1.5986086130142212,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region. The high abundance of lincRNA with respect to reduced Pi15",
            "probability": 0.25862332172403574,
            "start_logit": 2.4911048412323,
            "end_logit": 0.8419649004936218,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15",
            "probability": 0.09656236318223468,
            "start_logit": 1.5059212446212769,
            "end_logit": 0.8419649004936218,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15) gene and a putative long intergenic noncoding RNA",
            "probability": 0.04835203840761314,
            "start_logit": 0.05759686231613159,
            "end_logit": 1.5986086130142212,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "protease inhibitor 15 (Pi15) gene and a putative long intergenic noncoding RNA",
            "probability": 0.009417140906769192,
            "start_logit": -1.5783799886703491,
            "end_logit": 1.5986086130142212,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression, in conjunction with exertion of longitudinal strain, may be related to RIEL",
            "probability": 0.006997603396585512,
            "start_logit": 1.5059212446212769,
            "end_logit": -1.7826564311981201,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "R",
            "probability": 0.0049209932034715706,
            "start_logit": 2.4911048412323,
            "end_logit": -3.1198973655700684,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression,",
            "probability": 0.004884031418820749,
            "start_logit": 1.5059212446212769,
            "end_logit": -2.1422531604766846,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "protease inhibitor 15",
            "probability": 0.0032348810203662293,
            "start_logit": -1.5783799886703491,
            "end_logit": 0.5300692319869995,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region. The high abundance of lincRNA with respect to reduced Pi15 expression",
            "probability": 0.0031877811619358816,
            "start_logit": 2.4911048412323,
            "end_logit": -3.5540826320648193,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression, in conjunction with exertion of longitudinal strain, may be related to RIEL,",
            "probability": 0.0020784339476025756,
            "start_logit": 1.5059212446212769,
            "end_logit": -2.9966094493865967,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region.",
            "probability": 0.0018232349956394639,
            "start_logit": 2.4911048412323,
            "end_logit": -4.112795352935791,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region. The high abundance of lincRNA",
            "probability": 0.0016191632523327821,
            "start_logit": 2.4911048412323,
            "end_logit": -4.2314982414245605,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "15 (Pi15) gene and a putative long intergenic noncoding RNA",
            "probability": 0.001594154138824001,
            "start_logit": -3.3545682430267334,
            "end_logit": 1.5986086130142212,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression",
            "probability": 0.0011902239916042761,
            "start_logit": 1.5059212446212769,
            "end_logit": -3.5540826320648193,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "protease inhibitor 15 (Pi15",
            "probability": 0.0010588471836648638,
            "start_logit": -1.5783799886703491,
            "end_logit": -0.5867421627044678,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region. The high abundance",
            "probability": 0.0010173131010896663,
            "start_logit": 2.4911048412323,
            "end_logit": -4.696242809295654,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "Pi15 expression, in conjunction with exertion of longitudinal strain,",
            "probability": 0.000985294925185344,
            "start_logit": 1.5059212446212769,
            "end_logit": -3.7430384159088135,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA (lincRNA) within the linkage region. The high",
            "probability": 0.0007393709882913723,
            "start_logit": 2.4911048412323,
            "end_logit": -5.0153632164001465,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "NA",
            "probability": 0.0005586530599526392,
            "start_logit": -4.403138160705566,
            "end_logit": 1.5986086130142212,
            "question_text": "Which are the most abundant human lincRNA?"
        }
    ],
    "5720a8da0fd6f91b68000010": [
        {
            "text": "Excessive daytime sleepiness",
            "probability": 0.8561966579746324,
            "start_logit": 2.708254337310791,
            "end_logit": 2.699573278427124,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint of central nervous system",
            "probability": 0.045123923357896986,
            "start_logit": 2.708254337310791,
            "end_logit": -0.2435142546892166,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS)",
            "probability": 0.03870119125614897,
            "start_logit": 2.708254337310791,
            "end_logit": -0.3970564305782318,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "daytime sleepiness",
            "probability": 0.015508839774325047,
            "start_logit": -1.3028355836868286,
            "end_logit": 2.699573278427124,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "sleepiness",
            "probability": 0.009773606424538702,
            "start_logit": -1.7645602226257324,
            "end_logit": 2.699573278427124,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "central nervous system",
            "probability": 0.00832827244089406,
            "start_logit": 1.0184978246688843,
            "end_logit": -0.2435142546892166,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint of central nervous system (CNS) hypersomnias",
            "probability": 0.005547530932723139,
            "start_logit": 2.708254337310791,
            "end_logit": -2.339573860168457,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleep",
            "probability": 0.004087863397572803,
            "start_logit": 2.708254337310791,
            "end_logit": -2.644904375076294,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive",
            "probability": 0.00347475165084862,
            "start_logit": 2.708254337310791,
            "end_logit": -2.807403802871704,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint of central nervous system (CNS)",
            "probability": 0.003278540870439932,
            "start_logit": 2.708254337310791,
            "end_logit": -2.8655283451080322,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime",
            "probability": 0.0015509380985613192,
            "start_logit": 2.708254337310791,
            "end_logit": -3.6140668392181396,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint",
            "probability": 0.0015210425026525635,
            "start_logit": 2.708254337310791,
            "end_logit": -3.633530855178833,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "iness",
            "probability": 0.0013351545273156903,
            "start_logit": -3.7551987171173096,
            "end_logit": 2.699573278427124,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "central nervous system (CNS) hypersomnias",
            "probability": 0.0010238770378090342,
            "start_logit": 1.0184978246688843,
            "end_logit": -2.339573860168457,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint of central",
            "probability": 0.0010058120986458528,
            "start_logit": 2.708254337310791,
            "end_logit": -4.047131538391113,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint of central nervous system (CNS) hypersomnias.",
            "probability": 0.0008522668721192554,
            "start_logit": 2.708254337310791,
            "end_logit": -4.212782382965088,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "daytime sleepiness (EDS) is the core complaint of central nervous system",
            "probability": 0.000817358594930748,
            "start_logit": -1.3028355836868286,
            "end_logit": -0.2435142546892166,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "daytime sleepiness (EDS)",
            "probability": 0.0007010195247514118,
            "start_logit": -1.3028355836868286,
            "end_logit": -0.3970564305782318,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "central nervous system (CNS)",
            "probability": 0.0006051021175855098,
            "start_logit": 1.0184978246688843,
            "end_logit": -2.8655283451080322,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Excessive daytime sleepiness (EDS) is the core complaint of central nervous system (CNS) hypersomnia",
            "probability": 0.0005662505456080182,
            "start_logit": 2.708254337310791,
            "end_logit": -4.621645450592041,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        }
    ],
    "54d8d60d014675820d000007": [
        {
            "text": "V600R",
            "probability": 0.1867596145659352,
            "start_logit": -5.431870937347412,
            "end_logit": -5.088808536529541,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four",
            "probability": 0.0921331224992367,
            "start_logit": -5.6640095710754395,
            "end_logit": -5.563257694244385,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V600R,",
            "probability": 0.09203072885845327,
            "start_logit": -5.431870937347412,
            "end_logit": -5.796508312225342,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Three patients demonstrated partial objective response to BRAF/MEK targeted therapy",
            "probability": 0.07711133427274784,
            "start_logit": -5.847692012786865,
            "end_logit": -5.557559490203857,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "V600R, were not included in BRAF/MEK inhibitors clinical trials,",
            "probability": 0.07206651187434636,
            "start_logit": -5.431870937347412,
            "end_logit": -6.041041374206543,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Three patients demonstrated partial objective response to BRAF/MEK targeted therapy.",
            "probability": 0.05848177943149262,
            "start_logit": -5.847692012786865,
            "end_logit": -5.834094524383545,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Three patients demonstrated partial objective response",
            "probability": 0.05797569854437669,
            "start_logit": -5.847692012786865,
            "end_logit": -5.842785835266113,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors",
            "probability": 0.05454273290039014,
            "start_logit": -5.6640095710754395,
            "end_logit": -6.087507724761963,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Three",
            "probability": 0.049289540649979494,
            "start_logit": -5.847692012786865,
            "end_logit": -6.00509786605835,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors. Three patients demonstrated partial objective response to BRAF/MEK targeted therapy",
            "probability": 0.03749115821145314,
            "start_logit": -5.6640095710754395,
            "end_logit": -6.4623870849609375,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors. Three patients demonstrated partial objective response to BRAF/MEK targeted therapy.",
            "probability": 0.03077039172556943,
            "start_logit": -5.6640095710754395,
            "end_logit": -6.659939289093018,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "R",
            "probability": 0.03029429440346833,
            "start_logit": -7.250733852386475,
            "end_logit": -5.088808536529541,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "MEK inhibitors clinical trials,",
            "probability": 0.025100401670492045,
            "start_logit": -6.486576557159424,
            "end_logit": -6.041041374206543,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors.",
            "probability": 0.024880177977885703,
            "start_logit": -5.6640095710754395,
            "end_logit": -6.872420787811279,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "melanoma. Patients with the third most common pathologic variant in the BRAF gene, V600R",
            "probability": 0.023382618456481676,
            "start_logit": -7.509700298309326,
            "end_logit": -5.088808536529541,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "therapy",
            "probability": 0.02213477710715206,
            "start_logit": -7.095792293548584,
            "end_logit": -5.557559490203857,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Four patients in our cohort received BRAF inhibitors. Three patients demonstrated partial objective response",
            "probability": 0.01990282264952853,
            "start_logit": -5.6640095710754395,
            "end_logit": -7.095630645751953,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "therapy.",
            "probability": 0.01678717097498345,
            "start_logit": -7.095792293548584,
            "end_logit": -5.834094524383545,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "R,",
            "probability": 0.014928313065346636,
            "start_logit": -7.250733852386475,
            "end_logit": -5.796508312225342,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "seven patients with V600R-mutant melanoma, whose clinical records were available for review. Four",
            "probability": 0.013936810160681011,
            "start_logit": -7.55271053314209,
            "end_logit": -5.563257694244385,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        }
    ],
    "531375a6e3eabad021000011": [
        {
            "text": "syncope",
            "probability": 0.6616871031257707,
            "start_logit": 5.731740951538086,
            "end_logit": 5.520751476287842,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history",
            "probability": 0.10883388884705049,
            "start_logit": 5.731740951538086,
            "end_logit": 3.7157814502716064,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD (FH-SCD) as well as family history",
            "probability": 0.0736794344149359,
            "start_logit": 5.731740951538086,
            "end_logit": 3.3256824016571045,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history",
            "probability": 0.06940387079890376,
            "start_logit": 5.281860828399658,
            "end_logit": 3.7157814502716064,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD (FH-SCD) as well as family history",
            "probability": 0.04698571374084551,
            "start_logit": 5.281860828399658,
            "end_logit": 3.3256824016571045,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD (FH-SCD)",
            "probability": 0.008287041393987412,
            "start_logit": 5.731740951538086,
            "end_logit": 1.1406517028808594,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD (FH-SCD) as well as family history of HCM",
            "probability": 0.006792102553217631,
            "start_logit": 5.731740951538086,
            "end_logit": 0.9417192339897156,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD (FH-SCD)",
            "probability": 0.005284684359866618,
            "start_logit": 5.281860828399658,
            "end_logit": 1.1406517028808594,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD (FH-SCD) as well as family history of HCM",
            "probability": 0.0043313549947562695,
            "start_logit": 5.281860828399658,
            "end_logit": 0.9417192339897156,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of HCM",
            "probability": 0.0037866527192626813,
            "start_logit": 5.147462844848633,
            "end_logit": 0.9417192339897156,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD",
            "probability": 0.003158170437006927,
            "start_logit": 5.731740951538086,
            "end_logit": 0.17595157027244568,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of HCM (FH-HCM)",
            "probability": 0.0028281065851490277,
            "start_logit": 5.147462844848633,
            "end_logit": 0.649844229221344,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD",
            "probability": 0.002013979793361821,
            "start_logit": 5.281860828399658,
            "end_logit": 0.17595157027244568,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family",
            "probability": 0.0007712045352628587,
            "start_logit": 5.731740951538086,
            "end_logit": -1.2338429689407349,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "syncope and family history of SCD (FH-SCD) as well as family",
            "probability": 0.0005842031542061154,
            "start_logit": 5.731740951538086,
            "end_logit": -1.5115478038787842,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family",
            "probability": 0.0004918006743297828,
            "start_logit": 5.281860828399658,
            "end_logit": -1.2338429689407349,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of SCD (FH-SCD) as well as family",
            "probability": 0.0003725490347203753,
            "start_logit": 5.281860828399658,
            "end_logit": -1.5115478038787842,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "SCD (FH-SCD) as well as family history",
            "probability": 0.0003198840371522086,
            "start_logit": 0.29222050309181213,
            "end_logit": 3.3256824016571045,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "family history of HCM (FH-HCM) are documented in electronic health records (EHRs) as clinical narratives",
            "probability": 0.00020354732481265891,
            "start_logit": 5.147462844848633,
            "end_logit": -1.981619954109192,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "sudden cardiac death (SCD). SCD risk factors such as syncope",
            "probability": 0.0001847074754012975,
            "start_logit": -2.452033758163452,
            "end_logit": 5.520751476287842,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        }
    ],
    "56d1e23c67f0cb3d66000009": [
        {
            "text": "TAZ",
            "probability": 0.9118429913731586,
            "start_logit": 5.235596179962158,
            "end_logit": 4.473799705505371,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ binding motif",
            "probability": 0.03183295298601487,
            "start_logit": 5.235596179962158,
            "end_logit": 1.1188338994979858,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ",
            "probability": 0.023889638976928414,
            "start_logit": 5.235596179962158,
            "end_logit": 0.8317767381668091,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ binding motif)",
            "probability": 0.006768822768554096,
            "start_logit": 5.235596179962158,
            "end_logit": -0.4293409287929535,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes",
            "probability": 0.004629334159124257,
            "start_logit": 5.235596179962158,
            "end_logit": -0.809255063533783,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "PDZ binding motif",
            "probability": 0.004586078839745281,
            "start_logit": 3.29811954498291,
            "end_logit": 1.1188338994979858,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "PDZ",
            "probability": 0.003441709220296912,
            "start_logit": 3.29811954498291,
            "end_logit": 0.8317767381668091,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein",
            "probability": 0.0031045961736892785,
            "start_logit": 5.235596179962158,
            "end_logit": -1.2087844610214233,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator",
            "probability": 0.002995102360698579,
            "start_logit": 5.235596179962158,
            "end_logit": -1.244689702987671,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "YAP/TAZ",
            "probability": 0.001629178976007724,
            "start_logit": -1.0917954444885254,
            "end_logit": 4.473799705505371,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "PDZ binding motif)",
            "probability": 0.0009751641603117939,
            "start_logit": 3.29811954498291,
            "end_logit": -0.4293409287929535,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TA",
            "probability": 0.0008071589965818334,
            "start_logit": 5.235596179962158,
            "end_logit": -2.5559027194976807,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcription",
            "probability": 0.0006952873671273167,
            "start_logit": 5.235596179962158,
            "end_logit": -2.7050981521606445,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "transcriptional coactivator with PDZ binding motif",
            "probability": 0.0006426710713168701,
            "start_logit": 1.3329719305038452,
            "end_logit": 1.1188338994979858,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "transcriptional coactivator with PDZ",
            "probability": 0.00048230460684627453,
            "start_logit": 1.3329719305038452,
            "end_logit": 0.8317767381668091,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (",
            "probability": 0.00043706714481708743,
            "start_logit": 5.235596179962158,
            "end_logit": -3.1693365573883057,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ binding",
            "probability": 0.00040959789890589594,
            "start_logit": 5.235596179962158,
            "end_logit": -3.2342474460601807,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with P",
            "probability": 0.0003000839737912116,
            "start_logit": 5.235596179962158,
            "end_logit": -3.545361042022705,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ (Yes-associated protein/transcriptional coactivator with PDZ binding motif) pathway",
            "probability": 0.00028613227703008244,
            "start_logit": 5.235596179962158,
            "end_logit": -3.5929691791534424,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Z",
            "probability": 0.00024412666905370973,
            "start_logit": -2.9899396896362305,
            "end_logit": 4.473799705505371,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        }
    ],
    "531b3ff3b166e2b80600003d": [
        {
            "text": "E-cadherin",
            "probability": 0.9377486577432728,
            "start_logit": 4.796367168426514,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadherin. Although silencing mutations and transcriptional repression of the E-cadherin",
            "probability": 0.035670652897385094,
            "start_logit": 4.796367168426514,
            "end_logit": 0.9021901488304138,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadherin.",
            "probability": 0.009789699524458259,
            "start_logit": 4.796367168426514,
            "end_logit": -0.3908073902130127,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cadherin",
            "probability": 0.008410789154608815,
            "start_logit": 0.08240051567554474,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cell-adhesion protein E-cadherin",
            "probability": 0.001516033074961513,
            "start_logit": -1.6310176849365234,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E",
            "probability": 0.0012338248135833156,
            "start_logit": 4.796367168426514,
            "end_logit": -2.462019205093384,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadherin in tumors. We show that E-cadherin",
            "probability": 0.0012183736044645772,
            "start_logit": 1.119140386581421,
            "end_logit": 1.2026054859161377,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "loss of the cell-adhesion protein E-cadherin",
            "probability": 0.0009038508076769298,
            "start_logit": -2.1482057571411133,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadherin gene have been widely studied, not much is known about posttranslational regulation of E-cadherin",
            "probability": 0.0007323361206426375,
            "start_logit": 1.0473941564559937,
            "end_logit": 0.7653191685676575,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadheri",
            "probability": 0.0003501311928686498,
            "start_logit": 4.796367168426514,
            "end_logit": -3.721585512161255,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "protein E-cadherin",
            "probability": 0.00033936809326832036,
            "start_logit": -3.1277847290039062,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "dherin",
            "probability": 0.00033446293632067155,
            "start_logit": -3.1423439979553223,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "n",
            "probability": 0.00033200233711313485,
            "start_logit": -3.1497280597686768,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cadherin. Although silencing mutations and transcriptional repression of the E-cadherin",
            "probability": 0.00031993470537099714,
            "start_logit": 0.08240051567554474,
            "end_logit": 0.9021901488304138,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "the cell-adhesion protein E-cadherin",
            "probability": 0.00028366841742189755,
            "start_logit": -3.3070640563964844,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadh",
            "probability": 0.0002627351084329009,
            "start_logit": 4.796367168426514,
            "end_logit": -4.008747100830078,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "adhesion protein E-cadherin",
            "probability": 0.00021592053299525815,
            "start_logit": -3.5799596309661865,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadherin. Although silencing mutations and transcriptional repression of the E",
            "probability": 0.00013773038718550308,
            "start_logit": 4.796367168426514,
            "end_logit": -4.654595375061035,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "characterized by loss of the cell-adhesion protein E-cadherin",
            "probability": 0.00011202346511720565,
            "start_logit": -4.236161708831787,
            "end_logit": 4.171343803405762,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cadherin.",
            "probability": 8.780508285167233e-05,
            "start_logit": 0.08240051567554474,
            "end_logit": -0.3908073902130127,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        }
    ],
    "52f5417b2059c6d71c000024": [
        {
            "text": "PTEN",
            "probability": 0.2725486307773369,
            "start_logit": -1.6264361143112183,
            "end_logit": -1.2582919597625732,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "PTEN account for ~10% of cases of autism spectrum disorder (ASD) with coincident macrocephaly",
            "probability": 0.1403499086703798,
            "start_logit": -1.6264361143112183,
            "end_logit": -1.9219703674316406,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "Germline mutations in PTEN",
            "probability": 0.07014846564315684,
            "start_logit": -2.9836392402648926,
            "end_logit": -1.2582919597625732,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "macrocephaly",
            "probability": 0.059181872546426595,
            "start_logit": -2.489959478378296,
            "end_logit": -1.9219703674316406,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mouse",
            "probability": 0.04853573752803799,
            "start_logit": -1.9779126644134521,
            "end_logit": -2.6323320865631104,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mouse model with predominantly cytoplasmic localization of Pten",
            "probability": 0.04401125038272082,
            "start_logit": -1.9779126644134521,
            "end_logit": -2.730187177658081,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "cytoplasmic localization of Pten",
            "probability": 0.035892128629869055,
            "start_logit": -2.181839942932129,
            "end_logit": -2.730187177658081,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mouse model",
            "probability": 0.03526527893233495,
            "start_logit": -1.9779126644134521,
            "end_logit": -2.9517335891723633,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "generated a mouse",
            "probability": 0.031190432734043202,
            "start_logit": -2.4201016426086426,
            "end_logit": -2.6323320865631104,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mouse model with predominantly cytoplasmic localization",
            "probability": 0.03024632591823768,
            "start_logit": -1.9779126644134521,
            "end_logit": -3.105257749557495,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "generated a mouse model with predominantly cytoplasmic localization of Pten",
            "probability": 0.028282869788686982,
            "start_logit": -2.4201016426086426,
            "end_logit": -2.730187177658081,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "Pten",
            "probability": 0.02706820730093486,
            "start_logit": -2.4639980792999268,
            "end_logit": -2.730187177658081,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "predominantly cytoplasmic localization of Pten",
            "probability": 0.025860551332493098,
            "start_logit": -2.509639263153076,
            "end_logit": -2.730187177658081,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "cytoplasmic localization",
            "probability": 0.024666534374686765,
            "start_logit": -2.181839942932129,
            "end_logit": -3.105257749557495,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mutations in PTEN",
            "probability": 0.024608815696170027,
            "start_logit": -4.031148433685303,
            "end_logit": -1.2582919597625732,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mouse model with predominantly cytoplasmic localization of Pten (Pten",
            "probability": 0.02328309347876906,
            "start_logit": -1.9779126644134521,
            "end_logit": -3.3669049739837646,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "generated a mouse model",
            "probability": 0.022662462062121837,
            "start_logit": -2.4201016426086426,
            "end_logit": -2.9517335891723633,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "generated a mouse model with predominantly cytoplasmic localization",
            "probability": 0.01943714141481339,
            "start_logit": -2.4201016426086426,
            "end_logit": -3.105257749557495,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "cytoplasmic localization of Pten (Pten",
            "probability": 0.018987867392409725,
            "start_logit": -2.181839942932129,
            "end_logit": -3.3669049739837646,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "predominantly cytoplasmic localization",
            "probability": 0.017772425396370806,
            "start_logit": -2.509639263153076,
            "end_logit": -3.105257749557495,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        }
    ],
    "5717ab7ccb4ef8864c00000c": [
        {
            "text": "ketogenesis",
            "probability": 0.19930074520969254,
            "start_logit": 3.70462703704834,
            "end_logit": 3.7223336696624756,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitophagy",
            "probability": 0.09792734203553892,
            "start_logit": 3.1783018112182617,
            "end_logit": 3.538069725036621,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "ketogenesis, inhibits mTORC1 activation and mitochondrial anabolic pathways, and promotes mitochondrial turnover",
            "probability": 0.08893471348209198,
            "start_logit": 3.70462703704834,
            "end_logit": 2.9154212474823,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "ketogenesis, inhibits mTORC1 activation and mitochondrial anabolic pathways",
            "probability": 0.08787797375387976,
            "start_logit": 3.70462703704834,
            "end_logit": 2.903467893600464,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "reprograming of metabolic function. In the absence of CLUH, a mitophagy",
            "probability": 0.06554452114900008,
            "start_logit": 2.7768056392669678,
            "end_logit": 3.538069725036621,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "promotes mitochondrial turnover, thus allowing efficient reprograming of metabolic function. In the absence of CLUH, a mitophagy",
            "probability": 0.050671744639805005,
            "start_logit": 2.519444465637207,
            "end_logit": 3.538069725036621,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "metabolic function. In the absence of CLUH, a mitophagy",
            "probability": 0.04354358399402188,
            "start_logit": 2.3678383827209473,
            "end_logit": 3.538069725036621,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial turnover, thus allowing efficient reprograming of metabolic function. In the absence of CLUH, a mitophagy",
            "probability": 0.0408616458161001,
            "start_logit": 2.3042678833007812,
            "end_logit": 3.538069725036621,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial anabolic pathways, and promotes mitochondrial turnover",
            "probability": 0.036268390515389555,
            "start_logit": 2.807671070098877,
            "end_logit": 2.9154212474823,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial anabolic pathways",
            "probability": 0.03583744237787018,
            "start_logit": 2.807671070098877,
            "end_logit": 2.903467893600464,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial anabolic pathways, and promotes mitochondrial turnover, thus allowing efficient reprograming of metabolic function",
            "probability": 0.03381544988788992,
            "start_logit": 2.807671070098877,
            "end_logit": 2.8453924655914307,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "reprograming of metabolic function",
            "probability": 0.03278766457077033,
            "start_logit": 2.7768056392669678,
            "end_logit": 2.8453924655914307,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitophagy block causes mitochondrial clustering",
            "probability": 0.03236314147851377,
            "start_logit": 3.1783018112182617,
            "end_logit": 2.430864095687866,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "promotes mitochondrial turnover",
            "probability": 0.027186484943920352,
            "start_logit": 2.519444465637207,
            "end_logit": 2.9154212474823,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "promotes mitochondrial turnover, thus allowing efficient reprograming of metabolic function",
            "probability": 0.025347780979112416,
            "start_logit": 2.519444465637207,
            "end_logit": 2.8453924655914307,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial turnover",
            "probability": 0.021923155136256357,
            "start_logit": 2.3042678833007812,
            "end_logit": 2.9154212474823,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "metabolic function",
            "probability": 0.02178202542604026,
            "start_logit": 2.3678383827209473,
            "end_logit": 2.8453924655914307,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "reprograming of metabolic function. In the absence of CLUH, a mitophagy block causes mitochondrial clustering",
            "probability": 0.02166122930526094,
            "start_logit": 2.7768056392669678,
            "end_logit": 2.430864095687866,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "mitochondrial turnover, thus allowing efficient reprograming of metabolic function",
            "probability": 0.020440426039306715,
            "start_logit": 2.3042678833007812,
            "end_logit": 2.8453924655914307,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "ketogenesis, inhibits mTORC1 activation",
            "probability": 0.015924539259538902,
            "start_logit": 3.70462703704834,
            "end_logit": 1.1953799724578857,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        }
    ],
    "530a3e18970c65fa6b000005": [
        {
            "text": "Leifsonia",
            "probability": 0.7725904923516878,
            "start_logit": 0.323645681142807,
            "end_logit": -0.26648959517478943,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp.",
            "probability": 0.08626536383196637,
            "start_logit": 0.323645681142807,
            "end_logit": -2.458810567855835,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp. on uranium immobilization in soil. The findings implied that Leifsonia",
            "probability": 0.07581688491510863,
            "start_logit": -1.5620654821395874,
            "end_logit": -0.702206552028656,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp",
            "probability": 0.05002956154554097,
            "start_logit": 0.323645681142807,
            "end_logit": -3.003624677658081,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp. on uranium immobilization in soil. The findings implied that Leifsonia sp.",
            "probability": 0.006616625384295361,
            "start_logit": -1.5620654821395874,
            "end_logit": -3.140942096710205,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Le",
            "probability": 0.005866160196522222,
            "start_logit": 0.323645681142807,
            "end_logit": -5.147038459777832,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp. on uranium immobilization in soil. The findings implied that Leifsonia sp",
            "probability": 0.0010936549008109463,
            "start_logit": -1.5620654821395874,
            "end_logit": -4.941002368927002,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia sp. on uranium immobilization in soil. The findings implied that Le",
            "probability": 0.0005217891342037651,
            "start_logit": -1.5620654821395874,
            "end_logit": -5.681019306182861,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "ia",
            "probability": 0.0005018127620908825,
            "start_logit": -7.015631675720215,
            "end_logit": -0.26648959517478943,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia group, and 47% in the medium group, respectively. This indicated that Leifsonia",
            "probability": 0.0003203202480218774,
            "start_logit": -7.090957164764404,
            "end_logit": -0.6400699019432068,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "hexavalent uranium was converted into tetravalent by cells. This is the first report of effect of Leifsonia",
            "probability": 0.0001226266222154451,
            "start_logit": -7.053653240203857,
            "end_logit": -1.637550950050354,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "ia sp.",
            "probability": 5.603105516549447e-05,
            "start_logit": -7.015631675720215,
            "end_logit": -2.458810567855835,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "bacteria",
            "probability": 4.8475936588464064e-05,
            "start_logit": -4.9249467849731445,
            "end_logit": -4.694334030151367,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "ia sp",
            "probability": 3.2495186924893654e-05,
            "start_logit": -7.015631675720215,
            "end_logit": -3.003624677658081,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Leifsonia group, and 47% in the medium group, respectively. This indicated that Leifsonia sp.",
            "probability": 2.609011828715571e-05,
            "start_logit": -7.090957164764404,
            "end_logit": -3.147834539413452,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "cells have a good proliferation ability under the stress of uranium and play a role in retaining uranium in soil. Residual uranium in active Leifsonia",
            "probability": 2.5829692296527762e-05,
            "start_logit": -5.775386810302734,
            "end_logit": -4.4734368324279785,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "immobilization via the action of bacteria",
            "probability": 2.446866174952392e-05,
            "start_logit": -5.608621120452881,
            "end_logit": -4.694334030151367,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "bacteria) resulting in uranium bearing solid is supposed as an economic and clean in-situ approach for the treatment of uranium contaminated sites.",
            "probability": 1.5067561837352953e-05,
            "start_logit": -4.9249467849731445,
            "end_logit": -5.862857341766357,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Bioremediation approaches (i.e., immobilization via the action of bacteria",
            "probability": 1.457024667166849e-05,
            "start_logit": -6.12703275680542,
            "end_logit": -4.694334030151367,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "hexavalent uranium was converted into tetravalent by cells. This is the first report of effect of Leifsonia sp.",
            "probability": 1.1679648014692343e-05,
            "start_logit": -7.053653240203857,
            "end_logit": -3.988847255706787,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        }
    ],
    "570a922dcf1c325851000028": [
        {
            "text": "necroptosis",
            "probability": 0.8665629587655781,
            "start_logit": 3.161926746368408,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.08001267785334647,
            "start_logit": 0.7795770764350891,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "MLKL necroptosis",
            "probability": 0.026559123984030333,
            "start_logit": -0.3232346773147583,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "cell death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.007422729264062443,
            "start_logit": -1.598061203956604,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death",
            "probability": 0.0072109904680014636,
            "start_logit": 0.7795770764350891,
            "end_logit": 1.0974128246307373,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.0026513472507247735,
            "start_logit": -2.627540111541748,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis signaling",
            "probability": 0.0016983293278182566,
            "start_logit": 3.161926746368408,
            "end_logit": -2.730898141860962,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.0015614730680266666,
            "start_logit": -3.1569783687591553,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "RIP3/MLKL necroptosis",
            "probability": 0.0014230980001514225,
            "start_logit": -3.2497718334198,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "tosis",
            "probability": 0.001153470646006259,
            "start_logit": -3.4598326683044434,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "cell death",
            "probability": 0.0006689593625127141,
            "start_logit": -1.598061203956604,
            "end_logit": 1.0974128246307373,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "roptosis",
            "probability": 0.0006448444458273646,
            "start_logit": -4.041354179382324,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "ne",
            "probability": 0.0004424858011381647,
            "start_logit": 3.161926746368408,
            "end_logit": -4.075890064239502,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.00040277649719035766,
            "start_logit": -4.51198148727417,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "RIP1/RIP3/MLKL necroptosis",
            "probability": 0.0003844005652833241,
            "start_logit": -4.558678150177002,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation",
            "probability": 0.0002975705411118804,
            "start_logit": 0.7795770764350891,
            "end_logit": -2.0902974605560303,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway that associates with immune activation, RIP1/RIP3/MLKL",
            "probability": 0.00026743804899583505,
            "start_logit": 0.7795770764350891,
            "end_logit": -2.1970608234405518,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.00025087480705702125,
            "start_logit": -4.985409259796143,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "As a recently defined programmed cell death pathway that associates with immune activation, RIP1/RIP3/MLKL necroptosis",
            "probability": 0.00021142273666430926,
            "start_logit": -5.156503677368164,
            "end_logit": 3.5039916038513184,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "programmed cell death pathway",
            "probability": 0.000173028566472761,
            "start_logit": 0.7795770764350891,
            "end_logit": -2.6324920654296875,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        }
    ],
    "51bdb644047fa84d1d000001": [
        {
            "text": "PNET1",
            "probability": 0.2689446155735442,
            "start_logit": 4.187383651733398,
            "end_logit": 3.5121593475341797,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM209",
            "probability": 0.23401866183780318,
            "start_logit": 4.187383651733398,
            "end_logit": 3.3730547428131104,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM209",
            "probability": 0.16297112099163683,
            "start_logit": 3.8255558013916016,
            "end_logit": 3.3730547428131104,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET",
            "probability": 0.13865946857313577,
            "start_logit": 4.187383651733398,
            "end_logit": 2.849674940109253,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM209, a critical driver for lung cancer. A functional investigation revealed that PNET1",
            "probability": 0.11098862886669632,
            "start_logit": 3.8255558013916016,
            "end_logit": 2.9889094829559326,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM209, a critical driver for lung cancer. A functional investigation revealed that PNET",
            "probability": 0.06960333990846593,
            "start_logit": 3.8255558013916016,
            "end_logit": 2.522294282913208,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1,",
            "probability": 0.0045880090956313,
            "start_logit": 4.187383651733398,
            "end_logit": -0.5588999390602112,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM209,",
            "probability": 0.0031186017732425172,
            "start_logit": 4.187383651733398,
            "end_logit": -0.9449613690376282,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM209,",
            "probability": 0.0021718012696957415,
            "start_logit": 3.8255558013916016,
            "end_logit": -0.9449613690376282,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM",
            "probability": 0.001777791141757247,
            "start_logit": 4.187383651733398,
            "end_logit": -1.506974458694458,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "TMEM",
            "probability": 0.001238057738583214,
            "start_logit": 3.8255558013916016,
            "end_logit": -1.506974458694458,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "209",
            "probability": 0.00045933974894409545,
            "start_logit": -2.0459823608398438,
            "end_logit": 3.3730547428131104,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "209, a critical driver for lung cancer. A functional investigation revealed that PNET1",
            "probability": 0.00031282529450045264,
            "start_logit": -2.0459823608398438,
            "end_logit": 2.9889094829559326,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "1",
            "probability": 0.000210819089791027,
            "start_logit": -2.963876724243164,
            "end_logit": 3.5121593475341797,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "209, a critical driver for lung cancer. A functional investigation revealed that PNET",
            "probability": 0.0001961794242113974,
            "start_logit": -2.0459823608398438,
            "end_logit": 2.522294282913208,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "1, is a homologue of human TMEM209",
            "probability": 0.00018344149102055086,
            "start_logit": -2.963876724243164,
            "end_logit": 3.3730547428131104,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "P",
            "probability": 0.00017530074029451276,
            "start_logit": 4.187383651733398,
            "end_logit": -3.8235983848571777,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET) proteins, which unravelled the compositional diversity and uniqueness of the plant NE. One of the candidates, named PNET1",
            "probability": 0.0001309293899822371,
            "start_logit": -3.440218925476074,
            "end_logit": 3.5121593475341797,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "PNET1, is a homologue of human TMEM209, a critical driver for lung cancer. A functional investigation revealed that P",
            "probability": 0.00012613843505702088,
            "start_logit": 4.187383651733398,
            "end_logit": -4.152721405029297,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "1, is a homologue of human TMEM209, a critical driver for lung cancer. A functional investigation revealed that PNET1",
            "probability": 0.00012492961600649562,
            "start_logit": -2.963876724243164,
            "end_logit": 2.9889094829559326,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        }
    ],
    "534ab91eaeec6fbd07000012": [
        {
            "text": "TGS2",
            "probability": 0.4832724151329752,
            "start_logit": 4.742868423461914,
            "end_logit": 4.3117499351501465,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 promoter. DNA methylation analysis showed tumor-specific TGS2",
            "probability": 0.21679090441236215,
            "start_logit": 3.941221237182617,
            "end_logit": 4.3117499351501465,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "TGS2 promoter methylation in bladder tumors, which results in the loss of TGS2",
            "probability": 0.08624026943633448,
            "start_logit": 4.1112518310546875,
            "end_logit": 3.219923257827759,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2",
            "probability": 0.07752236774211224,
            "start_logit": 3.941221237182617,
            "end_logit": 3.2833831310272217,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 expression by increasing the methylation of CpG nucleotides of the RGS2",
            "probability": 0.04465775798698128,
            "start_logit": 3.3896827697753906,
            "end_logit": 3.2833831310272217,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "TGS2 promoter methylation in 73% (38/52) of bladder tumors. High UHRF1",
            "probability": 0.03334351300295154,
            "start_logit": 4.742868423461914,
            "end_logit": 1.6380326747894287,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "DNA methylation analysis showed tumor-specific TGS2",
            "probability": 0.015828846919091488,
            "start_logit": 1.3241219520568848,
            "end_logit": 4.3117499351501465,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "UHRF1 expression of correlated with aberrant TGS2",
            "probability": 0.015073114845382728,
            "start_logit": 2.0075855255126953,
            "end_logit": 3.5793650150299072,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "UHRF1 expression of correlated with aberrant TGS2 promoter methylation in bladder tumors, which results in the loss of TGS2",
            "probability": 0.01052202759468576,
            "start_logit": 2.0075855255126953,
            "end_logit": 3.219923257827759,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "TGS2 promoter methylation",
            "probability": 0.002530906670351194,
            "start_logit": 4.742868423461914,
            "end_logit": -0.940252959728241,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "TGS2 promoter",
            "probability": 0.0024129303342097295,
            "start_logit": 4.742868423461914,
            "end_logit": -0.9879886507987976,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "UHRF1",
            "probability": 0.002163182123325771,
            "start_logit": 2.0075855255126953,
            "end_logit": 1.6380326747894287,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "TGS",
            "probability": 0.0019412055951473887,
            "start_logit": 4.742868423461914,
            "end_logit": -1.2055213451385498,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "methylation in 73% (38/52) of bladder tumors. High UHRF1 expression of correlated with aberrant TGS2",
            "probability": 0.0014960744464614121,
            "start_logit": -0.3024825155735016,
            "end_logit": 3.5793650150299072,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 promoter.",
            "probability": 0.0013750341795287988,
            "start_logit": 3.941221237182617,
            "end_logit": -0.7487047910690308,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 promoter. DNA methylation analysis showed tumor-specific TGS2 promoter methylation",
            "probability": 0.001135338018201895,
            "start_logit": 3.941221237182617,
            "end_logit": -0.940252959728241,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 promoter. DNA methylation analysis showed tumor-specific TGS2 promoter",
            "probability": 0.0010824150790676023,
            "start_logit": 3.941221237182617,
            "end_logit": -0.9879886507987976,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "methylation analysis showed tumor-specific TGS2",
            "probability": 0.00094878599880422,
            "start_logit": -1.4902840852737427,
            "end_logit": 4.3117499351501465,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 promoter. DNA methylation analysis showed tumor-specific TGS",
            "probability": 0.0008708043402529911,
            "start_logit": 3.941221237182617,
            "end_logit": -1.2055213451385498,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "RGS2 expression by increasing the methylation of CpG nucleotides of the RGS2 promoter.",
            "probability": 0.0007921061417718683,
            "start_logit": 3.3896827697753906,
            "end_logit": -0.7487047910690308,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        }
    ],
    "51740da48ed59a060a000024": [
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment (SOPMA), PSIPRED",
            "probability": 0.202345657690769,
            "start_logit": 5.015660285949707,
            "end_logit": 4.773879051208496,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "PSIPRED",
            "probability": 0.16757239977532998,
            "start_logit": 4.827098369598389,
            "end_logit": 4.773879051208496,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment (SOPMA",
            "probability": 0.11570602841698704,
            "start_logit": 5.015660285949707,
            "end_logit": 4.214954376220703,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam",
            "probability": 0.10734343604792693,
            "start_logit": 5.015660285949707,
            "end_logit": 4.13993501663208,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA), PSIPRED",
            "probability": 0.08984961733782124,
            "start_logit": 4.20382022857666,
            "end_logit": 4.773879051208496,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools",
            "probability": 0.06772010931641151,
            "start_logit": 5.015660285949707,
            "end_logit": 3.6792848110198975,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA",
            "probability": 0.05137813430537297,
            "start_logit": 4.20382022857666,
            "end_logit": 4.214954376220703,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment",
            "probability": 0.02702846624233453,
            "start_logit": 5.015660285949707,
            "end_logit": 2.7607922554016113,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy ProtParam tools, self-optimized prediction method with alignment (SOPMA)",
            "probability": 0.024134613044464036,
            "start_logit": 5.015660285949707,
            "end_logit": 2.6475486755371094,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "PSIPRED, and SWISS-MODEL",
            "probability": 0.021193385359958378,
            "start_logit": 4.827098369598389,
            "end_logit": 2.7061526775360107,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ExPasy",
            "probability": 0.0203385683342612,
            "start_logit": 5.015660285949707,
            "end_logit": 2.4764206409454346,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SWISS-MODEL",
            "probability": 0.019512097259566347,
            "start_logit": 4.744443893432617,
            "end_logit": 2.7061526775360107,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "alignment (SOPMA), PSIPRED",
            "probability": 0.016857125239474004,
            "start_logit": 2.530456304550171,
            "end_logit": 4.773879051208496,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "PSIPRED, and SWISS",
            "probability": 0.012079531604135815,
            "start_logit": 4.827098369598389,
            "end_logit": 2.1439759731292725,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA), PSIPRED, and SWISS-MODEL",
            "probability": 0.01136355132013561,
            "start_logit": 4.20382022857666,
            "end_logit": 2.7061526775360107,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SWISS",
            "probability": 0.011121252763856051,
            "start_logit": 4.744443893432617,
            "end_logit": 2.1439759731292725,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA)",
            "probability": 0.010716739718504018,
            "start_logit": 4.20382022857666,
            "end_logit": 2.6475486755371094,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "alignment (SOPMA",
            "probability": 0.009639302539262096,
            "start_logit": 2.530456304550171,
            "end_logit": 4.214954376220703,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "self-optimized prediction method with alignment (SOPMA), PSIPRED",
            "probability": 0.007623133714658465,
            "start_logit": 1.7368704080581665,
            "end_logit": 4.773879051208496,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "SOPMA), PSIPRED, and SWISS",
            "probability": 0.006476849968770961,
            "start_logit": 4.20382022857666,
            "end_logit": 2.1439759731292725,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        }
    ],
    "552435602c8b63434a000009": [
        {
            "text": "retinoblastoma protein",
            "probability": 0.42644690396728185,
            "start_logit": 3.9931893348693848,
            "end_logit": 2.7319297790527344,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma",
            "probability": 0.3373936785779054,
            "start_logit": 3.9931893348693848,
            "end_logit": 2.497692346572876,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB",
            "probability": 0.14747195678175248,
            "start_logit": 3.9931893348693848,
            "end_logit": 1.6700799465179443,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB)",
            "probability": 0.05416729356633901,
            "start_logit": 3.9931893348693848,
            "end_logit": 0.6685191988945007,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB) is required for activity of the CDK4/6 inhibitor, and that loss of pRB",
            "probability": 0.01549279807982917,
            "start_logit": 3.9931893348693848,
            "end_logit": -0.5831828117370605,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "pRB",
            "probability": 0.011092460152498413,
            "start_logit": 1.405816912651062,
            "end_logit": 1.6700799465179443,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "pRB)",
            "probability": 0.004074324085510781,
            "start_logit": 1.405816912651062,
            "end_logit": 0.6685191988945007,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "re",
            "probability": 0.0015878492138093846,
            "start_logit": 3.9931893348693848,
            "end_logit": -2.861177682876587,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "pRB) is required for activity of the CDK4/6 inhibitor, and that loss of pRB",
            "probability": 0.0011653283044554634,
            "start_logit": 1.405816912651062,
            "end_logit": -0.5831828117370605,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (pRB) is required for activity of the CDK4/6 inhibitor,",
            "probability": 0.0001806902352213211,
            "start_logit": 3.9931893348693848,
            "end_logit": -5.034529209136963,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblast",
            "probability": 0.0001298532735808268,
            "start_logit": 3.9931893348693848,
            "end_logit": -5.364908218383789,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "blastoma protein",
            "probability": 0.00012985203520941266,
            "start_logit": -4.103658199310303,
            "end_logit": 2.7319297790527344,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "KRAS",
            "probability": 0.00012093584638182439,
            "start_logit": -0.6148068904876709,
            "end_logit": -0.8280569314956665,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "protein",
            "probability": 0.00011385637730243215,
            "start_logit": -4.235116004943848,
            "end_logit": 2.7319297790527344,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "(pRB",
            "probability": 0.00011031818727530657,
            "start_logit": -3.2048351764678955,
            "end_logit": 1.6700799465179443,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "blastoma",
            "probability": 0.0001027355467293831,
            "start_logit": -4.103658199310303,
            "end_logit": 2.497692346572876,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "retinoblastoma protein (p",
            "probability": 7.772828118274687e-05,
            "start_logit": 3.9931893348693848,
            "end_logit": -5.87809419631958,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "oma protein",
            "probability": 4.9382464851903534e-05,
            "start_logit": -5.07045841217041,
            "end_logit": 2.7319297790527344,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "expression of retinoblastoma protein",
            "probability": 4.6221110324345915e-05,
            "start_logit": -5.136617183685303,
            "end_logit": 2.7319297790527344,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "tinoblastoma protein",
            "probability": 4.583391255891818e-05,
            "start_logit": -5.145029544830322,
            "end_logit": 2.7319297790527344,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        }
    ],
    "54f21b69c409818c32000007": [
        {
            "text": "Hemochromatosis type 4",
            "probability": 0.5633694075556828,
            "start_logit": 4.873753070831299,
            "end_logit": 4.8859124183654785,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hemochromatosis",
            "probability": 0.43253937162079953,
            "start_logit": 4.701313018798828,
            "end_logit": 4.794090270996094,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "type 4",
            "probability": 0.002722026863936971,
            "start_logit": -0.45880571007728577,
            "end_logit": 4.8859124183654785,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "4",
            "probability": 0.00032987314109147575,
            "start_logit": -2.5692296028137207,
            "end_logit": 4.8859124183654785,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hem",
            "probability": 0.0002246324220599364,
            "start_logit": 4.873753070831299,
            "end_logit": -2.9413130283355713,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "tosis type 4",
            "probability": 0.00020604963602624253,
            "start_logit": -3.039820671081543,
            "end_logit": 4.8859124183654785,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "tosis",
            "probability": 0.00019781660453858726,
            "start_logit": -2.9887752532958984,
            "end_logit": 4.794090270996094,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Atransferrinemia and DMT1 deficiency",
            "probability": 0.000131870023044501,
            "start_logit": 0.9447169303894043,
            "end_logit": 0.4550744891166687,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "DMT1 deficiency",
            "probability": 8.990205355549475e-05,
            "start_logit": 0.5616209506988525,
            "end_logit": 0.4550744891166687,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Atransferrinemia",
            "probability": 7.839700936536637e-05,
            "start_logit": 0.9447169303894043,
            "end_logit": -0.06495649367570877,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hemochromatosis type",
            "probability": 4.917132357948592e-05,
            "start_logit": 4.873753070831299,
            "end_logit": -4.46046781539917,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Hemochromatosis type 4 is",
            "probability": 2.9675037183576726e-05,
            "start_logit": 4.873753070831299,
            "end_logit": -4.965472221374512,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Atransferrinemia and DMT1",
            "probability": 8.940881711798725e-06,
            "start_logit": 0.9447169303894043,
            "end_logit": -2.2361080646514893,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "tissue iron overload. The severity of hepcidin down-regulation defines the severity of iron overload and clinical complications. Hemochromatosis",
            "probability": 7.177347029136356e-06,
            "start_logit": -5.315059661865234,
            "end_logit": 3.803964138031006,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "iron overload. The severity of hepcidin down-regulation defines the severity of iron overload and clinical complications. Hemochromatosis",
            "probability": 7.170864461605509e-06,
            "start_logit": -5.315963268280029,
            "end_logit": 3.803964138031006,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "DMT1",
            "probability": 6.09542341716449e-06,
            "start_logit": 0.5616209506988525,
            "end_logit": -2.2361080646514893,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Aceruloplasminemia",
            "probability": 1.281732774704276e-06,
            "start_logit": -0.6881290674209595,
            "end_logit": -2.5456833839416504,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "At",
            "probability": 6.631778697933633e-07,
            "start_logit": 0.9447169303894043,
            "end_logit": -4.837454319000244,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "deficiency",
            "probability": 2.3970123311565545e-07,
            "start_logit": -5.365461826324463,
            "end_logit": 0.4550744891166687,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "type",
            "probability": 2.3758063878445328e-07,
            "start_logit": -0.45880571007728577,
            "end_logit": -4.46046781539917,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        }
    ],
    "52e203bc98d0239505000011": [
        {
            "text": "TEBP",
            "probability": 0.4439699829950897,
            "start_logit": 1.6095315217971802,
            "end_logit": 0.6978963613510132,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBP) which plays an essential role in telomere maintenance and protection. The nature of TEBPs",
            "probability": 0.23033772524337323,
            "start_logit": 1.6095315217971802,
            "end_logit": 0.041686009615659714,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs",
            "probability": 0.15718768493126484,
            "start_logit": 1.227425456047058,
            "end_logit": 0.041686009615659714,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "telomere-end binding proteins (TEBP",
            "probability": 0.1337703492652806,
            "start_logit": 0.4098990857601166,
            "end_logit": 0.6978963613510132,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBP)",
            "probability": 0.007001806940984685,
            "start_logit": 1.6095315217971802,
            "end_logit": -3.4516923427581787,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "(TEBP",
            "probability": 0.006931840375276398,
            "start_logit": -2.550100088119507,
            "end_logit": 0.6978963613510132,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "telomere maintenance and protection. The nature of TEBPs",
            "probability": 0.004095632112966829,
            "start_logit": -2.4200940132141113,
            "end_logit": 0.041686009615659714,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "(TEBP) which plays an essential role in telomere maintenance and protection. The nature of TEBPs",
            "probability": 0.0035963339976725303,
            "start_logit": -2.550100088119507,
            "end_logit": 0.041686009615659714,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes, but it remains undetermined in trypanosomatids.",
            "probability": 0.0025119346598166787,
            "start_logit": 1.227425456047058,
            "end_logit": -4.094701290130615,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes,",
            "probability": 0.002314505441677654,
            "start_logit": 1.227425456047058,
            "end_logit": -4.176558494567871,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "telomere-end binding proteins (TEBP)",
            "probability": 0.002109679023038696,
            "start_logit": 0.4098990857601166,
            "end_logit": -3.4516923427581787,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes, but it remains undetermined in trypanosomatids",
            "probability": 0.0017441953206836858,
            "start_logit": 1.227425456047058,
            "end_logit": -4.459461212158203,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "TEBPs is well known in higher and some primitive eukaryotes, but it remains undetermined",
            "probability": 0.0016721829741592705,
            "start_logit": 1.227425456047058,
            "end_logit": -4.501624584197998,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "telomere-end binding proteins",
            "probability": 0.000864983775293078,
            "start_logit": 0.4098990857601166,
            "end_logit": -4.343272686004639,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "te",
            "probability": 0.000614619294884133,
            "start_logit": 0.4098990857601166,
            "end_logit": -4.684980392456055,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "OB",
            "probability": 0.0006001718266564727,
            "start_logit": -0.8691450953483582,
            "end_logit": -3.4297232627868652,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "OB (oligonucleotide/oligosaccharide-binding)-fold containing telomere-end binding proteins",
            "probability": 0.00024072773600792031,
            "start_logit": -0.8691450953483582,
            "end_logit": -4.343272686004639,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "OB (oligonucleotide/oligosaccharide-binding)-fold containing te",
            "probability": 0.0001710505047497689,
            "start_logit": -0.8691450953483582,
            "end_logit": -4.684980392456055,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "DNA",
            "probability": 0.00013306427403631928,
            "start_logit": -1.9680349826812744,
            "end_logit": -3.837217092514038,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "O",
            "probability": 0.00013152930708738806,
            "start_logit": -0.8691450953483582,
            "end_logit": -4.947709560394287,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        }
    ],
    "56be2570ef6e39474100000d": [
        {
            "text": "Neuroticism",
            "probability": 0.1227734819857737,
            "start_logit": 5.55114221572876,
            "end_logit": 5.23034143447876,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion",
            "probability": 0.11354658424911586,
            "start_logit": 5.55114221572876,
            "end_logit": 5.1522135734558105,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness, Agreeableness, and Conscientiousness",
            "probability": 0.0901440316924794,
            "start_logit": 5.55114221572876,
            "end_logit": 4.9214091300964355,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness, Agreeableness",
            "probability": 0.08011996396375023,
            "start_logit": 5.55114221572876,
            "end_logit": 4.803525447845459,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness",
            "probability": 0.07964011048496906,
            "start_logit": 5.55114221572876,
            "end_logit": 4.797518253326416,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Conscientiousness",
            "probability": 0.07093606637548001,
            "start_logit": 5.311512470245361,
            "end_logit": 4.9214091300964355,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion",
            "probability": 0.06092735479208421,
            "start_logit": 4.9286112785339355,
            "end_logit": 5.1522135734558105,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness, Agreeableness, and Conscientiousness",
            "probability": 0.05478221968304085,
            "start_logit": 5.053099155426025,
            "end_logit": 4.9214091300964355,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Agreeableness, and Conscientiousness",
            "probability": 0.05020477818127636,
            "start_logit": 4.965843677520752,
            "end_logit": 4.9214091300964355,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness, Agreeableness",
            "probability": 0.04869040561479194,
            "start_logit": 5.053099155426025,
            "end_logit": 4.803525447845459,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness",
            "probability": 0.04839878965090939,
            "start_logit": 5.053099155426025,
            "end_logit": 4.797518253326416,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion, Openness, Agreeableness, and Conscientiousness",
            "probability": 0.04836990419074928,
            "start_logit": 4.9286112785339355,
            "end_logit": 4.9214091300964355,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Agreeableness",
            "probability": 0.044621978218304166,
            "start_logit": 4.965843677520752,
            "end_logit": 4.803525447845459,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion, Openness, Agreeableness",
            "probability": 0.04299114326185838,
            "start_logit": 4.9286112785339355,
            "end_logit": 4.803525447845459,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Extraversion, Openness",
            "probability": 0.04273366124825793,
            "start_logit": 4.9286112785339355,
            "end_logit": 4.797518253326416,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness, Agreeableness,",
            "probability": 0.0002828101652062646,
            "start_logit": 5.55114221572876,
            "end_logit": -0.8429790139198303,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion,",
            "probability": 0.0002598651681984,
            "start_logit": 5.55114221572876,
            "end_logit": -0.9275919795036316,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism, Extraversion, Openness,",
            "probability": 0.00023133478930619376,
            "start_logit": 5.55114221572876,
            "end_logit": -1.0438889265060425,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Neuroticism,",
            "probability": 0.00017364723989767947,
            "start_logit": 5.55114221572876,
            "end_logit": -1.3307290077209473,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "Openness, Agreeableness,",
            "probability": 0.00017186904455061358,
            "start_logit": 5.053099155426025,
            "end_logit": -0.8429790139198303,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        }
    ],
    "56c1f000ef6e394741000037": [
        {
            "text": "tipiracil",
            "probability": 0.1982094807847128,
            "start_logit": 5.195122718811035,
            "end_logit": 4.9319071769714355,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine (trifluridine",
            "probability": 0.16679510576164827,
            "start_logit": 5.016857624053955,
            "end_logit": 4.9376139640808105,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine",
            "probability": 0.15548748210285399,
            "start_logit": 4.946656703948975,
            "end_logit": 4.9376139640808105,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine, TFT) and a potent inhibitor of thymidine phosphorylase (tipiracil",
            "probability": 0.1546026752478192,
            "start_logit": 4.946656703948975,
            "end_logit": 4.9319071769714355,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine",
            "probability": 0.09765828287407965,
            "start_logit": 5.016857624053955,
            "end_logit": 4.402322292327881,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil hydrochloride",
            "probability": 0.06866631157552965,
            "start_logit": 5.195122718811035,
            "end_logit": 3.8718414306640625,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase (tipiracil",
            "probability": 0.0348299758695587,
            "start_logit": 3.4562766551971436,
            "end_logit": 4.9319071769714355,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine (trifluridine, TFT) and a potent inhibitor of thymidine phosphorylase",
            "probability": 0.031577383385014125,
            "start_logit": 5.016857624053955,
            "end_logit": 3.2732889652252197,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine, TFT) and a potent inhibitor of thymidine phosphorylase",
            "probability": 0.029436642109562962,
            "start_logit": 4.946656703948975,
            "end_logit": 3.2732889652252197,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase (tipiracil hydrochloride",
            "probability": 0.012066254175929188,
            "start_logit": 3.4562766551971436,
            "end_logit": 3.8718414306640625,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil hydrochloride, TPI",
            "probability": 0.01024850091760695,
            "start_logit": 5.195122718811035,
            "end_logit": 1.9697141647338867,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase",
            "probability": 0.0066316933566217574,
            "start_logit": 3.4562766551971436,
            "end_logit": 3.2732889652252197,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "tipiracil hydrochloride, TPI)",
            "probability": 0.00563057973288486,
            "start_logit": 5.195122718811035,
            "end_logit": 1.3707951307296753,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "oral fluoropyrimidine (trifluridine",
            "probability": 0.004933405756722714,
            "start_logit": 1.4961210489273071,
            "end_logit": 4.9376139640808105,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "potent inhibitor of thymidine phosphorylase (tipiracil",
            "probability": 0.00481151361196964,
            "start_logit": 1.4768099784851074,
            "end_logit": 4.9319071769714355,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine (trifluridine, TFT)",
            "probability": 0.004601586864379582,
            "start_logit": 5.016857624053955,
            "end_logit": 1.3472490310668945,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluridine, TFT)",
            "probability": 0.004289629194770192,
            "start_logit": 4.946656703948975,
            "end_logit": 1.3472490310668945,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "inhibitor of thymidine phosphorylase (tipiracil",
            "probability": 0.004130073967505787,
            "start_logit": 1.3240935802459717,
            "end_logit": 4.9319071769714355,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "oral fluoropyrimidine",
            "probability": 0.002888501630324328,
            "start_logit": 1.4961210489273071,
            "end_logit": 4.402322292327881,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidine (trifluridine, TFT",
            "probability": 0.002504921080505323,
            "start_logit": 5.016857624053955,
            "end_logit": 0.7391050457954407,
            "question_text": "Which drugs are included in TAS-102?"
        }
    ],
    "54cf6d40f693c3b16b00000e": [
        {
            "text": "bradykinin",
            "probability": 0.24137080918021375,
            "start_logit": -5.876750946044922,
            "end_logit": -3.8119266033172607,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin (BK) metabolism.",
            "probability": 0.12952874966987712,
            "start_logit": -5.876750946044922,
            "end_logit": -4.4343581199646,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "angiotensin converting enzyme",
            "probability": 0.07945687270293743,
            "start_logit": -5.415598392486572,
            "end_logit": -5.384199142456055,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": ".",
            "probability": 0.06887947731003445,
            "start_logit": -6.50829553604126,
            "end_logit": -4.4343581199646,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "degradation of the bradykinin",
            "probability": 0.0575385410767813,
            "start_logit": -7.3106303215026855,
            "end_logit": -3.8119266033172607,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "(BK) metabolism.",
            "probability": 0.0567412554510635,
            "start_logit": -6.702152252197266,
            "end_logit": -4.4343581199646,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin (BK)",
            "probability": 0.053815558530669945,
            "start_logit": -5.876750946044922,
            "end_logit": -5.3126983642578125,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "BK) metabolism.",
            "probability": 0.0416574043746802,
            "start_logit": -7.01117467880249,
            "end_logit": -4.4343581199646,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "angiotensin converting enzyme (ACE) inhibitors",
            "probability": 0.036190854369991816,
            "start_logit": -5.415598392486572,
            "end_logit": -6.170607089996338,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "metabolism.",
            "probability": 0.0328813592684889,
            "start_logit": -7.247747898101807,
            "end_logit": -4.4343581199646,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "degradation of the bradykinin (BK) metabolism.",
            "probability": 0.030877367933666827,
            "start_logit": -7.3106303215026855,
            "end_logit": -4.4343581199646,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "angiotensin converting enzyme (ACE) inhibitors result from the inhibition of the ACE",
            "probability": 0.024739095515859802,
            "start_logit": -5.415598392486572,
            "end_logit": -6.551028728485107,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "(BK)",
            "probability": 0.02357439843751176,
            "start_logit": -6.702152252197266,
            "end_logit": -5.3126983642578125,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin (BK) metabolism",
            "probability": 0.02332995431413825,
            "start_logit": -5.876750946044922,
            "end_logit": -6.148522853851318,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin (BK) metabolism. ACE inhibitors",
            "probability": 0.019091448275599554,
            "start_logit": -5.876750946044922,
            "end_logit": -6.349020481109619,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin (",
            "probability": 0.018116121662195377,
            "start_logit": -5.876750946044922,
            "end_logit": -6.401458740234375,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "BK)",
            "probability": 0.01730748184534309,
            "start_logit": -7.01117467880249,
            "end_logit": -5.3126983642578125,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "angiotensin converting enzyme (ACE",
            "probability": 0.017090898871907935,
            "start_logit": -5.415598392486572,
            "end_logit": -6.920867443084717,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ACE inhibitors",
            "probability": 0.013927053233320467,
            "start_logit": -6.192158222198486,
            "end_logit": -6.349020481109619,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin (BK) metabolism. ACE inhibitors block the degradation of BK and substance P by ACE",
            "probability": 0.013885297975718476,
            "start_logit": -5.876750946044922,
            "end_logit": -6.667430400848389,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        }
    ],
    "530cf4fe960c95ad0c000007": [
        {
            "text": "cardiac function and reduces fibrosis",
            "probability": 0.2753369072698153,
            "start_logit": 4.146614074707031,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "cardiac function",
            "probability": 0.2307945790016152,
            "start_logit": 4.146614074707031,
            "end_logit": 4.340005397796631,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "fibrosis",
            "probability": 0.1751390930577146,
            "start_logit": 3.6941990852355957,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "improves cardiac function and reduces fibrosis",
            "probability": 0.13098904454350538,
            "start_logit": 3.4037322998046875,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "improves cardiac function",
            "probability": 0.10979843453975043,
            "start_logit": 3.4037322998046875,
            "end_logit": 4.340005397796631,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "reduces fibrosis",
            "probability": 0.04994069414779502,
            "start_logit": 2.4394547939300537,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "cardiac function and reduces fibrosis. We determined whether these effects were common among the diuretics",
            "probability": 0.008482059161758369,
            "start_logit": 4.146614074707031,
            "end_logit": 1.0364305973052979,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "fibrosis. We determined whether these effects were common among the diuretics",
            "probability": 0.005395354235589241,
            "start_logit": 3.6941990852355957,
            "end_logit": 1.0364305973052979,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "improves cardiac function and reduces fibrosis. We determined whether these effects were common among the diuretics",
            "probability": 0.004035262967021851,
            "start_logit": 3.4037322998046875,
            "end_logit": 1.0364305973052979,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "reduces fibrosis. We determined whether these effects were common among the diuretics",
            "probability": 0.0015384785372262945,
            "start_logit": 2.4394547939300537,
            "end_logit": 1.0364305973052979,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "transforming growth factor (TGF)-\u03b2/Smad signaling pathway, improves cardiac function and reduces fibrosis",
            "probability": 0.0013705587898045926,
            "start_logit": -1.1561628580093384,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "function and reduces fibrosis",
            "probability": 0.0013210132746676905,
            "start_logit": -1.1929823160171509,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "transforming growth factor (TGF)-\u03b2/Smad signaling pathway, improves cardiac function",
            "probability": 0.0011488381344384757,
            "start_logit": -1.1561628580093384,
            "end_logit": 4.340005397796631,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "function",
            "probability": 0.0011073077910463565,
            "start_logit": -1.1929823160171509,
            "end_logit": 4.340005397796631,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "s cardiac function and reduces fibrosis",
            "probability": 0.0007600175603315857,
            "start_logit": -1.7457951307296753,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "s cardiac function",
            "probability": 0.0006370665473432979,
            "start_logit": -1.7457951307296753,
            "end_logit": 4.340005397796631,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "diuretics",
            "probability": 0.0005776610738572196,
            "start_logit": 1.4598928689956665,
            "end_logit": 1.0364305973052979,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "inhibits transforming growth factor (TGF)-\u03b2/Smad signaling pathway, improves cardiac function and reduces fibrosis",
            "probability": 0.0005740757611699635,
            "start_logit": -2.0263752937316895,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "cardiac",
            "probability": 0.000530645511597771,
            "start_logit": 4.146614074707031,
            "end_logit": -1.7351837158203125,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "brosis",
            "probability": 0.0005229080939515473,
            "start_logit": -2.1197309494018555,
            "end_logit": 4.516472816467285,
            "question_text": "What are the indications for hydrochlorothiazide?"
        }
    ],
    "5539029cbc4f83e828000012": [
        {
            "text": "DDX3X",
            "probability": 0.8459909578644322,
            "start_logit": 5.374157428741455,
            "end_logit": 4.945225238800049,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3x",
            "probability": 0.12801310914902098,
            "start_logit": 4.465631484985352,
            "end_logit": 3.9653751850128174,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3",
            "probability": 0.014827279695219162,
            "start_logit": 5.374157428741455,
            "end_logit": 0.9011852741241455,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3",
            "probability": 0.0034240955737902,
            "start_logit": 4.465631484985352,
            "end_logit": 0.3440798819065094,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3x regulates hindbrain patterning and development by controlling Hox",
            "probability": 0.002247925266981884,
            "start_logit": 3.8219070434570312,
            "end_logit": 0.5669746398925781,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3X)",
            "probability": 0.0013480355480023328,
            "start_logit": 3.5530786514282227,
            "end_logit": 0.3244437277317047,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3X) is frequently mutated in the Wingless (WNT) and Sonic hedghog",
            "probability": 0.0008914112066565691,
            "start_logit": 3.5530786514282227,
            "end_logit": -0.08915410190820694,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3X is a medulloblastoma tumor suppressor",
            "probability": 0.0008077329765339772,
            "start_logit": 5.374157428741455,
            "end_logit": -2.0088071823120117,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3X) is frequently mutated in the Wingless",
            "probability": 0.0007482151813142031,
            "start_logit": 3.5530786514282227,
            "end_logit": -0.26426932215690613,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Hox",
            "probability": 0.0005876282962950209,
            "start_logit": 2.480238676071167,
            "end_logit": 0.5669746398925781,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "(DDX3X",
            "probability": 0.00020864554777347055,
            "start_logit": -0.657706618309021,
            "end_logit": 2.669462203979492,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Deletion of Ddx3x",
            "probability": 0.00018282505827839566,
            "start_logit": -2.085726737976074,
            "end_logit": 3.9653751850128174,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Ddx3x regulates hindbrain patterning and development by controlling Hox gene",
            "probability": 0.00013320265760589274,
            "start_logit": 3.8219070434570312,
            "end_logit": -2.2589166164398193,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "X",
            "probability": 0.00011096535598585035,
            "start_logit": -3.5648884773254395,
            "end_logit": 4.945225238800049,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "3X",
            "probability": 9.308269510896916e-05,
            "start_logit": -3.7406182289123535,
            "end_logit": 4.945225238800049,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DDX3X) is frequently mutated in the Wingless (WNT",
            "probability": 8.47343925234208e-05,
            "start_logit": 3.5530786514282227,
            "end_logit": -2.4424383640289307,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "X3X",
            "probability": 8.425946037813428e-05,
            "start_logit": -3.840205669403076,
            "end_logit": 4.945225238800049,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Thus, DDX3X",
            "probability": 8.059843072921272e-05,
            "start_logit": -3.884627342224121,
            "end_logit": 4.945225238800049,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Wingless (WNT) and Sonic hedghog",
            "probability": 7.355581344434267e-05,
            "start_logit": 1.0583173036575317,
            "end_logit": -0.08915410190820694,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "Wingless",
            "probability": 6.173982992584915e-05,
            "start_logit": 1.0583173036575317,
            "end_logit": -0.26426932215690613,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        }
    ],
    "5300aad02059c6d71c000080": [
        {
            "text": "football, cricket, and rugby",
            "probability": 0.2650537865004683,
            "start_logit": 5.445497035980225,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "cricket, and rugby",
            "probability": 0.1774462292056792,
            "start_logit": 5.04423189163208,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "rugby",
            "probability": 0.15070275961644825,
            "start_logit": 4.880873680114746,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football",
            "probability": 0.13423320927237314,
            "start_logit": 5.445497035980225,
            "end_logit": 4.859516143798828,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football, cricket",
            "probability": 0.09917252094064583,
            "start_logit": 5.445497035980225,
            "end_logit": 4.556798458099365,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "cricket",
            "probability": 0.06639327856464247,
            "start_logit": 5.04423189163208,
            "end_logit": 4.556798458099365,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports such as football, cricket, and rugby",
            "probability": 0.05367362272938238,
            "start_logit": 3.8484859466552734,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports such as football",
            "probability": 0.02718234184602701,
            "start_logit": 3.8484859466552734,
            "end_logit": 4.859516143798828,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports such as football, cricket",
            "probability": 0.020082521907607585,
            "start_logit": 3.8484859466552734,
            "end_logit": 4.556798458099365,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball sports",
            "probability": 0.004095158332947999,
            "start_logit": 3.8484859466552734,
            "end_logit": 2.9667539596557617,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "ball",
            "probability": 0.0017276923742239423,
            "start_logit": 3.8484859466552734,
            "end_logit": 2.1037352085113525,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "sports such as football, cricket, and rugby",
            "probability": 7.281794516896316e-05,
            "start_logit": -2.7542285919189453,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "sports such as football",
            "probability": 3.68777469724333e-05,
            "start_logit": -2.7542285919189453,
            "end_logit": 4.859516143798828,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "sports such as football, cricket",
            "probability": 2.724556131595215e-05,
            "start_logit": -2.7542285919189453,
            "end_logit": 4.556798458099365,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football, cricket,",
            "probability": 2.5412838875611448e-05,
            "start_logit": 5.445497035980225,
            "end_logit": -3.7125632762908936,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "football,",
            "probability": 2.2228692563935652e-05,
            "start_logit": 5.445497035980225,
            "end_logit": -3.8464338779449463,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "cricket,",
            "probability": 1.701319755294565e-05,
            "start_logit": 5.04423189163208,
            "end_logit": -3.7125632762908936,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "such as football, cricket, and rugby",
            "probability": 1.5145931384229534e-05,
            "start_logit": -4.324459075927734,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "that ball sports such as football, cricket, and rugby",
            "probability": 1.0873884215947988e-05,
            "start_logit": -4.655827045440674,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "indicates that ball sports such as football, cricket, and rugby",
            "probability": 9.262911504081468e-06,
            "start_logit": -4.8161725997924805,
            "end_logit": 5.539870262145996,
            "question_text": "Which sports have a risk for commotio cordis?"
        }
    ],
    "56c1f034ef6e394741000050": [
        {
            "text": "parkinsonism",
            "probability": 0.32414879949052855,
            "start_logit": 4.645610809326172,
            "end_logit": 4.846710681915283,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation",
            "probability": 0.1475992029354875,
            "start_logit": 4.645610809326172,
            "end_logit": 4.060008525848389,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss",
            "probability": 0.12346752469851603,
            "start_logit": 4.645610809326172,
            "end_logit": 3.881486177444458,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss, and psychiatric symptoms",
            "probability": 0.11851163909607325,
            "start_logit": 4.645610809326172,
            "end_logit": 3.8405191898345947,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation",
            "probability": 0.04611553738930698,
            "start_logit": 3.482260227203369,
            "end_logit": 4.060008525848389,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation, weight loss",
            "probability": 0.03857589430268283,
            "start_logit": 3.482260227203369,
            "end_logit": 3.881486177444458,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "psychiatric symptoms",
            "probability": 0.03806821243840169,
            "start_logit": 3.509979248046875,
            "end_logit": 3.8405191898345947,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation, weight loss, and psychiatric symptoms",
            "probability": 0.037027489411252154,
            "start_logit": 3.482260227203369,
            "end_logit": 3.8405191898345947,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "weight loss",
            "probability": 0.030925523585781312,
            "start_logit": 3.2612144947052,
            "end_logit": 3.881486177444458,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "weight loss, and psychiatric symptoms",
            "probability": 0.029684198326681663,
            "start_logit": 3.2612144947052,
            "end_logit": 3.8405191898345947,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss, and psychiatric",
            "probability": 0.026065978528529325,
            "start_logit": 4.645610809326172,
            "end_logit": 2.326138973236084,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "psychiatric",
            "probability": 0.008372892448432515,
            "start_logit": 3.509979248046875,
            "end_logit": 2.326138973236084,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation, weight loss, and psychiatric",
            "probability": 0.008143991183656028,
            "start_logit": 3.482260227203369,
            "end_logit": 2.326138973236084,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "weight loss, and psychiatric",
            "probability": 0.006528874987482369,
            "start_logit": 3.2612144947052,
            "end_logit": 2.326138973236084,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism,",
            "probability": 0.005277207146674902,
            "start_logit": 4.645610809326172,
            "end_logit": 0.7289050221443176,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation,",
            "probability": 0.0036095815829734717,
            "start_logit": 4.645610809326172,
            "end_logit": 0.34909987449645996,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "characterized by parkinsonism",
            "probability": 0.002876465457796832,
            "start_logit": -0.07902958989143372,
            "end_logit": 4.846710681915283,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "parkinsonism, hypoventilation, weight loss,",
            "probability": 0.002563436848331568,
            "start_logit": 4.645610809326172,
            "end_logit": 0.006856890860944986,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "characterized by parkinsonism, hypoventilation",
            "probability": 0.0013097812162487434,
            "start_logit": -0.07902958989143372,
            "end_logit": 4.060008525848389,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "hypoventilation,",
            "probability": 0.0011277689251623006,
            "start_logit": 3.482260227203369,
            "end_logit": 0.34909987449645996,
            "question_text": "List features of the Perry syndrome."
        }
    ],
    "516e5f25298dcd4e5100007d": [
        {
            "text": "Methotrexate",
            "probability": 0.8372319015413922,
            "start_logit": 5.302320957183838,
            "end_logit": 5.056614398956299,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine",
            "probability": 0.10752254063343349,
            "start_logit": 4.076034069061279,
            "end_logit": 4.2305006980896,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (MTX)",
            "probability": 0.04880138619930628,
            "start_logit": 5.302320957183838,
            "end_logit": 2.2142720222473145,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (MTX",
            "probability": 0.0023564796687674844,
            "start_logit": 5.302320957183838,
            "end_logit": -0.8163178563117981,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine (Pyr)",
            "probability": 0.0012602722930121003,
            "start_logit": 4.076034069061279,
            "end_logit": -0.21587200462818146,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "MTX)",
            "probability": 0.0010009439731263525,
            "start_logit": 1.4155057668685913,
            "end_logit": 2.2142720222473145,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Met",
            "probability": 0.0005224338226816983,
            "start_logit": 5.302320957183838,
            "end_logit": -2.3227436542510986,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine (Pyr),",
            "probability": 0.000417246175069118,
            "start_logit": 4.076034069061279,
            "end_logit": -1.321278691291809,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "te",
            "probability": 0.00022139749216411583,
            "start_logit": -2.9355757236480713,
            "end_logit": 5.056614398956299,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "yrimethamine",
            "probability": 0.00010852976680250728,
            "start_logit": -2.822397232055664,
            "end_logit": 4.2305006980896,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "thamine",
            "probability": 8.847168836352764e-05,
            "start_logit": -3.0267391204833984,
            "end_logit": 4.2305006980896,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "P",
            "probability": 8.095480099562748e-05,
            "start_logit": 4.076034069061279,
            "end_logit": -2.961064100265503,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "imethamine",
            "probability": 6.703196318832783e-05,
            "start_logit": -3.3042521476745605,
            "end_logit": 4.2305006980896,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (MTX) is a widely used anticancer drug",
            "probability": 5.998969784943562e-05,
            "start_logit": 5.302320957183838,
            "end_logit": -4.487069129943848,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine (Pyr), an antimalarial drug",
            "probability": 5.0293574534601156e-05,
            "start_logit": 4.076034069061279,
            "end_logit": -3.437077760696411,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "MTX",
            "probability": 4.8332727939624104e-05,
            "start_logit": 1.4155057668685913,
            "end_logit": -0.8163178563117981,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "ine",
            "probability": 4.691545149857543e-05,
            "start_logit": -3.661074638366699,
            "end_logit": 4.2305006980896,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine (Pyr), an antimalarial",
            "probability": 4.386537118340998e-05,
            "start_logit": 4.076034069061279,
            "end_logit": -3.5738298892974854,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Methotrexate (",
            "probability": 3.9638972906087726e-05,
            "start_logit": 5.302320957183838,
            "end_logit": -4.901429176330566,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "Pyrimethamine (Pyr",
            "probability": 3.137418578563039e-05,
            "start_logit": 4.076034069061279,
            "end_logit": -3.9089696407318115,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        }
    ],
    "52fc8b772059c6d71c00006e": [
        {
            "text": "IRAK4",
            "probability": 0.5869477436797863,
            "start_logit": -2.8686318397521973,
            "end_logit": -3.961211919784546,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "Inhibition",
            "probability": 0.08567188722563829,
            "start_logit": -3.9772300720214844,
            "end_logit": -4.777024745941162,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "Inhibition of TPL2 blocked both MAPK and NF-kB signaling, and suppressed KRAS-mutant cell growth",
            "probability": 0.055602489854950705,
            "start_logit": -3.9772300720214844,
            "end_logit": -5.20932149887085,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "In",
            "probability": 0.04463424633039084,
            "start_logit": -3.9772300720214844,
            "end_logit": -5.42904806137085,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "IRAK4,",
            "probability": 0.035688348428500494,
            "start_logit": -2.8686318397521973,
            "end_logit": -6.76132345199585,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "Inhibition of TPL2",
            "probability": 0.033932231788094305,
            "start_logit": -3.9772300720214844,
            "end_logit": -5.703184127807617,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "Inhibition of TPL2 blocked both MAPK and NF-kB signaling, and suppressed KRAS-mutant cell growth.",
            "probability": 0.021532271853538034,
            "start_logit": -3.9772300720214844,
            "end_logit": -6.157996654510498,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "chemotherapy",
            "probability": 0.01974994855998457,
            "start_logit": -4.751071929931641,
            "end_logit": -5.470556735992432,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "hibition",
            "probability": 0.01843888113796998,
            "start_logit": -5.513293266296387,
            "end_logit": -4.777024745941162,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "Inhibition of TPL2 blocked both MAPK and NF-kB signaling,",
            "probability": 0.013576840863409167,
            "start_logit": -3.9772300720214844,
            "end_logit": -6.6191840171813965,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "chemotherapy to curb PDAC growth in vivo.",
            "probability": 0.013510412933054109,
            "start_logit": -4.751071929931641,
            "end_logit": -5.850246906280518,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "hibition of TPL2 blocked both MAPK and NF-kB signaling, and suppressed KRAS-mutant cell growth",
            "probability": 0.011967142718712057,
            "start_logit": -5.513293266296387,
            "end_logit": -5.20932149887085,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": ".",
            "probability": 0.010169034905700513,
            "start_logit": -6.303762912750244,
            "end_logit": -4.581669330596924,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "chemotherapy to curb PDAC growth in vivo. Finally, from TCGA we characterized two MAP3K8 point mutations",
            "probability": 0.008656672131499099,
            "start_logit": -4.751071929931641,
            "end_logit": -6.295377254486084,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": ". Inhibition",
            "probability": 0.00836446097325339,
            "start_logit": -6.303762912750244,
            "end_logit": -4.777024745941162,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "suppressed KRAS-mutant cell growth",
            "probability": 0.007443018379971645,
            "start_logit": -5.9881815910339355,
            "end_logit": -5.20932149887085,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "hibition of TPL2",
            "probability": 0.007303123684422326,
            "start_logit": -5.513293266296387,
            "end_logit": -5.703184127807617,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "development of TPL2 inhibitors",
            "probability": 0.006233338807745885,
            "start_logit": -6.172464847564697,
            "end_logit": -5.202402591705322,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": ". Inhibition of TPL2 blocked both MAPK and NF-kB signaling, and suppressed KRAS-mutant cell growth",
            "probability": 0.005428675280404828,
            "start_logit": -6.303762912750244,
            "end_logit": -5.20932149887085,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "TPL2 blocked both MAPK and NF-kB signaling, and suppressed KRAS-mutant cell growth",
            "probability": 0.005149230462973471,
            "start_logit": -6.3566107749938965,
            "end_logit": -5.20932149887085,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        }
    ],
    "5324d0429b2d7acc7e000023": [
        {
            "text": "photothermolysis",
            "probability": 0.9793451398138497,
            "start_logit": 5.131057262420654,
            "end_logit": 4.317752361297607,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Laser-induced photothermolysis",
            "probability": 0.01292041008079734,
            "start_logit": 0.8029813766479492,
            "end_logit": 4.317752361297607,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "photothermolysis and the formation of effective routes for transdermal drug delivery",
            "probability": 0.005793498661830532,
            "start_logit": 5.131057262420654,
            "end_logit": -0.8123953938484192,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "photo",
            "probability": 0.0013031476123917447,
            "start_logit": 5.131057262420654,
            "end_logit": -2.304349184036255,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "lysis",
            "probability": 0.00029730511826479893,
            "start_logit": -2.968823194503784,
            "end_logit": 4.317752361297607,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Laser-induced photothermolysis and the formation of effective routes for transdermal drug delivery",
            "probability": 7.64330933705651e-05,
            "start_logit": 0.8029813766479492,
            "end_logit": -0.8123953938484192,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "induced photothermolysis",
            "probability": 5.4728832706842216e-05,
            "start_logit": -4.661191463470459,
            "end_logit": 4.317752361297607,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "photothermolysis and the formation of effective routes for transdermal drug delivery are possible mechanisms. clinicaltrials.in.th,",
            "probability": 5.278919352112997e-05,
            "start_logit": 5.131057262420654,
            "end_logit": -5.510580539703369,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "thermolysis",
            "probability": 4.033119544704119e-05,
            "start_logit": -4.966456890106201,
            "end_logit": 4.317752361297607,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "photothermolysis and the formation of effective routes",
            "probability": 3.509091291506321e-05,
            "start_logit": 5.131057262420654,
            "end_logit": -5.918944835662842,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Laser",
            "probability": 2.756734957463433e-05,
            "start_logit": 0.8029813766479492,
            "end_logit": -1.832179069519043,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "photothermolysis and the formation of effective routes for transdermal drug delivery are possible mechanisms. clinicaltrials.in.th",
            "probability": 2.529230088197534e-05,
            "start_logit": 5.131057262420654,
            "end_logit": -6.246387004852295,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Laser-induced photo",
            "probability": 1.7192306229358156e-05,
            "start_logit": 0.8029813766479492,
            "end_logit": -2.304349184036255,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "transdermal drug delivery",
            "probability": 7.709077772699959e-06,
            "start_logit": -1.49103581905365,
            "end_logit": -0.8123953938484192,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "lysis and the formation of effective routes for transdermal drug delivery",
            "probability": 1.7587638257436752e-06,
            "start_logit": -2.968823194503784,
            "end_logit": -0.8123953938484192,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Laser-induced photothermolysis and the formation of effective routes",
            "probability": 4.6295117680202376e-07,
            "start_logit": 0.8029813766479492,
            "end_logit": -5.918944835662842,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "Laser-induced photothermolysis and the formation of effective routes for transdermal drug delivery are possible mechanisms. clinicaltrials.in.th",
            "probability": 3.3367899221325384e-07,
            "start_logit": 0.8029813766479492,
            "end_logit": -6.246387004852295,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "induced photothermolysis and the formation of effective routes for transdermal drug delivery",
            "probability": 3.237586078294167e-07,
            "start_logit": -4.661191463470459,
            "end_logit": -0.8123953938484192,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "formation of effective routes for transdermal drug delivery",
            "probability": 2.467111419580233e-07,
            "start_logit": -4.932971477508545,
            "end_logit": -0.8123953938484192,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "thermolysis and the formation of effective routes for transdermal drug delivery",
            "probability": 2.38586701820843e-07,
            "start_logit": -4.966456890106201,
            "end_logit": -0.8123953938484192,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        }
    ],
    "52ee065d98d0239505000033": [
        {
            "text": "treatment",
            "probability": 0.36582143549270135,
            "start_logit": 1.594251036643982,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis or treatment",
            "probability": 0.3442722049962321,
            "start_logit": 1.5335383415222168,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis",
            "probability": 0.12904934736584295,
            "start_logit": 1.5335383415222168,
            "end_logit": 1.426482081413269,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "diagnosis, prognosis or treatment",
            "probability": 0.1060319783719033,
            "start_logit": 0.35584643483161926,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "diagnosis, prognosis",
            "probability": 0.039745751792402334,
            "start_logit": 0.35584643483161926,
            "end_logit": 1.426482081413269,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "diagnosis",
            "probability": 0.007273612374326557,
            "start_logit": 0.35584643483161926,
            "end_logit": -0.27176782488822937,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "sis or treatment",
            "probability": 0.0007919845792237329,
            "start_logit": -4.541107654571533,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "treatment)",
            "probability": 0.0007709791258232967,
            "start_logit": 1.594251036643982,
            "end_logit": -3.754519462585449,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis or treatment)",
            "probability": 0.0007255635069491424,
            "start_logit": 1.5335383415222168,
            "end_logit": -3.754519462585449,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "treatment) are studied.",
            "probability": 0.0007040597040599836,
            "start_logit": 1.594251036643982,
            "end_logit": -3.8453176021575928,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "prognosis or treatment) are studied.",
            "probability": 0.0006625860686355575,
            "start_logit": 1.5335383415222168,
            "end_logit": -3.8453176021575928,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "gnosis or treatment",
            "probability": 0.0006200797909530808,
            "start_logit": -4.785801410675049,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "which types of algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.0005741400155308367,
            "start_logit": -4.862776279449463,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "pro",
            "probability": 0.0005681714213435093,
            "start_logit": 1.5335383415222168,
            "end_logit": -3.999044895172119,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "progno",
            "probability": 0.0005488155195836787,
            "start_logit": 1.5335383415222168,
            "end_logit": -4.033705711364746,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "(e.g., diagnosis, prognosis or treatment",
            "probability": 0.00044120640113257006,
            "start_logit": -5.126136779785156,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.00043945549564719153,
            "start_logit": -5.130113124847412,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.0003573911643683523,
            "start_logit": -5.336818695068359,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "types of algorithms and input data are used or which medical applications (e.g., diagnosis, prognosis or treatment",
            "probability": 0.00030436389827640154,
            "start_logit": -5.497425556182861,
            "end_logit": 2.407719850540161,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "sis",
            "probability": 0.00029687291506368644,
            "start_logit": -4.541107654571533,
            "end_logit": 1.426482081413269,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        }
    ],
    "56d094f33975bb303a000012": [
        {
            "text": "cytokinesis",
            "probability": 0.3303412545985885,
            "start_logit": 3.7350521087646484,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division machinery, and may generate constrictive forces necessary for cytokinesis",
            "probability": 0.1642362780583242,
            "start_logit": 3.0362319946289062,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "recruits the division machinery, and may generate constrictive forces necessary for cytokinesis",
            "probability": 0.1162889907458766,
            "start_logit": 2.6910042762756348,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division machinery",
            "probability": 0.0907708864722255,
            "start_logit": 3.0362319946289062,
            "end_logit": 3.2826287746429443,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "recruits the division machinery",
            "probability": 0.06427115191453062,
            "start_logit": 2.6910042762756348,
            "end_logit": 3.2826287746429443,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division",
            "probability": 0.04738710701368052,
            "start_logit": 2.879349708557129,
            "end_logit": 2.789522647857666,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "constrictive forces necessary for cytokinesis",
            "probability": 0.04616412315886204,
            "start_logit": 1.767128825187683,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "may generate constrictive forces necessary for cytokinesis",
            "probability": 0.03308330295762936,
            "start_logit": 1.4339545965194702,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "generate constrictive forces necessary for cytokinesis",
            "probability": 0.01781552555172604,
            "start_logit": 0.8149961829185486,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "polymerizes at midcell, recruits the division machinery, and may generate constrictive forces necessary for cytokinesis",
            "probability": 0.014796905968513062,
            "start_logit": 0.6293439865112305,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division",
            "probability": 0.013447323177834295,
            "start_logit": 3.0362319946289062,
            "end_logit": 1.373070240020752,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division machinery, and may generate constrictive forces",
            "probability": 0.01003929030861943,
            "start_logit": 3.0362319946289062,
            "end_logit": 1.0807965993881226,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "recruits the division",
            "probability": 0.009521499507122602,
            "start_logit": 2.6910042762756348,
            "end_logit": 1.373070240020752,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "polymerizes at midcell, recruits the division machinery",
            "probability": 0.008178024293336203,
            "start_logit": 0.6293439865112305,
            "end_logit": 3.2826287746429443,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "the division machinery, and may generate constrictive forces necessary for cytokinesis",
            "probability": 0.007684746810772071,
            "start_logit": -0.025836685672402382,
            "end_logit": 3.875596284866333,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "GTPase that polymerizes at midcell, recruits the division machinery",
            "probability": 0.007314973762084584,
            "start_logit": 0.5178168416023254,
            "end_logit": 3.2826287746429443,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "recruits the division machinery, and may generate constrictive forces",
            "probability": 0.00710841083100788,
            "start_logit": 2.6910042762756348,
            "end_logit": 1.0807965993881226,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "the division machinery",
            "probability": 0.004247242378938176,
            "start_logit": -0.025836685672402382,
            "end_logit": 3.2826287746429443,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "polymerizes at midcell",
            "probability": 0.0038548900894187703,
            "start_logit": 0.6293439865112305,
            "end_logit": 2.5305206775665283,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "GTPase that polymerizes at midcell",
            "probability": 0.003448072400909282,
            "start_logit": 0.5178168416023254,
            "end_logit": 2.5305206775665283,
            "question_text": "List functional roles of the FtsZ protein."
        }
    ],
    "56acc7ca0a360a5e45000002": [
        {
            "text": "Cranfield Genome Browser",
            "probability": 0.19116686063140573,
            "start_logit": 4.092851161956787,
            "end_logit": 4.07743501663208,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Cranfield Genome Browser (CRAMER",
            "probability": 0.1563372165323921,
            "start_logit": 4.092851161956787,
            "end_logit": 3.8763036727905273,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "CRAMER",
            "probability": 0.1423509996635237,
            "start_logit": 3.999131679534912,
            "end_logit": 3.8763036727905273,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Cranfield Genome Browser (CRAMER)",
            "probability": 0.098236215410814,
            "start_logit": 4.092851161956787,
            "end_logit": 3.411663293838501,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "CRAMER)",
            "probability": 0.08944782168354151,
            "start_logit": 3.999131679534912,
            "end_logit": 3.411663293838501,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Cranfield",
            "probability": 0.07654183635363096,
            "start_logit": 4.092851161956787,
            "end_logit": 3.162125825881958,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "The Cranfield Genome Browser",
            "probability": 0.06055686695135437,
            "start_logit": 2.9432873725891113,
            "end_logit": 4.07743501663208,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "The Cranfield Genome Browser (CRAMER",
            "probability": 0.04952370923405652,
            "start_logit": 2.9432873725891113,
            "end_logit": 3.8763036727905273,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "The Cranfield Genome Browser (CRAMER)",
            "probability": 0.03111876926151678,
            "start_logit": 2.9432873725891113,
            "end_logit": 3.411663293838501,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "The Cranfield",
            "probability": 0.024246534074837907,
            "start_logit": 2.9432873725891113,
            "end_logit": 3.162125825881958,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "(CRAMER",
            "probability": 0.02416335804747179,
            "start_logit": 2.225673198699951,
            "end_logit": 3.8763036727905273,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Genome Browser",
            "probability": 0.016181504994157516,
            "start_logit": 1.6235734224319458,
            "end_logit": 4.07743501663208,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "(CRAMER)",
            "probability": 0.015183312706019976,
            "start_logit": 2.225673198699951,
            "end_logit": 3.411663293838501,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Genome Browser (CRAMER",
            "probability": 0.013233315867279487,
            "start_logit": 1.6235734224319458,
            "end_logit": 3.8763036727905273,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Genome Browser (CRAMER)",
            "probability": 0.00831530007359483,
            "start_logit": 1.6235734224319458,
            "end_logit": 3.411663293838501,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Cranfield Genome",
            "probability": 0.0011105501815114277,
            "start_logit": 4.092851161956787,
            "end_logit": -1.0708560943603516,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Cranfield Genome Browser (CRAMER) is an open-source, lightweight and highly customisable web application",
            "probability": 0.0006166202658153265,
            "start_logit": 4.092851161956787,
            "end_logit": -1.6592135429382324,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "CRAMER) is an open-source, lightweight and highly customisable web application for interactive visualisation of genomic data",
            "probability": 0.0006122396022022882,
            "start_logit": 3.999131679534912,
            "end_logit": -1.5726237297058105,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "CRAMER) is an open-source, lightweight and highly customisable web application",
            "probability": 0.0005614562750860584,
            "start_logit": 3.999131679534912,
            "end_logit": -1.6592135429382324,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Browser",
            "probability": 0.0004955121897876414,
            "start_logit": -1.8624588251113892,
            "end_logit": 4.07743501663208,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        }
    ],
    "5321badd9b2d7acc7e00000a": [
        {
            "text": "melanoma",
            "probability": 0.36536561547512497,
            "start_logit": 5.1146979331970215,
            "end_logit": 4.979757785797119,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non-small cell lung cancer",
            "probability": 0.26977046151228906,
            "start_logit": 5.120264053344727,
            "end_logit": 4.670864582061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non-small cell lung cancer",
            "probability": 0.26827305794130885,
            "start_logit": 5.1146979331970215,
            "end_logit": 4.670864582061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non-small cell lung",
            "probability": 0.030029071776057716,
            "start_logit": 5.120264053344727,
            "end_logit": 2.475459098815918,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non-small cell lung",
            "probability": 0.02986239066850198,
            "start_logit": 5.1146979331970215,
            "end_logit": 2.475459098815918,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non-small cell lung cancer (NSCLC)",
            "probability": 0.01741459397465283,
            "start_logit": 5.120264053344727,
            "end_logit": 1.930601716041565,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non-small cell lung cancer (NSCLC)",
            "probability": 0.017317931519250436,
            "start_logit": 5.1146979331970215,
            "end_logit": 1.930601716041565,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lung cancer",
            "probability": 0.000684118516893527,
            "start_logit": -0.8569315075874329,
            "end_logit": 4.670864582061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lanoma",
            "probability": 0.0001759276829628354,
            "start_logit": -2.5238828659057617,
            "end_logit": 4.979757785797119,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "small cell lung cancer",
            "probability": 0.00014347687511879516,
            "start_logit": -2.418888807296753,
            "end_logit": 4.670864582061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "cancer",
            "probability": 0.00013302984313831736,
            "start_logit": -2.4944891929626465,
            "end_logit": 4.670864582061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lanoma and non-small cell lung cancer",
            "probability": 0.0001291765165794104,
            "start_logit": -2.5238828659057617,
            "end_logit": 4.670864582061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "oma",
            "probability": 0.00011366360047610512,
            "start_logit": -2.9607126712799072,
            "end_logit": 4.979757785797119,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "me",
            "probability": 0.00010614776163718145,
            "start_logit": 5.1146979331970215,
            "end_logit": -3.1640639305114746,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "non",
            "probability": 0.00010022288828801899,
            "start_logit": 5.120264053344727,
            "end_logit": -3.2270655632019043,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melanoma and non",
            "probability": 9.966658531112844e-05,
            "start_logit": 5.1146979331970215,
            "end_logit": -3.2270655632019043,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "oma and non-small cell lung cancer",
            "probability": 8.345854230615188e-05,
            "start_logit": -2.9607126712799072,
            "end_logit": 4.670864582061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "lung",
            "probability": 7.6151569493423e-05,
            "start_logit": -0.8569315075874329,
            "end_logit": 2.475459098815918,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "melan",
            "probability": 6.724845448358749e-05,
            "start_logit": 5.1146979331970215,
            "end_logit": -3.62050199508667,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "tumors such as melanoma",
            "probability": 5.458829612557046e-05,
            "start_logit": -3.694136381149292,
            "end_logit": 4.979757785797119,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        }
    ],
    "56cdf3745795f9a73e000039": [
        {
            "text": "rapamycin",
            "probability": 0.3184999475112851,
            "start_logit": 2.486332893371582,
            "end_logit": 2.4838411808013916,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target of rapamycin",
            "probability": 0.30834912674381915,
            "start_logit": 2.4539432525634766,
            "end_logit": 2.4838411808013916,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "target of rapamycin",
            "probability": 0.19016967970997498,
            "start_logit": 1.9706273078918457,
            "end_logit": 2.4838411808013916,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "rapamycin complex 1",
            "probability": 0.036613998284407756,
            "start_logit": 2.486332893371582,
            "end_logit": 0.32064950466156006,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target of rapamycin complex 1",
            "probability": 0.03544708401308858,
            "start_logit": 2.4539432525634766,
            "end_logit": 0.32064950466156006,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "rapamycin complex",
            "probability": 0.025083022857573068,
            "start_logit": 2.486332893371582,
            "end_logit": -0.05758989229798317,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target of rapamycin complex",
            "probability": 0.02428360900735743,
            "start_logit": 2.4539432525634766,
            "end_logit": -0.05758989229798317,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "target of rapamycin complex 1",
            "probability": 0.021861455177793046,
            "start_logit": 1.9706273078918457,
            "end_logit": 0.32064950466156006,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "target of rapamycin complex",
            "probability": 0.014976550107009483,
            "start_logit": 1.9706273078918457,
            "end_logit": -0.05758989229798317,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "rapamycin complex 1 (mTORC1)",
            "probability": 0.004685931632507684,
            "start_logit": 2.486332893371582,
            "end_logit": -1.7352163791656494,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target of rapamycin complex 1 (mTORC1)",
            "probability": 0.004536587645163702,
            "start_logit": 2.4539432525634766,
            "end_logit": -1.7352163791656494,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "target of rapamycin complex 1 (mTORC1)",
            "probability": 0.002797872102208909,
            "start_logit": 1.9706273078918457,
            "end_logit": -1.7352163791656494,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target",
            "probability": 0.0021816163338396733,
            "start_logit": 2.4539432525634766,
            "end_logit": -2.467325448989868,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "rap",
            "probability": 0.0016628298300333977,
            "start_logit": 2.486332893371582,
            "end_logit": -2.7712602615356445,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target of rap",
            "probability": 0.0016098342559262254,
            "start_logit": 2.4539432525634766,
            "end_logit": -2.7712602615356445,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "rapamycin complex 1 (mTORC1",
            "probability": 0.0015745199487876146,
            "start_logit": 2.486332893371582,
            "end_logit": -2.8258306980133057,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target of rapamycin complex 1 (mTORC1",
            "probability": 0.001524338873657684,
            "start_logit": 2.4539432525634766,
            "end_logit": -2.8258306980133057,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "rapamycin complex 1 (mTORC1).",
            "probability": 0.0014209010404856864,
            "start_logit": 2.486332893371582,
            "end_logit": -2.928489923477173,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mechanistic target of rapamycin complex 1 (mTORC1).",
            "probability": 0.0013756159096623445,
            "start_logit": 2.4539432525634766,
            "end_logit": -2.928489923477173,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "target",
            "probability": 0.001345479015418216,
            "start_logit": 1.9706273078918457,
            "end_logit": -2.467325448989868,
            "question_text": "Which are the main components of mTORC1?"
        }
    ],
    "5508685b4b2a315d4100000a": [
        {
            "text": "Inflammatory bowel disease",
            "probability": 0.8612520843059497,
            "start_logit": 5.7303338050842285,
            "end_logit": 5.741076946258545,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD)",
            "probability": 0.10823178291093226,
            "start_logit": 5.7303338050842285,
            "end_logit": 3.6669647693634033,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel",
            "probability": 0.0215281958164632,
            "start_logit": 5.7303338050842285,
            "end_logit": 2.052053213119507,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD",
            "probability": 0.001986722643047105,
            "start_logit": 5.7303338050842285,
            "end_logit": -0.3308239281177521,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "IBD)",
            "probability": 0.0015615530815927502,
            "start_logit": 1.4917396306991577,
            "end_logit": 3.6669647693634033,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "bowel disease",
            "probability": 0.0014817165790680675,
            "start_logit": -0.6348521709442139,
            "end_logit": 5.741076946258545,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "disease",
            "probability": 0.0005923639564616952,
            "start_logit": -1.551687479019165,
            "end_logit": 5.741076946258545,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "(IBD)",
            "probability": 0.0005615017845436135,
            "start_logit": 0.46891841292381287,
            "end_logit": 3.6669647693634033,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory",
            "probability": 0.0004689917756089702,
            "start_logit": 5.7303338050842285,
            "end_logit": -1.7744803428649902,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD) can be successfully",
            "probability": 0.0004479070908936202,
            "start_logit": 5.7303338050842285,
            "end_logit": -1.8204797506332397,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bow",
            "probability": 0.00044433896935299724,
            "start_logit": 5.7303338050842285,
            "end_logit": -1.8284778594970703,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD) can be successfully treated",
            "probability": 0.00039291967971341265,
            "start_logit": 5.7303338050842285,
            "end_logit": -1.951460361480713,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD) can be successfully treated with vedolizumab",
            "probability": 0.00032457396250459316,
            "start_logit": 5.7303338050842285,
            "end_logit": -2.142552137374878,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "bowel disease (IBD)",
            "probability": 0.00018620428332601294,
            "start_logit": -0.6348521709442139,
            "end_logit": 3.6669647693634033,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (",
            "probability": 0.00016766750318572462,
            "start_logit": 5.7303338050842285,
            "end_logit": -2.8030827045440674,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD) can be",
            "probability": 9.120693728975679e-05,
            "start_logit": 5.7303338050842285,
            "end_logit": -3.4119346141815186,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD) can be successfully treated with",
            "probability": 8.668139958911499e-05,
            "start_logit": 5.7303338050842285,
            "end_logit": -3.4628262519836426,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "disease (IBD)",
            "probability": 7.444116340419544e-05,
            "start_logit": -1.551687479019165,
            "end_logit": 3.6669647693634033,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Inflammatory bowel disease (IBD) can be successfully treated with vedolizumab.",
            "probability": 7.24275068014659e-05,
            "start_logit": 5.7303338050842285,
            "end_logit": -3.642479419708252,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "el disease",
            "probability": 4.67186502718073e-05,
            "start_logit": -4.091665267944336,
            "end_logit": 5.741076946258545,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        }
    ],
    "52bf1d6003868f1b0600000e": [
        {
            "text": "craniosynostosis",
            "probability": 0.2787047461452103,
            "start_logit": 0.346523642539978,
            "end_logit": -0.2914371192455292,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia",
            "probability": 0.14561946871530204,
            "start_logit": 0.346523642539978,
            "end_logit": -0.9405932426452637,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia",
            "probability": 0.11262554226826357,
            "start_logit": 0.08959533274173737,
            "end_logit": -0.9405932426452637,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three clinical subtypes",
            "probability": 0.06447021077697518,
            "start_logit": 0.08959533274173737,
            "end_logit": -1.4984585046768188,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three",
            "probability": 0.05978898806730221,
            "start_logit": 0.346523642539978,
            "end_logit": -1.8307685852050781,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs and toes",
            "probability": 0.05052221918192477,
            "start_logit": 0.346523642539978,
            "end_logit": -1.9991768598556519,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three",
            "probability": 0.04624221789955652,
            "start_logit": 0.08959533274173737,
            "end_logit": -1.8307685852050781,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes",
            "probability": 0.03907507960412175,
            "start_logit": 0.08959533274173737,
            "end_logit": -1.9991768598556519,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs",
            "probability": 0.029948425731600906,
            "start_logit": 0.346523642539978,
            "end_logit": -2.52211332321167,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs",
            "probability": 0.02316282100092521,
            "start_logit": 0.08959533274173737,
            "end_logit": -2.52211332321167,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis,",
            "probability": 0.022821692928920716,
            "start_logit": 0.346523642539978,
            "end_logit": -2.7938785552978516,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three clinical subtypes based on clinical findings.",
            "probability": 0.022187676524491308,
            "start_logit": 0.08959533274173737,
            "end_logit": -2.565124750137329,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant inherited disorder associated with craniosynostosis",
            "probability": 0.017754352321025808,
            "start_logit": -2.406998634338379,
            "end_logit": -0.2914371192455292,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three clinical subtype",
            "probability": 0.015662044644512138,
            "start_logit": 0.346523642539978,
            "end_logit": -3.1703498363494873,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three clinical subtypes based on clinical findings",
            "probability": 0.01333936383084206,
            "start_logit": 0.08959533274173737,
            "end_logit": -3.0739424228668213,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three clinical subtypes based",
            "probability": 0.013049362777705974,
            "start_logit": 0.08959533274173737,
            "end_logit": -3.0959224700927734,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three clinical subtype",
            "probability": 0.01211339587130751,
            "start_logit": 0.08959533274173737,
            "end_logit": -3.1703498363494873,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "broad thumbs and toes. The syndrome has been divided into three clinical subtypes",
            "probability": 0.011922832967695743,
            "start_logit": -1.5981526374816895,
            "end_logit": -1.4984585046768188,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs and toes.",
            "probability": 0.011231808556197712,
            "start_logit": 0.346523642539978,
            "end_logit": -3.502840280532837,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, midfacial hypoplasia, and broad thumbs and toes. The syndrome has been divided into three clinical",
            "probability": 0.009757750186118332,
            "start_logit": 0.346523642539978,
            "end_logit": -3.6435282230377197,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        }
    ],
    "553f96191d53b76422000004": [
        {
            "text": "TUNEL",
            "probability": 0.7759390417106591,
            "start_logit": 4.230308532714844,
            "end_logit": 3.1843247413635254,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL assay",
            "probability": 0.20073662724923574,
            "start_logit": 4.230308532714844,
            "end_logit": 1.8322445154190063,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL ass",
            "probability": 0.005766654667217685,
            "start_logit": 4.230308532714844,
            "end_logit": -1.7176570892333984,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "light microscopy, transmission electron microscopy, and TUNEL",
            "probability": 0.00440273064790083,
            "start_logit": -0.9415404796600342,
            "end_logit": 3.1843247413635254,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "transmission electron microscopy, and TUNEL",
            "probability": 0.0038850497199965097,
            "start_logit": -1.0666296482086182,
            "end_logit": 3.1843247413635254,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNE",
            "probability": 0.0019821401984140004,
            "start_logit": 4.230308532714844,
            "end_logit": -2.785572052001953,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "light microscopy, transmission electron microscopy, and TUNEL assay",
            "probability": 0.0011389932113713805,
            "start_logit": -0.9415404796600342,
            "end_logit": 1.8322445154190063,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "transmission electron microscopy, and TUNEL assay",
            "probability": 0.0010050683566177542,
            "start_logit": -1.0666296482086182,
            "end_logit": 1.8322445154190063,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL assay. We consequently detected two modes of cell death, i.e., dying cells showed both DNA fragmentation",
            "probability": 0.0008674258411421024,
            "start_logit": 4.230308532714844,
            "end_logit": -3.6119744777679443,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "L",
            "probability": 0.0007891615622117021,
            "start_logit": -2.6605496406555176,
            "end_logit": 3.1843247413635254,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL assay. We consequently detected two modes of cell death,",
            "probability": 0.0007566495516462041,
            "start_logit": 4.230308532714844,
            "end_logit": -3.7486042976379395,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL assay. We consequently detected two modes of cell death, i.e., dying cells",
            "probability": 0.0006050384121639225,
            "start_logit": 4.230308532714844,
            "end_logit": -3.972212553024292,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL assay. We consequently detected two modes of cell death, i.e., dying cells showed both DNA fragmentation derived",
            "probability": 0.0003551128837158724,
            "start_logit": 4.230308532714844,
            "end_logit": -4.505068778991699,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagic",
            "probability": 0.0003490761063924993,
            "start_logit": 1.4267420768737793,
            "end_logit": -1.718648076057434,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL assay. We consequently detected two modes of cell death, i.e., dying",
            "probability": 0.000333206117946247,
            "start_logit": 4.230308532714844,
            "end_logit": -4.5687432289123535,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagic vacuole formation",
            "probability": 0.00028575149965423297,
            "start_logit": 1.4267420768737793,
            "end_logit": -1.9188154935836792,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "assay",
            "probability": 0.0002773134149865025,
            "start_logit": -2.354292154312134,
            "end_logit": 1.8322445154190063,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagic vacuole",
            "probability": 0.00024634625795685064,
            "start_logit": 1.4267420768737793,
            "end_logit": -2.067199945449829,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "L assay",
            "probability": 0.00020415731370324077,
            "start_logit": -2.6605496406555176,
            "end_logit": 1.8322445154190063,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "autophagy",
            "probability": 7.44552770679658e-05,
            "start_logit": -1.0331978797912598,
            "end_logit": -0.8037994503974915,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        }
    ],
    "5306158358348c0f52000001": [
        {
            "text": "deletions, uniparental disomy",
            "probability": 0.34548405463980664,
            "start_logit": 2.645004987716675,
            "end_logit": 2.0134458541870117,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions",
            "probability": 0.3252343516910494,
            "start_logit": 2.645004987716675,
            "end_logit": 1.95304536819458,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy",
            "probability": 0.17595899743950183,
            "start_logit": 1.9703094959259033,
            "end_logit": 2.0134458541870117,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting defects",
            "probability": 0.04892129962090525,
            "start_logit": 2.645004987716675,
            "end_logit": 0.05871224030852318,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects",
            "probability": 0.024916179832688984,
            "start_logit": 1.9703094959259033,
            "end_logit": 0.05871224030852318,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting defects at chromosome 15",
            "probability": 0.024039375923178452,
            "start_logit": 2.645004987716675,
            "end_logit": -0.6518074870109558,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects at chromosome 15",
            "probability": 0.012243530286582453,
            "start_logit": 1.9703094959259033,
            "end_logit": -0.6518074870109558,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting defects",
            "probability": 0.011677378465024995,
            "start_logit": 1.212445616722107,
            "end_logit": 0.05871224030852318,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting",
            "probability": 0.0059968015660475694,
            "start_logit": 2.645004987716675,
            "end_logit": -2.0402743816375732,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting defects at chromosome 15",
            "probability": 0.005738132324636922,
            "start_logit": 1.212445616722107,
            "end_logit": -0.6518074870109558,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprinting defects at chromosome 15. The loss of function of specific genes",
            "probability": 0.00489221147079335,
            "start_logit": 2.645004987716675,
            "end_logit": -2.243856191635132,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting",
            "probability": 0.0030542399200029127,
            "start_logit": 1.9703094959259033,
            "end_logit": -2.0402743816375732,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy, and imprinting defects at chromosome 15. The loss of function of specific genes",
            "probability": 0.0024916594965874992,
            "start_logit": 1.9703094959259033,
            "end_logit": -2.243856191635132,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "disomy",
            "probability": 0.0016372828110142001,
            "start_logit": -2.7069034576416016,
            "end_logit": 2.0134458541870117,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy,",
            "probability": 0.0015903036788136723,
            "start_logit": 2.645004987716675,
            "end_logit": -3.3675756454467773,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions,",
            "probability": 0.0014835886016526258,
            "start_logit": 2.645004987716675,
            "end_logit": -3.4370367527008057,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting",
            "probability": 0.0014314198929512463,
            "start_logit": 1.212445616722107,
            "end_logit": -2.0402743816375732,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions, uniparental disomy, and imprint",
            "probability": 0.0011919238552645997,
            "start_logit": 2.645004987716675,
            "end_logit": -3.6559319496154785,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "imprinting defects at chromosome 15. The loss of function of specific genes",
            "probability": 0.0011677573024036806,
            "start_logit": 1.212445616722107,
            "end_logit": -2.243856191635132,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "del",
            "probability": 0.0008495111810937164,
            "start_logit": 2.645004987716675,
            "end_logit": -3.9945948123931885,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        }
    ],
    "514a11add24251bc05000054": [
        {
            "text": "breast cancer",
            "probability": 0.9935330717714439,
            "start_logit": 3.0733609199523926,
            "end_logit": 3.2231075763702393,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "cancer",
            "probability": 0.003454724024650196,
            "start_logit": -2.5881638526916504,
            "end_logit": 3.2231075763702393,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast",
            "probability": 0.001234146821325805,
            "start_logit": 3.0733609199523926,
            "end_logit": -3.4677798748016357,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer and treated at The Ohio State University Comprehensive Cancer",
            "probability": 0.0007667820326349338,
            "start_logit": 3.0733609199523926,
            "end_logit": -3.9437124729156494,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer and treated at The Ohio State University Comprehensive Cancer Center as compared to comprehensively matched female subjects. Secondary objectives included assessment of clinical",
            "probability": 0.00045688144826476024,
            "start_logit": 3.0733609199523926,
            "end_logit": -4.461491107940674,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer and treated at The Ohio State University Comprehensive Cancer Center as compared to comprehensively matched female subjects. Secondary objectives included assessment",
            "probability": 0.00041117115103439137,
            "start_logit": 3.0733609199523926,
            "end_logit": -4.566905498504639,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "overall and distant disease-free survival in males diagnosed with breast cancer",
            "probability": 6.961620505251973e-05,
            "start_logit": -6.492664337158203,
            "end_logit": 3.2231075763702393,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "distant disease-free survival in males diagnosed with breast cancer",
            "probability": 5.992661779248423e-05,
            "start_logit": -6.64254093170166,
            "end_logit": 3.2231075763702393,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "cancer and treated at The Ohio State University Comprehensive Cancer",
            "probability": 2.666262840240317e-06,
            "start_logit": -2.5881638526916504,
            "end_logit": -3.9437124729156494,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "cancer and treated at The Ohio State University Comprehensive Cancer Center as compared to comprehensively matched female subjects. Secondary objectives included assessment of clinical",
            "probability": 1.5886731509832858e-06,
            "start_logit": -2.5881638526916504,
            "end_logit": -4.461491107940674,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "cancer and treated at The Ohio State University Comprehensive Cancer Center as compared to comprehensively matched female subjects. Secondary objectives included assessment",
            "probability": 1.4297288073047248e-06,
            "start_logit": -2.5881638526916504,
            "end_logit": -4.566905498504639,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "recurrence score",
            "probability": 1.1617035731639269e-06,
            "start_logit": -3.2459545135498047,
            "end_logit": -4.1167120933532715,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "recurrence score,",
            "probability": 1.0874085824958795e-06,
            "start_logit": -3.2459545135498047,
            "end_logit": -4.182802200317383,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical and histopathologic features",
            "probability": 9.625186413331466e-07,
            "start_logit": -3.616976499557495,
            "end_logit": -3.93377947807312,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "Cancer Center as compared to comprehensively matched female subjects. Secondary objectives included assessment of clinical and histopathologic features",
            "probability": 8.97065282791664e-07,
            "start_logit": -3.687401294708252,
            "end_logit": -3.93377947807312,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "Cancer",
            "probability": 8.88198845999754e-07,
            "start_logit": -3.687401294708252,
            "end_logit": -3.9437124729156494,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical and histopathologic features and recurrence score",
            "probability": 8.016088881760409e-07,
            "start_logit": -3.616976499557495,
            "end_logit": -4.1167120933532715,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assessment of clinical and histopathologic features and recurrence score,",
            "probability": 7.503432071174367e-07,
            "start_logit": -3.616976499557495,
            "end_logit": -4.182802200317383,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "Cancer Center as compared to comprehensively matched female subjects. Secondary objectives included assessment of clinical and histopathologic features and recurrence score",
            "probability": 7.470977424021218e-07,
            "start_logit": -3.687401294708252,
            "end_logit": -4.1167120933532715,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "Cancer Center as compared to comprehensively matched female subjects. Secondary objectives included assessment of clinical and histopathologic features and recurrence score,",
            "probability": 6.993182390226892e-07,
            "start_logit": -3.687401294708252,
            "end_logit": -4.182802200317383,
            "question_text": "Which diseases can Oncotype DX be used for?"
        }
    ],
    "5165932e298dcd4e51000059": [
        {
            "text": "met",
            "probability": 0.15704716757803794,
            "start_logit": -4.781088829040527,
            "end_logit": -4.985304355621338,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitors",
            "probability": 0.1362420361950815,
            "start_logit": -4.885477542877197,
            "end_logit": -5.02302885055542,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA methyltransferase inhibitors",
            "probability": 0.09017681761684106,
            "start_logit": -5.29813814163208,
            "end_logit": -5.02302885055542,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitors have been used for disease treatment. Therefore, the detection of DNA methyltransferases and screening",
            "probability": 0.0824272623015502,
            "start_logit": -4.885477542877197,
            "end_logit": -5.525545597076416,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA met",
            "probability": 0.07663603818707755,
            "start_logit": -5.29813814163208,
            "end_logit": -5.185733795166016,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitor",
            "probability": 0.05820842768623489,
            "start_logit": -4.885477542877197,
            "end_logit": -5.87343168258667,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "screening",
            "probability": 0.053551521302099836,
            "start_logit": -5.316749572753906,
            "end_logit": -5.525545597076416,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "inhibitors",
            "probability": 0.042087080956750775,
            "start_logit": -6.060169696807861,
            "end_logit": -5.02302885055542,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA methyltransferase inhibitor",
            "probability": 0.03852739516978962,
            "start_logit": -5.29813814163208,
            "end_logit": -5.87343168258667,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase",
            "probability": 0.03171429540786507,
            "start_logit": -4.885477542877197,
            "end_logit": -6.48069429397583,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase activity will disturb DNA met",
            "probability": 0.03033051122892988,
            "start_logit": -4.781088829040527,
            "end_logit": -6.629696369171143,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitors have been used for disease treatment.",
            "probability": 0.025508731462543625,
            "start_logit": -4.885477542877197,
            "end_logit": -6.698441028594971,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "inhibitors have been used for disease treatment. Therefore, the detection of DNA methyltransferases and screening",
            "probability": 0.025462940502161364,
            "start_logit": -6.060169696807861,
            "end_logit": -5.525545597076416,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferase inhibitors have been used for disease treatment. Therefore, the detection",
            "probability": 0.02469498455662122,
            "start_logit": -4.885477542877197,
            "end_logit": -6.730861663818359,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methylation systems, leading to the occurrence of various human diseases including cancers. Moreover, DNA met",
            "probability": 0.024580686179394576,
            "start_logit": -5.825130939483643,
            "end_logit": -5.795847415924072,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases",
            "probability": 0.023708733116727807,
            "start_logit": -5.29813814163208,
            "end_logit": -6.358957767486572,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "screening of their inhibitors",
            "probability": 0.023240310860024916,
            "start_logit": -5.316749572753906,
            "end_logit": -6.360301494598389,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets, and DNA methyltransferase",
            "probability": 0.02099127635428657,
            "start_logit": -5.29813814163208,
            "end_logit": -6.48069429397583,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "inhibitor",
            "probability": 0.017981401899248645,
            "start_logit": -6.060169696807861,
            "end_logit": -5.87343168258667,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methyltransferases may serve as promising therapeutic targets,",
            "probability": 0.01688238143873303,
            "start_logit": -5.29813814163208,
            "end_logit": -6.698530673980713,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        }
    ],
    "5131bef65274a5fb07000008": [
        {
            "text": "histone profiles",
            "probability": 0.0714530872103252,
            "start_logit": -5.083586692810059,
            "end_logit": -4.908420085906982,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "our model produced accurate annotation of enhancers with detailed information on how histone profiles",
            "probability": 0.06936353770783933,
            "start_logit": -5.113266468048096,
            "end_logit": -4.908420085906982,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "accurate annotation of enhancers with detailed information on how histone profiles",
            "probability": 0.061893571967517845,
            "start_logit": -5.2272114753723145,
            "end_logit": -4.908420085906982,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "our model produced accurate annotation",
            "probability": 0.059844967756346436,
            "start_logit": -5.113266468048096,
            "end_logit": -5.056024074554443,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modification marks can represent enhancer regions in which histone marks",
            "probability": 0.05683436473240727,
            "start_logit": -5.278287410736084,
            "end_logit": -4.942619323730469,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone marks",
            "probability": 0.055685200168273274,
            "start_logit": -5.2987141609191895,
            "end_logit": -4.942619323730469,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "accurate annotation",
            "probability": 0.053400085132950074,
            "start_logit": -5.2272114753723145,
            "end_logit": -5.056024074554443,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "our model produced accurate annotation of enhancers with detailed information",
            "probability": 0.05268688093951592,
            "start_logit": -5.113266468048096,
            "end_logit": -5.183414936065674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "Enhancer is a DNA sequence of a genome that controls transcription of downstream target genes.",
            "probability": 0.052681354155644344,
            "start_logit": -5.214732646942139,
            "end_logit": -5.0820536613464355,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone marks indicate active or repressed enhancers. In summary, our model produced accurate annotation",
            "probability": 0.04971514696948838,
            "start_logit": -5.2987141609191895,
            "end_logit": -5.056024074554443,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "accurate annotation of enhancers with detailed information",
            "probability": 0.047012873981561974,
            "start_logit": -5.2272114753723145,
            "end_logit": -5.183414936065674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "Enhancer-CRNN",
            "probability": 0.04608918746211394,
            "start_logit": -5.305185317993164,
            "end_logit": -5.125284194946289,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "our model produced accurate",
            "probability": 0.044685787028614164,
            "start_logit": -5.113266468048096,
            "end_logit": -5.34812593460083,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone marks indicate active or repressed enhancers. In summary, our model produced accurate annotation of enhancers with detailed information",
            "probability": 0.04376869313283563,
            "start_logit": -5.2987141609191895,
            "end_logit": -5.183414936065674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "information on how histone profiles",
            "probability": 0.04236682374883558,
            "start_logit": -5.60626220703125,
            "end_logit": -4.908420085906982,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "detailed information on how histone profiles",
            "probability": 0.04103395376639979,
            "start_logit": -5.638227939605713,
            "end_logit": -4.908420085906982,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "accurate",
            "probability": 0.039873441678106976,
            "start_logit": -5.2272114753723145,
            "end_logit": -5.34812593460083,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modification marks can represent enhancer regions in which histone marks indicate active or repressed enhancers. In summary, our model produced accurate",
            "probability": 0.037888003998820335,
            "start_logit": -5.278287410736084,
            "end_logit": -5.34812593460083,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone marks indicate active or repressed enhancers. In summary, our model produced accurate",
            "probability": 0.03712192608440696,
            "start_logit": -5.2987141609191895,
            "end_logit": -5.34812593460083,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "Enhancer",
            "probability": 0.03660111237799647,
            "start_logit": -5.214732646942139,
            "end_logit": -5.446236610412598,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        }
    ],
    "5160412d298dcd4e5100003c": [
        {
            "text": "H3K37",
            "probability": 0.22440599614064682,
            "start_logit": 5.202934741973877,
            "end_logit": 5.312201023101807,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3 lysine 37 (H3K37",
            "probability": 0.13456805049443743,
            "start_logit": 4.691547870635986,
            "end_logit": 5.312201023101807,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3 lysine 37",
            "probability": 0.12610853456239157,
            "start_logit": 4.691547870635986,
            "end_logit": 5.247273921966553,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3K37) mark. Set7 forms a dimer with its substrate-binding site structurally specific to K37",
            "probability": 0.11009320235364332,
            "start_logit": 5.202934741973877,
            "end_logit": 4.600071430206299,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K37",
            "probability": 0.0631910379917735,
            "start_logit": 4.647769927978516,
            "end_logit": 4.600071430206299,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K37, not the neighboring well-studied K36",
            "probability": 0.04825477862508344,
            "start_logit": 4.647769927978516,
            "end_logit": 4.330403804779053,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "histone H3 lysine 37 (H3K37",
            "probability": 0.040614916279864965,
            "start_logit": 3.4936132431030273,
            "end_logit": 5.312201023101807,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3K37)",
            "probability": 0.040030100265792526,
            "start_logit": 5.202934741973877,
            "end_logit": 3.5883758068084717,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "histone H3 lysine 37",
            "probability": 0.03806169112660001,
            "start_logit": 3.4936132431030273,
            "end_logit": 5.247273921966553,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K36",
            "probability": 0.036654536691312065,
            "start_logit": 4.372812271118164,
            "end_logit": 4.330403804779053,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3 lysine 37 (H3K37)",
            "probability": 0.02400458386365217,
            "start_logit": 4.691547870635986,
            "end_logit": 3.5883758068084717,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "lysine 37 (H3K37",
            "probability": 0.023314422197323055,
            "start_logit": 2.9385499954223633,
            "end_logit": 5.312201023101807,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "lysine 37",
            "probability": 0.021848779161698854,
            "start_logit": 2.9385499954223633,
            "end_logit": 5.247273921966553,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K37, not the neighboring well-studied K36 mark. We also discovered that H3K37",
            "probability": 0.017846178990048495,
            "start_logit": 4.647769927978516,
            "end_logit": 3.335698366165161,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "K36 mark. We also discovered that H3K37",
            "probability": 0.013556034059814818,
            "start_logit": 4.372812271118164,
            "end_logit": 3.335698366165161,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "lysine 37 (H3K37) mark. Set7 forms a dimer with its substrate-binding site structurally specific to K37",
            "probability": 0.011438016117534755,
            "start_logit": 2.9385499954223633,
            "end_logit": 4.600071430206299,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "(H3K37",
            "probability": 0.009523897669697122,
            "start_logit": 2.0432820320129395,
            "end_logit": 5.312201023101807,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "histone H3 lysine 37 (H3K37)",
            "probability": 0.00724498987964109,
            "start_logit": 3.4936132431030273,
            "end_logit": 3.5883758068084717,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "(H3K37) mark. Set7 forms a dimer with its substrate-binding site structurally specific to K37",
            "probability": 0.004672408096832662,
            "start_logit": 2.0432820320129395,
            "end_logit": 4.600071430206299,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H3K37) mark",
            "probability": 0.0045678454322113865,
            "start_logit": 5.202934741973877,
            "end_logit": 1.4177857637405396,
            "question_text": "Which histone marks are deposited by Set7?"
        }
    ],
    "551adceb622b194345000018": [
        {
            "text": "transient ischaemic attack",
            "probability": 0.4844230425117358,
            "start_logit": -0.06356539577245712,
            "end_logit": -0.5585720539093018,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk",
            "probability": 0.15164444332982513,
            "start_logit": -0.06356539577245712,
            "end_logit": -1.7199920415878296,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk factors",
            "probability": 0.10373167665681196,
            "start_logit": -0.06356539577245712,
            "end_logit": -2.0997231006622314,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk",
            "probability": 0.0609693907020788,
            "start_logit": -0.9747320413589478,
            "end_logit": -1.7199920415878296,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke",
            "probability": 0.04914100547376015,
            "start_logit": -0.06356539577245712,
            "end_logit": -2.846836805343628,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors",
            "probability": 0.041705828340279145,
            "start_logit": -0.9747320413589478,
            "end_logit": -2.0997231006622314,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk factors to prevent recurrent stroke",
            "probability": 0.02781482438023281,
            "start_logit": -0.06356539577245712,
            "end_logit": -3.415961503982544,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "stroke need rapid treatment of risk",
            "probability": 0.013382985029870446,
            "start_logit": -2.491119861602783,
            "end_logit": -1.7199920415878296,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors to prevent recurrent stroke",
            "probability": 0.011183086288626205,
            "start_logit": -0.9747320413589478,
            "end_logit": -3.415961503982544,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "stroke need rapid treatment of risk factors",
            "probability": 0.009154568709135417,
            "start_logit": -2.491119861602783,
            "end_logit": -2.0997231006622314,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "attack",
            "probability": 0.008276444370188837,
            "start_logit": -4.133110523223877,
            "end_logit": -0.5585720539093018,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors to prevent recurrent stroke. ABCD2 score or magnetic resonance diffusion-weighted brain imaging",
            "probability": 0.007364623204163939,
            "start_logit": -0.9747320413589478,
            "end_logit": -3.8336760997772217,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment",
            "probability": 0.006780803579686209,
            "start_logit": -0.06356539577245712,
            "end_logit": -4.82743501663208,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "ischaemic attack",
            "probability": 0.005100783588836958,
            "start_logit": -4.617129802703857,
            "end_logit": -0.5585720539093018,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "stroke",
            "probability": 0.004336811334245359,
            "start_logit": -2.491119861602783,
            "end_logit": -2.846836805343628,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors to prevent recurrent stroke. ABCD2 score or magnetic resonance diffusion-weighted brain imaging (MR DWI)",
            "probability": 0.0036891156971690466,
            "start_logit": -0.9747320413589478,
            "end_logit": -4.524977207183838,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA) or minor stroke need rapid treatment of risk factors to prevent recurrent stroke.",
            "probability": 0.003182369007796871,
            "start_logit": -0.06356539577245712,
            "end_logit": -5.58390474319458,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "transient ischaemic attack (TIA)",
            "probability": 0.0029355602274278264,
            "start_logit": -0.06356539577245712,
            "end_logit": -5.664632320404053,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "risk factors to prevent recurrent stroke. ABCD2 score or magnetic resonance diffusion",
            "probability": 0.0025917682470496203,
            "start_logit": -0.9747320413589478,
            "end_logit": -4.878023624420166,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "attack (TIA) or minor stroke need rapid treatment of risk",
            "probability": 0.0025908693210793038,
            "start_logit": -4.133110523223877,
            "end_logit": -1.7199920415878296,
            "question_text": "Which factors are considered in the ABCD2 score?"
        }
    ],
    "532f0b2cd6d3ac6a3400002c": [
        {
            "text": "eyes",
            "probability": 0.9001925869139297,
            "start_logit": -1.2388650178909302,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal, and cardiovascular system.",
            "probability": 0.03467409852238289,
            "start_logit": -1.2388650178909302,
            "end_logit": -4.112340450286865,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal, and cardiovascular system",
            "probability": 0.01846470822113218,
            "start_logit": -1.2388650178909302,
            "end_logit": -4.742472171783447,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes",
            "probability": 0.007530078885530105,
            "start_logit": -6.022568225860596,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "connective tissue, whose cardinal features affect eyes",
            "probability": 0.006527388620660841,
            "start_logit": -6.165466785430908,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal,",
            "probability": 0.004860448031919984,
            "start_logit": -1.2388650178909302,
            "end_logit": -6.077202796936035,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardinal features affect eyes",
            "probability": 0.004385074049996777,
            "start_logit": -6.563267230987549,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "syndrome is an autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes",
            "probability": 0.0037900861743947146,
            "start_logit": -6.709084987640381,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal, and cardiovascular",
            "probability": 0.003326739277904153,
            "start_logit": -1.2388650178909302,
            "end_logit": -6.456340789794922,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes, musculoskeletal",
            "probability": 0.003024534758146056,
            "start_logit": -1.2388650178909302,
            "end_logit": -6.551576137542725,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "Marfan syndrome is an autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes",
            "probability": 0.0029428878400380044,
            "start_logit": -6.962082386016846,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "an autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes",
            "probability": 0.0025525008035230156,
            "start_logit": -7.104400157928467,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "features affect eyes",
            "probability": 0.002425383228463215,
            "start_logit": -7.155484199523926,
            "end_logit": -0.8557246923446655,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "eyes,",
            "probability": 0.002151556641006576,
            "start_logit": -1.2388650178909302,
            "end_logit": -6.892141819000244,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardiovascular system.",
            "probability": 0.0013938864585573106,
            "start_logit": -4.452762126922607,
            "end_logit": -4.112340450286865,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardiovascular system",
            "probability": 0.0007422747193855303,
            "start_logit": -4.452762126922607,
            "end_logit": -4.742472171783447,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "autosomal dominant disorder of the connective tissue, whose cardinal features affect eyes, musculoskeletal, and cardiovascular system.",
            "probability": 0.0002900475975405366,
            "start_logit": -6.022568225860596,
            "end_logit": -4.112340450286865,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "musculoskeletal, and cardiovascular system.",
            "probability": 0.00028317359795264596,
            "start_logit": -6.046553134918213,
            "end_logit": -4.112340450286865,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "connective tissue, whose cardinal features affect eyes, musculoskeletal, and cardiovascular system.",
            "probability": 0.0002514254387526024,
            "start_logit": -6.165466785430908,
            "end_logit": -4.112340450286865,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": ".",
            "probability": 0.00019112021878292832,
            "start_logit": -6.43971061706543,
            "end_logit": -4.112340450286865,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        }
    ],
    "5512c1ee6a8cde6b72000009": [
        {
            "text": "MKK6",
            "probability": 0.40235297983436313,
            "start_logit": 4.4201579093933105,
            "end_logit": 3.7662642002105713,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MAP kinase kinase 6",
            "probability": 0.20673255559475381,
            "start_logit": 3.6039583683013916,
            "end_logit": 3.916559934616089,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MAP kinase kinase 6 (MKK6",
            "probability": 0.17788374546390553,
            "start_logit": 3.6039583683013916,
            "end_logit": 3.7662642002105713,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6)",
            "probability": 0.11072217636683014,
            "start_logit": 4.4201579093933105,
            "end_logit": 2.4759585857391357,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MAP kinase kinase 6 (MKK6)",
            "probability": 0.048951235420587665,
            "start_logit": 3.6039583683013916,
            "end_logit": 2.4759585857391357,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6), which activates the p38 subfamily of MAPKs, we found that decaging active MKK6",
            "probability": 0.012291124511831618,
            "start_logit": 4.4201579093933105,
            "end_logit": 0.27781185507774353,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6),",
            "probability": 0.010928992155252634,
            "start_logit": 4.4201579093933105,
            "end_logit": 0.16035352647304535,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "6",
            "probability": 0.0051177549527166785,
            "start_logit": -0.09475173056125641,
            "end_logit": 3.916559934616089,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "(MKK6",
            "probability": 0.004944261343907772,
            "start_logit": 0.02105572633445263,
            "end_logit": 3.7662642002105713,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MAP kinase kinase 6 (MKK6),",
            "probability": 0.0048318023132879594,
            "start_logit": 3.6039583683013916,
            "end_logit": 0.16035352647304535,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "6 (MKK6",
            "probability": 0.004403590023528919,
            "start_logit": -0.09475173056125641,
            "end_logit": 3.7662642002105713,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "kinase 6",
            "probability": 0.0022109632779322833,
            "start_logit": -0.934039294719696,
            "end_logit": 3.916559934616089,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "kinase 6 (MKK6",
            "probability": 0.0019024310313886963,
            "start_logit": -0.934039294719696,
            "end_logit": 3.7662642002105713,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MAP kinase kinase",
            "probability": 0.001790350586670879,
            "start_logit": 3.6039583683013916,
            "end_logit": -0.8324545621871948,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "(MKK6)",
            "probability": 0.0013605948109275136,
            "start_logit": 0.02105572633445263,
            "end_logit": 2.4759585857391357,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "6 (MKK6)",
            "probability": 0.001211809271135765,
            "start_logit": -0.09475173056125641,
            "end_logit": 2.4759585857391357,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MKK6), which activates the p38 subfamily of MAPKs,",
            "probability": 0.0008850180214376247,
            "start_logit": 4.4201579093933105,
            "end_logit": -2.353212833404541,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MAP",
            "probability": 0.0005638172099391009,
            "start_logit": 3.6039583683013916,
            "end_logit": -1.9878911972045898,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "kinase 6 (MKK6)",
            "probability": 0.0005235236589272052,
            "start_logit": -0.934039294719696,
            "end_logit": 2.4759585857391357,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "MAP kinase kinase 6 (MKK6), which activates the p38 subfamily of MAPKs,",
            "probability": 0.0003912741506753327,
            "start_logit": 3.6039583683013916,
            "end_logit": -2.353212833404541,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        }
    ],
    "515db70c298dcd4e51000017": [
        {
            "text": "bacterial bronchitis",
            "probability": 0.48116518609839604,
            "start_logit": 2.8969602584838867,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "Persistent bacterial bronchitis",
            "probability": 0.22257871626499143,
            "start_logit": 2.126030445098877,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bronchitis",
            "probability": 0.09252766254064884,
            "start_logit": 1.2482572793960571,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bacterial bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.07579921356342625,
            "start_logit": 2.8969602584838867,
            "end_logit": 1.7170482873916626,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "Persistent bacterial bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.03506340885891367,
            "start_logit": 2.126030445098877,
            "end_logit": 1.7170482873916626,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "wet cough",
            "probability": 0.03197344931743618,
            "start_logit": 2.033778190612793,
            "end_logit": 1.7170482873916626,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.014576125322601882,
            "start_logit": 1.2482572793960571,
            "end_logit": 1.7170482873916626,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough",
            "probability": 0.00989564910165009,
            "start_logit": 0.8609675168991089,
            "end_logit": 1.7170482873916626,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "asthma",
            "probability": 0.00876744277150631,
            "start_logit": 1.3746196031570435,
            "end_logit": 1.0823462009429932,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough variant asthma",
            "probability": 0.007967766050395914,
            "start_logit": 1.2789785861968994,
            "end_logit": 1.0823462009429932,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "asthma (CVA)/eosinophilic bronchitis",
            "probability": 0.00596596141836844,
            "start_logit": 1.3746196031570435,
            "end_logit": 0.697371244430542,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough variant asthma (CVA)/eosinophilic bronchitis",
            "probability": 0.005421807257383557,
            "start_logit": 1.2789785861968994,
            "end_logit": 0.697371244430542,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "inhalation of a foreign body is common. Persistent bacterial bronchitis",
            "probability": 0.003384450443744975,
            "start_logit": -2.060058832168579,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "eosinophilic bronchitis",
            "probability": 0.001132856738060527,
            "start_logit": -0.2867080867290497,
            "end_logit": 0.697371244430542,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "tis",
            "probability": 0.0010545271540409445,
            "start_logit": -3.2261579036712646,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "cough is advocated. Thus, in toddlers, inhalation of a foreign body is common. Persistent bacterial bronchitis",
            "probability": 0.0009975946230299712,
            "start_logit": -3.28165864944458,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "inhalation of a foreign body is common. Persistent bacterial bronchitis is a common and previously unrecognised cause of wet cough",
            "probability": 0.0005331613537139763,
            "start_logit": -2.060058832168579,
            "end_logit": 1.7170482873916626,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "chitis",
            "probability": 0.000515223070356622,
            "start_logit": -3.9424057006835938,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "onchitis",
            "probability": 0.00040404413036840297,
            "start_logit": -4.185481548309326,
            "end_logit": 3.565171003341675,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "bacterial br",
            "probability": 0.0002757539209655635,
            "start_logit": 2.8969602584838867,
            "end_logit": -3.8992860317230225,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        }
    ],
    "54fb5c69d176fff445000003": [
        {
            "text": "Gata4",
            "probability": 0.20051489430018027,
            "start_logit": 3.6889007091522217,
            "end_logit": 3.305588960647583,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5",
            "probability": 0.19772508841256436,
            "start_logit": 3.7969441413879395,
            "end_logit": 3.183534622192383,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5",
            "probability": 0.1774757875281333,
            "start_logit": 3.6889007091522217,
            "end_logit": 3.183534622192383,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5",
            "probability": 0.1747548181027533,
            "start_logit": 3.673450469970703,
            "end_logit": 3.183534622192383,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C",
            "probability": 0.11924959798640107,
            "start_logit": 3.7969441413879395,
            "end_logit": 2.6778757572174072,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C",
            "probability": 0.10703708105513725,
            "start_logit": 3.6889007091522217,
            "end_logit": 2.6778757572174072,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5 and Hand2",
            "probability": 0.0050805569408798835,
            "start_logit": 3.7969441413879395,
            "end_logit": -0.47792211174964905,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5 and Hand2",
            "probability": 0.004560250049213706,
            "start_logit": 3.6889007091522217,
            "end_logit": -0.47792211174964905,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 and Hand2",
            "probability": 0.004490334591286629,
            "start_logit": 3.673450469970703,
            "end_logit": -0.47792211174964905,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5 and Hand2 (GMTH",
            "probability": 0.001311796513467332,
            "start_logit": 3.7969441413879395,
            "end_logit": -1.8319454193115234,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2",
            "probability": 0.0012814629712389115,
            "start_logit": 2.419525623321533,
            "end_logit": -0.47792211174964905,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5 and Hand2 (GMTH",
            "probability": 0.001177453610836167,
            "start_logit": 3.6889007091522217,
            "end_logit": -1.8319454193115234,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 and Hand2 (GMTH",
            "probability": 0.001159401484855993,
            "start_logit": 3.673450469970703,
            "end_logit": -1.8319454193115234,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5 and Hand",
            "probability": 0.001129693734610924,
            "start_logit": 3.7969441413879395,
            "end_logit": -1.9813964366912842,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2C, Tbx5 and Hand",
            "probability": 0.0010140002304479003,
            "start_logit": 3.6889007091522217,
            "end_logit": -1.9813964366912842,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 and Hand",
            "probability": 0.0009984540894063252,
            "start_logit": 3.673450469970703,
            "end_logit": -1.9813964366912842,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand2 (GMTH",
            "probability": 0.00033087290967701716,
            "start_logit": 2.419525623321533,
            "end_logit": -1.8319454193115234,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Hand",
            "probability": 0.00028494133745379926,
            "start_logit": 2.419525623321533,
            "end_logit": -1.9813964366912842,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "4",
            "probability": 0.00021669959499534498,
            "start_logit": -3.141231060028076,
            "end_logit": 3.305588960647583,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2C, Tbx5 and Hand2 (GMTH). To further clarify the role of GMTH",
            "probability": 0.00020681455646035996,
            "start_logit": 3.7969441413879395,
            "end_logit": -3.6792757511138916,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        }
    ],
    "513f45abbee46bd34c000013": [
        {
            "text": "pancreatic cells",
            "probability": 0.5887619629083639,
            "start_logit": 6.232635021209717,
            "end_logit": 3.9738259315490723,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic",
            "probability": 0.4009391654983493,
            "start_logit": 6.232635021209717,
            "end_logit": 3.589613676071167,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pan",
            "probability": 0.0031039764061632936,
            "start_logit": 6.232635021209717,
            "end_logit": -1.2715120315551758,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells.",
            "probability": 0.0017424316678878358,
            "start_logit": 6.232635021209717,
            "end_logit": -1.848914384841919,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "creatic cells",
            "probability": 0.001155607841769761,
            "start_logit": -0.0007604676065966487,
            "end_logit": 3.9738259315490723,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We used thyrotropin receptor (TSHR) knockout mice",
            "probability": 0.0009219744344523238,
            "start_logit": 6.232635021209717,
            "end_logit": -2.48543381690979,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancre",
            "probability": 0.0008592165070357217,
            "start_logit": 6.232635021209717,
            "end_logit": -2.5559303760528564,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "creatic",
            "probability": 0.0007869537655485902,
            "start_logit": -0.0007604676065966487,
            "end_logit": 3.589613676071167,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "cells",
            "probability": 0.000675705798252389,
            "start_logit": -0.5373844504356384,
            "end_logit": 3.9738259315490723,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We used thyrotropin receptor (TSHR) knockout",
            "probability": 0.00014853934536576853,
            "start_logit": 6.232635021209717,
            "end_logit": -4.31110143661499,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We",
            "probability": 0.0001248915372137627,
            "start_logit": 6.232635021209717,
            "end_logit": -4.484505653381348,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We used thyrotropin receptor (TSHR) knockout mice (",
            "probability": 0.0001247720716660155,
            "start_logit": 6.232635021209717,
            "end_logit": -4.485462665557861,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "atic cells",
            "probability": 0.00011793907968754555,
            "start_logit": -2.2829740047454834,
            "end_logit": 3.9738259315490723,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "on pancreatic cells",
            "probability": 0.00010158893662006374,
            "start_logit": -2.4322075843811035,
            "end_logit": 3.9738259315490723,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We used thyrotropin receptor",
            "probability": 8.937554662515304e-05,
            "start_logit": 6.232635021209717,
            "end_logit": -4.819104194641113,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We used thyrotropin receptor (TSHR)",
            "probability": 8.826351281585305e-05,
            "start_logit": 6.232635021209717,
            "end_logit": -4.831624507904053,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "atic",
            "probability": 8.031496456731457e-05,
            "start_logit": -2.2829740047454834,
            "end_logit": 3.589613676071167,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pancreatic cells. We used",
            "probability": 7.50185089893398e-05,
            "start_logit": 6.232635021209717,
            "end_logit": -4.994216442108154,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "on pancreatic",
            "probability": 6.918073183788963e-05,
            "start_logit": -2.4322075843811035,
            "end_logit": 3.589613676071167,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "Thyrotropin (TSH) is a modulator of glucose metabolism by binding to its receptor on pancreatic cells",
            "probability": 3.31209367882089e-05,
            "start_logit": -3.552976608276367,
            "end_logit": 3.9738259315490723,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        }
    ],
    "56ddbbaf51531f7e33000009": [
        {
            "text": "dimethylation of H3 Lys4",
            "probability": 0.3042452600839851,
            "start_logit": 4.417081832885742,
            "end_logit": 3.233121395111084,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "dimethylation",
            "probability": 0.2284068389925802,
            "start_logit": 4.417081832885742,
            "end_logit": 2.946415662765503,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4 and the dimethylation of H3 Lys4",
            "probability": 0.10824801549194514,
            "start_logit": 3.3836727142333984,
            "end_logit": 3.233121395111084,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4 and the dimethylation",
            "probability": 0.08126531548563802,
            "start_logit": 3.3836727142333984,
            "end_logit": 2.946415662765503,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation",
            "probability": 0.0654444294022523,
            "start_logit": 3.3836727142333984,
            "end_logit": 2.7298977375030518,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4",
            "probability": 0.046251812008720715,
            "start_logit": 3.3836727142333984,
            "end_logit": 2.3827970027923584,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3",
            "probability": 0.028129365988025772,
            "start_logit": 3.3836727142333984,
            "end_logit": 1.8855104446411133,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 Lys4",
            "probability": 0.02488973336620152,
            "start_logit": 1.9137030839920044,
            "end_logit": 3.233121395111084,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 and H4 and the dimethylation of H3 Lys4",
            "probability": 0.02360799083570205,
            "start_logit": 1.860832929611206,
            "end_logit": 3.233121395111084,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "dimethylation of H3",
            "probability": 0.02079877739883412,
            "start_logit": 4.417081832885742,
            "end_logit": 0.5501814484596252,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 and H4 and the dimethylation",
            "probability": 0.017723288639763905,
            "start_logit": 1.860832929611206,
            "end_logit": 2.946415662765503,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3 and H4",
            "probability": 0.010087135076557067,
            "start_logit": 1.860832929611206,
            "end_logit": 2.3827970027923584,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "acetylation of histones H3 and H4 and the dimethylation of H3",
            "probability": 0.007400037645487135,
            "start_logit": 3.3836727142333984,
            "end_logit": 0.5501814484596252,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "histones H3 and H4 and the dimethylation of H3 Lys4",
            "probability": 0.006538191189101676,
            "start_logit": 0.5769082307815552,
            "end_logit": 3.233121395111084,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3",
            "probability": 0.006134780498667306,
            "start_logit": 1.860832929611206,
            "end_logit": 1.8855104446411133,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H4 and the dimethylation of H3 Lys4",
            "probability": 0.005445190453823306,
            "start_logit": 0.3939804136753082,
            "end_logit": 3.233121395111084,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "histones H3 and H4 and the dimethylation",
            "probability": 0.004908433353471532,
            "start_logit": 0.5769082307815552,
            "end_logit": 2.946415662765503,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H4 and the dimethylation",
            "probability": 0.00408788205583559,
            "start_logit": 0.3939804136753082,
            "end_logit": 2.946415662765503,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "the dimethylation of H3 Lys4",
            "probability": 0.0035939078652302173,
            "start_logit": -0.021512167528271675,
            "end_logit": 3.233121395111084,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "histones H3 and H4",
            "probability": 0.0027936141681775876,
            "start_logit": 0.5769082307815552,
            "end_logit": 2.3827970027923584,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        }
    ],
    "517843638ed59a060a000036": [
        {
            "text": "LINE-1",
            "probability": 0.40191483310046777,
            "start_logit": 4.080626010894775,
            "end_logit": 2.742767572402954,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1 or L1) retrotransposons",
            "probability": 0.1412784011010627,
            "start_logit": 4.080626010894775,
            "end_logit": 1.697259783744812,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1",
            "probability": 0.1028893303925444,
            "start_logit": 2.7180397510528564,
            "end_logit": 2.742767572402954,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1",
            "probability": 0.08000464354367808,
            "start_logit": 2.7180397510528564,
            "end_logit": 2.4911983013153076,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1 or L1)",
            "probability": 0.051904370547443686,
            "start_logit": 4.080626010894775,
            "end_logit": 0.6959303617477417,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1 or L1",
            "probability": 0.04429300163251379,
            "start_logit": 4.080626010894775,
            "end_logit": 0.537354052066803,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1 or L1) retrotransposons",
            "probability": 0.036166965961627086,
            "start_logit": 2.7180397510528564,
            "end_logit": 1.697259783744812,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1) retrotransposons",
            "probability": 0.026547387120812446,
            "start_logit": 2.408824920654297,
            "end_logit": 1.697259783744812,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "class 1 (LINE-1",
            "probability": 0.020074955536040554,
            "start_logit": 1.083858847618103,
            "end_logit": 2.742767572402954,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "class 1",
            "probability": 0.015609875734330685,
            "start_logit": 1.083858847618103,
            "end_logit": 2.4911983013153076,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1 or L1)",
            "probability": 0.013287406908761755,
            "start_logit": 2.7180397510528564,
            "end_logit": 0.6959303617477417,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element",
            "probability": 0.012444529549866155,
            "start_logit": 2.7180397510528564,
            "end_logit": 0.6303947567939758,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long interspersed element class 1 (LINE-1 or L1",
            "probability": 0.011338912883332237,
            "start_logit": 2.7180397510528564,
            "end_logit": 0.537354052066803,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1)",
            "probability": 0.009753263113442176,
            "start_logit": 2.408824920654297,
            "end_logit": 0.6959303617477417,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "L1",
            "probability": 0.0083230235614004,
            "start_logit": 2.408824920654297,
            "end_logit": 0.537354052066803,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "(LINE-1",
            "probability": 0.007789634770233992,
            "start_logit": 0.13717977702617645,
            "end_logit": 2.742767572402954,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "class 1 (LINE-1 or L1) retrotransposons",
            "probability": 0.007056613458199425,
            "start_logit": 1.083858847618103,
            "end_logit": 1.697259783744812,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE",
            "probability": 0.003992156867663649,
            "start_logit": 4.080626010894775,
            "end_logit": -1.8691409826278687,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "(LINE-1 or L1) retrotransposons",
            "probability": 0.0027381600649329747,
            "start_logit": 0.13717977702617645,
            "end_logit": 1.697259783744812,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "class 1 (LINE-1 or L1)",
            "probability": 0.0025925341516461,
            "start_logit": 1.083858847618103,
            "end_logit": 0.6959303617477417,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        }
    ],
    "55031286e9bde6963400001b": [
        {
            "text": "myelodysplastic syndrome",
            "probability": 0.19133481726898402,
            "start_logit": 4.845512390136719,
            "end_logit": 4.706799030303955,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "myelodysplastic syndrome in 3 patients; breast cancer",
            "probability": 0.13506470640153306,
            "start_logit": 4.845512390136719,
            "end_logit": 4.358528137207031,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "myelodysplastic syndrome in 3 patients; breast cancer in 2 patients; colorectal cancer",
            "probability": 0.07621426616530227,
            "start_logit": 4.845512390136719,
            "end_logit": 3.786322832107544,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "breast cancer",
            "probability": 0.0587837965628952,
            "start_logit": 4.013624668121338,
            "end_logit": 4.358528137207031,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "myelodysplastic syndrome in 3 patients; breast cancer in 2 patients; colorectal cancer plus ocular tumor",
            "probability": 0.05304152924239699,
            "start_logit": 4.845512390136719,
            "end_logit": 3.42384934425354,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "colorectal cancer plus ocular tumor, diffuse large B-cell lymphoma",
            "probability": 0.050621740442546435,
            "start_logit": 4.213921070098877,
            "end_logit": 4.00874662399292,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "colorectal cancer plus ocular tumor, diffuse large B-cell lymphoma and multiple myeloma",
            "probability": 0.04643171663651702,
            "start_logit": 4.213921070098877,
            "end_logit": 3.9223482608795166,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "diffuse large B-cell lymphoma",
            "probability": 0.04425953779067135,
            "start_logit": 4.079610824584961,
            "end_logit": 4.00874662399292,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "multiple myeloma",
            "probability": 0.04259345149374489,
            "start_logit": 4.127638816833496,
            "end_logit": 3.9223482608795166,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "breast cancer in 2 patients; colorectal cancer plus ocular tumor, diffuse large B-cell lymphoma",
            "probability": 0.04143329294445664,
            "start_logit": 4.013624668121338,
            "end_logit": 4.00874662399292,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "diffuse large B-cell lymphoma and multiple myeloma",
            "probability": 0.0405961213343121,
            "start_logit": 4.079610824584961,
            "end_logit": 3.9223482608795166,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "colorectal cancer",
            "probability": 0.040526551226455,
            "start_logit": 4.213921070098877,
            "end_logit": 3.786322832107544,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "breast cancer in 2 patients; colorectal cancer plus ocular tumor, diffuse large B-cell lymphoma and multiple myeloma",
            "probability": 0.03800380825503748,
            "start_logit": 4.013624668121338,
            "end_logit": 3.9223482608795166,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "breast cancer in 2 patients; colorectal cancer",
            "probability": 0.03317050054610434,
            "start_logit": 4.013624668121338,
            "end_logit": 3.786322832107544,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "colorectal cancer plus ocular tumor",
            "probability": 0.028204565367187736,
            "start_logit": 4.213921070098877,
            "end_logit": 3.42384934425354,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "breast cancer in 2 patients; colorectal cancer plus ocular tumor",
            "probability": 0.023085101559399905,
            "start_logit": 4.013624668121338,
            "end_logit": 3.42384934425354,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "ocular tumor, diffuse large B-cell lymphoma",
            "probability": 0.016906519280156997,
            "start_logit": 3.117239236831665,
            "end_logit": 4.00874662399292,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "ocular tumor, diffuse large B-cell lymphoma and multiple myeloma",
            "probability": 0.015507145855978661,
            "start_logit": 3.117239236831665,
            "end_logit": 3.9223482608795166,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "Malignant or predisposing condition developed in 8/62 patients (13%): myelodysplastic syndrome",
            "probability": 0.014801143089336487,
            "start_logit": 2.286191940307617,
            "end_logit": 4.706799030303955,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "ocular tumor",
            "probability": 0.009419688536983483,
            "start_logit": 3.117239236831665,
            "end_logit": 3.42384934425354,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        }
    ],
    "533ec7abc45e133714000015": [
        {
            "text": "transcription",
            "probability": 0.543485276616737,
            "start_logit": 2.172337293624878,
            "end_logit": -0.34780606627464294,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors",
            "probability": 0.29034452553007195,
            "start_logit": 2.172337293624878,
            "end_logit": -0.9747404456138611,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors play in transitioning paused Pol II into productive Pol II is, however, little known",
            "probability": 0.11621160188893694,
            "start_logit": 2.172337293624878,
            "end_logit": -1.890395998954773,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors play in transitioning paused Pol II into productive Pol II is, however, little",
            "probability": 0.013576123062383734,
            "start_logit": 2.172337293624878,
            "end_logit": -4.037496089935303,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors play in transitioning paused Pol II into productive Pol II is, however, little known. By",
            "probability": 0.00881939524653464,
            "start_logit": 2.172337293624878,
            "end_logit": -4.468855381011963,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors play in transitioning paused Pol II into productive Pol II is",
            "probability": 0.006658898748891019,
            "start_logit": 2.172337293624878,
            "end_logit": -4.749854564666748,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors play in transitioning paused Pol II into productive Pol II",
            "probability": 0.005338047697423963,
            "start_logit": 2.172337293624878,
            "end_logit": -4.970948696136475,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors play in transitioning paused Pol II into productive Pol II is, however,",
            "probability": 0.004908493952608144,
            "start_logit": 2.172337293624878,
            "end_logit": -5.0548415184021,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "transcription factors play",
            "probability": 0.0032998223142809446,
            "start_logit": 2.172337293624878,
            "end_logit": -5.451940059661865,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "role transcription",
            "probability": 0.0023101464615859785,
            "start_logit": -3.2883543968200684,
            "end_logit": -0.34780606627464294,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "role transcription factors",
            "probability": 0.001234142684544437,
            "start_logit": -3.2883543968200684,
            "end_logit": -0.9747404456138611,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "the role transcription",
            "probability": 0.0010946249551064915,
            "start_logit": -4.035253524780273,
            "end_logit": -0.34780606627464294,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "the role transcription factors",
            "probability": 0.0005847782394441837,
            "start_logit": -4.035253524780273,
            "end_logit": -0.9747404456138611,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "role transcription factors play in transitioning paused Pol II into productive Pol II is, however, little known",
            "probability": 0.0004939707337983452,
            "start_logit": -3.2883543968200684,
            "end_logit": -1.890395998954773,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "little known",
            "probability": 0.00041242129310700313,
            "start_logit": -3.468785285949707,
            "end_logit": -1.890395998954773,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "While critical in recruiting Pol II to the promoter, the role transcription",
            "probability": 0.00038932822022696707,
            "start_logit": -5.068997859954834,
            "end_logit": -0.34780606627464294,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "the role transcription factors play in transitioning paused Pol II into productive Pol II is, however, little known",
            "probability": 0.0002340599184073897,
            "start_logit": -4.035253524780273,
            "end_logit": -1.890395998954773,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "factors",
            "probability": 0.00021236390807191866,
            "start_logit": -5.048184871673584,
            "end_logit": -0.9747404456138611,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "While critical in recruiting Pol II to the promoter, the role transcription factors",
            "probability": 0.0002079896590409033,
            "start_logit": -5.068997859954834,
            "end_logit": -0.9747404456138611,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "critical in recruiting Pol II to the promoter, the role transcription",
            "probability": 0.0001839888687984182,
            "start_logit": -5.818545341491699,
            "end_logit": -0.34780606627464294,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        }
    ],
    "54ecb640445c3b5a5f000001": [
        {
            "text": "cytopenia",
            "probability": 0.2958577768810218,
            "start_logit": 5.754975318908691,
            "end_logit": 5.503389835357666,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects",
            "probability": 0.20076697738412702,
            "start_logit": 5.754975318908691,
            "end_logit": 5.115655899047852,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects, and tumor predisposition",
            "probability": 0.12843983165502637,
            "start_logit": 5.754975318908691,
            "end_logit": 4.668971538543701,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects",
            "probability": 0.11706351900193104,
            "start_logit": 5.21554708480835,
            "end_logit": 5.115655899047852,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects, and tumor predisposition",
            "probability": 0.07489089525308432,
            "start_logit": 5.21554708480835,
            "end_logit": 4.668971538543701,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "tumor predisposition",
            "probability": 0.06180511691195702,
            "start_logit": 5.023500919342041,
            "end_logit": 4.668971538543701,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects, and tumor",
            "probability": 0.037537614212731066,
            "start_logit": 5.754975318908691,
            "end_logit": 3.438854455947876,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects, and tumor",
            "probability": 0.021887490024176753,
            "start_logit": 5.21554708480835,
            "end_logit": 3.438854455947876,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "tumor",
            "probability": 0.01806306194206999,
            "start_logit": 5.023500919342041,
            "end_logit": 3.438854455947876,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "sensitivity to DNA interstrand crosslinking agents. The clinical features of cytopenia",
            "probability": 0.008540344042641855,
            "start_logit": 2.209897756576538,
            "end_logit": 5.503389835357666,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "sensitivity to DNA interstrand crosslinking agents. The clinical features of cytopenia, developmental defects",
            "probability": 0.005795416559055906,
            "start_logit": 2.209897756576538,
            "end_logit": 5.115655899047852,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "DNA interstrand crosslinking agents. The clinical features of cytopenia",
            "probability": 0.0057085066670109616,
            "start_logit": 1.8070539236068726,
            "end_logit": 5.503389835357666,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental defects,",
            "probability": 0.0055724648966061245,
            "start_logit": 5.754975318908691,
            "end_logit": 1.531348466873169,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "DNA interstrand crosslinking agents. The clinical features of cytopenia, developmental defects",
            "probability": 0.003873751912135202,
            "start_logit": 1.8070539236068726,
            "end_logit": 5.115655899047852,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "sensitivity to DNA interstrand crosslinking agents. The clinical features of cytopenia, developmental defects, and tumor predisposition",
            "probability": 0.0037075934345104276,
            "start_logit": 2.209897756576538,
            "end_logit": 4.668971538543701,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "developmental defects,",
            "probability": 0.003249201431485113,
            "start_logit": 5.21554708480835,
            "end_logit": 1.531348466873169,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "DNA interstrand crosslinking agents. The clinical features of cytopenia, developmental defects, and tumor predisposition",
            "probability": 0.0024782165371550714,
            "start_logit": 1.8070539236068726,
            "end_logit": 4.668971538543701,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia,",
            "probability": 0.001976036853906606,
            "start_logit": 5.754975318908691,
            "end_logit": 0.494604229927063,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "sensitivity to DNA interstrand crosslinking agents",
            "probability": 0.0015181251080962866,
            "start_logit": 2.209897756576538,
            "end_logit": 3.77606463432312,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cytopenia, developmental",
            "probability": 0.001268059291270678,
            "start_logit": 5.754975318908691,
            "end_logit": 0.05099859461188316,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        }
    ],
    "513f3d1fbee46bd34c000010": [
        {
            "text": "hypothyroidism",
            "probability": 0.5919471203745766,
            "start_logit": -0.3368605077266693,
            "end_logit": -1.1046438217163086,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "iatrogenic hypothyroidism",
            "probability": 0.11633770054995293,
            "start_logit": -1.9637806415557861,
            "end_logit": -1.1046438217163086,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "hypothyroidism treated with thyroxine",
            "probability": 0.059862756157149005,
            "start_logit": -0.3368605077266693,
            "end_logit": -3.3960065841674805,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine",
            "probability": 0.058459467711551916,
            "start_logit": -1.0051424503326416,
            "end_logit": -2.7514455318450928,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "hypothyroidism treated with thyroxine,",
            "probability": 0.0332134890877595,
            "start_logit": -0.3368605077266693,
            "end_logit": -3.985105037689209,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "food, and other factors. We present a 35-year-old woman with longstanding iatrogenic hypothyroidism",
            "probability": 0.029551934194632496,
            "start_logit": -3.3341286182403564,
            "end_logit": -1.1046438217163086,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Levothyroxine malabsorption has been reported following gastric bypass",
            "probability": 0.018903303330759288,
            "start_logit": -1.0420600175857544,
            "end_logit": -3.843524932861328,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Levo",
            "probability": 0.013415210875508532,
            "start_logit": -1.0420600175857544,
            "end_logit": -4.186472415924072,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Levothyroxine malabsorption",
            "probability": 0.012486958947034114,
            "start_logit": -1.0420600175857544,
            "end_logit": -4.258176803588867,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine daily.",
            "probability": 0.01200700359394151,
            "start_logit": -1.0051424503326416,
            "end_logit": -4.334289073944092,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "iatrogenic hypothyroidism treated with thyroxine",
            "probability": 0.011765063398734558,
            "start_logit": -1.9637806415557861,
            "end_logit": -3.3960065841674805,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "Levothyroxine",
            "probability": 0.009696492167393652,
            "start_logit": -1.0420600175857544,
            "end_logit": -4.511097431182861,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "iatrogenic hypothyroidism treated with thyroxine,",
            "probability": 0.006527577911462455,
            "start_logit": -1.9637806415557861,
            "end_logit": -3.985105037689209,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "thyroxine, whose thyroid-stimulating hormone level rose following a gastric sleeve procedure despite taking levothyroxine",
            "probability": 0.006125560278892651,
            "start_logit": -3.2610058784484863,
            "end_logit": -2.7514455318450928,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "gastric sleeve procedure despite taking levothyroxine",
            "probability": 0.0042108209275610615,
            "start_logit": -3.6358184814453125,
            "end_logit": -2.7514455318450928,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "ism",
            "probability": 0.0032252794021247664,
            "start_logit": -5.549258232116699,
            "end_logit": -1.1046438217163086,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "thyroxine",
            "probability": 0.0032152630502946377,
            "start_logit": -3.2610058784484863,
            "end_logit": -3.3960065841674805,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "pothyroidism",
            "probability": 0.0031204795398419804,
            "start_logit": -5.582291126251221,
            "end_logit": -1.1046438217163086,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "gastric pH, other drugs, food",
            "probability": 0.0031089565256327023,
            "start_logit": -3.2364230155944824,
            "end_logit": -3.454211473464966,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "food",
            "probability": 0.0028195619751953302,
            "start_logit": -3.3341286182403564,
            "end_logit": -3.454211473464966,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        }
    ],
    "553f7a71ab98a37113000009": [
        {
            "text": "homologous recombination",
            "probability": 0.3845625715272988,
            "start_logit": 3.3808135986328125,
            "end_logit": 2.2437524795532227,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non-homologous end joining",
            "probability": 0.29438316427942146,
            "start_logit": 3.7576801776885986,
            "end_logit": 1.5996615886688232,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "homologous recombination and non-homologous end joining",
            "probability": 0.20194908670407619,
            "start_logit": 3.3808135986328125,
            "end_logit": 1.5996615886688232,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide damage repair",
            "probability": 0.03796439735403002,
            "start_logit": 1.6318196058273315,
            "end_logit": 1.6772887706756592,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide damage repair/removal",
            "probability": 0.023912870177274923,
            "start_logit": 1.6318196058273315,
            "end_logit": 1.2150567770004272,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "end joining",
            "probability": 0.00951031253719133,
            "start_logit": 0.3251747190952301,
            "end_logit": 1.5996615886688232,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombination",
            "probability": 0.009428781274760706,
            "start_logit": -0.3275260627269745,
            "end_logit": 2.2437524795532227,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide damage",
            "probability": 0.009196128760576931,
            "start_logit": 1.6318196058273315,
            "end_logit": 0.25942257046699524,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non",
            "probability": 0.006583326177334954,
            "start_logit": 3.7576801776885986,
            "end_logit": -2.2006804943084717,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "recombination and non-homologous end joining",
            "probability": 0.004951427695129326,
            "start_logit": -0.3275260627269745,
            "end_logit": 1.5996615886688232,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "homologous recombination and non",
            "probability": 0.004516211761776922,
            "start_logit": 3.3808135986328125,
            "end_logit": -2.2006804943084717,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non-homologous end joining, play important roles in spore survival under EB treatment. Furthermore, exoA, nfo",
            "probability": 0.002221765099567848,
            "start_logit": 3.7576801776885986,
            "end_logit": -3.2869186401367188,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non-homologous end",
            "probability": 0.0018364675388171726,
            "start_logit": 3.7576801776885986,
            "end_logit": -3.477376699447632,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "ho",
            "probability": 0.0017283082106988434,
            "start_logit": 3.3808135986328125,
            "end_logit": -3.1612110137939453,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "removal",
            "probability": 0.001531474051093492,
            "start_logit": -1.1163665056228638,
            "end_logit": 1.2150567770004272,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "polY2, which are involved in nucleotide damage repair",
            "probability": 0.001318931902170728,
            "start_logit": -1.7280069589614868,
            "end_logit": 1.6772887706756592,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "homologous recombination and non-homologous end",
            "probability": 0.001259830680649206,
            "start_logit": 3.3808135986328125,
            "end_logit": -3.477376699447632,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "repair",
            "probability": 0.0011317049825966246,
            "start_logit": -1.8811038732528687,
            "end_logit": 1.6772887706756592,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "damage repair",
            "probability": 0.0010167618653635962,
            "start_logit": -1.9882062673568726,
            "end_logit": 1.6772887706756592,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "non-homologous",
            "probability": 0.000996477420170869,
            "start_logit": 3.7576801776885986,
            "end_logit": -4.088749408721924,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        }
    ],
    "53355befd6d3ac6a34000046": [
        {
            "text": "FRODOCK, and HawkDock",
            "probability": 0.09477207986357845,
            "start_logit": 3.9468326568603516,
            "end_logit": 3.3801846504211426,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK",
            "probability": 0.09278059165994038,
            "start_logit": 3.7864065170288086,
            "end_logit": 3.5193734169006348,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "FRODOCK",
            "probability": 0.08868060274146315,
            "start_logit": 3.9468326568603516,
            "end_logit": 3.313750982284546,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "FRODOCK, and HawkDock), three small molecule docking programs (GOLD, Surflex-Dock",
            "probability": 0.08828362302629955,
            "start_logit": 3.9468326568603516,
            "end_logit": 3.3092644214630127,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK, and HawkDock",
            "probability": 0.08072503174105207,
            "start_logit": 3.7864065170288086,
            "end_logit": 3.3801846504211426,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK",
            "probability": 0.07553642888733726,
            "start_logit": 3.7864065170288086,
            "end_logit": 3.313750982284546,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK, and HawkDock), three small molecule docking programs (GOLD, Surflex-Dock",
            "probability": 0.075198289214205,
            "start_logit": 3.7864065170288086,
            "end_logit": 3.3092644214630127,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HawkDock",
            "probability": 0.05610170297831137,
            "start_logit": 3.4225239753723145,
            "end_logit": 3.3801846504211426,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HawkDock), three small molecule docking programs (GOLD, Surflex-Dock",
            "probability": 0.05226076713732739,
            "start_logit": 3.4225239753723145,
            "end_logit": 3.3092644214630127,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "FRODOCK, and HawkDock), three small molecule dock",
            "probability": 0.04003478911789298,
            "start_logit": 3.9468326568603516,
            "end_logit": 2.518458604812622,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "Surflex-Dock",
            "probability": 0.03631531882067076,
            "start_logit": 3.0585176944732666,
            "end_logit": 3.3092644214630127,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "ZDOCK, FRODOCK, and HawkDock), three small molecule dock",
            "probability": 0.034100862057056563,
            "start_logit": 3.7864065170288086,
            "end_logit": 2.518458604812622,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "MDockPeP, HPEPDOCK",
            "probability": 0.03090404322040085,
            "start_logit": 3.365169048309326,
            "end_logit": 2.8412604331970215,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "MDockPeP, HPEPDOCK, CABS-dock",
            "probability": 0.02840750193900138,
            "start_logit": 3.365169048309326,
            "end_logit": 2.7570266723632812,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HawkDock), three small molecule dock",
            "probability": 0.02369917227863356,
            "start_logit": 3.4225239753723145,
            "end_logit": 2.518458604812622,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "AutoDock Vina), and eight protein-peptide docking programs (GalaxyPepDock, MDockPeP, HPEPDOCK",
            "probability": 0.022066717427217594,
            "start_logit": 3.0283524990081787,
            "end_logit": 2.8412604331970215,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "HPEPDOCK",
            "probability": 0.020485308244154884,
            "start_logit": 2.9539899826049805,
            "end_logit": 2.8412604331970215,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "Surflex-Dock, and AutoDock Vina), and eight protein-peptide docking programs (GalaxyPepDock",
            "probability": 0.02035428871591649,
            "start_logit": 3.0585176944732666,
            "end_logit": 2.730316400527954,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "AutoDock Vina), and eight protein-peptide docking programs (GalaxyPepDock",
            "probability": 0.019749465781241215,
            "start_logit": 3.0283524990081787,
            "end_logit": 2.730316400527954,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking programs (ZDOCK",
            "probability": 0.019543415148298934,
            "start_logit": 2.2288074493408203,
            "end_logit": 3.5193734169006348,
            "question_text": "List programs suitable for protein docking"
        }
    ],
    "52f89f4f2059c6d71c00004e": [
        {
            "text": "NBEAL2",
            "probability": 0.9399982354472144,
            "start_logit": 5.003601551055908,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene",
            "probability": 0.05316656876426425,
            "start_logit": 5.003601551055908,
            "end_logit": 2.119940996170044,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL",
            "probability": 0.0017773094101014777,
            "start_logit": 5.003601551055908,
            "end_logit": -1.2783881425857544,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the human NBEAL2",
            "probability": 0.0011887134439246216,
            "start_logit": -1.6694048643112183,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "human NBEAL2",
            "probability": 0.001070383503742383,
            "start_logit": -1.7742594480514526,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "Mutations in the human NBEAL2",
            "probability": 0.0008066892956449421,
            "start_logit": -2.0570931434631348,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "2",
            "probability": 0.0007233521536937886,
            "start_logit": -2.166135549545288,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene cause gray platelet syndrome (GPS),",
            "probability": 0.000433160512337855,
            "start_logit": 5.003601551055908,
            "end_logit": -2.6901357173919678,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "N",
            "probability": 0.00019994800026498495,
            "start_logit": 5.003601551055908,
            "end_logit": -3.463186740875244,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "BEAL2",
            "probability": 0.00012141664394762292,
            "start_logit": -3.950803756713867,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "in the human NBEAL2",
            "probability": 7.600440136476822e-05,
            "start_logit": -4.419240474700928,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene cause gray platelet syndrome (GPS)",
            "probability": 6.920289394857133e-05,
            "start_logit": 5.003601551055908,
            "end_logit": -4.524201393127441,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the human NBEAL2 gene",
            "probability": 6.7233972016294e-05,
            "start_logit": -1.6694048643112183,
            "end_logit": 2.119940996170044,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "human NBEAL2 gene",
            "probability": 6.054119679147972e-05,
            "start_logit": -1.7742594480514526,
            "end_logit": 2.119940996170044,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene cause gray platelet syndrome",
            "probability": 6.0223191849894094e-05,
            "start_logit": 5.003601551055908,
            "end_logit": -4.663186550140381,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "AL2",
            "probability": 5.22199008293588e-05,
            "start_logit": -4.794568061828613,
            "end_logit": 4.99238920211792,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "Mutations in the human NBEAL2 gene",
            "probability": 4.562657704128333e-05,
            "start_logit": -2.0570931434631348,
            "end_logit": 2.119940996170044,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "2 gene",
            "probability": 4.091300448222923e-05,
            "start_logit": -2.166135549545288,
            "end_logit": 2.119940996170044,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 in immunity by analyzing the phenotype of Nbeal2",
            "probability": 2.9268016069171864e-05,
            "start_logit": -0.14371901750564575,
            "end_logit": -0.2374281883239746,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "Nbeal2",
            "probability": 1.298967047095269e-05,
            "start_logit": -0.9560598731040955,
            "end_logit": -0.2374281883239746,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        }
    ],
    "550712739d0faaa527000008": [
        {
            "text": "ryanodine receptor",
            "probability": 0.16117930805966027,
            "start_logit": 0.9572340250015259,
            "end_logit": -0.7983909249305725,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor",
            "probability": 0.10136520681582036,
            "start_logit": 0.4934464693069458,
            "end_logit": -0.7983909249305725,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene (RYR2)",
            "probability": 0.08851646011981841,
            "start_logit": 0.9572340250015259,
            "end_logit": -1.3977198600769043,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene (RYR2) are identified in the majority of patients with CPVT.",
            "probability": 0.06934244482186573,
            "start_logit": 0.9572340250015259,
            "end_logit": -1.6418511867523193,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene (RYR2",
            "probability": 0.05824097574623408,
            "start_logit": 0.9572340250015259,
            "end_logit": -1.816319227218628,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene (RYR2)",
            "probability": 0.055667749133955544,
            "start_logit": 0.4934464693069458,
            "end_logit": -1.3977198600769043,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor gene",
            "probability": 0.05521316363581799,
            "start_logit": 0.9572340250015259,
            "end_logit": -1.8697069883346558,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2)",
            "probability": 0.05441072762823526,
            "start_logit": 0.47060683369636536,
            "end_logit": -1.3977198600769043,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene (RYR2) are identified in the majority of patients with CPVT.",
            "probability": 0.04360926563775351,
            "start_logit": 0.4934464693069458,
            "end_logit": -1.6418511867523193,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT.",
            "probability": 0.04262453416202213,
            "start_logit": 0.47060683369636536,
            "end_logit": -1.6418511867523193,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel",
            "probability": 0.040834118537159764,
            "start_logit": 0.4934464693069458,
            "end_logit": -1.707602858543396,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium",
            "probability": 0.038280833181953786,
            "start_logit": 0.4934464693069458,
            "end_logit": -1.7721714973449707,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.03662758342086307,
            "start_logit": 0.4934464693069458,
            "end_logit": -1.816319227218628,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2",
            "probability": 0.035800503814109146,
            "start_logit": 0.47060683369636536,
            "end_logit": -1.816319227218628,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine receptor gene",
            "probability": 0.03472340102632042,
            "start_logit": 0.4934464693069458,
            "end_logit": -1.8697069883346558,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine",
            "probability": 0.02173905211140886,
            "start_logit": 0.9572340250015259,
            "end_logit": -2.801798105239868,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "Mutations in the cardiac calcium release channel/ryanodine receptor",
            "probability": 0.020741682775000696,
            "start_logit": -1.0931380987167358,
            "end_logit": -0.7983909249305725,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "(RYR2)",
            "probability": 0.014028420975751372,
            "start_logit": -0.8848691582679749,
            "end_logit": -1.3977198600769043,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "calcium release channel/ryanodine",
            "probability": 0.013671627827296555,
            "start_logit": 0.4934464693069458,
            "end_logit": -2.801798105239868,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "Mutations",
            "probability": 0.01338294056895314,
            "start_logit": -1.0931380987167358,
            "end_logit": -1.2365554571151733,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        }
    ],
    "511a20f3df1ebcce7d00000c": [
        {
            "text": "psychotic symptoms, and reports on steroid-induced psychosis",
            "probability": 0.32498294745567696,
            "start_logit": 5.36347770690918,
            "end_logit": 5.321493625640869,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychosis",
            "probability": 0.23941781735607345,
            "start_logit": 5.057915210723877,
            "end_logit": 5.321493625640869,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychotic",
            "probability": 0.1417748290754424,
            "start_logit": 5.36347770690918,
            "end_logit": 4.4919610023498535,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychotic symptoms",
            "probability": 0.13231487928447497,
            "start_logit": 5.36347770690918,
            "end_logit": 4.422905445098877,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychosis in the pediatric population are few. Here, we report the first case of steroid-induced psychosis",
            "probability": 0.07991130365669231,
            "start_logit": 5.057915210723877,
            "end_logit": 4.22420072555542,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "steroid-induced psychosis",
            "probability": 0.05512741462709207,
            "start_logit": 3.5893521308898926,
            "end_logit": 5.321493625640869,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychotic symptoms, including auditory hallucination",
            "probability": 0.010362867099130844,
            "start_logit": 3.371248960494995,
            "end_logit": 3.868178606033325,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "auditory hallucination",
            "probability": 0.010329965243995537,
            "start_logit": 3.3680689334869385,
            "end_logit": 3.868178606033325,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroids are associated with various side effects. Under rare circumstances, they can even cause psychotic",
            "probability": 0.00142760484073846,
            "start_logit": 0.7652357220649719,
            "end_logit": 4.4919610023498535,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychotic symptoms,",
            "probability": 0.0013481568523156678,
            "start_logit": 5.36347770690918,
            "end_logit": -0.16354072093963623,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroids are associated with various side effects. Under rare circumstances, they can even cause psychotic symptoms",
            "probability": 0.001332347662840249,
            "start_logit": 0.7652357220649719,
            "end_logit": 4.422905445098877,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "hallucination",
            "probability": 0.0005777861649246815,
            "start_logit": 0.48446857929229736,
            "end_logit": 3.868178606033325,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "they can even cause psychotic symptoms, and reports on steroid-induced psychosis",
            "probability": 0.0001801719977924273,
            "start_logit": -2.134138345718384,
            "end_logit": 5.321493625640869,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "ps",
            "probability": 0.00017352421245647493,
            "start_logit": 5.36347770690918,
            "end_logit": -2.213717222213745,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "reports on steroid-induced psychosis",
            "probability": 0.00013954618856387157,
            "start_logit": -2.3896546363830566,
            "end_logit": 5.321493625640869,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psych",
            "probability": 0.00013010385419521902,
            "start_logit": 5.36347770690918,
            "end_logit": -2.5017013549804688,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychotic symptoms, and reports on steroid-induced",
            "probability": 0.00012475020829257906,
            "start_logit": 5.36347770690918,
            "end_logit": -2.5437209606170654,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychotic symptoms, and reports on steroid-induced ps",
            "probability": 0.00012185351633154771,
            "start_logit": 5.36347770690918,
            "end_logit": -2.5672147274017334,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "psychotic symptoms, and reports on steroid",
            "probability": 0.0001140918370142894,
            "start_logit": 5.36347770690918,
            "end_logit": -2.633030652999878,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "Steroids",
            "probability": 0.00010803886595611042,
            "start_logit": 0.7652357220649719,
            "end_logit": 1.910698652267456,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        }
    ],
    "518cca6f310faafe0800000a": [
        {
            "text": "IGF1/PI3K/AKT",
            "probability": 0.1762063980535895,
            "start_logit": 1.868066430091858,
            "end_logit": 1.1932839155197144,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "mTOR",
            "probability": 0.15776418974833914,
            "start_logit": 2.196681499481201,
            "end_logit": 0.7541142702102661,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1",
            "probability": 0.12483151973492447,
            "start_logit": 1.868066430091858,
            "end_logit": 0.8485928773880005,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K/AKT/mTOR",
            "probability": 0.11357760852995416,
            "start_logit": 1.868066430091858,
            "end_logit": 0.7541142702102661,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "AKT",
            "probability": 0.10210328701964876,
            "start_logit": 1.3223953247070312,
            "end_logit": 1.1932839155197144,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K/AKT",
            "probability": 0.0778236206353685,
            "start_logit": 1.0508553981781006,
            "end_logit": 1.1932839155197144,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "AKT/mTOR",
            "probability": 0.06581286088835625,
            "start_logit": 1.3223953247070312,
            "end_logit": 0.7541142702102661,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K/AKT/mTOR",
            "probability": 0.05016288180534365,
            "start_logit": 1.0508553981781006,
            "end_logit": 0.7541142702102661,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K",
            "probability": 0.03874134905401293,
            "start_logit": 1.868066430091858,
            "end_logit": -0.3214646279811859,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "mTOR axis",
            "probability": 0.018271116697912194,
            "start_logit": 2.196681499481201,
            "end_logit": -1.4016656875610352,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K",
            "probability": 0.017110570813466987,
            "start_logit": 1.0508553981781006,
            "end_logit": -0.3214646279811859,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K/AKT/mTOR axis",
            "probability": 0.013153743844093277,
            "start_logit": 1.868066430091858,
            "end_logit": -1.4016656875610352,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNAs",
            "probability": 0.010490145386647042,
            "start_logit": -0.45769453048706055,
            "end_logit": 0.6978251338005066,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "AKT/mTOR axis",
            "probability": 0.007621973423961235,
            "start_logit": 1.3223953247070312,
            "end_logit": -1.4016656875610352,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "PI3K/AKT/mTOR axis",
            "probability": 0.005809505115394281,
            "start_logit": 1.0508553981781006,
            "end_logit": -1.4016656875610352,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNAs are recognized as regulators of signalling pathways such as the IGF1/PI3K/AKT",
            "probability": 0.0056367211334764095,
            "start_logit": -1.5742870569229126,
            "end_logit": 1.1932839155197144,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "mTOR axis,",
            "probability": 0.004218780058785029,
            "start_logit": 2.196681499481201,
            "end_logit": -2.867441177368164,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNAs are recognized as regulators of signalling pathways such as the IGF1",
            "probability": 0.003993274212437102,
            "start_logit": -1.5742870569229126,
            "end_logit": 0.8485928773880005,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNAs are recognized as regulators of signalling pathways such as the IGF1/PI3K/AKT/mTOR",
            "probability": 0.003633269355496376,
            "start_logit": -1.5742870569229126,
            "end_logit": 0.7541142702102661,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "IGF1/PI3K/AKT/mTOR axis,",
            "probability": 0.0030371844887930742,
            "start_logit": 1.868066430091858,
            "end_logit": -2.867441177368164,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        }
    ],
    "56df03c751531f7e3300000a": [
        {
            "text": "cell fate",
            "probability": 0.2659395777854509,
            "start_logit": 4.387722969055176,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "translation, altering cell fate",
            "probability": 0.12532808939425835,
            "start_logit": 3.6353888511657715,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability and translation, altering cell fate",
            "probability": 0.11525849344261108,
            "start_logit": 3.551631212234497,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability",
            "probability": 0.08996557459782592,
            "start_logit": 3.551631212234497,
            "end_logit": 4.71390962600708,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "translation",
            "probability": 0.07915122906484433,
            "start_logit": 3.6353888511657715,
            "end_logit": 4.502085208892822,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "stability and translation",
            "probability": 0.07279175371010572,
            "start_logit": 3.551631212234497,
            "end_logit": 4.502085208892822,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNA stability and translation, altering cell fate",
            "probability": 0.05126346692057412,
            "start_logit": 2.7414321899414062,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "altering cell fate",
            "probability": 0.040153972598304936,
            "start_logit": 2.4971752166748047,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNA stability",
            "probability": 0.040013947082194426,
            "start_logit": 2.7414321899414062,
            "end_logit": 4.71390962600708,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNA stability and translation",
            "probability": 0.032375554694080586,
            "start_logit": 2.7414321899414062,
            "end_logit": 4.502085208892822,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNA methylation fine tunes RNA stability and translation, altering cell fate",
            "probability": 0.017711336000302967,
            "start_logit": 1.6786587238311768,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNA methylation fine tunes RNA stability",
            "probability": 0.013824668990279655,
            "start_logit": 1.6786587238311768,
            "end_logit": 4.71390962600708,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "fine tunes RNA stability and translation, altering cell fate",
            "probability": 0.01136358668930894,
            "start_logit": 1.2348679304122925,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "RNA methylation fine tunes RNA stability and translation",
            "probability": 0.011185633001987088,
            "start_logit": 1.6786587238311768,
            "end_logit": 4.502085208892822,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "fine tunes RNA stability",
            "probability": 0.008869902559544727,
            "start_logit": 1.2348679304122925,
            "end_logit": 4.71390962600708,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "fine tunes RNA stability and translation",
            "probability": 0.007176698036257738,
            "start_logit": 1.2348679304122925,
            "end_logit": 4.502085208892822,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "methylation fine tunes RNA stability and translation, altering cell fate",
            "probability": 0.005809161627544493,
            "start_logit": 0.5638900995254517,
            "end_logit": 4.961659908294678,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "methylation fine tunes RNA stability",
            "probability": 0.004534369209102187,
            "start_logit": 0.5638900995254517,
            "end_logit": 4.71390962600708,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "methylation fine tunes RNA stability and translation",
            "probability": 0.003668788735859745,
            "start_logit": 0.5638900995254517,
            "end_logit": 4.502085208892822,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "cell fate. The fat mass- and obesity-associated protein (FTO) is an m6A demethylase",
            "probability": 0.0036141958595622757,
            "start_logit": 4.387722969055176,
            "end_logit": 0.6632601618766785,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        }
    ],
    "517775c78ed59a060a000033": [
        {
            "text": "rapamycin",
            "probability": 0.7442912127451184,
            "start_logit": 5.283883094787598,
            "end_logit": 5.259692668914795,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rapamycin",
            "probability": 0.15443059117620675,
            "start_logit": 4.408738136291504,
            "end_logit": 4.562150001525879,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mTORC1 with rapamycin",
            "probability": 0.055195520198153505,
            "start_logit": 2.6823325157165527,
            "end_logit": 5.259692668914795,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition of mTORC1 with rapamycin",
            "probability": 0.041332694933702396,
            "start_logit": 2.3931045532226562,
            "end_logit": 5.259692668914795,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mTORC1",
            "probability": 0.001255349805157274,
            "start_logit": 2.6823325157165527,
            "end_logit": 1.4762251377105713,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "with rapamycin",
            "probability": 0.0011943784291931746,
            "start_logit": -1.1509233713150024,
            "end_logit": 5.259692668914795,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition of mTORC1",
            "probability": 0.0009400580037179205,
            "start_logit": 2.3931045532226562,
            "end_logit": 1.4762251377105713,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "p70S6K in SH-SY5Y cells. Taken together, these data demonstrated that rapamycin",
            "probability": 0.0003713606377655476,
            "start_logit": -1.8563165664672852,
            "end_logit": 4.796878337860107,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rap",
            "probability": 0.00025510010918787464,
            "start_logit": 5.283883094787598,
            "end_logit": -2.718838930130005,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "cin",
            "probability": 0.00015583583710465372,
            "start_logit": -3.1875014305114746,
            "end_logit": 5.259692668914795,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rapamycin improved STZ-induced AD-like tauopathies and memory deficit in mice via improving",
            "probability": 0.000144326882366347,
            "start_logit": 5.048423767089844,
            "end_logit": -3.052954912185669,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rapamycin attenuated HG-induced tau hyperphosphorylation via the AKT",
            "probability": 0.00010095745204013047,
            "start_logit": 4.408738136291504,
            "end_logit": -2.770650863647461,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "hibition of mTORC1 with rapamycin",
            "probability": 8.552877023733131e-05,
            "start_logit": -3.78745174407959,
            "end_logit": 5.259692668914795,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition",
            "probability": 6.31326806955663e-05,
            "start_logit": 2.3931045532226562,
            "end_logit": -1.2244778871536255,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rapamycin attenuated HG-induced tau hyperphosphorylation via the AKT/AMPK",
            "probability": 6.299969350981586e-05,
            "start_logit": 4.408738136291504,
            "end_logit": -3.242220163345337,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Rap",
            "probability": 5.595397584745994e-05,
            "start_logit": 4.408738136291504,
            "end_logit": -3.3608205318450928,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "improved memory deficit in both STZ mice. Rapamycin",
            "probability": 2.0251030640833708e-05,
            "start_logit": -4.5305562019348145,
            "end_logit": 4.562150001525879,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mTORC1 with rap",
            "probability": 1.8917841549275834e-05,
            "start_logit": 2.6823325157165527,
            "end_logit": -2.718838930130005,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Inhibition of mTORC1 with rap",
            "probability": 1.4166464429598696e-05,
            "start_logit": 2.3931045532226562,
            "end_logit": -2.718838930130005,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mTORC1 with",
            "probability": 1.1663333375983384e-05,
            "start_logit": 2.6823325157165527,
            "end_logit": -3.2024943828582764,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        }
    ],
    "517539e68ed59a060a000028": [
        {
            "text": "MO25",
            "probability": 0.3648961476204344,
            "start_logit": 4.105838298797607,
            "end_logit": 2.9049317836761475,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1",
            "probability": 0.35472937599355664,
            "start_logit": 3.6273090839385986,
            "end_logit": 3.35520339012146,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25",
            "probability": 0.2261240112604721,
            "start_logit": 3.6273090839385986,
            "end_logit": 2.9049317836761475,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "cytochrome c",
            "probability": 0.015992416420465998,
            "start_logit": 2.333875894546509,
            "end_logit": 1.54939603805542,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content with subsequent activation of AMPK",
            "probability": 0.009294263279433865,
            "start_logit": 4.105838298797607,
            "end_logit": -0.7652836441993713,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB",
            "probability": 0.008973272228464493,
            "start_logit": 3.6273090839385986,
            "end_logit": -0.3219013810157776,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "uncoupling protein 3, cytochrome c",
            "probability": 0.006824917612367588,
            "start_logit": 1.4823415279388428,
            "end_logit": 1.54939603805542,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25 content with subsequent activation of AMPK",
            "probability": 0.00575960066490656,
            "start_logit": 3.6273090839385986,
            "end_logit": -0.7652836441993713,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content",
            "probability": 0.0012997015651644577,
            "start_logit": 4.105838298797607,
            "end_logit": -2.732546329498291,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO",
            "probability": 0.0009340328957019818,
            "start_logit": 4.105838298797607,
            "end_logit": -3.06292462348938,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25 content",
            "probability": 0.0008054174681564733,
            "start_logit": 3.6273090839385986,
            "end_logit": -2.732546329498291,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content with subsequent activation of AMPK, phosphorylation of CREB, and expression",
            "probability": 0.0006280004662755573,
            "start_logit": 4.105838298797607,
            "end_logit": -3.459895372390747,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content with subsequent activation of AMPK, phosphorylation of CREB",
            "probability": 0.0005975030258919177,
            "start_logit": 4.105838298797607,
            "end_logit": -3.509676933288574,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO",
            "probability": 0.0005788147296229185,
            "start_logit": 3.6273090839385986,
            "end_logit": -3.06292462348938,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "uncoupling protein 3",
            "probability": 0.0005777348517738385,
            "start_logit": 1.4823415279388428,
            "end_logit": -0.919824481010437,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "cytochrome c, and hexokinase II",
            "probability": 0.000445323472469601,
            "start_logit": 2.333875894546509,
            "end_logit": -2.031672954559326,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 mRNA increased with thyroid hormone treatment, and STRAD mRNA",
            "probability": 0.00039050372500411745,
            "start_logit": -0.059702806174755096,
            "end_logit": 0.23054233193397522,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "LKB1 and MO25 content with subsequent activation of AMPK, phosphorylation of CREB, and expression",
            "probability": 0.0003891682206943734,
            "start_logit": 3.6273090839385986,
            "end_logit": -3.459895372390747,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "M",
            "probability": 0.0003875790990067168,
            "start_logit": 4.105838298797607,
            "end_logit": -3.942516326904297,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "MO25 content with subsequent activation of AMPK, phosphorylation of CREB, and expression of mitochondrial protein genes",
            "probability": 0.000372215400136691,
            "start_logit": 4.105838298797607,
            "end_logit": -3.9829635620117188,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        }
    ],
    "518cb5ab310faafe08000008": [
        {
            "text": "levofloxacin",
            "probability": 0.26364999129366384,
            "start_logit": 5.482151508331299,
            "end_logit": 5.280966281890869,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based treatment (quadruple therapy) may be used afterwards, and then a levofloxacin",
            "probability": 0.20152745958961538,
            "start_logit": 5.213454723358154,
            "end_logit": 5.280966281890869,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin",
            "probability": 0.14919982210663227,
            "start_logit": 5.065725803375244,
            "end_logit": 5.128056049346924,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole",
            "probability": 0.10536017035489396,
            "start_logit": 5.213454723358154,
            "end_logit": 4.632425308227539,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin-based regimen was used, a second-line metronidazole",
            "probability": 0.09089052445536273,
            "start_logit": 5.065725803375244,
            "end_logit": 4.632425308227539,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "amoxicillin",
            "probability": 0.05176376366210739,
            "start_logit": 4.54653263092041,
            "end_logit": 4.588653087615967,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin-amoxicillin",
            "probability": 0.0463037743244042,
            "start_logit": 4.435065746307373,
            "end_logit": 4.588653087615967,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin-based \"rescue\" therapy constitutes an encouraging 2nd-line strategy, representing an alternative to quadruple therapy",
            "probability": 0.01591423293103207,
            "start_logit": 5.332377910614014,
            "end_logit": 2.623331308364868,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based treatment (quadruple therapy",
            "probability": 0.011947236819347434,
            "start_logit": 5.213454723358154,
            "end_logit": 2.455540657043457,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin-based \"rescue\" therapy",
            "probability": 0.01119561716611429,
            "start_logit": 5.332377910614014,
            "end_logit": 2.271639823913574,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin-based combination",
            "probability": 0.007666049151001521,
            "start_logit": 5.482151508331299,
            "end_logit": 1.743145227432251,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy in patients with previous PPI-clarithromycin-amoxicillin",
            "probability": 0.007509446193557361,
            "start_logit": 2.61600399017334,
            "end_logit": 4.588653087615967,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy in patients with previous PPI-clarithromycin",
            "probability": 0.0071899189116811845,
            "start_logit": 2.61600399017334,
            "end_logit": 4.54517126083374,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "metronidazole-based treatment",
            "probability": 0.00717865167426331,
            "start_logit": 5.213454723358154,
            "end_logit": 1.9461522102355957,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy) may be used afterwards, and then a levofloxacin",
            "probability": 0.00639305352053698,
            "start_logit": 1.7627410888671875,
            "end_logit": 5.280966281890869,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin-based regimen was used, a second-line metronidazole-based treatment",
            "probability": 0.006192771076189256,
            "start_logit": 5.065725803375244,
            "end_logit": 1.9461522102355957,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "PPI-clarithromycin-amoxicillin",
            "probability": 0.0033911817271814375,
            "start_logit": 1.8210207223892212,
            "end_logit": 4.588653087615967,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "PPI-clarithromycin",
            "probability": 0.0032468867882864652,
            "start_logit": 1.8210207223892212,
            "end_logit": 4.54517126083374,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "clarithromycin-based regimen",
            "probability": 0.0021752351711634105,
            "start_logit": 5.065725803375244,
            "end_logit": 0.8999063372612,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "first-line clarithromycin",
            "probability": 0.0013042130829657899,
            "start_logit": 0.3260391652584076,
            "end_logit": 5.128056049346924,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        }
    ],
    "54db7217c4c6ce8e1d000003": [
        {
            "text": "RYR2",
            "probability": 0.4439824435428578,
            "start_logit": 2.8464136123657227,
            "end_logit": 2.9190237522125244,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT. RyR2",
            "probability": 0.21039841669943268,
            "start_logit": 2.8464136123657227,
            "end_logit": 2.172241687774658,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2",
            "probability": 0.20608312622247082,
            "start_logit": 2.825690269470215,
            "end_logit": 2.172241687774658,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "ryanodine receptor gene (RYR2",
            "probability": 0.0563896330804316,
            "start_logit": 0.7829139232635498,
            "end_logit": 2.9190237522125244,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "(RYR2",
            "probability": 0.02793612898587453,
            "start_logit": 0.08054938912391663,
            "end_logit": 2.9190237522125244,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "ryanodine receptor gene (RYR2) are identified in the majority of patients with CPVT. RyR2",
            "probability": 0.026722429435972722,
            "start_logit": 0.7829139232635498,
            "end_logit": 2.172241687774658,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "(RYR2) are identified in the majority of patients with CPVT. RyR2",
            "probability": 0.013238625519596139,
            "start_logit": 0.08054938912391663,
            "end_logit": 2.172241687774658,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR",
            "probability": 0.004148035457017823,
            "start_logit": 2.8464136123657227,
            "end_logit": -1.7541264295578003,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2)",
            "probability": 0.002717124907385428,
            "start_logit": 2.8464136123657227,
            "end_logit": -2.177186965942383,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2 is also the major RyR isoform expressed in the brain.",
            "probability": 0.0016278369589526002,
            "start_logit": 2.825690269470215,
            "end_logit": -2.668785810470581,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "2",
            "probability": 0.0013789249866011937,
            "start_logit": -2.928067207336426,
            "end_logit": 2.9190237522125244,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT.",
            "probability": 0.0010910041138615044,
            "start_logit": 2.8464136123657227,
            "end_logit": -3.089662790298462,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "Mutations in the cardiac calcium release channel/ryanodine receptor gene (RYR2",
            "probability": 0.0009831757184248148,
            "start_logit": -3.26633882522583,
            "end_logit": 2.9190237522125244,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "2) are identified in the majority of patients with CPVT. RyR2",
            "probability": 0.0006534574466798074,
            "start_logit": -2.928067207336426,
            "end_logit": 2.172241687774658,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT. RyR2 is also the major RyR",
            "probability": 0.0005537840817837366,
            "start_logit": 2.8464136123657227,
            "end_logit": -3.7677416801452637,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2 is also the major RyR",
            "probability": 0.0005424259203873591,
            "start_logit": 2.825690269470215,
            "end_logit": -3.7677416801452637,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "ryanodine receptor gene (RYR",
            "probability": 0.0005268365919141943,
            "start_logit": 0.7829139232635498,
            "end_logit": -1.7541264295578003,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "R",
            "probability": 0.0003839039026784958,
            "start_logit": 2.8464136123657227,
            "end_logit": -4.134124279022217,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "ryanodine receptor gene (RYR2)",
            "probability": 0.0003450985028563991,
            "start_logit": 0.7829139232635498,
            "end_logit": -2.177186965942383,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RYR2) are identified in the majority of patients with CPVT. RyR",
            "probability": 0.00029758792482000273,
            "start_logit": 2.8464136123657227,
            "end_logit": -4.3888068199157715,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        }
    ],
    "532c0ac4d6d3ac6a3400001a": [
        {
            "text": "docking calculations",
            "probability": 0.3330698135165844,
            "start_logit": 1.9922288656234741,
            "end_logit": 1.3697142601013184,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking",
            "probability": 0.1487116001399654,
            "start_logit": 1.9922288656234741,
            "end_logit": 0.5633710026741028,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "dock",
            "probability": 0.08776433777847858,
            "start_logit": 1.9922288656234741,
            "end_logit": 0.03601738438010216,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses of binding free energy",
            "probability": 0.08756431977682394,
            "start_logit": 1.9922288656234741,
            "end_logit": 0.03373574838042259,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses of binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity",
            "probability": 0.07195171863438961,
            "start_logit": 1.9922288656234741,
            "end_logit": -0.16264253854751587,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses",
            "probability": 0.04765295558447796,
            "start_logit": 1.9922288656234741,
            "end_logit": -0.5746932029724121,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding free energy",
            "probability": 0.04684057916863564,
            "start_logit": 1.3666051626205444,
            "end_logit": 0.03373574838042259,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity",
            "probability": 0.03848896652887088,
            "start_logit": 1.3666051626205444,
            "end_logit": -0.16264253854751587,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses",
            "probability": 0.025490885378464348,
            "start_logit": 1.3666051626205444,
            "end_logit": -0.5746932029724121,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, docking calculations",
            "probability": 0.01867151494498423,
            "start_logit": -0.8891241550445557,
            "end_logit": 1.3697142601013184,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "binding free energy",
            "probability": 0.016342246035636793,
            "start_logit": 0.3136087954044342,
            "end_logit": 0.03373574838042259,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "calculations",
            "probability": 0.013878169935780118,
            "start_logit": -1.185806155204773,
            "end_logit": 1.3697142601013184,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity",
            "probability": 0.013428445417117555,
            "start_logit": 0.3136087954044342,
            "end_logit": -0.16264253854751587,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "docking calculations, and analyses of binding",
            "probability": 0.011990399737181296,
            "start_logit": 1.9922288656234741,
            "end_logit": -1.9545315504074097,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding free energy. One of the eight compounds exhibited concentration-dependent chymase inhibitory activity, which could be further optimized",
            "probability": 0.00915190854014354,
            "start_logit": 1.3666051626205444,
            "end_logit": -1.5990517139434814,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, docking",
            "probability": 0.008336603173939765,
            "start_logit": -0.8891241550445557,
            "end_logit": 0.5633710026741028,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "analyses of binding",
            "probability": 0.006413996814963892,
            "start_logit": 1.3666051626205444,
            "end_logit": -1.9545315504074097,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, dock",
            "probability": 0.004919968961359845,
            "start_logit": -0.8891241550445557,
            "end_logit": 0.03601738438010216,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search, docking calculations, and analyses of binding free energy",
            "probability": 0.004908756179667833,
            "start_logit": -0.8891241550445557,
            "end_logit": 0.03373574838042259,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "search",
            "probability": 0.004422813752534365,
            "start_logit": -0.8891241550445557,
            "end_logit": -0.07050874829292297,
            "question_text": "What are the main benefits of pharmacophore models?"
        }
    ],
    "52e7b7cb98d023950500001c": [
        {
            "text": "anti-diabetic",
            "probability": 0.6654512680990252,
            "start_logit": 3.4048008918762207,
            "end_logit": 2.7751729488372803,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabetic",
            "probability": 0.19290153311953429,
            "start_logit": 2.166515350341797,
            "end_logit": 2.7751729488372803,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabetic drugs",
            "probability": 0.098469933672821,
            "start_logit": 3.4048008918762207,
            "end_logit": 0.8644587993621826,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabetic drugs",
            "probability": 0.028544541249321643,
            "start_logit": 2.166515350341797,
            "end_logit": 0.8644587993621826,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabe",
            "probability": 0.006726098553576936,
            "start_logit": 3.4048008918762207,
            "end_logit": -1.819297194480896,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabe",
            "probability": 0.001949766699828419,
            "start_logit": 2.166515350341797,
            "end_logit": -1.819297194480896,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-obesity or anti-diabetic",
            "probability": 0.0019132383732507025,
            "start_logit": -2.4468672275543213,
            "end_logit": 2.7751729488372803,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti",
            "probability": 0.0012915751119217484,
            "start_logit": 3.4048008918762207,
            "end_logit": -3.4694299697875977,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-di",
            "probability": 0.000598520535896066,
            "start_logit": 3.4048008918762207,
            "end_logit": -4.238586902618408,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "abetic",
            "probability": 0.00036169277043860966,
            "start_logit": -4.112624645233154,
            "end_logit": 2.7751729488372803,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-obesity or anti-diabetic drugs",
            "probability": 0.00028311082230330573,
            "start_logit": -2.4468672275543213,
            "end_logit": 0.8644587993621826,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "tic",
            "probability": 0.00027771460531338533,
            "start_logit": -4.37682580947876,
            "end_logit": 2.7751729488372803,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabetic drugs effects",
            "probability": 0.0002607153078220921,
            "start_logit": 3.4048008918762207,
            "end_logit": -5.0696187019348145,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabetic drugs effects on each co-culturing cell type.",
            "probability": 0.00023211797524925174,
            "start_logit": 3.4048008918762207,
            "end_logit": -5.185801982879639,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "drugs",
            "probability": 0.00021229712940232478,
            "start_logit": -2.7347187995910645,
            "end_logit": 0.8644587993621826,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "di",
            "probability": 0.00017349960021519645,
            "start_logit": 2.166515350341797,
            "end_logit": -4.238586902618408,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "anti-diabetic drugs effects on each co-culturing cell type",
            "probability": 0.00013445634229183187,
            "start_logit": 3.4048008918762207,
            "end_logit": -5.731808185577393,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabetic drugs effects",
            "probability": 7.557635697393984e-05,
            "start_logit": 2.166515350341797,
            "end_logit": -5.0696187019348145,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "investigation of anti-obesity or anti-diabetic",
            "probability": 7.505713493274718e-05,
            "start_logit": -5.6851701736450195,
            "end_logit": 2.7751729488372803,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "diabetic drugs effects on each co-culturing cell type.",
            "probability": 6.728653988156455e-05,
            "start_logit": 2.166515350341797,
            "end_logit": -5.185801982879639,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        }
    ],
    "58a7fb2860087bc10a000034": [
        {
            "text": "ASH1L",
            "probability": 0.9084442716332441,
            "start_logit": 3.525472640991211,
            "end_logit": 2.9503226280212402,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L,",
            "probability": 0.07973450300705497,
            "start_logit": 3.525472640991211,
            "end_logit": 0.5172914862632751,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1",
            "probability": 0.0034050312575255055,
            "start_logit": 3.525472640991211,
            "end_logit": -2.6361567974090576,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH",
            "probability": 0.00277481259998877,
            "start_logit": 3.525472640991211,
            "end_logit": -2.840827703475952,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based on a transmission disequilibrium test",
            "probability": 0.0010755879626970595,
            "start_logit": 3.525472640991211,
            "end_logit": -3.788543462753296,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated",
            "probability": 0.0008957482135406773,
            "start_logit": 3.525472640991211,
            "end_logit": -3.9715068340301514,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based",
            "probability": 0.0006577732936377306,
            "start_logit": 3.525472640991211,
            "end_logit": -4.280305862426758,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "risk gene, ASH1L",
            "probability": 0.0006299788863017218,
            "start_logit": -3.7483298778533936,
            "end_logit": 2.9503226280212402,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based on a transmission",
            "probability": 0.0004912091739478355,
            "start_logit": 3.525472640991211,
            "end_logit": -4.572296142578125,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "a risk gene, ASH1L",
            "probability": 0.0004103963604240603,
            "start_logit": -4.1768927574157715,
            "end_logit": 2.9503226280212402,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "L",
            "probability": 0.00040587686934557193,
            "start_logit": -4.187966346740723,
            "end_logit": 2.9503226280212402,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "ASH1L, that was both de novo mutated and associated with TS based on a transmission disequilibrium test.",
            "probability": 0.0003971852750711381,
            "start_logit": 3.525472640991211,
            "end_logit": -4.784763336181641,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "identified a risk gene, ASH1L",
            "probability": 0.0003422405303136106,
            "start_logit": -4.358502388000488,
            "end_logit": 2.9503226280212402,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": ", ASH1L",
            "probability": 0.00015709903232955508,
            "start_logit": -5.137139797210693,
            "end_logit": 2.9503226280212402,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "risk gene, ASH1L,",
            "probability": 5.529348906994374e-05,
            "start_logit": -3.7483298778533936,
            "end_logit": 0.5172914862632751,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "a risk gene, ASH1L,",
            "probability": 3.602064634684321e-05,
            "start_logit": -4.1768927574157715,
            "end_logit": 0.5172914862632751,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "L,",
            "probability": 3.562396887719477e-05,
            "start_logit": -4.187966346740723,
            "end_logit": 0.5172914862632751,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "identified a risk gene, ASH1L,",
            "probability": 3.003858293295893e-05,
            "start_logit": -4.358502388000488,
            "end_logit": 0.5172914862632751,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": ", ASH1L,",
            "probability": 1.3788642470237736e-05,
            "start_logit": -5.137139797210693,
            "end_logit": 0.5172914862632751,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "point mutations in ASH1L",
            "probability": 7.520574880469678e-06,
            "start_logit": -4.144250392913818,
            "end_logit": -1.0818005800247192,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        }
    ],
    "58846be0e56acf5176000005": [
        {
            "text": "Parkinson's disease",
            "probability": 0.9780622428731421,
            "start_logit": 3.6913695335388184,
            "end_logit": 3.7637836933135986,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.015348743387972635,
            "start_logit": 3.6913695335388184,
            "end_logit": -0.3907560110092163,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Parkinson's",
            "probability": 0.004067490669833482,
            "start_logit": 3.6913695335388184,
            "end_logit": -1.7187633514404297,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "disease",
            "probability": 0.0013452905887614594,
            "start_logit": -2.8975937366485596,
            "end_logit": 3.7637836933135986,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Park",
            "probability": 0.001053937921566013,
            "start_logit": 3.6913695335388184,
            "end_logit": -3.069256067276001,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Parkinson's disease (PD) is a neurodegenerative disorder",
            "probability": 8.13258392831954e-05,
            "start_logit": 3.6913695335388184,
            "end_logit": -5.6310811042785645,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "disease (PD)",
            "probability": 2.1111662554826224e-05,
            "start_logit": -2.8975937366485596,
            "end_logit": -0.3907560110092163,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "park",
            "probability": 4.920749101083155e-06,
            "start_logit": -0.34661564230918884,
            "end_logit": -4.398098945617676,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "high-intensity focused ultrasound thalamotomy",
            "probability": 3.6048847826600403e-06,
            "start_logit": -3.0407419204711914,
            "end_logit": -2.015143632888794,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "high-intensity focused ultrasound thalamotomy or sub-thalamotomy",
            "probability": 2.3318742955553467e-06,
            "start_logit": -3.0407419204711914,
            "end_logit": -2.450761079788208,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": ")",
            "probability": 1.9860550009799914e-06,
            "start_logit": -5.2612690925598145,
            "end_logit": -0.3907560110092163,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy",
            "probability": 1.2198593215794943e-06,
            "start_logit": -4.124296188354492,
            "end_logit": -2.015143632888794,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "(PD)",
            "probability": 1.134588469149186e-06,
            "start_logit": -5.8211493492126465,
            "end_logit": -0.3907560110092163,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "gamma knife thalamotomy",
            "probability": 1.0251202304554755e-06,
            "start_logit": -4.124296188354492,
            "end_logit": -2.1890692710876465,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "gamma knife thalamotomy or high-intensity focused ultrasound thalamotomy or sub-thalamotomy",
            "probability": 7.890844694586356e-07,
            "start_logit": -4.124296188354492,
            "end_logit": -2.450761079788208,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "high-intensity focused ultrasound thalamotomy or sub-thalamotomy,",
            "probability": 7.13456010509842e-07,
            "start_logit": -3.0407419204711914,
            "end_logit": -3.635067939758301,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "high-intensity focused ultrasound",
            "probability": 6.951012914925082e-07,
            "start_logit": -3.0407419204711914,
            "end_logit": -3.6611311435699463,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "focused ultrasound thalamotomy",
            "probability": 5.237031546284971e-07,
            "start_logit": -4.96986198425293,
            "end_logit": -2.015143632888794,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "sub-thalamotomy",
            "probability": 4.951491294318557e-07,
            "start_logit": -4.590310573577881,
            "end_logit": -2.450761079788208,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "thalamotomy",
            "probability": 4.1743162923131075e-07,
            "start_logit": -5.196666240692139,
            "end_logit": -2.015143632888794,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        }
    ],
    "58919aad621ea6ff7e00000d": [
        {
            "text": "chlorophenol",
            "probability": 0.28152651844338683,
            "start_logit": -5.205338954925537,
            "end_logit": -5.955976963043213,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "chlorophenol (CP) degradation",
            "probability": 0.1436495987326612,
            "start_logit": -5.205338954925537,
            "end_logit": -6.62882661819458,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "chlorophenol (CP) degradation has been studied,",
            "probability": 0.1366453931566314,
            "start_logit": -5.205338954925537,
            "end_logit": -6.67881441116333,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "chlorophenol (CP) degradation has been studied",
            "probability": 0.13198456589476487,
            "start_logit": -5.205338954925537,
            "end_logit": -6.7135186195373535,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "0.0139 d(-1).",
            "probability": 0.032779681024973556,
            "start_logit": -6.584969997406006,
            "end_logit": -6.726763725280762,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "Although chlorophenol",
            "probability": 0.03224223938468122,
            "start_logit": -7.372288227081299,
            "end_logit": -5.955976963043213,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2,4-dichlorophenol",
            "probability": 0.02919514017023842,
            "start_logit": -6.827062129974365,
            "end_logit": -6.600478172302246,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "0.0139 d(-1",
            "probability": 0.02095716833528548,
            "start_logit": -6.584969997406006,
            "end_logit": -7.174091815948486,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "Degradation of CP [2-CP, 3-CP, 4-CP, 2,4-dichlorophenol",
            "probability": 0.02031366260364351,
            "start_logit": -7.189770698547363,
            "end_logit": -6.600478172302246,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "3-CP, 4-CP, 2,4-dichlorophenol",
            "probability": 0.018015049668125213,
            "start_logit": -7.30985689163208,
            "end_logit": -6.600478172302246,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2,4-dichlorophenol (DCP) or 2,6-DCP] under denitrifying conditions",
            "probability": 0.017069902006942264,
            "start_logit": -6.827062129974365,
            "end_logit": -7.1371636390686035,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2,4-dichlorophenol (DCP) or 2,6-DCP",
            "probability": 0.016594824960443573,
            "start_logit": -6.827062129974365,
            "end_logit": -7.165389537811279,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "Although chlorophenol (CP) degradation",
            "probability": 0.016451681978169472,
            "start_logit": -7.372288227081299,
            "end_logit": -6.62882661819458,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "enrichment culture was greater than 50 d,",
            "probability": 0.015942285812324087,
            "start_logit": -7.7341718673706055,
            "end_logit": -6.29839563369751,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "Although chlorophenol (CP) degradation has been studied,",
            "probability": 0.015649515013115754,
            "start_logit": -7.372288227081299,
            "end_logit": -6.67881441116333,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "Although chlorophenol (CP) degradation has been studied",
            "probability": 0.015115726902714463,
            "start_logit": -7.372288227081299,
            "end_logit": -6.7135186195373535,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2-CP-degrading enrichment culture degraded 2-CP in the presence of nitrate,",
            "probability": 0.014371982120087935,
            "start_logit": -7.4548821449279785,
            "end_logit": -6.681379795074463,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "studied,",
            "probability": 0.014046059542546525,
            "start_logit": -7.480386257171631,
            "end_logit": -6.67881441116333,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "2-CP, 3-CP, 4-CP, 2,4-dichlorophenol",
            "probability": 0.013882040677137166,
            "start_logit": -7.570468425750732,
            "end_logit": -6.600478172302246,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "studied",
            "probability": 0.013566963572127236,
            "start_logit": -7.480386257171631,
            "end_logit": -6.7135186195373535,
            "question_text": "List selective estrogen receptor degraders."
        }
    ],
    "587d2700fe8a08052f000001": [
        {
            "text": "SEdb, http://www.licpathway.net/sedb",
            "probability": 0.23122213225358593,
            "start_logit": 0.5249309539794922,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "sedb",
            "probability": 0.2058855845645796,
            "start_logit": 0.40887269377708435,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEdb",
            "probability": 0.1766762371542699,
            "start_logit": 0.5249309539794922,
            "end_logit": 0.1538688689470291,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEdb, http://www.licpathway",
            "probability": 0.07123670621498043,
            "start_logit": 0.5249309539794922,
            "end_logit": -0.7544417977333069,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "(SEdb, http://www.licpathway.net/sedb",
            "probability": 0.038518057366119816,
            "start_logit": -1.2673207521438599,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEdb,",
            "probability": 0.03582431224634824,
            "start_logit": 0.5249309539794922,
            "end_logit": -1.4418232440948486,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "(SEdb",
            "probability": 0.02943154866539735,
            "start_logit": -1.2673207521438599,
            "end_logit": 0.1538688689470291,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "super-enhancer database (SEdb, http://www.licpathway.net/sedb",
            "probability": 0.023172499404755915,
            "start_logit": -1.7754817008972168,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "licpathway.net/sedb",
            "probability": 0.023124856007958678,
            "start_logit": -1.777539849281311,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEdb, http://www.licpathway.net/sedb)",
            "probability": 0.019224453720805487,
            "start_logit": 0.5249309539794922,
            "end_logit": -2.0642669200897217,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "developed a comprehensive human super-enhancer database (SEdb, http://www.licpathway.net/sedb",
            "probability": 0.018615864463625384,
            "start_logit": -1.9944337606430054,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "super-enhancer database (SEdb",
            "probability": 0.017706047255899488,
            "start_logit": -1.7754817008972168,
            "end_logit": 0.1538688689470291,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "sedb)",
            "probability": 0.017117902398295876,
            "start_logit": 0.40887269377708435,
            "end_logit": -2.0642669200897217,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "SEdb, http://www.licpathway.net",
            "probability": 0.015236505549658557,
            "start_logit": 0.5249309539794922,
            "end_logit": -2.296755790710449,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "developed a comprehensive human super-enhancer database (SEdb",
            "probability": 0.014224334205170861,
            "start_logit": -1.9944337606430054,
            "end_logit": 0.1538688689470291,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "comprehensive human super-enhancer database (SEdb, http://www.licpathway.net/sedb",
            "probability": 0.013640437312547866,
            "start_logit": -2.3054091930389404,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "sedb) that aimed to provide a large number of available resources on human super-enhancers.",
            "probability": 0.013107461175046818,
            "start_logit": 0.40887269377708435,
            "end_logit": -2.331210136413574,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "a comprehensive human super-enhancer database (SEdb, http://www.licpathway.net/sedb",
            "probability": 0.012576985936171297,
            "start_logit": -2.3865792751312256,
            "end_logit": 0.4229288399219513,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "(SEdb, http://www.licpathway",
            "probability": 0.011866941584781994,
            "start_logit": -1.2673207521438599,
            "end_logit": -0.7544417977333069,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "sedb) that aimed to provide a large number of available resources on human super-enhancers",
            "probability": 0.011591132520000309,
            "start_logit": 0.40887269377708435,
            "end_logit": -2.4541513919830322,
            "question_text": "List all the available databases of super enhancers"
        }
    ],
    "58a2efec60087bc10a000008": [
        {
            "text": "relocalization",
            "probability": 0.35782470785330894,
            "start_logit": 3.971669912338257,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "subcellular relocalization",
            "probability": 0.3279740118693611,
            "start_logit": 3.884561061859131,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.10605041941640105,
            "start_logit": 3.971669912338257,
            "end_logit": 3.5871479511260986,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "subcellular relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.09720340924776025,
            "start_logit": 3.884561061859131,
            "end_logit": 3.5871479511260986,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "detachment from microtubules",
            "probability": 0.05457732403047788,
            "start_logit": 3.3073737621307373,
            "end_logit": 3.5871479511260986,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "relocalization driven by Tau phosphorylation and detachment",
            "probability": 0.011360908222594243,
            "start_logit": 3.971669912338257,
            "end_logit": 1.3534116744995117,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "subcellular relocalization driven by Tau phosphorylation and detachment",
            "probability": 0.010413150815095088,
            "start_logit": 3.884561061859131,
            "end_logit": 1.3534116744995117,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "a process of subcellular relocalization",
            "probability": 0.010365730217393326,
            "start_logit": 0.4301318824291229,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "detachment",
            "probability": 0.005846728120050734,
            "start_logit": 3.3073737621307373,
            "end_logit": 1.3534116744995117,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "process of subcellular relocalization",
            "probability": 0.004461273792845836,
            "start_logit": -0.4129389822483063,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "a process of subcellular relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.003072146816542587,
            "start_logit": 0.4301318824291229,
            "end_logit": 3.5871479511260986,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "microtubules",
            "probability": 0.0028915023345968214,
            "start_logit": 0.3695314824581146,
            "end_logit": 3.5871479511260986,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "zation",
            "probability": 0.0018402505692055068,
            "start_logit": -1.2984715700149536,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "process of subcellular relocalization driven by Tau phosphorylation and detachment from microtubules",
            "probability": 0.0013222115367635702,
            "start_logit": -0.4129389822483063,
            "end_logit": 3.5871479511260986,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "somatodendritic domain. Consequently, a process of subcellular relocalization",
            "probability": 0.0011983858326081436,
            "start_logit": -1.7273977994918823,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "localization",
            "probability": 0.0011345465507019386,
            "start_logit": -1.7821402549743652,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "cellular relocalization",
            "probability": 0.0007165205730866662,
            "start_logit": -2.2417216300964355,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "aggregates in the somatodendritic domain. Consequently, a process of subcellular relocalization",
            "probability": 0.0006017675305327045,
            "start_logit": -2.416257381439209,
            "end_logit": 4.803276538848877,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "relocalization driven by Tau phosphorylation and detachment from microtubules has been proposed",
            "probability": 0.0005974215903174234,
            "start_logit": 3.971669912338257,
            "end_logit": -1.5918989181518555,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "subcellular relocalization driven by Tau phosphorylation and detachment from microtubules has been proposed",
            "probability": 0.0005475830803559399,
            "start_logit": 3.884561061859131,
            "end_logit": -1.5918989181518555,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        }
    ],
    "58a0da5278275d0c4a000054": [
        {
            "text": "rheumatoid arthritis",
            "probability": 0.16691201590420646,
            "start_logit": 2.7629032135009766,
            "end_logit": 2.842895746231079,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "ankylosing spondylarthritis",
            "probability": 0.16418988117929306,
            "start_logit": 2.8642568588256836,
            "end_logit": 2.7250988483428955,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "rheumatoid arthritis, ankylosing spondylarthritis",
            "probability": 0.14836417968638996,
            "start_logit": 2.7629032135009766,
            "end_logit": 2.7250988483428955,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Crohn's disease, rheumatoid arthritis",
            "probability": 0.10326096032455605,
            "start_logit": 2.282695770263672,
            "end_logit": 2.842895746231079,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Crohn's disease, rheumatoid arthritis, ankylosing spondylarthritis",
            "probability": 0.09178624791743063,
            "start_logit": 2.282695770263672,
            "end_logit": 2.7250988483428955,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "ankylosing spondylarthritis, systemic sclerosis",
            "probability": 0.07879768756918855,
            "start_logit": 2.8642568588256836,
            "end_logit": 1.9909589290618896,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "rheumatoid arthritis, ankylosing spondylarthritis, systemic sclerosis",
            "probability": 0.07120264777231287,
            "start_logit": 2.7629032135009766,
            "end_logit": 1.9909589290618896,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "Crohn's disease",
            "probability": 0.06966124474579403,
            "start_logit": 2.282695770263672,
            "end_logit": 2.4492805004119873,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "systemic sclerosis",
            "probability": 0.059300763776362383,
            "start_logit": 2.5799953937530518,
            "end_logit": 1.9909589290618896,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "cutaneous lupus erythematosus, and chronic graft-versus-host disease",
            "probability": 0.010985652782663634,
            "start_logit": 1.7081385850906372,
            "end_logit": 1.1767836809158325,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "cutaneous lupus erythematosus",
            "probability": 0.008683235339688422,
            "start_logit": 1.7081385850906372,
            "end_logit": 0.9415877461433411,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "chronic graft-versus-host disease",
            "probability": 0.006606640290367055,
            "start_logit": 1.199623703956604,
            "end_logit": 1.1767836809158325,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "ankylosing spondylarthritis, systemic sclerosis, and a few other systemic disorders",
            "probability": 0.0061312567635387885,
            "start_logit": 2.8642568588256836,
            "end_logit": -0.5625249743461609,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "systemic sclerosis, and a few other systemic disorders",
            "probability": 0.004614198972115623,
            "start_logit": 2.5799953937530518,
            "end_logit": -0.5625249743461609,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "hn's disease, rheumatoid arthritis",
            "probability": 0.0021945918738807994,
            "start_logit": -1.5685675144195557,
            "end_logit": 2.842895746231079,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "hn's disease, rheumatoid arthritis, ankylosing spondylarthritis",
            "probability": 0.00195072129080035,
            "start_logit": -1.5685675144195557,
            "end_logit": 2.7250988483428955,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "hn's disease",
            "probability": 0.0014805014514975984,
            "start_logit": -1.5685675144195557,
            "end_logit": 2.4492805004119873,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "skin diseases",
            "probability": 0.0014158968356977279,
            "start_logit": 0.17039036750793457,
            "end_logit": 0.6657049059867859,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "graft-versus-host disease",
            "probability": 0.0013311161764384021,
            "start_logit": -0.40243372321128845,
            "end_logit": 1.1767836809158325,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "lymphocytic skin infiltrations, cutaneous lupus erythematosus, and chronic graft-versus-host disease",
            "probability": 0.0011305593477776395,
            "start_logit": -0.5657390356063843,
            "end_logit": 1.1767836809158325,
            "question_text": "For what indications is thalidomide currently marketed?"
        }
    ],
    "589a246378275d0c4a00002c": [
        {
            "text": "Middle East Respiratory",
            "probability": 0.22709719057804276,
            "start_logit": -1.396461009979248,
            "end_logit": -1.8650283813476562,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory",
            "probability": 0.1712960781663817,
            "start_logit": -1.67844557762146,
            "end_logit": -1.8650283813476562,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome",
            "probability": 0.12887836721676293,
            "start_logit": -1.396461009979248,
            "end_logit": -2.431537389755249,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome",
            "probability": 0.09721106108149609,
            "start_logit": -1.67844557762146,
            "end_logit": -2.431537389755249,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus",
            "probability": 0.08718521277412115,
            "start_logit": -1.396461009979248,
            "end_logit": -2.8223717212677,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus",
            "probability": 0.0657625265389454,
            "start_logit": -1.67844557762146,
            "end_logit": -2.8223717212677,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome (MERS)",
            "probability": 0.03714857374048755,
            "start_logit": -1.396461009979248,
            "end_logit": -3.675481081008911,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome (MERS)",
            "probability": 0.02802062401134524,
            "start_logit": -1.67844557762146,
            "end_logit": -3.675481081008911,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "coronavirus",
            "probability": 0.027066529102695185,
            "start_logit": -2.5661978721618652,
            "end_logit": -2.8223717212677,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle",
            "probability": 0.022141566689856874,
            "start_logit": -1.396461009979248,
            "end_logit": -4.1929497718811035,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome (MERS",
            "probability": 0.016036689825207485,
            "start_logit": -1.396461009979248,
            "end_logit": -4.515527248382568,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome (MERS) is a respiratory",
            "probability": 0.014626268465348901,
            "start_logit": -1.396461009979248,
            "end_logit": -4.6075873374938965,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia.",
            "probability": 0.012334287405108547,
            "start_logit": -1.67844557762146,
            "end_logit": -4.496038913726807,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome (MERS",
            "probability": 0.012096239794233543,
            "start_logit": -1.67844557762146,
            "end_logit": -4.515527248382568,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome (MERS) is a respiratory",
            "probability": 0.011032379660645306,
            "start_logit": -1.67844557762146,
            "end_logit": -4.6075873374938965,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome (MERS) is a respiratory disease",
            "probability": 0.010770488304123646,
            "start_logit": -1.396461009979248,
            "end_logit": -4.9135966300964355,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia",
            "probability": 0.008814226276113842,
            "start_logit": -1.396461009979248,
            "end_logit": -5.114039421081543,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome (MERS) is a respiratory disease",
            "probability": 0.008124021269207393,
            "start_logit": -1.67844557762146,
            "end_logit": -4.9135966300964355,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "respiratory disease caused by a novel coronavirus",
            "probability": 0.007709227569947096,
            "start_logit": -3.822077751159668,
            "end_logit": -2.8223717212677,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Respiratory Syndrome (MERS) is a respiratory disease caused by a novel coronavirus that was identified in 2012 in Saudi Arabia",
            "probability": 0.006648441529929494,
            "start_logit": -1.67844557762146,
            "end_logit": -5.114039421081543,
            "question_text": "List symptoms of EAST syndrome."
        }
    ],
    "58a326da60087bc10a00000e": [
        {
            "text": "antiobesity",
            "probability": 0.6528485129515719,
            "start_logit": 2.193068504333496,
            "end_logit": 1.056847333908081,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs",
            "probability": 0.28273589213876754,
            "start_logit": 2.193068504333496,
            "end_logit": 0.22001543641090393,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often involving cardiotoxicity",
            "probability": 0.0397048818325238,
            "start_logit": 2.193068504333496,
            "end_logit": -1.7430236339569092,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events,",
            "probability": 0.007470379016475713,
            "start_logit": 2.193068504333496,
            "end_logit": -3.4135520458221436,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "anti",
            "probability": 0.003096041220939159,
            "start_logit": 2.193068504333496,
            "end_logit": -4.294373512268066,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often involving cardiotoxicity.",
            "probability": 0.0020918886702932927,
            "start_logit": 2.193068504333496,
            "end_logit": -4.68643045425415,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often involving cardiotoxicity. This",
            "probability": 0.0020420372281044355,
            "start_logit": 2.193068504333496,
            "end_logit": -4.710549831390381,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "many antiobesity",
            "probability": 0.0016567928334444756,
            "start_logit": -3.783392906188965,
            "end_logit": 1.056847333908081,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events",
            "probability": 0.0015585595095440707,
            "start_logit": 2.193068504333496,
            "end_logit": -4.980735778808594,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "drugs",
            "probability": 0.0015402216564753747,
            "start_logit": -3.0195183753967285,
            "end_logit": 0.22001543641090393,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often involving cardiotoxicity. This study",
            "probability": 0.0008258968167894188,
            "start_logit": 2.193068504333496,
            "end_logit": -5.615783214569092,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often",
            "probability": 0.0007432036525856854,
            "start_logit": 2.193068504333496,
            "end_logit": -5.721282958984375,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "many antiobesity drugs",
            "probability": 0.000717524495438023,
            "start_logit": -3.783392906188965,
            "end_logit": 0.22001543641090393,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "antiobesity drugs have been withdrawn from the market due to unanticipated adverse events, often involving card",
            "probability": 0.000672839701424286,
            "start_logit": 2.193068504333496,
            "end_logit": -5.820745944976807,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sity",
            "probability": 0.0006287741683656632,
            "start_logit": -4.752259731292725,
            "end_logit": 1.056847333908081,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "cardiotoxicity",
            "probability": 0.000493761415861371,
            "start_logit": -2.194108486175537,
            "end_logit": -1.7430236339569092,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "Over the past several decades, many antiobesity",
            "probability": 0.00043316394876402847,
            "start_logit": -5.124915599822998,
            "end_logit": 1.056847333908081,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sity drugs",
            "probability": 0.00027230976546601223,
            "start_logit": -4.752259731292725,
            "end_logit": 0.22001543641090393,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "obesity",
            "probability": 0.0002499812687347318,
            "start_logit": -5.674645900726318,
            "end_logit": 1.056847333908081,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": ", many antiobesity",
            "probability": 0.0002173377084310304,
            "start_logit": -5.814579486846924,
            "end_logit": 1.056847333908081,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        }
    ],
    "589aec4778275d0c4a000037": [
        {
            "text": "Neisseria meningitidis",
            "probability": 0.3058438433877243,
            "start_logit": 2.553452491760254,
            "end_logit": 1.7740404605865479,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Streptococcus pneumoniae",
            "probability": 0.2550626021392135,
            "start_logit": 1.915167212486267,
            "end_logit": 2.230760097503662,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Streptococcus pneumoniae, and Neisseria meningitidis",
            "probability": 0.16154591032080443,
            "start_logit": 1.915167212486267,
            "end_logit": 1.7740404605865479,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Haemophilus influenzae type b, Streptococcus pneumoniae",
            "probability": 0.09740030957740645,
            "start_logit": 0.952487587928772,
            "end_logit": 2.230760097503662,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis",
            "probability": 0.06168925410563448,
            "start_logit": 0.952487587928772,
            "end_logit": 1.7740404605865479,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Haemophilus influenzae type b",
            "probability": 0.03707757778060712,
            "start_logit": 0.952487587928772,
            "end_logit": 1.2649431228637695,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Neisseria meningitidis has led to a substantial reduction in cases of acute bacterial meningitis",
            "probability": 0.015362998859707024,
            "start_logit": 2.553452491760254,
            "end_logit": -1.2170722484588623,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Neisseria meningitidis has led to a substantial reduction in cases of acute bacterial",
            "probability": 0.011222728752065599,
            "start_logit": 2.553452491760254,
            "end_logit": -1.5310931205749512,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Neisseria",
            "probability": 0.01088054900602008,
            "start_logit": 2.553452491760254,
            "end_logit": -1.5620574951171875,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Streptococcus pneumoniae, and Neisseria meningitidis has led to a substantial reduction in cases of acute bacterial",
            "probability": 0.005927815686770404,
            "start_logit": 1.915167212486267,
            "end_logit": -1.5310931205749512,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Streptococcus pneumoniae, and Neisseria",
            "probability": 0.005747077248631604,
            "start_logit": 1.915167212486267,
            "end_logit": -1.5620574951171875,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "aseptic meningitis",
            "probability": 0.00525388015247319,
            "start_logit": 0.7708523273468018,
            "end_logit": -0.5074671506881714,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral or aseptic meningitis",
            "probability": 0.005094593246129766,
            "start_logit": 0.7400652766227722,
            "end_logit": -0.5074671506881714,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Haemophilus influenzae",
            "probability": 0.004915903269536943,
            "start_logit": 0.952487587928772,
            "end_logit": -0.7555937767028809,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "aseptic",
            "probability": 0.0035913023310639356,
            "start_logit": 0.7708523273468018,
            "end_logit": -0.8879191279411316,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral or aseptic",
            "probability": 0.0034824213856564134,
            "start_logit": 0.7400652766227722,
            "end_logit": -0.8879191279411316,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral",
            "probability": 0.0032188643826560723,
            "start_logit": 0.7400652766227722,
            "end_logit": -0.9666183590888977,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "type b, Streptococcus pneumoniae",
            "probability": 0.0022458228935271275,
            "start_logit": -2.817269802093506,
            "end_logit": 2.230760097503662,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "meningitidis",
            "probability": 0.002241919141513673,
            "start_logit": -2.3622899055480957,
            "end_logit": 1.7740404605865479,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria",
            "probability": 0.0021946263328579464,
            "start_logit": 0.952487587928772,
            "end_logit": -1.5620574951171875,
            "question_text": "Which are the types of viral meningitis?"
        }
    ],
    "58a0c09778275d0c4a000052": [
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4) inhibitors",
            "probability": 0.5176622295461681,
            "start_logit": 1.6347976922988892,
            "end_logit": 3.3727385997772217,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "DPP-4) inhibitors",
            "probability": 0.1256624403072948,
            "start_logit": 0.21907399594783783,
            "end_logit": 3.3727385997772217,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "(DPP-4) inhibitors",
            "probability": 0.09678379066821147,
            "start_logit": -0.04204574227333069,
            "end_logit": 3.3727385997772217,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "inhibitors",
            "probability": 0.06954859489837932,
            "start_logit": -0.37249955534935,
            "end_logit": 3.3727385997772217,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "linagliptin",
            "probability": 0.06269720205678862,
            "start_logit": 1.5747718811035156,
            "end_logit": 1.3217582702636719,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4)",
            "probability": 0.038349309209688855,
            "start_logit": 1.6347976922988892,
            "end_logit": 0.7701521515846252,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "linagliptin, for which renal excretion is a minor elimination pathway. Thus, linagliptin",
            "probability": 0.029870089588509403,
            "start_logit": 1.5747718811035156,
            "end_logit": 0.5802990794181824,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "DPP-4)",
            "probability": 0.009309289927552504,
            "start_logit": 0.21907399594783783,
            "end_logit": 0.7701521515846252,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4 (DPP-4) inhibitor",
            "probability": 0.008567848949898278,
            "start_logit": 1.6347976922988892,
            "end_logit": -0.7285676598548889,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "(DPP-4)",
            "probability": 0.007169909842707616,
            "start_logit": -0.04204574227333069,
            "end_logit": 0.7701521515846252,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "type 2 diabetes",
            "probability": 0.006283597158714207,
            "start_logit": 0.3727429211139679,
            "end_logit": 0.22341302037239075,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "DPP-4) inhibitors represent a highly promising novel class of oral agents used in the treatment of type 2 diabetes",
            "probability": 0.00538853574876302,
            "start_logit": 0.21907399594783783,
            "end_logit": 0.22341302037239075,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "(DPP-4) inhibitors represent a highly promising novel class of oral agents used in the treatment of type 2 diabetes",
            "probability": 0.004150189305898586,
            "start_logit": -0.04204574227333069,
            "end_logit": 0.22341302037239075,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "Dipeptidyl peptidase-4",
            "probability": 0.004118187312555826,
            "start_logit": 1.6347976922988892,
            "end_logit": -1.461171269416809,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "type 2 diabetes mellitus",
            "probability": 0.003016181268129726,
            "start_logit": 0.3727429211139679,
            "end_logit": -0.5105380415916443,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "inhibitors represent a highly promising novel class of oral agents used in the treatment of type 2 diabetes",
            "probability": 0.0029823158691626886,
            "start_logit": -0.37249955534935,
            "end_logit": 0.22341302037239075,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "DPP-4) inhibitors represent a highly promising novel class of oral agents used in the treatment of type 2 diabetes mellitus",
            "probability": 0.0025865440093540575,
            "start_logit": 0.21907399594783783,
            "end_logit": -0.5105380415916443,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "DPP-4) inhibitor",
            "probability": 0.0020798442416252974,
            "start_logit": 0.21907399594783783,
            "end_logit": -0.7285676598548889,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "(DPP-4) inhibitors represent a highly promising novel class of oral agents used in the treatment of type 2 diabetes mellitus",
            "probability": 0.001992126950131394,
            "start_logit": -0.04204574227333069,
            "end_logit": -0.5105380415916443,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "diabetic nephropathy. Dipeptidyl peptidase-4 (DPP-4) inhibitors",
            "probability": 0.0017817731404659012,
            "start_logit": -4.036916255950928,
            "end_logit": 3.3727385997772217,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        }
    ],
    "5884fe4ce56acf5176000010": [
        {
            "text": "breast cancer",
            "probability": 0.4469008987641596,
            "start_logit": 3.1394338607788086,
            "end_logit": 3.1764960289001465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer. However, the biological function and regulatory mechanism of SPAG5 in breast cancer",
            "probability": 0.2706953702541389,
            "start_logit": 3.1394338607788086,
            "end_logit": 2.6751532554626465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer remain unclear. In this study, we aimed to investigate the potential biological function of SPAG5 in breast cancer",
            "probability": 0.0864719440964147,
            "start_logit": 2.5313377380371094,
            "end_logit": 2.142075300216675,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cells. Herein, we found that both the mRNA and protein expression of SPAG5 were significantly up-regulated in breast cancer",
            "probability": 0.07692578545970812,
            "start_logit": 2.2662508487701416,
            "end_logit": 2.2901833057403564,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cell lines. Functional experiments showed that silencing of SPAG5 inhibited the proliferation and invasion of breast cancer",
            "probability": 0.04664566810671117,
            "start_logit": 2.355497360229492,
            "end_logit": 1.7006757259368896,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer. Taken together, these findings demonstrate that SPAG5 promotes the proliferation and invasion of breast cancer",
            "probability": 0.026642305100849716,
            "start_logit": 1.6029702425003052,
            "end_logit": 1.8931231498718262,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cells, while the overexpression of SPAG5 promoted the proliferation and invasion of breast cancer",
            "probability": 0.022599947017806,
            "start_logit": 1.5125092267990112,
            "end_logit": 1.8190313577651978,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast",
            "probability": 0.006184173297884566,
            "start_logit": 3.1394338607788086,
            "end_logit": -1.1038475036621094,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer.",
            "probability": 0.0044898079954944475,
            "start_logit": 3.1394338607788086,
            "end_logit": -1.4240309000015259,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer. However, the biological function and regulatory mechanism of SPAG5 in breast",
            "probability": 0.0027632406386996836,
            "start_logit": 3.1394338607788086,
            "end_logit": -1.9094367027282715,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "various cancers. High expression of SPAG5 has been frequently detected in breast cancer",
            "probability": 0.0016566309602801396,
            "start_logit": -2.4581170082092285,
            "end_logit": 3.1764960289001465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer remain unclear. In this study, we aimed to investigate the potential biological function of SPAG5 in breast",
            "probability": 0.0013085238406898528,
            "start_logit": 2.5313377380371094,
            "end_logit": -2.048845052719116,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cells. Herein, we found that both the mRNA and protein expression of SPAG5 were significantly up-regulated in breast",
            "probability": 0.0011733973644038743,
            "start_logit": 2.2662508487701416,
            "end_logit": -1.8927545547485352,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "novel oncogene in various cancers. High expression of SPAG5 has been frequently detected in breast cancer",
            "probability": 0.0010101002314898534,
            "start_logit": -2.9528534412384033,
            "end_logit": 3.1764960289001465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "a novel oncogene in various cancers. High expression of SPAG5 has been frequently detected in breast cancer",
            "probability": 0.001009652633924758,
            "start_logit": -2.953296661376953,
            "end_logit": 3.1764960289001465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancers. High expression of SPAG5 has been frequently detected in breast cancer",
            "probability": 0.0009488993160932596,
            "start_logit": -3.0153555870056152,
            "end_logit": 3.1764960289001465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "breast cancer cell lines. Functional experiments showed that silencing of SPAG5 inhibited the proliferation and invasion of breast",
            "probability": 0.0008673778403538405,
            "start_logit": 2.355497360229492,
            "end_logit": -2.2841849327087402,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.0007573313879953392,
            "start_logit": -3.2408573627471924,
            "end_logit": 3.1764960289001465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "as a novel oncogene in various cancers. High expression of SPAG5 has been frequently detected in breast cancer",
            "probability": 0.0004902173684673928,
            "start_logit": -3.675809383392334,
            "end_logit": 3.1764960289001465,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer. However, the biological function and regulatory mechanism of SPAG5 in breast cancer",
            "probability": 0.000458728324434778,
            "start_logit": -3.2408573627471924,
            "end_logit": 2.6751532554626465,
            "question_text": "SPAG5 was implicated in which cancers?"
        }
    ],
    "58a3275960087bc10a00000f": [
        {
            "text": "reproductive effects",
            "probability": 0.6445708255066899,
            "start_logit": 5.0149245262146,
            "end_logit": 3.7701263427734375,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive",
            "probability": 0.18188685334680263,
            "start_logit": 5.0149245262146,
            "end_logit": 2.5049264430999756,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health outcomes, including reproductive effects",
            "probability": 0.059278177071525,
            "start_logit": 2.6285810470581055,
            "end_logit": 3.7701263427734375,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "potentially serious health outcomes, including reproductive effects",
            "probability": 0.022271461530083695,
            "start_logit": 1.6496459245681763,
            "end_logit": 3.7701263427734375,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "health outcomes, including reproductive effects",
            "probability": 0.02136021173227659,
            "start_logit": 1.6078697443008423,
            "end_logit": 3.7701263427734375,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health outcomes",
            "probability": 0.019026815975048603,
            "start_logit": 2.6285810470581055,
            "end_logit": 2.6337344646453857,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health outcomes, including reproductive",
            "probability": 0.016727286859746903,
            "start_logit": 2.6285810470581055,
            "end_logit": 2.5049264430999756,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "potentially serious health outcomes",
            "probability": 0.007148583525383624,
            "start_logit": 1.6496459245681763,
            "end_logit": 2.6337344646453857,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "health outcomes",
            "probability": 0.006856095074039113,
            "start_logit": 1.6078697443008423,
            "end_logit": 2.6337344646453857,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "potentially serious health outcomes, including reproductive",
            "probability": 0.006284625206170221,
            "start_logit": 1.6496459245681763,
            "end_logit": 2.5049264430999756,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "health outcomes, including reproductive",
            "probability": 0.006027486111787917,
            "start_logit": 1.6078697443008423,
            "end_logit": 2.5049264430999756,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects, sometimes associated with Zika",
            "probability": 0.005524312636558422,
            "start_logit": 5.0149245262146,
            "end_logit": -0.9892995357513428,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health",
            "probability": 0.000639126115500841,
            "start_logit": 2.6285810470581055,
            "end_logit": -0.7597683668136597,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "serious health outcomes, including reproductive effects, sometimes associated with Zika",
            "probability": 0.0005080453065975363,
            "start_logit": 2.6285810470581055,
            "end_logit": -0.9892995357513428,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects, sometimes associated with Zika,",
            "probability": 0.0004457047141983442,
            "start_logit": 5.0149245262146,
            "end_logit": -3.506556987762451,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects,",
            "probability": 0.0003328383178428317,
            "start_logit": 5.0149245262146,
            "end_logit": -3.7985568046569824,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "effects",
            "probability": 0.0003280701669855967,
            "start_logit": -2.568187952041626,
            "end_logit": 3.7701263427734375,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "reproductive effects, sometimes associated",
            "probability": 0.00028754041904831127,
            "start_logit": 5.0149245262146,
            "end_logit": -3.944850206375122,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "outcomes, including reproductive effects",
            "probability": 0.0002558136895839907,
            "start_logit": -2.8169660568237305,
            "end_logit": 3.7701263427734375,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "potentially serious health",
            "probability": 0.00024012669413018127,
            "start_logit": 1.6496459245681763,
            "end_logit": -0.7597683668136597,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        }
    ],
    "58a94483ee23e0236b000003": [
        {
            "text": "type V",
            "probability": 0.6739810370729024,
            "start_logit": 1.2713476419448853,
            "end_logit": 2.11201548576355,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V FimA showed a difference from other types of FimA. In addition, type V",
            "probability": 0.3025312391949673,
            "start_logit": 0.47033020853996277,
            "end_logit": 2.11201548576355,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "V",
            "probability": 0.015079847659090777,
            "start_logit": -2.5284950733184814,
            "end_logit": 2.11201548576355,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "V FimA showed a difference from other types of FimA. In addition, type V",
            "probability": 0.00421911204823309,
            "start_logit": -3.802229642868042,
            "end_logit": 2.11201548576355,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V P. gingivalis",
            "probability": 0.00218888902789075,
            "start_logit": 1.2713476419448853,
            "end_logit": -3.6177923679351807,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V FimA showed a difference from other types of FimA. In addition, type V P. gingivalis",
            "probability": 0.0009825310708206573,
            "start_logit": 0.47033020853996277,
            "end_logit": -3.6177923679351807,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin",
            "probability": 0.0002632557846006233,
            "start_logit": -1.6518900394439697,
            "end_logit": -2.812577962875366,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V) of fimA from dental plaque samples. P. gingivalis with type V",
            "probability": 0.000211067105218656,
            "start_logit": -1.1364518404006958,
            "end_logit": -3.5489661693573,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "disease-associated genotypes of P. gingivalis involved in the development of adult periodontitis",
            "probability": 0.00011509996583478631,
            "start_logit": -3.434255599975586,
            "end_logit": -1.8575375080108643,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin (FimA), was classified into four typeable variants",
            "probability": 7.421341240542875e-05,
            "start_logit": -1.6518900394439697,
            "end_logit": -4.07875919342041,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "periodontitis",
            "probability": 5.7408501552092274e-05,
            "start_logit": -4.12986421585083,
            "end_logit": -1.8575375080108643,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "determining the disease-associated genotypes of P. gingivalis involved in the development of adult periodontitis",
            "probability": 5.407524590912265e-05,
            "start_logit": -4.189680099487305,
            "end_logit": -1.8575375080108643,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "V P. gingivalis",
            "probability": 4.897483945038268e-05,
            "start_logit": -2.5284950733184814,
            "end_logit": -3.6177923679351807,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin (FimA),",
            "probability": 4.6278114486892046e-05,
            "start_logit": -1.6518900394439697,
            "end_logit": -4.551034927368164,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "type V)",
            "probability": 4.545568148340722e-05,
            "start_logit": -1.1364518404006958,
            "end_logit": -5.084404468536377,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin (FimA)",
            "probability": 3.071632413311268e-05,
            "start_logit": -1.6518900394439697,
            "end_logit": -4.960909843444824,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "disease-associated genotypes",
            "probability": 2.689455388436187e-05,
            "start_logit": -3.434255599975586,
            "end_logit": -3.3114147186279297,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "disease",
            "probability": 1.531464260286923e-05,
            "start_logit": -3.434255599975586,
            "end_logit": -3.8745291233062744,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimbrillin (FimA), was classified into four",
            "probability": 1.4633799986769522e-05,
            "start_logit": -1.6518900394439697,
            "end_logit": -5.7023701667785645,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "disease-associated genotypes of P. gingivalis",
            "probability": 1.3955954546360655e-05,
            "start_logit": -3.434255599975586,
            "end_logit": -3.9674322605133057,
            "question_text": "Which fimA genotypes are associated with disease?"
        }
    ],
    "58bc666702b8c60953000004": [
        {
            "text": "degradation",
            "probability": 0.16132416120260318,
            "start_logit": -3.602090835571289,
            "end_logit": -3.5860979557037354,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation and disaggregation, as well as degradation",
            "probability": 0.1015389680577559,
            "start_logit": -4.065063953399658,
            "end_logit": -3.5860979557037354,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation and disaggregation",
            "probability": 0.0744583958789502,
            "start_logit": -4.065063953399658,
            "end_logit": -3.8963000774383545,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Hsp100 AAA+ disaggregases,",
            "probability": 0.07141421990842313,
            "start_logit": -3.8604536056518555,
            "end_logit": -4.142653942108154,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Hsp100",
            "probability": 0.07128374616417678,
            "start_logit": -3.8604536056518555,
            "end_logit": -4.144482612609863,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting, aggregation and disaggregation, as well as degradation",
            "probability": 0.06432855534979555,
            "start_logit": -4.52150297164917,
            "end_logit": -3.5860979557037354,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation",
            "probability": 0.05811277834552998,
            "start_logit": -4.065063953399658,
            "end_logit": -4.144155025482178,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "disease",
            "probability": 0.04996966250922735,
            "start_logit": -4.079946041107178,
            "end_logit": -4.280242443084717,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting, aggregation and disaggregation",
            "probability": 0.04717204765988534,
            "start_logit": -4.52150297164917,
            "end_logit": -3.8963000774383545,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "disaggregation, as well as degradation",
            "probability": 0.03937945586597669,
            "start_logit": -5.012262344360352,
            "end_logit": -3.5860979557037354,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting, aggregation",
            "probability": 0.03681651635660168,
            "start_logit": -4.52150297164917,
            "end_logit": -4.144155025482178,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "protein folding, unfolding, regulation, targeting, aggregation and disaggregation, as well as degradation",
            "probability": 0.03454440659807813,
            "start_logit": -5.143260955810547,
            "end_logit": -3.5860979557037354,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "disaggregation",
            "probability": 0.028876904802683522,
            "start_logit": -5.012262344360352,
            "end_logit": -3.8963000774383545,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "protein folding, unfolding, regulation, targeting, aggregation and disaggregation",
            "probability": 0.0253313693361556,
            "start_logit": -5.143260955810547,
            "end_logit": -3.8963000774383545,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "a dynamic and functionally versatile network for protein folding, unfolding, regulation, targeting, aggregation and disaggregation",
            "probability": 0.024458466667737384,
            "start_logit": -5.178328037261963,
            "end_logit": -3.8963000774383545,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "aggregation and disaggregation,",
            "probability": 0.024417186407687166,
            "start_logit": -4.065063953399658,
            "end_logit": -5.011253356933594,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "degradation.",
            "probability": 0.02377836308251346,
            "start_logit": -3.602090835571289,
            "end_logit": -5.50073766708374,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "targeting",
            "probability": 0.022855644068704085,
            "start_logit": -4.52150297164917,
            "end_logit": -4.620903491973877,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Hsp100 AAA+ disaggregases, together constituting a dynamic and functionally versatile network for protein folding, unfolding",
            "probability": 0.020168698264222604,
            "start_logit": -3.8604536056518555,
            "end_logit": -5.407019138336182,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "protein folding, unfolding, regulation, targeting, aggregation",
            "probability": 0.019770453473292315,
            "start_logit": -5.143260955810547,
            "end_logit": -4.144155025482178,
            "question_text": "List diseases that could be targeted by disaggregases?"
        }
    ],
    "58bbb71f22d3005309000016": [
        {
            "text": "RNA CoSSMos",
            "probability": 0.7358451378542491,
            "start_logit": 2.544856071472168,
            "end_logit": 2.5486321449279785,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.056990072682966075,
            "start_logit": -0.013286525383591652,
            "end_logit": 2.5486321449279785,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA CoSSMos,",
            "probability": 0.05400050210738098,
            "start_logit": 2.544856071472168,
            "end_logit": -0.06339419633150101,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Characterization of Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.030824897937468777,
            "start_logit": -0.6278408765792847,
            "end_logit": 2.5486321449279785,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "CoSSMos",
            "probability": 0.030750120358546903,
            "start_logit": -0.6302697062492371,
            "end_logit": 2.5486321449279785,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "The RNA Characterization of Secondary Structure Motifs, RNA CoSSMos",
            "probability": 0.03011683140371896,
            "start_logit": -0.6510794162750244,
            "end_logit": 2.5486321449279785,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA CoSSMos, database",
            "probability": 0.027153214534144945,
            "start_logit": 2.544856071472168,
            "end_logit": -0.7508921027183533,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs",
            "probability": 0.005351510270622368,
            "start_logit": -0.013286525383591652,
            "end_logit": 0.18313387036323547,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs, RNA CoSSMos,",
            "probability": 0.004182255724336759,
            "start_logit": -0.013286525383591652,
            "end_logit": -0.06339419633150101,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs,",
            "probability": 0.003134786654653794,
            "start_logit": -0.013286525383591652,
            "end_logit": -0.3516838252544403,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Characterization of Secondary Structure Motifs",
            "probability": 0.002894534962622634,
            "start_logit": -0.6278408765792847,
            "end_logit": 0.18313387036323547,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "The RNA Characterization of Secondary Structure Motifs",
            "probability": 0.0028280457453035853,
            "start_logit": -0.6510794162750244,
            "end_logit": 0.18313387036323547,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Characterization of Secondary Structure Motifs, RNA CoSSMos,",
            "probability": 0.00226210635961529,
            "start_logit": -0.6278408765792847,
            "end_logit": -0.06339419633150101,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "CoSSMos,",
            "probability": 0.002256618755498029,
            "start_logit": -0.6302697062492371,
            "end_logit": -0.06339419633150101,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "The RNA Characterization of Secondary Structure Motifs, RNA CoSSMos,",
            "probability": 0.002210144409497062,
            "start_logit": -0.6510794162750244,
            "end_logit": -0.06339419633150101,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA CoSSMos, database is a freely accessible online database",
            "probability": 0.002124467683609481,
            "start_logit": 2.544856071472168,
            "end_logit": -3.2988662719726562,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "Characterization of Secondary Structure Motifs, RNA CoSSMos, database",
            "probability": 0.0021029746481570173,
            "start_logit": -0.013286525383591652,
            "end_logit": -0.7508921027183533,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Characterization of Secondary Structure Motifs,",
            "probability": 0.0016955493147550284,
            "start_logit": -0.6278408765792847,
            "end_logit": -0.3516838252544403,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "The RNA Characterization of Secondary Structure Motifs,",
            "probability": 0.0016566015223394325,
            "start_logit": -0.6510794162750244,
            "end_logit": -0.3516838252544403,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA CoSSMos, database is a freely accessible online database that allows users to identify secondary structure motifs among RNA 3D structures",
            "probability": 0.001619627070513964,
            "start_logit": 2.544856071472168,
            "end_logit": -3.5701916217803955,
            "question_text": "List RNA modifications databases"
        }
    ],
    "58bc9a5002b8c60953000008": [
        {
            "text": "elevated liver enzymes",
            "probability": 0.3614413921799906,
            "start_logit": 6.049881935119629,
            "end_logit": 6.177445888519287,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver enzymes",
            "probability": 0.1830914281058801,
            "start_logit": 5.369767665863037,
            "end_logit": 6.177445888519287,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes and low platelet",
            "probability": 0.153942774871341,
            "start_logit": 6.049881935119629,
            "end_logit": 5.32392692565918,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "low platelet",
            "probability": 0.12715755885990407,
            "start_logit": 5.858727931976318,
            "end_logit": 5.32392692565918,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver enzymes and low platelet",
            "probability": 0.07798111424864129,
            "start_logit": 5.369767665863037,
            "end_logit": 5.32392692565918,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis",
            "probability": 0.04613845750504549,
            "start_logit": 5.369767665863037,
            "end_logit": 4.799107074737549,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes",
            "probability": 0.032505969747653615,
            "start_logit": 3.6412057876586914,
            "end_logit": 6.177445888519287,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes and low platelet",
            "probability": 0.013844731929169142,
            "start_logit": 3.6412057876586914,
            "end_logit": 5.32392692565918,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "platelet",
            "probability": 0.002675823658342516,
            "start_logit": 1.9975582361221313,
            "end_logit": 5.32392692565918,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated",
            "probability": 0.00019758758836097367,
            "start_logit": 6.049881935119629,
            "end_logit": -1.3342273235321045,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver",
            "probability": 0.00016542172813152465,
            "start_logit": 6.049881935119629,
            "end_logit": -1.511911153793335,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes and low",
            "probability": 0.0001159613932967092,
            "start_logit": 6.049881935119629,
            "end_logit": -1.8671519756317139,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes and low plate",
            "probability": 0.00011137618860791019,
            "start_logit": 6.049881935119629,
            "end_logit": -1.9074957370758057,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "Innate and adaptive immune involvement in hemolysis, elevated liver enzymes",
            "probability": 0.00010031560183397722,
            "start_logit": -2.1396520137786865,
            "end_logit": 6.177445888519287,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated",
            "probability": 0.00010008979190460904,
            "start_logit": 5.369767665863037,
            "end_logit": -1.3342273235321045,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "enzymes",
            "probability": 9.967735609637141e-05,
            "start_logit": -2.1460347175598145,
            "end_logit": 6.177445888519287,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "low",
            "probability": 9.578473368384036e-05,
            "start_logit": 5.858727931976318,
            "end_logit": -1.8671519756317139,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "low plate",
            "probability": 9.199732998406974e-05,
            "start_logit": 5.858727931976318,
            "end_logit": -1.9074957370758057,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver",
            "probability": 8.379588253760659e-05,
            "start_logit": 5.369767665863037,
            "end_logit": -1.511911153793335,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "hemolysis, elevated liver enzymes and low",
            "probability": 5.8741299594345404e-05,
            "start_logit": 5.369767665863037,
            "end_logit": -1.8671519756317139,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        }
    ],
    "58bbbe6822d300530900001a": [
        {
            "text": "\u03b3-aminobutyrate",
            "probability": 0.09692256009697801,
            "start_logit": -4.975735664367676,
            "end_logit": -5.68609094619751,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate, taurine",
            "probability": 0.07386788858392342,
            "start_logit": -4.975735664367676,
            "end_logit": -5.9577250480651855,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine",
            "probability": 0.07224367082330274,
            "start_logit": -4.997969150543213,
            "end_logit": -5.9577250480651855,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine",
            "probability": 0.07184202002883387,
            "start_logit": -4.932243347167969,
            "end_logit": -6.029026031494141,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate, taurine, and valine",
            "probability": 0.06878441718217128,
            "start_logit": -4.975735664367676,
            "end_logit": -6.029026031494141,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine, and valine",
            "probability": 0.06727197552202696,
            "start_logit": -4.997969150543213,
            "end_logit": -6.029026031494141,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine,",
            "probability": 0.061616218059605245,
            "start_logit": -4.932243347167969,
            "end_logit": -6.182570457458496,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "valine, were significantly less abundant in the feces of mice transplanted with microbiota from the affected patient.",
            "probability": 0.05947571735865451,
            "start_logit": -4.932243347167969,
            "end_logit": -6.2179274559021,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "\u03b3-aminobutyrate, taurine, and valine,",
            "probability": 0.05899382626627847,
            "start_logit": -4.975735664367676,
            "end_logit": -6.182570457458496,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "taurine, and valine,",
            "probability": 0.05769666152764109,
            "start_logit": -4.997969150543213,
            "end_logit": -6.182570457458496,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "C57BL/6N mice with fecal samples from a healthy volunteer and from an affected patient.",
            "probability": 0.046986232615678435,
            "start_logit": -5.965626239776611,
            "end_logit": -5.420258045196533,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "mice with fecal samples from a healthy volunteer and from an affected patient.",
            "probability": 0.04304960734172468,
            "start_logit": -6.053127765655518,
            "end_logit": -5.420258045196533,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "transplanting germ-free C57BL/6N mice",
            "probability": 0.03383542678396435,
            "start_logit": -5.940337657928467,
            "end_logit": -5.773892879486084,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "C57BL/6N mice",
            "probability": 0.03299050528527465,
            "start_logit": -5.965626239776611,
            "end_logit": -5.773892879486084,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "mice",
            "probability": 0.03022647740568718,
            "start_logit": -6.053127765655518,
            "end_logit": -5.773892879486084,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "samples from a healthy volunteer and from an affected patient.",
            "probability": 0.0269852815671883,
            "start_logit": -6.52018928527832,
            "end_logit": -5.420258045196533,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "metabolites related to the nervous system, including \u03b3-aminobutyrate",
            "probability": 0.02598989379472062,
            "start_logit": -6.291940212249756,
            "end_logit": -5.68609094619751,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "model mice of the human gut microbiota by transplanting germ-free C57BL/6N mice",
            "probability": 0.025569565394602842,
            "start_logit": -6.220443248748779,
            "end_logit": -5.773892879486084,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "created model mice of the human gut microbiota by transplanting germ-free C57BL/6N mice",
            "probability": 0.024295521865439512,
            "start_logit": -6.271553993225098,
            "end_logit": -5.773892879486084,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "we have created model mice of the human gut microbiota by transplanting germ-free C57BL/6N mice",
            "probability": 0.02135653249630402,
            "start_logit": -6.400488376617432,
            "end_logit": -5.773892879486084,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        }
    ],
    "58b53bf722d3005309000004": [
        {
            "text": "fissured tongue",
            "probability": 0.193472998792647,
            "start_logit": 4.555232524871826,
            "end_logit": 4.852379322052002,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy",
            "probability": 0.13243064793120585,
            "start_logit": 3.952968120574951,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial edema with peripheral facial palsy",
            "probability": 0.1243175960060623,
            "start_logit": 3.8897485733032227,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial palsy and fissured tongue",
            "probability": 0.10594007004718473,
            "start_logit": 3.952968120574951,
            "end_logit": 4.852379322052002,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "peripheral facial palsy",
            "probability": 0.10577982780261,
            "start_logit": 3.72826886177063,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial edema with peripheral facial palsy and fissured tongue",
            "probability": 0.0994499010215628,
            "start_logit": 3.8897485733032227,
            "end_logit": 4.852379322052002,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "peripheral facial palsy and fissured tongue",
            "probability": 0.08462030913576006,
            "start_logit": 3.72826886177063,
            "end_logit": 4.852379322052002,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial edema",
            "probability": 0.07098578136013696,
            "start_logit": 3.8897485733032227,
            "end_logit": 4.515204906463623,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "edema with peripheral facial palsy",
            "probability": 0.02715426130536786,
            "start_logit": 2.368443012237549,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "edema with peripheral facial palsy and fissured tongue",
            "probability": 0.021722496942434423,
            "start_logit": 2.368443012237549,
            "end_logit": 4.852379322052002,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "edema",
            "probability": 0.01550517801136432,
            "start_logit": 2.368443012237549,
            "end_logit": 4.515204906463623,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "tongue",
            "probability": 0.009539441316053452,
            "start_logit": 1.5455294847488403,
            "end_logit": 4.852379322052002,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "palsy",
            "probability": 0.002489853070512926,
            "start_logit": -0.020867275074124336,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "palsy and fissured tongue",
            "probability": 0.001991798823142219,
            "start_logit": -0.020867275074124336,
            "end_logit": 4.852379322052002,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial",
            "probability": 0.0010017144071645966,
            "start_logit": 3.952968120574951,
            "end_logit": 0.19121870398521423,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial edema with peripheral facial",
            "probability": 0.0009403467318836262,
            "start_logit": 3.8897485733032227,
            "end_logit": 0.19121870398521423,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "peripheral facial",
            "probability": 0.0008001257952940664,
            "start_logit": 3.72826886177063,
            "end_logit": 0.19121870398521423,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "alternating facial edema with peripheral facial palsy",
            "probability": 0.0006575609014907366,
            "start_logit": -1.3523088693618774,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent and alternating facial edema with peripheral facial palsy",
            "probability": 0.0006321558574251975,
            "start_logit": -1.3917102813720703,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "a recurrent and alternating facial edema with peripheral facial palsy",
            "probability": 0.0005679347406967537,
            "start_logit": -1.4988397359848022,
            "end_logit": 5.075564861297607,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        }
    ],
    "58a8071760087bc10a000037": [
        {
            "text": "electron capture dissociation",
            "probability": 0.17276991648176543,
            "start_logit": 5.337634563446045,
            "end_logit": 5.156627178192139,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD) and electron capture dissociation",
            "probability": 0.17225833479330488,
            "start_logit": 5.33466911315918,
            "end_logit": 5.156627178192139,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation",
            "probability": 0.12087180973306758,
            "start_logit": 5.33466911315918,
            "end_logit": 4.802362442016602,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron capture dissociation (ECD)",
            "probability": 0.08037248706815377,
            "start_logit": 5.337634563446045,
            "end_logit": 4.391338348388672,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron capture dissociation (ECD",
            "probability": 0.08023035202427857,
            "start_logit": 5.337634563446045,
            "end_logit": 4.389568328857422,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD) and electron capture dissociation (ECD)",
            "probability": 0.08013449949787882,
            "start_logit": 5.33466911315918,
            "end_logit": 4.391338348388672,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD) and electron capture dissociation (ECD",
            "probability": 0.07999278532406723,
            "start_logit": 5.33466911315918,
            "end_logit": 4.389568328857422,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron capture dissociation (ECD) have become well-established fragmentation methods complementary to collision-induced dissociation",
            "probability": 0.06265402815712406,
            "start_logit": 5.337634563446045,
            "end_logit": 4.142294406890869,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD)",
            "probability": 0.026663695456110786,
            "start_logit": 5.33466911315918,
            "end_logit": 3.2909348011016846,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "collision-induced dissociation",
            "probability": 0.025361007199856407,
            "start_logit": 4.4332194328308105,
            "end_logit": 4.142294406890869,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ECD)",
            "probability": 0.016531532457485763,
            "start_logit": 3.756232261657715,
            "end_logit": 4.391338348388672,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ECD",
            "probability": 0.016502297203272762,
            "start_logit": 3.756232261657715,
            "end_logit": 4.389568328857422,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation",
            "probability": 0.01495097361574263,
            "start_logit": 2.8904502391815186,
            "end_logit": 5.156627178192139,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "electron transfer dissociation (ETD",
            "probability": 0.014751065383082384,
            "start_logit": 5.33466911315918,
            "end_logit": 2.6989471912384033,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ECD) have become well-established fragmentation methods complementary to collision-induced dissociation",
            "probability": 0.012887085342941052,
            "start_logit": 3.756232261657715,
            "end_logit": 4.142294406890869,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation (ECD)",
            "probability": 0.0069551861693144205,
            "start_logit": 2.8904502391815186,
            "end_logit": 4.391338348388672,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation (ECD",
            "probability": 0.006942886242717684,
            "start_logit": 2.8904502391815186,
            "end_logit": 4.389568328857422,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD) and electron capture dissociation (ECD) have become well-established fragmentation methods complementary to collision-induced dissociation",
            "probability": 0.005421885597751178,
            "start_logit": 2.8904502391815186,
            "end_logit": 4.142294406890869,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "ETD)",
            "probability": 0.0023142462612381126,
            "start_logit": 2.8904502391815186,
            "end_logit": 3.2909348011016846,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "(ETD) and electron capture dissociation",
            "probability": 0.001433925990846404,
            "start_logit": 0.5460899472236633,
            "end_logit": 5.156627178192139,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        }
    ],
    "588f220e3b87a8a73800000d": [
        {
            "text": "RNase R",
            "probability": 0.3275978905516607,
            "start_logit": 1.777650237083435,
            "end_logit": -0.6461533904075623,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple bioinformatics",
            "probability": 0.2538414624153079,
            "start_logit": 1.777650237083435,
            "end_logit": -0.9012303948402405,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple bioinformatics tools",
            "probability": 0.11388968116754576,
            "start_logit": 1.777650237083435,
            "end_logit": -1.7027100324630737,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics",
            "probability": 0.04799824414684901,
            "start_logit": 0.11210475862026215,
            "end_logit": -0.9012303948402405,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple bio",
            "probability": 0.04231227849791922,
            "start_logit": 1.777650237083435,
            "end_logit": -2.6928629875183105,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase",
            "probability": 0.038282404892176686,
            "start_logit": 1.777650237083435,
            "end_logit": -2.792949914932251,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple bioinformatics tools have also been developed",
            "probability": 0.03678819877308917,
            "start_logit": 1.777650237083435,
            "end_logit": -2.832763195037842,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment",
            "probability": 0.02592130935077022,
            "start_logit": 1.777650237083435,
            "end_logit": -3.182874917984009,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple bioinformatics tools have also been developed for circular RNA detection",
            "probability": 0.022638137928090035,
            "start_logit": 1.777650237083435,
            "end_logit": -3.3183043003082275,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools",
            "probability": 0.021535113572356237,
            "start_logit": 0.11210475862026215,
            "end_logit": -1.7027100324630737,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple",
            "probability": 0.011206511899218126,
            "start_logit": 1.777650237083435,
            "end_logit": -4.021445274353027,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "R",
            "probability": 0.009228323047656861,
            "start_logit": 1.777650237083435,
            "end_logit": -4.215662956237793,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bio",
            "probability": 0.008000722397469618,
            "start_logit": 0.11210475862026215,
            "end_logit": -2.6928629875183105,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment,",
            "probability": 0.007591275718540849,
            "start_logit": 1.777650237083435,
            "end_logit": -4.410940647125244,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed for circular RNA detection with high-throughput sequence data",
            "probability": 0.00725670863837398,
            "start_logit": 0.11210475862026215,
            "end_logit": -2.790468454360962,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed",
            "probability": 0.006956188046004025,
            "start_logit": 0.11210475862026215,
            "end_logit": -2.832763195037842,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed for circular RNA detection with high-throughput sequence",
            "probability": 0.0064592379512952445,
            "start_logit": 0.11210475862026215,
            "end_logit": -2.906883478164673,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "bioinformatics tools have also been developed for circular RNA detection",
            "probability": 0.004280588604255461,
            "start_logit": 0.11210475862026215,
            "end_logit": -3.3183043003082275,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple bioinformatics tools have also been developed for circular RNA detection with",
            "probability": 0.004139935585477494,
            "start_logit": 1.777650237083435,
            "end_logit": -5.0172600746154785,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNase R treatment, have been developed to identify circular RNA. Multiple bioinformatics tools have also been developed for",
            "probability": 0.004075786815943213,
            "start_logit": 1.777650237083435,
            "end_logit": -5.032876491546631,
            "question_text": "List available circular RNA prediction tools."
        }
    ],
    "589a245878275d0c4a000025": [
        {
            "text": "visual analogue",
            "probability": 0.4984220517783769,
            "start_logit": -1.1852275133132935,
            "end_logit": -1.8474186658859253,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual analogue scale",
            "probability": 0.1770806567321945,
            "start_logit": -1.1852275133132935,
            "end_logit": -2.88226056098938,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual analogue scale (VAS)",
            "probability": 0.049190231793672906,
            "start_logit": -1.1852275133132935,
            "end_logit": -4.16317081451416,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual",
            "probability": 0.04584961617652643,
            "start_logit": -1.1852275133132935,
            "end_logit": -4.233499050140381,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "EORTC QLQ-C30",
            "probability": 0.03060587253593382,
            "start_logit": -3.094301700592041,
            "end_logit": -2.728599786758423,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "analogue",
            "probability": 0.02940676424336329,
            "start_logit": -4.0154500007629395,
            "end_logit": -1.8474186658859253,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual analogue scale (VAS",
            "probability": 0.026637306242330683,
            "start_logit": -1.1852275133132935,
            "end_logit": -4.776553153991699,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual analogue scale (VAS) was 7.86\u00b10.86",
            "probability": 0.01958811465897329,
            "start_logit": -1.1852275133132935,
            "end_logit": -5.083942890167236,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "C30",
            "probability": 0.01881367715342699,
            "start_logit": -3.580909490585327,
            "end_logit": -2.728599786758423,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "QLQ-C30",
            "probability": 0.01794407848882064,
            "start_logit": -3.6282334327697754,
            "end_logit": -2.728599786758423,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual analogue scale (VAS) was 7.86",
            "probability": 0.012626899225768408,
            "start_logit": -1.1852275133132935,
            "end_logit": -5.523036479949951,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "52.21\u00b113.28",
            "probability": 0.012438767014203062,
            "start_logit": -2.648587942123413,
            "end_logit": -4.074687480926514,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "analogue scale",
            "probability": 0.01044771014043945,
            "start_logit": -4.0154500007629395,
            "end_logit": -2.88226056098938,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual analogue scale (VAS) was 7",
            "probability": 0.009609217773774362,
            "start_logit": -1.1852275133132935,
            "end_logit": -5.796143054962158,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "EORTC QLQ-C30 score was 86.13\u00b18.51 preoperatively and 52.21\u00b113.28",
            "probability": 0.007965376482223436,
            "start_logit": -3.094301700592041,
            "end_logit": -4.074687480926514,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "52",
            "probability": 0.007626978485472348,
            "start_logit": -2.648587942123413,
            "end_logit": -4.56381368637085,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "52.21",
            "probability": 0.00750679279472077,
            "start_logit": -2.648587942123413,
            "end_logit": -4.579697132110596,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "EORTC QLQ-C",
            "probability": 0.007085234923220929,
            "start_logit": -3.094301700592041,
            "end_logit": -4.191778659820557,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "visual analogue scale (VAS) was 7.86\u00b10.86. In the post-operation analysis at 3 months, the mean VAS",
            "probability": 0.0062582720700546,
            "start_logit": -1.1852275133132935,
            "end_logit": -6.224961757659912,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "C30 score was 86.13\u00b18.51 preoperatively and 52.21\u00b113.28",
            "probability": 0.004896381286503301,
            "start_logit": -3.580909490585327,
            "end_logit": -4.074687480926514,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        }
    ],
    "58ca746d02b8c6095300002d": [
        {
            "text": "adipose tissue, while CIDEB is expressed in the liver",
            "probability": 0.5340263183871147,
            "start_logit": 2.992187023162842,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "liver",
            "probability": 0.2708425051921103,
            "start_logit": 2.313279390335083,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissue",
            "probability": 0.14085208537934235,
            "start_logit": 2.992187023162842,
            "end_logit": 0.8889594078063965,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissue, while CIDEB is expressed in the liver.",
            "probability": 0.01647494213325007,
            "start_logit": 2.992187023162842,
            "end_logit": -1.2569103240966797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissue,",
            "probability": 0.008799465544635494,
            "start_logit": 2.992187023162842,
            "end_logit": -1.8840599060058594,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "liver.",
            "probability": 0.008355608041455966,
            "start_logit": 2.313279390335083,
            "end_logit": -1.2569103240966797,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "the liver",
            "probability": 0.004924303647063971,
            "start_logit": -1.6940752267837524,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "fat-specific protein 27 (FSP27)). CIDEA and FSP27 are primarily expressed in adipose tissue",
            "probability": 0.004535788398915774,
            "start_logit": -0.4435243606567383,
            "end_logit": 0.8889594078063965,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose",
            "probability": 0.003886019703002727,
            "start_logit": 2.992187023162842,
            "end_logit": -2.7013654708862305,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "ad",
            "probability": 0.0023323729486586925,
            "start_logit": 2.992187023162842,
            "end_logit": -3.211864709854126,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "tissue, while CIDEB is expressed in the liver",
            "probability": 0.0011682792123153887,
            "start_logit": -3.1327261924743652,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "ipose tissue, while CIDEB is expressed in the liver",
            "probability": 0.0008343914180311377,
            "start_logit": -3.469310760498047,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissue, while",
            "probability": 0.0006759903323415673,
            "start_logit": 2.992187023162842,
            "end_logit": -4.450327396392822,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "in the liver",
            "probability": 0.00042157801338675566,
            "start_logit": -4.152008533477783,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "ose tissue, while CIDEB is expressed in the liver",
            "probability": 0.0003461950811649565,
            "start_logit": -4.349010944366455,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "in adipose tissue, while CIDEB is expressed in the liver",
            "probability": 0.0003288751077671028,
            "start_logit": -4.400335311889648,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "CIDEB is expressed in the liver",
            "probability": 0.0003120041996481694,
            "start_logit": -4.452996730804443,
            "end_logit": 2.221694231033325,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "tissue",
            "probability": 0.00030813942626826247,
            "start_logit": -3.1327261924743652,
            "end_logit": 0.8889594078063965,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissue, while CIDEB",
            "probability": 0.00029177309933407634,
            "start_logit": 2.992187023162842,
            "end_logit": -5.290529727935791,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "fat-specific protein 27 (FSP27)). CIDEA and FSP27 are primarily expressed in adipose tissue,",
            "probability": 0.0002833647341927846,
            "start_logit": -0.4435243606567383,
            "end_logit": -1.8840599060058594,
            "question_text": "Which cells express CIDEC protein in humans?"
        }
    ],
    "588f952994c1512c50000007": [
        {
            "text": "optic nerve hypoplasia",
            "probability": 0.21082700979726787,
            "start_logit": 5.537108421325684,
            "end_logit": 5.506023406982422,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia, pituitary gland hypoplasia",
            "probability": 0.18586096798563873,
            "start_logit": 5.537108421325684,
            "end_logit": 5.379984378814697,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia, pituitary gland hypoplasia, and midline brain abnormalities",
            "probability": 0.13370572276294154,
            "start_logit": 5.537108421325684,
            "end_logit": 5.050626754760742,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary gland hypoplasia",
            "probability": 0.09495144604638833,
            "start_logit": 4.865475177764893,
            "end_logit": 5.379984378814697,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary gland hypoplasia, and midline brain abnormalities",
            "probability": 0.06830671258528995,
            "start_logit": 4.865475177764893,
            "end_logit": 5.050626754760742,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "midline brain abnormalities",
            "probability": 0.062000082329101466,
            "start_logit": 4.7686028480529785,
            "end_logit": 5.050626754760742,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "midline brain abnormalities, including absence of septum pellucidum and corpus callosum dysgenesis",
            "probability": 0.04993552660383027,
            "start_logit": 4.7686028480529785,
            "end_logit": 4.834223747253418,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "absence of septum pellucidum and corpus callosum dysgenesis",
            "probability": 0.04795465641490006,
            "start_logit": 4.728126049041748,
            "end_logit": 4.834223747253418,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary gland hypoplasia, and midline brain abnormalities, including absence of septum pellucidum",
            "probability": 0.02985603686788782,
            "start_logit": 4.865475177764893,
            "end_logit": 4.223005771636963,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "midline brain abnormalities, including absence of septum pellucidum",
            "probability": 0.027099485157017614,
            "start_logit": 4.7686028480529785,
            "end_logit": 4.223005771636963,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "absence of septum pellucidum",
            "probability": 0.02602448773666848,
            "start_logit": 4.728126049041748,
            "end_logit": 4.223005771636963,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "corpus callosum dysgenesis",
            "probability": 0.024240157334997965,
            "start_logit": 4.0458807945251465,
            "end_logit": 4.834223747253418,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia, pituitary gland hypoplasia, and midline brain abnormalities,",
            "probability": 0.008309747436954432,
            "start_logit": 5.537108421325684,
            "end_logit": 2.2724146842956543,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia, pituitary gland hypoplasia,",
            "probability": 0.005629538246950632,
            "start_logit": 5.537108421325684,
            "end_logit": 1.8830128908157349,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "optic nerve hypoplasia,",
            "probability": 0.005198547012966238,
            "start_logit": 5.537108421325684,
            "end_logit": 1.803364634513855,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septum pellucidum and corpus callosum dysgenesis",
            "probability": 0.004752403323455149,
            "start_logit": 2.416520595550537,
            "end_logit": 4.834223747253418,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "pituitary gland hypoplasia, and midline brain abnormalities,",
            "probability": 0.004245229883232177,
            "start_logit": 4.865475177764893,
            "end_logit": 2.2724146842956543,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "septo-optic dysplasia",
            "probability": 0.003953414466231459,
            "start_logit": 3.7717461585998535,
            "end_logit": 3.2949273586273193,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "midline brain abnormalities,",
            "probability": 0.0038532757953723957,
            "start_logit": 4.7686028480529785,
            "end_logit": 2.2724146842956543,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        },
        {
            "text": "midline brain abnormalities, including absence of septum pellucidum and corpus callosum",
            "probability": 0.003295552212907037,
            "start_logit": 4.7686028480529785,
            "end_logit": 2.1160647869110107,
            "question_text": "What are clinical features of the de Morsier syndrome?"
        }
    ],
    "58c66a4b02b8c60953000025": [
        {
            "text": "kernicterus",
            "probability": 0.9169860153680911,
            "start_logit": 3.257909059524536,
            "end_logit": 2.4119484424591064,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "subtle kernicterus",
            "probability": 0.05096682381774357,
            "start_logit": 0.36799174547195435,
            "end_logit": 2.4119484424591064,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus). However, the underlying biological mechanisms or pathways by which subtle kernicterus",
            "probability": 0.018752166945120215,
            "start_logit": 3.257909059524536,
            "end_logit": -1.4778344631195068,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus). However, the underlying biological mechanisms or pathways by which subtle kernicterus could lead to developmental disorders",
            "probability": 0.003614169653357956,
            "start_logit": 3.257909059524536,
            "end_logit": -3.124281644821167,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus)",
            "probability": 0.002817226432125018,
            "start_logit": 3.257909059524536,
            "end_logit": -3.3733909130096436,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "(subtle kernicterus",
            "probability": 0.0013869796972102776,
            "start_logit": -3.2360546588897705,
            "end_logit": 2.4119484424591064,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "k",
            "probability": 0.0013551995783671908,
            "start_logit": 3.257909059524536,
            "end_logit": -4.105195045471191,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "subtle kernicterus). However, the underlying biological mechanisms or pathways by which subtle kernicterus",
            "probability": 0.00104226059380983,
            "start_logit": 0.36799174547195435,
            "end_logit": -1.4778344631195068,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus). However, the underlying biological mechanisms or pathways by which subtle kernicterus could lead to developmental",
            "probability": 0.0008469516966393855,
            "start_logit": 3.257909059524536,
            "end_logit": -4.575255393981934,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus).",
            "probability": 0.0007226100777915833,
            "start_logit": 3.257909059524536,
            "end_logit": -4.734029293060303,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "neurological dysfunction (subtle kernicterus",
            "probability": 0.0005070943386563757,
            "start_logit": -4.242241382598877,
            "end_logit": 2.4119484424591064,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "subtle kernicterus). However, the underlying biological mechanisms or pathways by which subtle kernicterus could lead to developmental disorders",
            "probability": 0.00020087847020893625,
            "start_logit": 0.36799174547195435,
            "end_logit": -3.124281644821167,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "bilirubin-induced neurological dysfunction (subtle kernicterus",
            "probability": 0.0001673189535827876,
            "start_logit": -5.351036548614502,
            "end_logit": 2.4119484424591064,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "subtle kernicterus)",
            "probability": 0.0001565837219046018,
            "start_logit": 0.36799174547195435,
            "end_logit": -3.3733909130096436,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "erus",
            "probability": 0.0001258227174419528,
            "start_logit": -5.636064529418945,
            "end_logit": 2.4119484424591064,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "developmental disorders that may reflect subtle kernicterus",
            "probability": 0.00012407437509610221,
            "start_logit": -2.741513729095459,
            "end_logit": -0.4965950846672058,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "subtle k",
            "probability": 7.532308780172097e-05,
            "start_logit": 0.36799174547195435,
            "end_logit": -4.105195045471191,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "kernicterus could lead to developmental disorders",
            "probability": 6.0093258964870864e-05,
            "start_logit": -0.8388106822967529,
            "end_logit": -3.124281644821167,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "subtle kernicterus). However, the underlying biological mechanisms or pathways by which subtle kernicterus could lead to developmental",
            "probability": 4.707425978293785e-05,
            "start_logit": 0.36799174547195435,
            "end_logit": -4.575255393981934,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "subtle",
            "probability": 4.533295630377618e-05,
            "start_logit": 0.36799174547195435,
            "end_logit": -4.612947463989258,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        }
    ],
    "58bfcb8702b8c60953000016": [
        {
            "text": "Koebner phenomenon",
            "probability": 0.336883077253074,
            "start_logit": -3.5984535217285156,
            "end_logit": -3.647108793258667,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon is well described and well known in clinical practice. Sometimes it can take on a linear appearance,",
            "probability": 0.14495549355899953,
            "start_logit": -3.5984535217285156,
            "end_logit": -4.490417957305908,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon is well described and well known in clinical practice.",
            "probability": 0.11768692673911535,
            "start_logit": -3.5984535217285156,
            "end_logit": -4.698816776275635,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "dermatoscopy. In this case, we present a comparison between a linear Koebner phenomenon on light and dark skin,",
            "probability": 0.0502978926638078,
            "start_logit": -4.774246692657471,
            "end_logit": -4.373088359832764,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon is well described",
            "probability": 0.03940822957400654,
            "start_logit": -3.5984535217285156,
            "end_logit": -5.792870044708252,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon is well described and well known in clinical practice",
            "probability": 0.036515679977760285,
            "start_logit": -3.5984535217285156,
            "end_logit": -5.869102954864502,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "dermatoscopy",
            "probability": 0.0350757180767378,
            "start_logit": -4.774246692657471,
            "end_logit": -4.733542442321777,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon is well described and well known in clinical practice. Sometimes it can take on a linear appearance",
            "probability": 0.03353279127298213,
            "start_logit": -3.5984535217285156,
            "end_logit": -5.954320907592773,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "dermatoscopy. In this case,",
            "probability": 0.028643546638962833,
            "start_logit": -4.774246692657471,
            "end_logit": -4.936123371124268,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "Koebner phenomenon is well described and well known in clinical practice. Sometimes it can take on a linear appearance, the diagnosis",
            "probability": 0.025614277485741386,
            "start_logit": -3.5984535217285156,
            "end_logit": -6.223694801330566,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "phenomenon",
            "probability": 0.025399722897511634,
            "start_logit": -6.183451175689697,
            "end_logit": -3.647108793258667,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "The Koebner phenomenon",
            "probability": 0.022641829347056008,
            "start_logit": -6.2983903884887695,
            "end_logit": -3.647108793258667,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "In this case, we present a comparison between a linear Koebner phenomenon on light and dark skin,",
            "probability": 0.017126106262850747,
            "start_logit": -5.8516058921813965,
            "end_logit": -4.373088359832764,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "use of dermatoscopy. In this case, we present a comparison between a linear Koebner phenomenon on light and dark skin,",
            "probability": 0.013956694719124012,
            "start_logit": -6.05625057220459,
            "end_logit": -4.373088359832764,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "dermatoscopy.",
            "probability": 0.013537139128978389,
            "start_logit": -4.774246692657471,
            "end_logit": -5.685614585876465,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "a comparison between a linear Koebner phenomenon on light and dark skin,",
            "probability": 0.012573172058567787,
            "start_logit": -6.16064453125,
            "end_logit": -4.373088359832764,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "comparison between a linear Koebner phenomenon on light and dark skin,",
            "probability": 0.012115966824407118,
            "start_logit": -6.197685718536377,
            "end_logit": -4.373088359832764,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "diagnosis of which can be facilitated by the use of dermatoscopy",
            "probability": 0.011691548990476907,
            "start_logit": -5.872889518737793,
            "end_logit": -4.733542442321777,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "linear Koebner phenomenon on light and dark skin,",
            "probability": 0.011415084958778306,
            "start_logit": -6.257274150848389,
            "end_logit": -4.373088359832764,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "phenomenon is well described and well known in clinical practice. Sometimes it can take on a linear appearance,",
            "probability": 0.010929101571061552,
            "start_logit": -6.183451175689697,
            "end_logit": -4.490417957305908,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        }
    ],
    "58c6a6c502b8c60953000027": [
        {
            "text": "vertigo",
            "probability": 0.9971082833369116,
            "start_logit": 6.429990291595459,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration of the balance system.",
            "probability": 0.0010088391136498062,
            "start_logit": 6.429990291595459,
            "end_logit": -0.822047770023346,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant",
            "probability": 0.0007075975043846063,
            "start_logit": 6.429990291595459,
            "end_logit": -1.1767278909683228,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration of the balance system",
            "probability": 0.00028188407812414933,
            "start_logit": 6.429990291595459,
            "end_logit": -2.097107410430908,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "rtigo",
            "probability": 0.00023473390542159316,
            "start_logit": -1.924171805381775,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "igo",
            "probability": 0.00021510820232760973,
            "start_logit": -2.0114831924438477,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "ve",
            "probability": 0.00020844523670197055,
            "start_logit": 6.429990291595459,
            "end_logit": -2.3989269733428955,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration of the balance",
            "probability": 7.689904878755114e-05,
            "start_logit": 6.429990291595459,
            "end_logit": -3.3961098194122314,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vert",
            "probability": 2.8514522923321068e-05,
            "start_logit": 6.429990291595459,
            "end_logit": -4.388189792633057,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is",
            "probability": 2.739718510628762e-05,
            "start_logit": 6.429990291595459,
            "end_logit": -4.428163051605225,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "fluctuating symptoms, whereby vertigo",
            "probability": 1.9023754953911744e-05,
            "start_logit": -4.436935901641846,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "whereby vertigo",
            "probability": 1.878255092616632e-05,
            "start_logit": -4.449696063995361,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "symptoms, whereby vertigo",
            "probability": 1.2367040219170561e-05,
            "start_logit": -4.867589473724365,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them",
            "probability": 1.1994945595418457e-05,
            "start_logit": 6.429990291595459,
            "end_logit": -5.254117965698242,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most unpleasant among them and often accompanied by deterioration",
            "probability": 8.197417000640987e-06,
            "start_logit": 6.429990291595459,
            "end_logit": -5.63478422164917,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the",
            "probability": 7.501357477155077e-06,
            "start_logit": 6.429990291595459,
            "end_logit": -5.723519325256348,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "vertigo is the most",
            "probability": 7.060720779436837e-06,
            "start_logit": 6.429990291595459,
            "end_logit": -5.784056186676025,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "set of fluctuating symptoms, whereby vertigo",
            "probability": 6.3193822950693625e-06,
            "start_logit": -5.539002895355225,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "composed of a set of fluctuating symptoms, whereby vertigo",
            "probability": 5.969825074066315e-06,
            "start_logit": -5.595906734466553,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "uating symptoms, whereby vertigo",
            "probability": 5.080871339964543e-06,
            "start_logit": -5.757141590118408,
            "end_logit": 6.074011325836182,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        }
    ],
    "58ce5c7c1f5fb2b734000001": [
        {
            "text": "RNA",
            "probability": 0.47786448156834993,
            "start_logit": 1.6549822092056274,
            "end_logit": 0.8104856610298157,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "influenza RNA",
            "probability": 0.187149199511589,
            "start_logit": 0.7175611853599548,
            "end_logit": 0.8104856610298157,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "RNA polymerase PA",
            "probability": 0.09597954690465302,
            "start_logit": 1.6549822092056274,
            "end_logit": -0.794706404209137,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "RNA polymerase",
            "probability": 0.08004841037748282,
            "start_logit": 1.6549822092056274,
            "end_logit": -0.9762099385261536,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "influenza RNA polymerase PA",
            "probability": 0.037589099139023606,
            "start_logit": 0.7175611853599548,
            "end_logit": -0.794706404209137,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "influenza RNA polymerase",
            "probability": 0.03134988370584375,
            "start_logit": 0.7175611853599548,
            "end_logit": -0.9762099385261536,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "influenza",
            "probability": 0.03064509562197617,
            "start_logit": 0.7175611853599548,
            "end_logit": -0.9989478588104248,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "fluenza RNA",
            "probability": 0.015869309956717568,
            "start_logit": -1.7499579191207886,
            "end_logit": 0.8104856610298157,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "RNA polymerase P",
            "probability": 0.006787783939096033,
            "start_logit": 1.6549822092056274,
            "end_logit": -3.4437170028686523,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "polymerase PA",
            "probability": 0.006579098324782612,
            "start_logit": -1.0252552032470703,
            "end_logit": -0.794706404209137,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "R",
            "probability": 0.006489609786840507,
            "start_logit": 1.6549822092056274,
            "end_logit": -3.4886391162872314,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "polymerase",
            "probability": 0.005487068647439893,
            "start_logit": -1.0252552032470703,
            "end_logit": -0.9762099385261536,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "fluenza RNA polymerase PA",
            "probability": 0.003187366372860241,
            "start_logit": -1.7499579191207886,
            "end_logit": -0.794706404209137,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "influenza RNA polymerase P",
            "probability": 0.0026583443207376053,
            "start_logit": 0.7175611853599548,
            "end_logit": -3.4437170028686523,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "fluenza RNA polymerase",
            "probability": 0.002658312314097164,
            "start_logit": -1.7499579191207886,
            "end_logit": -0.9762099385261536,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "fluenza",
            "probability": 0.002598549832687228,
            "start_logit": -1.7499579191207886,
            "end_logit": -0.9989478588104248,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "influenza R",
            "probability": 0.002541568422837592,
            "start_logit": 0.7175611853599548,
            "end_logit": -3.4886391162872314,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "RNA polymer",
            "probability": 0.001651363515787495,
            "start_logit": 1.6549822092056274,
            "end_logit": -4.857240200042725,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "PA",
            "probability": 0.001612197430651418,
            "start_logit": -2.4315547943115234,
            "end_logit": -0.794706404209137,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "inhibition of the metalloenzyme influenza RNA",
            "probability": 0.0012537103065463921,
            "start_logit": -4.288237571716309,
            "end_logit": 0.8104856610298157,
            "question_text": "List metalloenzyme inhibitors."
        }
    ],
    "58c99acf02b8c60953000028": [
        {
            "text": "postoperative protection of external rotation",
            "probability": 0.459683938114324,
            "start_logit": 0.16468624770641327,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical treatment",
            "probability": 0.1269745217195329,
            "start_logit": -0.7563157677650452,
            "end_logit": 0.6492683291435242,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "protection of external rotation",
            "probability": 0.08967197591737494,
            "start_logit": -1.4696946144104004,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "adaptation of the surgical approach and postoperative protection of external rotation",
            "probability": 0.08278922917707426,
            "start_logit": -1.5495549440383911,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "Subscapularis tears required adaptation of the surgical approach and postoperative protection of external rotation",
            "probability": 0.0640727233377574,
            "start_logit": -1.805834174156189,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "external rotation",
            "probability": 0.06289566018966894,
            "start_logit": -1.8243757486343384,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical",
            "probability": 0.03781648374464005,
            "start_logit": -0.7563157677650452,
            "end_logit": -0.5619730353355408,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical approach and postoperative protection of external rotation",
            "probability": 0.029154932153637847,
            "start_logit": -2.593228816986084,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical treatment was shorter when the subscapularis was torn. Subscapularis tears required adaptation of the surgical approach",
            "probability": 0.010454871789131953,
            "start_logit": -0.7563157677650452,
            "end_logit": -1.8476500511169434,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical treatment was shorter when the subscapularis was torn. Subscapularis",
            "probability": 0.004993797956083479,
            "start_logit": -0.7563157677650452,
            "end_logit": -2.5865213871002197,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "adaptation of the surgical approach",
            "probability": 0.004729544479954901,
            "start_logit": -1.5495549440383911,
            "end_logit": -1.8476500511169434,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "treatment",
            "probability": 0.004699220567098659,
            "start_logit": -4.052905559539795,
            "end_logit": 0.6492683291435242,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "Subscapularis tears required adaptation of the surgical approach",
            "probability": 0.0036603166618403966,
            "start_logit": -1.805834174156189,
            "end_logit": -1.8476500511169434,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "subscapularis was torn. Subscapularis tears required adaptation of the surgical approach and postoperative protection of external rotation",
            "probability": 0.003249607461770102,
            "start_logit": -4.787318706512451,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical treatment was shorter when the subscapularis was torn. Subscapularis tears required adaptation",
            "probability": 0.003228078017978434,
            "start_logit": -0.7563157677650452,
            "end_logit": -3.0228312015533447,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "rotation",
            "probability": 0.0029672955627520637,
            "start_logit": -4.878201961517334,
            "end_logit": 1.0148190259933472,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "postoperative protection of external rotation for 4-6 weeks. Outcomes were less satisfactory when the subscapularis",
            "probability": 0.0028377609526087557,
            "start_logit": 0.16468624770641327,
            "end_logit": -4.072704792022705,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical treatment was shorter when the subscapularis was torn. Subscapularis tears required adaptation of the surgical",
            "probability": 0.0023541218997750954,
            "start_logit": -0.7563157677650452,
            "end_logit": -3.338550329208374,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "postoperative",
            "probability": 0.002017560084341607,
            "start_logit": 0.16468624770641327,
            "end_logit": -4.4138312339782715,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "Subscapularis",
            "probability": 0.0017483602126539836,
            "start_logit": -1.805834174156189,
            "end_logit": -2.5865213871002197,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        }
    ],
    "58cd59cb02b8c60953000039": [
        {
            "text": "Dengue viruses",
            "probability": 0.42247754466237464,
            "start_logit": 1.807964563369751,
            "end_logit": 0.3750346004962921,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Dengue",
            "probability": 0.3821436047908645,
            "start_logit": 1.807964563369751,
            "end_logit": 0.2746947705745697,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Dengue viruses (DENV)",
            "probability": 0.12602966064603338,
            "start_logit": 1.807964563369751,
            "end_logit": -0.8345844149589539,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV",
            "probability": 0.03534460828697956,
            "start_logit": 0.5304000973701477,
            "end_logit": -0.8283913731575012,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV infection",
            "probability": 0.022856258226920355,
            "start_logit": 0.5304000973701477,
            "end_logit": -1.2643122673034668,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "gue viruses",
            "probability": 0.002810822721038463,
            "start_logit": -3.2046945095062256,
            "end_logit": 0.3750346004962921,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "gue",
            "probability": 0.0025424734180939917,
            "start_logit": -3.2046945095062256,
            "end_logit": 0.2746947705745697,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "viruses",
            "probability": 0.002024601169401178,
            "start_logit": -3.532799005508423,
            "end_logit": 0.3750346004962921,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV infection.",
            "probability": 0.0010859667484342695,
            "start_logit": 0.5304000973701477,
            "end_logit": -4.311066627502441,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "gue viruses (DENV)",
            "probability": 0.0008384990827186711,
            "start_logit": -3.2046945095062256,
            "end_logit": -0.8345844149589539,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "viruses (DENV)",
            "probability": 0.0006039606164798774,
            "start_logit": -3.532799005508423,
            "end_logit": -0.8345844149589539,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV infection. Antagonism",
            "probability": 0.0005426968303006516,
            "start_logit": 0.5304000973701477,
            "end_logit": -5.004741668701172,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "D4 dopamine receptor (DRD4), in DENV",
            "probability": 0.00011873895661464046,
            "start_logit": -5.165573596954346,
            "end_logit": -0.8283913731575012,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "infection",
            "probability": 0.00011099771785481453,
            "start_logit": -4.797070503234863,
            "end_logit": -1.2643122673034668,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "the D4 dopamine receptor (DRD4), in DENV",
            "probability": 9.554259704053664e-05,
            "start_logit": -5.382928848266602,
            "end_logit": -0.8283913731575012,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "(DRD4), in DENV",
            "probability": 8.74524775825e-05,
            "start_logit": -5.471405506134033,
            "end_logit": -0.8283913731575012,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "dopamine receptor (DRD4), in DENV",
            "probability": 7.865020468936046e-05,
            "start_logit": -5.57749080657959,
            "end_logit": -0.8283913731575012,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "D4 dopamine receptor (DRD4), in DENV infection",
            "probability": 7.678478799209348e-05,
            "start_logit": -5.165573596954346,
            "end_logit": -1.2643122673034668,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "DENV)",
            "probability": 6.935163444167263e-05,
            "start_logit": -5.697118282318115,
            "end_logit": -0.8345844149589539,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "the D4 dopamine receptor (DRD4), in DENV infection",
            "probability": 6.178442414464564e-05,
            "start_logit": -5.382928848266602,
            "end_logit": -1.2643122673034668,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        }
    ],
    "58b548d722d3005309000005": [
        {
            "text": "Corynebacterium diphtheriae",
            "probability": 0.9639341740402131,
            "start_logit": 5.830346584320068,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphtheriae,",
            "probability": 0.0148380702821826,
            "start_logit": 5.830346584320068,
            "end_logit": 1.7251728773117065,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium",
            "probability": 0.009799401212870693,
            "start_logit": 5.830346584320068,
            "end_logit": 1.310297966003418,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae",
            "probability": 0.00679701570861955,
            "start_logit": 0.8758072257041931,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium dip",
            "probability": 0.0016197677849773557,
            "start_logit": 5.830346584320068,
            "end_logit": -0.4897405207157135,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Co",
            "probability": 0.0009899757361479427,
            "start_logit": 5.830346584320068,
            "end_logit": -0.9820981621742249,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "heriae",
            "probability": 0.00032704442469969893,
            "start_logit": -2.1583356857299805,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "iae",
            "probability": 0.0002942811827790487,
            "start_logit": -2.2638959884643555,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacteri",
            "probability": 0.0002525680695731581,
            "start_logit": 5.830346584320068,
            "end_logit": -2.348097801208496,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "caused by Corynebacterium diphtheriae",
            "probability": 0.00018085928682047314,
            "start_logit": -2.7507123947143555,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphther",
            "probability": 0.00016562392824492095,
            "start_logit": 5.830346584320068,
            "end_logit": -2.7700588703155518,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebact",
            "probability": 0.0001623679701527716,
            "start_logit": 5.830346584320068,
            "end_logit": -2.7899134159088135,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Coryn",
            "probability": 0.00011290063697100346,
            "start_logit": 5.830346584320068,
            "end_logit": -3.1532704830169678,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "um diphtheriae",
            "probability": 0.00010734121940776,
            "start_logit": -3.272418975830078,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae,",
            "probability": 0.00010462809547552014,
            "start_logit": 0.8758072257041931,
            "end_logit": 1.7251728773117065,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "by Corynebacterium diphtheriae",
            "probability": 8.655081665712074e-05,
            "start_logit": -3.4876999855041504,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium dipht",
            "probability": 6.273198240735487e-05,
            "start_logit": 5.830346584320068,
            "end_logit": -3.7409071922302246,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "ebacterium diphtheriae",
            "probability": 6.028330879635046e-05,
            "start_logit": -3.8493764400482178,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "rynebacterium diphtheriae",
            "probability": 5.712991439555495e-05,
            "start_logit": -3.903103828430176,
            "end_logit": 5.8989996910095215,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Coryneb",
            "probability": 4.728439860819245e-05,
            "start_logit": 5.830346584320068,
            "end_logit": -4.0235981941223145,
            "question_text": "Which bacteria cause diphtheria?"
        }
    ],
    "58cea0768acda34529000001": [
        {
            "text": "Tay-Sachs disease",
            "probability": 0.7867929417351197,
            "start_logit": 5.780833721160889,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs",
            "probability": 0.15794946074935975,
            "start_logit": 5.780833721160889,
            "end_logit": 4.665304660797119,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD)",
            "probability": 0.026592731362856344,
            "start_logit": 5.780833721160889,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD",
            "probability": 0.01948837350298908,
            "start_logit": 5.780833721160889,
            "end_logit": 2.572847604751587,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease",
            "probability": 0.0037698911472519837,
            "start_logit": 0.439914733171463,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD),",
            "probability": 0.002266331022284296,
            "start_logit": 5.780833721160889,
            "end_logit": 0.4211917817592621,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "TSD)",
            "probability": 0.0008279270806278389,
            "start_logit": 2.3113656044006348,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs",
            "probability": 0.0007568093741144665,
            "start_logit": 0.439914733171463,
            "end_logit": 4.665304660797119,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "TSD",
            "probability": 0.0006067429464222444,
            "start_logit": 2.3113656044006348,
            "end_logit": 2.572847604751587,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "disease",
            "probability": 0.00028608458421905647,
            "start_logit": -2.138599157333374,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease (TSD)",
            "probability": 0.0001274181518774133,
            "start_logit": 0.439914733171463,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease (TSD",
            "probability": 9.337786709326203e-05,
            "start_logit": 0.439914733171463,
            "end_logit": 2.572847604751587,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD), a deficiency of b-hexosaminidase A (Hex A),",
            "probability": 8.975744064494137e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -2.807614803314209,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "chs disease",
            "probability": 7.813889348571468e-05,
            "start_logit": -3.43639874458313,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Ta",
            "probability": 7.400338606945432e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -3.000614881515503,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "TSD),",
            "probability": 7.055901108514798e-05,
            "start_logit": 2.3113656044006348,
            "end_logit": 0.4211917817592621,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (",
            "probability": 5.1812797023583645e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -3.357088565826416,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "y-Sachs disease",
            "probability": 3.0164605214068485e-05,
            "start_logit": -4.388217449188232,
            "end_logit": 6.270994663238525,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay",
            "probability": 2.385537484863159e-05,
            "start_logit": 5.780833721160889,
            "end_logit": -4.132716178894043,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "(TSD)",
            "probability": 2.3618967412861197e-05,
            "start_logit": -1.245509386062622,
            "end_logit": 2.883667469024658,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        }
    ],
    "58c1b2f702b8c6095300001e": [
        {
            "text": "antidepressant",
            "probability": 0.276925138247456,
            "start_logit": 5.730165958404541,
            "end_logit": 5.221168041229248,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation",
            "probability": 0.20721043083939483,
            "start_logit": 5.936795711517334,
            "end_logit": 4.7245259284973145,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking cessation",
            "probability": 0.16852853757150713,
            "start_logit": 5.730165958404541,
            "end_logit": 4.7245259284973145,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation aid",
            "probability": 0.16672356828346688,
            "start_logit": 5.936795711517334,
            "end_logit": 4.5071282386779785,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking cessation aid",
            "probability": 0.13559973321658694,
            "start_logit": 5.730165958404541,
            "end_logit": 4.5071282386779785,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepress",
            "probability": 0.00846946075900954,
            "start_logit": 5.730165958404541,
            "end_logit": 1.7338876724243164,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant",
            "probability": 0.007355188721463867,
            "start_logit": 2.1018247604370117,
            "end_logit": 5.221168041229248,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant and smoking cessation",
            "probability": 0.004476152676623738,
            "start_logit": 2.1018247604370117,
            "end_logit": 4.7245259284973145,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant and smoking cessation aid",
            "probability": 0.003601556849262716,
            "start_logit": 2.1018247604370117,
            "end_logit": 4.5071282386779785,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depressant",
            "probability": 0.0034878206860816286,
            "start_logit": 1.3556958436965942,
            "end_logit": 5.221168041229248,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking",
            "probability": 0.002478552771804994,
            "start_logit": 5.936795711517334,
            "end_logit": 0.29846590757369995,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "smoking cessation aid,",
            "probability": 0.0022070270247236613,
            "start_logit": 5.936795711517334,
            "end_logit": 0.1824374496936798,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depressant and smoking cessation",
            "probability": 0.002122585631831448,
            "start_logit": 1.3556958436965942,
            "end_logit": 4.7245259284973145,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking",
            "probability": 0.002015858334129223,
            "start_logit": 5.730165958404541,
            "end_logit": 0.29846590757369995,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "pressant",
            "probability": 0.001830407574155596,
            "start_logit": 0.710957407951355,
            "end_logit": 5.221168041229248,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant and smoking cessation aid,",
            "probability": 0.0017950208170058905,
            "start_logit": 5.730165958404541,
            "end_logit": 0.1824374496936798,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depressant and smoking cessation aid",
            "probability": 0.0017078534564722093,
            "start_logit": 1.3556958436965942,
            "end_logit": 4.5071282386779785,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "cessation",
            "probability": 0.0013028710593148782,
            "start_logit": 0.867631196975708,
            "end_logit": 4.7245259284973145,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "pressant and smoking cessation",
            "probability": 0.0011139325002578974,
            "start_logit": 0.710957407951355,
            "end_logit": 4.7245259284973145,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "cessation aid",
            "probability": 0.0010483029794508742,
            "start_logit": 0.867631196975708,
            "end_logit": 4.5071282386779785,
            "question_text": "List 3 indications for Bupropion"
        }
    ],
    "587d2b7efe8a08052f000003": [
        {
            "text": "316 TFFMs",
            "probability": 0.4008256759798352,
            "start_logit": 1.5225657224655151,
            "end_logit": 1.0136873722076416,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs",
            "probability": 0.3848299763183532,
            "start_logit": 1.48184072971344,
            "end_logit": 1.0136873722076416,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "316",
            "probability": 0.1021470707772998,
            "start_logit": 1.5225657224655151,
            "end_logit": -0.3534255921840668,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "316 TFFMs (95 for vertebrates, 218 for plants and 3 for insects)",
            "probability": 0.01778170579094458,
            "start_logit": 1.5225657224655151,
            "end_logit": -2.1016690731048584,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs (95 for vertebrates, 218 for plants and 3 for insects)",
            "probability": 0.01707209350224705,
            "start_logit": 1.48184072971344,
            "end_logit": -2.1016690731048584,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "316 TFFMs (95 for vertebrates, 218 for plants and 3 for insects",
            "probability": 0.010167793487760379,
            "start_logit": 1.5225657224655151,
            "end_logit": -2.660614013671875,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs (95 for vertebrates, 218 for plants and 3 for insects",
            "probability": 0.009762028636363062,
            "start_logit": 1.48184072971344,
            "end_logit": -2.660614013671875,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "316 TFFMs (95 for vertebrates, 218 for plants and 3 for insects). This release incorporates clusters of similar PFMs",
            "probability": 0.007750676948396006,
            "start_logit": 1.5225657224655151,
            "end_logit": -2.9320590496063232,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs (95 for vertebrates, 218 for plants and 3 for insects). This release incorporates clusters of similar PFMs",
            "probability": 0.007441371661660952,
            "start_logit": 1.48184072971344,
            "end_logit": -2.9320590496063232,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we have introduced 316 TFFMs",
            "probability": 0.006796779269574458,
            "start_logit": -2.5545120239257812,
            "end_logit": 1.0136873722076416,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "316 TFFMs (95 for vertebrates, 218 for plants and 3 for insects).",
            "probability": 0.004322263068029137,
            "start_logit": 1.5225657224655151,
            "end_logit": -3.5160601139068604,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs (95 for vertebrates, 218 for plants and 3 for insects).",
            "probability": 0.004149775061303769,
            "start_logit": 1.48184072971344,
            "end_logit": -3.5160601139068604,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "316 TFFMs (95 for vertebrates, 218 for plants and 3 for insects). This release incorporates clusters",
            "probability": 0.003973608347172855,
            "start_logit": 1.5225657224655151,
            "end_logit": -3.6001646518707275,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs (95 for vertebrates, 218 for plants and 3 for insects). This release incorporates clusters",
            "probability": 0.003815034060387563,
            "start_logit": 1.48184072971344,
            "end_logit": -3.6001646518707275,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "33",
            "probability": 0.0036038347509228523,
            "start_logit": -0.6817149519920349,
            "end_logit": -1.4935600757598877,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "33 PFMs",
            "probability": 0.0033966239682009414,
            "start_logit": -0.6817149519920349,
            "end_logit": -1.552776575088501,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "316 TFFMs (95 for vertebrates, 218 for plants and 3",
            "probability": 0.003202268670600077,
            "start_logit": 1.5225657224655151,
            "end_logit": -3.8159797191619873,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "TFFMs (95 for vertebrates, 218 for plants and 3",
            "probability": 0.003074476138933845,
            "start_logit": 1.48184072971344,
            "end_logit": -3.8159797191619873,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "insects). These new profiles represent a 30% expansion compared to the 2016 release. In addition, we have introduced 316 TFFMs",
            "probability": 0.0030065569061537016,
            "start_logit": -3.3701653480529785,
            "end_logit": 1.0136873722076416,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "1 for insects). These new profiles represent a 30% expansion compared to the 2016 release. In addition, we have introduced 316 TFFMs",
            "probability": 0.0028803866558609306,
            "start_logit": -3.413036346435547,
            "end_logit": 1.0136873722076416,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        }
    ],
    "58dfd83a6fddd3e83e000003": [
        {
            "text": "Pnpla3",
            "probability": 0.9310479452200543,
            "start_logit": 4.540698528289795,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Pnpla3,",
            "probability": 0.04810733657895571,
            "start_logit": 4.540698528289795,
            "end_logit": 1.7267024517059326,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "NASH gene', Pnpla3",
            "probability": 0.013395309415558873,
            "start_logit": 0.29929235577583313,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "hepatokines and Pnpla3",
            "probability": 0.002422634534649151,
            "start_logit": 0.26871103048324585,
            "end_logit": 3.010110855102539,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "3",
            "probability": 0.0009731936650054857,
            "start_logit": -2.322784423828125,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "NASH gene', Pnpla3,",
            "probability": 0.0006921369215644823,
            "start_logit": 0.29929235577583313,
            "end_logit": 1.7267024517059326,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Pnpla",
            "probability": 0.0006323677137022841,
            "start_logit": 4.540698528289795,
            "end_logit": -2.6050164699554443,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "npla3",
            "probability": 0.0005466967903665359,
            "start_logit": -2.899473190307617,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "The 'NASH gene', Pnpla3",
            "probability": 0.0005148866834251028,
            "start_logit": -2.959420680999756,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "la3",
            "probability": 0.0002932719054556694,
            "start_logit": -3.5222673416137695,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Fgf21, Igf1",
            "probability": 0.00027680417909024064,
            "start_logit": 0.5457288026809692,
            "end_logit": 0.5637925267219543,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Igf1",
            "probability": 0.0001946264474830693,
            "start_logit": 0.1935005486011505,
            "end_logit": 0.5637925267219543,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "pla3",
            "probability": 0.00017741868448965724,
            "start_logit": -4.024855136871338,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Fgf21",
            "probability": 0.0001556958864260261,
            "start_logit": 0.5457288026809692,
            "end_logit": -0.011613136157393456,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "P",
            "probability": 0.00015190186075010858,
            "start_logit": 4.540698528289795,
            "end_logit": -4.031252861022949,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "lipid metabolism genes in different manners. The 'NASH gene', Pnpla3",
            "probability": 0.00013425807440567983,
            "start_logit": -4.303603649139404,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "'NASH gene', Pnpla3",
            "probability": 0.00010997596972230235,
            "start_logit": -4.503105640411377,
            "end_logit": 4.689578533172607,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Pnpla3, was elevated by Aroclor 1260,",
            "probability": 7.040667061426787e-05,
            "start_logit": 4.540698528289795,
            "end_logit": -4.800199508666992,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Pnpla3 as well as 'PCB",
            "probability": 5.284778832074905e-05,
            "start_logit": 2.948659896850586,
            "end_logit": -3.495033025741577,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "3,",
            "probability": 5.028500996032051e-05,
            "start_logit": -2.322784423828125,
            "end_logit": 1.7267024517059326,
            "question_text": "List genes associated with hypolipidemia."
        }
    ],
    "58c6665602b8c60953000024": [
        {
            "text": "hemolytic anemia",
            "probability": 0.9910146632464649,
            "start_logit": 6.035048484802246,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "anemia",
            "probability": 0.0054584888955596655,
            "start_logit": 0.8334911465644836,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolytic anemia.",
            "probability": 0.0017638877587071763,
            "start_logit": 6.035048484802246,
            "end_logit": -0.7592642903327942,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolytic",
            "probability": 0.00031480826287193263,
            "start_logit": 6.035048484802246,
            "end_logit": -2.4825761318206787,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hem",
            "probability": 0.00028600583337965834,
            "start_logit": 6.035048484802246,
            "end_logit": -2.5785276889801025,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemolytic an",
            "probability": 0.00025611786696725383,
            "start_logit": 6.035048484802246,
            "end_logit": -2.6889021396636963,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "emia",
            "probability": 0.0002312740627218481,
            "start_logit": -2.3278326988220215,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "one of the important causes of hemolytic anemia",
            "probability": 0.00022351192011698715,
            "start_logit": -2.361971378326416,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "olytic anemia",
            "probability": 0.0001590713770900641,
            "start_logit": -2.702083110809326,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "causes of hemolytic anemia",
            "probability": 0.0001236294500861537,
            "start_logit": -2.9541473388671875,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "tic anemia",
            "probability": 0.00011995708824853812,
            "start_logit": -2.984302043914795,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "hemoly",
            "probability": 2.9311170775918825e-05,
            "start_logit": 6.035048484802246,
            "end_logit": -4.856571197509766,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "anemia.",
            "probability": 9.715458409440537e-06,
            "start_logit": 0.8334911465644836,
            "end_logit": -0.7592642903327942,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "It is more common in tropical and subtropical countries and is one of the important causes of hemolytic anemia",
            "probability": 6.620768776263872e-06,
            "start_logit": -5.881224632263184,
            "end_logit": 5.571944713592529,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "an",
            "probability": 1.4106920761549786e-06,
            "start_logit": 0.8334911465644836,
            "end_logit": -2.6889021396636963,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "emia.",
            "probability": 4.116402140864072e-07,
            "start_logit": -2.3278326988220215,
            "end_logit": -0.7592642903327942,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "one of the important causes of hemolytic anemia.",
            "probability": 3.978245271648823e-07,
            "start_logit": -2.361971378326416,
            "end_logit": -0.7592642903327942,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "olytic anemia.",
            "probability": 2.8312805573501e-07,
            "start_logit": -2.702083110809326,
            "end_logit": -0.7592642903327942,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "causes of hemolytic anemia.",
            "probability": 2.200456579605955e-07,
            "start_logit": -2.9541473388671875,
            "end_logit": -0.7592642903327942,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "tic anemia.",
            "probability": 2.1350929242419326e-07,
            "start_logit": -2.984302043914795,
            "end_logit": -0.7592642903327942,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        }
    ],
    "58d8e9bd8acda3452900000b": [
        {
            "text": "heart failure, arrhythmias and sudden cardiac death",
            "probability": 0.2064325925780596,
            "start_logit": 6.352005958557129,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "sudden cardiac death",
            "probability": 0.1799458183858702,
            "start_logit": 6.214687824249268,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmias and sudden cardiac death",
            "probability": 0.16473339657236624,
            "start_logit": 6.1263604164123535,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, arrhythmias",
            "probability": 0.162292619902418,
            "start_logit": 6.352005958557129,
            "end_logit": 5.888743877410889,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure",
            "probability": 0.14969886964729076,
            "start_logit": 6.352005958557129,
            "end_logit": 5.807968616485596,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmias",
            "probability": 0.12950965824373808,
            "start_logit": 6.1263604164123535,
            "end_logit": 5.888743877410889,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure,",
            "probability": 0.0014775330233306918,
            "start_logit": 6.352005958557129,
            "end_logit": 1.1897166967391968,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "cardiac death",
            "probability": 0.0014115000515118453,
            "start_logit": 1.3666850328445435,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "asymptomatic to heart failure, arrhythmias and sudden cardiac death",
            "probability": 0.0011128981550779084,
            "start_logit": 1.1289995908737183,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "asymptomatic to heart failure, arrhythmias",
            "probability": 0.0008749352755615088,
            "start_logit": 1.1289995908737183,
            "end_logit": 5.888743877410889,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "asymptomatic to heart failure",
            "probability": 0.0008070411448459667,
            "start_logit": 1.1289995908737183,
            "end_logit": 5.807968616485596,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, arrhythmia",
            "probability": 0.0006004588417404553,
            "start_logit": 6.352005958557129,
            "end_logit": 0.2892816960811615,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmia",
            "probability": 0.0004791667016651479,
            "start_logit": 6.1263604164123535,
            "end_logit": 0.2892816960811615,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "failure, arrhythmias and sudden cardiac death",
            "probability": 0.0001264104386281299,
            "start_logit": -1.0461891889572144,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "failure, arrhythmias",
            "probability": 9.93810183351516e-05,
            "start_logit": -1.0461891889572144,
            "end_logit": 5.888743877410889,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "failure",
            "probability": 9.166914748257888e-05,
            "start_logit": -1.0461891889572144,
            "end_logit": 5.807968616485596,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "death",
            "probability": 9.116233384182518e-05,
            "start_logit": -1.3730814456939697,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "rrhythmias and sudden cardiac death",
            "probability": 8.594286192099136e-05,
            "start_logit": -1.4320405721664429,
            "end_logit": 6.129316806793213,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "rrhythmias",
            "probability": 6.75663278210065e-05,
            "start_logit": -1.4320405721664429,
            "end_logit": 5.888743877410889,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, a",
            "probability": 6.137934849396403e-05,
            "start_logit": 6.352005958557129,
            "end_logit": -1.9913389682769775,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        }
    ],
    "5880b2a6c872c95565000004": [
        {
            "text": "JAK-STAT-pathway",
            "probability": 0.6301854764369275,
            "start_logit": 5.764357089996338,
            "end_logit": 4.530917644500732,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "JAK-STAT",
            "probability": 0.25100818114787804,
            "start_logit": 5.764357089996338,
            "end_logit": 3.610388994216919,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "JAK",
            "probability": 0.06342130468151416,
            "start_logit": 5.764357089996338,
            "end_logit": 2.234703302383423,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "the JAK-STAT-pathway",
            "probability": 0.022990713380432064,
            "start_logit": 2.4534332752227783,
            "end_logit": 4.530917644500732,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "the JAK-STAT",
            "probability": 0.00915739471106649,
            "start_logit": 2.4534332752227783,
            "end_logit": 3.610388994216919,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT-pathway",
            "probability": 0.0046166914045755285,
            "start_logit": 0.8480212092399597,
            "end_logit": 4.530917644500732,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 and IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT-pathway",
            "probability": 0.004049084490243671,
            "start_logit": 0.7168337106704712,
            "end_logit": 4.530917644500732,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "the JAK",
            "probability": 0.0023137649036119633,
            "start_logit": 2.4534332752227783,
            "end_logit": 2.234703302383423,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "downstream the JAK-STAT-pathway",
            "probability": 0.0020589022410251127,
            "start_logit": 0.04051585495471954,
            "end_logit": 4.530917644500732,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT",
            "probability": 0.0018388670569426044,
            "start_logit": 0.8480212092399597,
            "end_logit": 3.610388994216919,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 and IL-13 and thereby inhibits receptor signaling downstream the JAK-STAT",
            "probability": 0.001612784443964997,
            "start_logit": 0.7168337106704712,
            "end_logit": 3.610388994216919,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "JAK-STAT-pathway.",
            "probability": 0.0013895334805671185,
            "start_logit": 5.764357089996338,
            "end_logit": -1.5861284732818604,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "receptor signaling downstream the JAK-STAT-pathway",
            "probability": 0.0012623553670580744,
            "start_logit": -0.44867777824401855,
            "end_logit": 4.530917644500732,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "STAT-pathway",
            "probability": 0.0009526996584761887,
            "start_logit": -0.7301126718521118,
            "end_logit": 4.530917644500732,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "downstream the JAK-STAT",
            "probability": 0.0008200780976467456,
            "start_logit": 0.04051585495471954,
            "end_logit": 3.610388994216919,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "J",
            "probability": 0.0005677774691302435,
            "start_logit": 5.764357089996338,
            "end_logit": -2.4811222553253174,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "receptor signaling downstream the JAK-STAT",
            "probability": 0.0005028067711732206,
            "start_logit": -0.44867777824401855,
            "end_logit": 3.610388994216919,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-13 and thereby inhibits receptor signaling downstream the JAK",
            "probability": 0.00046461970822556233,
            "start_logit": 0.8480212092399597,
            "end_logit": 2.234703302383423,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 and IL-13 and thereby inhibits receptor signaling downstream the JAK",
            "probability": 0.00040749625425973965,
            "start_logit": 0.7168337106704712,
            "end_logit": 2.234703302383423,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "STAT",
            "probability": 0.00037946829528091603,
            "start_logit": -0.7301126718521118,
            "end_logit": 3.610388994216919,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        }
    ],
    "58e0035f6fddd3e83e000009": [
        {
            "text": "slit diaphragm",
            "probability": 0.309149031768015,
            "start_logit": 4.963408470153809,
            "end_logit": 4.939080715179443,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal adhesions",
            "probability": 0.28937732222341744,
            "start_logit": 5.181355953216553,
            "end_logit": 4.655041217803955,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit diaphragm and focal adhesions",
            "probability": 0.2327078878258339,
            "start_logit": 4.963408470153809,
            "end_logit": 4.655041217803955,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit diaphragm",
            "probability": 0.06784238129274935,
            "start_logit": 3.4467720985412598,
            "end_logit": 4.939080715179443,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit diaphragm and focal adhesions",
            "probability": 0.05106746466396004,
            "start_logit": 3.4467720985412598,
            "end_logit": 4.655041217803955,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal adhesions.",
            "probability": 0.02259168166459807,
            "start_logit": 5.181355953216553,
            "end_logit": 2.104891538619995,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit diaphragm and focal adhesions.",
            "probability": 0.018167500072943866,
            "start_logit": 4.963408470153809,
            "end_logit": 2.104891538619995,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit diaphragm and focal adhesions.",
            "probability": 0.003986835928406191,
            "start_logit": 3.4467720985412598,
            "end_logit": 2.104891538619995,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal adhesion",
            "probability": 0.0009799217272247773,
            "start_logit": 5.181355953216553,
            "end_logit": -1.032972812652588,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit diaphragm and focal adhesion",
            "probability": 0.0007880213750857199,
            "start_logit": 4.963408470153809,
            "end_logit": -1.032972812652588,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit",
            "probability": 0.000617038607531874,
            "start_logit": 4.963408470153809,
            "end_logit": -1.2775664329528809,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "adhesions",
            "probability": 0.0005689752707701533,
            "start_logit": -1.0502938032150269,
            "end_logit": 4.655041217803955,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin cytoskeleton: the slit diaphragm",
            "probability": 0.0005587344105545471,
            "start_logit": -1.3524960279464722,
            "end_logit": 4.939080715179443,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin cytoskeleton: the slit diaphragm and focal adhesions",
            "probability": 0.0004205800153801847,
            "start_logit": -1.3524960279464722,
            "end_logit": 4.655041217803955,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "foot processes that regulate the actin cytoskeleton: the slit diaphragm",
            "probability": 0.0002531639194614351,
            "start_logit": -2.1441330909729004,
            "end_logit": 4.939080715179443,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "diaphragm",
            "probability": 0.00020471750890845727,
            "start_logit": -2.356539249420166,
            "end_logit": 4.939080715179443,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "focal",
            "probability": 0.00019690274087961245,
            "start_logit": 5.181355953216553,
            "end_logit": -2.637735605239868,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "foot processes that regulate the actin cytoskeleton: the slit diaphragm and focal adhesions",
            "probability": 0.00019056582721497405,
            "start_logit": -2.1441330909729004,
            "end_logit": 4.655041217803955,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "the slit diaphragm and focal adhesion",
            "probability": 0.0001729303381274029,
            "start_logit": 3.4467720985412598,
            "end_logit": -1.032972812652588,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "slit diaphragm and focal",
            "probability": 0.00015834281893670833,
            "start_logit": 4.963408470153809,
            "end_logit": -2.637735605239868,
            "question_text": "List the three main structures of the cytoskeleton."
        }
    ],
    "5880b583c872c95565000005": [
        {
            "text": "treatment",
            "probability": 0.21926304532353214,
            "start_logit": -4.0390095710754395,
            "end_logit": -5.097364902496338,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification",
            "probability": 0.14573912201535572,
            "start_logit": -4.0390095710754395,
            "end_logit": -5.505818843841553,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification for HPV-related OPSCC,",
            "probability": 0.12295636738118741,
            "start_logit": -4.0390095710754395,
            "end_logit": -5.675807476043701,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification for HPV-related OPSCC, summarize available results from published clinical trials,",
            "probability": 0.07904731556210043,
            "start_logit": -4.0390095710754395,
            "end_logit": -6.117590427398682,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification",
            "probability": 0.06745721067015234,
            "start_logit": -4.8093342781066895,
            "end_logit": -5.505818843841553,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification for HPV-related OPSCC, summarize available results from published clinical trials",
            "probability": 0.0645662106838629,
            "start_logit": -4.0390095710754395,
            "end_logit": -6.319945812225342,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification for HPV-related OPSCC,",
            "probability": 0.056911922227687664,
            "start_logit": -4.8093342781066895,
            "end_logit": -5.675807476043701,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment deintensification for HPV-related OPSCC, summarize available results from published clinical trials, explore",
            "probability": 0.043671645840174016,
            "start_logit": -4.0390095710754395,
            "end_logit": -6.710937976837158,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification for HPV-related OPSCC, summarize available results from published clinical trials,",
            "probability": 0.036588057791515895,
            "start_logit": -4.8093342781066895,
            "end_logit": -6.117590427398682,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification for HPV-related OPSCC, summarize available results from published clinical trials",
            "probability": 0.029885293777300728,
            "start_logit": -4.8093342781066895,
            "end_logit": -6.319945812225342,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "de-escalation",
            "probability": 0.02290362495262129,
            "start_logit": -5.828274250030518,
            "end_logit": -5.567077159881592,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "deintensification for HPV-related OPSCC, summarize available results from published clinical trials, explore",
            "probability": 0.020213978052114934,
            "start_logit": -4.8093342781066895,
            "end_logit": -6.710937976837158,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "treatment de-escalation",
            "probability": 0.017123155647986454,
            "start_logit": -6.119137763977051,
            "end_logit": -5.567077159881592,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "explore the methods by which risk groups are assigned, and provide context for the multitude of clinical trials that are currently underway.",
            "probability": 0.013157607781978683,
            "start_logit": -6.140081882476807,
            "end_logit": -5.809564590454102,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Human papillomavirus (HPV)-related oropharyngeal squamous cell cancer",
            "probability": 0.011645316338922806,
            "start_logit": -5.616917133331299,
            "end_logit": -6.454825401306152,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "The purpose of this review is to describe the rationale for treatment",
            "probability": 0.010581109512630709,
            "start_logit": -7.070211410522461,
            "end_logit": -5.097364902496338,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Human papillomavirus (HPV)-related oropharyngeal squamous cell cancer (OPSCC)",
            "probability": 0.01022092541575543,
            "start_logit": -5.616917133331299,
            "end_logit": -6.585292339324951,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "Human papillomavirus",
            "probability": 0.010022489256204766,
            "start_logit": -5.616917133331299,
            "end_logit": -6.604897975921631,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "de-escalation,",
            "probability": 0.009195723551721314,
            "start_logit": -5.828274250030518,
            "end_logit": -6.479633808135986,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "explore the methods by which risk groups are assigned,",
            "probability": 0.008849878217194703,
            "start_logit": -6.140081882476807,
            "end_logit": -6.206161022186279,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        }
    ],
    "58add7699ef3c34033000009": [
        {
            "text": "CPSF",
            "probability": 0.4781690587203739,
            "start_logit": 4.27704381942749,
            "end_logit": 4.136725902557373,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF/CPSF",
            "probability": 0.30539202427734824,
            "start_logit": 3.8286757469177246,
            "end_logit": 4.136725902557373,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF",
            "probability": 0.09887525381133763,
            "start_logit": 3.8286757469177246,
            "end_logit": 3.008988618850708,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPSF) is a multi-protein complex essential for formation of eukaryotic mRNA 3' ends. CPF",
            "probability": 0.05255729176391142,
            "start_logit": 4.27704381942749,
            "end_logit": 1.9286653995513916,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF/CPSF) is a multi-protein complex essential for formation of eukaryotic mRNA 3' ends. CPF",
            "probability": 0.03356674261874868,
            "start_logit": 3.8286757469177246,
            "end_logit": 1.9286653995513916,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh1 endonuclease into an eight-subunit \"CPF",
            "probability": 0.011268112573573357,
            "start_logit": 2.6477408409118652,
            "end_logit": 2.0180413722991943,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh1",
            "probability": 0.00988534473845514,
            "start_logit": 2.6477408409118652,
            "end_logit": 1.887117862701416,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Cleavage and polyadenylation factor (CPF/CPSF",
            "probability": 0.002317053704067132,
            "start_logit": -1.0526241064071655,
            "end_logit": 4.136725902557373,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "(CPF/CPSF",
            "probability": 0.0021043897173747155,
            "start_logit": -1.148895025253296,
            "end_logit": 4.136725902557373,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPSF)",
            "probability": 0.0011403155417438872,
            "start_logit": 4.27704381942749,
            "end_logit": -1.9019334316253662,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Cleavage and polyadenylation factor (CPF",
            "probability": 0.0007501809309730902,
            "start_logit": -1.0526241064071655,
            "end_logit": 3.008988618850708,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF/CPSF)",
            "probability": 0.0007282848299302742,
            "start_logit": 3.8286757469177246,
            "end_logit": -1.9019334316253662,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "(CPF",
            "probability": 0.0006813277717902318,
            "start_logit": -1.148895025253296,
            "end_logit": 3.008988618850708,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "F",
            "probability": 0.0006047184169647394,
            "start_logit": -2.3959128856658936,
            "end_logit": 4.136725902557373,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ysh1 endonuclease",
            "probability": 0.0004680368875701985,
            "start_logit": 2.6477408409118652,
            "end_logit": -1.1631436347961426,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "polyadenylation factor (CPF/CPSF",
            "probability": 0.0004014883992130237,
            "start_logit": -2.805497169494629,
            "end_logit": 4.136725902557373,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "C",
            "probability": 0.0003422877694512351,
            "start_logit": 4.27704381942749,
            "end_logit": -3.105341911315918,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "PF/CPSF",
            "probability": 0.0002981776569384935,
            "start_logit": -3.1029863357543945,
            "end_logit": 4.136725902557373,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "(CPF/CPSF) is a multi-protein complex essential for formation of eukaryotic mRNA 3' ends. CPF",
            "probability": 0.00023130108973804566,
            "start_logit": -1.148895025253296,
            "end_logit": 1.9286653995513916,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "CPF/C",
            "probability": 0.00021860878049664793,
            "start_logit": 3.8286757469177246,
            "end_logit": -3.105341911315918,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        }
    ],
    "587d30fb31b33e8760000001": [
        {
            "text": "accelerated particle swarm optimization algorithm",
            "probability": 0.23248637620822526,
            "start_logit": 2.8193750381469727,
            "end_logit": 2.658230781555176,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm optimization",
            "probability": 0.2039451114864748,
            "start_logit": 2.8193750381469727,
            "end_logit": 2.527250051498413,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm",
            "probability": 0.1393955439860757,
            "start_logit": 2.307858943939209,
            "end_logit": 2.658230781555176,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization",
            "probability": 0.122282605211652,
            "start_logit": 2.307858943939209,
            "end_logit": 2.527250051498413,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm optimization algorithm and deep artificial neural network",
            "probability": 0.04674184149628724,
            "start_logit": 2.8193750381469727,
            "end_logit": 1.0540388822555542,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos",
            "probability": 0.039498381840636185,
            "start_logit": 2.307858943939209,
            "end_logit": 1.3971749544143677,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm and deep artificial neural network",
            "probability": 0.02802574726550952,
            "start_logit": 2.307858943939209,
            "end_logit": 1.0540388822555542,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "particle swarm optimization algorithm",
            "probability": 0.026778402823038425,
            "start_logit": 0.6581391096115112,
            "end_logit": 2.658230781555176,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "particle swarm optimization",
            "probability": 0.02349094359096077,
            "start_logit": 0.6581391096115112,
            "end_logit": 2.527250051498413,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm",
            "probability": 0.019032855688257386,
            "start_logit": 2.8193750381469727,
            "end_logit": 0.15556588768959045,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep artificial neural network",
            "probability": 0.018757017995180012,
            "start_logit": 1.9063032865524292,
            "end_logit": 1.0540388822555542,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm optimization algorithm and deep artificial neural network (CAPSO BP DNN",
            "probability": 0.015956789346299242,
            "start_logit": 2.8193750381469727,
            "end_logit": -0.020716441795229912,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated",
            "probability": 0.013131748186101924,
            "start_logit": 2.8193750381469727,
            "end_logit": -0.21556802093982697,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "accelerated particle swarm optimization algorithm and deep artificial neural network (CAPSO BP DNN)",
            "probability": 0.011811297581636447,
            "start_logit": 2.8193750381469727,
            "end_logit": -0.321544349193573,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm",
            "probability": 0.011411831159933786,
            "start_logit": 2.307858943939209,
            "end_logit": 0.15556588768959045,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep learning and intelligence algorithms, we propose a prediction model based on the chaos-enhanced accelerated particle swarm optimization algorithm",
            "probability": 0.010644062483844422,
            "start_logit": -0.26445436477661133,
            "end_logit": 2.658230781555176,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced accelerated particle swarm optimization algorithm and deep artificial neural network (CAPSO BP DNN",
            "probability": 0.009567465274637909,
            "start_logit": 2.307858943939209,
            "end_logit": -0.020716441795229912,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep learning and intelligence algorithms, we propose a prediction model based on the chaos-enhanced accelerated particle swarm optimization",
            "probability": 0.009337340730849469,
            "start_logit": -0.26445436477661133,
            "end_logit": 2.527250051498413,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "optimization algorithm",
            "probability": 0.009301572120520624,
            "start_logit": -0.399273157119751,
            "end_logit": 2.658230781555176,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "chaos-enhanced",
            "probability": 0.008403065523878811,
            "start_logit": 2.307858943939209,
            "end_logit": -0.15048816800117493,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        }
    ],
    "58a6c94860087bc10a00002a": [
        {
            "text": "H3K27M",
            "probability": 0.9835104332097224,
            "start_logit": 3.66666316986084,
            "end_logit": 3.00081467628479,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M mutation",
            "probability": 0.01406441507160904,
            "start_logit": 3.66666316986084,
            "end_logit": -1.2466657161712646,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H",
            "probability": 0.0010230732819778725,
            "start_logit": 3.66666316986084,
            "end_logit": -3.867502450942993,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M",
            "probability": 0.0005111717444247192,
            "start_logit": -3.8543143272399902,
            "end_logit": 2.9596142768859863,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "M",
            "probability": 0.0003390313457698475,
            "start_logit": -4.264927387237549,
            "end_logit": 2.9596142768859863,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3",
            "probability": 0.00024342061656154054,
            "start_logit": 3.66666316986084,
            "end_logit": -5.303277969360352,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27",
            "probability": 0.00011735794187087254,
            "start_logit": 3.5303611755371094,
            "end_logit": -5.896538257598877,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3K27M-mutant is a new entity introduced to HGG in the latest WHO classification. In this study we evaluated the presence of H",
            "probability": 8.888396150174328e-05,
            "start_logit": 2.0990657806396484,
            "end_logit": -4.743139743804932,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "3K27M",
            "probability": 6.950842807314997e-05,
            "start_logit": -5.890772342681885,
            "end_logit": 3.00081467628479,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "M-mutant is a new entity introduced to HGG in the latest WHO classification. In this study we evaluated the presence of H3K27M",
            "probability": 2.0519355069785404e-05,
            "start_logit": -5.546928405761719,
            "end_logit": 1.4368913173675537,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "M mutation",
            "probability": 3.7785976267214186e-06,
            "start_logit": -4.555387020111084,
            "end_logit": -1.2466657161712646,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "mutation",
            "probability": 2.2064087354743547e-06,
            "start_logit": -5.093373775482178,
            "end_logit": -1.2466657161712646,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M mutation",
            "probability": 2.0686720161639825e-06,
            "start_logit": -3.8543143272399902,
            "end_logit": -2.550184488296509,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.1 variants to examine its prevalence, prognostic impact, and assess its potential clinical value in limited resource settings. H",
            "probability": 1.0495779082366862e-06,
            "start_logit": -3.21551513671875,
            "end_logit": -3.867502450942993,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "3K27M mutation",
            "probability": 9.9398577827532e-07,
            "start_logit": -5.890772342681885,
            "end_logit": -1.2466657161712646,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.1",
            "probability": 6.94327138229624e-07,
            "start_logit": -3.21551513671875,
            "end_logit": -4.280702590942383,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.3",
            "probability": 4.414348405865069e-07,
            "start_logit": -3.8145875930786133,
            "end_logit": -4.134542942047119,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.3 and H3.1",
            "probability": 3.814084216528699e-07,
            "start_logit": -3.8145875930786133,
            "end_logit": -4.280702590942383,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.1 variants to examine its prevalence, prognostic impact, and assess its potential clinical value in limited resource settings.",
            "probability": 3.2090407134422436e-07,
            "start_logit": -3.21551513671875,
            "end_logit": -5.05250358581543,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.1 variants to examine its prevalence, prognostic impact, and assess its potential clinical value in limited resource settings. H3",
            "probability": 2.4972688276876733e-07,
            "start_logit": -3.21551513671875,
            "end_logit": -5.303277969360352,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        }
    ],
    "58da14178acda34529000011": [
        {
            "text": "rob(13;15) and rob(13;14",
            "probability": 0.12390926449139769,
            "start_logit": 2.852466583251953,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;14",
            "probability": 0.10541665052155769,
            "start_logit": 2.6908376216888428,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;15",
            "probability": 0.09921020917538355,
            "start_logit": 2.852466583251953,
            "end_logit": 2.4150476455688477,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13;15) and rob(13;14",
            "probability": 0.08505384366295948,
            "start_logit": 2.4762015342712402,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13;15",
            "probability": 0.06809990887774495,
            "start_logit": 2.4762015342712402,
            "end_logit": 2.4150476455688477,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13",
            "probability": 0.05384443221819984,
            "start_logit": 2.852466583251953,
            "end_logit": 1.803905725479126,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22",
            "probability": 0.050786867872047434,
            "start_logit": 2.4762015342712402,
            "end_logit": 2.1217095851898193,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;15) and rob(13",
            "probability": 0.04796018092282707,
            "start_logit": 2.852466583251953,
            "end_logit": 1.6881778240203857,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14",
            "probability": 0.04377293827047927,
            "start_logit": 1.8119328022003174,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13",
            "probability": 0.03695991529612806,
            "start_logit": 2.4762015342712402,
            "end_logit": 1.803905725479126,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;15) and rob(13;14",
            "probability": 0.03531186817648533,
            "start_logit": 1.59713613986969,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;22), rob(13;15) and rob(13",
            "probability": 0.03292084532178448,
            "start_logit": 2.4762015342712402,
            "end_logit": 1.6881778240203857,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;14",
            "probability": 0.030975189034383958,
            "start_logit": 1.4661035537719727,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22), rob(13;15) and rob(13;14",
            "probability": 0.030710812348091667,
            "start_logit": 1.4575318098068237,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "rob(13;15)",
            "probability": 0.030177788098696996,
            "start_logit": 2.852466583251953,
            "end_logit": 1.2249128818511963,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;15",
            "probability": 0.028273090333821593,
            "start_logit": 1.59713613986969,
            "end_logit": 2.4150476455688477,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22), rob(13;15) and rob(13;14",
            "probability": 0.027171317988565532,
            "start_logit": 1.3350789546966553,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22), rob(13;15",
            "probability": 0.024589171193181037,
            "start_logit": 1.4575318098068237,
            "end_logit": 2.4150476455688477,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "15) and rob(13;14",
            "probability": 0.023100495621161857,
            "start_logit": 1.1727710962295532,
            "end_logit": 2.6373562812805176,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22), rob(13;15",
            "probability": 0.021755210575102664,
            "start_logit": 1.3350789546966553,
            "end_logit": 2.4150476455688477,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        }
    ],
    "58ea59273e8b6dc87c000012": [
        {
            "text": "Viral",
            "probability": 0.5675925983406277,
            "start_logit": -0.3017512261867523,
            "end_logit": -0.895757257938385,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector",
            "probability": 0.23069506788391306,
            "start_logit": -0.3017512261867523,
            "end_logit": -1.7960643768310547,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy",
            "probability": 0.04222919692966922,
            "start_logit": -0.3017512261867523,
            "end_logit": -3.494049310684204,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic",
            "probability": 0.03600546951610255,
            "start_logit": -0.3017512261867523,
            "end_logit": -3.6534903049468994,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based",
            "probability": 0.02604484832970242,
            "start_logit": -0.3017512261867523,
            "end_logit": -3.9773411750793457,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is a potent strategy to enhance the intrinsic reparative abilities of human orthopaedic tissues.",
            "probability": 0.023951892235574947,
            "start_logit": -0.3017512261867523,
            "end_logit": -4.0611138343811035,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "vector",
            "probability": 0.015581589048106689,
            "start_logit": -2.996757984161377,
            "end_logit": -1.7960643768310547,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene",
            "probability": 0.01357025948597924,
            "start_logit": -0.3017512261867523,
            "end_logit": -4.6292805671691895,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is a potent strategy to enhance the intrinsic reparative abilities of human orthopaedic tissues",
            "probability": 0.008068217596314077,
            "start_logit": -0.3017512261867523,
            "end_logit": -5.149228572845459,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is a potent strategy",
            "probability": 0.006473298532692265,
            "start_logit": -0.3017512261867523,
            "end_logit": -5.369475364685059,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-",
            "probability": 0.004963115251415117,
            "start_logit": -0.3017512261867523,
            "end_logit": -5.635127544403076,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is a potent strategy to enhance the intrinsic reparative abilities",
            "probability": 0.004938116153170346,
            "start_logit": -0.3017512261867523,
            "end_logit": -5.640177249908447,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Viral vector-based therapeutic gene therapy is",
            "probability": 0.003972561989248413,
            "start_logit": -0.3017512261867523,
            "end_logit": -5.857749938964844,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "gene therapy",
            "probability": 0.003414444449621534,
            "start_logit": -2.8168482780456543,
            "end_logit": -3.494049310684204,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "vector-based therapeutic gene therapy",
            "probability": 0.0028522412656034,
            "start_logit": -2.996757984161377,
            "end_logit": -3.494049310684204,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "vector-based therapeutic",
            "probability": 0.002431878733386498,
            "start_logit": -2.996757984161377,
            "end_logit": -3.6534903049468994,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "gene therapy is a potent strategy to enhance the intrinsic reparative abilities of human orthopaedic tissues.",
            "probability": 0.0019366317961929712,
            "start_logit": -2.8168482780456543,
            "end_logit": -4.0611138343811035,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "therapeutic gene therapy",
            "probability": 0.0018997164763868834,
            "start_logit": -3.40315842628479,
            "end_logit": -3.494049310684204,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "vector-based",
            "probability": 0.0017591192010134424,
            "start_logit": -2.996757984161377,
            "end_logit": -3.9773411750793457,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "therapeutic",
            "probability": 0.0016197367852792237,
            "start_logit": -3.40315842628479,
            "end_logit": -3.6534903049468994,
            "question_text": "List viral vectors used in gene therapy."
        }
    ],
    "5895b7157d9090f353000009": [
        {
            "text": "microcephaly",
            "probability": 0.38053939730325703,
            "start_logit": 2.9367690086364746,
            "end_logit": 3.4573252201080322,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency, microcephaly",
            "probability": 0.2749860360879207,
            "start_logit": 2.6118996143341064,
            "end_logit": 3.4573252201080322,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly and a distinctive facial gestalt",
            "probability": 0.06269287766193357,
            "start_logit": 2.9367690086364746,
            "end_logit": 1.6539833545684814,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency",
            "probability": 0.05918897701810468,
            "start_logit": 2.6118996143341064,
            "end_logit": 1.9213402271270752,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency, microcephaly and a distinctive facial gestalt",
            "probability": 0.04530323546358471,
            "start_logit": 2.6118996143341064,
            "end_logit": 1.6539833545684814,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability, growth deficiency, microcephaly",
            "probability": 0.04498614896604291,
            "start_logit": 0.8015339374542236,
            "end_logit": 3.4573252201080322,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "facial gestalt",
            "probability": 0.03153691115378068,
            "start_logit": 2.2496798038482666,
            "end_logit": 1.6539833545684814,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "moderate to severe intellectual disability, growth deficiency, microcephaly",
            "probability": 0.021085262004762146,
            "start_logit": 0.04375360906124115,
            "end_logit": 3.4573252201080322,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability, growth deficiency",
            "probability": 0.009682979452937794,
            "start_logit": 0.8015339374542236,
            "end_logit": 1.9213402271270752,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly and a distinctive facial gestalt. Common craniofacial features",
            "probability": 0.009429307131636271,
            "start_logit": 2.9367690086364746,
            "end_logit": -0.24044187366962433,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "distinctive facial gestalt",
            "probability": 0.008196594452633243,
            "start_logit": 0.9022399187088013,
            "end_logit": 1.6539833545684814,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "malformations including moderate to severe intellectual disability, growth deficiency, microcephaly",
            "probability": 0.008142024545965439,
            "start_logit": -0.9077818393707275,
            "end_logit": 3.4573252201080322,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability, growth deficiency, microcephaly and a distinctive facial gestalt",
            "probability": 0.007411351238784098,
            "start_logit": 0.8015339374542236,
            "end_logit": 1.6539833545684814,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "facial gestalt. Common craniofacial features include short upslanting palpebral fissures",
            "probability": 0.006989601579978619,
            "start_logit": 2.2496798038482666,
            "end_logit": 0.1472482681274414,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "growth deficiency, microcephaly and a distinctive facial gestalt. Common craniofacial features",
            "probability": 0.006813822194388669,
            "start_logit": 2.6118996143341064,
            "end_logit": -0.24044187366962433,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "intellectual disability",
            "probability": 0.006604438500314403,
            "start_logit": 0.8015339374542236,
            "end_logit": 1.538712501525879,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "facial gestalt. Common craniofacial features",
            "probability": 0.004743301509553839,
            "start_logit": 2.2496798038482666,
            "end_logit": -0.24044187366962433,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "moderate to severe intellectual disability, growth deficiency",
            "probability": 0.004538467138096994,
            "start_logit": 0.04375360906124115,
            "end_logit": 1.9213402271270752,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly and a distinctive facial gestalt. Common craniofacial",
            "probability": 0.0036349311384165127,
            "start_logit": 2.9367690086364746,
            "end_logit": -1.1936743259429932,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly and a distinctive facial",
            "probability": 0.0034943354579076596,
            "start_logit": 2.9367690086364746,
            "end_logit": -1.2331212759017944,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        }
    ],
    "58f4b73b70f9fc6f0f000014": [
        {
            "text": "rubella",
            "probability": 0.9962111901052817,
            "start_logit": 3.8954524993896484,
            "end_logit": 3.973059892654419,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rub",
            "probability": 0.0021809526795389987,
            "start_logit": 3.8954524993896484,
            "end_logit": -2.151137590408325,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella",
            "probability": 0.0014174666516257647,
            "start_logit": -2.659635543823242,
            "end_logit": 3.973059892654419,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.",
            "probability": 6.660859392552265e-05,
            "start_logit": 3.8954524993896484,
            "end_logit": -5.6398210525512695,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella is lacking.",
            "probability": 5.504088829165454e-05,
            "start_logit": 3.498800277709961,
            "end_logit": -5.433926105499268,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine",
            "probability": 3.091718647124703e-05,
            "start_logit": 3.8954524993896484,
            "end_logit": -6.407342433929443,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella and that susceptible HCWs and doubt cases receive two",
            "probability": 2.8236175359183604e-05,
            "start_logit": 3.8954524993896484,
            "end_logit": -6.498050689697266,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "decline over time, but a formal recommendation regarding the testing of immunized HCWs for the persistence of IgG against rubella",
            "probability": 9.020753634173418e-06,
            "start_logit": -6.962789535522461,
            "end_logit": 3.2191152572631836,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "wild viruses",
            "probability": 1.345194619334155e-07,
            "start_logit": -4.322168827056885,
            "end_logit": -3.627079725265503,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine.",
            "probability": 9.477454332864182e-08,
            "start_logit": -2.659635543823242,
            "end_logit": -5.6398210525512695,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "viruses",
            "probability": 5.975507437683993e-08,
            "start_logit": -5.1336236000061035,
            "end_logit": -3.627079725265503,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella is lacking.",
            "probability": 4.893936732153058e-08,
            "start_logit": -3.526449203491211,
            "end_logit": -5.433926105499268,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella and that susceptible HCWs and doubt cases receive two doses of the MMR vaccine",
            "probability": 4.3990753386795925e-08,
            "start_logit": -2.659635543823242,
            "end_logit": -6.407342433929443,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "ella and that susceptible HCWs and doubt cases receive two",
            "probability": 4.017605638104719e-08,
            "start_logit": -2.659635543823242,
            "end_logit": -6.498050689697266,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "wild",
            "probability": 3.366460918203295e-08,
            "start_logit": -4.322168827056885,
            "end_logit": -5.012341499328613,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "wild viruses.",
            "probability": 3.2023325692155106e-08,
            "start_logit": -4.322168827056885,
            "end_logit": -5.062324047088623,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "two doses of the MMR vaccine. However, a small percentage of the fully immunized will remain unprotected against wild viruses",
            "probability": 2.5213945872566784e-08,
            "start_logit": -5.996480464935303,
            "end_logit": -3.627079725265503,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "wild viruses. Moreover, protective levels of antibodies induced by the vaccine have been shown to decline over time,",
            "probability": 1.9231951858096965e-08,
            "start_logit": -4.322168827056885,
            "end_logit": -5.572215557098389,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "decline over time, but a formal recommendation regarding the testing of immunized HCWs for the persistence of IgG against rub",
            "probability": 1.8026052853671378e-08,
            "start_logit": -6.962789535522461,
            "end_logit": -2.996349811553955,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "a small percentage of the fully immunized will remain unprotected against wild viruses",
            "probability": 1.6650729526203407e-08,
            "start_logit": -6.411423683166504,
            "end_logit": -3.627079725265503,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        }
    ],
    "5895bfdc7d9090f35300000c": [
        {
            "text": "primary adrenal insufficiency",
            "probability": 0.2898445063905738,
            "start_logit": 4.332472324371338,
            "end_logit": 4.867963790893555,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.2251883230622318,
            "start_logit": 4.08006477355957,
            "end_logit": 4.867963790893555,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance, achalasia",
            "probability": 0.11842459461675701,
            "start_logit": 4.08006477355957,
            "end_logit": 4.2253031730651855,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia",
            "probability": 0.10664298766005173,
            "start_logit": 3.9752750396728516,
            "end_logit": 4.2253031730651855,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrima",
            "probability": 0.07933560028267551,
            "start_logit": 3.9752750396728516,
            "end_logit": 3.9295034408569336,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrima",
            "probability": 0.028667964900445736,
            "start_logit": 2.9573683738708496,
            "end_logit": 3.9295034408569336,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.028553530357229517,
            "start_logit": 4.332472324371338,
            "end_logit": 2.5503997802734375,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.02218403825803943,
            "start_logit": 4.08006477355957,
            "end_logit": 2.5503997802734375,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance, achalasia",
            "probability": 0.019902785118377262,
            "start_logit": 2.2966480255126953,
            "end_logit": 4.2253031730651855,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI)",
            "probability": 0.01842526688013299,
            "start_logit": 4.332472324371338,
            "end_logit": 2.112342119216919,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance, achalasia, and alacrima",
            "probability": 0.014806406303028317,
            "start_logit": 2.2966480255126953,
            "end_logit": 3.9295034408569336,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI)",
            "probability": 0.014315106407847944,
            "start_logit": 4.08006477355957,
            "end_logit": 2.112342119216919,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI) due to adrenocorticotropic hormone",
            "probability": 0.010809846710268163,
            "start_logit": 4.332472324371338,
            "end_logit": 1.5790766477584839,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone",
            "probability": 0.008398472972832017,
            "start_logit": 4.08006477355957,
            "end_logit": 1.5790766477584839,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.0037283146118124314,
            "start_logit": 2.2966480255126953,
            "end_logit": 2.5503997802734375,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "primary adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance,",
            "probability": 0.0036573290068657688,
            "start_logit": 4.332472324371338,
            "end_logit": 0.49535229802131653,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency (AI) due to adrenocorticotropic hormone (ACTH) resistance,",
            "probability": 0.0028414814418913016,
            "start_logit": 4.08006477355957,
            "end_logit": 0.49535229802131653,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "cardinal features of primary adrenal insufficiency",
            "probability": 0.001729001153120779,
            "start_logit": -0.789328396320343,
            "end_logit": 4.867963790893555,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone",
            "probability": 0.0014114720294522557,
            "start_logit": 2.2966480255126953,
            "end_logit": 1.5790766477584839,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "insufficiency",
            "probability": 0.0011329718363659055,
            "start_logit": -1.2120281457901,
            "end_logit": 4.867963790893555,
            "question_text": "List cardinal features of the Triple A syndrome."
        }
    ],
    "58dbb3f18acda34529000019": [
        {
            "text": "monoclonal antibodies",
            "probability": 0.8495539531217438,
            "start_logit": 0.7871068716049194,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "antibodies",
            "probability": 0.1278145501370917,
            "start_logit": -1.1070241928100586,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "mon",
            "probability": 0.004216970614682335,
            "start_logit": 0.7871068716049194,
            "end_logit": -4.2619218826293945,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "in the form of monoclonal antibodies",
            "probability": 0.003816821870497445,
            "start_logit": -4.6181864738464355,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "(FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0019268643132558715,
            "start_logit": -5.301710605621338,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "monoclonal",
            "probability": 0.0016366040288050866,
            "start_logit": 0.7871068716049194,
            "end_logit": -5.208415508270264,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Current Food and Drug Administration (FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0012745248367723747,
            "start_logit": -5.715031147003174,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "lonal antibodies",
            "probability": 0.0011304000981321447,
            "start_logit": -5.835032939910889,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "al antibodies",
            "probability": 0.001085220279196773,
            "start_logit": -5.875821590423584,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "form of monoclonal antibodies",
            "probability": 0.0010279917430602002,
            "start_logit": -5.929997444152832,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Food and Drug Administration (FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0010194224675402455,
            "start_logit": -5.938368320465088,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Drug Administration (FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0007874857313517679,
            "start_logit": -6.19651460647583,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0007587685392178848,
            "start_logit": -6.233663082122803,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0007410471470887084,
            "start_logit": -6.257295608520508,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": ") approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0006309214057696838,
            "start_logit": -6.418178558349609,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0006036492257297582,
            "start_logit": -6.462366580963135,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "the form of monoclonal antibodies",
            "probability": 0.0005868698890520663,
            "start_logit": -6.490556716918945,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "Administration (FDA) approved modalities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0005627729609936578,
            "start_logit": -6.5324835777282715,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "lities to inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.00041741166910350325,
            "start_logit": -6.831286907196045,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "inhibit PCSK9 are in the form of monoclonal antibodies",
            "probability": 0.0004077499209148892,
            "start_logit": -6.854705810546875,
            "end_logit": 1.0436725616455078,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        }
    ],
    "5895e4637d9090f353000012": [
        {
            "text": "SAPHO syndrome",
            "probability": 0.4890725563781612,
            "start_logit": 1.964128017425537,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO",
            "probability": 0.36608952571418685,
            "start_logit": 1.964128017425537,
            "end_logit": 0.41384729743003845,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "SAPHO syndrome.",
            "probability": 0.027618866292665096,
            "start_logit": 1.964128017425537,
            "end_logit": -2.1705315113067627,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "imaging features in patients with SAPHO syndrome",
            "probability": 0.02297320681943051,
            "start_logit": -1.0940542221069336,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "imaging features in patients with SAPHO",
            "probability": 0.017196324510501168,
            "start_logit": -1.0940542221069336,
            "end_logit": 0.41384729743003845,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.014637363895976958,
            "start_logit": -1.5448054075241089,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "clinical and imaging features in patients with SAPHO",
            "probability": 0.01095662706177444,
            "start_logit": -1.5448054075241089,
            "end_logit": 0.41384729743003845,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "assess the clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.0066606344037202295,
            "start_logit": -2.3321681022644043,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "The aim was to comparatively assess the clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.006315719413199832,
            "start_logit": -2.385341167449951,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "assess the clinical and imaging features in patients with SAPHO",
            "probability": 0.0049857397599061375,
            "start_logit": -2.3321681022644043,
            "end_logit": 0.41384729743003845,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "The aim was to comparatively assess the clinical and imaging features in patients with SAPHO",
            "probability": 0.004727557689281649,
            "start_logit": -2.385341167449951,
            "end_logit": 0.41384729743003845,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "to comparatively assess the clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.004489347317883401,
            "start_logit": -2.726675510406494,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "aim was to comparatively assess the clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.0038679561206361626,
            "start_logit": -2.8756566047668457,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "imaging",
            "probability": 0.0033979828468024974,
            "start_logit": -1.0940542221069336,
            "end_logit": -1.2076663970947266,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "to comparatively assess the clinical and imaging features in patients with SAPHO",
            "probability": 0.003360448278965381,
            "start_logit": -2.726675510406494,
            "end_logit": 0.41384729743003845,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "syndrome",
            "probability": 0.0031330728911359946,
            "start_logit": -3.0863685607910156,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "aim was to comparatively assess the clinical and imaging features in patients with SAPHO",
            "probability": 0.002895313186602283,
            "start_logit": -2.8756566047668457,
            "end_logit": 0.41384729743003845,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "features in patients with SAPHO syndrome",
            "probability": 0.002856041517914059,
            "start_logit": -3.1789462566375732,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "imaging features",
            "probability": 0.0024266621262715097,
            "start_logit": -1.0940542221069336,
            "end_logit": -1.544331669807434,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "comparatively assess the clinical and imaging features in patients with SAPHO syndrome",
            "probability": 0.0023390537749848265,
            "start_logit": -3.378636360168457,
            "end_logit": 0.7034802436828613,
            "question_text": "List clinical features of the IMAGe syndrome."
        }
    ],
    "5a6d0b2db750ff445500002d": [
        {
            "text": "inter-strand cross-links",
            "probability": 0.3528022906618026,
            "start_logit": 0.5113931894302368,
            "end_logit": -2.2366116046905518,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter-strand cross-links (ICLs",
            "probability": 0.2539366248235798,
            "start_logit": 0.5113931894302368,
            "end_logit": -2.565434694290161,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter-strand cross-links (ICLs)",
            "probability": 0.1553801205051571,
            "start_logit": 0.5113931894302368,
            "end_logit": -3.056644916534424,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter-strand cross-links (ICLs) in S phase",
            "probability": 0.036247315351247644,
            "start_logit": 0.5113931894302368,
            "end_logit": -4.5121541023254395,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links",
            "probability": 0.02703733877457948,
            "start_logit": -2.057295799255371,
            "end_logit": -2.2366116046905518,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis",
            "probability": 0.024186032778731038,
            "start_logit": -2.057295799255371,
            "end_logit": -2.348055124282837,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter",
            "probability": 0.02384596529923062,
            "start_logit": 0.5113931894302368,
            "end_logit": -4.930904388427734,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "ICLs",
            "probability": 0.022850884929364223,
            "start_logit": -1.896701693534851,
            "end_logit": -2.565434694290161,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links (ICLs",
            "probability": 0.01946067453175911,
            "start_logit": -2.057295799255371,
            "end_logit": -2.565434694290161,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "inter-strand cross-links (ICLs) in S phase.",
            "probability": 0.014298003609708931,
            "start_logit": 0.5113931894302368,
            "end_logit": -5.442399501800537,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "ICLs)",
            "probability": 0.013982123517790395,
            "start_logit": -1.896701693534851,
            "end_logit": -3.056644916534424,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mitosis and inter-strand cross-links (ICLs)",
            "probability": 0.011907703175771243,
            "start_logit": -2.057295799255371,
            "end_logit": -3.056644916534424,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "cross-links",
            "probability": 0.009191721410114574,
            "start_logit": -3.136211395263672,
            "end_logit": -2.2366116046905518,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "cross-links (ICLs",
            "probability": 0.006615928447699963,
            "start_logit": -3.136211395263672,
            "end_logit": -2.565434694290161,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "under-replicated DNA in mitosis and inter-strand cross-links",
            "probability": 0.0060240092788322016,
            "start_logit": -3.5587615966796875,
            "end_logit": -2.2366116046905518,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "under-replicated DNA in mitosis",
            "probability": 0.005388728790653014,
            "start_logit": -3.5587615966796875,
            "end_logit": -2.348055124282837,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "mit",
            "probability": 0.004586802398138072,
            "start_logit": -2.057295799255371,
            "end_logit": -4.010647296905518,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "under-replicated DNA in mitosis and inter-strand cross-links (ICLs",
            "probability": 0.004335903208856905,
            "start_logit": -3.5587615966796875,
            "end_logit": -2.565434694290161,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "cross-links (ICLs)",
            "probability": 0.004048190213488501,
            "start_logit": -3.136211395263672,
            "end_logit": -3.056644916534424,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "DNA in mitosis and inter-strand cross-links",
            "probability": 0.003873638293494572,
            "start_logit": -4.0003204345703125,
            "end_logit": -2.2366116046905518,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        }
    ],
    "5a894f6abc7bade53a000004": [
        {
            "text": "oxidative stress",
            "probability": 0.5253166260802806,
            "start_logit": 4.8032612800598145,
            "end_logit": 5.098818302154541,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance oxidative stress",
            "probability": 0.11055132661259191,
            "start_logit": 3.2447400093078613,
            "end_logit": 5.098818302154541,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "myocardial infarction",
            "probability": 0.07514364509246557,
            "start_logit": 4.291574954986572,
            "end_logit": 3.665904998779297,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "hypertension",
            "probability": 0.06992909988720533,
            "start_logit": 4.174817085266113,
            "end_logit": 3.7107431888580322,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "hypertension, and myocardial infarction",
            "probability": 0.06686286159812475,
            "start_logit": 4.174817085266113,
            "end_logit": 3.665904998779297,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxidative stress in vivo. Thus, these findings suggest that ALDH2 functions as a protector against oxidative stress",
            "probability": 0.05192612295686259,
            "start_logit": 4.8032612800598145,
            "end_logit": 2.7846391201019287,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxidative stress in vivo",
            "probability": 0.014249616351340682,
            "start_logit": 4.8032612800598145,
            "end_logit": 1.4915471076965332,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "Alzheimer's disease",
            "probability": 0.014137133965463086,
            "start_logit": 3.1228768825531006,
            "end_logit": 3.164006471633911,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance oxidative stress in vivo. Thus, these findings suggest that ALDH2 functions as a protector against oxidative stress",
            "probability": 0.010927698636845428,
            "start_logit": 3.2447400093078613,
            "end_logit": 2.7846391201019287,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "Alzheimer's disease (LOAD), hypertension",
            "probability": 0.009573381818666885,
            "start_logit": 3.1228768825531006,
            "end_logit": 2.7741880416870117,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxidative stress and the decrease in protection may influence the onset of AD, hypertension",
            "probability": 0.009221758724966193,
            "start_logit": 2.1489009857177734,
            "end_logit": 3.7107431888580322,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oxidative stress and the decrease in protection may influence the onset of AD, hypertension, and myocardial infarction",
            "probability": 0.00881740474728361,
            "start_logit": 2.1489009857177734,
            "end_logit": 3.665904998779297,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "Alzheimer's disease (LOAD), hypertension, and myocardial infarction",
            "probability": 0.007908326580197958,
            "start_logit": 3.1228768825531006,
            "end_logit": 2.583117723464966,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "late-onset Alzheimer's disease",
            "probability": 0.0059103092672179135,
            "start_logit": 2.250770092010498,
            "end_logit": 3.164006471633911,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "alcohol sensitivity",
            "probability": 0.004462703578156153,
            "start_logit": 2.0514841079711914,
            "end_logit": 3.0823490619659424,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "late-onset Alzheimer's disease (LOAD), hypertension",
            "probability": 0.004002342159288504,
            "start_logit": 2.250770092010498,
            "end_logit": 2.7741880416870117,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "late-onset Alzheimer's disease (LOAD), hypertension, and myocardial infarction",
            "probability": 0.0033062327901339,
            "start_logit": 2.250770092010498,
            "end_logit": 2.583117723464966,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "enhance oxidative stress in vivo",
            "probability": 0.0029987895169349722,
            "start_logit": 3.2447400093078613,
            "end_logit": 1.4915471076965332,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "onset of AD, hypertension",
            "probability": 0.0024305980252015405,
            "start_logit": 0.8154725432395935,
            "end_logit": 3.7107431888580322,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "onset of AD, hypertension, and myocardial infarction",
            "probability": 0.002324021610772385,
            "start_logit": 0.8154725432395935,
            "end_logit": 3.665904998779297,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        }
    ],
    "5a76196faacfb9cd4c000001": [
        {
            "text": "immune thrombocytopenic purpura",
            "probability": 0.6522773033240387,
            "start_logit": 4.962793827056885,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.1461389943827368,
            "start_logit": 3.4668822288513184,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "anemia and immune thrombocytopenic purpura",
            "probability": 0.03824710396075415,
            "start_logit": 2.126391887664795,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "direct Coombs' positive hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.03754717091181124,
            "start_logit": 2.107922077178955,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.03365099250526309,
            "start_logit": 3.4668822288513184,
            "end_logit": 3.9827864170074463,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "thrombocytopenic purpura",
            "probability": 0.023737787874920688,
            "start_logit": 1.6493922472000122,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenic purpura without a known underlying etiology",
            "probability": 0.0153772333703218,
            "start_logit": 4.962793827056885,
            "end_logit": 1.7037203311920166,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "a direct Coombs' positive hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.00885691911673696,
            "start_logit": 0.6635230183601379,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "anemia",
            "probability": 0.008807047114068508,
            "start_logit": 2.126391887664795,
            "end_logit": 3.9827864170074463,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "direct Coombs' positive hemolytic anemia",
            "probability": 0.008645875608245241,
            "start_logit": 2.107922077178955,
            "end_logit": 3.9827864170074463,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "purpura",
            "probability": 0.006850718043243432,
            "start_logit": 0.4066775143146515,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenic",
            "probability": 0.005277920722234,
            "start_logit": 4.962793827056885,
            "end_logit": 0.6343644857406616,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "characterized by a direct Coombs' positive hemolytic anemia and immune thrombocytopenic purpura",
            "probability": 0.004301472128890006,
            "start_logit": -0.05871863663196564,
            "end_logit": 5.4513020515441895,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia and immune thrombocytopenic purpura without a known underlying etiology",
            "probability": 0.0034451810750973175,
            "start_logit": 3.4668822288513184,
            "end_logit": 1.7037203311920166,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "a direct Coombs' positive hemolytic anemia",
            "probability": 0.0020394564782378463,
            "start_logit": 0.6635230183601379,
            "end_logit": 3.9827864170074463,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia and immune thrombocytopenic",
            "probability": 0.00118248791250048,
            "start_logit": 3.4668822288513184,
            "end_logit": 0.6343644857406616,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "characterized by a direct Coombs' positive hemolytic anemia",
            "probability": 0.0009904872206235368,
            "start_logit": -0.05871863663196564,
            "end_logit": 3.9827864170074463,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "anemia and immune thrombocytopenic purpura without a known underlying etiology",
            "probability": 0.0009016635108201856,
            "start_logit": 2.126391887664795,
            "end_logit": 1.7037203311920166,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "direct Coombs' positive hemolytic anemia and immune thrombocytopenic purpura without a known underlying etiology",
            "probability": 0.0008851628081553114,
            "start_logit": 2.107922077178955,
            "end_logit": 1.7037203311920166,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenic purpura without a known underlying etiology.",
            "probability": 0.0008390219313008539,
            "start_logit": 4.962793827056885,
            "end_logit": -1.204686164855957,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        }
    ],
    "5a82fc89faa1ab7d2e000028": [
        {
            "text": "H2A.Z-rich\u00a0+1",
            "probability": 0.7659204340409921,
            "start_logit": 4.500911712646484,
            "end_logit": 3.4813809394836426,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A.Z-rich\u00a0+1 nucleosomes",
            "probability": 0.12399787124324887,
            "start_logit": 4.500911712646484,
            "end_logit": 1.660567045211792,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ",
            "probability": 0.09821326954916468,
            "start_logit": 3.119832992553711,
            "end_logit": 2.8085227012634277,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ nucleosomes",
            "probability": 0.0031316658501565095,
            "start_logit": 3.119832992553711,
            "end_logit": -0.6370535492897034,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "the\u00a0+1 nucleosome. How SWR accesses the opposite side of\u00a0+1 to generate a ZZ",
            "probability": 0.0019685043620819346,
            "start_logit": 1.3190346956253052,
            "end_logit": 0.6994537115097046,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "the\u00a0+1",
            "probability": 0.001908212233757259,
            "start_logit": 1.3190346956253052,
            "end_logit": 0.6683464646339417,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic ZZ",
            "probability": 0.0018737886727781092,
            "start_logit": -0.8393459320068359,
            "end_logit": 2.8085227012634277,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "nucleosomes",
            "probability": 0.0010470927003533319,
            "start_logit": -0.27333521842956543,
            "end_logit": 1.660567045211792,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A.Z-rich\u00a0+1 nucleosomes in yeast",
            "probability": 0.0005601288935851298,
            "start_logit": 4.500911712646484,
            "end_logit": -3.739285707473755,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ nucleosomes at promoters",
            "probability": 0.00046080823407155684,
            "start_logit": 3.119832992553711,
            "end_logit": -2.553391933441162,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "Z",
            "probability": 0.00037215326201208386,
            "start_logit": 3.119832992553711,
            "end_logit": -2.7670681476593018,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ nucleosomes at promoter",
            "probability": 0.0002990325487682478,
            "start_logit": 3.119832992553711,
            "end_logit": -2.985821485519409,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ nucleosomes at promoters by replacing the two nucleosomal H2A",
            "probability": 6.989897345938947e-05,
            "start_logit": 3.119832992553711,
            "end_logit": -4.4393229484558105,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic ZZ nucleosomes",
            "probability": 5.974834178605354e-05,
            "start_logit": -0.8393459320068359,
            "end_logit": -0.6370535492897034,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "the\u00a0+1 nucleosome. How SWR accesses the opposite side of\u00a0+1",
            "probability": 3.49512157218398e-05,
            "start_logit": 1.3190346956253052,
            "end_logit": -3.331622362136841,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "s",
            "probability": 2.3497357565554784e-05,
            "start_logit": -4.070219993591309,
            "end_logit": 1.660567045211792,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "nucleosome",
            "probability": 2.2947843642478053e-05,
            "start_logit": -0.27333521842956543,
            "end_logit": -2.1599817276000977,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "ZZ nucleosome",
            "probability": 1.5109240089893495e-05,
            "start_logit": 1.5416498184204102,
            "end_logit": -4.392884254455566,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "the\u00a0+1 nucleosome. How SWR accesses the opposite side of\u00a0+1 to generate a ZZ nucleosome",
            "probability": 1.2093781082526233e-05,
            "start_logit": 1.3190346956253052,
            "end_logit": -4.392884254455566,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "homotypic ZZ nucleosomes at promoters",
            "probability": 8.791655682473007e-06,
            "start_logit": -0.8393459320068359,
            "end_logit": -2.553391933441162,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        }
    ],
    "5a882b5761bb38fb24000013": [
        {
            "text": "Type I",
            "probability": 0.4672928278049773,
            "start_logit": 0.29830944538116455,
            "end_logit": -0.5873925089836121,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy",
            "probability": 0.3110475840306605,
            "start_logit": 0.29830944538116455,
            "end_logit": -0.9944027066230774,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group of autoinflammatory disorders",
            "probability": 0.05674980705819658,
            "start_logit": 0.29830944538116455,
            "end_logit": -2.6956963539123535,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group of autoinflammatory disorders associated with prominent enhanced type I interferon signaling",
            "probability": 0.03350331664564815,
            "start_logit": 0.29830944538116455,
            "end_logit": -3.2227041721343994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group of autoinflammatory disorders associated with prominent enhanced type I interferon signaling.",
            "probability": 0.025816857213886206,
            "start_logit": 0.29830944538116455,
            "end_logit": -3.483320951461792,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group of autoinflammatory",
            "probability": 0.0223800964992068,
            "start_logit": 0.29830944538116455,
            "end_logit": -3.626176595687866,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group of autoinflammatory disorders associated with prominent enhanced type I",
            "probability": 0.016668361476192675,
            "start_logit": 0.29830944538116455,
            "end_logit": -3.9208362102508545,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group of autoinflammatory disorders associated with prominent enhanced type I interferon",
            "probability": 0.015327161133874853,
            "start_logit": 0.29830944538116455,
            "end_logit": -4.0047221183776855,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group",
            "probability": 0.013001196328665646,
            "start_logit": 0.29830944538116455,
            "end_logit": -4.169307231903076,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathy",
            "probability": 0.010283513518784568,
            "start_logit": -3.1110944747924805,
            "end_logit": -0.9944027066230774,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferonopathy is a group of autoinflammatory disorders associated",
            "probability": 0.006183408685312013,
            "start_logit": 0.29830944538116455,
            "end_logit": -4.912478923797607,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type",
            "probability": 0.005829772127410389,
            "start_logit": 0.29830944538116455,
            "end_logit": -4.971370697021484,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "autoinflammatory disorders",
            "probability": 0.0032241289979317305,
            "start_logit": -2.5696799755096436,
            "end_logit": -2.6956963539123535,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "I",
            "probability": 0.002083919636009022,
            "start_logit": -5.114396095275879,
            "end_logit": -0.5873925089836121,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "autoinflammatory disorders associated with prominent enhanced type I interferon signaling",
            "probability": 0.0019034252330294304,
            "start_logit": -2.5696799755096436,
            "end_logit": -3.2227041721343994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathy is a group of autoinflammatory disorders",
            "probability": 0.0018761997778894664,
            "start_logit": -3.1110944747924805,
            "end_logit": -2.6956963539123535,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "pathy",
            "probability": 0.0018695753828741205,
            "start_logit": -4.815925121307373,
            "end_logit": -0.9944027066230774,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "type I interferon signaling",
            "probability": 0.0017838321037076835,
            "start_logit": -2.634571075439453,
            "end_logit": -3.2227041721343994,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "group of autoinflammatory disorders",
            "probability": 0.0017082822316802913,
            "start_logit": -3.2048544883728027,
            "end_logit": -2.6956963539123535,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "autoinflammatory disorders associated with prominent enhanced type I interferon signaling.",
            "probability": 0.001466734114063059,
            "start_logit": -2.5696799755096436,
            "end_logit": -3.483320951461792,
            "question_text": "List the four most important interferonopathies"
        }
    ],
    "5a43b2d7966455904c00000c": [
        {
            "text": "computational",
            "probability": 0.7043200691189393,
            "start_logit": -1.040872573852539,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "a feasible and effective computational",
            "probability": 0.061573064825282284,
            "start_logit": -3.4778809547424316,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method",
            "probability": 0.060683621200457415,
            "start_logit": -1.040872573852539,
            "end_logit": -3.8107404708862305,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method to predict circRNA-disease associations is worthy of more studies.",
            "probability": 0.05442764616774084,
            "start_logit": -1.040872573852539,
            "end_logit": -3.919542074203491,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method to predict circRNA-disease associations is worthy of more studies",
            "probability": 0.027109529623688584,
            "start_logit": -1.040872573852539,
            "end_logit": -4.6165289878845215,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "effective computational",
            "probability": 0.015081302277201336,
            "start_logit": -4.884649753570557,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "feasible and effective computational",
            "probability": 0.013166570828034518,
            "start_logit": -5.0204243659973145,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method to predict circRNA-disease associations",
            "probability": 0.008740066236165628,
            "start_logit": -1.040872573852539,
            "end_logit": -5.7484965324401855,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method to predict",
            "probability": 0.0073889119354177725,
            "start_logit": -1.040872573852539,
            "end_logit": -5.916433811187744,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "identifying disease-related circRNAs in vivo is time- and labor-consuming, a feasible and effective computational",
            "probability": 0.007320449069599118,
            "start_logit": -5.607433795928955,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method to predict circRNA-disease",
            "probability": 0.006413741660879634,
            "start_logit": -1.040872573852539,
            "end_logit": -6.057971477508545,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method to predict circRNA-disease associations is worthy of more",
            "probability": 0.005695123229652521,
            "start_logit": -1.040872573852539,
            "end_logit": -6.176804065704346,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "a feasible and effective computational method",
            "probability": 0.0053050831657867415,
            "start_logit": -3.4778809547424316,
            "end_logit": -3.8107404708862305,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "a feasible and effective computational method to predict circRNA-disease associations is worthy of more studies.",
            "probability": 0.004758173354290577,
            "start_logit": -3.4778809547424316,
            "end_logit": -3.919542074203491,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "computational method to predict circRNA-disease associations is",
            "probability": 0.004482678805248433,
            "start_logit": -1.040872573852539,
            "end_logit": -6.41619348526001,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "While identifying disease-related circRNAs in vivo is time- and labor-consuming, a feasible and effective computational",
            "probability": 0.003289555818142136,
            "start_logit": -6.407352924346924,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "time- and labor-consuming, a feasible and effective computational",
            "probability": 0.0029006179572479795,
            "start_logit": -6.533181667327881,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": ", a feasible and effective computational",
            "probability": 0.0025835093675708395,
            "start_logit": -6.648956775665283,
            "end_logit": -1.3591814041137695,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "a",
            "probability": 0.002390316223754502,
            "start_logit": -3.4778809547424316,
            "end_logit": -4.607980251312256,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "a feasible and effective computational method to predict circRNA-disease associations is worthy of more studies",
            "probability": 0.002369969134899669,
            "start_logit": -3.4778809547424316,
            "end_logit": -4.6165289878845215,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        }
    ],
    "590c740d70f9fc6f0f00001d": [
        {
            "text": "STARD1",
            "probability": 0.19208498351733244,
            "start_logit": 4.607018947601318,
            "end_logit": 3.528169870376587,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD1",
            "probability": 0.1203474923066538,
            "start_logit": 4.139464378356934,
            "end_logit": 3.528169870376587,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh4) and some other sterol-binding proteins (human LXR\u03b2 and STARD1",
            "probability": 0.07628435537357889,
            "start_logit": 3.683548927307129,
            "end_logit": 3.528169870376587,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "STARD1; yeast START-kins Lam4S2",
            "probability": 0.0683757840859889,
            "start_logit": 4.607018947601318,
            "end_logit": 2.495250701904297,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2",
            "probability": 0.06479496633912185,
            "start_logit": 4.139464378356934,
            "end_logit": 2.9090144634246826,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "STARD1; yeast START-kins Lam4S2 and Lam2S2",
            "probability": 0.05797389242681066,
            "start_logit": 4.607018947601318,
            "end_logit": 2.3302247524261475,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Atf2p",
            "probability": 0.050835991165046626,
            "start_logit": 3.4982104301452637,
            "end_logit": 3.307645082473755,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD1; yeast START-kins Lam4S2",
            "probability": 0.042839653566711294,
            "start_logit": 4.139464378356934,
            "end_logit": 2.495250701904297,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh4) and some other sterol-binding proteins (human LXR\u03b2",
            "probability": 0.041071418638603176,
            "start_logit": 3.683548927307129,
            "end_logit": 2.9090144634246826,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Osh4",
            "probability": 0.03980157735692582,
            "start_logit": 3.683548927307129,
            "end_logit": 2.87760853767395,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD1; yeast START-kins Lam4S2 and Lam2S2",
            "probability": 0.036322529981594395,
            "start_logit": 4.139464378356934,
            "end_logit": 2.3302247524261475,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Smoothened and yeast Osh4) and some other sterol-binding proteins (human LXR\u03b2 and STARD1",
            "probability": 0.034695379729876144,
            "start_logit": 2.8956875801086426,
            "end_logit": 3.528169870376587,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Lam2S2",
            "probability": 0.030139391211894562,
            "start_logit": 3.9528591632843018,
            "end_logit": 2.3302247524261475,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "STARD",
            "probability": 0.028767210919270942,
            "start_logit": 4.607018947601318,
            "end_logit": 1.6294682025909424,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Lam4S2",
            "probability": 0.02507800805574161,
            "start_logit": 3.6039915084838867,
            "end_logit": 2.495250701904297,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Lam4S2 and Lam2S2",
            "probability": 0.02126293337234538,
            "start_logit": 3.6039915084838867,
            "end_logit": 2.3302247524261475,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Smoothened and yeast Osh4) and some other sterol-binding proteins (human LXR\u03b2",
            "probability": 0.01867995683692433,
            "start_logit": 2.8956875801086426,
            "end_logit": 2.9090144634246826,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Smoothened and yeast Osh4",
            "probability": 0.018102412132656853,
            "start_logit": 2.8956875801086426,
            "end_logit": 2.87760853767395,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR\u03b2 and STARD",
            "probability": 0.018023593679192804,
            "start_logit": 4.139464378356934,
            "end_logit": 1.6294682025909424,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "LXR",
            "probability": 0.014518469303729829,
            "start_logit": 4.139464378356934,
            "end_logit": 1.4132081270217896,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        }
    ],
    "5a67afb7b750ff445500000d": [
        {
            "text": "polyneuropathy, organomegaly",
            "probability": 0.1893738237289196,
            "start_logit": 3.5901613235473633,
            "end_logit": 3.6099798679351807,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy",
            "probability": 0.18320192893391302,
            "start_logit": 3.5901613235473633,
            "end_logit": 3.57684588432312,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes",
            "probability": 0.11905520797508583,
            "start_logit": 3.5901613235473633,
            "end_logit": 3.1458442211151123,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly",
            "probability": 0.11083495401780014,
            "start_logit": 3.05448055267334,
            "end_logit": 3.6099798679351807,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.09134255475475123,
            "start_logit": 3.5901613235473633,
            "end_logit": 2.880873680114746,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy, M-protein, and skin changes",
            "probability": 0.06967952720005816,
            "start_logit": 3.05448055267334,
            "end_logit": 3.1458442211151123,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy",
            "probability": 0.05346012271792767,
            "start_logit": 3.05448055267334,
            "end_logit": 2.880873680114746,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "skin changes",
            "probability": 0.04261782764952372,
            "start_logit": 2.5628466606140137,
            "end_logit": 3.1458442211151123,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "endocrinopathy, M-protein, and skin changes",
            "probability": 0.031431376513560885,
            "start_logit": 2.258380651473999,
            "end_logit": 3.1458442211151123,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy, M-protein",
            "probability": 0.0289391906441283,
            "start_logit": 3.5901613235473633,
            "end_logit": 1.7314536571502686,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "endocrinopathy",
            "probability": 0.024115049471905032,
            "start_logit": 2.258380651473999,
            "end_logit": 2.880873680114746,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "M-protein, and skin changes",
            "probability": 0.018315047674252526,
            "start_logit": 1.718297004699707,
            "end_logit": 3.1458442211151123,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy, M-protein",
            "probability": 0.01693726092232088,
            "start_logit": 3.05448055267334,
            "end_logit": 1.7314536571502686,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "endocrinopathy, M-protein",
            "probability": 0.007640141179910946,
            "start_logit": 2.258380651473999,
            "end_logit": 1.7314536571502686,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "M-protein",
            "probability": 0.0044519065172890886,
            "start_logit": 1.718297004699707,
            "end_logit": 1.7314536571502686,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "skin changes (POEMS) syndrome at early stage is challenging for neurologists. Since polyneuropathy",
            "probability": 0.002406196696077125,
            "start_logit": 2.5628466606140137,
            "end_logit": 0.27161893248558044,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin",
            "probability": 0.002315129734990755,
            "start_logit": 3.5901613235473633,
            "end_logit": -0.7942773699760437,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy, M-protein, and skin",
            "probability": 0.0013549776451166242,
            "start_logit": 3.05448055267334,
            "end_logit": -0.7942773699760437,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy,",
            "probability": 0.001280299868589624,
            "start_logit": 3.5901613235473633,
            "end_logit": -1.3866487741470337,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy, M-protein,",
            "probability": 0.0012474761538790687,
            "start_logit": 3.5901613235473633,
            "end_logit": -1.4126206636428833,
            "question_text": "List main clinical features of the POEMS syndrome."
        }
    ],
    "5a678d63b750ff4455000003": [
        {
            "text": "redness, swelling, and pain",
            "probability": 0.2783906325239826,
            "start_logit": 4.886386394500732,
            "end_logit": 4.438299655914307,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling, and pain",
            "probability": 0.15528989012673575,
            "start_logit": 4.30265474319458,
            "end_logit": 4.438299655914307,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness",
            "probability": 0.12588135597483324,
            "start_logit": 4.886386394500732,
            "end_logit": 3.6446142196655273,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, swelling",
            "probability": 0.12304493951375875,
            "start_logit": 4.886386394500732,
            "end_logit": 3.621824026107788,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "pain",
            "probability": 0.09165730628850952,
            "start_logit": 3.7754178047180176,
            "end_logit": 4.438299655914307,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, redness, swelling, and pain",
            "probability": 0.06958129872136033,
            "start_logit": 3.499856948852539,
            "end_logit": 4.438299655914307,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling",
            "probability": 0.06863605633747884,
            "start_logit": 4.30265474319458,
            "end_logit": 3.621824026107788,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, redness",
            "probability": 0.03146294167344229,
            "start_logit": 3.499856948852539,
            "end_logit": 3.6446142196655273,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, redness, swelling",
            "probability": 0.03075400423798743,
            "start_logit": 3.499856948852539,
            "end_logit": 3.621824026107788,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat",
            "probability": 0.01671004537095779,
            "start_logit": 3.499856948852539,
            "end_logit": 3.0118138790130615,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "bee sting-heat, redness, swelling, and pain",
            "probability": 0.0028248849709469667,
            "start_logit": 0.29582875967025757,
            "end_logit": 4.438299655914307,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "bee sting-heat, redness",
            "probability": 0.0012773430894270394,
            "start_logit": 0.29582875967025757,
            "end_logit": 3.6446142196655273,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "bee sting-heat, redness, swelling",
            "probability": 0.001248561408953126,
            "start_logit": 0.29582875967025757,
            "end_logit": 3.621824026107788,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "red",
            "probability": 0.0007216730078432644,
            "start_logit": 4.886386394500732,
            "end_logit": -1.5169087648391724,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "bee sting-heat",
            "probability": 0.0006784000428231406,
            "start_logit": 0.29582875967025757,
            "end_logit": 3.0118138790130615,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "sting-heat, redness, swelling, and pain",
            "probability": 0.0005708581486355743,
            "start_logit": -1.303253412246704,
            "end_logit": 4.438299655914307,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness,",
            "probability": 0.00042166487958696265,
            "start_logit": 4.886386394500732,
            "end_logit": -2.054270029067993,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "-heat, redness, swelling, and pain",
            "probability": 0.0003064385217016605,
            "start_logit": -1.9253770112991333,
            "end_logit": 4.438299655914307,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat,",
            "probability": 0.0002835772306233206,
            "start_logit": 3.499856948852539,
            "end_logit": -1.064466953277588,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "sting-heat, redness",
            "probability": 0.0002581279304120925,
            "start_logit": -1.303253412246704,
            "end_logit": 3.6446142196655273,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        }
    ],
    "5a70dbe599e2c3af26000004": [
        {
            "text": "SMAD4",
            "probability": 0.8161503567044199,
            "start_logit": 4.465485572814941,
            "end_logit": 4.20823860168457,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene",
            "probability": 0.1299358420568781,
            "start_logit": 4.465485572814941,
            "end_logit": 2.370680809020996,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "Mutations of the SMAD4",
            "probability": 0.021530059466869377,
            "start_logit": 0.8303370475769043,
            "end_logit": 4.20823860168457,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "the SMAD4",
            "probability": 0.01995308123802489,
            "start_logit": 0.7542705535888672,
            "end_logit": 4.20823860168457,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "Mutations of the SMAD4 gene",
            "probability": 0.0034277095922112,
            "start_logit": 0.8303370475769043,
            "end_logit": 2.370680809020996,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "the SMAD4 gene",
            "probability": 0.0031766455665852428,
            "start_logit": 0.7542705535888672,
            "end_logit": 2.370680809020996,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD",
            "probability": 0.003149457077821581,
            "start_logit": 4.465485572814941,
            "end_logit": -1.3491299152374268,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "4",
            "probability": 0.0006525901165717625,
            "start_logit": -2.665919065475464,
            "end_logit": 4.20823860168457,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "MAD4",
            "probability": 0.0006419632253971268,
            "start_logit": -2.6823372840881348,
            "end_logit": 4.20823860168457,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "S",
            "probability": 0.00039926583062213666,
            "start_logit": 4.465485572814941,
            "end_logit": -3.414487838745117,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with combined clinical features of both juvenile polyposis syndrome (JPS)",
            "probability": 0.00012461794400568416,
            "start_logit": 4.465485572814941,
            "end_logit": -4.57886266708374,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can",
            "probability": 0.00012260521675211446,
            "start_logit": 4.465485572814941,
            "end_logit": -4.5951457023620605,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "4 gene",
            "probability": 0.00010389610887036324,
            "start_logit": -2.665919065475464,
            "end_logit": 2.370680809020996,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "MAD4 gene",
            "probability": 0.00010220424652921477,
            "start_logit": -2.6823372840881348,
            "end_logit": 2.370680809020996,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "of the SMAD4",
            "probability": 0.00010031617897966298,
            "start_logit": -4.538541316986084,
            "end_logit": 4.20823860168457,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with combined clinical features",
            "probability": 9.592684158471758e-05,
            "start_logit": 4.465485572814941,
            "end_logit": -4.840529441833496,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with combined clinical features of both juvenile polyposis syndrome",
            "probability": 8.549058863115351e-05,
            "start_logit": 4.465485572814941,
            "end_logit": -4.955708980560303,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in a distinct syndrome with combined clinical features of both juvenile polyposis",
            "probability": 8.342661952230078e-05,
            "start_logit": 4.465485572814941,
            "end_logit": -4.980147838592529,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "Mutations of the SMAD",
            "probability": 8.30827280988482e-05,
            "start_logit": 0.8303370475769043,
            "end_logit": -1.3491299152374268,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene can result in",
            "probability": 8.146265162467021e-05,
            "start_logit": 4.465485572814941,
            "end_logit": -5.003970623016357,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        }
    ],
    "5a70ce4ab750ff4455000064": [
        {
            "text": "WNT1",
            "probability": 0.9441644877897577,
            "start_logit": 0.3450247049331665,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "collagen metabolism, bone mineralization, or osteoblast differentiation. Bi-allelic mutations in WNT1",
            "probability": 0.021499841895413565,
            "start_logit": -3.437230110168457,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "osteoblast differentiation. Bi-allelic mutations in WNT1",
            "probability": 0.009353420052055512,
            "start_logit": -4.269533634185791,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "bone mineralization, or osteoblast differentiation. Bi-allelic mutations in WNT1",
            "probability": 0.00672874230997057,
            "start_logit": -4.5988874435424805,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "WNT1 have been associated with a rare form of AR OI,",
            "probability": 0.005386230305468746,
            "start_logit": 0.3450247049331665,
            "end_logit": -4.9110188484191895,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Bi-allelic mutations in WNT1",
            "probability": 0.0021074086083548646,
            "start_logit": -5.759816646575928,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "genes involved in collagen metabolism, bone mineralization, or osteoblast differentiation. Bi-allelic mutations in WNT1",
            "probability": 0.002099078492990932,
            "start_logit": -5.763777256011963,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "mutations in WNT1",
            "probability": 0.00200690115675329,
            "start_logit": -5.8086838722229,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "1",
            "probability": 0.0019117540786726449,
            "start_logit": -5.857254505157471,
            "end_logit": 0.2554357945919037,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "Heterozygous WNT1",
            "probability": 0.001033028622275615,
            "start_logit": -4.670530796051025,
            "end_logit": -1.546814203262329,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "type I procollagen-encoding genes account for the majority of OI, but increasingly more rare autosomal recessive",
            "probability": 0.00102304540538255,
            "start_logit": -2.5062758922576904,
            "end_logit": -3.72078013420105,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "WNT1 mutations",
            "probability": 0.00040613510344166497,
            "start_logit": -1.3941863775253296,
            "end_logit": -5.756722927093506,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "collagen metabolism, bone mineralization, or osteoblast differentiation.",
            "probability": 0.0003880150359982191,
            "start_logit": -3.437230110168457,
            "end_logit": -3.7593209743499756,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "type I procollagen-encoding genes",
            "probability": 0.0003657725350488867,
            "start_logit": -2.5062758922576904,
            "end_logit": -4.749307632446289,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "type I procollagen",
            "probability": 0.0003220046393871275,
            "start_logit": -2.5062758922576904,
            "end_logit": -4.876753330230713,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "collagen metabolism",
            "probability": 0.0003125348388778513,
            "start_logit": -3.437230110168457,
            "end_logit": -3.975649118423462,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "type I procollagen-encoding genes account for the majority of OI,",
            "probability": 0.00027416201938877427,
            "start_logit": -2.5062758922576904,
            "end_logit": -5.037600040435791,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "collagen metabolism, bone mineralization, or osteoblast differentiation",
            "probability": 0.0002581299139214747,
            "start_logit": -3.437230110168457,
            "end_logit": -4.1669020652771,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "type I procollagen-encoding",
            "probability": 0.00019050281047075998,
            "start_logit": -2.5062758922576904,
            "end_logit": -5.4016523361206055,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "osteoblast differentiation.",
            "probability": 0.00016880438636988278,
            "start_logit": -4.269533634185791,
            "end_logit": -3.7593209743499756,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        }
    ],
    "5a736efc3b9d13c708000006": [
        {
            "text": "11",
            "probability": 0.45221321219431276,
            "start_logit": 2.374701976776123,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 and 22",
            "probability": 0.19180652186451352,
            "start_logit": 2.374701976776123,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22",
            "probability": 0.10096090599691315,
            "start_logit": 1.7329481840133667,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "chromosomes 11",
            "probability": 0.09517174586345908,
            "start_logit": 0.8162313103675842,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "chromosomes 11 and 22",
            "probability": 0.040367156601341485,
            "start_logit": 0.8162313103675842,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "11 and 22.",
            "probability": 0.023036778377842213,
            "start_logit": 2.374701976776123,
            "end_logit": -0.23848798871040344,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "translocation of chromosomes 11",
            "probability": 0.013871197108490914,
            "start_logit": -1.1096372604370117,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "unbalanced translocation of chromosomes 11",
            "probability": 0.012784180515267285,
            "start_logit": -1.191243290901184,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "22.",
            "probability": 0.012125833854179034,
            "start_logit": 1.7329481840133667,
            "end_logit": -0.23848798871040344,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "an unbalanced translocation of chromosomes 11",
            "probability": 0.00948981068998053,
            "start_logit": -1.489233136177063,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "caused by an unbalanced translocation of chromosomes 11",
            "probability": 0.007365824570497182,
            "start_logit": -1.7426007986068726,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "by an unbalanced translocation of chromosomes 11",
            "probability": 0.006546657952603636,
            "start_logit": -1.8604971170425415,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "translocation of chromosomes 11 and 22",
            "probability": 0.005883477084993935,
            "start_logit": -1.1096372604370117,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.005422418304903169,
            "start_logit": -1.191243290901184,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "syndrome is a rare inherited chromosomal abnormality caused by an unbalanced translocation of chromosomes 11",
            "probability": 0.004900556195877184,
            "start_logit": -2.1501030921936035,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "chromosomes 11 and 22.",
            "probability": 0.0048482670522831785,
            "start_logit": 0.8162313103675842,
            "end_logit": -0.23848798871040344,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "an unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.004025109246068898,
            "start_logit": -1.489233136177063,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "s 11",
            "probability": 0.003279358206586588,
            "start_logit": -2.5518040657043457,
            "end_logit": 2.7385737895965576,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "caused by an unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.003124219181203761,
            "start_logit": -1.7426007986068726,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "by an unbalanced translocation of chromosomes 11 and 22",
            "probability": 0.0027767691386823058,
            "start_logit": -1.8604971170425415,
            "end_logit": 1.8809071779251099,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        }
    ],
    "5a8a9abdfcd1d6a10c000019": [
        {
            "text": "IMD",
            "probability": 0.3933481464397173,
            "start_logit": 4.404305934906006,
            "end_logit": 4.226905822753906,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2, IMD",
            "probability": 0.1838972260851584,
            "start_logit": 3.6439878940582275,
            "end_logit": 4.226905822753906,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD is rapidly conjugated with K63",
            "probability": 0.10897129578980067,
            "start_logit": 4.404305934906006,
            "end_logit": 2.9432952404022217,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2. Through its association with DIAP2, IMD",
            "probability": 0.08296398581291864,
            "start_logit": 2.848017454147339,
            "end_logit": 4.226905822753906,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2, IMD is rapidly conjugated with K63",
            "probability": 0.05094601105924064,
            "start_logit": 3.6439878940582275,
            "end_logit": 2.9432952404022217,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "K63",
            "probability": 0.04736861452503711,
            "start_logit": 3.571181297302246,
            "end_logit": 2.9432952404022217,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2",
            "probability": 0.03763026670390868,
            "start_logit": 3.6439878940582275,
            "end_logit": 2.6403374671936035,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD with the ubiquitin E3-ligase DIAP2. Through its association with DIAP2, IMD",
            "probability": 0.035273208333266776,
            "start_logit": 1.9927345514297485,
            "end_logit": 4.226905822753906,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2. Through its association with DIAP2, IMD is rapidly conjugated with K63",
            "probability": 0.022983947222707753,
            "start_logit": 2.848017454147339,
            "end_logit": 2.9432952404022217,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2. Through its association with DIAP2",
            "probability": 0.016976639503598165,
            "start_logit": 2.848017454147339,
            "end_logit": 2.6403374671936035,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD with the ubiquitin E3-ligase DIAP2. Through its association with DIAP2",
            "probability": 0.007217837187324962,
            "start_logit": 1.9927345514297485,
            "end_logit": 2.6403374671936035,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD with the ubiquitin E3-ligase DIAP2",
            "probability": 0.003432882704689067,
            "start_logit": 1.9927345514297485,
            "end_logit": 1.8971824645996094,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2,",
            "probability": 0.0028344755263098238,
            "start_logit": 3.6439878940582275,
            "end_logit": 0.05438569560647011,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP",
            "probability": 0.0014284630763778837,
            "start_logit": 3.6439878940582275,
            "end_logit": -0.6308721303939819,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2. Through its association with DIAP2,",
            "probability": 0.0012787544018904157,
            "start_logit": 2.848017454147339,
            "end_logit": 0.05438569560647011,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD is rapidly conjugated with K63-linked polyubiquitin chains",
            "probability": 0.0010986533675918812,
            "start_logit": 4.404305934906006,
            "end_logit": -1.653704047203064,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD is rapidly conjugated with K",
            "probability": 0.0006478320024845766,
            "start_logit": 4.404305934906006,
            "end_logit": -2.181913137435913,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2. Through its association with DIAP",
            "probability": 0.0006444414248424457,
            "start_logit": 2.848017454147339,
            "end_logit": -0.6308721303939819,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "IMD with the ubiquitin E3-ligase DIAP2. Through its association with DIAP2,",
            "probability": 0.0005436789226433115,
            "start_logit": 1.9927345514297485,
            "end_logit": 0.05438569560647011,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "DIAP2, IMD is rapidly conjugated with K63-linked polyubiquitin chains",
            "probability": 0.0005136399104914264,
            "start_logit": 3.6439878940582275,
            "end_logit": -1.653704047203064,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        }
    ],
    "5a7723b79e632bc06600000b": [
        {
            "text": "deflazacort",
            "probability": 0.6100414331922476,
            "start_logit": -3.1219193935394287,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort). Deflazacort",
            "probability": 0.10388687277467772,
            "start_logit": -3.1219193935394287,
            "end_logit": -4.118611812591553,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "Deflazacort",
            "probability": 0.07146074057397478,
            "start_logit": -3.4960737228393555,
            "end_logit": -4.118611812591553,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "corticosteroids (prednisone, deflazacort",
            "probability": 0.059619588713264754,
            "start_logit": -5.44746208190918,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids (prednisone, deflazacort",
            "probability": 0.033529479954640236,
            "start_logit": -6.023021221160889,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort).",
            "probability": 0.016893093645683786,
            "start_logit": -3.1219193935394287,
            "end_logit": -5.935009479522705,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort)",
            "probability": 0.015638009631970866,
            "start_logit": -3.1219193935394287,
            "end_logit": -6.012209892272949,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "deflazacort). Deflazacort received FDA approval for DMD in 2016,",
            "probability": 0.012194729459658007,
            "start_logit": -3.1219193935394287,
            "end_logit": -6.260910511016846,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "corticosteroids (prednisone, deflazacort). Deflazacort",
            "probability": 0.010152904852909681,
            "start_logit": -5.44746208190918,
            "end_logit": -4.118611812591553,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "Deflazacort received FDA approval for DMD in 2016,",
            "probability": 0.008388397638809685,
            "start_logit": -3.4960737228393555,
            "end_logit": -6.260910511016846,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "(prednisone, deflazacort",
            "probability": 0.008226882926799092,
            "start_logit": -7.428039073944092,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "off-label prescription of high-dose, daily corticosteroids (prednisone, deflazacort",
            "probability": 0.008108847049532408,
            "start_logit": -7.442490577697754,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "daily corticosteroids (prednisone, deflazacort",
            "probability": 0.007663940735749936,
            "start_logit": -7.49891996383667,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": ", deflazacort",
            "probability": 0.0067020629383252,
            "start_logit": -7.633030891418457,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "oids (prednisone, deflazacort",
            "probability": 0.0061682060659830765,
            "start_logit": -7.716038227081299,
            "end_logit": -2.3483874797821045,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "def",
            "probability": 0.00572086073376383,
            "start_logit": -3.1219193935394287,
            "end_logit": -7.017795085906982,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids (prednisone, deflazacort). Deflazacort",
            "probability": 0.005709895473855632,
            "start_logit": -6.023021221160889,
            "end_logit": -4.118611812591553,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "corticosteroids",
            "probability": 0.004873554497428343,
            "start_logit": -5.44746208190918,
            "end_logit": -4.852548122406006,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids",
            "probability": 0.0027408399044023227,
            "start_logit": -6.023021221160889,
            "end_logit": -4.852548122406006,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "corticosteroids (prednisone,",
            "probability": 0.002279659236323109,
            "start_logit": -5.44746208190918,
            "end_logit": -5.6123456954956055,
            "question_text": "What are the prednisone side effects in DMD patients?"
        }
    ],
    "5a7727f39e632bc06600000d": [
        {
            "text": "inflammation",
            "probability": 0.3672061503333164,
            "start_logit": -4.497118949890137,
            "end_logit": -3.938277006149292,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic inflammation",
            "probability": 0.17713495013897015,
            "start_logit": -5.226130485534668,
            "end_logit": -3.938277006149292,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "inflammation and the fibrofatty replacement of muscle",
            "probability": 0.048122485210953865,
            "start_logit": -4.497118949890137,
            "end_logit": -5.9704508781433105,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "corticosteroid",
            "probability": 0.04762706613312145,
            "start_logit": -5.471648216247559,
            "end_logit": -5.006269931793213,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "dystrophin in patient muscle while also targeting both chronic inflammation",
            "probability": 0.04598997975715539,
            "start_logit": -6.574618816375732,
            "end_logit": -3.938277006149292,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "corticosteroid use",
            "probability": 0.04485570867656693,
            "start_logit": -5.471648216247559,
            "end_logit": -5.066220283508301,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "severe side effects associated with corticosteroid",
            "probability": 0.029568017299826048,
            "start_logit": -5.9483561515808105,
            "end_logit": -5.006269931793213,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "Translarna",
            "probability": 0.029515178733704333,
            "start_logit": -5.234615325927734,
            "end_logit": -5.721799373626709,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "severe side effects associated with corticosteroid use",
            "probability": 0.02784749256730594,
            "start_logit": -5.9483561515808105,
            "end_logit": -5.066220283508301,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "chronic inflammation and the fibrofatty replacement of muscle",
            "probability": 0.02321359272078687,
            "start_logit": -5.226130485534668,
            "end_logit": -5.9704508781433105,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "muscle while also targeting both chronic inflammation",
            "probability": 0.02317928726961675,
            "start_logit": -7.2597832679748535,
            "end_logit": -3.938277006149292,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "corticosteroids",
            "probability": 0.021285916716579922,
            "start_logit": -6.010909557342529,
            "end_logit": -5.272364139556885,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "inflammation and the fibrofatty replacement of muscle.",
            "probability": 0.020117815996609664,
            "start_logit": -4.497118949890137,
            "end_logit": -6.842594623565674,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids",
            "probability": 0.019030651643355063,
            "start_logit": -6.122904300689697,
            "end_logit": -5.272364139556885,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "corticosteroids (prednisone",
            "probability": 0.016734113703621295,
            "start_logit": -6.010909557342529,
            "end_logit": -5.512960433959961,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "high-dose, daily corticosteroids (prednisone",
            "probability": 0.014961116906271502,
            "start_logit": -6.122904300689697,
            "end_logit": -5.512960433959961,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "associated with corticosteroid",
            "probability": 0.011217205449638768,
            "start_logit": -6.917600631713867,
            "end_logit": -5.006269931793213,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "use",
            "probability": 0.01098578795696925,
            "start_logit": -6.8784966468811035,
            "end_logit": -5.066220283508301,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "fibrofatty replacement of muscle",
            "probability": 0.01084299203140641,
            "start_logit": -5.987349510192871,
            "end_logit": -5.9704508781433105,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "associated with corticosteroid use",
            "probability": 0.010564490754224398,
            "start_logit": -6.917600631713867,
            "end_logit": -5.066220283508301,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        }
    ],
    "5a86f074faa1ab7d2e00003a": [
        {
            "text": "renal medullary carcinoma",
            "probability": 0.836824551468869,
            "start_logit": 5.124366283416748,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Renal medullary carcinoma",
            "probability": 0.08255653386519661,
            "start_logit": 3.5487828254699707,
            "end_logit": 3.836848258972168,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary",
            "probability": 0.05162850032251898,
            "start_logit": 5.124366283416748,
            "end_logit": 1.7918553352355957,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "medullary carcinoma",
            "probability": 0.009656391454771537,
            "start_logit": 0.6623718738555908,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal",
            "probability": 0.0035996625135127592,
            "start_logit": 5.124366283416748,
            "end_logit": -0.8713784217834473,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary carcin",
            "probability": 0.0028230147505776044,
            "start_logit": 5.124366283416748,
            "end_logit": -1.1144131422042847,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary car",
            "probability": 0.0028094834588782342,
            "start_logit": 5.124366283416748,
            "end_logit": -1.119217872619629,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medullary carcinoma.",
            "probability": 0.002693061054616191,
            "start_logit": 5.124366283416748,
            "end_logit": -1.1615400314331055,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Renal medullary",
            "probability": 0.0019189676782321121,
            "start_logit": 3.5487828254699707,
            "end_logit": 0.07515231519937515,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "carcinoma",
            "probability": 0.0018963636266301177,
            "start_logit": -0.9653099775314331,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "re",
            "probability": 0.0006080926620079579,
            "start_logit": 5.124366283416748,
            "end_logit": -2.649646520614624,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "medullary",
            "probability": 0.0005957581054020836,
            "start_logit": 0.6623718738555908,
            "end_logit": 1.7918553352355957,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "oma",
            "probability": 0.0005186443549986197,
            "start_logit": -2.2617850303649902,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Renal medullary carcinoma is a rare but highly aggressive type of renal cancer",
            "probability": 0.0005115835925947905,
            "start_logit": 3.5487828254699707,
            "end_logit": -1.2468793392181396,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal me",
            "probability": 0.0002699529934061279,
            "start_logit": 5.124366283416748,
            "end_logit": -3.461725950241089,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "nal medullary carcinoma",
            "probability": 0.00024782776654582903,
            "start_logit": -3.0002694129943848,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "dullary carcinoma",
            "probability": 0.0002383952381766459,
            "start_logit": -3.0390734672546387,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "llary carcinoma",
            "probability": 0.0002265007839593196,
            "start_logit": -3.09025502204895,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "y carcinoma",
            "probability": 0.00019789899223335612,
            "start_logit": -3.2252466678619385,
            "end_logit": 4.577395915985107,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "renal medu",
            "probability": 0.00017881531687224912,
            "start_logit": 5.124366283416748,
            "end_logit": -3.8736202716827393,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        }
    ],
    "5a75fbf383b0d9ea6600000a": [
        {
            "text": "Tofacitinib,",
            "probability": 0.1882009520060933,
            "start_logit": -4.7998881340026855,
            "end_logit": -4.074599742889404,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, a pan-JAK inhibitor,",
            "probability": 0.10116459978066358,
            "start_logit": -4.7998881340026855,
            "end_logit": -4.695361137390137,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, a pan-JAK inhibitor",
            "probability": 0.0997929480616967,
            "start_logit": -4.7998881340026855,
            "end_logit": -4.709012508392334,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": ",",
            "probability": 0.05286117256887276,
            "start_logit": -6.069729328155518,
            "end_logit": -4.074599742889404,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "pan-JAK inhibitor,",
            "probability": 0.04864556612887736,
            "start_logit": -5.532076358795166,
            "end_logit": -4.695361137390137,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "pan-JAK inhibitor",
            "probability": 0.04798599969412194,
            "start_logit": -5.532076358795166,
            "end_logit": -4.709012508392334,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "JAK inhibitor,",
            "probability": 0.047527077253845314,
            "start_logit": -5.555337429046631,
            "end_logit": -4.695361137390137,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "JAK inhibitor",
            "probability": 0.04688267597756834,
            "start_logit": -5.555337429046631,
            "end_logit": -4.709012508392334,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "a pan-JAK inhibitor,",
            "probability": 0.044210653230691906,
            "start_logit": -5.627671241760254,
            "end_logit": -4.695361137390137,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "filgotinib",
            "probability": 0.04376556403292997,
            "start_logit": -4.7993083000183105,
            "end_logit": -5.53384256362915,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "a pan-JAK inhibitor",
            "probability": 0.043611218066296406,
            "start_logit": -5.627671241760254,
            "end_logit": -4.709012508392334,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, a pan-JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.041287908797114026,
            "start_logit": -4.7998881340026855,
            "end_logit": -5.591540336608887,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, a pan-JAK",
            "probability": 0.03494644953902395,
            "start_logit": -4.7998881340026855,
            "end_logit": -5.758293151855469,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": ", a pan-JAK inhibitor,",
            "probability": 0.028414730690062954,
            "start_logit": -6.069729328155518,
            "end_logit": -4.695361137390137,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": ", a pan-JAK inhibitor",
            "probability": 0.028029466335936042,
            "start_logit": -6.069729328155518,
            "end_logit": -4.709012508392334,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib",
            "probability": 0.025598732153034157,
            "start_logit": -4.7998881340026855,
            "end_logit": -6.0695672035217285,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "pan-JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.01985352289306406,
            "start_logit": -5.532076358795166,
            "end_logit": -5.591540336608887,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative colitis",
            "probability": 0.019780204949599155,
            "start_logit": -5.535776138305664,
            "end_logit": -5.591540336608887,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.019397038443335263,
            "start_logit": -5.555337429046631,
            "end_logit": -5.591540336608887,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "a pan-JAK inhibitor, showed efficacy in ulcerative colitis",
            "probability": 0.018043519397172955,
            "start_logit": -5.627671241760254,
            "end_logit": -5.591540336608887,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        }
    ],
    "5a76155c83b0d9ea6600001e": [
        {
            "text": "tofacitinib",
            "probability": 0.24004106357288607,
            "start_logit": -0.6725881099700928,
            "end_logit": -0.3482602834701538,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib",
            "probability": 0.1966940089539031,
            "start_logit": -0.20893721282482147,
            "end_logit": -1.0110719203948975,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib, ruxolitinib",
            "probability": 0.12371720670427473,
            "start_logit": -0.6725881099700928,
            "end_logit": -1.0110719203948975,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib, filgotinib, upadacitinib",
            "probability": 0.08799957907257656,
            "start_logit": -0.20893721282482147,
            "end_logit": -1.8153891563415527,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "filgotinib, upadacitinib",
            "probability": 0.06310734851308729,
            "start_logit": -0.5414320230484009,
            "end_logit": -1.8153891563415527,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib, filgotinib",
            "probability": 0.05295616291585817,
            "start_logit": -0.20893721282482147,
            "end_logit": -2.323256731033325,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "filgotinib",
            "probability": 0.03797657970944021,
            "start_logit": -0.5414320230484009,
            "end_logit": -2.323256731033325,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib",
            "probability": 0.03648226422872514,
            "start_logit": -0.20893721282482147,
            "end_logit": -2.695894956588745,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib, ruxolitinib, peficitinib, filgotinib",
            "probability": 0.03330853129981144,
            "start_logit": -0.6725881099700928,
            "end_logit": -2.323256731033325,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib, ruxolitinib, peficitinib",
            "probability": 0.02294672750141022,
            "start_logit": -0.6725881099700928,
            "end_logit": -2.695894956588745,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "peficitinib, filgotinib, upadacitinib",
            "probability": 0.02201859744765695,
            "start_logit": -1.5943818092346191,
            "end_logit": -1.8153891563415527,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "ruxolitinib, peficitinib, filgotinib, upadacitinib, solcitinib",
            "probability": 0.01385211146720355,
            "start_logit": -0.20893721282482147,
            "end_logit": -3.664283514022827,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tofacitinib, baricitinib",
            "probability": 0.013632696535455367,
            "start_logit": -0.6725881099700928,
            "end_logit": -3.216599225997925,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "peficitinib, filgotinib",
            "probability": 0.013250295579881803,
            "start_logit": -1.5943818092346191,
            "end_logit": -2.323256731033325,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "filgotinib, upadacitinib, solcitinib",
            "probability": 0.009933797811487106,
            "start_logit": -0.5414320230484009,
            "end_logit": -3.664283514022827,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "peficitinib",
            "probability": 0.00912831968626636,
            "start_logit": -1.5943818092346191,
            "end_logit": -2.695894956588745,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "upadacitinib",
            "probability": 0.008343806493323567,
            "start_logit": -2.5647497177124023,
            "end_logit": -1.8153891563415527,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "filgotinib, upadacitinib, solcitinib, itacitinib",
            "probability": 0.006219289262591403,
            "start_logit": -0.5414320230484009,
            "end_logit": -4.132570743560791,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "baricitinib, ruxolitinib",
            "probability": 0.0043147820886989844,
            "start_logit": -4.028539657592773,
            "end_logit": -1.0110719203948975,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "filgotinib, upadacitinib, solcitinib, itacitinib, decernotinib",
            "probability": 0.004076831155462074,
            "start_logit": -0.5414320230484009,
            "end_logit": -4.554906368255615,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        }
    ],
    "5a89a20ffcd1d6a10c00000e": [
        {
            "text": "transforming growth factor-\u03b2",
            "probability": 0.37789554324796876,
            "start_logit": 5.654438018798828,
            "end_logit": 4.436811923980713,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor-C",
            "probability": 0.34027209946859305,
            "start_logit": 5.423373222351074,
            "end_logit": 4.563004493713379,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein (TGFBIp",
            "probability": 0.10341091917755486,
            "start_logit": 5.654438018798828,
            "end_logit": 3.140904664993286,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein",
            "probability": 0.08831223418967782,
            "start_logit": 5.654438018798828,
            "end_logit": 2.9830727577209473,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein (TGFBIp)",
            "probability": 0.0519771300825356,
            "start_logit": 5.654438018798828,
            "end_logit": 2.452997922897339,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced protein (TGFBIp),",
            "probability": 0.011494628829074604,
            "start_logit": 5.654438018798828,
            "end_logit": 0.9440739750862122,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "TGFBIp",
            "probability": 0.007386534227898613,
            "start_logit": 3.0153861045837402,
            "end_logit": 3.140904664993286,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor",
            "probability": 0.004263955954112047,
            "start_logit": 5.654438018798828,
            "end_logit": -0.04760853573679924,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.003971263459930132,
            "start_logit": 5.423373222351074,
            "end_logit": 0.1123431995511055,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "TGFBIp)",
            "probability": 0.0037126722543040632,
            "start_logit": 3.0153861045837402,
            "end_logit": 2.452997922897339,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "extracellular matrix protein, transforming growth factor-\u03b2",
            "probability": 0.0018713626832498,
            "start_logit": 0.3464870750904083,
            "end_logit": 4.436811923980713,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "endothelial growth factor-C",
            "probability": 0.0009547812489071527,
            "start_logit": -0.4526453912258148,
            "end_logit": 4.563004493713379,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth",
            "probability": 0.0008338656301868369,
            "start_logit": 5.654438018798828,
            "end_logit": -1.6794888973236084,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "TGFBIp),",
            "probability": 0.0008210493626612912,
            "start_logit": 3.0153861045837402,
            "end_logit": 0.9440739750862122,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "transforming growth factor-\u03b2 induced",
            "probability": 0.000774774299482125,
            "start_logit": 5.654438018798828,
            "end_logit": -1.752989411354065,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "extracellular matrix protein, transforming growth factor-\u03b2 induced protein (TGFBIp",
            "probability": 0.0005120974265167586,
            "start_logit": 0.3464870750904083,
            "end_logit": 3.140904664993286,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "extracellular matrix protein, transforming growth factor-\u03b2 induced protein",
            "probability": 0.00043732778141957753,
            "start_logit": 0.3464870750904083,
            "end_logit": 2.9830727577209473,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "(TGFBIp",
            "probability": 0.00038816739686285684,
            "start_logit": 0.06940886378288269,
            "end_logit": 3.140904664993286,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "a versatile extracellular matrix protein, transforming growth factor-\u03b2",
            "probability": 0.0003703589469489804,
            "start_logit": -1.2734624147415161,
            "end_logit": 4.436811923980713,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vascular endothelial growth",
            "probability": 0.00033923433211528606,
            "start_logit": 5.423373222351074,
            "end_logit": -2.3478052616119385,
            "question_text": "List factors that promote lymphangiogenesis."
        }
    ],
    "5a86ebf2faa1ab7d2e000038": [
        {
            "text": "clock",
            "probability": 0.8292773478793948,
            "start_logit": 2.0654850006103516,
            "end_logit": 2.7807462215423584,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcriptional clock",
            "probability": 0.13527867326323129,
            "start_logit": 0.2522672414779663,
            "end_logit": 2.7807462215423584,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "The transcriptional clock",
            "probability": 0.011642083113161427,
            "start_logit": -2.2004432678222656,
            "end_logit": 2.7807462215423584,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcription factors and enzymes",
            "probability": 0.0046655317712149215,
            "start_logit": 0.41016724705696106,
            "end_logit": -0.7442888617515564,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcription factors",
            "probability": 0.004031522733683319,
            "start_logit": 0.41016724705696106,
            "end_logit": -0.8903465270996094,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox-sensitive transcription factors and enzymes",
            "probability": 0.004014102147603332,
            "start_logit": 0.2597791254520416,
            "end_logit": -0.7442888617515564,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox-sensitive transcription factors",
            "probability": 0.0034686172674322537,
            "start_logit": 0.2597791254520416,
            "end_logit": -0.8903465270996094,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "transcription",
            "probability": 0.0017426335217032474,
            "start_logit": 0.41016724705696106,
            "end_logit": -1.7290931940078735,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox-sensitive transcription",
            "probability": 0.0014993165420311798,
            "start_logit": 0.2597791254520416,
            "end_logit": -1.7290931940078735,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "enzymes",
            "probability": 0.0005973833066737183,
            "start_logit": -1.6452308893203735,
            "end_logit": -0.7442888617515564,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "cellular redox poise has been shown to feed back to the transcriptional oscillator via redox-sensitive transcription factors and enzymes",
            "probability": 0.000594590518326267,
            "start_logit": -1.6499168872833252,
            "end_logit": -0.7442888617515564,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox poise has been shown to feed back to the transcriptional oscillator via redox-sensitive transcription factors and enzymes",
            "probability": 0.0005164047887728368,
            "start_logit": -1.7908989191055298,
            "end_logit": -0.7442888617515564,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "cellular redox poise has been shown to feed back to the transcriptional oscillator via redox-sensitive transcription factors",
            "probability": 0.0005137903478986874,
            "start_logit": -1.6499168872833252,
            "end_logit": -0.8903465270996094,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors, and, conversely, the cellular",
            "probability": 0.00045468615820208716,
            "start_logit": 2.0654850006103516,
            "end_logit": -4.727956295013428,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "redox poise has been shown to feed back to the transcriptional oscillator via redox-sensitive transcription factors",
            "probability": 0.00044622944346138055,
            "start_logit": -1.7908989191055298,
            "end_logit": -0.8903465270996094,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors,",
            "probability": 0.00034292883713652497,
            "start_logit": 2.0654850006103516,
            "end_logit": -5.010040760040283,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors, and, conversely, the cellular redox",
            "probability": 0.00024602825921819527,
            "start_logit": 2.0654850006103516,
            "end_logit": -5.3421173095703125,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "locomotor activity, and exposure to exogenous and internally generated oxidants. The transcriptional clock",
            "probability": 0.00023599208225954314,
            "start_logit": -6.099026679992676,
            "end_logit": 2.7807462215423584,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "cellular redox poise has been shown to feed back to the transcriptional oscillator via redox-sensitive transcription",
            "probability": 0.00022208687449414664,
            "start_logit": -1.6499168872833252,
            "end_logit": -1.7290931940078735,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock controls the levels of many antioxidant proteins and redox-active cofactors, and, conversely,",
            "probability": 0.00021005114410089856,
            "start_logit": 2.0654850006103516,
            "end_logit": -5.500212669372559,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        }
    ],
    "5a7600b983b0d9ea6600000c": [
        {
            "text": "Oral-treatment Psoriasis Trial",
            "probability": 0.30479721463133896,
            "start_logit": 1.9578529596328735,
            "end_logit": 2.649883270263672,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial",
            "probability": 0.2940358290860804,
            "start_logit": 1.921907901763916,
            "end_logit": 2.649883270263672,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis",
            "probability": 0.08657067190334858,
            "start_logit": 1.9578529596328735,
            "end_logit": 1.391197681427002,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis",
            "probability": 0.08351414667102046,
            "start_logit": 1.921907901763916,
            "end_logit": 1.391197681427002,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "The Oral-treatment Psoriasis Trial",
            "probability": 0.05361995259601748,
            "start_logit": 0.22012752294540405,
            "end_logit": 2.649883270263672,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment",
            "probability": 0.027206319102250808,
            "start_logit": 1.9578529596328735,
            "end_logit": 0.23368585109710693,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial (OPT)",
            "probability": 0.022270912560998737,
            "start_logit": 1.9578529596328735,
            "end_logit": 0.03351804241538048,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial (OPT)",
            "probability": 0.021484600006261213,
            "start_logit": 1.921907901763916,
            "end_logit": 0.03351804241538048,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "The Oral-treatment Psoriasis",
            "probability": 0.015229520155810689,
            "start_logit": 0.22012752294540405,
            "end_logit": 1.391197681427002,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriatic Arthritis triaL",
            "probability": 0.013646623851908552,
            "start_logit": 1.048451542854309,
            "end_logit": 0.45313015580177307,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriatic Arthritis",
            "probability": 0.013430225454567886,
            "start_logit": 1.048451542854309,
            "end_logit": 0.43714579939842224,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial (OPT",
            "probability": 0.009945429647164349,
            "start_logit": 1.9578529596328735,
            "end_logit": -0.7726503014564514,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial (OPT",
            "probability": 0.009594289289875216,
            "start_logit": 1.921907901763916,
            "end_logit": -0.7726503014564514,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Trial",
            "probability": 0.00756822947468085,
            "start_logit": -1.7378345727920532,
            "end_logit": 2.649883270263672,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral-treatment Psoriasis Trial (OPT) study series demonstrated that tofacitinib is efficacious in the treatment of plaque",
            "probability": 0.006855221022986446,
            "start_logit": 1.9578529596328735,
            "end_logit": -1.144752860069275,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Psoriasis Trial (OPT) study series demonstrated that tofacitinib is efficacious in the treatment of plaque",
            "probability": 0.0066131857520422945,
            "start_logit": 1.921907901763916,
            "end_logit": -1.144752860069275,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "OPT)",
            "probability": 0.00646907161021787,
            "start_logit": 0.7216041088104248,
            "end_logit": 0.03351804241538048,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral Psoriatic Arthritis triaL",
            "probability": 0.0059859496315225495,
            "start_logit": 0.22437438368797302,
            "end_logit": 0.45313015580177307,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral Psoriatic Arthritis",
            "probability": 0.005891028725012602,
            "start_logit": 0.22437438368797302,
            "end_logit": 0.43714579939842224,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Oral",
            "probability": 0.005271578826894029,
            "start_logit": 1.9578529596328735,
            "end_logit": -1.4074335098266602,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        }
    ],
    "5a7244aa2dc08e987e00000f": [
        {
            "text": "interleukin 12",
            "probability": 0.4536787701990445,
            "start_logit": 2.844377279281616,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 12 and 23",
            "probability": 0.3411254537265612,
            "start_logit": 2.844377279281616,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12",
            "probability": 0.0901070859647338,
            "start_logit": 1.2279866933822632,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "12 and 23",
            "probability": 0.06775238914135728,
            "start_logit": 1.2279866933822632,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "23",
            "probability": 0.017102264980393918,
            "start_logit": -0.14866212010383606,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "ukin 12",
            "probability": 0.011146996366551485,
            "start_logit": -0.8618420362472534,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "ukin 12 and 23",
            "probability": 0.008381534343253281,
            "start_logit": -0.8618420362472534,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "n 12",
            "probability": 0.002226591572853112,
            "start_logit": -2.4725401401519775,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin",
            "probability": 0.0017752917695949928,
            "start_logit": 2.844377279281616,
            "end_logit": -2.5079987049102783,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "n 12 and 23",
            "probability": 0.0016741957315305187,
            "start_logit": -2.4725401401519775,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inhibits interleukin 12",
            "probability": 0.0011929875359315007,
            "start_logit": -3.0965514183044434,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inter",
            "probability": 0.0010277631179168175,
            "start_logit": 2.844377279281616,
            "end_logit": -3.0545787811279297,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inhibits interleukin 12 and 23",
            "probability": 0.0008970188627213453,
            "start_logit": -3.0965514183044434,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleukin 12 and 23 and",
            "probability": 0.0004608354325283948,
            "start_logit": 2.844377279281616,
            "end_logit": -3.856677770614624,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "interleuki",
            "probability": 0.00033884193269294435,
            "start_logit": 2.844377279281616,
            "end_logit": -4.164185047149658,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "leukin 12",
            "probability": 0.0002557403333258738,
            "start_logit": -4.6366047859191895,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "hibits interleukin 12",
            "probability": 0.0002446633126682894,
            "start_logit": -4.68088436126709,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "s interleukin 12",
            "probability": 0.00023531733674188988,
            "start_logit": -4.719832420349121,
            "end_logit": 3.035425901412964,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "leukin 12 and 23",
            "probability": 0.00019229362926481157,
            "start_logit": -4.6366047859191895,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "hibits interleukin 12 and 23",
            "probability": 0.00018396471033369397,
            "start_logit": -4.68088436126709,
            "end_logit": 2.750286817550659,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        }
    ],
    "5a8842a261bb38fb24000015": [
        {
            "text": "programmed cell death-1",
            "probability": 0.16069219252743971,
            "start_logit": 5.080427646636963,
            "end_logit": 4.3196330070495605,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "cytotoxic T-lymphocyte antigen-4",
            "probability": 0.11490381088365142,
            "start_logit": 4.723665714263916,
            "end_logit": 4.340999603271484,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death-1 (PD-1), programmed cell death ligand-1",
            "probability": 0.10818300962211878,
            "start_logit": 5.080427646636963,
            "end_logit": 3.923966646194458,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death ligand-1",
            "probability": 0.09978506751823539,
            "start_logit": 4.999621868133545,
            "end_logit": 3.923966646194458,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death-1 (PD-1)",
            "probability": 0.06575459553038994,
            "start_logit": 5.080427646636963,
            "end_logit": 3.426071882247925,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death",
            "probability": 0.06154167110571238,
            "start_logit": 5.080427646636963,
            "end_logit": 3.3598568439483643,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "cytotoxic T-lymphocyte antigen-4 (CTLA-4",
            "probability": 0.060756366138419386,
            "start_logit": 4.723665714263916,
            "end_logit": 3.7037761211395264,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death-1 (PD-1",
            "probability": 0.05589438848601267,
            "start_logit": 5.080427646636963,
            "end_logit": 3.263606309890747,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death-1 (PD-1), programmed cell death ligand-1 (PD-L1)",
            "probability": 0.05456889658558174,
            "start_logit": 5.080427646636963,
            "end_logit": 3.2396063804626465,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death ligand-1 (PD-L1)",
            "probability": 0.050332866955797625,
            "start_logit": 4.999621868133545,
            "end_logit": 3.2396063804626465,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "cytotoxic T-lymphocyte antigen-4 (CTLA-4)",
            "probability": 0.04250293014402506,
            "start_logit": 4.723665714263916,
            "end_logit": 3.3464772701263428,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death-1 (PD-1), programmed cell death ligand-1 (PD-L1",
            "probability": 0.031856616051284495,
            "start_logit": 5.080427646636963,
            "end_logit": 2.701387405395508,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death ligand-1 (PD-L1",
            "probability": 0.02938367674076978,
            "start_logit": 4.999621868133545,
            "end_logit": 2.701387405395508,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "CTLA-4",
            "probability": 0.01567868576801382,
            "start_logit": 3.369096040725708,
            "end_logit": 3.7037761211395264,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "PD-1), programmed cell death ligand-1",
            "probability": 0.011228866324610155,
            "start_logit": 2.815091133117676,
            "end_logit": 3.923966646194458,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "CTLA-4)",
            "probability": 0.010968234743167405,
            "start_logit": 3.369096040725708,
            "end_logit": 3.3464772701263428,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "PD-L1) and cytotoxic T-lymphocyte antigen-4",
            "probability": 0.007449703305093446,
            "start_logit": 1.9877445697784424,
            "end_logit": 4.340999603271484,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "PD-1)",
            "probability": 0.0068250048322615366,
            "start_logit": 2.815091133117676,
            "end_logit": 3.426071882247925,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death-1 (PD-1), programmed cell death ligand",
            "probability": 0.0058918530834036675,
            "start_logit": 5.080427646636963,
            "end_logit": 1.0137128829956055,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "PD-1",
            "probability": 0.005801563654011543,
            "start_logit": 2.815091133117676,
            "end_logit": 3.263606309890747,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        }
    ],
    "5a86c938faa1ab7d2e000034": [
        {
            "text": "ETTIN",
            "probability": 0.7759942014489348,
            "start_logit": 2.0065560340881348,
            "end_logit": 0.8127021789550781,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARFs indirectly by facilitating degradation of Aux/IAA repressors, direct ETTIN",
            "probability": 0.1045060794456097,
            "start_logit": 0.001656232518143952,
            "end_logit": 0.8127021789550781,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ETTIN-auxin",
            "probability": 0.03830893257850046,
            "start_logit": 2.0065560340881348,
            "end_logit": -2.1957597732543945,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin affects canonical ARFs indirectly by facilitating degradation of Aux/IAA repressors, direct ETTIN",
            "probability": 0.027652368186075513,
            "start_logit": -1.3278776407241821,
            "end_logit": 0.8127021789550781,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "Aux/IAA repressors, direct ETTIN",
            "probability": 0.016903787365028775,
            "start_logit": -1.8200513124465942,
            "end_logit": 0.8127021789550781,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARFs indirectly by facilitating degradation of Aux",
            "probability": 0.011040415486798466,
            "start_logit": 0.001656232518143952,
            "end_logit": -1.4349803924560547,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARFs indirectly by facilitating degradation of Aux/IAA repressors, direct ETTIN-auxin",
            "probability": 0.005159209107555079,
            "start_logit": 0.001656232518143952,
            "end_logit": -2.1957597732543945,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARFs indirectly by facilitating degradation of Aux/IAA repressors",
            "probability": 0.0039202292131765345,
            "start_logit": 0.001656232518143952,
            "end_logit": -2.470392942428589,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin affects canonical ARFs indirectly by facilitating degradation of Aux",
            "probability": 0.0029213002304530203,
            "start_logit": -1.3278776407241821,
            "end_logit": -1.4349803924560547,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ET",
            "probability": 0.0020710293359180324,
            "start_logit": 2.0065560340881348,
            "end_logit": -5.113397121429443,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "Aux",
            "probability": 0.0017857797058355917,
            "start_logit": -1.8200513124465942,
            "end_logit": -1.4349803924560547,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "repressors, direct ETTIN",
            "probability": 0.0017499451150704878,
            "start_logit": -4.0880045890808105,
            "end_logit": 0.8127021789550781,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ETTIN towards target genes without the requirement for protein degradation. Here we show that ETTIN",
            "probability": 0.0014948527574606626,
            "start_logit": -0.6344394087791443,
            "end_logit": -2.798419713973999,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin affects canonical ARFs indirectly by facilitating degradation of Aux/IAA repressors, direct ETTIN-auxin",
            "probability": 0.001365129670425699,
            "start_logit": -1.3278776407241821,
            "end_logit": -2.1957597732543945,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin affects canonical ARFs indirectly by facilitating degradation of Aux/IAA repressors",
            "probability": 0.0010372948841984395,
            "start_logit": -1.3278776407241821,
            "end_logit": -2.470392942428589,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARFs",
            "probability": 0.0009724821360640716,
            "start_logit": 0.001656232518143952,
            "end_logit": -3.8644466400146484,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin",
            "probability": 0.0008560742172571732,
            "start_logit": -1.7945252656936646,
            "end_logit": -2.1957597732543945,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "Aux/IAA repressors, direct ETTIN-auxin",
            "probability": 0.0008344985687767527,
            "start_logit": -1.8200513124465942,
            "end_logit": -2.1957597732543945,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "ARFs indirectly by facilitating degradation of Aux/IAA repressors,",
            "probability": 0.0007922961344280685,
            "start_logit": 0.001656232518143952,
            "end_logit": -4.069363117218018,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "Aux/IAA repressors",
            "probability": 0.0006340944124327119,
            "start_logit": -1.8200513124465942,
            "end_logit": -2.470392942428589,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        }
    ],
    "5a76018c83b0d9ea6600000e": [
        {
            "text": "thoracopagus",
            "probability": 0.8099553803347223,
            "start_logit": 4.732145309448242,
            "end_logit": 4.546738147735596,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus. Conjoined twins are either symmetrical twins or asymmetrical or heteropagus",
            "probability": 0.08469558074371339,
            "start_logit": 4.732145309448242,
            "end_logit": 2.2888224124908447,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus. Conjoined twins are either symmetrical twins",
            "probability": 0.042764306823878086,
            "start_logit": 4.732145309448242,
            "end_logit": 1.6054627895355225,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus. Conjoined twins are either symmetrical twins or asymmetrical",
            "probability": 0.019946391419377346,
            "start_logit": 4.732145309448242,
            "end_logit": 0.8428072333335876,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "asymmetrical or heteropagus",
            "probability": 0.008675581221745221,
            "start_logit": 2.453594207763672,
            "end_logit": 2.2888224124908447,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical twins or asymmetrical or heteropagus",
            "probability": 0.006181149332637471,
            "start_logit": 2.114586114883423,
            "end_logit": 2.2888224124908447,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "heteropagus",
            "probability": 0.006156911860953324,
            "start_logit": 2.110657215118408,
            "end_logit": 2.2888224124908447,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus. Conjoined twins are either symmetrical",
            "probability": 0.005394633608186014,
            "start_logit": 4.732145309448242,
            "end_logit": -0.46483632922172546,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus.",
            "probability": 0.004647729938567504,
            "start_logit": 4.732145309448242,
            "end_logit": -0.6138620972633362,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical twins",
            "probability": 0.0031209723608246033,
            "start_logit": 2.114586114883423,
            "end_logit": 1.6054627895355225,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "asymmetrical",
            "probability": 0.0020431590092423405,
            "start_logit": 2.453594207763672,
            "end_logit": 0.8428072333335876,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical twins or asymmetrical",
            "probability": 0.0014557031539046562,
            "start_logit": 2.114586114883423,
            "end_logit": 0.8428072333335876,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "most common types of conjoined twins are thoracopagus",
            "probability": 0.0009963654874136365,
            "start_logit": -1.9684749841690063,
            "end_logit": 4.546738147735596,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "either symmetrical twins or asymmetrical or heteropagus",
            "probability": 0.0008150430625930851,
            "start_logit": 0.08856755495071411,
            "end_logit": 2.2888224124908447,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "The most common types of conjoined twins are thoracopagus",
            "probability": 0.0008145334683319867,
            "start_logit": -2.169973611831665,
            "end_logit": 4.546738147735596,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus. Conjoined twins are either symmetrical twins or asymmetrical or heteropagus.",
            "probability": 0.0006281162117639803,
            "start_logit": 4.732145309448242,
            "end_logit": -2.6152710914611816,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "th",
            "probability": 0.00045534804412277114,
            "start_logit": 4.732145309448242,
            "end_logit": -2.936934232711792,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "thoracopagus. Conjoined twins",
            "probability": 0.0004478596079012722,
            "start_logit": 4.732145309448242,
            "end_logit": -2.9535164833068848,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "either symmetrical twins",
            "probability": 0.0004115297551223307,
            "start_logit": 0.08856755495071411,
            "end_logit": 1.6054627895355225,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "symmetrical",
            "probability": 0.00039370455499872947,
            "start_logit": 2.114586114883423,
            "end_logit": -0.46483632922172546,
            "question_text": "List the ten types of conjoined twins."
        }
    ],
    "5a7636d39e632bc066000004": [
        {
            "text": "maftools",
            "probability": 0.6689196018861906,
            "start_logit": 4.552398204803467,
            "end_logit": 3.98695969581604,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR",
            "probability": 0.23614698218917776,
            "start_logit": 4.552398204803467,
            "end_logit": 2.9457502365112305,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "GenVisR",
            "probability": 0.07569128451110264,
            "start_logit": 3.414606809616089,
            "end_logit": 2.9457502365112305,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "Deseq2",
            "probability": 0.005864499186883281,
            "start_logit": 2.190300941467285,
            "end_logit": 1.6123101711273193,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R package maftools",
            "probability": 0.005293218402825737,
            "start_logit": -0.28683921694755554,
            "end_logit": 3.98695969581604,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftool",
            "probability": 0.0021545136563262883,
            "start_logit": 4.552398204803467,
            "end_logit": -1.7511391639709473,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R package maftools and GenVisR",
            "probability": 0.0018686514020083797,
            "start_logit": -0.28683921694755554,
            "end_logit": 2.9457502365112305,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "ma",
            "probability": 0.0014782336953489568,
            "start_logit": 4.552398204803467,
            "end_logit": -2.1278562545776367,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maft",
            "probability": 0.0007344370688981848,
            "start_logit": 4.552398204803467,
            "end_logit": -2.827355146408081,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and G",
            "probability": 0.000603078891367147,
            "start_logit": 4.552398204803467,
            "end_logit": -3.02441143989563,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "G",
            "probability": 0.00019330255896534196,
            "start_logit": 3.414606809616089,
            "end_logit": -3.02441143989563,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR were applied to analyze frequently mutated genes",
            "probability": 0.00019147578778908988,
            "start_logit": 4.552398204803467,
            "end_logit": -4.171698093414307,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR were applied to analyze frequently mutated genes and mutant-allele tumor heterogeneity",
            "probability": 0.00016424371769808033,
            "start_logit": 4.552398204803467,
            "end_logit": -4.325108051300049,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R package Deseq2",
            "probability": 0.0001420235777298031,
            "start_logit": -1.5303783416748047,
            "end_logit": 1.6123101711273193,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "s",
            "probability": 0.00014137240319417609,
            "start_logit": -3.909623384475708,
            "end_logit": 3.98695969581604,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "package maftools",
            "probability": 0.00012572533897975923,
            "start_logit": -4.026921272277832,
            "end_logit": 3.98695969581604,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR were applied",
            "probability": 0.00010293666906588034,
            "start_logit": 4.552398204803467,
            "end_logit": -4.7923455238342285,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "maftools and GenVisR were",
            "probability": 6.966504907689136e-05,
            "start_logit": 4.552398204803467,
            "end_logit": -5.182760715484619,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "GenVisR were applied to analyze frequently mutated genes",
            "probability": 6.137299827495195e-05,
            "start_logit": 3.414606809616089,
            "end_logit": -4.171698093414307,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "R",
            "probability": 5.338100909683734e-05,
            "start_logit": -3.8423564434051514,
            "end_logit": 2.9457502365112305,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        }
    ],
    "5a981e66fcd1d6a10c00002f": [
        {
            "text": "hypertension",
            "probability": 0.48340461478955543,
            "start_logit": -0.02917771227657795,
            "end_logit": -1.1130003929138184,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia (88.4 cm), hypertension",
            "probability": 0.28235538874083516,
            "start_logit": -0.5668652057647705,
            "end_logit": -1.1130003929138184,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia",
            "probability": 0.08477452031259046,
            "start_logit": -0.5668652057647705,
            "end_logit": -2.316171884536743,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension (90.1 cm), hypo-high density lipoproteinaemia",
            "probability": 0.04764030293235574,
            "start_logit": -0.02917771227657795,
            "end_logit": -3.430175304412842,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance (89.0 cm), dysglycaemia (88.4 cm), hypertension",
            "probability": 0.01696320051304315,
            "start_logit": -3.3789854049682617,
            "end_logit": -1.1130003929138184,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia, hypertension",
            "probability": 0.010658887190727748,
            "start_logit": -2.244248390197754,
            "end_logit": -2.7123897075653076,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension and dyslipidaemia were obtained using receiver operator characteristic curve analysis. The prevalence of obesity, type 2 diabetes",
            "probability": 0.009701237867198136,
            "start_logit": -2.1922242641448975,
            "end_logit": -2.8585543632507324,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance, dysglycaemia, hypertension",
            "probability": 0.007873526889871753,
            "start_logit": -2.5471363067626953,
            "end_logit": -2.7123897075653076,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia (88.4 cm),",
            "probability": 0.006975465083827677,
            "start_logit": -0.5668652057647705,
            "end_logit": -4.813767910003662,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hyper-low density lipoproteinaemia",
            "probability": 0.006041706369594409,
            "start_logit": -2.1363792419433594,
            "end_logit": -3.3879663944244385,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypo-high density lipoproteinaemia (87.6 cm) and hyper-low density lipoproteinaemia",
            "probability": 0.005995854385740644,
            "start_logit": -2.1439974308013916,
            "end_logit": -3.3879663944244385,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypo-high density lipoproteinaemia",
            "probability": 0.005748042630239727,
            "start_logit": -2.1439974308013916,
            "end_logit": -3.430175304412842,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance (89.0 cm), dysglycaemia",
            "probability": 0.005093039636581748,
            "start_logit": -3.3789854049682617,
            "end_logit": -2.316171884536743,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension (90.1 cm),",
            "probability": 0.004667463282084481,
            "start_logit": -0.02917771227657795,
            "end_logit": -5.753238677978516,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance, dysglycaemia",
            "probability": 0.004352713419849393,
            "start_logit": -2.5471363067626953,
            "end_logit": -3.305096387863159,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance",
            "probability": 0.004269578784079014,
            "start_logit": -2.5471363067626953,
            "end_logit": -3.32438063621521,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "(89.0 cm), dysglycaemia (88.4 cm), hypertension",
            "probability": 0.0037080639695688624,
            "start_logit": -4.899521827697754,
            "end_logit": -1.1130003929138184,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "hypertension and dyslipidaemia",
            "probability": 0.003430554070697144,
            "start_logit": -2.1922242641448975,
            "end_logit": -3.8980860710144043,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia, hypertension and dyslipidaemia",
            "probability": 0.003256645437630419,
            "start_logit": -2.244248390197754,
            "end_logit": -3.8980860710144043,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "dysglycaemia (88.4 cm)",
            "probability": 0.003089193693928686,
            "start_logit": -0.5668652057647705,
            "end_logit": -5.628256797790527,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        }
    ],
    "5a8861eb8cb19eca6b000001": [
        {
            "text": "gap detection",
            "probability": 0.170932038058022,
            "start_logit": -3.033109188079834,
            "end_logit": -4.3784098625183105,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap",
            "probability": 0.14478921924839977,
            "start_logit": -3.033109188079834,
            "end_logit": -4.544396877288818,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker",
            "probability": 0.11734578083045341,
            "start_logit": -4.132538318634033,
            "end_logit": -3.6551218032836914,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was evoked by the onset of the second marker",
            "probability": 0.07733437111295875,
            "start_logit": -4.132538318634033,
            "end_logit": -4.072108268737793,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker.",
            "probability": 0.05542070755800767,
            "start_logit": -4.132538318634033,
            "end_logit": -4.4052934646606445,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was driven by a different (potentially partially overlapping) synaptic population than that underlying the onset response to the first marker",
            "probability": 0.04260056279834702,
            "start_logit": -3.9595932960510254,
            "end_logit": -4.841324329376221,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap is bounded by two short markers",
            "probability": 0.041746981845693115,
            "start_logit": -5.300912380218506,
            "end_logit": -3.5202455520629883,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "two short markers",
            "probability": 0.03510910174042256,
            "start_logit": -5.474079132080078,
            "end_logit": -3.5202455520629883,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "second marker with minimal contribution from the offset of the first marker",
            "probability": 0.03493370718521583,
            "start_logit": -5.344211101531982,
            "end_logit": -3.6551218032836914,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "two short markers, a gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker",
            "probability": 0.03067917711150154,
            "start_logit": -5.474079132080078,
            "end_logit": -3.6551218032836914,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "When a gap is bounded by two short markers",
            "probability": 0.029585967695985625,
            "start_logit": -5.645239353179932,
            "end_logit": -3.5202455520629883,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "markers",
            "probability": 0.02776557431182507,
            "start_logit": -5.708742618560791,
            "end_logit": -3.5202455520629883,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker. Importantly,",
            "probability": 0.026137789170129714,
            "start_logit": -4.132538318634033,
            "end_logit": -5.156864643096924,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "a gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker",
            "probability": 0.026005550896699255,
            "start_logit": -5.639353275299072,
            "end_logit": -3.6551218032836914,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap-related responses. When a gap is bounded by two short markers",
            "probability": 0.02444279491061176,
            "start_logit": -5.8362040519714355,
            "end_logit": -3.5202455520629883,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "markers, a gap termination response was evoked by the onset of the second marker with minimal contribution from the offset of the first marker",
            "probability": 0.024262226308521515,
            "start_logit": -5.708742618560791,
            "end_logit": -3.6551218032836914,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "gap is bounded by two short markers, a gap termination response was evoked by the onset of the second marker",
            "probability": 0.024041089787248563,
            "start_logit": -5.300912380218506,
            "end_logit": -4.072108268737793,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "first marker",
            "probability": 0.023626510819257155,
            "start_logit": -5.735293865203857,
            "end_logit": -3.6551218032836914,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "second marker",
            "probability": 0.02302235544127723,
            "start_logit": -5.344211101531982,
            "end_logit": -4.072108268737793,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "two short markers, a gap termination response was evoked by the onset of the second marker",
            "probability": 0.02021849316942231,
            "start_logit": -5.474079132080078,
            "end_logit": -4.072108268737793,
            "question_text": "List the two most important synaptic markers."
        }
    ],
    "5a68fd01b750ff445500001b": [
        {
            "text": "integrative literature review",
            "probability": 0.1457816739156984,
            "start_logit": -6.283701419830322,
            "end_logit": -6.407148838043213,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "integrative literature review is to identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.1394765969493581,
            "start_logit": -6.283701419830322,
            "end_logit": -6.451362133026123,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "in",
            "probability": 0.08117989153758418,
            "start_logit": -6.283701419830322,
            "end_logit": -6.992591381072998,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "review",
            "probability": 0.06589253072888472,
            "start_logit": -7.077786445617676,
            "end_logit": -6.407148838043213,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "review is to identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.06304266992955812,
            "start_logit": -7.077786445617676,
            "end_logit": -6.451362133026123,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "testing is an essential tool for identifying people at risk for HIV infection",
            "probability": 0.04538976918118718,
            "start_logit": -7.083362102508545,
            "end_logit": -6.774311542510986,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "to identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.044395521573815454,
            "start_logit": -7.428459644317627,
            "end_logit": -6.451362133026123,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "integrative literature review is to",
            "probability": 0.04434180490368233,
            "start_logit": -6.283701419830322,
            "end_logit": -7.5973310470581055,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "integrative",
            "probability": 0.04089875896775738,
            "start_logit": -6.283701419830322,
            "end_logit": -7.678159236907959,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "testing",
            "probability": 0.04040240651482434,
            "start_logit": -7.083362102508545,
            "end_logit": -6.890708923339844,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "The main aim of this integrative literature review",
            "probability": 0.03986646625455756,
            "start_logit": -7.580276012420654,
            "end_logit": -6.407148838043213,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.032001575034553996,
            "start_logit": -7.755813121795654,
            "end_logit": -6.451362133026123,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "treatment, and the process of HIV prevention. The main aim of this integrative literature review",
            "probability": 0.03123927866823211,
            "start_logit": -7.8241353034973145,
            "end_logit": -6.407148838043213,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "this integrative literature review",
            "probability": 0.030348945829113454,
            "start_logit": -7.8530497550964355,
            "end_logit": -6.407148838043213,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "testing is an essential tool for identifying people at risk for HIV infection and linking those who are infected to care",
            "probability": 0.02964780757729536,
            "start_logit": -7.083362102508545,
            "end_logit": -7.200210094451904,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "this integrative literature review is to identify facilitators, barriers, and outcomes of self-initiated HIV testing.",
            "probability": 0.02903634984801293,
            "start_logit": -7.8530497550964355,
            "end_logit": -6.451362133026123,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "identifying people at risk for HIV infection",
            "probability": 0.028431482822212688,
            "start_logit": -7.551151752471924,
            "end_logit": -6.774311542510986,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "infection",
            "probability": 0.026384197581484043,
            "start_logit": -7.62588357925415,
            "end_logit": -6.774311542510986,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "The main aim of this in",
            "probability": 0.022200015403878805,
            "start_logit": -7.580276012420654,
            "end_logit": -6.992591381072998,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "review is to",
            "probability": 0.020042256778308724,
            "start_logit": -7.077786445617676,
            "end_logit": -7.5973310470581055,
            "question_text": "What is included in the fourth generation HIV test?"
        }
    ],
    "5a6f7e6ab750ff4455000052": [
        {
            "text": "beneficence, justice and autonomy or individual freedom",
            "probability": 0.23167118708065787,
            "start_logit": 4.5800676345825195,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence",
            "probability": 0.19386373994012876,
            "start_logit": 4.5800676345825195,
            "end_logit": 4.030810832977295,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, justice and autonomy",
            "probability": 0.1690461759035344,
            "start_logit": 4.5800676345825195,
            "end_logit": 3.893827199935913,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, justice",
            "probability": 0.14549753956302455,
            "start_logit": 4.5800676345825195,
            "end_logit": 3.743814468383789,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "individual freedom",
            "probability": 0.05917064946320039,
            "start_logit": 3.2151741981506348,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "justice and autonomy or individual freedom",
            "probability": 0.050202777549465054,
            "start_logit": 3.050818920135498,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "autonomy or individual freedom",
            "probability": 0.045515379420479736,
            "start_logit": 2.952798843383789,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "justice and autonomy",
            "probability": 0.0366320372913625,
            "start_logit": 3.050818920135498,
            "end_logit": 3.893827199935913,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "autonomy",
            "probability": 0.03321172966214284,
            "start_logit": 2.952798843383789,
            "end_logit": 3.893827199935913,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "justice",
            "probability": 0.031529085272627974,
            "start_logit": 3.050818920135498,
            "end_logit": 3.743814468383789,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, justice and autonomy or individual freedom.",
            "probability": 0.0010245021326243913,
            "start_logit": 4.5800676345825195,
            "end_logit": -1.2121379375457764,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence, justice and autonomy or individual freedom",
            "probability": 0.00041936483417774834,
            "start_logit": -1.7342654466629028,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence",
            "probability": 0.00035092682943246286,
            "start_logit": -1.7342654466629028,
            "end_logit": 4.030810832977295,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence, justice and autonomy",
            "probability": 0.00030600275510949337,
            "start_logit": -1.7342654466629028,
            "end_logit": 3.893827199935913,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "ethics are beneficence, justice and autonomy or individual freedom",
            "probability": 0.0002973920283795416,
            "start_logit": -2.077955484390259,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "basic principles of ethics are beneficence, justice",
            "probability": 0.000263375658928509,
            "start_logit": -1.7342654466629028,
            "end_logit": 3.743814468383789,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "individual freedom.",
            "probability": 0.0002616659297503132,
            "start_logit": 3.2151741981506348,
            "end_logit": -1.2121379375457764,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "principles of ethics are beneficence, justice and autonomy or individual freedom",
            "probability": 0.0002517418187310627,
            "start_logit": -2.244602680206299,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "ethics are beneficence",
            "probability": 0.0002488593060558989,
            "start_logit": -2.077955484390259,
            "end_logit": 4.030810832977295,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "freedom",
            "probability": 0.0002358675601868947,
            "start_logit": -2.3097362518310547,
            "end_logit": 4.208974361419678,
            "question_text": "List four principles of medical ethics."
        }
    ],
    "5a70d12899e2c3af26000001": [
        {
            "text": "uveitis",
            "probability": 0.21084771826706286,
            "start_logit": 4.7704925537109375,
            "end_logit": 5.170101165771484,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis, or facial paralysis",
            "probability": 0.1405046309247755,
            "start_logit": 4.7704925537109375,
            "end_logit": 4.764205455780029,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever, uveitis",
            "probability": 0.1212876255473904,
            "start_logit": 4.2175211906433105,
            "end_logit": 5.170101165771484,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever, uveitis",
            "probability": 0.11535616331445919,
            "start_logit": 4.1673808097839355,
            "end_logit": 5.170101165771484,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial paralysis",
            "probability": 0.10098067381635903,
            "start_logit": 4.440181255340576,
            "end_logit": 4.764205455780029,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever, uveitis, or facial paralysis",
            "probability": 0.08082360674016628,
            "start_logit": 4.2175211906433105,
            "end_logit": 4.764205455780029,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever, uveitis, or facial paralysis",
            "probability": 0.0768710009508703,
            "start_logit": 4.1673808097839355,
            "end_logit": 4.764205455780029,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis",
            "probability": 0.05485087388353248,
            "start_logit": 4.2175211906433105,
            "end_logit": 4.376554489135742,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever",
            "probability": 0.045332811006004226,
            "start_logit": 4.2175211906433105,
            "end_logit": 4.185967445373535,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever",
            "probability": 0.04311585065921551,
            "start_logit": 4.1673808097839355,
            "end_logit": 4.185967445373535,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis,",
            "probability": 0.0023700760029088976,
            "start_logit": 4.7704925537109375,
            "end_logit": 0.6818870306015015,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever,",
            "probability": 0.0015770328492138892,
            "start_logit": 4.2175211906433105,
            "end_logit": 0.8274815082550049,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever,",
            "probability": 0.0014999094762153044,
            "start_logit": 4.1673808097839355,
            "end_logit": 0.8274815082550049,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis, and other major symptoms include fever, uveitis,",
            "probability": 0.001363357844809911,
            "start_logit": 4.2175211906433105,
            "end_logit": 0.6818870306015015,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever, uveitis,",
            "probability": 0.001296684055707652,
            "start_logit": 4.1673808097839355,
            "end_logit": 0.6818870306015015,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "paralysis",
            "probability": 0.0011207770625772584,
            "start_logit": -0.06072564423084259,
            "end_logit": 4.764205455780029,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotitis,",
            "probability": 0.0002507550937840867,
            "start_logit": 4.2175211906433105,
            "end_logit": -1.011342167854309,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis, or facial",
            "probability": 0.00020451579044058175,
            "start_logit": 4.7704925537109375,
            "end_logit": -1.7681450843811035,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "veitis",
            "probability": 0.0001989512223641272,
            "start_logit": -2.1953392028808594,
            "end_logit": 5.170101165771484,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial",
            "probability": 0.00014698549214247697,
            "start_logit": 4.440181255340576,
            "end_logit": -1.7681450843811035,
            "question_text": "List symptoms of Heerfordt syndrome."
        }
    ],
    "5a8dc6b4fcd1d6a10c000026": [
        {
            "text": "infliximab",
            "probability": 0.9833335907170208,
            "start_logit": 5.482542991638184,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab",
            "probability": 0.012670856867413411,
            "start_logit": 1.13089919090271,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "liximab",
            "probability": 0.001363836804569183,
            "start_logit": -1.0981035232543945,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "inflixima",
            "probability": 0.0006770007164821678,
            "start_logit": 5.482542991638184,
            "end_logit": -2.0087692737579346,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "inflix",
            "probability": 0.00031374520326415934,
            "start_logit": 5.482542991638184,
            "end_logit": -2.777860403060913,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "There are limited data concerning infliximab",
            "probability": 0.0002493156944121544,
            "start_logit": -2.797440767288208,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "in",
            "probability": 0.0002312742560162634,
            "start_logit": 5.482542991638184,
            "end_logit": -3.0828373432159424,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug monitoring",
            "probability": 0.0001937839136026798,
            "start_logit": 5.482542991638184,
            "end_logit": -3.259697914123535,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug monitoring during de-escalation of the treatment of inflammatory bowel disease (IBD).",
            "probability": 0.0001890165227084892,
            "start_logit": 5.482542991638184,
            "end_logit": -3.284607172012329,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "b",
            "probability": 0.00014671379237258479,
            "start_logit": -3.327677011489868,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "limited data concerning infliximab",
            "probability": 0.00012223243615269662,
            "start_logit": -3.5102362632751465,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug",
            "probability": 0.00010605733028452952,
            "start_logit": 5.482542991638184,
            "end_logit": -3.862461805343628,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "inf",
            "probability": 7.690979781916532e-05,
            "start_logit": 5.482542991638184,
            "end_logit": -4.183808326721191,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "imab",
            "probability": 6.458013088645786e-05,
            "start_logit": -4.148253917694092,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug monitoring during de-escalation",
            "probability": 6.331917114951986e-05,
            "start_logit": 5.482542991638184,
            "end_logit": -4.37825345993042,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug monitoring during de-escalation of the treatment of inflammatory bowel disease",
            "probability": 5.376545133776437e-05,
            "start_logit": 5.482542991638184,
            "end_logit": -4.541810512542725,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "infliximab drug monitoring during de-escalation of the treatment",
            "probability": 5.3512596795058344e-05,
            "start_logit": 5.482542991638184,
            "end_logit": -4.546524524688721,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "data concerning infliximab",
            "probability": 4.1677520345003855e-05,
            "start_logit": -4.586198806762695,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "concerning infliximab",
            "probability": 2.78478176070708e-05,
            "start_logit": -4.989406108856201,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "are limited data concerning infliximab",
            "probability": 2.096325976099794e-05,
            "start_logit": -5.2733893394470215,
            "end_logit": 5.272262096405029,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        }
    ],
    "5a75dff883b0d9ea66000003": [
        {
            "text": "manually",
            "probability": 0.5686319659351492,
            "start_logit": 2.1445765495300293,
            "end_logit": 2.4316086769104004,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories",
            "probability": 0.20613962819862527,
            "start_logit": 2.1445765495300293,
            "end_logit": 1.416929006576538,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated",
            "probability": 0.0519090498573826,
            "start_logit": 2.1445765495300293,
            "end_logit": 0.03786840662360191,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data",
            "probability": 0.04365215309138817,
            "start_logit": 2.1445765495300293,
            "end_logit": -0.135372132062912,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions",
            "probability": 0.026229467755496255,
            "start_logit": 2.1445765495300293,
            "end_logit": -0.6447412371635437,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding",
            "probability": 0.020819919545987862,
            "start_logit": 2.1445765495300293,
            "end_logit": -0.8757145404815674,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories,",
            "probability": 0.01814342267677098,
            "start_logit": 2.1445765495300293,
            "end_logit": -1.0133166313171387,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data,",
            "probability": 0.012576184034924302,
            "start_logit": 2.1445765495300293,
            "end_logit": -1.3798198699951172,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "(1) manually",
            "probability": 0.010163440956858897,
            "start_logit": -1.8798598051071167,
            "end_logit": 2.4316086769104004,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "repositories",
            "probability": 0.005768564349187892,
            "start_logit": -1.4315539598464966,
            "end_logit": 1.416929006576538,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP",
            "probability": 0.005738188546955995,
            "start_logit": 2.1445765495300293,
            "end_logit": -2.1644811630249023,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived",
            "probability": 0.005263357100049582,
            "start_logit": 2.1445765495300293,
            "end_logit": -2.2508556842803955,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "interactions derived from ChIP-seq binding data",
            "probability": 0.004742020077165442,
            "start_logit": -0.07521283626556396,
            "end_logit": -0.135372132062912,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq",
            "probability": 0.003830053031571109,
            "start_logit": 2.1445765495300293,
            "end_logit": -2.5687460899353027,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "(1) manually curated repositories",
            "probability": 0.0036844357432844563,
            "start_logit": -1.8798598051071167,
            "end_logit": 1.416929006576538,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "interactions",
            "probability": 0.0028493591702001306,
            "start_logit": -0.07521283626556396,
            "end_logit": -0.6447412371635437,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "ChIP-seq binding data",
            "probability": 0.002562469581296648,
            "start_logit": -0.6907045841217041,
            "end_logit": -0.135372132062912,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data, (3) in silico prediction",
            "probability": 0.0025140298668177544,
            "start_logit": 2.1445765495300293,
            "end_logit": -2.9897377490997314,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "manually curated re",
            "probability": 0.002418714593110655,
            "start_logit": 2.1445765495300293,
            "end_logit": -3.028388500213623,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "curated repositories",
            "probability": 0.002363575887776674,
            "start_logit": -2.3238015174865723,
            "end_logit": 1.416929006576538,
            "question_text": "Name curated data resources for ChIP-seq data"
        }
    ],
    "5a75df9883b0d9ea66000002": [
        {
            "text": "gastric stromal sarcomas",
            "probability": 0.18980250867125292,
            "start_logit": 5.917974948883057,
            "end_logit": 5.142306804656982,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcoma",
            "probability": 0.18771418769002723,
            "start_logit": 5.917974948883057,
            "end_logit": 5.1312432289123535,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas",
            "probability": 0.1709949482224732,
            "start_logit": 5.8057026863098145,
            "end_logit": 5.150228977203369,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcomas",
            "probability": 0.1696456484876744,
            "start_logit": 5.8057026863098145,
            "end_logit": 5.142306804656982,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcoma",
            "probability": 0.16777910536561239,
            "start_logit": 5.8057026863098145,
            "end_logit": 5.1312432289123535,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paraganglioma",
            "probability": 0.07481280918039009,
            "start_logit": 5.8057026863098145,
            "end_logit": 4.323584079742432,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome",
            "probability": 0.010174310532328017,
            "start_logit": 5.917974948883057,
            "end_logit": 2.216188669204712,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcomas or Carney-Stratakis syndrome",
            "probability": 0.009093807664899338,
            "start_logit": 5.8057026863098145,
            "end_logit": 2.216188669204712,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis and renal cancer",
            "probability": 0.00426945835920443,
            "start_logit": 5.917974948883057,
            "end_logit": 1.3478096723556519,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis",
            "probability": 0.0033062516393090814,
            "start_logit": 5.917974948883057,
            "end_logit": 1.0921378135681152,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric",
            "probability": 0.002964465923535244,
            "start_logit": 5.917974948883057,
            "end_logit": 0.9830195903778076,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis",
            "probability": 0.0029551306109737267,
            "start_logit": 5.8057026863098145,
            "end_logit": 1.0921378135681152,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric",
            "probability": 0.0026496422388642463,
            "start_logit": 5.8057026863098145,
            "end_logit": 0.9830195903778076,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "Carney-Stratakis syndrome",
            "probability": 0.0006787907828514504,
            "start_logit": 3.2106666564941406,
            "end_logit": 2.216188669204712,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "stromal sarcomas",
            "probability": 0.0006590246519976318,
            "start_logit": 0.25499650835990906,
            "end_logit": 5.142306804656982,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "stromal sarcoma",
            "probability": 0.000651773667711142,
            "start_logit": 0.25499650835990906,
            "end_logit": 5.1312432289123535,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis syndrome, hereditary leiomyomatosis and renal cancer syndrome",
            "probability": 0.0005614052493765715,
            "start_logit": 5.917974948883057,
            "end_logit": -0.6809895634651184,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "gastric stromal sarcomas or Carney-Stratakis",
            "probability": 0.0004645218538451529,
            "start_logit": 5.917974948883057,
            "end_logit": -0.8704239726066589,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "paragangliomas and gastric stromal sarcomas or Carney-Stratakis",
            "probability": 0.00041519003981528075,
            "start_logit": 5.8057026863098145,
            "end_logit": -0.8704239726066589,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "Stratakis syndrome",
            "probability": 0.0004070191678587641,
            "start_logit": 2.699213981628418,
            "end_logit": 2.216188669204712,
            "question_text": "Which cancers compose Carney's triad?"
        }
    ],
    "5a981bcffcd1d6a10c00002d": [
        {
            "text": "lactic acidosis",
            "probability": 0.8645578007882988,
            "start_logit": 2.841660976409912,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "encephalopathy (Wernicke) and lactic acidosis",
            "probability": 0.0969142298082271,
            "start_logit": 0.6532691717147827,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "encephalopathy",
            "probability": 0.03261448501390249,
            "start_logit": 0.6532691717147827,
            "end_logit": 1.8055408000946045,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "Thiamine deficiency can cause encephalopathy (Wernicke) and lactic acidosis",
            "probability": 0.0015073165296208453,
            "start_logit": -3.510226249694824,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "acidosis",
            "probability": 0.0009067263974516486,
            "start_logit": -4.018471717834473,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "la",
            "probability": 0.0007416061903031874,
            "start_logit": 2.841660976409912,
            "end_logit": -4.166544437408447,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "athy (Wernicke) and lactic acidosis",
            "probability": 0.0006473123430446694,
            "start_logit": -4.355483531951904,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "Thiamine deficiency can cause encephalopathy",
            "probability": 0.0005072562869643042,
            "start_logit": -3.510226249694824,
            "end_logit": 1.8055408000946045,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "osis",
            "probability": 0.00037180263527866915,
            "start_logit": -4.90994930267334,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lopathy (Wernicke) and lactic acidosis",
            "probability": 0.00021989641560153688,
            "start_logit": -5.435155868530273,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "athy",
            "probability": 0.0002178396170853363,
            "start_logit": -4.355483531951904,
            "end_logit": 1.8055408000946045,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "en",
            "probability": 0.00021548835542010167,
            "start_logit": 0.6532691717147827,
            "end_logit": -3.214064121246338,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "deficiency can cause encephalopathy (Wernicke) and lactic acidosis",
            "probability": 9.783277575780998e-05,
            "start_logit": -6.245052814483643,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "acidosis. Herein we report a 6-year-old girl on total parenteral nutrition (TPN) who developed lactic acidosis",
            "probability": 9.202513210613217e-05,
            "start_logit": -4.018471717834473,
            "end_logit": 0.6068316102027893,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "encephalopathy (Wernicke) and la",
            "probability": 8.313173820040055e-05,
            "start_logit": 0.6532691717147827,
            "end_logit": -4.166544437408447,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lopathy",
            "probability": 7.400160291670996e-05,
            "start_logit": -5.435155868530273,
            "end_logit": 1.8055408000946045,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "encephalop",
            "probability": 7.039816996144996e-05,
            "start_logit": 0.6532691717147827,
            "end_logit": -4.332803726196289,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "phalopathy (Wernicke) and lactic acidosis",
            "probability": 6.748012222871766e-05,
            "start_logit": -6.616479396820068,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "cephalopathy (Wernicke) and lactic acidosis",
            "probability": 5.2159467971278936e-05,
            "start_logit": -6.874006748199463,
            "end_logit": 2.894610643386841,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "lactic acidosis and neurological symptoms",
            "probability": 4.121060965870095e-05,
            "start_logit": 0.27271297574043274,
            "end_logit": -4.4877190589904785,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        }
    ],
    "5a7240aa2dc08e987e00000d": [
        {
            "text": "bezlotoxumab",
            "probability": 0.7504770948335732,
            "start_logit": 4.76915168762207,
            "end_logit": 4.464408874511719,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab, the anti-toxin B monoclonal, bezlotoxumab",
            "probability": 0.1764708127933555,
            "start_logit": 3.3215980529785156,
            "end_logit": 4.464408874511719,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab",
            "probability": 0.0664935770721137,
            "start_logit": 3.3215980529785156,
            "end_logit": 3.488358736038208,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab,",
            "probability": 0.002568096936485443,
            "start_logit": 4.76915168762207,
            "end_logit": -1.2131351232528687,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "anti-toxin B monoclonal, bezlotoxumab",
            "probability": 0.001861286849532014,
            "start_logit": -1.230289340019226,
            "end_logit": 4.464408874511719,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab, alone was shown to be effective in clinical trials. Intravenous infusion of bezlotoxumab",
            "probability": 0.0006810451242315756,
            "start_logit": 4.76915168762207,
            "end_logit": -2.5404269695281982,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab, the anti-toxin B monoclonal, bezlotoxumab,",
            "probability": 0.0006038747309326121,
            "start_logit": 3.3215980529785156,
            "end_logit": -1.2131351232528687,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "be",
            "probability": 0.00017188020462308333,
            "start_logit": 4.76915168762207,
            "end_logit": -3.917257785797119,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "b",
            "probability": 0.0001524233317242307,
            "start_logit": -3.7326509952545166,
            "end_logit": 4.464408874511719,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "the anti-toxin B monoclonal, bezlotoxumab",
            "probability": 0.00012034087690116684,
            "start_logit": -3.968984365463257,
            "end_logit": 4.464408874511719,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "b, the anti-toxin B monoclonal, bezlotoxumab",
            "probability": 8.630361875363418e-05,
            "start_logit": -4.301441192626953,
            "end_logit": 4.464408874511719,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "developed. Despite preclinical studies suggesting efficacy for the anti-toxin A monoclonal, actoxumab",
            "probability": 8.416989706165475e-05,
            "start_logit": -3.3504252433776855,
            "end_logit": 3.488358736038208,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab,",
            "probability": 6.917380064233952e-05,
            "start_logit": 3.3215980529785156,
            "end_logit": -3.3798797130584717,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab, the anti-toxin B",
            "probability": 4.064987352059278e-05,
            "start_logit": 3.3215980529785156,
            "end_logit": -3.911506175994873,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "actoxumab, the anti-toxin B monoclonal, be",
            "probability": 4.041674239191831e-05,
            "start_logit": 3.3215980529785156,
            "end_logit": -3.917257785797119,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "monoclonal, bezlotoxumab",
            "probability": 2.787797868564816e-05,
            "start_logit": -5.431475639343262,
            "end_logit": 4.464408874511719,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "act",
            "probability": 2.2488708974737654e-05,
            "start_logit": 3.3215980529785156,
            "end_logit": -4.503488540649414,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "were developed. Despite preclinical studies suggesting efficacy for the anti-toxin A monoclonal, actoxumab",
            "probability": 2.1595806000239538e-05,
            "start_logit": -4.710763454437256,
            "end_logit": 3.488358736038208,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "anti-toxin B monoclonal, bezlotoxumab,",
            "probability": 6.369235102723313e-06,
            "start_logit": -1.230289340019226,
            "end_logit": -1.2131351232528687,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "b,",
            "probability": 5.215853940708307e-07,
            "start_logit": -3.7326509952545166,
            "end_logit": -1.2131351232528687,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        }
    ],
    "5aa80873d6d6b54f79000013": [
        {
            "text": "Rpl22",
            "probability": 0.9400723712912331,
            "start_logit": 3.9365103244781494,
            "end_logit": 3.958754539489746,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 0.04709691139146447,
            "start_logit": 3.9365103244781494,
            "end_logit": 0.965005099773407,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22,",
            "probability": 0.00400726860708152,
            "start_logit": 3.9365103244781494,
            "end_logit": -1.49909245967865,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit,",
            "probability": 0.003872600027744731,
            "start_logit": 3.9365103244781494,
            "end_logit": -1.5332762002944946,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit",
            "probability": 0.0029922276295416355,
            "start_logit": 3.9365103244781494,
            "end_logit": -1.7911841869354248,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "22",
            "probability": 0.00035246290279751014,
            "start_logit": -3.952256441116333,
            "end_logit": 3.958754539489746,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 0.0003207562997504306,
            "start_logit": -1.052770733833313,
            "end_logit": 0.965005099773407,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum;",
            "probability": 0.0002751936406111143,
            "start_logit": 3.9365103244781494,
            "end_logit": -4.177482604980469,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl",
            "probability": 0.00025255584387967096,
            "start_logit": 3.9365103244781494,
            "end_logit": -4.263325214385986,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "l22",
            "probability": 0.00023592648522363549,
            "start_logit": -4.353681564331055,
            "end_logit": 3.958754539489746,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "R",
            "probability": 0.0001633124798023222,
            "start_logit": 3.9365103244781494,
            "end_logit": -4.699292182922363,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 0.00012325608743075364,
            "start_logit": -2.009188175201416,
            "end_logit": 0.965005099773407,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein",
            "probability": 5.6817830841346285e-05,
            "start_logit": 3.9365103244781494,
            "end_logit": -5.755107402801514,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component of the large",
            "probability": 4.833517167824866e-05,
            "start_logit": 3.9365103244781494,
            "end_logit": -5.916798114776611,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Rpl22, a ribosomal protein component",
            "probability": 4.3638255444560095e-05,
            "start_logit": 3.9365103244781494,
            "end_logit": -6.019023418426514,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "large 60S subunit,",
            "probability": 2.6374571465803927e-05,
            "start_logit": -1.052770733833313,
            "end_logit": -1.5332762002944946,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "large 60S subunit",
            "probability": 2.037874319369317e-05,
            "start_logit": -1.052770733833313,
            "end_logit": -1.7911841869354248,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 1.7658123575137027e-05,
            "start_logit": -3.952256441116333,
            "end_logit": 0.965005099773407,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "l22, a ribosomal protein component of the large 60S subunit, provides insight into this conundrum; Rpl22",
            "probability": 1.1819737616812605e-05,
            "start_logit": -4.353681564331055,
            "end_logit": 0.965005099773407,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "ribosomal protein component of the large 60S subunit,",
            "probability": 1.0134879623774013e-05,
            "start_logit": -2.009188175201416,
            "end_logit": -1.5332762002944946,
            "question_text": "List ribosomal biogenesis proteins."
        }
    ],
    "5aacdcf1fcf4565872000009": [
        {
            "text": "BRD4",
            "probability": 0.1843861610755031,
            "start_logit": 4.220576763153076,
            "end_logit": 4.029930591583252,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD3, and BRD4",
            "probability": 0.17494196450061994,
            "start_logit": 4.167998790740967,
            "end_logit": 4.029930591583252,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD3",
            "probability": 0.13527923764507424,
            "start_logit": 4.167998790740967,
            "end_logit": 3.772817373275757,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain-containing protein 2 (BRD2), BRD3, and BRD4",
            "probability": 0.11545828556323567,
            "start_logit": 3.7524538040161133,
            "end_logit": 4.029930591583252,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain-containing protein 2 (BRD2), BRD3",
            "probability": 0.08928165917987307,
            "start_logit": 3.7524538040161133,
            "end_logit": 3.772817373275757,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2), BRD3, and BRD4",
            "probability": 0.06999717436077685,
            "start_logit": 3.2519993782043457,
            "end_logit": 4.029930591583252,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain-containing protein 2 (BRD2",
            "probability": 0.058897987496127485,
            "start_logit": 3.7524538040161133,
            "end_logit": 3.356828212738037,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2), BRD3",
            "probability": 0.054127461137557266,
            "start_logit": 3.2519993782043457,
            "end_logit": 3.772817373275757,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain-containing protein 2",
            "probability": 0.03695781176378705,
            "start_logit": 3.7524538040161133,
            "end_logit": 2.890798330307007,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2",
            "probability": 0.035707205248663776,
            "start_logit": 3.2519993782043457,
            "end_logit": 3.356828212738037,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain-containing protein 2 (BRD2)",
            "probability": 0.016771343679566765,
            "start_logit": 3.7524538040161133,
            "end_logit": 2.1006929874420166,
            "question_text": "List BET proteins."
        },
        {
            "text": "BRD2)",
            "probability": 0.01016771262518172,
            "start_logit": 3.2519993782043457,
            "end_logit": 2.1006929874420166,
            "question_text": "List BET proteins."
        },
        {
            "text": "(BRD2), BRD3, and BRD4",
            "probability": 0.0051741291351793325,
            "start_logit": 0.6472155451774597,
            "end_logit": 4.029930591583252,
            "question_text": "List BET proteins."
        },
        {
            "text": "(BRD2), BRD3",
            "probability": 0.0040010539888601,
            "start_logit": 0.6472155451774597,
            "end_logit": 3.772817373275757,
            "question_text": "List BET proteins."
        },
        {
            "text": "(BRD2",
            "probability": 0.002639444987603199,
            "start_logit": 0.6472155451774597,
            "end_logit": 3.356828212738037,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain and extraterminal motif (BET) proteins bromodomain-containing protein 2 (BRD2",
            "probability": 0.002157641775768805,
            "start_logit": 0.4456627368927002,
            "end_logit": 3.356828212738037,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain and extraterminal motif (BET) proteins bromodomain-containing protein 2",
            "probability": 0.001353895472367196,
            "start_logit": 0.4456627368927002,
            "end_logit": 2.890798330307007,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain-containing protein",
            "probability": 0.0013338483640290345,
            "start_logit": 3.7524538040161133,
            "end_logit": -0.4309104382991791,
            "question_text": "List BET proteins."
        },
        {
            "text": "(BRD2)",
            "probability": 0.0007515883121356845,
            "start_logit": 0.6472155451774597,
            "end_logit": 2.1006929874420166,
            "question_text": "List BET proteins."
        },
        {
            "text": "bromodomain and extraterminal motif (BET) proteins bromodomain-containing protein 2 (BRD2)",
            "probability": 0.0006143936880897435,
            "start_logit": 0.4456627368927002,
            "end_logit": 2.1006929874420166,
            "question_text": "List BET proteins."
        }
    ],
    "5aa55b65d6d6b54f7900000e": [
        {
            "text": "Izumi fever",
            "probability": 0.8945542631451411,
            "start_logit": 5.240087985992432,
            "end_logit": 4.904844760894775,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi",
            "probability": 0.09797166381363172,
            "start_logit": 5.240087985992432,
            "end_logit": 2.69319748878479,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever,",
            "probability": 0.0024017487059489516,
            "start_logit": 5.240087985992432,
            "end_logit": -1.0152837038040161,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet fever",
            "probability": 0.0017058810076156078,
            "start_logit": 5.240087985992432,
            "end_logit": -1.3573991060256958,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "I",
            "probability": 0.0013262354768040165,
            "start_logit": 5.240087985992432,
            "end_logit": -1.6091363430023193,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet fever,",
            "probability": 0.0007891940116706501,
            "start_logit": 5.240087985992432,
            "end_logit": -2.1282238960266113,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "fever",
            "probability": 0.000778566953360868,
            "start_logit": -1.8065378665924072,
            "end_logit": 4.904844760894775,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical",
            "probability": 7.379625165626636e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -4.497928142547607,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet fever, in Japan.",
            "probability": 6.211387873297586e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -4.670266628265381,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms",
            "probability": 6.0775866515044796e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -4.692043304443359,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical",
            "probability": 6.009298831223734e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -4.703342914581299,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet",
            "probability": 4.0883225602241154e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -5.0885162353515625,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "mi fever",
            "probability": 3.392839245498837e-05,
            "start_logit": -4.9397406578063965,
            "end_logit": 4.904844760894775,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "zumi fever",
            "probability": 3.00196997031697e-05,
            "start_logit": -5.06213903427124,
            "end_logit": 4.904844760894775,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izu",
            "probability": 2.708908017980486e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -5.500105381011963,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic",
            "probability": 2.5214642645005678e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -5.571811199188232,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease",
            "probability": 1.9847373940227658e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -5.811164379119873,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a",
            "probability": 1.8342258503823045e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -5.890028476715088,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "Izumi fever, a disease showing clinical symptoms characteristic of atypical scarlet fever, in Japan",
            "probability": 1.6627386970433092e-05,
            "start_logit": 5.240087985992432,
            "end_logit": -5.988184928894043,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "mi",
            "probability": 3.7158406105519375e-06,
            "start_logit": -4.9397406578063965,
            "end_logit": 2.69319748878479,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        }
    ],
    "5a736f0c3b9d13c708000007": [
        {
            "text": "ferritin",
            "probability": 0.2738010757774999,
            "start_logit": -0.42615869641304016,
            "end_logit": -2.7008044719696045,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron",
            "probability": 0.2613664281018456,
            "start_logit": -1.5172065496444702,
            "end_logit": -1.6562350988388062,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "TIBC",
            "probability": 0.14303976019269904,
            "start_logit": -1.3630536794662476,
            "end_logit": -2.4131886959075928,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, ferritin",
            "probability": 0.09196002655652562,
            "start_logit": -1.5172065496444702,
            "end_logit": -2.7008044719696045,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, TIBC",
            "probability": 0.06726515808988154,
            "start_logit": -2.1175339221954346,
            "end_logit": -2.4131886959075928,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin, TIBC",
            "probability": 0.051745443886381276,
            "start_logit": -0.42615869641304016,
            "end_logit": -4.366869926452637,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, ferritin, TIBC",
            "probability": 0.017379451050213397,
            "start_logit": -1.5172065496444702,
            "end_logit": -4.366869926452637,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "TIBC, ferritin",
            "probability": 0.01691024264190156,
            "start_logit": -1.3630536794662476,
            "end_logit": -4.548391819000244,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin, TIBC, MCV",
            "probability": 0.01690907499646299,
            "start_logit": -0.42615869641304016,
            "end_logit": -5.485355854034424,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "serum iron",
            "probability": 0.010726853934797932,
            "start_logit": -4.710379600524902,
            "end_logit": -1.6562350988388062,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, TIBC, ferritin",
            "probability": 0.00795212564054496,
            "start_logit": -2.1175339221954346,
            "end_logit": -4.548391819000244,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "f",
            "probability": 0.007500637850090697,
            "start_logit": -0.42615869641304016,
            "end_logit": -6.298218250274658,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "serum iron, TIBC",
            "probability": 0.006688456589785423,
            "start_logit": -4.425793170928955,
            "end_logit": -2.4131886959075928,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "iron, ferritin, TIBC, MCV",
            "probability": 0.005679155866372975,
            "start_logit": -1.5172065496444702,
            "end_logit": -5.485355854034424,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin, TIBC,",
            "probability": 0.003947047527688587,
            "start_logit": -0.42615869641304016,
            "end_logit": -6.9402384757995605,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin, TIBC, MCV,",
            "probability": 0.003936409210091413,
            "start_logit": -0.42615869641304016,
            "end_logit": -6.94293737411499,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "serum iron, ferritin",
            "probability": 0.0037741716863789647,
            "start_logit": -4.710379600524902,
            "end_logit": -2.7008044719696045,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "ferritin,",
            "probability": 0.003693941882876307,
            "start_logit": -0.42615869641304016,
            "end_logit": -7.00651216506958,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "TIBC, ferritin were significantly different between IDA and \u03b2-TT patients (P<0.001",
            "probability": 0.0030768406365656244,
            "start_logit": -1.3630536794662476,
            "end_logit": -6.252408027648926,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "TIBC,",
            "probability": 0.0026476978813961285,
            "start_logit": -1.3630536794662476,
            "end_logit": -6.402620792388916,
            "question_text": "What is included in the Mentzer index?"
        }
    ],
    "5aa13fd3d6d6b54f79000003": [
        {
            "text": "buprenorphine",
            "probability": 0.32728200122675155,
            "start_logit": 1.9807859659194946,
            "end_logit": 1.2348096370697021,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine/naloxone",
            "probability": 0.2909914799372012,
            "start_logit": 1.9807859659194946,
            "end_logit": 1.117281436920166,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone and buprenorphine",
            "probability": 0.13448849928197795,
            "start_logit": 1.0914424657821655,
            "end_logit": 1.2348096370697021,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone and buprenorphine/naloxone",
            "probability": 0.11957580097257468,
            "start_logit": 1.0914424657821655,
            "end_logit": 1.117281436920166,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone",
            "probability": 0.06239552467627574,
            "start_logit": 0.4409855306148529,
            "end_logit": 1.117281436920166,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone",
            "probability": 0.0434222637561746,
            "start_logit": 1.0914424657821655,
            "end_logit": 0.10430324822664261,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "analgesic",
            "probability": 0.006800240435599962,
            "start_logit": -0.5186430811882019,
            "end_logit": -0.13962553441524506,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "Opioid analgesic",
            "probability": 0.005968400281634614,
            "start_logit": -0.6491221189498901,
            "end_logit": -0.13962553441524506,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "opioid medications",
            "probability": 0.002377963987504757,
            "start_logit": -1.2059472799301147,
            "end_logit": -0.5030346512794495,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "Opioid",
            "probability": 0.002025547011374347,
            "start_logit": -0.6491221189498901,
            "end_logit": -1.2202646732330322,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "analgesic consumption has led to an unprecedented epidemic of overdose death and opioid addiction",
            "probability": 0.0009127276068474645,
            "start_logit": -0.5186430811882019,
            "end_logit": -2.1479012966156006,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "Opioid analgesic consumption has led to an unprecedented epidemic of overdose death and opioid addiction",
            "probability": 0.0008010781026573333,
            "start_logit": -0.6491221189498901,
            "end_logit": -2.1479012966156006,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naloxone in patients with failed back surgery syndrome and opioid addiction. Nineteen participants were randomly assigned to methadone",
            "probability": 0.0007160706972091897,
            "start_logit": 0.4409855306148529,
            "end_logit": -3.3501884937286377,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "medications",
            "probability": 0.0005998753974875194,
            "start_logit": -2.5832252502441406,
            "end_logit": -0.5030346512794495,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "addiction in the US history. The treatment of chronic pain in patients with opioid addiction who receive prescriptions for opioid medications",
            "probability": 0.0003886587393914434,
            "start_logit": -3.0172455310821533,
            "end_logit": -0.5030346512794495,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "opioid addiction in the US history. The treatment of chronic pain in patients with opioid addiction who receive prescriptions for opioid medications",
            "probability": 0.0003482761699891083,
            "start_logit": -3.1269514560699463,
            "end_logit": -0.5030346512794495,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "analgesic consumption has led to an unprecedented epidemic of overdose",
            "probability": 0.0002441182582329147,
            "start_logit": -0.5186430811882019,
            "end_logit": -3.4666860103607178,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "met",
            "probability": 0.00023646503385908092,
            "start_logit": 1.0914424657821655,
            "end_logit": -5.10862398147583,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "Opioid analgesic consumption has led to an unprecedented epidemic of overdose",
            "probability": 0.00021425646563347342,
            "start_logit": -0.6491221189498901,
            "end_logit": -3.4666860103607178,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "opioid addiction who receive prescriptions for opioid medications",
            "probability": 0.00021075196162323375,
            "start_logit": -3.629265308380127,
            "end_logit": -0.5030346512794495,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        }
    ],
    "5aa82388fcf4565872000001": [
        {
            "text": "mTOR",
            "probability": 0.8278305424766177,
            "start_logit": 2.4082417488098145,
            "end_logit": 1.7129125595092773,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "mTOR pathway. As a result, BRSK2 kinase activation suppressed ribosome-RNA",
            "probability": 0.03226830222129754,
            "start_logit": 2.4082417488098145,
            "end_logit": -1.5318105220794678,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "mTOR pathway. As a result, BRSK2 kinase activation suppressed ribosome-RNA complexes, global protein synthesis, and NRF2",
            "probability": 0.032089260767361655,
            "start_logit": 2.4082417488098145,
            "end_logit": -1.537374496459961,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "antioxidant response",
            "probability": 0.029841865612897173,
            "start_logit": 0.789710521697998,
            "end_logit": 0.008547605946660042,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2/NRF2 is a transcription factor and master regulator of cellular antioxidant response",
            "probability": 0.016229466460299297,
            "start_logit": 0.1806267350912094,
            "end_logit": 0.008547605946660042,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "mTOR pathway. As a result, BRSK2",
            "probability": 0.012110761455615297,
            "start_logit": 2.4082417488098145,
            "end_logit": -2.5118014812469482,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "BRSK1",
            "probability": 0.010967413357178359,
            "start_logit": -0.15726791322231293,
            "end_logit": -0.04545779898762703,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "mTOR pathway",
            "probability": 0.005847453652167873,
            "start_logit": 2.4082417488098145,
            "end_logit": -3.239889621734619,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NRF2",
            "probability": 0.005710041236568524,
            "start_logit": 0.6819465756416321,
            "end_logit": -1.537374496459961,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "BRSK2 drives AMPK signaling and suppresses the mTOR",
            "probability": 0.004695398559613801,
            "start_logit": -2.763983726501465,
            "end_logit": 1.7129125595092773,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "Brain Specific Kinase 2 (BRSK2) and the related BRSK1",
            "probability": 0.0036015821903020457,
            "start_logit": -1.2708231210708618,
            "end_logit": -0.04545779898762703,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NRF2 protein levels. Collectively our data illuminate the BRSK2 and BRSK1",
            "probability": 0.002862140644295637,
            "start_logit": 0.6819465756416321,
            "end_logit": -2.2280309200286865,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "cellular antioxidant response",
            "probability": 0.002728157167084674,
            "start_logit": -1.602575421333313,
            "end_logit": 0.008547605946660042,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "AMPK signaling and suppresses the mTOR",
            "probability": 0.0025085986439332968,
            "start_logit": -3.3908424377441406,
            "end_logit": 1.7129125595092773,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "BRSK2) and the related BRSK1",
            "probability": 0.002433083601761518,
            "start_logit": -1.6630369424819946,
            "end_logit": -0.04545779898762703,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "RNA",
            "probability": 0.002008177570568271,
            "start_logit": -0.3686160147190094,
            "end_logit": -1.5318105220794678,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "RNA complexes, global protein synthesis, and NRF2",
            "probability": 0.0019970351488340816,
            "start_logit": -0.3686160147190094,
            "end_logit": -1.537374496459961,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NFE2L2",
            "probability": 0.0014594710814319557,
            "start_logit": 0.1806267350912094,
            "end_logit": -2.4002068042755127,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "antioxidant",
            "probability": 0.0014205562660888737,
            "start_logit": 0.789710521697998,
            "end_logit": -3.036316156387329,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "antioxidant response.",
            "probability": 0.001390691886082524,
            "start_logit": 0.789710521697998,
            "end_logit": -3.057563304901123,
            "question_text": "Which proteins are regulated by Nrf2?"
        }
    ],
    "5a9d96564e03427e73000001": [
        {
            "text": "disease-modifying therapies",
            "probability": 0.4609077037213464,
            "start_logit": -2.6820852756500244,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "In the absence of disease-modifying therapies",
            "probability": 0.09387725809460608,
            "start_logit": -4.273294925689697,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease",
            "probability": 0.08202565323110082,
            "start_logit": -2.6820852756500244,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "absence of disease-modifying therapies",
            "probability": 0.07259324303209398,
            "start_logit": -4.530411243438721,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "therapies",
            "probability": 0.04210780909113921,
            "start_logit": -5.075049877166748,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable risk factors",
            "probability": 0.03492715642191096,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.357529163360596,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease",
            "probability": 0.03208677335560523,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.442349910736084,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease,",
            "probability": 0.031741771456086317,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.453160285949707,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify",
            "probability": 0.019185833421820012,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.9566216468811035,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer",
            "probability": 0.01902328887178501,
            "start_logit": -2.6820852756500244,
            "end_logit": -4.965129852294922,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "In the absence of disease-modifying therapies for Alzheimer disease",
            "probability": 0.016706909770833753,
            "start_logit": -4.273294925689697,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable",
            "probability": 0.016330921453316532,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.117733478546143,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable risk",
            "probability": 0.014122900293775654,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.262996196746826,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "absence of disease-modifying therapies for Alzheimer disease",
            "probability": 0.01291909016012351,
            "start_logit": -4.530411243438721,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "ies",
            "probability": 0.011837779879392404,
            "start_logit": -6.343986988067627,
            "end_logit": -1.7775959968566895,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there",
            "probability": 0.008272139106993748,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.797900676727295,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need",
            "probability": 0.008239838014973215,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.801813125610352,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therap",
            "probability": 0.008144171080373073,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.813491344451904,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "therapies for Alzheimer disease",
            "probability": 0.007493735771705253,
            "start_logit": -5.075049877166748,
            "end_logit": -3.5037617683410645,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "disease-modifying therapies for Alzheimer disease, there is a critical need to identify modifiable risk factors that",
            "probability": 0.00745602377101865,
            "start_logit": -2.6820852756500244,
            "end_logit": -5.901771545410156,
            "question_text": "List major risk factors for Alzheimer's disease. "
        }
    ],
    "5a9d2dd21d1251d03b00001a": [
        {
            "text": "V3-glycan regions of the HIV-1 envelope glycoprotein (Env)",
            "probability": 0.20985448189907058,
            "start_logit": 1.8114982843399048,
            "end_logit": 1.572542428970337,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions of the HIV-1 envelope glycoprotein",
            "probability": 0.17735623363111117,
            "start_logit": 1.8114982843399048,
            "end_logit": 1.404288411140442,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope glycoprotein (Env)",
            "probability": 0.17480041025433796,
            "start_logit": 1.6287287473678589,
            "end_logit": 1.572542428970337,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope glycoprotein",
            "probability": 0.14773066612317012,
            "start_logit": 1.6287287473678589,
            "end_logit": 1.404288411140442,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan",
            "probability": 0.05401547703500656,
            "start_logit": 1.8114982843399048,
            "end_logit": 0.21539869904518127,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan regions of the HIV-1 envelope glycoprotein",
            "probability": 0.05293395176763792,
            "start_logit": 0.6023828983306885,
            "end_logit": 1.404288411140442,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions",
            "probability": 0.040273293534152335,
            "start_logit": 1.8114982843399048,
            "end_logit": -0.0781833603978157,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions of the HIV-1 envelope",
            "probability": 0.020020041840947134,
            "start_logit": 1.8114982843399048,
            "end_logit": -0.7771380543708801,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "Env)",
            "probability": 0.019016766606858273,
            "start_logit": -0.5895950198173523,
            "end_logit": 1.572542428970337,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope",
            "probability": 0.01667589605634279,
            "start_logit": 1.6287287473678589,
            "end_logit": -0.7771380543708801,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan",
            "probability": 0.016121523318002123,
            "start_logit": 0.6023828983306885,
            "end_logit": 0.21539869904518127,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V3-glycan regions of the HIV-1 envelope glycoprotein (Env",
            "probability": 0.014412442741600123,
            "start_logit": 1.8114982843399048,
            "end_logit": -1.105780005455017,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan regions",
            "probability": 0.012020014937252181,
            "start_logit": 0.6023828983306885,
            "end_logit": -0.0781833603978157,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "envelope glycoprotein (Env",
            "probability": 0.012004989749089626,
            "start_logit": 1.6287287473678589,
            "end_logit": -1.105780005455017,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan",
            "probability": 0.008459105754021782,
            "start_logit": 0.6023828983306885,
            "end_logit": -0.4295130670070648,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V2-glycan (apex) and V3-glycan regions of the HIV-1 envelope",
            "probability": 0.00597520542412383,
            "start_logit": 0.6023828983306885,
            "end_logit": -0.7771380543708801,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "HIV-1 envelope glycoprotein (Env)",
            "probability": 0.005446295751678142,
            "start_logit": -1.8399803638458252,
            "end_logit": 1.572542428970337,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "(Env)",
            "probability": 0.00463750934063927,
            "start_logit": -2.0007386207580566,
            "end_logit": 1.572542428970337,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "HIV-1 envelope glycoprotein",
            "probability": 0.004602877637006211,
            "start_logit": -1.8399803638458252,
            "end_logit": 1.404288411140442,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "glycoprotein (Env)",
            "probability": 0.0036428165979517325,
            "start_logit": -2.242158889770508,
            "end_logit": 1.572542428970337,
            "question_text": "What do the trispecific HIV antibodies target?"
        }
    ],
    "5ac721230340b9f058000005": [
        {
            "text": "11",
            "probability": 0.17420382748364166,
            "start_logit": -1.525891900062561,
            "end_logit": -0.8920393586158752,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circRNAs",
            "probability": 0.1430463877628127,
            "start_logit": -1.225517988204956,
            "end_logit": -1.3894703388214111,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "11 up\u2011regulated and 12 downregulated circular RNAs (circRNAs",
            "probability": 0.10593175391242282,
            "start_logit": -1.525891900062561,
            "end_logit": -1.3894703388214111,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "11 up\u2011regulated and 12",
            "probability": 0.08343620001434911,
            "start_logit": -1.525891900062561,
            "end_logit": -1.628183126449585,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "12 downregulated circular RNAs (circRNAs",
            "probability": 0.08233135727346305,
            "start_logit": -1.7779349088668823,
            "end_logit": -1.3894703388214111,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "12",
            "probability": 0.06484755834969622,
            "start_logit": -1.7779349088668823,
            "end_logit": -1.628183126449585,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "11 up\u2011regulated and 12 downregulated",
            "probability": 0.037576496563874046,
            "start_logit": -1.525891900062561,
            "end_logit": -2.425886631011963,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circRNAs)",
            "probability": 0.03732853318005065,
            "start_logit": -1.225517988204956,
            "end_logit": -2.7328813076019287,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "(circRNAs",
            "probability": 0.03506090928564066,
            "start_logit": -2.6316001415252686,
            "end_logit": -1.3894703388214111,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "downregulated circular RNAs (circRNAs",
            "probability": 0.02991324122487211,
            "start_logit": -2.7903857231140137,
            "end_logit": -1.3894703388214111,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "12 downregulated",
            "probability": 0.029204878135436627,
            "start_logit": -1.7779349088668823,
            "end_logit": -2.425886631011963,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "11 up\u2011regulated and 12 downregulated circular RNAs (circRNAs)",
            "probability": 0.02764331943353564,
            "start_logit": -1.525891900062561,
            "end_logit": -2.7328813076019287,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "results of RNA sequencing revealed 11",
            "probability": 0.02487971283181354,
            "start_logit": -3.4720652103424072,
            "end_logit": -0.8920393586158752,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "11 up\u2011regulated",
            "probability": 0.023611966613057922,
            "start_logit": -1.525891900062561,
            "end_logit": -2.8905117511749268,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "12 downregulated circular RNAs (circRNAs)",
            "probability": 0.021484700521322973,
            "start_logit": -1.7779349088668823,
            "end_logit": -2.7328813076019287,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "up\u2011regulated and 12 downregulated circular RNAs (circRNAs",
            "probability": 0.018987104274543604,
            "start_logit": -3.244926929473877,
            "end_logit": -1.3894703388214111,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "sequencing revealed 11",
            "probability": 0.01727649530252397,
            "start_logit": -3.836771011352539,
            "end_logit": -0.8920393586158752,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "results of RNA sequencing revealed 11 up\u2011regulated and 12 downregulated circular RNAs (circRNAs",
            "probability": 0.01512912577858777,
            "start_logit": -3.4720652103424072,
            "end_logit": -1.3894703388214111,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "up\u2011regulated and 12",
            "probability": 0.014955023129833586,
            "start_logit": -3.244926929473877,
            "end_logit": -1.628183126449585,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circRNAs).",
            "probability": 0.01315140892852113,
            "start_logit": -1.225517988204956,
            "end_logit": -3.7761104106903076,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        }
    ],
    "5ace20fa0340b9f05800000c": [
        {
            "text": "EPAS1",
            "probability": 0.17625738441003758,
            "start_logit": 4.621410846710205,
            "end_logit": 4.099972248077393,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2",
            "probability": 0.15968739325233938,
            "start_logit": 4.621410846710205,
            "end_logit": 4.001245021820068,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2",
            "probability": 0.15014624674372665,
            "start_logit": 4.559802532196045,
            "end_logit": 4.001245021820068,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2, and THSD7A",
            "probability": 0.1330129099443071,
            "start_logit": 4.621410846710205,
            "end_logit": 3.8184731006622314,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A",
            "probability": 0.12506553454122746,
            "start_logit": 4.559802532196045,
            "end_logit": 3.8184731006622314,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A",
            "probability": 0.11971533031994835,
            "start_logit": 4.5160813331604,
            "end_logit": 3.8184731006622314,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A genes, related to hypoxia and circulation. We validated four non-coding mutations nearby EPAS1",
            "probability": 0.03775437543545908,
            "start_logit": 4.5160813331604,
            "end_logit": 2.6644577980041504,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2, and THSD7A genes",
            "probability": 0.03000586736589686,
            "start_logit": 4.621410846710205,
            "end_logit": 2.3294198513031006,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A genes",
            "probability": 0.028213049718710238,
            "start_logit": 4.559802532196045,
            "end_logit": 2.3294198513031006,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A genes",
            "probability": 0.02700611786291233,
            "start_logit": 4.5160813331604,
            "end_logit": 2.3294198513031006,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1 and CYP4F2",
            "probability": 0.00467585283394415,
            "start_logit": 2.8639729022979736,
            "end_logit": 2.2278764247894287,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS",
            "probability": 0.001764455370802284,
            "start_logit": 4.621410846710205,
            "end_logit": -0.504131019115448,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2, and THSD7A genes,",
            "probability": 0.0011034779200187412,
            "start_logit": 4.621410846710205,
            "end_logit": -0.9735061526298523,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7A genes,",
            "probability": 0.0010375463252354203,
            "start_logit": 4.559802532196045,
            "end_logit": -0.9735061526298523,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "THSD7A genes,",
            "probability": 0.0009931609176216441,
            "start_logit": 4.5160813331604,
            "end_logit": -0.9735061526298523,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2,",
            "probability": 0.0009066993382661647,
            "start_logit": 4.621410846710205,
            "end_logit": -1.1699174642562866,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2,",
            "probability": 0.0008525250478011098,
            "start_logit": 4.559802532196045,
            "end_logit": -1.1699174642562866,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "hypoxia and circulation. We validated four non-coding mutations nearby EPAS1",
            "probability": 0.0006343385324108274,
            "start_logit": 0.4298074543476105,
            "end_logit": 2.6644577980041504,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, CYP4F2, and THSD7",
            "probability": 0.0006018469057482632,
            "start_logit": 4.621410846710205,
            "end_logit": -1.5797252655029297,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "CYP4F2, and THSD7",
            "probability": 0.0005658872135863068,
            "start_logit": 4.559802532196045,
            "end_logit": -1.5797252655029297,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        }
    ],
    "5abd2ce0fcf456587200002a": [
        {
            "text": "Bacteroidetes",
            "probability": 0.5059037436206709,
            "start_logit": 6.421066761016846,
            "end_logit": 5.714023113250732,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes",
            "probability": 0.29450121021646,
            "start_logit": 5.4718708992004395,
            "end_logit": 6.122155666351318,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and Bacteroidetes",
            "probability": 0.1958111274891956,
            "start_logit": 5.4718708992004395,
            "end_logit": 5.714023113250732,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes -",
            "probability": 0.0018289079429367622,
            "start_logit": 6.421066761016846,
            "end_logit": 0.09139572829008102,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and Bacteroidetes -",
            "probability": 0.0007078827363825821,
            "start_logit": 5.4718708992004395,
            "end_logit": 0.09139572829008102,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "B",
            "probability": 0.0003505420568707203,
            "start_logit": 6.421066761016846,
            "end_logit": -1.5605978965759277,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bact",
            "probability": 0.00022968496220538188,
            "start_logit": 6.421066761016846,
            "end_logit": -1.9833699464797974,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and B",
            "probability": 0.00013567805388628256,
            "start_logit": 5.4718708992004395,
            "end_logit": -1.5605978965759277,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "utes",
            "probability": 9.630580112931696e-05,
            "start_logit": -2.5536389350891113,
            "end_logit": 6.122155666351318,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes and Bact",
            "probability": 8.890005655002918e-05,
            "start_logit": 5.4718708992004395,
            "end_logit": -1.9833699464797974,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "- Firmicutes",
            "probability": 8.088717411390582e-05,
            "start_logit": -2.72811222076416,
            "end_logit": 6.122155666351318,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "utes and Bacteroidetes",
            "probability": 6.403283534563832e-05,
            "start_logit": -2.5536389350891113,
            "end_logit": 5.714023113250732,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "- Firmicutes and Bacteroidetes",
            "probability": 5.378113302494516e-05,
            "start_logit": -2.72811222076416,
            "end_logit": 5.714023113250732,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "acteroidetes",
            "probability": 2.7210054450645573e-05,
            "start_logit": -3.4094483852386475,
            "end_logit": 5.714023113250732,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "tes",
            "probability": 2.4579698025168868e-05,
            "start_logit": -3.5111141204833984,
            "end_logit": 5.714023113250732,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroide",
            "probability": 2.2233432880153644e-05,
            "start_logit": 6.421066761016846,
            "end_logit": -4.3184814453125,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firm",
            "probability": 2.152840447813784e-05,
            "start_logit": 5.4718708992004395,
            "end_logit": -3.4015095233917236,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bactero",
            "probability": 2.074280034786624e-05,
            "start_logit": 6.421066761016846,
            "end_logit": -4.387879371643066,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes - are predominant",
            "probability": 1.8492961107846926e-05,
            "start_logit": 6.421066761016846,
            "end_logit": -4.502688407897949,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes - are predominant in the human gut",
            "probability": 1.2528569938109322e-05,
            "start_logit": 6.421066761016846,
            "end_logit": -4.892066955566406,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        }
    ],
    "5aac5469fcf4565872000005": [
        {
            "text": "liver failure",
            "probability": 0.7986054333240806,
            "start_logit": 1.3748992681503296,
            "end_logit": 0.27273693680763245,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "hepatitis. On the sixth day, the newborn developed liver failure",
            "probability": 0.13011190515906454,
            "start_logit": -0.43957284092903137,
            "end_logit": 0.27273693680763245,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "liver failure and died 13 days later. Yellow fever polymerase chain reaction",
            "probability": 0.021886777801420003,
            "start_logit": 1.3748992681503296,
            "end_logit": -3.324247360229492,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fulminant hepatitis. On the sixth day, the newborn developed liver failure",
            "probability": 0.01107406285470586,
            "start_logit": -2.9033620357513428,
            "end_logit": 0.27273693680763245,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "hepatitis",
            "probability": 0.009004141635918889,
            "start_logit": -0.43957284092903137,
            "end_logit": -2.3979732990264893,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "liver failure and died 13 days later.",
            "probability": 0.0070521427576003175,
            "start_logit": 1.3748992681503296,
            "end_logit": -4.456798553466797,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "hepatitis. On the sixth day, the newborn developed liver failure and died 13 days later. Yellow fever polymerase chain reaction",
            "probability": 0.0035658790169791474,
            "start_logit": -0.43957284092903137,
            "end_logit": -3.324247360229492,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "liver",
            "probability": 0.0033983953197322904,
            "start_logit": 1.3748992681503296,
            "end_logit": -5.186826705932617,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "liver failure and died 13 days later. Yellow fever polymerase chain reaction was positive for both.",
            "probability": 0.003005891072480419,
            "start_logit": 1.3748992681503296,
            "end_logit": -5.309556007385254,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "liver failure and died 13 days later. Yellow fever polymer",
            "probability": 0.002431527842021481,
            "start_logit": 1.3748992681503296,
            "end_logit": -5.521610260009766,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "failure",
            "probability": 0.001935973433085276,
            "start_logit": -4.64735746383667,
            "end_logit": 0.27273693680763245,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "liver failure and died 13 days later. Yellow fever polymerase chain",
            "probability": 0.001666642109661198,
            "start_logit": 1.3748992681503296,
            "end_logit": -5.899319171905518,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "liver failure and died 13 days later. Yellow fever polymerase chain reaction was positive",
            "probability": 0.0015703803082397685,
            "start_logit": 1.3748992681503296,
            "end_logit": -5.958812236785889,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "patitis. On the sixth day, the newborn developed liver failure",
            "probability": 0.0012037481300385012,
            "start_logit": -5.122527599334717,
            "end_logit": 0.27273693680763245,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "hepatitis. On the sixth day, the newborn developed liver failure and died 13 days later.",
            "probability": 0.0011489625431495402,
            "start_logit": -0.43957284092903137,
            "end_logit": -4.456798553466797,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fulminant hepatitis",
            "probability": 0.0007663590069405201,
            "start_logit": -2.9033620357513428,
            "end_logit": -2.3979732990264893,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "hepatitis. On the sixth day, the newborn developed liver",
            "probability": 0.0005536797911498552,
            "start_logit": -0.43957284092903137,
            "end_logit": -5.186826705932617,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "hepatitis. On the sixth day, the newborn developed liver failure and died 13 days later. Yellow fever polymer",
            "probability": 0.0003961539788877669,
            "start_logit": -0.43957284092903137,
            "end_logit": -5.521610260009766,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "titis. On the sixth day, the newborn developed liver failure",
            "probability": 0.0003184454123970511,
            "start_logit": -6.452271938323975,
            "end_logit": 0.27273693680763245,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fulminant hepatitis. On the sixth day, the newborn developed liver failure and died 13 days later. Yellow fever polymerase chain reaction",
            "probability": 0.0003034985024470126,
            "start_logit": -2.9033620357513428,
            "end_logit": -3.324247360229492,
            "question_text": "What are 7 symptoms of yellow fever?"
        }
    ],
    "5a7d5580faa1ab7d2e00001a": [
        {
            "text": "Several tracers have been designed",
            "probability": 0.11642594423570679,
            "start_logit": -0.7056527137756348,
            "end_logit": -1.8831791877746582,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers",
            "probability": 0.10794034565493367,
            "start_logit": -0.7056527137756348,
            "end_logit": -1.9588558673858643,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.",
            "probability": 0.08512493607977106,
            "start_logit": -0.7056527137756348,
            "end_logit": -2.196314573287964,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo",
            "probability": 0.07275641549764758,
            "start_logit": -0.7056527137756348,
            "end_logit": -2.3533174991607666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several",
            "probability": 0.06512765365590734,
            "start_logit": -0.7056527137756348,
            "end_logit": -2.464085340499878,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation of tau",
            "probability": 0.061189733544367804,
            "start_logit": -0.7056527137756348,
            "end_logit": -2.5264551639556885,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "designed",
            "probability": 0.0563548949691631,
            "start_logit": -1.4312390089035034,
            "end_logit": -1.8831791877746582,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation of tau pathology",
            "probability": 0.05432640883597318,
            "start_logit": -0.7056527137756348,
            "end_logit": -2.6454241275787354,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "tracers have been designed",
            "probability": 0.043671894655528364,
            "start_logit": -1.6862033605575562,
            "end_logit": -1.8831791877746582,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "designed for tracking the abnormal accumulation of tau pathology in vivo.",
            "probability": 0.041203933225743686,
            "start_logit": -1.4312390089035034,
            "end_logit": -2.196314573287964,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "tracers",
            "probability": 0.04048890851149183,
            "start_logit": -1.6862033605575562,
            "end_logit": -1.9588558673858643,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "designed for tracking the abnormal accumulation of tau pathology in vivo",
            "probability": 0.03521706592648988,
            "start_logit": -1.4312390089035034,
            "end_logit": -2.3533174991607666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for",
            "probability": 0.03284490312346941,
            "start_logit": -0.7056527137756348,
            "end_logit": -3.1486380100250244,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo.",
            "probability": 0.03193074589550293,
            "start_logit": -1.6862033605575562,
            "end_logit": -2.196314573287964,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "designed for tracking the abnormal accumulation of tau",
            "probability": 0.029618321154455785,
            "start_logit": -1.4312390089035034,
            "end_logit": -2.5264551639556885,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking the abnormal accumulation",
            "probability": 0.028067463483608727,
            "start_logit": -0.7056527137756348,
            "end_logit": -3.305823564529419,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "tracers have been designed for tracking the abnormal accumulation of tau pathology in vivo",
            "probability": 0.027291258267095362,
            "start_logit": -1.6862033605575562,
            "end_logit": -2.3533174991607666,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "designed for tracking the abnormal accumulation of tau pathology",
            "probability": 0.026296192692282498,
            "start_logit": -1.4312390089035034,
            "end_logit": -2.6454241275787354,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "tracers have been designed for tracking the abnormal accumulation of tau",
            "probability": 0.022952543910139227,
            "start_logit": -1.6862033605575562,
            "end_logit": -2.5264551639556885,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "Several tracers have been designed for tracking",
            "probability": 0.021170436680721782,
            "start_logit": -0.7056527137756348,
            "end_logit": -3.5878288745880127,
            "question_text": "What in vivo tau tracers are being used?"
        }
    ],
    "5ac2776195d0062724000006": [
        {
            "text": "celiac disease",
            "probability": 0.8667494491678391,
            "start_logit": 4.433716773986816,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac",
            "probability": 0.1270096744636706,
            "start_logit": 4.433716773986816,
            "end_logit": 2.2244560718536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "ac disease",
            "probability": 0.0017930556984352948,
            "start_logit": -1.7471119165420532,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac disease.",
            "probability": 0.0013603870349577704,
            "start_logit": 4.433716773986816,
            "end_logit": -2.312037944793701,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Wheat gluten proteins are the known cause of celiac disease",
            "probability": 0.0013285249211878376,
            "start_logit": -2.046963930130005,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "disease",
            "probability": 0.00045570799713047895,
            "start_logit": -3.116936206817627,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "ac",
            "probability": 0.00026274654200489394,
            "start_logit": -1.7471119165420532,
            "end_logit": 2.2244560718536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "c",
            "probability": 0.00021801508312200112,
            "start_logit": 4.433716773986816,
            "end_logit": -4.142998218536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "eliac disease",
            "probability": 0.00021785587809468592,
            "start_logit": -3.854954719543457,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "Wheat gluten proteins are the known cause of celiac",
            "probability": 0.00019467623304398154,
            "start_logit": -2.046963930130005,
            "end_logit": 2.2244560718536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "proteins are the known cause of celiac disease",
            "probability": 0.0001342857381519389,
            "start_logit": -4.338818550109863,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "gluten proteins are the known cause of celiac disease",
            "probability": 9.47662549435802e-05,
            "start_logit": -4.687375068664551,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac disease. The repetitive tracts of proline and glutamine residues",
            "probability": 4.517553974225118e-05,
            "start_logit": 4.433716773986816,
            "end_logit": -5.717006683349609,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "celiac disease. The repetitive tracts of proline",
            "probability": 3.495005765503868e-05,
            "start_logit": 4.433716773986816,
            "end_logit": -5.973642349243164,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "eliac",
            "probability": 3.192364781237389e-05,
            "start_logit": -3.854954719543457,
            "end_logit": 2.2244560718536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "cause of celiac disease",
            "probability": 2.6447007021754793e-05,
            "start_logit": -5.9636454582214355,
            "end_logit": 4.144942760467529,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "proteins are the known cause of celiac",
            "probability": 1.9677644911302155e-05,
            "start_logit": -4.338818550109863,
            "end_logit": 2.2244560718536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "gluten proteins are the known cause of celiac",
            "probability": 1.3886632638856877e-05,
            "start_logit": -4.687375068664551,
            "end_logit": 2.2244560718536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "allergic reaction or celiac disease",
            "probability": 4.919028865380965e-06,
            "start_logit": -5.901443958282471,
            "end_logit": 2.400709390640259,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "cause of celiac",
            "probability": 3.875428770790067e-06,
            "start_logit": -5.9636454582214355,
            "end_logit": 2.2244560718536377,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        }
    ],
    "5abd44b1fcf4565872000030": [
        {
            "text": "\u03b2-catenin",
            "probability": 0.46077303859533414,
            "start_logit": -3.8276865482330322,
            "end_logit": -3.5662717819213867,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "lysine myristoylated peptides",
            "probability": 0.07020502551974928,
            "start_logit": -4.779431343078613,
            "end_logit": -4.4960126876831055,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "proteins harboring HEAT and ARM repeats bind to lysine myristoylated peptides",
            "probability": 0.05762419642813494,
            "start_logit": -4.9769086837768555,
            "end_logit": -4.4960126876831055,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "We discovered that proteins harboring HEAT and ARM repeats bind to lysine myristoylated peptides",
            "probability": 0.04617358250847199,
            "start_logit": -5.198443412780762,
            "end_logit": -4.4960126876831055,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFAs",
            "probability": 0.04316252158402554,
            "start_logit": -4.7135329246521,
            "end_logit": -5.04835844039917,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "myristoylated peptides",
            "probability": 0.04222851698670267,
            "start_logit": -5.287755489349365,
            "end_logit": -4.4960126876831055,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFA and LCFA). Lipidomic experiments suggest that MCFAs",
            "probability": 0.027199321134079493,
            "start_logit": -5.175313472747803,
            "end_logit": -5.04835844039917,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFAs and LCFAs",
            "probability": 0.027106694357842177,
            "start_logit": -4.7135329246521,
            "end_logit": -5.513550281524658,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "ARM repeats bind to lysine myristoylated peptides",
            "probability": 0.0261976246654048,
            "start_logit": -5.7651824951171875,
            "end_logit": -4.4960126876831055,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "proteins harboring HEAT and ARM repeats",
            "probability": 0.02491019284687783,
            "start_logit": -4.9769086837768555,
            "end_logit": -5.3346781730651855,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "lysine myristoylated peptides. Recombinant HEAT and ARM repeats bind to myristoylated peptides",
            "probability": 0.023029716027624377,
            "start_logit": -4.779431343078613,
            "end_logit": -5.610647201538086,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "lysine myristoylated peptides.",
            "probability": 0.022876019054552554,
            "start_logit": -4.779431343078613,
            "end_logit": -5.617343425750732,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "We discovered that proteins harboring HEAT and ARM repeats",
            "probability": 0.019960240940656005,
            "start_logit": -5.198443412780762,
            "end_logit": -5.3346781730651855,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "proteins harboring HEAT and ARM repeats bind to lysine myristoylated peptides.",
            "probability": 0.018776607596595347,
            "start_logit": -4.9769086837768555,
            "end_logit": -5.617343425750732,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFA and LCFA). Lipidomic experiments suggest that MCFAs and LCFAs",
            "probability": 0.017081571179454885,
            "start_logit": -5.175313472747803,
            "end_logit": -5.513550281524658,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MCFAs and LCFAs interact with HEAT and ARM repeat proteins in mammalian cells.",
            "probability": 0.015551864816630286,
            "start_logit": -4.7135329246521,
            "end_logit": -6.069150447845459,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "We discovered that proteins harboring HEAT and ARM repeats bind to lysine myristoylated peptides.",
            "probability": 0.015045472107742812,
            "start_logit": -5.198443412780762,
            "end_logit": -5.617343425750732,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "bind to lysine myristoylated peptides",
            "probability": 0.014485367055967154,
            "start_logit": -6.357712268829346,
            "end_logit": -4.4960126876831055,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "myristoylated peptides. Recombinant HEAT and ARM repeats bind to myristoylated peptides",
            "probability": 0.013852437874235932,
            "start_logit": -5.287755489349365,
            "end_logit": -5.610647201538086,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "myristoylated peptides.",
            "probability": 0.01375998871991802,
            "start_logit": -5.287755489349365,
            "end_logit": -5.617343425750732,
            "question_text": "List proteins with HEAT repeats"
        }
    ],
    "5ace34eb0340b9f058000010": [
        {
            "text": "16",
            "probability": 0.37885510070672873,
            "start_logit": -2.4829630851745605,
            "end_logit": -2.3286054134368896,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "16 genes",
            "probability": 0.11408646115280105,
            "start_logit": -2.4829630851745605,
            "end_logit": -3.5288026332855225,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "variants in at least 16",
            "probability": 0.0924731348756561,
            "start_logit": -3.8931987285614014,
            "end_logit": -2.3286054134368896,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Pathogenic variants in at least 16",
            "probability": 0.08615392371750294,
            "start_logit": -3.9639813899993896,
            "end_logit": -2.3286054134368896,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "variants",
            "probability": 0.04022715098535393,
            "start_logit": -3.8931987285614014,
            "end_logit": -3.1609814167022705,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "in at least 16",
            "probability": 0.03903740384232405,
            "start_logit": -4.75559663772583,
            "end_logit": -2.3286054134368896,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Pathogenic variants",
            "probability": 0.037478202745314534,
            "start_logit": -3.9639813899993896,
            "end_logit": -3.1609814167022705,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "at least 16",
            "probability": 0.02827943743828955,
            "start_logit": -5.077981948852539,
            "end_logit": -2.3286054134368896,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "variants in at least 16 genes",
            "probability": 0.027846880482773177,
            "start_logit": -3.8931987285614014,
            "end_logit": -3.5288026332855225,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "16 genes that encode proteins essential for the integrity and adhesion of skin layers have already been associated",
            "probability": 0.027076333279904285,
            "start_logit": -2.4829630851745605,
            "end_logit": -4.967099189758301,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Pathogenic variants in at least 16 genes",
            "probability": 0.025943945991549148,
            "start_logit": -3.9639813899993896,
            "end_logit": -3.5288026332855225,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "intraepidermal",
            "probability": 0.022121346988007135,
            "start_logit": -3.5936012268066406,
            "end_logit": -4.058578014373779,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "16 genes that encode proteins essential for the integrity and adhesion of skin layers",
            "probability": 0.014556163505582165,
            "start_logit": -2.4829630851745605,
            "end_logit": -5.58774471282959,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "in at least 16 genes",
            "probability": 0.011755521434594768,
            "start_logit": -4.75559663772583,
            "end_logit": -3.5288026332855225,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "16 genes that encode proteins",
            "probability": 0.010934966858939865,
            "start_logit": -2.4829630851745605,
            "end_logit": -5.873793601989746,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "genes",
            "probability": 0.010676915164979884,
            "start_logit": -4.85183572769165,
            "end_logit": -3.5288026332855225,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "16 genes that encode proteins essential for the integrity and adhesion of skin layers have already been associated with different subtypes",
            "probability": 0.009700847145830976,
            "start_logit": -2.4829630851745605,
            "end_logit": -5.993546009063721,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "at least 16 genes",
            "probability": 0.008515923197834847,
            "start_logit": -5.077981948852539,
            "end_logit": -3.5288026332855225,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "epidermolysis bullosa simplex (intraepidermal",
            "probability": 0.007671393121565462,
            "start_logit": -4.652646064758301,
            "end_logit": -4.058578014373779,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "variants in at least 16 genes that encode proteins essential for the integrity and adhesion of skin layers have already been associated",
            "probability": 0.006608947364467502,
            "start_logit": -3.8931987285614014,
            "end_logit": -4.967099189758301,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        }
    ],
    "5aae6a86fcf456587200000e": [
        {
            "text": "ultraviolet A",
            "probability": 0.45380582802368974,
            "start_logit": 0.028714125975966454,
            "end_logit": -0.027867021039128304,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A",
            "probability": 0.1666995651462149,
            "start_logit": -0.9727621078491211,
            "end_logit": -0.027867021039128304,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A) band. The longer-wavelength limit for UV-A",
            "probability": 0.14323511582707776,
            "start_logit": 0.028714125975966454,
            "end_logit": -1.1810489892959595,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet radiation in the ultraviolet A",
            "probability": 0.05270400904287469,
            "start_logit": -2.1242637634277344,
            "end_logit": -0.027867021039128304,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A (UV-A) band. The longer-wavelength limit for UV-A",
            "probability": 0.052615524190216305,
            "start_logit": -0.9727621078491211,
            "end_logit": -1.1810489892959595,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A) band",
            "probability": 0.024234934715618762,
            "start_logit": 0.028714125975966454,
            "end_logit": -2.9577412605285645,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A)",
            "probability": 0.01903900604022163,
            "start_logit": 0.028714125975966454,
            "end_logit": -3.1990466117858887,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet radiation in the ultraviolet A (UV-A) band. The longer-wavelength limit for UV-A",
            "probability": 0.016635010776929537,
            "start_logit": -2.1242637634277344,
            "end_logit": -1.1810489892959595,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "solar ultraviolet radiation in the ultraviolet A",
            "probability": 0.012365803779388737,
            "start_logit": -3.5740203857421875,
            "end_logit": -0.027867021039128304,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A (UV-A) band",
            "probability": 0.00890238253667747,
            "start_logit": -0.9727621078491211,
            "end_logit": -2.9577412605285645,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A",
            "probability": 0.008724085428954573,
            "start_logit": 0.028714125975966454,
            "end_logit": -3.9794487953186035,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A (UV-A)",
            "probability": 0.006993726901972323,
            "start_logit": -0.9727621078491211,
            "end_logit": -3.1990466117858887,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet",
            "probability": 0.006494291319197763,
            "start_logit": 0.028714125975966454,
            "end_logit": -4.274612903594971,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "radiation in the ultraviolet A",
            "probability": 0.00531596851771768,
            "start_logit": -4.418240070343018,
            "end_logit": -0.027867021039128304,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet A (UV-A) band.",
            "probability": 0.004166672842510314,
            "start_logit": 0.028714125975966454,
            "end_logit": -4.718418598175049,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "let A",
            "probability": 0.00392850458097919,
            "start_logit": -4.720696449279785,
            "end_logit": -0.027867021039128304,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "solar ultraviolet radiation in the ultraviolet A (UV-A) band. The longer-wavelength limit for UV-A",
            "probability": 0.003903029064984155,
            "start_logit": -3.5740203857421875,
            "end_logit": -1.1810489892959595,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "ultraviolet radiation",
            "probability": 0.0038477276319410034,
            "start_logit": -2.1242637634277344,
            "end_logit": -2.645075798034668,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "A (UV-A",
            "probability": 0.0032046773256275566,
            "start_logit": -0.9727621078491211,
            "end_logit": -3.9794487953186035,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "violet A",
            "probability": 0.0031841363072059475,
            "start_logit": -4.930774211883545,
            "end_logit": -0.027867021039128304,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        }
    ],
    "5aaef38dfcf456587200000f": [
        {
            "text": "obstructive sleep apnea",
            "probability": 0.5471440375036363,
            "start_logit": 3.6021413803100586,
            "end_logit": 3.372148275375366,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about obstructive sleep apnea",
            "probability": 0.4150200295833912,
            "start_logit": 3.6021413803100586,
            "end_logit": 3.0957629680633545,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnea",
            "probability": 0.011463960817396915,
            "start_logit": -0.26336243748664856,
            "end_logit": 3.372148275375366,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "sleep apnea are common conditions, but little is known about obstructive sleep apnea",
            "probability": 0.008695650562667944,
            "start_logit": -0.26336243748664856,
            "end_logit": 3.0957629680633545,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about obstructive sleep",
            "probability": 0.0036420224775311374,
            "start_logit": 3.6021413803100586,
            "end_logit": -1.6400246620178223,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about obstructive",
            "probability": 0.0033125606965921915,
            "start_logit": 3.6021413803100586,
            "end_logit": -1.734842300415039,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep",
            "probability": 0.0026514173649452165,
            "start_logit": 3.6021413803100586,
            "end_logit": -1.9574694633483887,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "Atrial fibrillation and obstructive sleep apnea",
            "probability": 0.0017368336895153458,
            "start_logit": -2.1505069732666016,
            "end_logit": 3.372148275375366,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive",
            "probability": 0.001726522024372725,
            "start_logit": 2.950528860092163,
            "end_logit": -1.734842300415039,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea and cardiovascular risk among atrial fibrillation patients.",
            "probability": 0.0010790515937021926,
            "start_logit": 2.950528860092163,
            "end_logit": -2.204868793487549,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "o",
            "probability": 0.00045386657745158615,
            "start_logit": 3.6021413803100586,
            "end_logit": -3.722515821456909,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about obstructive sleep apnea and cardiovascular risk",
            "probability": 0.0004303786890567809,
            "start_logit": 3.6021413803100586,
            "end_logit": -3.775653600692749,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions,",
            "probability": 0.0003988643605933918,
            "start_logit": 3.6021413803100586,
            "end_logit": -3.8516976833343506,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known about o",
            "probability": 0.00037878508235686533,
            "start_logit": 3.6021413803100586,
            "end_logit": -3.9033501148223877,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions",
            "probability": 0.0003490010945068706,
            "start_logit": 3.6021413803100586,
            "end_logit": -3.985244035720825,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "little is known about obstructive sleep apnea",
            "probability": 0.00034389077789254515,
            "start_logit": -3.4936165809631348,
            "end_logit": 3.0957629680633545,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common",
            "probability": 0.00032592235498864235,
            "start_logit": 3.6021413803100586,
            "end_logit": -4.053659915924072,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "nea",
            "probability": 0.00030456024248808056,
            "start_logit": -3.8914570808410645,
            "end_logit": 3.372148275375366,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "apnea",
            "probability": 0.0002948848339975359,
            "start_logit": -3.923741102218628,
            "end_logit": 3.372148275375366,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "obstructive sleep apnea are common conditions, but little is known",
            "probability": 0.0002477596729164295,
            "start_logit": 3.6021413803100586,
            "end_logit": -4.327859878540039,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        }
    ],
    "5abce6acfcf4565872000022": [
        {
            "text": "simvastatin",
            "probability": 0.36485307611420625,
            "start_logit": 6.122527122497559,
            "end_logit": 6.200331687927246,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastatin",
            "probability": 0.335494717328431,
            "start_logit": 6.250055313110352,
            "end_logit": 5.988914966583252,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastatin",
            "probability": 0.29532546518819375,
            "start_logit": 6.122527122497559,
            "end_logit": 5.988914966583252,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin,",
            "probability": 0.001064982052013835,
            "start_logit": 6.122527122497559,
            "end_logit": 0.36379489302635193,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastatin,",
            "probability": 0.0003539716189904501,
            "start_logit": 6.250055313110352,
            "end_logit": -0.8652297854423523,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastatin,",
            "probability": 0.00031159010154975677,
            "start_logit": 6.122527122497559,
            "end_logit": -0.8652297854423523,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastatin, and many HIV antiretroviral",
            "probability": 0.00030712504710275697,
            "start_logit": 6.250055313110352,
            "end_logit": -1.00719153881073,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvas",
            "probability": 0.00030389576250431424,
            "start_logit": 6.122527122497559,
            "end_logit": -0.89023357629776,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastatin, and many HIV antiretroviral",
            "probability": 0.00027035253529126494,
            "start_logit": 6.122527122497559,
            "end_logit": -1.00719153881073,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "mvastatin",
            "probability": 0.00024262162157340927,
            "start_logit": -1.193219780921936,
            "end_logit": 6.200331687927246,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "mvastatin, and atorvastatin",
            "probability": 0.0001963868415719548,
            "start_logit": -1.193219780921936,
            "end_logit": 5.988914966583252,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastatin, and many HIV antiretroviral medications",
            "probability": 0.00018067198793568032,
            "start_logit": 6.250055313110352,
            "end_logit": -1.5377633571624756,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "sim",
            "probability": 0.0001663651138161651,
            "start_logit": 6.122527122497559,
            "end_logit": -1.4927334785461426,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastatin, and many HIV antiretroviral medications",
            "probability": 0.00015903987791064648,
            "start_logit": 6.122527122497559,
            "end_logit": -1.5377633571624756,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvastat",
            "probability": 0.00014411418934202265,
            "start_logit": 6.250055313110352,
            "end_logit": -1.7638405561447144,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "atorvas",
            "probability": 0.00014295989097157024,
            "start_logit": 6.250055313110352,
            "end_logit": -1.77188241481781,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastat",
            "probability": 0.0001404587179475584,
            "start_logit": 6.122527122497559,
            "end_logit": -1.6620047092437744,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvastat",
            "probability": 0.00012685919571719449,
            "start_logit": 6.122527122497559,
            "end_logit": -1.7638405561447144,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, and atorvas",
            "probability": 0.00012584310310645417,
            "start_logit": 6.122527122497559,
            "end_logit": -1.77188241481781,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "ator",
            "probability": 8.950371182392371e-05,
            "start_logit": 6.250055313110352,
            "end_logit": -2.240166425704956,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        }
    ],
    "5c34ad63da8336e21a000007": [
        {
            "text": "non-essential genes",
            "probability": 0.351015053420004,
            "start_logit": -2.567274808883667,
            "end_logit": -2.8044228553771973,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "unique genomic positions",
            "probability": 0.0802310293720029,
            "start_logit": -3.08732533454895,
            "end_logit": -3.76029109954834,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "4-6 base pairs in non-essential genes",
            "probability": 0.07773101281792319,
            "start_logit": -4.074849605560303,
            "end_logit": -2.8044228553771973,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "unique",
            "probability": 0.06537927681793934,
            "start_logit": -3.08732533454895,
            "end_logit": -3.964996099472046,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "genes",
            "probability": 0.05987108086963678,
            "start_logit": -4.335910320281982,
            "end_logit": -2.8044228553771973,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertions occurring as frequently as every 4-6 base pairs in non-essential genes",
            "probability": 0.04914916146281713,
            "start_logit": -4.5332441329956055,
            "end_logit": -2.8044228553771973,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "6 base pairs in non-essential genes",
            "probability": 0.04420133246524313,
            "start_logit": -4.639348983764648,
            "end_logit": -2.8044228553771973,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "high-density insertion libraries, with insertions occurring as frequently as every 4-6 base pairs in non-essential genes",
            "probability": 0.039961510387260694,
            "start_logit": -4.740187168121338,
            "end_logit": -2.8044228553771973,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "non",
            "probability": 0.02896675245205181,
            "start_logit": -2.567274808883667,
            "end_logit": -5.299103260040283,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertional bias. This method thus allows the creation of large mutant libraries in which transposons have been inserted into unique genomic positions",
            "probability": 0.026606209113208892,
            "start_logit": -4.191091060638428,
            "end_logit": -3.76029109954834,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertion libraries, with insertions occurring as frequently as every 4-6 base pairs in non-essential genes",
            "probability": 0.02634331335161846,
            "start_logit": -5.15688943862915,
            "end_logit": -2.8044228553771973,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "4-6 base pairs",
            "probability": 0.023385435931881176,
            "start_logit": -4.074849605560303,
            "end_logit": -4.005563735961914,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertional bias. This method thus allows the creation of large mutant libraries in which transposons have been inserted into unique",
            "probability": 0.021681071828494724,
            "start_logit": -4.191091060638428,
            "end_logit": -3.964996099472046,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "unique genomic positions in a recipient strain of either Escherichia coli or Shigella flexneri bacteria",
            "probability": 0.02008452641609281,
            "start_logit": -3.08732533454895,
            "end_logit": -5.145251750946045,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "transposons have been inserted into unique genomic positions",
            "probability": 0.018134119068104495,
            "start_logit": -4.5744404792785645,
            "end_logit": -3.76029109954834,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertions occurring as frequently as every 4-6 base pairs",
            "probability": 0.014786563622767703,
            "start_logit": -4.5332441329956055,
            "end_logit": -4.005563735961914,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "transposons have been inserted into unique",
            "probability": 0.014777270087186451,
            "start_logit": -4.5744404792785645,
            "end_logit": -3.964996099472046,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "6 base pairs",
            "probability": 0.013298005403467223,
            "start_logit": -4.639348983764648,
            "end_logit": -4.005563735961914,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "mutant libraries in which transposons have been inserted into unique genomic positions",
            "probability": 0.012316086018802986,
            "start_logit": -4.961329460144043,
            "end_logit": -3.76029109954834,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertional bias",
            "probability": 0.012081189093495925,
            "start_logit": -4.191091060638428,
            "end_logit": -4.54978609085083,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        }
    ],
    "5ad4eddf133db5eb78000009": [
        {
            "text": "APID, and HIPPIE",
            "probability": 0.16862777459275513,
            "start_logit": 0.8853482007980347,
            "end_logit": -0.23779991269111633,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot",
            "probability": 0.155058597228575,
            "start_logit": 0.7624484300613403,
            "end_logit": -0.19879081845283508,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, APID, and HIPPIE",
            "probability": 0.14912635964700746,
            "start_logit": 0.7624484300613403,
            "end_logit": -0.23779991269111633,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HIPPIE",
            "probability": 0.11766847515422675,
            "start_logit": 0.5255255699157715,
            "end_logit": -0.23779991269111633,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "APID",
            "probability": 0.1139867917639045,
            "start_logit": 0.8853482007980347,
            "end_logit": -0.6294111013412476,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, APID",
            "probability": 0.10080448102125925,
            "start_logit": 0.7624484300613403,
            "end_logit": -0.6294111013412476,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING",
            "probability": 0.074997826457047,
            "start_logit": 0.7624484300613403,
            "end_logit": -0.9251347780227661,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "STRING, APID, and HIPPIE",
            "probability": 0.038337872176912195,
            "start_logit": -0.5959073305130005,
            "end_logit": -0.23779991269111633,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "STRING, APID",
            "probability": 0.025915132089329187,
            "start_logit": -0.5959073305130005,
            "end_logit": -0.6294111013412476,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "STRING",
            "probability": 0.01928067640799686,
            "start_logit": -0.5959073305130005,
            "end_logit": -0.9251347780227661,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS",
            "probability": 0.009100636593655016,
            "start_logit": 0.7624484300613403,
            "end_logit": -3.0342495441436768,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "G",
            "probability": 0.007250698749902586,
            "start_logit": 0.7624484300613403,
            "end_logit": -3.261496067047119,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "APID, and HIPPIE,",
            "probability": 0.004944295858833309,
            "start_logit": 0.8853482007980347,
            "end_logit": -3.767259120941162,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, APID, and HIPPIE,",
            "probability": 0.0043724993953473176,
            "start_logit": 0.7624484300613403,
            "end_logit": -3.767259120941162,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HIPPIE,",
            "probability": 0.0034501300620572214,
            "start_logit": 0.5255255699157715,
            "end_logit": -3.767259120941162,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "APID, and HIP",
            "probability": 0.0017673955617585624,
            "start_logit": 0.8853482007980347,
            "end_logit": -4.795986652374268,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, APID, and HIP",
            "probability": 0.0015630003231546878,
            "start_logit": 0.7624484300613403,
            "end_logit": -4.795986652374268,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "A",
            "probability": 0.0013341815918918418,
            "start_logit": 0.8853482007980347,
            "end_logit": -5.077175617218018,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "HIP",
            "probability": 0.0012332887701846777,
            "start_logit": 0.5255255699157715,
            "end_logit": -4.795986652374268,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "GPS-Prot, STRING, A",
            "probability": 0.001179886554201302,
            "start_logit": 0.7624484300613403,
            "end_logit": -5.077175617218018,
            "question_text": "List the main PPI databases."
        }
    ],
    "5c34a029da8336e21a000003": [
        {
            "text": "tissues",
            "probability": 0.35046499244120777,
            "start_logit": -1.7340444326400757,
            "end_logit": -0.9418992400169373,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues",
            "probability": 0.13623634183212593,
            "start_logit": -2.6789140701293945,
            "end_logit": -0.9418992400169373,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs",
            "probability": 0.1059738869772853,
            "start_logit": -1.7340444326400757,
            "end_logit": -2.137967348098755,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs. Tetra-arsenic tetra-sulfide",
            "probability": 0.08413874712435261,
            "start_logit": -1.7340444326400757,
            "end_logit": -2.3686928749084473,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Tetra-arsenic tetra-sulfide",
            "probability": 0.05427646142898148,
            "start_logit": -2.1724209785461426,
            "end_logit": -2.3686928749084473,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues and organs",
            "probability": 0.041195254883948165,
            "start_logit": -2.6789140701293945,
            "end_logit": -2.137967348098755,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues and organs. Tetra-arsenic tetra-sulfide",
            "probability": 0.032707275653168236,
            "start_logit": -2.6789140701293945,
            "end_logit": -2.3686928749084473,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "tissues and organs.",
            "probability": 0.029805604298691876,
            "start_logit": -1.7340444326400757,
            "end_logit": -3.406463623046875,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "affects multiple tissues",
            "probability": 0.028385724909041368,
            "start_logit": -4.2474188804626465,
            "end_logit": -0.9418992400169373,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "organs",
            "probability": 0.025210280124750652,
            "start_logit": -3.169985294342041,
            "end_logit": -2.137967348098755,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "autoimmune disease of uncertain etiology that affects multiple tissues",
            "probability": 0.022419286652281753,
            "start_logit": -4.483383655548096,
            "end_logit": -0.9418992400169373,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "organs. Tetra-arsenic tetra-sulfide",
            "probability": 0.020015887355392958,
            "start_logit": -3.169985294342041,
            "end_logit": -2.3686928749084473,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Systemic lupus erythematosus (SLE) is an autoimmune disease of uncertain etiology that affects multiple tissues",
            "probability": 0.014879681367299454,
            "start_logit": -4.893308639526367,
            "end_logit": -0.9418992400169373,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple tissues and organs.",
            "probability": 0.011586339815183838,
            "start_logit": -2.6789140701293945,
            "end_logit": -3.406463623046875,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "affects multiple tissues and organs",
            "probability": 0.008583298384028167,
            "start_logit": -4.2474188804626465,
            "end_logit": -2.137967348098755,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "organs.",
            "probability": 0.007090497999932311,
            "start_logit": -3.169985294342041,
            "end_logit": -3.406463623046875,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "multiple",
            "probability": 0.006863700499729949,
            "start_logit": -2.6789140701293945,
            "end_logit": -3.9300436973571777,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "affects multiple tissues and organs. Tetra-arsenic tetra-sulfide",
            "probability": 0.0068147728919427655,
            "start_logit": -4.2474188804626465,
            "end_logit": -2.3686928749084473,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "autoimmune disease of uncertain etiology that affects multiple tissues and organs",
            "probability": 0.006779161973499619,
            "start_logit": -4.483383655548096,
            "end_logit": -2.137967348098755,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "is an autoimmune disease of uncertain etiology that affects multiple tissues",
            "probability": 0.006572803387155691,
            "start_logit": -5.710364818572998,
            "end_logit": -0.9418992400169373,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        }
    ],
    "5be94f3d133db5eb78000022": [
        {
            "text": "hepatocellular carcinoma",
            "probability": 0.9860971946340336,
            "start_logit": 5.800764560699463,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "patocellular carcinoma",
            "probability": 0.005021342135996296,
            "start_logit": 0.5207068920135498,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "carcinoma",
            "probability": 0.0031310817809042965,
            "start_logit": 0.048388198018074036,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular carcinoma.",
            "probability": 0.002559867419944172,
            "start_logit": 5.800764560699463,
            "end_logit": -0.41079971194267273,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cellular carcinoma",
            "probability": 0.0008733428859704213,
            "start_logit": -1.2284173965454102,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "he",
            "probability": 0.0005381847575557413,
            "start_logit": 5.800764560699463,
            "end_logit": -1.970308542251587,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "oma",
            "probability": 0.00036926864102479993,
            "start_logit": -2.089221239089966,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "tocellular carcinoma",
            "probability": 0.0003520902927704364,
            "start_logit": -2.1368579864501953,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular carcin",
            "probability": 0.0002419570188480695,
            "start_logit": 5.800764560699463,
            "end_logit": -2.7697503566741943,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cinoma",
            "probability": 0.00022233768368246315,
            "start_logit": -2.596548318862915,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular",
            "probability": 0.00018961509064661532,
            "start_logit": 5.800764560699463,
            "end_logit": -3.013514280319214,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepatocellular car",
            "probability": 0.00016825509266430843,
            "start_logit": 5.800764560699463,
            "end_logit": -3.1330292224884033,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "treatment of hepatocellular carcinoma",
            "probability": 6.670825419373492e-05,
            "start_logit": -3.800416946411133,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepa",
            "probability": 6.413673491030736e-05,
            "start_logit": 5.800764560699463,
            "end_logit": -4.0974931716918945,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "hepato",
            "probability": 5.273960597189603e-05,
            "start_logit": 5.800764560699463,
            "end_logit": -4.2931437492370605,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "patocellular carcinoma.",
            "probability": 1.3035195930255372e-05,
            "start_logit": 0.5207068920135498,
            "end_logit": -0.41079971194267273,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "evaluated in a phase 1b trial for treatment of hepatocellular carcinoma",
            "probability": 1.2454900330047277e-05,
            "start_logit": -5.478631496429443,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "phase 1b trial for treatment of hepatocellular carcinoma",
            "probability": 9.590619152086493e-06,
            "start_logit": -5.739960193634033,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "trial for treatment of hepatocellular carcinoma",
            "probability": 8.669097025706338e-06,
            "start_logit": -5.8409810066223145,
            "end_logit": 5.542999744415283,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "carcinoma.",
            "probability": 8.128158444961723e-06,
            "start_logit": 0.048388198018074036,
            "end_logit": -0.41079971194267273,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        }
    ],
    "5c34a761da8336e21a000005": [
        {
            "text": "metabolism",
            "probability": 0.1504469875865373,
            "start_logit": -2.9722485542297363,
            "end_logit": -2.7147738933563232,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell metabolism",
            "probability": 0.14775790094269797,
            "start_logit": -2.9902842044830322,
            "end_logit": -2.7147738933563232,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "metabolism signatures",
            "probability": 0.0965216807302707,
            "start_logit": -2.9722485542297363,
            "end_logit": -3.1586170196533203,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell metabolism signatures",
            "probability": 0.09479645401316282,
            "start_logit": -2.9902842044830322,
            "end_logit": -3.1586170196533203,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress",
            "probability": 0.06827258522323496,
            "start_logit": -2.708989143371582,
            "end_logit": -3.7681357860565186,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "metabolism signatures, specifically associated with systemic lupus erythematosus (SLE) and the consequences of heightened oxidative stress",
            "probability": 0.05247038354600068,
            "start_logit": -2.9722485542297363,
            "end_logit": -3.7681357860565186,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "metabolism signatures,",
            "probability": 0.05088838728261358,
            "start_logit": -2.9722485542297363,
            "end_logit": -3.7987499237060547,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell metabolism signatures,",
            "probability": 0.049978809199572954,
            "start_logit": -2.9902842044830322,
            "end_logit": -3.7987499237060547,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "insights into the immune cell metabolism",
            "probability": 0.04253440263961712,
            "start_logit": -4.235546112060547,
            "end_logit": -2.7147738933563232,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "Recent insights into the immune cell metabolism",
            "probability": 0.032368158463317795,
            "start_logit": -4.508684158325195,
            "end_logit": -2.7147738933563232,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell",
            "probability": 0.028048340810273187,
            "start_logit": -2.9902842044830322,
            "end_logit": -4.376419544219971,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "insights into the immune cell metabolism signatures",
            "probability": 0.027288629021384847,
            "start_logit": -4.235546112060547,
            "end_logit": -3.1586170196533203,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "metabolism signatures, specifically",
            "probability": 0.024789857941636045,
            "start_logit": -2.9722485542297363,
            "end_logit": -4.517950057983398,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "immune cell metabolism signatures, specifically",
            "probability": 0.02434676448418025,
            "start_logit": -2.9902842044830322,
            "end_logit": -4.517950057983398,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "Recent insights into the immune cell metabolism signatures",
            "probability": 0.020766311822801434,
            "start_logit": -4.508684158325195,
            "end_logit": -3.1586170196533203,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients,",
            "probability": 0.01947707208309154,
            "start_logit": -2.708989143371582,
            "end_logit": -5.022406101226807,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "the immune cell metabolism",
            "probability": 0.017714717436428842,
            "start_logit": -5.11146354675293,
            "end_logit": -2.7147738933563232,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients, are discussed herein",
            "probability": 0.017562044330266483,
            "start_logit": -2.708989143371582,
            "end_logit": -5.125904083251953,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "insights",
            "probability": 0.01747096447914912,
            "start_logit": -4.235546112060547,
            "end_logit": -3.6045467853546143,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "oxidative stress in patients, are discussed",
            "probability": 0.016499547963762014,
            "start_logit": -2.708989143371582,
            "end_logit": -5.1883111000061035,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        }
    ],
    "5be44d8b133db5eb78000015": [
        {
            "text": "lactic acid bacteria",
            "probability": 0.095625710750379,
            "start_logit": 6.285292148590088,
            "end_logit": 6.262904644012451,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, lactic acid bacteria",
            "probability": 0.08170229767076156,
            "start_logit": 6.127932548522949,
            "end_logit": 6.262904644012451,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Bifidobacterium",
            "probability": 0.07268592960263737,
            "start_logit": 6.520599842071533,
            "end_logit": 5.753303050994873,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus",
            "probability": 0.07121279004104836,
            "start_logit": 6.127932548522949,
            "end_logit": 6.125494956970215,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "lactic acid bacteria, and other gram-positive bacteria (Corynebacterium",
            "probability": 0.06871534888935815,
            "start_logit": 6.285292148590088,
            "end_logit": 5.932435512542725,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Propionibacterium",
            "probability": 0.06683646428363904,
            "start_logit": 6.377706527709961,
            "end_logit": 5.812297344207764,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, lactic acid bacteria",
            "probability": 0.06580355551274834,
            "start_logit": 5.911524295806885,
            "end_logit": 6.262904644012451,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium",
            "probability": 0.06481797323495907,
            "start_logit": 6.226902484893799,
            "end_logit": 5.932435512542725,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Propionibacterium, and Bifidobacterium",
            "probability": 0.06300754687634356,
            "start_logit": 6.377706527709961,
            "end_logit": 5.753303050994873,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "lactic acid bacteria, and other gram-positive bacteria (Corynebacterium, Propionibacterium",
            "probability": 0.060936627152127845,
            "start_logit": 6.285292148590088,
            "end_logit": 5.812297344207764,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, lactic acid bacteria, and other gram-positive bacteria (Corynebacterium",
            "probability": 0.05871017162072516,
            "start_logit": 6.127932548522949,
            "end_logit": 5.932435512542725,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium, Propionibacterium",
            "probability": 0.0574804426029335,
            "start_logit": 6.226902484893799,
            "end_logit": 5.812297344207764,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus",
            "probability": 0.05735523866865246,
            "start_logit": 5.911524295806885,
            "end_logit": 6.125494956970215,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium, Propionibacterium, and Bifidobacterium",
            "probability": 0.054187511571641714,
            "start_logit": 6.226902484893799,
            "end_logit": 5.753303050994873,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus",
            "probability": 0.0512363032193806,
            "start_logit": 5.911524295806885,
            "end_logit": 6.012679100036621,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Bifidobacter",
            "probability": 0.0025572523080182406,
            "start_logit": 6.520599842071533,
            "end_logit": 2.4060885906219482,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Propionibacterium, and Bifidobacter",
            "probability": 0.002216745325442611,
            "start_logit": 6.377706527709961,
            "end_logit": 2.4060885906219482,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Corynebacterium, Propionibacterium, and Bifidobacter",
            "probability": 0.001906436910002977,
            "start_logit": 6.226902484893799,
            "end_logit": 2.4060885906219482,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Propionibacter",
            "probability": 0.001572218906723145,
            "start_logit": 6.377706527709961,
            "end_logit": 2.0625364780426025,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "lactic acid bacteria, and other gram-positive bacteria (Corynebacterium, Propionibacter",
            "probability": 0.0014334348524771784,
            "start_logit": 6.285292148590088,
            "end_logit": 2.0625364780426025,
            "question_text": "What are the 3 main bacteria found in human milk?"
        }
    ],
    "5c0e82b2133db5eb7800002d": [
        {
            "text": "senescence",
            "probability": 0.15090639286488425,
            "start_logit": -2.930962562561035,
            "end_logit": -2.083760976791382,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "CD8",
            "probability": 0.13112401671712526,
            "start_logit": -1.7462900876998901,
            "end_logit": -3.408949613571167,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype",
            "probability": 0.13089567198468213,
            "start_logit": -2.930962562561035,
            "end_logit": -2.226020097732544,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype",
            "probability": 0.10149072893673144,
            "start_logit": -3.1853957176208496,
            "end_logit": -2.226020097732544,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "Cellular senescence",
            "probability": 0.062370053230907045,
            "start_logit": -3.8145370483398438,
            "end_logit": -2.083760976791382,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "Cellular senescence is accompanied by a senescence-associated secretory phenotype",
            "probability": 0.054099563805024994,
            "start_logit": -3.8145370483398438,
            "end_logit": -2.226020097732544,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype (SASP).",
            "probability": 0.03741810603403186,
            "start_logit": -2.930962562561035,
            "end_logit": -3.4782660007476807,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "primary human senescent CD8",
            "probability": 0.035639917725677144,
            "start_logit": -3.0489673614501953,
            "end_logit": -3.408949613571167,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype (SASP)",
            "probability": 0.03274602837550644,
            "start_logit": -2.930962562561035,
            "end_logit": -3.6116390228271484,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype (SASP). We show here that primary human senescent CD8",
            "probability": 0.031094717142221995,
            "start_logit": -3.1853957176208496,
            "end_logit": -3.408949613571167,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype (SASP).",
            "probability": 0.02901234853105158,
            "start_logit": -3.1853957176208496,
            "end_logit": -3.4782660007476807,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "We show here that primary human senescent CD8",
            "probability": 0.026367027468845707,
            "start_logit": -3.3503193855285645,
            "end_logit": -3.408949613571167,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype (SASP)",
            "probability": 0.02538982564680945,
            "start_logit": -3.1853957176208496,
            "end_logit": -3.6116390228271484,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype (SASP",
            "probability": 0.025045192649129588,
            "start_logit": -2.930962562561035,
            "end_logit": -3.8797388076782227,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescent CD8",
            "probability": 0.023185515211434693,
            "start_logit": -3.4789059162139893,
            "end_logit": -3.408949613571167,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "a senescence-associated secretory phenotype",
            "probability": 0.022324127875784333,
            "start_logit": -4.699695110321045,
            "end_logit": -2.226020097732544,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence",
            "probability": 0.021382640185561002,
            "start_logit": -2.930962562561035,
            "end_logit": -4.037841320037842,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "show here that primary human senescent CD8",
            "probability": 0.020808052763558408,
            "start_logit": -3.5870935916900635,
            "end_logit": -3.408949613571167,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype (SASP",
            "probability": 0.019418937385634005,
            "start_logit": -3.1853957176208496,
            "end_logit": -3.8797388076782227,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence is accompanied by a senescence-associated secretory phenotype (SASP). We show here",
            "probability": 0.019281135465398596,
            "start_logit": -2.930962562561035,
            "end_logit": -4.141293525695801,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        }
    ],
    "5c61f379e842deac67000006": [
        {
            "text": "c.1482delinsGCCAGG",
            "probability": 0.37406712799612485,
            "start_logit": 1.2875165939331055,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.20439614435956543,
            "start_logit": 1.2875165939331055,
            "end_logit": -0.4721519649028778,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG",
            "probability": 0.17416569726216063,
            "start_logit": 0.5230884552001953,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.09516686801853846,
            "start_logit": 0.5230884552001953,
            "end_logit": -0.4721519649028778,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.05344517815721407,
            "start_logit": -0.6582622528076172,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23",
            "probability": 0.016001593951354927,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.0195236206054688,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.009083606759802456,
            "start_logit": -2.4304473400115967,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23).",
            "probability": 0.00879635627357415,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.6178743839263916,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482",
            "probability": 0.008276441006718826,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.6787989139556885,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23",
            "probability": 0.007450343960382893,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.0195236206054688,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delins",
            "probability": 0.007227922969760528,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.814260244369507,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1516C>T (p.Arg506Ter)",
            "probability": 0.006910688691611336,
            "start_logit": -0.7239497900009155,
            "end_logit": -1.8476762771606445,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482del",
            "probability": 0.006593513840269952,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.906125545501709,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1516C>T",
            "probability": 0.006505202842123624,
            "start_logit": -0.7239497900009155,
            "end_logit": -1.9081432819366455,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter)",
            "probability": 0.0043457544040511505,
            "start_logit": -0.6582622528076172,
            "end_logit": -2.3772337436676025,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23).",
            "probability": 0.004095584479610552,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.6178743839263916,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482",
            "probability": 0.003853511872337673,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.6787989139556885,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delins",
            "probability": 0.0033653217552935327,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.814260244369507,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T",
            "probability": 0.0031832006069254333,
            "start_logit": -0.6582622528076172,
            "end_logit": -2.6885459423065186,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482del",
            "probability": 0.003069940792579398,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.906125545501709,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        }
    ],
    "5c53131e7e3cb0e231000012": [
        {
            "text": "clinical",
            "probability": 0.3559153527331329,
            "start_logit": -4.318701267242432,
            "end_logit": -4.6096014976501465,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "clinical symptoms",
            "probability": 0.28658776592539204,
            "start_logit": -4.318701267242432,
            "end_logit": -4.826249599456787,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "symptoms",
            "probability": 0.05961156682535387,
            "start_logit": -5.888896465301514,
            "end_logit": -4.826249599456787,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "clinical symptoms while anticipating that weaker symptoms than those in typical cases would be seen;",
            "probability": 0.05877999229885906,
            "start_logit": -4.318701267242432,
            "end_logit": -6.410492897033691,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "clinical symptoms while anticipating that weaker symptoms than those in typical cases would be seen",
            "probability": 0.045366699305292406,
            "start_logit": -4.318701267242432,
            "end_logit": -6.669516086578369,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "classifying measles patients based on their clinical",
            "probability": 0.039579804066399014,
            "start_logit": -6.515075206756592,
            "end_logit": -4.6096014976501465,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "classifying measles patients based on their clinical symptoms",
            "probability": 0.031870183559232816,
            "start_logit": -6.515075206756592,
            "end_logit": -4.826249599456787,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "strategies for classifying measles patients based on their clinical",
            "probability": 0.01853990993377754,
            "start_logit": -7.273468494415283,
            "end_logit": -4.6096014976501465,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "measles patients based on their clinical",
            "probability": 0.015624934460321874,
            "start_logit": -7.444526195526123,
            "end_logit": -4.6096014976501465,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "strategies for classifying measles patients based on their clinical symptoms",
            "probability": 0.014928581550577948,
            "start_logit": -7.273468494415283,
            "end_logit": -4.826249599456787,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "measles patients based on their clinical symptoms",
            "probability": 0.012581404610190786,
            "start_logit": -7.444526195526123,
            "end_logit": -4.826249599456787,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "symptoms while anticipating that weaker symptoms than those in typical cases would be seen;",
            "probability": 0.012226507393303792,
            "start_logit": -5.888896465301514,
            "end_logit": -6.410492897033691,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "symptoms while anticipating that weaker symptoms than those in typical cases would be seen",
            "probability": 0.009436481067329335,
            "start_logit": -5.888896465301514,
            "end_logit": -6.669516086578369,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "sporadic outbreaks of measles",
            "probability": 0.00756757284557772,
            "start_logit": -6.641944408416748,
            "end_logit": -6.137178897857666,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "classifying measles patients based on their clinical symptoms while anticipating that weaker symptoms than those in typical cases would be seen;",
            "probability": 0.006536668228407967,
            "start_logit": -6.515075206756592,
            "end_logit": -6.410492897033691,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "nationwide survey of measles immunity",
            "probability": 0.006251019752733879,
            "start_logit": -6.5097174644470215,
            "end_logit": -6.460533618927002,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "classifying measles patients based on their clinical symptoms while anticipating that weaker symptoms than those in typical cases would be seen",
            "probability": 0.005045034039284806,
            "start_logit": -6.515075206756592,
            "end_logit": -6.669516086578369,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "sporadic outbreaks of measles have repeatedly occurred even after the declaration of measles elimination.",
            "probability": 0.005025384485838846,
            "start_logit": -6.641944408416748,
            "end_logit": -6.546549320220947,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "survey of measles immunity",
            "probability": 0.004370076750634985,
            "start_logit": -6.867681503295898,
            "end_logit": -6.460533618927002,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "sporadic outbreaks",
            "probability": 0.0041550601683587145,
            "start_logit": -6.641944408416748,
            "end_logit": -6.736724376678467,
            "question_text": "Please list symptoms of measles."
        }
    ],
    "5c5315727e3cb0e231000014": [
        {
            "text": "MERTK",
            "probability": 0.8218725710994956,
            "start_logit": 5.461372375488281,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and MERTK",
            "probability": 0.10353197431165574,
            "start_logit": 3.389667510986328,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO) and MERTK",
            "probability": 0.051799864511818706,
            "start_logit": 2.697174549102783,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL",
            "probability": 0.01271805288284129,
            "start_logit": 3.389667510986328,
            "end_logit": 1.8924672603607178,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL",
            "probability": 0.0063631879964174175,
            "start_logit": 2.697174549102783,
            "end_logit": 1.8924672603607178,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "ME",
            "probability": 0.002315310437880579,
            "start_logit": 5.461372375488281,
            "end_logit": -1.8827162981033325,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and ME",
            "probability": 0.00029166158989523143,
            "start_logit": 3.389667510986328,
            "end_logit": -1.8827162981033325,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (TAM)",
            "probability": 0.0002454518635556565,
            "start_logit": 5.461372375488281,
            "end_logit": -4.1269145011901855,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3",
            "probability": 0.00018517119842546405,
            "start_logit": 2.697174549102783,
            "end_logit": -1.6445367336273193,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO) and ME",
            "probability": 0.000145926231392013,
            "start_logit": 2.697174549102783,
            "end_logit": -1.8827162981033325,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERT",
            "probability": 0.00012745660031500663,
            "start_logit": 5.461372375488281,
            "end_logit": -4.7822394371032715,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (TAM) family",
            "probability": 7.93549189099014e-05,
            "start_logit": 5.461372375488281,
            "end_logit": -5.25608491897583,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "K",
            "probability": 6.98239215951552e-05,
            "start_logit": -3.911991596221924,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (",
            "probability": 5.3024856975077035e-05,
            "start_logit": 5.461372375488281,
            "end_logit": -5.659254550933838,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (TAM) family of receptor tyrosine kinases",
            "probability": 5.0595779319744445e-05,
            "start_logit": 5.461372375488281,
            "end_logit": -5.706147193908691,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "L (also known as UFO) and MERTK",
            "probability": 4.322543809355085e-05,
            "start_logit": -4.391539096832275,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO)",
            "probability": 3.432033282163536e-05,
            "start_logit": 3.389667510986328,
            "end_logit": -4.0225725173950195,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and MERTK (TAM)",
            "probability": 3.091977628404863e-05,
            "start_logit": 3.389667510986328,
            "end_logit": -4.1269145011901855,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "A",
            "probability": 2.159731225421386e-05,
            "start_logit": 3.389667510986328,
            "end_logit": -4.48574161529541,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "3, AXL (also known as UFO) and MERTK",
            "probability": 2.0508940053590804e-05,
            "start_logit": -5.1371073722839355,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        }
    ],
    "5c658a8f7c78d69471000007": [
        {
            "text": "ivosidenib",
            "probability": 0.4252259995812952,
            "start_logit": -2.88940167427063,
            "end_logit": -2.932819366455078,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib, ivosidenib",
            "probability": 0.1334263425347575,
            "start_logit": -4.048472881317139,
            "end_logit": -2.932819366455078,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib",
            "probability": 0.11380212687199528,
            "start_logit": -2.88940167427063,
            "end_logit": -4.250978946685791,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin, enasidenib, ivosidenib",
            "probability": 0.07324741333801818,
            "start_logit": -4.648179531097412,
            "end_logit": -2.932819366455078,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib, ivosidenib, gilteritinib",
            "probability": 0.035708544576667715,
            "start_logit": -4.048472881317139,
            "end_logit": -4.250978946685791,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib",
            "probability": 0.03554545739356691,
            "start_logit": -4.048472881317139,
            "end_logit": -4.255556583404541,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib, glasdegib",
            "probability": 0.023015587904115776,
            "start_logit": -2.88940167427063,
            "end_logit": -5.849268436431885,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib, glasdegib, and venetoclax. With an increase in oral medications",
            "probability": 0.02099135483726796,
            "start_logit": -2.88940167427063,
            "end_logit": -5.941329479217529,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin, enasidenib, ivosidenib, gilteritinib",
            "probability": 0.019603014476881703,
            "start_logit": -4.648179531097412,
            "end_logit": -4.250978946685791,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin, enasidenib",
            "probability": 0.01951348407318645,
            "start_logit": -4.648179531097412,
            "end_logit": -4.255556583404541,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ivosidenib, gilteritinib, glasdegib, and venetoclax.",
            "probability": 0.018286701221240192,
            "start_logit": -2.88940167427063,
            "end_logit": -6.07926607131958,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "gilteritinib",
            "probability": 0.016156486260337343,
            "start_logit": -4.841541290283203,
            "end_logit": -4.250978946685791,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "midostaurin",
            "probability": 0.014155412153140737,
            "start_logit": -4.648179531097412,
            "end_logit": -4.576565265655518,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ib, ivosidenib",
            "probability": 0.009338180733826152,
            "start_logit": -6.707911014556885,
            "end_logit": -2.932819366455078,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Since 2017, eight novel agents have been introduced, 6 of which are oral: midostaurin, enasidenib, ivosidenib",
            "probability": 0.008090821995285682,
            "start_logit": -6.851292133331299,
            "end_logit": -2.932819366455078,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "ib",
            "probability": 0.007860484970160017,
            "start_logit": -6.880174160003662,
            "end_logit": -2.932819366455078,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib, ivosidenib, gilteritinib, glasdegib",
            "probability": 0.007221773170871874,
            "start_logit": -4.048472881317139,
            "end_logit": -5.849268436431885,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "oral: midostaurin, enasidenib, ivosidenib",
            "probability": 0.006784558028564045,
            "start_logit": -7.027373313903809,
            "end_logit": -2.932819366455078,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "venetoclax. With an increase in oral medications (OMs), patients face associated side effects that accompany OMs",
            "probability": 0.006288300854014684,
            "start_logit": -5.131013870239258,
            "end_logit": -4.905137062072754,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "enasidenib, ivosidenib, gilteritinib, glasdegib, and venetoclax.",
            "probability": 0.00573795502480674,
            "start_logit": -4.048472881317139,
            "end_logit": -6.07926607131958,
            "question_text": "Name 4 side effects of enasidenib"
        }
    ],
    "5c76c1457c78d694710000a6": [
        {
            "text": "inflammatory bowel disease",
            "probability": 0.1356751141591694,
            "start_logit": -3.218012809753418,
            "end_logit": -3.3890645503997803,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1",
            "probability": 0.13376657848644277,
            "start_logit": -2.9705538749694824,
            "end_logit": -3.6506903171539307,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1",
            "probability": 0.12056910530126691,
            "start_logit": -3.0744271278381348,
            "end_logit": -3.6506903171539307,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "autoimmune disorders. The study examined the level and function of MAIT cells in patients with inflammatory bowel disease",
            "probability": 0.09695694465179974,
            "start_logit": -3.554008960723877,
            "end_logit": -3.3890645503997803,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1)",
            "probability": 0.05804209551757516,
            "start_logit": -2.9705538749694824,
            "end_logit": -4.4856181144714355,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1)-dependent and -independent stimulations was decreased in IBD patients,",
            "probability": 0.05742127621922082,
            "start_logit": -2.9705538749694824,
            "end_logit": -4.496371746063232,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1)",
            "probability": 0.052315635232263694,
            "start_logit": -3.0744271278381348,
            "end_logit": -4.4856181144714355,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1)-dependent and -independent stimulations was decreased in IBD patients,",
            "probability": 0.051756066256191474,
            "start_logit": -3.0744271278381348,
            "end_logit": -4.496371746063232,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b",
            "probability": 0.0425518859449119,
            "start_logit": -3.0744271278381348,
            "end_logit": -4.6921892166137695,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "autoimmune disorders",
            "probability": 0.03695524898600378,
            "start_logit": -3.554008960723877,
            "end_logit": -4.353623867034912,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein",
            "probability": 0.029697746900755592,
            "start_logit": -3.0744271278381348,
            "end_logit": -5.051842212677002,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1)-dependent and -independent stimulations was decreased",
            "probability": 0.026442442584590678,
            "start_logit": -2.9705538749694824,
            "end_logit": -5.271816253662109,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1)-dependent and -independent stimulations was decreased",
            "probability": 0.023833618834224243,
            "start_logit": -3.0744271278381348,
            "end_logit": -5.271816253662109,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "inflammatory bowel disease (IBD)",
            "probability": 0.023344210325959132,
            "start_logit": -3.218012809753418,
            "end_logit": -5.1489787101745605,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "(MR1",
            "probability": 0.021624086652678502,
            "start_logit": -4.792842388153076,
            "end_logit": -3.6506903171539307,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "play an important role in autoimmune disorders. The study examined the level and function of MAIT cells in patients with inflammatory bowel disease",
            "probability": 0.021075486438343262,
            "start_logit": -5.080165386199951,
            "end_logit": -3.3890645503997803,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MR1)-dependent and -independent stimulations",
            "probability": 0.01821208101100276,
            "start_logit": -2.9705538749694824,
            "end_logit": -5.6447014808654785,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "autoimmune disorders. The study examined the level and function of MAIT cells in patients with inflammatory bowel disease (IBD)",
            "probability": 0.016682376296795795,
            "start_logit": -3.554008960723877,
            "end_logit": -5.1489787101745605,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "inflammatory bowel disease (IBD).",
            "probability": 0.016662731618649788,
            "start_logit": -3.218012809753418,
            "end_logit": -5.4861531257629395,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "MHC class 1b-like related protein (MR1)-dependent and -independent stimulations",
            "probability": 0.016415268582154405,
            "start_logit": -3.0744271278381348,
            "end_logit": -5.6447014808654785,
            "question_text": "List MHC-I-associated inflammatory disorders."
        }
    ],
    "5c6c46677c78d69471000035": [
        {
            "text": "limma",
            "probability": 0.7630051779004148,
            "start_logit": 3.9965171813964844,
            "end_logit": 3.111646890640259,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package",
            "probability": 0.11477718514865057,
            "start_logit": 3.9965171813964844,
            "end_logit": 1.2173748016357422,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R/Bioconductor",
            "probability": 0.0810707792173032,
            "start_logit": 3.9965171813964844,
            "end_logit": 0.8697046637535095,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R/Bioconductor)",
            "probability": 0.008495049149440518,
            "start_logit": 3.9965171813964844,
            "end_logit": -1.386134386062622,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "the limma",
            "probability": 0.005721383746203941,
            "start_logit": -0.8965369462966919,
            "end_logit": 3.111646890640259,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R",
            "probability": 0.005654330577922573,
            "start_logit": 3.9965171813964844,
            "end_logit": -1.793196201324463,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "l",
            "probability": 0.004856480554947284,
            "start_logit": 3.9965171813964844,
            "end_logit": -1.9453039169311523,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "Bioconductor",
            "probability": 0.00474350896112252,
            "start_logit": 1.157971739768982,
            "end_logit": 0.8697046637535095,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R/Bio",
            "probability": 0.0026016462606803944,
            "start_logit": 3.9965171813964844,
            "end_logit": -2.5694735050201416,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "lim",
            "probability": 0.001993981081421164,
            "start_logit": 3.9965171813964844,
            "end_logit": -2.835484743118286,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (",
            "probability": 0.0013043330615055296,
            "start_logit": 3.9965171813964844,
            "end_logit": -3.2599260807037354,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "the limma package",
            "probability": 0.000860655131268635,
            "start_logit": -0.8965369462966919,
            "end_logit": 1.2173748016357422,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "in the limma",
            "probability": 0.0007999245227091899,
            "start_logit": -2.863985538482666,
            "end_logit": 3.111646890640259,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "mRNA counts were normalized, log2 transformed for differential expression analysis using linear models in the limma",
            "probability": 0.0006962069088096248,
            "start_logit": -2.5742146968841553,
            "end_logit": 2.6830055713653564,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "R/Bioconductor",
            "probability": 0.0006248078381341886,
            "start_logit": -0.8691165447235107,
            "end_logit": 0.8697046637535095,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "ma",
            "probability": 0.0006164959508726473,
            "start_logit": -3.124451160430908,
            "end_logit": 3.111646890640259,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "the limma package (R/Bioconductor",
            "probability": 0.000607908113785442,
            "start_logit": -0.8965369462966919,
            "end_logit": 0.8697046637535095,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "(R/Bioconductor",
            "probability": 0.0005874950945378392,
            "start_logit": -0.9306927919387817,
            "end_logit": 0.8697046637535095,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "Bioconductor)",
            "probability": 0.0004970513686261296,
            "start_logit": 1.157971739768982,
            "end_logit": -1.386134386062622,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "limma package (R/Bioconductor).",
            "probability": 0.0004855994116441131,
            "start_logit": 3.9965171813964844,
            "end_logit": -4.247989177703857,
            "question_text": "List available R packages for processing NanoString data"
        }
    ],
    "5c76e6d27c78d694710000ac": [
        {
            "text": "acridine orange",
            "probability": 0.9557172293047438,
            "start_logit": 4.26535177230835,
            "end_logit": 4.925291538238525,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (AO), the electronopaque colloidal Thorotrast",
            "probability": 0.023386596731546323,
            "start_logit": 4.26535177230835,
            "end_logit": 1.2149925231933594,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (AO)",
            "probability": 0.0074161324398459875,
            "start_logit": 4.26535177230835,
            "end_logit": 0.0664871409535408,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Thorotrast",
            "probability": 0.00722575434643435,
            "start_logit": 3.0908403396606445,
            "end_logit": 1.2149925231933594,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "orange",
            "probability": 0.0024858301371684494,
            "start_logit": -1.6865036487579346,
            "end_logit": 4.925291538238525,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "cridine orange",
            "probability": 0.0024631778943438416,
            "start_logit": -1.6956579685211182,
            "end_logit": 4.925291538238525,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (AO), the electronopaque colloidal Th",
            "probability": 0.0003244744245596168,
            "start_logit": 4.26535177230835,
            "end_logit": -3.0627191066741943,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (AO",
            "probability": 0.00028037804700279507,
            "start_logit": 4.26535177230835,
            "end_logit": -3.208786964416504,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "a",
            "probability": 0.0001244227589814829,
            "start_logit": 4.26535177230835,
            "end_logit": -4.021240711212158,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Th",
            "probability": 0.00010025282902346486,
            "start_logit": 3.0908403396606445,
            "end_logit": -3.0627191066741943,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Thorotrast, or both markers. After phagocytosis of heat-killed C. albicans",
            "probability": 8.288530323299582e-05,
            "start_logit": 3.0908403396606445,
            "end_logit": -3.2529566287994385,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Candida albicans. The macrophages were labeled with acridine orange",
            "probability": 8.068402047337621e-05,
            "start_logit": -5.114325046539307,
            "end_logit": 4.925291538238525,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "acridine orange (",
            "probability": 6.164121259273897e-05,
            "start_logit": 4.26535177230835,
            "end_logit": -4.723595142364502,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "orange (AO), the electronopaque colloidal Thorotrast",
            "probability": 6.082877359381142e-05,
            "start_logit": -1.6865036487579346,
            "end_logit": 1.2149925231933594,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "cridine orange (AO), the electronopaque colloidal Thorotrast",
            "probability": 6.027446856324339e-05,
            "start_logit": -1.6956579685211182,
            "end_logit": 1.2149925231933594,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "colloidal Thorotrast",
            "probability": 5.894743727186314e-05,
            "start_logit": -1.7179204225540161,
            "end_logit": 1.2149925231933594,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "orange (AO)",
            "probability": 1.928943515396582e-05,
            "start_logit": -1.6865036487579346,
            "end_logit": 0.0664871409535408,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "cridine orange (AO)",
            "probability": 1.9113659278324182e-05,
            "start_logit": -1.6956579685211182,
            "end_logit": 0.0664871409535408,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Thorotrast, or both markers. After phagocytosis of heat-killed C. albicans,",
            "probability": 1.6129726104588833e-05,
            "start_logit": 3.0908403396606445,
            "end_logit": -4.8897504806518555,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "AO), the electronopaque colloidal Thorotrast",
            "probability": 1.595705008484162e-05,
            "start_logit": -3.0246658325195312,
            "end_logit": 1.2149925231933594,
            "question_text": "List phagosomal markers."
        }
    ],
    "5c5214207e3cb0e231000003": [
        {
            "text": "Large-scale investigation of the reasons why potentially important genes are ignored\"",
            "probability": 0.23516093143449895,
            "start_logit": -0.5105272531509399,
            "end_logit": -0.0004751139786094427,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation of the reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.12530606691245433,
            "start_logit": -0.5105272531509399,
            "end_logit": -0.6299859285354614,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation of the reasons why potentially important genes are ignored",
            "probability": 0.1202914037851083,
            "start_logit": -0.5105272531509399,
            "end_logit": -0.6708280444145203,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation of the reasons why potentially important genes are ignored\"",
            "probability": 0.07009463567438223,
            "start_logit": -1.7209510803222656,
            "end_logit": -0.0004751139786094427,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "investigation of the reasons why potentially important genes are ignored\"",
            "probability": 0.06416485805128921,
            "start_logit": -1.8093416690826416,
            "end_logit": -0.0004751139786094427,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation",
            "probability": 0.06251895477832504,
            "start_logit": -0.5105272531509399,
            "end_logit": -1.3252754211425781,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation of the reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.03735009490921632,
            "start_logit": -1.7209510803222656,
            "end_logit": -0.6299859285354614,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation of the reasons why potentially important genes are ignored",
            "probability": 0.035855369646831545,
            "start_logit": -1.7209510803222656,
            "end_logit": -0.6708280444145203,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "investigation of the reasons why potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.03419039866595565,
            "start_logit": -1.8093416690826416,
            "end_logit": -0.6299859285354614,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "investigation of the reasons why potentially important genes are ignored",
            "probability": 0.03282212228697381,
            "start_logit": -1.8093416690826416,
            "end_logit": -0.6708280444145203,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "potentially important genes are ignored\"",
            "probability": 0.028821673672001644,
            "start_logit": -2.6096696853637695,
            "end_logit": -0.0004751139786094427,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "ignored\"",
            "probability": 0.02557484834839005,
            "start_logit": -2.7291879653930664,
            "end_logit": -0.0004751139786094427,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "Large-scale investigation of the reasons",
            "probability": 0.020974770089770972,
            "start_logit": -0.5105272531509399,
            "end_logit": -2.4174249172210693,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "\"Large-scale investigation",
            "probability": 0.018635082499452036,
            "start_logit": -1.7209510803222656,
            "end_logit": -1.3252754211425781,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "investigation",
            "probability": 0.01705861528271567,
            "start_logit": -1.8093416690826416,
            "end_logit": -1.3252754211425781,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "potentially important genes are ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.015357698014045781,
            "start_logit": -2.6096696853637695,
            "end_logit": -0.6299859285354614,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "potentially important genes are ignored",
            "probability": 0.014743093439426449,
            "start_logit": -2.6096696853637695,
            "end_logit": -0.6708280444145203,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "reasons why potentially important genes are ignored\"",
            "probability": 0.014369511828164391,
            "start_logit": -3.3056886196136475,
            "end_logit": -0.0004751139786094427,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "ignored\" maintain that it can be read as an opportunity to explore the unknown",
            "probability": 0.01362761934506055,
            "start_logit": -2.7291879653930664,
            "end_logit": -0.6299859285354614,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "ignored",
            "probability": 0.013082251335936719,
            "start_logit": -2.7291879653930664,
            "end_logit": -0.6708280444145203,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        }
    ],
    "5c7ab080d774d0424000000b": [
        {
            "text": "cyclic GMP-AMP (cGAMP",
            "probability": 0.3707190208982695,
            "start_logit": 5.035603046417236,
            "end_logit": 4.761023044586182,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP",
            "probability": 0.2507770535923194,
            "start_logit": 5.035603046417236,
            "end_logit": 4.370142936706543,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP",
            "probability": 0.1769666086573109,
            "start_logit": 4.296119689941406,
            "end_logit": 4.761023044586182,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP (cGAMP)",
            "probability": 0.09881907104647031,
            "start_logit": 5.035603046417236,
            "end_logit": 3.4388692378997803,
            "question_text": "List STING agonists."
        },
        {
            "text": "cGAMP)",
            "probability": 0.04717231889366307,
            "start_logit": 4.296119689941406,
            "end_logit": 3.4388692378997803,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP",
            "probability": 0.025164399959157254,
            "start_logit": 5.035603046417236,
            "end_logit": 2.0710089206695557,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP-AMP (cGAMP",
            "probability": 0.01046563354045962,
            "start_logit": 1.4682555198669434,
            "end_logit": 4.761023044586182,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP-AMP",
            "probability": 0.007079595583992515,
            "start_logit": 1.4682555198669434,
            "end_logit": 4.370142936706543,
            "question_text": "List STING agonists."
        },
        {
            "text": "(cGAMP",
            "probability": 0.0048304826461602396,
            "start_logit": 0.6951050162315369,
            "end_logit": 4.761023044586182,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP-AMP (cGAMP)",
            "probability": 0.0027897251721130376,
            "start_logit": 1.4682555198669434,
            "end_logit": 3.4388692378997803,
            "question_text": "List STING agonists."
        },
        {
            "text": "(cGAMP)",
            "probability": 0.0012876161752990829,
            "start_logit": 0.6951050162315369,
            "end_logit": 3.4388692378997803,
            "question_text": "List STING agonists."
        },
        {
            "text": "AMP (cGAMP",
            "probability": 0.001125135549123055,
            "start_logit": -0.7619378566741943,
            "end_logit": 4.761023044586182,
            "question_text": "List STING agonists."
        },
        {
            "text": "AMP",
            "probability": 0.0007611106039754141,
            "start_logit": -0.7619378566741943,
            "end_logit": 4.370142936706543,
            "question_text": "List STING agonists."
        },
        {
            "text": "GMP",
            "probability": 0.0007104070020468869,
            "start_logit": 1.4682555198669434,
            "end_logit": 2.0710089206695557,
            "question_text": "List STING agonists."
        },
        {
            "text": "c",
            "probability": 0.0004964205239931607,
            "start_logit": 5.035603046417236,
            "end_logit": -1.8547532558441162,
            "question_text": "List STING agonists."
        },
        {
            "text": "AMP (cGAMP)",
            "probability": 0.00029991676579284884,
            "start_logit": -0.7619378566741943,
            "end_logit": 3.4388692378997803,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP (c",
            "probability": 0.00021958765174271314,
            "start_logit": 5.035603046417236,
            "end_logit": -2.6704251766204834,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP (cGAM",
            "probability": 0.0001271107038664348,
            "start_logit": 5.035603046417236,
            "end_logit": -3.217118263244629,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AMP (",
            "probability": 0.00010516177562863175,
            "start_logit": 5.035603046417236,
            "end_logit": -3.406676769256592,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic GMP-AM",
            "probability": 8.3623258616043e-05,
            "start_logit": 5.035603046417236,
            "end_logit": -3.635854959487915,
            "question_text": "List STING agonists."
        }
    ],
    "5c6e01af7c78d69471000048": [
        {
            "text": "cytomegalovirus",
            "probability": 0.45733832270098107,
            "start_logit": 2.31394100189209,
            "end_logit": 2.160142421722412,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection or cytomegalovirus",
            "probability": 0.4057030268998027,
            "start_logit": 2.31394100189209,
            "end_logit": 2.0403404235839844,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection",
            "probability": 0.06253861317838721,
            "start_logit": 2.31394100189209,
            "end_logit": 0.170503169298172,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus disease",
            "probability": 0.02759886671687108,
            "start_logit": 2.3839774131774902,
            "end_logit": -0.7175427079200745,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus infection or cytomegalovirus disease",
            "probability": 0.0257320758082046,
            "start_logit": 2.31394100189209,
            "end_logit": -0.7175427079200745,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prospective clinical trials have recently been completed. However, management of patients with resistant or refractory cytomegalovirus",
            "probability": 0.004473047749571062,
            "start_logit": -2.3134124279022217,
            "end_logit": 2.160142421722412,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus disease. Antiviral drugs including maribavir",
            "probability": 0.004045419087458289,
            "start_logit": 0.1594914197921753,
            "end_logit": -0.4132462739944458,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus in patients with haematological malignancies",
            "probability": 0.003568072036865376,
            "start_logit": 0.9334295392036438,
            "end_logit": -1.312744140625,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "resistant or refractory cytomegalovirus",
            "probability": 0.0015281323077809788,
            "start_logit": -3.3874361515045166,
            "end_logit": 2.160142421722412,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "clinical trials have recently been completed. However, management of patients with resistant or refractory cytomegalovirus",
            "probability": 0.0014846138613900867,
            "start_logit": -3.416327714920044,
            "end_logit": 2.160142421722412,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "resistant or refractory cytomegalovirus infection or cytomegalovirus",
            "probability": 0.0013556001585624264,
            "start_logit": -3.3874361515045166,
            "end_logit": 2.0403404235839844,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "infection or cytomegalovirus",
            "probability": 0.001141360782924327,
            "start_logit": -3.5594592094421387,
            "end_logit": 2.0403404235839844,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "trials have recently been completed. However, management of patients with resistant or refractory cytomegalovirus",
            "probability": 0.0007864446400978252,
            "start_logit": -4.05171537399292,
            "end_logit": 2.160142421722412,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus disease. Antiviral drugs including maribavir and letermovir are in development and prospective clinical trials",
            "probability": 0.0006135021399339799,
            "start_logit": 0.1594914197921753,
            "end_logit": -2.299402952194214,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prospective clinical trials have recently been completed. However, management of patients with resistant or refractory cytomegalovirus infection",
            "probability": 0.000611665782317962,
            "start_logit": -2.3134124279022217,
            "end_logit": 0.170503169298172,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "Antiviral drugs including maribavir",
            "probability": 0.00043057393411736274,
            "start_logit": -2.0807299613952637,
            "end_logit": -0.4132462739944458,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus disease. Antiviral drugs including maribavir and letermovir are in development",
            "probability": 0.0003619609224443349,
            "start_logit": 0.1594914197921753,
            "end_logit": -2.8270504474639893,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "maribavir",
            "probability": 0.0002767240799584028,
            "start_logit": -2.5228281021118164,
            "end_logit": -0.4132462739944458,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "resistant or refractory cytomegalovirus infection",
            "probability": 0.00020896406563373658,
            "start_logit": -3.3874361515045166,
            "end_logit": 0.170503169298172,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "clinical trials have recently been completed. However, management of patients with resistant or refractory cytomegalovirus infection",
            "probability": 0.00020301314669720166,
            "start_logit": -3.416327714920044,
            "end_logit": 0.170503169298172,
            "question_text": "List two indications of Letermovir?"
        }
    ],
    "5c6b7daa7c78d6947100002b": [
        {
            "text": "telangiectasias",
            "probability": 0.17256266621110705,
            "start_logit": 3.9929540157318115,
            "end_logit": 4.48756742477417,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, (2) elevated erythropoietin and erythrocytosis",
            "probability": 0.11862586547188261,
            "start_logit": 3.9929540157318115,
            "end_logit": 4.112781524658203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, (2) elevated erythropoietin",
            "probability": 0.09007127778966151,
            "start_logit": 3.9929540157318115,
            "end_logit": 3.8374083042144775,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin and erythrocytosis",
            "probability": 0.08004407816052904,
            "start_logit": 3.5995569229125977,
            "end_logit": 4.112781524658203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis",
            "probability": 0.06231350081572607,
            "start_logit": 3.3491575717926025,
            "end_logit": 4.112781524658203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin",
            "probability": 0.060776563110709336,
            "start_logit": 3.5995569229125977,
            "end_logit": 3.8374083042144775,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin and erythrocytosis, (3) monoclonal gammopathy",
            "probability": 0.05638827088593437,
            "start_logit": 3.5995569229125977,
            "end_logit": 3.762465238571167,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin and erythrocytosis",
            "probability": 0.051447006367849095,
            "start_logit": 3.15753173828125,
            "end_logit": 4.112781524658203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy",
            "probability": 0.04395580984025515,
            "start_logit": 3.350480556488037,
            "end_logit": 3.762465238571167,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, (3) monoclonal gammopathy",
            "probability": 0.04389769542727695,
            "start_logit": 3.3491575717926025,
            "end_logit": 3.762465238571167,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin",
            "probability": 0.03906312998073236,
            "start_logit": 3.15753173828125,
            "end_logit": 3.8374083042144775,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin and erythrocytosis, (3) monoclonal gammopathy",
            "probability": 0.03624262778718835,
            "start_logit": 3.15753173828125,
            "end_logit": 3.762465238571167,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(1) telangiectasias",
            "probability": 0.02695035886338495,
            "start_logit": 2.136190176010132,
            "end_logit": 4.48756742477417,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy, (4) perinephric fluid collections",
            "probability": 0.025858801248816916,
            "start_logit": 3.350480556488037,
            "end_logit": 3.231931447982788,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, (3) monoclonal gammopathy, (4) perinephric fluid collections",
            "probability": 0.025824613070727233,
            "start_logit": 3.3491575717926025,
            "end_logit": 3.231931447982788,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(1) telangiectasias, (2) elevated erythropoietin and erythrocytosis",
            "probability": 0.018526658837293083,
            "start_logit": 2.136190176010132,
            "end_logit": 4.112781524658203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(1) telangiectasias, (2) elevated erythropoietin",
            "probability": 0.014067082486691255,
            "start_logit": 2.136190176010132,
            "end_logit": 3.8374083042144775,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "perinephric fluid collections",
            "probability": 0.012448403967154706,
            "start_logit": 2.61942195892334,
            "end_logit": 3.231931447982788,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias,",
            "probability": 0.010924674155465998,
            "start_logit": 3.9929540157318115,
            "end_logit": 1.7278308868408203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "(2) elevated erythropoietin and erythrocytosis",
            "probability": 0.010010915521613971,
            "start_logit": 1.5206555128097534,
            "end_logit": 4.112781524658203,
            "question_text": "List major features of TEMPI Syndrome."
        }
    ],
    "5c56bbb107647bbc4b000011": [
        {
            "text": "E6V'",
            "probability": 0.3772812401589303,
            "start_logit": -0.28847774863243103,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V",
            "probability": 0.2551405174665124,
            "start_logit": -0.28847774863243103,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V'),",
            "probability": 0.07568203573108204,
            "start_logit": -0.28847774863243103,
            "end_logit": -3.940426826477051,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V'",
            "probability": 0.06809951694638625,
            "start_logit": -2.0004985332489014,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V",
            "probability": 0.04605303456276093,
            "start_logit": -2.0004985332489014,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E",
            "probability": 0.044952922638191346,
            "start_logit": -0.28847774863243103,
            "end_logit": -4.4613518714904785,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V'), leaving relevant mentions natural language",
            "probability": 0.034038619160167836,
            "start_logit": -0.28847774863243103,
            "end_logit": -4.739471912384033,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V')",
            "probability": 0.01708386012404264,
            "start_logit": -0.28847774863243103,
            "end_logit": -5.428833484649658,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V'), leaving relevant mentions natural language (NL) largely untapped",
            "probability": 0.013943041340525349,
            "start_logit": -0.28847774863243103,
            "end_logit": -5.63198709487915,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V'),",
            "probability": 0.013660658220469003,
            "start_logit": -2.0004985332489014,
            "end_logit": -3.940426826477051,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing methods primarily target standard (ST) mutation mentions (e.g. 'E6V'",
            "probability": 0.0091975717481104,
            "start_logit": -4.002529144287109,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E",
            "probability": 0.008114032692692424,
            "start_logit": -2.0004985332489014,
            "end_logit": -4.4613518714904785,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing methods primarily target standard (ST) mutation mentions (e.g. 'E6V",
            "probability": 0.006219957330133146,
            "start_logit": -4.002529144287109,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V'), leaving relevant mentions natural language",
            "probability": 0.0061439935930897895,
            "start_logit": -2.0004985332489014,
            "end_logit": -4.739471912384033,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g. 'E6V'",
            "probability": 0.005216929857455082,
            "start_logit": -4.569559574127197,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "mutation mentions (e.g. 'E6V'",
            "probability": 0.004733770527873394,
            "start_logit": -4.666746616363525,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation mentions (e.g. 'E6V'",
            "probability": 0.00459894375478923,
            "start_logit": -4.695641994476318,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g. 'E6V",
            "probability": 0.003528005216630654,
            "start_logit": -4.569559574127197,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "mutation mentions (e.g. 'E6V",
            "probability": 0.0032012634965379295,
            "start_logit": -4.666746616363525,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation mentions (e.g. 'E6V",
            "probability": 0.0031100854336198187,
            "start_logit": -4.695641994476318,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        }
    ],
    "5c6f107c7c78d69471000051": [
        {
            "text": "FAK",
            "probability": 0.8675385627154085,
            "start_logit": 6.039067268371582,
            "end_logit": 5.539059638977051,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor",
            "probability": 0.08369528053381932,
            "start_logit": 6.039067268371582,
            "end_logit": 3.200582265853882,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK and PROX1 (the target of SOX18) by the transfection of respective siRNAs. FAK",
            "probability": 0.019617167186404952,
            "start_logit": 4.593076705932617,
            "end_logit": 3.1957952976226807,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK, which transduced signals causing the retraction of LECs. The FAK",
            "probability": 0.007947917831850908,
            "start_logit": 1.3463172912597656,
            "end_logit": 5.539059638977051,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK and PROX1",
            "probability": 0.007683742720544731,
            "start_logit": 4.593076705932617,
            "end_logit": 2.2584969997406006,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor defactinib",
            "probability": 0.0052399061610833245,
            "start_logit": 6.039067268371582,
            "end_logit": 0.4297032654285431,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "PROX1 (the target of SOX18) by the transfection of respective siRNAs. FAK",
            "probability": 0.003801684912087102,
            "start_logit": 2.952116012573242,
            "end_logit": 3.1957952976226807,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "PROX1",
            "probability": 0.0014890615189994336,
            "start_logit": 2.952116012573242,
            "end_logit": 2.2584969997406006,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK, which transduced signals causing the retraction of LECs. The FAK\u2011inhibitor",
            "probability": 0.0007667707709896039,
            "start_logit": 1.3463172912597656,
            "end_logit": 3.200582265853882,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor defactinib and the NF\u2011\u03baB",
            "probability": 0.00048460375065985807,
            "start_logit": 6.039067268371582,
            "end_logit": -1.951024055480957,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "F",
            "probability": 0.0002775520076726498,
            "start_logit": 6.039067268371582,
            "end_logit": -2.508347272872925,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK and PROX1 (the target of SOX18",
            "probability": 0.0002581030314090485,
            "start_logit": 4.593076705932617,
            "end_logit": -1.1350061893463135,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "inhibitor",
            "probability": 0.00023876631422191198,
            "start_logit": 0.17961470782756805,
            "end_logit": 3.200582265853882,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "AK",
            "probability": 0.0002289932469421403,
            "start_logit": -2.200655460357666,
            "end_logit": 5.539059638977051,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011inhibitor defactinib and the NF\u2011\u03baB inhibitor Bay11\u20117082 attenuated LEC retraction",
            "probability": 0.00019465473865763102,
            "start_logit": 6.039067268371582,
            "end_logit": -2.863128185272217,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "SOX18) by the transfection of respective siRNAs. FAK",
            "probability": 0.0001426620069905924,
            "start_logit": -0.3306053876876831,
            "end_logit": 3.1957952976226807,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK and PROX1 (the target of SOX18)",
            "probability": 0.00012183749885769627,
            "start_logit": 4.593076705932617,
            "end_logit": -1.8856768608093262,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "SOX18 and FAK, which transduced signals causing the retraction of LECs. The FAK",
            "probability": 9.444438313805537e-05,
            "start_logit": -3.086336851119995,
            "end_logit": 5.539059638977051,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK\u2011",
            "probability": 9.035103393234538e-05,
            "start_logit": 6.039067268371582,
            "end_logit": -3.630653142929077,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "The FAK",
            "probability": 8.79376363303248e-05,
            "start_logit": -3.1577200889587402,
            "end_logit": 5.539059638977051,
            "question_text": "Which molecules are targeted by defactinib?"
        }
    ],
    "5c6ffa257c78d69471000056": [
        {
            "text": "Mucopolysaccharidosis (MPS) type III",
            "probability": 0.1765155818638434,
            "start_logit": -2.343217611312866,
            "end_logit": -3.4801318645477295,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis",
            "probability": 0.13580541709558783,
            "start_logit": -2.343217611312866,
            "end_logit": -3.7423179149627686,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III, Sanfilippo Syndrome,",
            "probability": 0.09903621771030229,
            "start_logit": -2.343217611312866,
            "end_logit": -4.058055400848389,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III, Sanfilippo Syndrome",
            "probability": 0.09644408970219295,
            "start_logit": -2.343217611312866,
            "end_logit": -4.084577560424805,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type III,",
            "probability": 0.09524256311139857,
            "start_logit": -2.343217611312866,
            "end_logit": -4.097114086151123,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "autosomal recessive",
            "probability": 0.07199345832955631,
            "start_logit": -2.444474697113037,
            "end_logit": -4.2757086753845215,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "autosomal recessive lysosomal storage disorder.",
            "probability": 0.047831938894643905,
            "start_logit": -2.444474697113037,
            "end_logit": -4.6845903396606445,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "autosomal recessive lysosomal storage disorder",
            "probability": 0.04730315945751534,
            "start_logit": -2.444474697113037,
            "end_logit": -4.695706844329834,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS)",
            "probability": 0.03459320357466886,
            "start_logit": -2.343217611312866,
            "end_logit": -5.109883785247803,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "autosomal recessive lysosomal storage",
            "probability": 0.03409338744673521,
            "start_logit": -2.444474697113037,
            "end_logit": -5.0231804847717285,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "type III",
            "probability": 0.027028016543049507,
            "start_logit": -4.219752788543701,
            "end_logit": -3.4801318645477295,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type II",
            "probability": 0.02083068109357309,
            "start_logit": -2.343217611312866,
            "end_logit": -5.617114067077637,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Sanfilippo Syndrome,",
            "probability": 0.015219808479565404,
            "start_logit": -4.2161054611206055,
            "end_logit": -4.058055400848389,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "type III, Sanfilippo Syndrome,",
            "probability": 0.015164397966293059,
            "start_logit": -4.219752788543701,
            "end_logit": -4.058055400848389,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Sanfilippo Syndrome",
            "probability": 0.014821452274632942,
            "start_logit": -4.2161054611206055,
            "end_logit": -4.084577560424805,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "type III, Sanfilippo Syndrome",
            "probability": 0.014767492050423707,
            "start_logit": -4.219752788543701,
            "end_logit": -4.084577560424805,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "type III,",
            "probability": 0.014583514634775753,
            "start_logit": -4.219752788543701,
            "end_logit": -4.097114086151123,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (MPS) type",
            "probability": 0.014163389714953178,
            "start_logit": -2.343217611312866,
            "end_logit": -6.002880573272705,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "M",
            "probability": 0.012288613753005122,
            "start_logit": -2.343217611312866,
            "end_logit": -6.144867897033691,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "Mucopolysaccharidosis (",
            "probability": 0.012273616303283576,
            "start_logit": -2.343217611312866,
            "end_logit": -6.14608907699585,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        }
    ],
    "5c78174b7c78d694710000b1": [
        {
            "text": "Bolt",
            "probability": 0.9828708666271829,
            "start_logit": 2.1282291412353516,
            "end_logit": 2.808899164199829,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt,",
            "probability": 0.011377801233721773,
            "start_logit": 2.1282291412353516,
            "end_logit": -1.6499143838882446,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics search engine",
            "probability": 0.0018679196533869522,
            "start_logit": 2.1282291412353516,
            "end_logit": -3.4567532539367676,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics search",
            "probability": 0.0014221700458600561,
            "start_logit": 2.1282291412353516,
            "end_logit": -3.7293946743011475,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud",
            "probability": 0.0006274365274904688,
            "start_logit": 1.4103562831878662,
            "end_logit": -3.8298184871673584,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics",
            "probability": 0.0005812484779411114,
            "start_logit": 2.1282291412353516,
            "end_logit": -4.624155521392822,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "We present and examine the abilities of Bolt",
            "probability": 0.00030866878288099295,
            "start_logit": -5.937735080718994,
            "end_logit": 2.808899164199829,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "examine the abilities of Bolt",
            "probability": 0.00026598535453985407,
            "start_logit": -6.086562633514404,
            "end_logit": 2.808899164199829,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based proteomics search engine to search for the presence of over 2.3 million known cancer mutations",
            "probability": 0.00023679579023710976,
            "start_logit": 2.1282291412353516,
            "end_logit": -5.5221357345581055,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a",
            "probability": 0.00021933504236282882,
            "start_logit": 2.1282291412353516,
            "end_logit": -5.598733425140381,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Bolt, a new cloud-based",
            "probability": 0.00017726464184395578,
            "start_logit": 1.4103562831878662,
            "end_logit": -5.093817234039307,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud",
            "probability": 8.840641374582337e-06,
            "start_logit": -2.851926803588867,
            "end_logit": -3.8298184871673584,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud-based proteomics search engine",
            "probability": 6.3759849261541695e-06,
            "start_logit": -3.5518128871917725,
            "end_logit": -3.4567532539367676,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud-based proteomics search",
            "probability": 5.760569821920986e-06,
            "start_logit": -2.851926803588867,
            "end_logit": -4.25814151763916,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "search engine",
            "probability": 4.794236723147587e-06,
            "start_logit": -3.8369369506835938,
            "end_logit": -3.4567532539367676,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "cloud-based proteomics",
            "probability": 4.3141197746309335e-06,
            "start_logit": -2.851926803588867,
            "end_logit": -4.5472846031188965,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": ",",
            "probability": 4.119854505162499e-06,
            "start_logit": -5.795372486114502,
            "end_logit": -1.6499143838882446,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "search",
            "probability": 3.650167633313257e-06,
            "start_logit": -3.8369369506835938,
            "end_logit": -3.7293946743011475,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "We present and examine the abilities of Bolt,",
            "probability": 3.573177492508689e-06,
            "start_logit": -5.937735080718994,
            "end_logit": -1.6499143838882446,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "examine the abilities of Bolt,",
            "probability": 3.0790703008835898e-06,
            "start_logit": -6.086562633514404,
            "end_logit": -1.6499143838882446,
            "question_text": "List search engines used in proteomics."
        }
    ],
    "5c62a276e842deac6700000a": [
        {
            "text": "tumor necrosis factor alpha-induced protein 3",
            "probability": 0.45981254950900546,
            "start_logit": 3.1767163276672363,
            "end_logit": 2.849060297012329,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3 (TNFAIP3",
            "probability": 0.25827871729385316,
            "start_logit": 3.1767163276672363,
            "end_logit": 2.272280693054199,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "TNFAIP3",
            "probability": 0.2515906803342866,
            "start_logit": 2.4453635215759277,
            "end_logit": 2.9773976802825928,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha",
            "probability": 0.009097748337894559,
            "start_logit": 3.1767163276672363,
            "end_logit": -1.0737316608428955,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)",
            "probability": 0.0036484473392664495,
            "start_logit": 3.1767163276672363,
            "end_logit": -1.9874569177627563,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "3",
            "probability": 0.003557079753356118,
            "start_logit": -1.6851626634597778,
            "end_logit": 2.849060297012329,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "3 (TNFAIP3",
            "probability": 0.0019980272330317518,
            "start_logit": -1.6851626634597778,
            "end_logit": 2.272280693054199,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "(TNFAIP3",
            "probability": 0.0017634205889116162,
            "start_logit": -1.8100675344467163,
            "end_logit": 2.272280693054199,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3 (TNFAIP3,",
            "probability": 0.0013355136848114632,
            "start_logit": 3.1767163276672363,
            "end_logit": -2.9924426078796387,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "3, A20) as a susceptibility gene. Here, we report a de novo mutation in TNFAIP3",
            "probability": 0.0012295185402674915,
            "start_logit": -2.87581729888916,
            "end_logit": 2.9773976802825928,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein",
            "probability": 0.0011199821893063647,
            "start_logit": 3.1767163276672363,
            "end_logit": -3.1684458255767822,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "study of systemic lupus erythematosus (SLE) revealed tumor necrosis factor alpha-induced protein 3",
            "probability": 0.001067720063435048,
            "start_logit": -2.8885769844055176,
            "end_logit": 2.849060297012329,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "induced protein 3",
            "probability": 0.0009894788368378406,
            "start_logit": -2.964679479598999,
            "end_logit": 2.849060297012329,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "Genome-wide association study of systemic lupus erythematosus (SLE) revealed tumor necrosis factor alpha-induced protein 3",
            "probability": 0.0009398719304268651,
            "start_logit": -3.0161142349243164,
            "end_logit": 2.849060297012329,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "TNFAIP3, A20)",
            "probability": 0.0009143829165626493,
            "start_logit": 1.792908787727356,
            "end_logit": -1.9874569177627563,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor",
            "probability": 0.0006952900745967034,
            "start_logit": 3.1767163276672363,
            "end_logit": -3.6451847553253174,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "protein 3",
            "probability": 0.000577946222361009,
            "start_logit": -3.5023770332336426,
            "end_logit": 2.849060297012329,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "induced protein 3 (TNFAIP3",
            "probability": 0.0005557945842078112,
            "start_logit": -2.964679479598999,
            "end_logit": 2.272280693054199,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "tumor necrosis factor alpha-induced protein 3 (TNFAIP",
            "probability": 0.0004628158790599622,
            "start_logit": 3.1767163276672363,
            "end_logit": -4.052184581756592,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "in TNFAIP3",
            "probability": 0.0003650146885211503,
            "start_logit": -4.09025764465332,
            "end_logit": 2.9773976802825928,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        }
    ],
    "5c72fb4a7c78d69471000082": [
        {
            "text": "achalasia",
            "probability": 0.19022728925246077,
            "start_logit": 4.543915271759033,
            "end_logit": 4.415915012359619,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "alacrimia",
            "probability": 0.17683722484241765,
            "start_logit": 4.550863742828369,
            "end_logit": 4.335976600646973,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrimia",
            "probability": 0.17561273559233492,
            "start_logit": 4.543915271759033,
            "end_logit": 4.335976600646973,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, achalasia",
            "probability": 0.1414176406981726,
            "start_logit": 4.247413158416748,
            "end_logit": 4.415915012359619,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, achalasia, and alacrimia",
            "probability": 0.13055297608252464,
            "start_logit": 4.247413158416748,
            "end_logit": 4.335976600646973,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.09997222328568273,
            "start_logit": 4.247413158416748,
            "end_logit": 4.069089889526367,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Achalasia",
            "probability": 0.023284012236030358,
            "start_logit": 3.442037582397461,
            "end_logit": 3.417340040206909,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Achalasia, Alacrimia",
            "probability": 0.019287427730655227,
            "start_logit": 3.442037582397461,
            "end_logit": 3.2290265560150146,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Alacrimia",
            "probability": 0.013403247379007398,
            "start_logit": 3.0780811309814453,
            "end_logit": 3.2290265560150146,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency, Achalasia",
            "probability": 0.010953823426734273,
            "start_logit": 2.6879591941833496,
            "end_logit": 3.417340040206909,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency, Achalasia, Alacrimia",
            "probability": 0.00907365429874532,
            "start_logit": 2.6879591941833496,
            "end_logit": 3.2290265560150146,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency",
            "probability": 0.003871312954604551,
            "start_logit": 2.6879591941833496,
            "end_logit": 2.3772451877593994,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency,",
            "probability": 0.0015235491552469174,
            "start_logit": 4.247413158416748,
            "end_logit": -0.1147599071264267,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "achalasia,",
            "probability": 0.0008336038959154167,
            "start_logit": 4.543915271759033,
            "end_logit": -1.0143015384674072,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Achalasia, Alacrimia and Autonomic dysfunction",
            "probability": 0.0008105816813337941,
            "start_logit": 3.442037582397461,
            "end_logit": 0.05956992134451866,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency, achalasia,",
            "probability": 0.0006197128535049988,
            "start_logit": 4.247413158416748,
            "end_logit": -1.0143015384674072,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Alacrimia and Autonomic dysfunction",
            "probability": 0.000563290602952761,
            "start_logit": 3.0780811309814453,
            "end_logit": 0.05956992134451866,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "cardinal features of adrenal insufficiency, achalasia",
            "probability": 0.00040264743574811647,
            "start_logit": -1.613998293876648,
            "end_logit": 4.415915012359619,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Adrenal insufficiency, Achalasia, Alacrimia and Autonomic dysfunction",
            "probability": 0.00038133327367592576,
            "start_logit": 2.6879591941833496,
            "end_logit": 0.05956992134451866,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "cardinal features of adrenal insufficiency, achalasia, and alacrimia",
            "probability": 0.00037171332225169134,
            "start_logit": -1.613998293876648,
            "end_logit": 4.335976600646973,
            "question_text": "List features of the Triple A syndrome."
        }
    ],
    "5c8d00980101eac870000006": [
        {
            "text": "Tenovin-1",
            "probability": 0.6858230177424353,
            "start_logit": 5.06431770324707,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "tenovin-1 was antiviral against the flaviviruses Zika virus and dengue virus. Tenovin-1",
            "probability": 0.1974903677596036,
            "start_logit": 3.819387912750244,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "tenovin-1",
            "probability": 0.04820997680249218,
            "start_logit": 3.819387912750244,
            "end_logit": 4.038493633270264,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Tenovin",
            "probability": 0.04230587466311702,
            "start_logit": 5.06431770324707,
            "end_logit": 2.662923812866211,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "tenovin-1 was antiviral against the flaviviruses Zika virus and dengue virus. Tenovin",
            "probability": 0.01218244726330904,
            "start_logit": 3.819387912750244,
            "end_logit": 2.662923812866211,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "tenovin",
            "probability": 0.004911217919928433,
            "start_logit": 3.819387912750244,
            "end_logit": 1.7544496059417725,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Tenovin-1 is a sirtuin inhibitor,",
            "probability": 0.002713133765285244,
            "start_logit": 5.06431770324707,
            "end_logit": -0.08389780670404434,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Zika virus and dengue virus. Tenovin-1",
            "probability": 0.0024286411041055406,
            "start_logit": -0.5789700150489807,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "dengue virus. Tenovin-1",
            "probability": 0.001383167566579539,
            "start_logit": -1.1419256925582886,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "1",
            "probability": 0.0006318055674499187,
            "start_logit": -1.9254754781723022,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Ten",
            "probability": 0.00043367521828143845,
            "start_logit": 5.06431770324707,
            "end_logit": -1.9174615144729614,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Tenovin-1 is a sirtuin inhibitor",
            "probability": 0.00029264519134941327,
            "start_logit": 5.06431770324707,
            "end_logit": -2.3107964992523193,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "tenovin-1 was antiviral against the flaviviruses Zika virus",
            "probability": 0.0002427867416649273,
            "start_logit": 3.819387912750244,
            "end_logit": -1.2526441812515259,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "1 was antiviral against the flaviviruses Zika virus and dengue virus. Tenovin-1",
            "probability": 0.00017530254829747864,
            "start_logit": -3.2075438499450684,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Tenovin-1 is a sirtuin inhibitor, and here we found that inhibition of sirtuins,",
            "probability": 0.0001606408018222971,
            "start_logit": 5.06431770324707,
            "end_logit": -2.9105865955352783,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "Zika virus and dengue virus. Tenovin",
            "probability": 0.00014981384919129372,
            "start_logit": -0.5789700150489807,
            "end_logit": 2.662923812866211,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "ovin-1",
            "probability": 0.00013224920039662445,
            "start_logit": -3.4893691539764404,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "tenovin-1 was antiviral against the flaviviruses Zika virus and dengue virus. Ten",
            "probability": 0.0001248816037533356,
            "start_logit": 3.819387912750244,
            "end_logit": -1.9174615144729614,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "tenovin-1 was antiviral against the flaviviruses Zika virus and dengue",
            "probability": 0.00011352024182306855,
            "start_logit": 3.819387912750244,
            "end_logit": -2.0128464698791504,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "-1",
            "probability": 9.48344491142548e-05,
            "start_logit": -3.8219244480133057,
            "end_logit": 5.448617458343506,
            "question_text": "List sirtuin inhibitors."
        }
    ],
    "5c8d0a980101eac870000008": [
        {
            "text": "p16INK4a",
            "probability": 0.6988726538128074,
            "start_logit": 4.95059061050415,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16",
            "probability": 0.21785602024004824,
            "start_logit": 4.95059061050415,
            "end_logit": 3.591987133026123,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a protein",
            "probability": 0.07120031428960225,
            "start_logit": 4.95059061050415,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "overexpression of p16INK4a",
            "probability": 0.004176614633129451,
            "start_logit": -0.1693769097328186,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16INK4a",
            "probability": 0.0030121954684205893,
            "start_logit": -0.49620872735977173,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "overexpression of p16",
            "probability": 0.0013019548512677214,
            "start_logit": -0.1693769097328186,
            "end_logit": 3.591987133026123,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "INK4a",
            "probability": 0.0009887676693148665,
            "start_logit": -1.6101738214492798,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16",
            "probability": 0.0009389763834012985,
            "start_logit": -0.49620872735977173,
            "end_logit": 3.591987133026123,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "overexpression of p16INK4a protein",
            "probability": 0.0004255085285180163,
            "start_logit": -0.1693769097328186,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "16INK4a protein",
            "probability": 0.0003068788897135859,
            "start_logit": -0.49620872735977173,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p",
            "probability": 0.00029437141228185116,
            "start_logit": 4.95059061050415,
            "end_logit": -3.0147602558135986,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "a",
            "probability": 0.00019609947959814365,
            "start_logit": -3.228011131286621,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "4a",
            "probability": 0.0001096387564230536,
            "start_logit": -3.8094422817230225,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "INK4a protein",
            "probability": 0.00010073447348459673,
            "start_logit": -1.6101738214492798,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4",
            "probability": 8.235689405386146e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -4.288540363311768,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK",
            "probability": 3.3702253433296366e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -5.182037830352783,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a protein depends on the presence of transcriptionally-active",
            "probability": 3.366438052133537e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -5.183162212371826,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "p16INK4a protein depends on the presence of transcriptionally-active HPV,",
            "probability": 2.5803967639775486e-05,
            "start_logit": 4.95059061050415,
            "end_logit": -5.4490742683410645,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "ion of p16INK4a",
            "probability": 2.37652347241132e-05,
            "start_logit": -5.338409423828125,
            "end_logit": 4.7576212882995605,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "a protein",
            "probability": 1.997838161679606e-05,
            "start_logit": -3.228011131286621,
            "end_logit": 2.4736499786376953,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        }
    ],
    "5c5f0f581a4c55d80b000012": [
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer. An analysis of the CD4-positive T cells",
            "probability": 0.2305940770263008,
            "start_logit": -0.31611397862434387,
            "end_logit": -0.47190430760383606,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood",
            "probability": 0.2294782187626366,
            "start_logit": -0.31611397862434387,
            "end_logit": -0.4767551124095917,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4-positive T cells",
            "probability": 0.09184234255291111,
            "start_logit": -1.2366994619369507,
            "end_logit": -0.47190430760383606,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes",
            "probability": 0.06950439688774117,
            "start_logit": -0.31611397862434387,
            "end_logit": -1.6711732149124146,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4-positive T cells showed a tendency for higher proportions of effector and central memory T cells",
            "probability": 0.045017561418948845,
            "start_logit": -1.2366994619369507,
            "end_logit": -1.1849250793457031,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "central memory T cells and a normal proportion of regulatory T (Treg) cells",
            "probability": 0.034852474918843135,
            "start_logit": -1.532023310661316,
            "end_logit": -1.1455297470092773,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "central memory T cells",
            "probability": 0.03350614378795163,
            "start_logit": -1.532023310661316,
            "end_logit": -1.1849250793457031,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "effector and central memory T cells and a normal proportion of regulatory T (Treg) cells",
            "probability": 0.026835335757777228,
            "start_logit": -1.7934279441833496,
            "end_logit": -1.1455297470092773,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "effector and central memory T cells",
            "probability": 0.025798702117763105,
            "start_logit": -1.7934279441833496,
            "end_logit": -1.1849250793457031,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "T cells",
            "probability": 0.025759685033646586,
            "start_logit": -2.507962226867676,
            "end_logit": -0.47190430760383606,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "analysis of the CD4-positive T cells",
            "probability": 0.024279770830238346,
            "start_logit": -2.567129373550415,
            "end_logit": -0.47190430760383606,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "phenotype of peripheral blood",
            "probability": 0.022898573880512703,
            "start_logit": -2.620847463607788,
            "end_logit": -0.4767551124095917,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "lymphocytes was analyzed using an 8-color flow cytometer. An analysis of the CD4-positive T cells",
            "probability": 0.02256089270573443,
            "start_logit": -2.640554904937744,
            "end_logit": -0.47190430760383606,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "regulatory T (Treg) cells",
            "probability": 0.020357737257835684,
            "start_logit": -2.0696864128112793,
            "end_logit": -1.1455297470092773,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer. An analysis of the CD4-positive T",
            "probability": 0.019191659540990207,
            "start_logit": -0.31611397862434387,
            "end_logit": -2.95808744430542,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer",
            "probability": 0.017944890169809186,
            "start_logit": -0.31611397862434387,
            "end_logit": -3.0252578258514404,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral blood lymphocytes was analyzed using an 8-color flow cytometer. An analysis of the CD4",
            "probability": 0.015600614524696979,
            "start_logit": -0.31611397862434387,
            "end_logit": -3.165252923965454,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "central memory T cells and a normal proportion of regulatory T (Treg)",
            "probability": 0.015246651803023412,
            "start_logit": -1.532023310661316,
            "end_logit": -1.9722939729690552,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "peripheral",
            "probability": 0.014420530457307732,
            "start_logit": -0.31611397862434387,
            "end_logit": -3.243910312652588,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "CD4-positive T cells showed a tendency for higher proportions of effector and central memory",
            "probability": 0.014309740565331115,
            "start_logit": -1.2366994619369507,
            "end_logit": -2.3310372829437256,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        }
    ],
    "5c851a8175a4a5d219000005": [
        {
            "text": "cytotoxin",
            "probability": 0.18060932270474284,
            "start_logit": -5.409613132476807,
            "end_logit": -5.265238285064697,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin",
            "probability": 0.10905772793538843,
            "start_logit": -6.218121528625488,
            "end_logit": -4.961188793182373,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin and cytotoxin",
            "probability": 0.08046544714254787,
            "start_logit": -6.218121528625488,
            "end_logit": -5.265238285064697,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "cytotoxin were produced in their intestinal tract.",
            "probability": 0.07315221802365393,
            "start_logit": -5.409613132476807,
            "end_logit": -6.169032096862793,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "cytotoxin were produced in their intestinal tract",
            "probability": 0.06981804604826225,
            "start_logit": -5.409613132476807,
            "end_logit": -6.215682029724121,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "both enterotoxin",
            "probability": 0.06626154444870022,
            "start_logit": -6.716389179229736,
            "end_logit": -4.961188793182373,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "strains of Clostridium difficile, 100% of them died 3 days after inoculation and both enterotoxin",
            "probability": 0.054579642202378695,
            "start_logit": -6.910337924957275,
            "end_logit": -4.961188793182373,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "both enterotoxin and cytotoxin",
            "probability": 0.048889380911908364,
            "start_logit": -6.716389179229736,
            "end_logit": -5.265238285064697,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "died 3 days after inoculation and both enterotoxin",
            "probability": 0.03515762857429524,
            "start_logit": -7.350157260894775,
            "end_logit": -4.961188793182373,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin and cytotoxin were produced in their intestinal tract.",
            "probability": 0.03259093077030785,
            "start_logit": -6.218121528625488,
            "end_logit": -6.169032096862793,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxigenic strains of Clostridium difficile, 100% of them died 3 days after inoculation and both enterotoxin",
            "probability": 0.03128714326807757,
            "start_logit": -7.46679162979126,
            "end_logit": -4.961188793182373,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "enterotoxin and cytotoxin were produced in their intestinal tract",
            "probability": 0.03110548342555127,
            "start_logit": -6.218121528625488,
            "end_logit": -6.215682029724121,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "Clostridium difficile, 100% of them died 3 days after inoculation and both enterotoxin",
            "probability": 0.029189911613819702,
            "start_logit": -7.536175727844238,
            "end_logit": -4.961188793182373,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "ulation and both enterotoxin",
            "probability": 0.028735637448760294,
            "start_logit": -7.551860809326172,
            "end_logit": -4.961188793182373,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "died 3 days after inoculation and both enterotoxin and cytotoxin",
            "probability": 0.02594015442333732,
            "start_logit": -7.350157260894775,
            "end_logit": -5.265238285064697,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "Clostridium difficile, 100% of them died 3 days after inoculation and both enterotoxin and cytotoxin",
            "probability": 0.021537027540579196,
            "start_logit": -7.536175727844238,
            "end_logit": -5.265238285064697,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "ulation and both enterotoxin and cytotoxin",
            "probability": 0.021201853000371747,
            "start_logit": -7.551860809326172,
            "end_logit": -5.265238285064697,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "mice fed a commercial diet were monoassociated with two toxigenic strains of Clostridium difficile,",
            "probability": 0.020224381012970496,
            "start_logit": -6.8978095054626465,
            "end_logit": -5.966489315032959,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "axenic mice fed a commercial diet were monoassociated with two toxigenic strains of Clostridium difficile,",
            "probability": 0.02022393740596271,
            "start_logit": -6.897831439971924,
            "end_logit": -5.966489315032959,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "strains of Clostridium difficile,",
            "probability": 0.01997258209838427,
            "start_logit": -6.910337924957275,
            "end_logit": -5.966489315032959,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        }
    ],
    "5c7d520ed774d0424000000f": [
        {
            "text": "Diabetes\" focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes.",
            "probability": 0.13446278789595803,
            "start_logit": -2.59916353225708,
            "end_logit": -2.1124167442321777,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes",
            "probability": 0.12159841862144119,
            "start_logit": -2.59916353225708,
            "end_logit": -2.212980270385742,
            "question_text": "List adipokines."
        },
        {
            "text": "adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes.",
            "probability": 0.1080491404959685,
            "start_logit": -2.8178648948669434,
            "end_logit": -2.1124167442321777,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes\" focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes",
            "probability": 0.0680344063955151,
            "start_logit": -2.59916353225708,
            "end_logit": -2.7936906814575195,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes\"",
            "probability": 0.0655678429439427,
            "start_logit": -2.59916353225708,
            "end_logit": -2.8306188583374023,
            "question_text": "List adipokines."
        },
        {
            "text": "adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes",
            "probability": 0.0546698402600189,
            "start_logit": -2.8178648948669434,
            "end_logit": -2.7936906814575195,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes",
            "probability": 0.05309205198627718,
            "start_logit": -3.4278602600097656,
            "end_logit": -2.212980270385742,
            "question_text": "List adipokines."
        },
        {
            "text": "diabetes.",
            "probability": 0.05281961620958903,
            "start_logit": -3.5335683822631836,
            "end_logit": -2.1124167442321777,
            "question_text": "List adipokines."
        },
        {
            "text": "focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes.",
            "probability": 0.043308270535416485,
            "start_logit": -3.732107400894165,
            "end_logit": -2.1124167442321777,
            "question_text": "List adipokines."
        },
        {
            "text": ".",
            "probability": 0.03923897515362162,
            "start_logit": -3.830780506134033,
            "end_logit": -2.1124167442321777,
            "question_text": "List adipokines."
        },
        {
            "text": "Diabetes\" focused on adipokines",
            "probability": 0.03595235184353622,
            "start_logit": -2.59916353225708,
            "end_logit": -3.4315097332000732,
            "question_text": "List adipokines."
        },
        {
            "text": "type 2 diabetes.",
            "probability": 0.03434924438507082,
            "start_logit": -3.9638710021972656,
            "end_logit": -2.1124167442321777,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes\" focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes",
            "probability": 0.029705042895757566,
            "start_logit": -3.4278602600097656,
            "end_logit": -2.7936906814575195,
            "question_text": "List adipokines."
        },
        {
            "text": "adipokines",
            "probability": 0.028889931380186036,
            "start_logit": -2.8178648948669434,
            "end_logit": -3.4315097332000732,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines in Diabetes\"",
            "probability": 0.028628097023574637,
            "start_logit": -3.4278602600097656,
            "end_logit": -2.8306188583374023,
            "question_text": "List adipokines."
        },
        {
            "text": "diabetes",
            "probability": 0.026725247119216835,
            "start_logit": -3.5335683822631836,
            "end_logit": -2.7936906814575195,
            "question_text": "List adipokines."
        },
        {
            "text": "focused on adipokines as shared diagnostic biomarkers and therapeutic targets for both obesity and type 2 diabetes",
            "probability": 0.021912772477789805,
            "start_logit": -3.732107400894165,
            "end_logit": -2.7936906814575195,
            "question_text": "List adipokines."
        },
        {
            "text": "Adipokines",
            "probability": 0.019856398136362932,
            "start_logit": -3.4278602600097656,
            "end_logit": -3.196481227874756,
            "question_text": "List adipokines."
        },
        {
            "text": "type 2 diabetes",
            "probability": 0.01737975605325837,
            "start_logit": -3.9638710021972656,
            "end_logit": -2.7936906814575195,
            "question_text": "List adipokines."
        },
        {
            "text": "\"Pathogenetic and Therapeutic Significance of Adipokines in Diabetes",
            "probability": 0.015759808187498132,
            "start_logit": -4.642424583435059,
            "end_logit": -2.212980270385742,
            "question_text": "List adipokines."
        }
    ],
    "5c73ace67c78d69471000083": [
        {
            "text": "blepharophimosis, hypertelorism",
            "probability": 0.17828440071778665,
            "start_logit": 0.0588349848985672,
            "end_logit": -0.2884710431098938,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "blepharophimosis",
            "probability": 0.15164475785103027,
            "start_logit": 0.0588349848985672,
            "end_logit": -0.4503104090690613,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hallux varus",
            "probability": 0.11765555838057679,
            "start_logit": -0.3453082740306854,
            "end_logit": -0.29994645714759827,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hypertelorism",
            "probability": 0.10719139327775071,
            "start_logit": -0.4499290883541107,
            "end_logit": -0.2884710431098938,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly, ptosis, blepharophimosis, hypertelorism",
            "probability": 0.05924961507910724,
            "start_logit": -1.0427857637405396,
            "end_logit": -0.2884710431098938,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "ptosis, blepharophimosis, hypertelorism",
            "probability": 0.05254710709235774,
            "start_logit": -1.1628350019454956,
            "end_logit": -0.2884710431098938,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly, ptosis, blepharophimosis",
            "probability": 0.050396408745039395,
            "start_logit": -1.0427857637405396,
            "end_logit": -0.4503104090690613,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "ptosis, blepharophimosis",
            "probability": 0.044695404077479475,
            "start_logit": -1.1628350019454956,
            "end_logit": -0.4503104090690613,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly",
            "probability": 0.036608725455100286,
            "start_logit": -1.0427857637405396,
            "end_logit": -0.7699437141418457,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "small or absent terminal phalanges, nails, and the presence of hallux varus",
            "probability": 0.028876428656921423,
            "start_logit": -1.7500439882278442,
            "end_logit": -0.29994645714759827,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hallux varus and multicystic dysplastic kidneys",
            "probability": 0.02785055342187309,
            "start_logit": -0.3453082740306854,
            "end_logit": -1.7408549785614014,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "blepharophimosis, hypertelorism, short palpebral fissures, cleft palate",
            "probability": 0.02562701486564937,
            "start_logit": 0.0588349848985672,
            "end_logit": -2.2282040119171143,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "blepharophimosis, hypertelorism, short palpebral fissures",
            "probability": 0.02250565017418735,
            "start_logit": 0.0588349848985672,
            "end_logit": -2.3580846786499023,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "nails, and the presence of hallux varus",
            "probability": 0.019847455887149264,
            "start_logit": -2.1249938011169434,
            "end_logit": -0.29994645714759827,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hypertelorism, short palpebral fissures, cleft palate",
            "probability": 0.015407940447616123,
            "start_logit": -0.4499290883541107,
            "end_logit": -2.2282040119171143,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "hypertelorism, short palpebral fissures",
            "probability": 0.013531256739682439,
            "start_logit": -0.4499290883541107,
            "end_logit": -2.3580846786499023,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "brachycephaly, ptosis",
            "probability": 0.013097822540229044,
            "start_logit": -1.0427857637405396,
            "end_logit": -1.7977843284606934,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "multicystic dysplastic kidneys",
            "probability": 0.012545751960511544,
            "start_logit": -1.142778992652893,
            "end_logit": -1.7408549785614014,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "ptosis",
            "probability": 0.011616154514745635,
            "start_logit": -1.1628350019454956,
            "end_logit": -1.7977843284606934,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "small or absent terminal phalanges, nails",
            "probability": 0.010820600115206138,
            "start_logit": -1.7500439882278442,
            "end_logit": -1.2815203666687012,
            "question_text": "List features of the DOOR syndrome."
        }
    ],
    "5c6d783e7c78d6947100003a": [
        {
            "text": "In\u00a0the\u00a0course\u00a0of\u00a0my\u00a0duties\u00a0as\u00a0a\u00a0curator\u00a0for\u00a0the\u00a0ArachnoServer\u00a0database\u00a0[1,2],\u00a0I\u00a0recently\u00a0came\u00a0",
            "probability": 0.9854602227743388,
            "start_logit": 4.018553733825684,
            "end_logit": 3.5854671001434326,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "In\u00a0the\u00a0course\u00a0of\u00a0my\u00a0duties\u00a0as\u00a0a\u00a0curator\u00a0for\u00a0the\u00a0ArachnoServer\u00a0database\u00a0[1,2],\u00a0I\u00a0recently\u00a0came\u00a0 across\u00a0the\u00a0article\u00a0published\u00a0by\u00a0Binda\u00a0et\u00a0al.\u00a0in\u00a0Toxins\u00a0[3].[...].",
            "probability": 0.014298802299344457,
            "start_logit": 4.018553733825684,
            "end_logit": -0.6474658846855164,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "across\u00a0the\u00a0article\u00a0published\u00a0by\u00a0Binda\u00a0et\u00a0al.\u00a0in\u00a0Toxins\u00a0[3].[...].",
            "probability": 0.0002409749263167972,
            "start_logit": -0.0646844357252121,
            "end_logit": -0.6474658846855164,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        }
    ],
    "5c851c2675a4a5d219000006": [
        {
            "text": "bezlotoxumab",
            "probability": 0.2687422009237222,
            "start_logit": 6.606626987457275,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab",
            "probability": 0.23267948524113957,
            "start_logit": 6.462536334991455,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab",
            "probability": 0.2030850859572285,
            "start_logit": 6.606626987457275,
            "end_logit": 6.343417167663574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab",
            "probability": 0.15578084318615026,
            "start_logit": 6.462536334991455,
            "end_logit": 6.222332954406738,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotoxumab",
            "probability": 0.13821405670395778,
            "start_logit": 6.221805572509766,
            "end_logit": 6.343417167663574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotox",
            "probability": 0.0003107207322350604,
            "start_logit": 6.606626987457275,
            "end_logit": -0.139068603515625,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotox",
            "probability": 0.0002690248862355803,
            "start_logit": 6.462536334991455,
            "end_logit": -0.139068603515625,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxuma",
            "probability": 0.000191893712117036,
            "start_logit": 6.606626987457275,
            "end_logit": -0.6210215091705322,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxuma",
            "probability": 0.00016614335226448643,
            "start_logit": 6.462536334991455,
            "end_logit": -0.6210215091705322,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "TcdB, respectively. Bezlotoxumab",
            "probability": 9.618323330393774e-05,
            "start_logit": -1.048498272895813,
            "end_logit": 6.343417167663574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "antitoxin antibodies actoxumab and bezlotoxumab",
            "probability": 6.739652251613074e-05,
            "start_logit": -1.684287428855896,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB",
            "probability": 5.562883224662827e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -1.8592615127563477,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bez",
            "probability": 5.1417970837491446e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -1.9379754066467285,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB",
            "probability": 4.8163957901740234e-05,
            "start_logit": 6.462536334991455,
            "end_logit": -1.8592615127563477,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "antitoxin antibodies actoxumab",
            "probability": 4.512253022434006e-05,
            "start_logit": -1.684287428855896,
            "end_logit": 6.222332954406738,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bez",
            "probability": 4.451815511478669e-05,
            "start_logit": 6.462536334991455,
            "end_logit": -1.9379754066467285,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotox",
            "probability": 4.0786707066673486e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -2.169606924057007,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "act",
            "probability": 3.9255337277804667e-05,
            "start_logit": 6.462536334991455,
            "end_logit": -2.0637850761413574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxuma",
            "probability": 3.828883617260711e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -2.232804775238037,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "antibodies actoxumab and bezlotoxumab",
            "probability": 3.378322228769002e-05,
            "start_logit": -2.3749165534973145,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        }
    ],
    "5c8bfe25d558e5f23200000f": [
        {
            "text": "calcium ionophore-induced acrosome reaction",
            "probability": 0.18338873909691877,
            "start_logit": 2.1943743228912354,
            "end_logit": 3.010053873062134,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.15597376937668492,
            "start_logit": 2.032454013824463,
            "end_logit": 3.010053873062134,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.15041432097213175,
            "start_logit": 2.1943743228912354,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.1279287306613698,
            "start_logit": 2.032454013824463,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "acrosome reaction",
            "probability": 0.11893693643027345,
            "start_logit": 1.7613595724105835,
            "end_logit": 3.010053873062134,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.09755134704432766,
            "start_logit": 1.7613595724105835,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "protein tyrosine phosphorylation",
            "probability": 0.07980585040453068,
            "start_logit": 1.5605775117874146,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "functionality, particularly a decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.011698879714679936,
            "start_logit": -0.5577407479286194,
            "end_logit": 3.010053873062134,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "a decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.010554252548870574,
            "start_logit": -0.6607049703598022,
            "end_logit": 3.010053873062134,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "functionality, particularly a decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.009595349513190445,
            "start_logit": -0.5577407479286194,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "a decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.008656533320008148,
            "start_logit": -0.6607049703598022,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "sperm functionality, particularly a decrease of calcium ionophore-induced acrosome reaction",
            "probability": 0.008496917394775146,
            "start_logit": -0.8775303959846497,
            "end_logit": 3.010053873062134,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "sperm functionality, particularly a decrease of calcium ionophore-induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.006969119623075439,
            "start_logit": -0.8775303959846497,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "decrease",
            "probability": 0.005800468548591399,
            "start_logit": 2.032454013824463,
            "end_logit": -0.28169527649879456,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "tyrosine phosphorylation",
            "probability": 0.005426707325830614,
            "start_logit": -1.1276867389678955,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "calcium ionophore",
            "probability": 0.004385041849810186,
            "start_logit": 2.1943743228912354,
            "end_logit": -0.7233551144599915,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "functionality",
            "probability": 0.00389368253051131,
            "start_logit": -0.5577407479286194,
            "end_logit": 1.9099161624908447,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "induced acrosome reaction",
            "probability": 0.0037324794130826015,
            "start_logit": -1.700161099433899,
            "end_logit": 3.010053873062134,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "decrease of calcium ionophore",
            "probability": 0.0037295174695974403,
            "start_logit": 2.032454013824463,
            "end_logit": -0.7233551144599915,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "induced acrosome reaction and protein tyrosine phosphorylation",
            "probability": 0.0030613567617397567,
            "start_logit": -1.700161099433899,
            "end_logit": 2.8118393421173096,
            "question_text": "List the functions of the protein lactotransferrin."
        }
    ],
    "5c900983ecadf2e73f000002": [
        {
            "text": "givosiran",
            "probability": 0.9673837424592471,
            "start_logit": 5.351512908935547,
            "end_logit": 4.981630802154541,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "Givosiran",
            "probability": 0.032171182372651805,
            "start_logit": 3.6224141120910645,
            "end_logit": 3.3072054386138916,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "g",
            "probability": 0.00020355501669478605,
            "start_logit": 5.351512908935547,
            "end_logit": -3.484783411026001,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "an",
            "probability": 9.285715626718866e-05,
            "start_logit": -3.899775266647339,
            "end_logit": 4.981630802154541,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "givosir",
            "probability": 2.9358088429732963e-05,
            "start_logit": 5.351512908935547,
            "end_logit": -5.421151638031006,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "2019 givosiran",
            "probability": 2.7158526508918586e-05,
            "start_logit": -5.129146575927734,
            "end_logit": 4.981630802154541,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "givosiran became the second small interfering RNA (siRNA)-based drug to receive US Food and Drug Administration (FDA) approval",
            "probability": 2.0447056763744054e-05,
            "start_logit": 5.351512908935547,
            "end_logit": -5.782880783081055,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siran",
            "probability": 1.729127566114613e-05,
            "start_logit": -5.5806355476379395,
            "end_logit": 4.981630802154541,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "In November 2019 givosiran",
            "probability": 1.4302157469478234e-05,
            "start_logit": -5.770427227020264,
            "end_logit": 4.981630802154541,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "givosiran became the second small interfering RNA (siRNA)",
            "probability": 1.350638156589593e-05,
            "start_logit": 5.351512908935547,
            "end_logit": -6.19755744934082,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "G",
            "probability": 1.0552837292401589e-05,
            "start_logit": 3.6224141120910645,
            "end_logit": -4.715226173400879,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "givosiran revealed that suppression of ALAS1 by GalNac",
            "probability": 7.044996921423796e-06,
            "start_logit": 2.90462064743042,
            "end_logit": -4.401509761810303,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "Givosiran makes use of a new hepatic-delivery system that conjugates three GalNac",
            "probability": 3.0435815313681125e-06,
            "start_logit": 2.5519750118255615,
            "end_logit": -4.888146877288818,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "placebo-controlled randomized controlled trial. In preliminary results, givosiran",
            "probability": 3.0110632229840567e-06,
            "start_logit": -4.970375061035156,
            "end_logit": 2.6234614849090576,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "givosiran revealed that suppression of ALAS1 by GalNac-decorated siRNAs",
            "probability": 2.8872449069934567e-06,
            "start_logit": 2.90462064743042,
            "end_logit": -5.293524742126465,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "GalNac",
            "probability": 1.899150091484292e-08,
            "start_logit": -3.011460781097412,
            "end_logit": -4.401509761810303,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "an became the second small interfering RNA (siRNA)-based drug to receive US Food and Drug Administration (FDA) approval,",
            "probability": 1.487113045892591e-08,
            "start_logit": -3.899775266647339,
            "end_logit": -3.757765054702759,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "NCT03338816",
            "probability": 9.374914801337421e-09,
            "start_logit": -4.059027194976807,
            "end_logit": -4.059897422790527,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "03338816",
            "probability": 8.764048969729343e-09,
            "start_logit": -4.126406669616699,
            "end_logit": -4.059897422790527,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "GalNac-decorated siRNAs",
            "probability": 7.783270156697247e-09,
            "start_logit": -3.011460781097412,
            "end_logit": -5.293524742126465,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        }
    ],
    "5c6bda9d7c78d69471000031": [
        {
            "text": "manually curated repositories",
            "probability": 0.3947731517749597,
            "start_logit": 2.9022271633148193,
            "end_logit": 2.6710774898529053,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually",
            "probability": 0.2935047508082957,
            "start_logit": 2.9022271633148193,
            "end_logit": 2.374660015106201,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated",
            "probability": 0.0743420750643409,
            "start_logit": 2.9022271633148193,
            "end_logit": 1.0014432668685913,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions",
            "probability": 0.04114093021153846,
            "start_logit": 2.9022271633148193,
            "end_logit": 0.4097696840763092,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data",
            "probability": 0.0337379919316669,
            "start_logit": 2.9022271633148193,
            "end_logit": 0.21139074862003326,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories,",
            "probability": 0.033469940228070864,
            "start_logit": 2.9022271633148193,
            "end_logit": 0.2034139186143875,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data,",
            "probability": 0.02718906620488821,
            "start_logit": 2.9022271633148193,
            "end_logit": -0.004418896045535803,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding",
            "probability": 0.024501736483100618,
            "start_logit": 2.9022271633148193,
            "end_logit": -0.10848981887102127,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "repositories",
            "probability": 0.012480118294766212,
            "start_logit": -0.551947295665741,
            "end_logit": 2.6710774898529053,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding data, (3) in silico prediction of TF binding on gene promoters",
            "probability": 0.009665006953454024,
            "start_logit": 1.0571788549423218,
            "end_logit": 0.8063263297080994,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "in silico prediction of TF binding on gene promoters",
            "probability": 0.007949147934079146,
            "start_logit": 0.861731767654419,
            "end_logit": 0.8063263297080994,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP-seq binding data, (3) in silico prediction",
            "probability": 0.007465406579087163,
            "start_logit": 2.9022271633148193,
            "end_logit": -1.2969539165496826,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "in silico prediction of TF binding on gene promoters, and (4) reverse-engineered regulons",
            "probability": 0.006938041480742906,
            "start_logit": 0.861731767654419,
            "end_logit": 0.6702811121940613,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions",
            "probability": 0.006500994638320575,
            "start_logit": 1.0571788549423218,
            "end_logit": 0.4097696840763092,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding data",
            "probability": 0.00533119945338415,
            "start_logit": 1.0571788549423218,
            "end_logit": 0.21139074862003326,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "manually curated repositories, (2) interactions derived from ChIP",
            "probability": 0.0047188457111177135,
            "start_logit": 2.9022271633148193,
            "end_logit": -1.7556695938110352,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "reverse-engineered regulons",
            "probability": 0.004488181945146773,
            "start_logit": 0.42615994811058044,
            "end_logit": 0.6702811121940613,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding data,",
            "probability": 0.004296353356865714,
            "start_logit": 1.0571788549423218,
            "end_logit": -0.004418896045535803,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "interactions derived from ChIP-seq binding",
            "probability": 0.003871707729678586,
            "start_logit": 1.0571788549423218,
            "end_logit": -0.10848981887102127,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "(1) manually curated repositories",
            "probability": 0.0036353532164956808,
            "start_logit": -1.785377860069275,
            "end_logit": 2.6710774898529053,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        }
    ],
    "5c6c497d7c78d69471000036": [
        {
            "text": "GAL80",
            "probability": 0.41503451988109497,
            "start_logit": 2.8079473972320557,
            "end_logit": 2.3789994716644287,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 or GAL80",
            "probability": 0.271376765490243,
            "start_logit": 2.38309383392334,
            "end_logit": 2.3789994716644287,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4",
            "probability": 0.18021656893406782,
            "start_logit": 2.38309383392334,
            "end_logit": 1.9696506261825562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 line into Split GAL4 or GAL80",
            "probability": 0.07261262933818069,
            "start_logit": 1.0647245645523071,
            "end_logit": 2.3789994716644287,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 line into Split GAL4",
            "probability": 0.048220778580540066,
            "start_logit": 1.0647245645523071,
            "end_logit": 1.9696506261825562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL80 lines",
            "probability": 0.002185216298516648,
            "start_logit": 2.8079473972320557,
            "end_logit": -2.867647409439087,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL",
            "probability": 0.002031954914189423,
            "start_logit": 2.38309383392334,
            "end_logit": -2.515510320663452,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 or GAL80 lines",
            "probability": 0.0014288376088762574,
            "start_logit": 2.38309383392334,
            "end_logit": -2.867647409439087,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 or GAL",
            "probability": 0.0011429828510845649,
            "start_logit": 2.38309383392334,
            "end_logit": -3.090867280960083,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "80",
            "probability": 0.0009769390370231452,
            "start_logit": -3.2437453269958496,
            "end_logit": 2.3789994716644287,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "4 or GAL80",
            "probability": 0.0008755487982088828,
            "start_logit": -3.353318691253662,
            "end_logit": 2.3789994716644287,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "4",
            "probability": 0.000581436660808106,
            "start_logit": -3.353318691253662,
            "end_logit": 1.9696506261825562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 line into Split GAL",
            "probability": 0.0005436927835343226,
            "start_logit": 1.0647245645523071,
            "end_logit": -2.515510320663452,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL80 lines. We demonstrated how this toolkit can be used with recently developed computational methods",
            "probability": 0.0005325765763545902,
            "start_logit": 2.8079473972320557,
            "end_logit": -4.279390811920166,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "4 line into Split GAL4 or GAL80",
            "probability": 0.0004924612247859678,
            "start_logit": -3.9287538528442383,
            "end_logit": 2.3789994716644287,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 line into Split GAL4 or GAL80 lines",
            "probability": 0.00038231591230869147,
            "start_logit": 1.0647245645523071,
            "end_logit": -2.867647409439087,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL80 lines.",
            "probability": 0.0003667029153387937,
            "start_logit": 2.8079473972320557,
            "end_logit": -4.6525654792785645,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "GAL4 or GAL80 lines. We demonstrated how this toolkit can be used with recently developed computational methods",
            "probability": 0.00034823346431131285,
            "start_logit": 2.38309383392334,
            "end_logit": -4.279390811920166,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "4 line into Split GAL4",
            "probability": 0.00032703489594501303,
            "start_logit": -3.9287538528442383,
            "end_logit": 1.9696506261825562,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "Split GAL4 or GAL80",
            "probability": 0.00032280383458763336,
            "start_logit": -4.3511247634887695,
            "end_logit": 2.3789994716644287,
            "question_text": "Which tools have been developed for computing split-networks?"
        }
    ],
    "5c88550075a4a5d219000008": [
        {
            "text": "L-5F",
            "probability": 0.4658538209054685,
            "start_logit": 1.721181035041809,
            "end_logit": 1.504234790802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L-5F",
            "probability": 0.3081606050153368,
            "start_logit": 1.3079302310943604,
            "end_logit": 1.504234790802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F",
            "probability": 0.17279323866778468,
            "start_logit": 1.3079302310943604,
            "end_logit": 0.9257094264030457,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "L",
            "probability": 0.013154256353756865,
            "start_logit": 1.721181035041809,
            "end_logit": -2.062891721725464,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D",
            "probability": 0.008901142420553221,
            "start_logit": 1.3079302310943604,
            "end_logit": -2.0402066707611084,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L",
            "probability": 0.008701492645529078,
            "start_logit": 1.3079302310943604,
            "end_logit": -2.062891721725464,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "4F and L-5F",
            "probability": 0.0033243713425546158,
            "start_logit": -3.2214102745056152,
            "end_logit": 1.504234790802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "5F",
            "probability": 0.0032988791711041437,
            "start_logit": -3.2291080951690674,
            "end_logit": 1.504234790802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "F and L-5F",
            "probability": 0.0029936681320216207,
            "start_logit": -3.3261914253234863,
            "end_logit": 1.504234790802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "(D-4F and L-5F",
            "probability": 0.0028640072127293793,
            "start_logit": -3.370469093322754,
            "end_logit": 1.504234790802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "F",
            "probability": 0.0026630946320773995,
            "start_logit": -3.443202018737793,
            "end_logit": 1.504234790802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "4F",
            "probability": 0.0018640568634196272,
            "start_logit": -3.2214102745056152,
            "end_logit": 0.9257094264030457,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "(D-4F",
            "probability": 0.001605919360882533,
            "start_logit": -3.370469093322754,
            "end_logit": 0.9257094264030457,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "L-5F)",
            "probability": 0.001018456501307767,
            "start_logit": 1.721181035041809,
            "end_logit": -4.621348857879639,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "L-5",
            "probability": 0.0007010792290127536,
            "start_logit": 1.721181035041809,
            "end_logit": -4.994771480560303,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L-5F)",
            "probability": 0.000673705264485726,
            "start_logit": 1.3079302310943604,
            "end_logit": -4.621348857879639,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "L-5F) treatment will emulate the effects of full-length apo-AI to improve insulin sensitivity.",
            "probability": 0.00047231975748351354,
            "start_logit": 1.721181035041809,
            "end_logit": -5.389736175537109,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L-5",
            "probability": 0.0004637613553460498,
            "start_logit": 1.3079302310943604,
            "end_logit": -4.994771480560303,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4F and L-5F) treatment will emulate the effects of full-length apo-AI to improve insulin sensitivity.",
            "probability": 0.00031243779850064147,
            "start_logit": 1.3079302310943604,
            "end_logit": -5.389736175537109,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "D-4",
            "probability": 0.00017968737064511043,
            "start_logit": 1.3079302310943604,
            "end_logit": -5.942923069000244,
            "question_text": "List 3 apoE mimetics."
        }
    ],
    "5ca60a77ecadf2e73f00004d": [
        {
            "text": "heat",
            "probability": 0.3342946603078125,
            "start_logit": -1.7690141201019287,
            "end_logit": -3.919461965560913,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Biochar",
            "probability": 0.13990029974247806,
            "start_logit": -2.37796688079834,
            "end_logit": -4.1816020011901855,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage",
            "probability": 0.09412262708278683,
            "start_logit": -1.7690141201019287,
            "end_logit": -5.186886310577393,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposite",
            "probability": 0.09266171197657891,
            "start_logit": -1.7690141201019287,
            "end_logit": -5.202529430389404,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "biochar",
            "probability": 0.08503256549572571,
            "start_logit": -2.985349178314209,
            "end_logit": -4.072115421295166,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "biochar. Biochar",
            "probability": 0.07621419463940188,
            "start_logit": -2.985349178314209,
            "end_logit": -4.1816020011901855,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites, which are prepared by vacuum impregnating the phase change material into biochar",
            "probability": 0.04343932174201715,
            "start_logit": -3.6570184230804443,
            "end_logit": -4.072115421295166,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites, which are prepared by vacuum impregnating the phase change material into biochar. Biochar",
            "probability": 0.03893441180974498,
            "start_logit": -3.6570184230804443,
            "end_logit": -4.1816020011901855,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "latent heat",
            "probability": 0.019160012834169966,
            "start_logit": -4.628211498260498,
            "end_logit": -3.919461965560913,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites,",
            "probability": 0.012991820713368085,
            "start_logit": -3.6570184230804443,
            "end_logit": -5.279160499572754,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "gypsum board",
            "probability": 0.011914471738843201,
            "start_logit": -4.102789402008057,
            "end_logit": -4.919955730438232,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "biochar.",
            "probability": 0.009759198709856694,
            "start_logit": -2.985349178314209,
            "end_logit": -6.236939430236816,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "phase change material into biochar",
            "probability": 0.006346917041378747,
            "start_logit": -5.580414295196533,
            "end_logit": -4.072115421295166,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "phase change material into biochar. Biochar",
            "probability": 0.005688704885378198,
            "start_logit": -5.580414295196533,
            "end_logit": -4.1816020011901855,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "latent heat storage",
            "probability": 0.005394614264049147,
            "start_logit": -4.628211498260498,
            "end_logit": -5.186886310577393,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "latent heat storage biocomposite",
            "probability": 0.005310882288914387,
            "start_logit": -4.628211498260498,
            "end_logit": -5.202529430389404,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites, which are prepared by vacuum impregnating the phase change material into biochar.",
            "probability": 0.004985536661516503,
            "start_logit": -3.6570184230804443,
            "end_logit": -6.236939430236816,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "vacuum impregnating the phase change material into biochar",
            "probability": 0.004812559752093935,
            "start_logit": -5.857154369354248,
            "end_logit": -4.072115421295166,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "heat storage biocomposites",
            "probability": 0.00472201895633334,
            "start_logit": -3.6570184230804443,
            "end_logit": -6.291244029998779,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "vacuum impregnating the phase change material into biochar. Biochar",
            "probability": 0.00431346935755191,
            "start_logit": -5.857154369354248,
            "end_logit": -4.1816020011901855,
            "question_text": "Which enhancers are characterized as latent?"
        }
    ],
    "5c8c095e0101eac870000002": [
        {
            "text": "LX-2",
            "probability": 0.8447689001189289,
            "start_logit": 2.4771385192871094,
            "end_logit": 0.641893744468689,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "LX-2 cells",
            "probability": 0.09525464658629987,
            "start_logit": 2.4771385192871094,
            "end_logit": -1.5406155586242676,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "FGF21_ADSCs",
            "probability": 0.02822380270659533,
            "start_logit": 0.9834078550338745,
            "end_logit": -1.263273000717163,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "FGF21",
            "probability": 0.011820528697105367,
            "start_logit": 0.9834078550338745,
            "end_logit": -2.133600950241089,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "LX-2 cells. These results suggest that transplantation of FGF21_ADSCs",
            "probability": 0.005359911179563672,
            "start_logit": 2.4771385192871094,
            "end_logit": -4.418221950531006,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "L",
            "probability": 0.0043063886487168124,
            "start_logit": 2.4771385192871094,
            "end_logit": -4.6370697021484375,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "2",
            "probability": 0.003988244511448009,
            "start_logit": -2.878573417663574,
            "end_logit": 0.641893744468689,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "\u03b1-lactoalbumin",
            "probability": 0.001507969334544252,
            "start_logit": -2.0229053497314453,
            "end_logit": -1.18636155128479,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "adipose derived stem cells",
            "probability": 0.0011817544890913496,
            "start_logit": -0.4828532338142395,
            "end_logit": -2.970177412033081,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "FGF21_ADSCs inhibited TGF-\u03b21-induced expression of \u03b1-SMA and collagen in L",
            "probability": 0.0009669282238269274,
            "start_logit": 0.9834078550338745,
            "end_logit": -4.6370697021484375,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "F",
            "probability": 0.0005354448843783621,
            "start_logit": 0.9834078550338745,
            "end_logit": -5.228096008300781,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "2 cells",
            "probability": 0.0004497073949860691,
            "start_logit": -2.878573417663574,
            "end_logit": -1.5406155586242676,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "\u03b1-SMA and collagen in LX-2",
            "probability": 0.00040927462848576267,
            "start_logit": -5.1552934646606445,
            "end_logit": 0.641893744468689,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "lactoalbumin",
            "probability": 0.00035198176523766123,
            "start_logit": -3.4778451919555664,
            "end_logit": -1.18636155128479,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "adipose derived stem",
            "probability": 0.00025011473821887244,
            "start_logit": -0.4828532338142395,
            "end_logit": -4.523013114929199,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "cells",
            "probability": 0.00014818649712878523,
            "start_logit": -3.988698959350586,
            "end_logit": -1.5406155586242676,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "lactotransferrin (LTF), secretory factors produced from FGF21_ADSCs",
            "probability": 0.000132685795938223,
            "start_logit": -4.376529216766357,
            "end_logit": -1.263273000717163,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "(LTF), secretory factors produced from FGF21_ADSCs",
            "probability": 0.00012515843374960473,
            "start_logit": -4.434932708740234,
            "end_logit": -1.263273000717163,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "\u03b1-lactoalbumin (LA) and lactotransferrin",
            "probability": 0.00011283477602147615,
            "start_logit": -2.0229053497314453,
            "end_logit": -3.778956174850464,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "\u03b1-lactoalbumin (LA) and lactotransferrin (LTF),",
            "probability": 0.0001055365897347736,
            "start_logit": -2.0229053497314453,
            "end_logit": -3.845823049545288,
            "question_text": "Which cells secrete lactotransferrin?"
        }
    ],
    "5c9d18f1ecadf2e73f000033": [
        {
            "text": "naproxen moiety (1a-o) was designed and synthesized to create naproxen",
            "probability": 0.3069912518040659,
            "start_logit": -2.3311541080474854,
            "end_logit": -2.3194456100463867,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen",
            "probability": 0.2610238148965137,
            "start_logit": -2.493361711502075,
            "end_logit": -2.3194456100463867,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Mannich derivatives containing a naproxen moiety (1a-o) was designed and synthesized to create naproxen",
            "probability": 0.1203909972145414,
            "start_logit": -3.267228603363037,
            "end_logit": -2.3194456100463867,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs, with the aim of developing novel anti-inflammatory",
            "probability": 0.06046743023692323,
            "start_logit": -2.493361711502075,
            "end_logit": -3.781952381134033,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Mannich derivatives containing a naproxen",
            "probability": 0.052651540675388166,
            "start_logit": -3.267228603363037,
            "end_logit": -3.1464948654174805,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "1,2,4-triazole-5-thione Mannich derivatives containing a naproxen",
            "probability": 0.02510766344567194,
            "start_logit": -4.007750988006592,
            "end_logit": -3.1464948654174805,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "thione Mannich derivatives containing a naproxen moiety (1a-o) was designed and synthesized to create naproxen",
            "probability": 0.024958669447538814,
            "start_logit": -4.840752124786377,
            "end_logit": -2.3194456100463867,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "triazole-5-thione Mannich derivatives containing a naproxen",
            "probability": 0.023226263217832277,
            "start_logit": -4.0856404304504395,
            "end_logit": -3.1464948654174805,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs, with the aim of developing novel anti-inflammatory/analgesic agents with improved safety profiles.",
            "probability": 0.01724299757756201,
            "start_logit": -2.493361711502075,
            "end_logit": -5.036651134490967,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen moiety",
            "probability": 0.015456257807023442,
            "start_logit": -2.3311541080474854,
            "end_logit": -5.308250904083252,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "anti-inflammatory",
            "probability": 0.013098626220691146,
            "start_logit": -4.022959232330322,
            "end_logit": -3.781952381134033,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "thione Mannich derivatives containing a naproxen",
            "probability": 0.010915370999700738,
            "start_logit": -4.840752124786377,
            "end_logit": -3.1464948654174805,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs, with the aim of developing novel anti",
            "probability": 0.010695995779529687,
            "start_logit": -2.493361711502075,
            "end_logit": -5.514187812805176,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen moiety (1a-o) was designed and synthesized to create naproxen analogs,",
            "probability": 0.010080702020872941,
            "start_logit": -2.3311541080474854,
            "end_logit": -5.735641956329346,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "inflammatory",
            "probability": 0.008954483728755479,
            "start_logit": -4.4033122062683105,
            "end_logit": -3.781952381134033,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs,",
            "probability": 0.008571264760347806,
            "start_logit": -2.493361711502075,
            "end_logit": -5.735641956329346,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen moiety (1a-o) was designed and synthesized to create naproxen analogs",
            "probability": 0.008322740503253968,
            "start_logit": -2.3311541080474854,
            "end_logit": -5.927273273468018,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs, with the aim of developing novel anti-inflammatory/analgesic agents with improved safety profiles",
            "probability": 0.007515019465784386,
            "start_logit": -2.493361711502075,
            "end_logit": -5.867153644561768,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "5-thione Mannich derivatives containing a naproxen",
            "probability": 0.007252378004376654,
            "start_logit": -5.249594688415527,
            "end_logit": -3.1464948654174805,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "naproxen analogs",
            "probability": 0.0070765321936262044,
            "start_logit": -2.493361711502075,
            "end_logit": -5.927273273468018,
            "question_text": "List targets of classical analgesics."
        }
    ],
    "5c961603ecadf2e73f000022": [
        {
            "text": "Membranous Nephropathy",
            "probability": 0.9634177007269361,
            "start_logit": 2.0096077919006348,
            "end_logit": 1.2133289575576782,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Nephropathy",
            "probability": 0.01802491483157196,
            "start_logit": -1.9691243171691895,
            "end_logit": 1.2133289575576782,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Me",
            "probability": 0.004436577108934981,
            "start_logit": 2.0096077919006348,
            "end_logit": -4.1672749519348145,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous",
            "probability": 0.002565675644879895,
            "start_logit": 2.0096077919006348,
            "end_logit": -4.714936256408691,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "phropathy",
            "probability": 0.0023732436938045044,
            "start_logit": -3.996621608734131,
            "end_logit": 1.2133289575576782,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Rituximab a chimeric monoclonal antibody induces remission",
            "probability": 0.002344255026886089,
            "start_logit": -1.6380316019058228,
            "end_logit": -1.1575510501861572,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous Nephropathy (MN)",
            "probability": 0.0017657349586337353,
            "start_logit": 2.0096077919006348,
            "end_logit": -5.0885910987854,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Membranous Neph",
            "probability": 0.001539021513143927,
            "start_logit": 2.0096077919006348,
            "end_logit": -5.226011276245117,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "remission",
            "probability": 0.0008703535918951391,
            "start_logit": -2.628854990005493,
            "end_logit": -1.1575510501861572,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "athy",
            "probability": 0.000820982592007544,
            "start_logit": -5.058132648468018,
            "end_logit": 1.2133289575576782,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "ropathy",
            "probability": 0.0005275738456757572,
            "start_logit": -5.500345706939697,
            "end_logit": 1.2133289575576782,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "induces remission",
            "probability": 0.0005052217277711058,
            "start_logit": -3.172757148742676,
            "end_logit": -1.1575510501861572,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Rituximab a chimeric monoclonal antibody induces remission in 60-80% of primary MN patients.",
            "probability": 0.00015908348952095683,
            "start_logit": -1.6380316019058228,
            "end_logit": -3.8478448390960693,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "chimeric monoclonal antibody induces remission",
            "probability": 0.00015079272493664393,
            "start_logit": -4.381848335266113,
            "end_logit": -1.1575510501861572,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "monoclonal antibody induces remission",
            "probability": 0.0001445796515206309,
            "start_logit": -4.423923969268799,
            "end_logit": -1.1575510501861572,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Rituximab a chimeric monoclonal antibody",
            "probability": 0.00011602018088220126,
            "start_logit": -1.6380316019058228,
            "end_logit": -4.163509845733643,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Rituximab",
            "probability": 7.86749628402291e-05,
            "start_logit": -1.6380316019058228,
            "end_logit": -4.5519490242004395,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Rituximab a chimeric monoclonal antibody induces remission in 60-80% of primary MN patients",
            "probability": 6.624581189399365e-05,
            "start_logit": -1.6380316019058228,
            "end_logit": -4.723901748657227,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "remission in 60-80% of primary MN patients.",
            "probability": 5.90630647808377e-05,
            "start_logit": -2.628854990005493,
            "end_logit": -3.8478448390960693,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "induces remission in 60-80% of primary MN patients.",
            "probability": 3.428485148324258e-05,
            "start_logit": -3.172757148742676,
            "end_logit": -3.8478448390960693,
            "question_text": "List off label uses for Rituximab."
        }
    ],
    "5c979ffcecadf2e73f000028": [
        {
            "text": "Toxocara canis",
            "probability": 0.8954935338321275,
            "start_logit": 0.6293727159500122,
            "end_logit": 1.496453046798706,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. canis",
            "probability": 0.04800557096667678,
            "start_logit": -0.38918787240982056,
            "end_logit": -0.41104429960250854,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. canis larvae",
            "probability": 0.02143654786278346,
            "start_logit": -0.38918787240982056,
            "end_logit": -1.2172640562057495,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "canis",
            "probability": 0.018573554738411487,
            "start_logit": -3.2462635040283203,
            "end_logit": 1.496453046798706,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "is",
            "probability": 0.005405240932592295,
            "start_logit": -4.48063325881958,
            "end_logit": 1.496453046798706,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "larvae",
            "probability": 0.0035454060446898816,
            "start_logit": -2.1886324882507324,
            "end_logit": -1.2172640562057495,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "To",
            "probability": 0.002059000061299371,
            "start_logit": 0.6293727159500122,
            "end_logit": -4.578701496124268,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "canis larvae",
            "probability": 0.001725939665504464,
            "start_logit": -2.9085135459899902,
            "end_logit": -1.2172640562057495,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "larva migrans (VLM). Although the systemic immune response to T. canis",
            "probability": 0.0012435563461834674,
            "start_logit": -2.2929444313049316,
            "end_logit": -2.1606295108795166,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara",
            "probability": 0.0010966419833835963,
            "start_logit": 0.6293727159500122,
            "end_logit": -5.208669185638428,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara can",
            "probability": 0.00041909007734759025,
            "start_logit": 0.6293727159500122,
            "end_logit": -6.170591354370117,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "visceral larva migrans (VLM). Although the systemic immune response to T. canis",
            "probability": 0.0003067790202856493,
            "start_logit": -3.69254732131958,
            "end_logit": -2.1606295108795166,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "larva migrans",
            "probability": 0.0001643383774141478,
            "start_logit": -2.2929444313049316,
            "end_logit": -4.184432506561279,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. canis L3 larvae",
            "probability": 0.00013927375848932113,
            "start_logit": -1.661496877670288,
            "end_logit": -4.981366157531738,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "invasion by T. canis",
            "probability": 0.00012232853841399874,
            "start_logit": -6.3615498542785645,
            "end_logit": -0.41104429960250854,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "larva",
            "probability": 5.958302358634472e-05,
            "start_logit": -2.2929444313049316,
            "end_logit": -5.198989391326904,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "invasion by T. canis larvae",
            "probability": 5.4624942811664674e-05,
            "start_logit": -6.3615498542785645,
            "end_logit": -1.2172640562057495,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "ocular toxocariasis",
            "probability": 5.436253094934105e-05,
            "start_logit": -3.6318020820617676,
            "end_logit": -3.95182728767395,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "is larvae",
            "probability": 5.1546819890348496e-05,
            "start_logit": -6.419549942016602,
            "end_logit": -1.2172640562057495,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "ocular toxocariasis (OT), or visceral larva migrans",
            "probability": 4.3080477159403746e-05,
            "start_logit": -3.6318020820617676,
            "end_logit": -4.184432506561279,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        }
    ],
    "5c97f579ecadf2e73f00002a": [
        {
            "text": "nerve cells, many neuroendocrine cells",
            "probability": 0.30419446492948965,
            "start_logit": 1.9207266569137573,
            "end_logit": 1.0934854745864868,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells",
            "probability": 0.2864489770900295,
            "start_logit": 1.8606199026107788,
            "end_logit": 1.0934854745864868,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells",
            "probability": 0.2451521695079584,
            "start_logit": 1.9207266569137573,
            "end_logit": 0.8776974081993103,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells mediating inflammation and immune responses",
            "probability": 0.04391621813660274,
            "start_logit": 1.9207266569137573,
            "end_logit": -0.8418980240821838,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells mediating inflammation and immune responses",
            "probability": 0.04135432170275801,
            "start_logit": 1.8606199026107788,
            "end_logit": -0.8418980240821838,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells mediating inflammation",
            "probability": 0.016005131106519507,
            "start_logit": 1.9207266569137573,
            "end_logit": -1.8512723445892334,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells mediating inflammation",
            "probability": 0.015071455802843154,
            "start_logit": 1.8606199026107788,
            "end_logit": -1.8512723445892334,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve",
            "probability": 0.010781016293905963,
            "start_logit": 1.9207266569137573,
            "end_logit": -2.2463948726654053,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "many neuroendocrine cells",
            "probability": 0.006545856035999349,
            "start_logit": -1.918108344078064,
            "end_logit": 1.0934854745864868,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells mediating inflammation and immune responses.",
            "probability": 0.004930658437173303,
            "start_logit": 1.9207266569137573,
            "end_logit": -3.0287091732025146,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells mediating inflammation and immune responses.",
            "probability": 0.004643023554146514,
            "start_logit": 1.8606199026107788,
            "end_logit": -3.0287091732025146,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine",
            "probability": 0.0038424101604169142,
            "start_logit": 1.9207266569137573,
            "end_logit": -3.2780818939208984,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine",
            "probability": 0.0036182593271934975,
            "start_logit": 1.8606199026107788,
            "end_logit": -3.2780818939208984,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "uroendocrine cells",
            "probability": 0.0028574819119691454,
            "start_logit": -2.746999740600586,
            "end_logit": 1.0934854745864868,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "by nerve cells, many neuroendocrine cells",
            "probability": 0.0025186641621560047,
            "start_logit": -2.8732118606567383,
            "end_logit": 1.0934854745864868,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "by nerve cells",
            "probability": 0.002029806767712264,
            "start_logit": -2.8732118606567383,
            "end_logit": 0.8776974081993103,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "cells",
            "probability": 0.0016413109487373157,
            "start_logit": -3.301445245742798,
            "end_logit": 1.0934854745864868,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many neuroendocrine cells, and cells",
            "probability": 0.0015504166969101132,
            "start_logit": 1.9207266569137573,
            "end_logit": -4.185657978057861,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuroendocrine cells, and cells",
            "probability": 0.0014599715908576684,
            "start_logit": 1.8606199026107788,
            "end_logit": -4.185657978057861,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nerve cells, many ne",
            "probability": 0.0014383858366211796,
            "start_logit": 1.9207266569137573,
            "end_logit": -4.260660171508789,
            "question_text": "List places in the body where somatostatin is produced."
        }
    ],
    "5c9fb583ecadf2e73f000042": [
        {
            "text": "disease",
            "probability": 0.16319195816333662,
            "start_logit": -1.0022473335266113,
            "end_logit": 0.28316065669059753,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "disease states and quantitatively monitor the course of the disease",
            "probability": 0.10110083697867255,
            "start_logit": -1.4810560941696167,
            "end_logit": 0.28316065669059753,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "therapy. The ability to control numerous variables in performing the model allows us to mimic human disease states and quantitatively monitor the course of the disease",
            "probability": 0.09339802643700891,
            "start_logit": -1.5603042840957642,
            "end_logit": 0.28316065669059753,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "diagnosis",
            "probability": 0.0786577762860902,
            "start_logit": -0.296784371137619,
            "end_logit": -1.152122974395752,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "immunology, diagnosis",
            "probability": 0.0637296765482098,
            "start_logit": -0.5072405338287354,
            "end_logit": -1.152122974395752,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "diagnosis, and therapy. The ability to control numerous variables in performing the model allows us to mimic human disease",
            "probability": 0.04653440234152882,
            "start_logit": -0.296784371137619,
            "end_logit": -1.6770375967025757,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "immunology",
            "probability": 0.04380181995128175,
            "start_logit": -0.5072405338287354,
            "end_logit": -1.5270979404449463,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "diagnosis, and therapy",
            "probability": 0.03998337890295263,
            "start_logit": -0.296784371137619,
            "end_logit": -1.828765630722046,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "virulence, immunology, diagnosis",
            "probability": 0.03973362287418989,
            "start_logit": -0.9796931147575378,
            "end_logit": -1.152122974395752,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "quantitatively monitor the course of the disease",
            "probability": 0.03937840729388795,
            "start_logit": -2.423956871032715,
            "end_logit": 0.28316065669059753,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "immunology, diagnosis, and therapy. The ability to control numerous variables in performing the model allows us to mimic human disease",
            "probability": 0.03770285087647878,
            "start_logit": -0.5072405338287354,
            "end_logit": -1.6770375967025757,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "diagnosis, and therapy. The ability to control numerous variables in performing the model allows us to mimic human disease states",
            "probability": 0.03648834459869751,
            "start_logit": -0.296784371137619,
            "end_logit": -1.920236587524414,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "immunology, diagnosis, and therapy",
            "probability": 0.03239511622502219,
            "start_logit": -0.5072405338287354,
            "end_logit": -1.828765630722046,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "virulence",
            "probability": 0.0303505114436286,
            "start_logit": -0.9796931147575378,
            "end_logit": -1.4215073585510254,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "immunology, diagnosis, and therapy. The ability to control numerous variables in performing the model allows us to mimic human disease states",
            "probability": 0.029563388502070208,
            "start_logit": -0.5072405338287354,
            "end_logit": -1.920236587524414,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "virulence, immunology",
            "probability": 0.027309176656982178,
            "start_logit": -0.9796931147575378,
            "end_logit": -1.5270979404449463,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "pathogenesis, virulence, immunology, diagnosis",
            "probability": 0.02656516108509197,
            "start_logit": -1.382290244102478,
            "end_logit": -1.152122974395752,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "mimic human disease states and quantitatively monitor the course of the disease",
            "probability": 0.024297460643444933,
            "start_logit": -2.9068026542663574,
            "end_logit": 0.28316065669059753,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "virulence, immunology, diagnosis, and therapy. The ability to control numerous variables in performing the model allows us to mimic human disease",
            "probability": 0.02350664461437486,
            "start_logit": -0.9796931147575378,
            "end_logit": -1.6770375967025757,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "monitor the course of the disease",
            "probability": 0.022311439577049695,
            "start_logit": -2.992074966430664,
            "end_logit": 0.28316065669059753,
            "question_text": "What are 5 key questions in human performance modeling?"
        }
    ],
    "5ca9f932ecadf2e73f000054": [
        {
            "text": "KIAA0319",
            "probability": 0.1291469692607491,
            "start_logit": 2.8621301651000977,
            "end_logit": 1.4947985410690308,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DCDC2",
            "probability": 0.10536845454651267,
            "start_logit": 2.3657169342041016,
            "end_logit": 1.7877240180969238,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO1",
            "probability": 0.09516632406267643,
            "start_logit": 2.2437195777893066,
            "end_logit": 1.8078842163085938,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO1, DCDC2",
            "probability": 0.09326696219232437,
            "start_logit": 2.2437195777893066,
            "end_logit": 1.7877240180969238,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DCDC2, KIAA0319",
            "probability": 0.07861305828320674,
            "start_logit": 2.3657169342041016,
            "end_logit": 1.4947985410690308,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO1, DCDC2, KIAA0319",
            "probability": 0.06958440423444077,
            "start_logit": 2.2437195777893066,
            "end_logit": 1.4947985410690308,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO1",
            "probability": 0.06726119416352333,
            "start_logit": 1.8966768980026245,
            "end_logit": 1.8078842163085938,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO1, DCDC2",
            "probability": 0.0659187723687674,
            "start_logit": 1.8966768980026245,
            "end_logit": 1.7877240180969238,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia",
            "probability": 0.06007997118000186,
            "start_logit": 1.8787813186645508,
            "end_logit": 1.712872862815857,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO1, DCDC2, KIAA0319",
            "probability": 0.04918052861728015,
            "start_logit": 1.8966768980026245,
            "end_logit": 1.4947985410690308,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia risk genes--DYX1C1, ROBO1",
            "probability": 0.03625976048545567,
            "start_logit": 1.2788020372390747,
            "end_logit": 1.8078842163085938,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia risk genes--DYX1C1, ROBO1, DCDC2",
            "probability": 0.03553607585044954,
            "start_logit": 1.2788020372390747,
            "end_logit": 1.7877240180969238,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1",
            "probability": 0.03222069378773979,
            "start_logit": 1.8966768980026245,
            "end_logit": 1.0719096660614014,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "developmental dyslexia",
            "probability": 0.030831106233506888,
            "start_logit": 1.2116289138793945,
            "end_logit": 1.712872862815857,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "dyslexia risk genes--DYX1C1",
            "probability": 0.01736981708320973,
            "start_logit": 1.2788020372390747,
            "end_logit": 1.0719096660614014,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "KIAA",
            "probability": 0.012018270918952892,
            "start_logit": 2.8621301651000977,
            "end_logit": -0.8797244429588318,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DCDC2, KIAA",
            "probability": 0.0073156423075439354,
            "start_logit": 2.3657169342041016,
            "end_logit": -0.8797244429588318,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "ROBO1, DCDC2, KIAA",
            "probability": 0.006475445971441849,
            "start_logit": 2.2437195777893066,
            "end_logit": -0.8797244429588318,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "DYX1C1, ROBO1, DCDC2, KIAA",
            "probability": 0.004576684379378832,
            "start_logit": 1.8966768980026245,
            "end_logit": -0.8797244429588318,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "Kiaa0319",
            "probability": 0.0038098640728380833,
            "start_logit": 0.469123899936676,
            "end_logit": 0.3644472658634186,
            "question_text": "What are acoustic reported genes used to detect?"
        }
    ],
    "5ca64b5becadf2e73f000051": [
        {
            "text": "moesin",
            "probability": 0.41565276648471217,
            "start_logit": 4.135753154754639,
            "end_logit": 3.8741297721862793,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin",
            "probability": 0.29037731780589404,
            "start_logit": 3.7770841121673584,
            "end_logit": 3.8741297721862793,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin",
            "probability": 0.0991285406441112,
            "start_logit": 2.7023203372955322,
            "end_logit": 3.8741297721862793,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin",
            "probability": 0.06561524482253352,
            "start_logit": 3.7770841121673584,
            "end_logit": 2.386756658554077,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin proteins",
            "probability": 0.04177400537642832,
            "start_logit": 4.135753154754639,
            "end_logit": 1.5765538215637207,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin proteins",
            "probability": 0.029183550822492618,
            "start_logit": 3.7770841121673584,
            "end_logit": 1.5765538215637207,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin",
            "probability": 0.022399626501170864,
            "start_logit": 2.7023203372955322,
            "end_logit": 2.386756658554077,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin",
            "probability": 0.02171443293604194,
            "start_logit": 3.7770841121673584,
            "end_logit": 1.2809257507324219,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin proteins",
            "probability": 0.009962633533865582,
            "start_logit": 2.7023203372955322,
            "end_logit": 1.5765538215637207,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "m",
            "probability": 0.0008970021981896627,
            "start_logit": 4.135753154754639,
            "end_logit": -2.2644174098968506,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "e",
            "probability": 0.0006992934020068779,
            "start_logit": 3.7770841121673584,
            "end_logit": -2.154736280441284,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin proteins (ERM)",
            "probability": 0.0006467158480186852,
            "start_logit": 4.135753154754639,
            "end_logit": -2.5915687084198,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/m",
            "probability": 0.0006266506886966321,
            "start_logit": 3.7770841121673584,
            "end_logit": -2.2644174098968506,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "ezrin/radixin/moesin proteins (ERM)",
            "probability": 0.00045179926244310725,
            "start_logit": 3.7770841121673584,
            "end_logit": -2.5915687084198,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/m",
            "probability": 0.00021392500190269158,
            "start_logit": 2.7023203372955322,
            "end_logit": -2.2644174098968506,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "xin/moesin",
            "probability": 0.0002081236255500589,
            "start_logit": -3.4637200832366943,
            "end_logit": 3.8741297721862793,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin proteins (ERM)",
            "probability": 0.0001542345038809431,
            "start_logit": 2.7023203372955322,
            "end_logit": -2.5915687084198,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "rin/radixin/moesin",
            "probability": 0.00011575196842919592,
            "start_logit": -4.050402641296387,
            "end_logit": 3.8741297721862793,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "in",
            "probability": 9.312354733909142e-05,
            "start_logit": -4.267925262451172,
            "end_logit": 3.8741297721862793,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "/moesin",
            "probability": 8.526102629263442e-05,
            "start_logit": -4.35613489151001,
            "end_logit": 3.8741297721862793,
            "question_text": "List the ERM proteins."
        }
    ],
    "5c9007460101eac870000012": [
        {
            "text": "Arp2/3",
            "probability": 0.8999796847793958,
            "start_logit": 2.788090705871582,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "formin and Arp2/3",
            "probability": 0.04026712682730172,
            "start_logit": -0.31874606013298035,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Arp2",
            "probability": 0.03480433945700776,
            "start_logit": 2.788090705871582,
            "end_logit": -1.2041288614273071,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Arp",
            "probability": 0.01418186677724545,
            "start_logit": 2.788090705871582,
            "end_logit": -2.1019067764282227,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "A",
            "probability": 0.004359108661999291,
            "start_logit": 2.788090705871582,
            "end_logit": -3.2816033363342285,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "3",
            "probability": 0.0029036809224856,
            "start_logit": -2.9483022689819336,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "formin and Arp2",
            "probability": 0.0015572248738029274,
            "start_logit": -0.31874606013298035,
            "end_logit": -1.2041288614273071,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "formin and Arp",
            "probability": 0.0006345287986219588,
            "start_logit": -0.31874606013298035,
            "end_logit": -2.1019067764282227,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "2/3",
            "probability": 0.0003539268297604564,
            "start_logit": -5.0529465675354,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "formin",
            "probability": 0.00030486426962184727,
            "start_logit": -0.31874606013298035,
            "end_logit": -2.8349227905273438,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "formin and A",
            "probability": 0.00019503638172648394,
            "start_logit": -0.31874606013298035,
            "end_logit": -3.2816033363342285,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "rp2/3",
            "probability": 0.00015255592695060942,
            "start_logit": -5.894505500793457,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "we demonstrate a synergistic relationship between the nucleators formin and Arp2/3",
            "probability": 9.18412998300822e-05,
            "start_logit": -6.401974678039551,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "demonstrate a synergistic relationship between the nucleators formin and Arp2/3",
            "probability": 6.384991584947101e-05,
            "start_logit": -6.765501499176025,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "formin-enhanced filament turnover depletes cofilin at the surface and thus protects the dense, Arp2/3",
            "probability": 5.211628328410037e-05,
            "start_logit": -5.425450325012207,
            "end_logit": 0.5053922533988953,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "nucleators formin and Arp2/3",
            "probability": 4.139597888834265e-05,
            "start_logit": -7.198853015899658,
            "end_logit": 2.0485012531280518,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Arp2/3 polymerized network from debranching.",
            "probability": 1.992462243902028e-05,
            "start_logit": 0.19867388904094696,
            "end_logit": -6.0802531242370605,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "Arp2/3 polymerized network from debranching",
            "probability": 1.615013007554097e-05,
            "start_logit": 0.19867388904094696,
            "end_logit": -6.290281295776367,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "2",
            "probability": 1.3687186204591908e-05,
            "start_logit": -5.0529465675354,
            "end_logit": -1.2041288614273071,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "form",
            "probability": 7.090077509099786e-06,
            "start_logit": -0.31874606013298035,
            "end_logit": -6.59609317779541,
            "question_text": "Name three binding partners of cofilin 2."
        }
    ],
    "5c990afbecadf2e73f000030": [
        {
            "text": "Mdm2",
            "probability": 0.2751883360236134,
            "start_logit": 2.7786660194396973,
            "end_logit": 2.307633638381958,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 and MdmX",
            "probability": 0.253144467369916,
            "start_logit": 2.7786660194396973,
            "end_logit": 2.2241382598876953,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX",
            "probability": 0.2002665042525473,
            "start_logit": 2.5443546772003174,
            "end_logit": 2.2241382598876953,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 RING domain was observed mainly localized in the cell nucleus, contrasting the localization of MdmX",
            "probability": 0.13760758565137873,
            "start_logit": 2.3591907024383545,
            "end_logit": 2.0340592861175537,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX mediated inhibition of p53 transactivation. To investigate the role of the RING domain of Mdm2",
            "probability": 0.03902589965081966,
            "start_logit": 0.8254358172416687,
            "end_logit": 2.307633638381958,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING domain in the cytoplasm. Mdm2",
            "probability": 0.033990577396362326,
            "start_logit": 2.0067358016967773,
            "end_logit": 0.9881914854049683,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm proteins on p53 regulation was conducted in human osteosarcoma (U2OS) cell line. Mdm2",
            "probability": 0.023233461704998962,
            "start_logit": 0.4874393045902252,
            "end_logit": 2.12699818611145,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 RING was found to possess an endogenous E3 ligase activity, whereas MdmX",
            "probability": 0.014526885894759157,
            "start_logit": 1.4390869140625,
            "end_logit": 0.7057581543922424,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "p53 regulation was conducted in human osteosarcoma (U2OS) cell line. Mdm2",
            "probability": 0.014170185606495495,
            "start_logit": -0.007014097645878792,
            "end_logit": 2.12699818611145,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "p53",
            "probability": 0.0026609686419851305,
            "start_logit": 1.0278204679489136,
            "end_logit": -0.5802863240242004,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 RING was found to possess an endogenous E3 ligase activity, whereas MdmX RING",
            "probability": 0.0020162024053385443,
            "start_logit": 1.4390869140625,
            "end_logit": -1.2690272331237793,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING did not. Both Mdm2 and MdmX",
            "probability": 0.0016178229172079518,
            "start_logit": 1.6844037771224976,
            "end_logit": -1.73447847366333,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING did not. Both Mdm2",
            "probability": 0.0013420413334120783,
            "start_logit": 1.6844037771224976,
            "end_logit": -1.9213680028915405,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm",
            "probability": 0.0002902757365620227,
            "start_logit": -0.32117825746536255,
            "end_logit": -1.446901798248291,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm RING domains showed oncogenic activity in a colony formation assay, suggesting that the Mdm",
            "probability": 0.0002046914376725062,
            "start_logit": -0.6705058813095093,
            "end_logit": -1.446901798248291,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 or MdmX",
            "probability": 0.00019251238129485579,
            "start_logit": -1.0614982843399048,
            "end_logit": -1.1172525882720947,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 or MdmX RING domains interfered with the endogenous full-length Mdm2 and MdmX",
            "probability": 0.00014566614215149768,
            "start_logit": -1.0614982843399048,
            "end_logit": -1.3960957527160645,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "Mdm2 or MdmX RING domains interfered with the endogenous full-length Mdm2",
            "probability": 0.00013417397549380785,
            "start_logit": -1.0614982843399048,
            "end_logit": -1.4782757759094238,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING domains interfered with the endogenous full-length Mdm2 and MdmX",
            "probability": 0.0001258345257753977,
            "start_logit": -1.2078478336334229,
            "end_logit": -1.3960957527160645,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "MdmX RING domains interfered with the endogenous full-length Mdm2",
            "probability": 0.00011590695221476729,
            "start_logit": -1.2078478336334229,
            "end_logit": -1.4782757759094238,
            "question_text": "List proteins with RING domain."
        }
    ],
    "5c961281ecadf2e73f000021": [
        {
            "text": "rheumatoid arthritis",
            "probability": 0.8519860374483379,
            "start_logit": 5.850743770599365,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma",
            "probability": 0.11151452162267161,
            "start_logit": 5.015884876251221,
            "end_logit": 4.378610134124756,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "lymphoma orphan indication. It has since been approved for additional orphan indications, with rheumatoid arthritis",
            "probability": 0.009682925026176086,
            "start_logit": 1.3735376596450806,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "arthritis",
            "probability": 0.006680042605512194,
            "start_logit": 1.0022979974746704,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "Hodgkin lymphoma orphan indication. It has since been approved for additional orphan indications, with rheumatoid arthritis",
            "probability": 0.0062861450469818385,
            "start_logit": 0.9415216445922852,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "lymphoma",
            "probability": 0.0029206541190962268,
            "start_logit": 1.3735376596450806,
            "end_logit": 4.378610134124756,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "Hodgkin lymphoma",
            "probability": 0.0018960856740160386,
            "start_logit": 0.9415216445922852,
            "end_logit": 4.378610134124756,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma orphan indication",
            "probability": 0.001784502759564316,
            "start_logit": 5.015884876251221,
            "end_logit": 0.24359512329101562,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma orphan indication. It has since been approved for additional orphan indications,",
            "probability": 0.001592705030045228,
            "start_logit": 5.015884876251221,
            "end_logit": 0.12988916039466858,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma orphan",
            "probability": 0.0012727111543252246,
            "start_logit": 5.015884876251221,
            "end_logit": -0.09439529478549957,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "heumatoid arthritis",
            "probability": 0.0007608536472907607,
            "start_logit": -1.1701406240463257,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid",
            "probability": 0.0005783331598584008,
            "start_logit": 5.850743770599365,
            "end_logit": -1.7180087566375732,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin lymphoma orphan indication. It has since been approved for additional orphan indications",
            "probability": 0.0005254679220101583,
            "start_logit": 5.015884876251221,
            "end_logit": -0.979010820388794,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid arthritis as the only FDA-approved, nonorphan indication",
            "probability": 0.0004623346619979936,
            "start_logit": 5.850743770599365,
            "end_logit": -1.941869854927063,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "oma orphan indication. It has since been approved for additional orphan indications, with rheumatoid arthritis",
            "probability": 0.00045177761649174437,
            "start_logit": -1.6913915872573853,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "orphan indication. It has since been approved for additional orphan indications, with rheumatoid arthritis",
            "probability": 0.00039585972306823087,
            "start_logit": -1.8235217332839966,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "umatoid arthritis",
            "probability": 0.00033101520839454613,
            "start_logit": -2.0024173259735107,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "hritis",
            "probability": 0.0003216904076164858,
            "start_logit": -2.030992031097412,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "itis",
            "probability": 0.0003040490626006986,
            "start_logit": -2.087392568588257,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "orphan indications, with rheumatoid arthritis",
            "probability": 0.00025228810394463153,
            "start_logit": -2.274009943008423,
            "end_logit": 5.577166557312012,
            "question_text": "List 3 indications for rituximab."
        }
    ]
}
